1	nature	NN	O	nature	nn	2	SENT_1	[p1l21t124r112b145],
2	publishing	NN	O	publishing	_	0	SENT_1	[p1l121t121r269b152],
3	group	NN	O	group	nn	5	SENT_1	[p1l278t128r362b152],
4	S	NN	O	s	nn	5	SENT_1	[p1l1761t108r1783b145],
5	g	NN	O	g	dep	2	SENT_1	[p1l1790t108r1873b145],
6	+	CC	O	+	_	0	SENT_1	[p1l1790t108r1873b145],
7	E	NN	O	e	nn	8	SENT_1	[p1l1882t108r1902b145],
8	A	NN	O	a	dep	2	SENT_1	[p1l2045t108r2073b145],
9	+	CC	O	+	rcmod	8	SENT_1	[p1l2082t108r2139b145],

1	Biomarker	NN	O	biomarker	_	0	SENT_2	[p1l27t260r774b336],
2	.	.	O	.	_	0	SENT_2	[p1l27t260r774b336],

1	—	NN	O	—	_	0	SENT_3	[p1l27t260r774b336],
2	.	.	O	.	_	0	SENT_3	[p1l27t260r774b336],

1	Driven	NNP	O	Driven	nsubj	3	SENT_4	[p1l27t260r774b336],
2	Therapeutic	JJ	O	therapeutic	amod	1	SENT_4	[p1l794t260r1310b355],
3	Management	NN	O	management	_	0	SENT_4	[p1l1336t264r1910b356],
4	ofA	NN	O	ofa	nn	5	SENT_4	[p1l23t371r618b448],
5	|	NN	O	|	dobj	3	SENT_4	[p1l23t371r618b448],
6	zheimer	NN	O	zheimer	poss	8	SENT_4	[p1l23t371r618b448],
7	’s	POS	O	’s	_	0	SENT_4	[p1l23t371r618b448],
8	Disease	NN	O	disease	dep	5	SENT_4	[p1l647t375r987b448],
9	:	:	O	:	_	0	SENT_4	[p1l647t375r987b448],
10	Establishing	VBG	O	establish	dep	5	SENT_4	[p1l1016t372r1525b468],
11	the	DT	O	the	det	12	SENT_4	[p1l1551t372r1690b448],
12	Foundaﬁons	NNPS	O	Foundaﬁons	dobj	10	SENT_4	[p1l27t484r558b560],

1	I	PRP	O	I	_	0	SENT_5	[p1l20t636r36b677],
2	Cummings1	NN	O	cummings1	dep	1	SENT_5	[p1l47t628r289b681],
3	and	CC	O	and	_	0	SENT_5	[p1l302t633r378b669],
4	K	NN	O	k	nn	5	SENT_5	[p1l388t636r421b669],
5	Zhongl	NN	O	zhongl	dep	1	SENT_5	[p1l431t628r580b681],

1	Biomarkers	NNS	O	biomarker	nsubj	3	SENT_6	[p1l22t753r226b784],
2	are	VBP	O	be	cop	3	SENT_6	[p1l236t762r292b784],
3	characteristics	NNS	O	characteristic	_	0	SENT_6	[p1l302t753r564b784],
4	that	WDT	O	that	nsubjpass	9	SENT_6	[p1l573t753r647b784],
5	are	VBP	O	be	auxpass	7	SENT_6	[p1l657t762r713b784],
6	objectively	RB	O	objectively	advmod	7	SENT_6	[p1l723t753r924b792],
7	measured	VBN	O	measure	rcmod	3	SENT_6	[p1l935t753r1112b784],
8	and	CC	O	and	_	0	SENT_6	[p1l1123t753r1190b784],
9	evaluated	VBN	O	evaluate	rcmod	3	SENT_6	[p1l1201t753r1380b784],
10	as	IN	O	as	_	0	SENT_6	[p1l1391t762r1428b784],
11	indicators	NNS	O	indicator	prep_as	7	SENT_6	[p1l1439t753r1618b784],
12	of	IN	O	of	_	0	SENT_6	[p1l1629t753r1666b784],
13	normal	JJ	O	normal	amod	15	SENT_6	[p1l1675t753r1801b784],
14	biological	JJ	O	biological	amod	15	SENT_6	[p1l1814t753r1990b792],
15	processes	NNS	O	process	prep_of	11	SENT_6	[p1l21t815r207b844],
16	,	,	O	,	_	0	SENT_6	[p1l21t815r207b844],
17	pathogenic	JJ	O	pathogenic	amod	18	SENT_6	[p1l218t806r424b845],
18	processes	NNS	O	process	prep_of	11	SENT_6	[p1l435t815r621b844],
19	,	,	O	,	_	0	SENT_6	[p1l435t815r621b844],
20	or	CC	O	or	_	0	SENT_6	[p1l631t815r668b836],
21	pharmacologic	JJ	O	pharmacologic	amod	22	SENT_6	[p1l679t806r950b845],
22	responses	NNS	O	response	conj_or	15	SENT_6	[p1l961t815r1142b844],
23	to	TO	O	to	_	0	SENT_6	[p1l1152t810r1188b836],
24	a	DT	O	a	det	26	SENT_6	[p1l1198t815r1216b836],
25	therapeutic	JJ	O	therapeutic	amod	26	SENT_6	[p1l1227t806r1439b844],
26	intervention	NN	O	intervention	prep_to	22	SENT_6	[p1l1450t807r1685b836],
27	.	.	O	.	_	0	SENT_6	[p1l1450t807r1685b836],

1	Amyloid	JJ	MISC	amyloid	amod	2	SENT_7	[p1l1695t806r1845b845],
2	measures	NNS	O	measure	nsubj	13	SENT_7	[p1l1858t815r2029b836],
3	become	VBP	O	become	cop	5	SENT_7	[p1l21t859r165b890],
4	abnormal	JJ	O	abnormal	amod	5	SENT_7	[p1l175t859r349b890],
5	early	JJ	O	early	_	0	SENT_7	[p1l360t859r449b898],
6	in	IN	O	in	_	0	SENT_7	[p1l460t860r490b889],
7	the	DT	O	the	det	8	SENT_7	[p1l501t859r560b890],
8	Alzheimer	NN	O	alzheimer	poss	11	SENT_7	[p1l569t859r780b890],
9	's	POS	O	's	_	0	SENT_7	[p1l569t859r780b890],
10	disease	NN	O	disease	nn	11	SENT_7	[p1l790t859r924b890],
11	process	NN	O	process	prep_in	5	SENT_7	[p1l935t868r1071b897],
12	and	CC	O	and	_	0	SENT_7	[p1l1081t859r1148b890],
13	have	VBP	O	have	conj_and	5	SENT_7	[p1l1160t859r1245b890],
14	only	RB	O	only	advmod	16	SENT_7	[p1l1255t859r1333b898],
15	weak	JJ	O	weak	amod	16	SENT_7	[p1l1342t859r1438b890],
16	correlations	NNS	O	correlation	dobj	13	SENT_7	[p1l1446t859r1662b890],
17	with	IN	O	with	_	0	SENT_7	[p1l1672t859r1751b890],
18	disease	NN	O	disease	nn	19	SENT_7	[p1l1762t859r1896b890],
19	progression	NN	O	progression	prep_with	16	SENT_7	[p1l1907t860r2121b898],
20	and	CC	O	and	_	0	SENT_7	[p1l20t912r87b943],
21	cognitive	JJ	O	cognitive	amod	22	SENT_7	[p1l98t913r267b951],
22	decline	NN	O	decline	conj_and	19	SENT_7	[p1l277t912r418b947],
23	;	:	O	;	_	0	SENT_7	[p1l277t912r418b947],
24	cerebrospinal	JJ	O	cerebrospinal	amod	26	SENT_7	[p1l428t912r676b950],
25	fluid	NN	O	fluid	nn	26	SENT_7	[p1l686t912r768b943],
26	tau	NN	O	tau	dep	16	SENT_7	[p1l779t916r847b947],
27	,	,	O	,	_	0	SENT_7	[p1l779t916r847b947],
28	brain	NN	O	brain	nn	29	SENT_7	[p1l858t912r950b943],
29	atrophy	NN	O	atrophy	appos	16	SENT_7	[p1l961t912r1111b951],
30	,	,	O	,	_	0	SENT_7	[p1l961t912r1111b951],
31	and	CC	O	and	_	0	SENT_7	[p1l1122t912r1188b943],
32	reduced	VBD	O	reduce	conj_and	5	SENT_7	[p1l1201t912r1346b943],
33	cortical	JJ	O	cortical	amod	34	SENT_7	[p1l1358t912r1490b943],
34	metabolism	NN	O	metabolism	nsubj	35	SENT_7	[p1l1503t912r1717b943],
35	correlate	VBP	O	correlate	ccomp	32	SENT_7	[p1l1728t912r1889b943],
36	with	IN	O	with	_	0	SENT_7	[p1l1898t912r1977b943],
37	cognitive	JJ	O	cognitive	amod	38	SENT_7	[p1l20t966r189b1004],
38	measures	NNS	O	measure	prep_with	35	SENT_7	[p1l200t974r372b996],
39	and	CC	O	and	_	0	SENT_7	[p1l382t965r448b996],
40	disease	NN	O	disease	nn	41	SENT_7	[p1l460t965r594b996],
41	progression	NN	O	progression	prep_with	35	SENT_7	[p1l605t966r831b1004],
42	.	.	O	.	_	0	SENT_7	[p1l605t966r831b1004],

1	Combinations	NNS	O	combination	nsubj	4	SENT_8	[p1l841t965r1095b996],
2	of	IN	O	of	_	0	SENT_8	[p1l1106t965r1143b996],
3	biomarkers	NNS	O	biomarker	prep_of	1	SENT_8	[p1l1152t965r1356b996],
4	have	VBP	O	have	_	0	SENT_8	[p1l1368t965r1452b996],
5	higher	JJR	O	higher	amod	6	SENT_8	[p1l1463t965r1581b1004],
6	correlations	NNS	O	correlation	dobj	4	SENT_8	[p1l1591t965r1807b996],
7	and	CC	O	and	_	0	SENT_8	[p1l1817t965r1884b996],
8	are	VBP	O	be	cop	10	SENT_8	[p1l1895t974r1950b996],
9	better	RBR	O	better	amod	10	SENT_8	[p1l1962t965r2072b996],
10	predictors	NNS	O	predictor	conj_and	4	SENT_8	[p1l21t1019r206b1057],
11	of	IN	O	of	_	0	SENT_8	[p1l216t1018r254b1049],
12	future	JJ	DATE	future	amod	13	SENT_8	[p1l261t1018r372b1049],
13	decline	NN	O	decline	prep_of	10	SENT_8	[p1l383t1019r514b1049],
14	than	IN	O	than	_	0	SENT_8	[p1l523t1019r605b1049],
15	single	JJ	O	single	amod	16	SENT_8	[p1l617t1019r724b1057],
16	biomarkers	NNS	O	biomarker	prep_than	13	SENT_8	[p1l735t1019r950b1049],
17	.	.	O	.	_	0	SENT_8	[p1l735t1019r950b1049],

1	Current	JJ	DATE	current	amod	2	SENT_9	[p1l960t1020r1097b1049],
2	biomarkers	NNS	O	biomarker	nsubj	5	SENT_9	[p1l1108t1019r1313b1049],
3	do	VBP	O	do	aux	5	SENT_9	[p1l1323t1019r1368b1049],
4	not	RB	O	not	neg	5	SENT_9	[p1l1380t1023r1439b1049],
5	account	VB	O	account	_	0	SENT_9	[p1l1449t1023r1593b1049],
6	for	IN	O	for	_	0	SENT_9	[p1l1602t1018r1653b1049],
7	all	DT	O	all	det	9	SENT_9	[p1l1662t1019r1702b1049],
8	ofthe	NN	O	ofthe	nn	9	SENT_9	[p1l1714t1018r1817b1049],
9	variance	NN	O	variance	prep_for	5	SENT_9	[p1l1826t1019r1980b1049],
10	in	IN	O	in	_	0	SENT_9	[p1l1991t1019r2021b1049],
11	Alzheimer	NNP	O	Alzheimer	poss	13	SENT_9	[p1l20t1072r230b1103],
12	's	POS	O	's	_	0	SENT_9	[p1l20t1072r230b1103],
13	disease	NN	O	disease	prep_in	9	SENT_9	[p1l240t1072r385b1107],
14	;	:	O	;	_	0	SENT_9	[p1l240t1072r385b1107],
15	a	DT	O	a	det	18	SENT_9	[p1l395t1081r412b1103],
16	more	RBR	O	more	advmod	17	SENT_9	[p1l425t1081r517b1103],
17	complete	JJ	O	complete	amod	18	SENT_9	[p1l527t1072r698b1110],
18	repertoire	NN	O	repertoire	nsubj	28	SENT_9	[p1l709t1073r891b1111],
19	of	IN	O	of	_	0	SENT_9	[p1l901t1072r938b1103],
20	biomarkers	NNS	O	biomarker	prep_of	18	SENT_9	[p1l947t1072r1152b1103],
21	that	WDT	O	that	nsubj	24	SENT_9	[p1l1161t1072r1235b1103],
22	more	RBR	O	more	advmod	24	SENT_9	[p1l1246t1081r1339b1103],
23	comprehensively	RB	O	comprehensively	advmod	24	SENT_9	[p1l1349t1072r1662b1111],
24	assay	VB	O	assay	rcmod	20	SENT_9	[p1l1671t1081r1769b1111],
25	the	DT	O	the	det	27	SENT_9	[p1l1777t1072r1836b1103],
26	disease	NN	O	disease	nn	27	SENT_9	[p1l1846t1072r1980b1103],
27	process	NN	O	process	dobj	24	SENT_9	[p1l1992t1081r2127b1110],
28	isneeded	VBD	O	isneed	parataxis	5	SENT_9	[p1l12t1143r388b1205],
29	.	.	O	.	_	0	SENT_9	[p1l12t1143r388b1205],

1	Alzheimer	NN	O	alzheimer	poss	6	SENT_10	[p1l9t1362r416b1425],
2	’s	POS	O	’s	_	0	SENT_10	[p1l9t1362r416b1425],
3	disease	NN	O	disease	nn	6	SENT_10	[p1l441t1362r685b1425],
4	(	CD	NUMBER	(	num	6	SENT_10	[p1l712t1363r886b1438],
5	AD	NN	O	ad	nn	6	SENT_10	[p1l712t1363r886b1438],
6	)	NN	O	)	nsubj	10	SENT_10	[p1l712t1363r886b1438],
7	is	VBZ	O	be	cop	10	SENT_10	[p1l913t1368r964b1425],
8	a	DT	O	a	det	10	SENT_10	[p1l989t1385r1023b1425],
9	growing	VBG	O	grow	amod	10	SENT_10	[p1l1045t1368r1332b1446],
10	threat	NN	O	threat	_	0	SENT_10	[p1l1352t1362r1557b1425],
11	to	TO	O	to	_	0	SENT_10	[p1l1578t1374r1645b1425],
12	public	JJ	O	public	amod	13	SENT_10	[p1l1669t1362r1884b1445],
13	health	NN	O	health	prep_to	10	SENT_10	[p1l1906t1362r2139b1425],
14	.	.	O	.	_	0	SENT_10	[p1l1906t1362r2139b1425],

1	There	EX	O	there	expl	2	SENT_11	[p1l9t1465r202b1528],
2	are	VBP	O	be	_	0	SENT_11	[p1l224t1488r323b1528],
3	currently	RB	DATE	currently	advmod	2	SENT_11	[p1l345t1465r661b1549],
4	5.3	CD	NUMBER	5.3	number	5	SENT_11	[p1l680t1472r773b1528],
5	million	CD	NUMBER	million	num	6	SENT_11	[p1l797t1465r1045b1528],
6	victims	NNS	O	victim	nsubj	2	SENT_11	[p1l1063t1471r1314b1528],
7	in	IN	O	in	_	0	SENT_11	[p1l1335t1471r1402b1527],
8	the	DT	O	the	det	10	SENT_11	[p1l1421t1465r1528b1528],
9	United	NNP	LOCATION	United	nn	10	SENT_11	[p1l1549t1465r1783b1528],
10	States	NNPS	LOCATION	States	prep_in	6	SENT_11	[p1l1804t1469r1996b1528],
11	and	CC	O	and	_	0	SENT_11	[p1l2018t1465r2144b1528],
12	35	CD	NUMBER	35	number	13	SENT_11	[p1l11t1575r86b1631],
13	million	CD	NUMBER	million	num	14	SENT_11	[p1l108t1568r355b1631],
14	worldwide	JJ	O	worldwide	conj_and	6	SENT_11	[p1l374t1568r751b1631],
15	.	.	O	.	_	0	SENT_11	[p1l374t1568r751b1631],

1	Without	IN	O	without	_	0	SENT_12	[p1l773t1568r1060b1631],
2	successful	JJ	O	successful	amod	3	SENT_12	[p1l1080t1568r1418b1631],
3	treatment	NN	O	treatment	prep_without	13	SENT_12	[p1l1436t1580r1770b1631],
4	or	CC	O	or	_	0	SENT_12	[p1l1790t1591r1861b1631],
5	prevention	NN	O	prevention	prep_without	13	SENT_12	[p1l1879t1590r2139b1651, p1l9t1677r162b1743],
6	,	,	O	,	_	0	SENT_12	[p1l1879t1590r2139b1651, p1l9t1677r162b1743],
7	the	DT	O	the	det	8	SENT_12	[p1l183t1671r288b1734],
8	number	NN	O	number	nsubj	13	SENT_12	[p1l308t1671r578b1734],
9	of	IN	O	of	_	0	SENT_12	[p1l598t1671r671b1734],
10	affected	VBN	O	affect	amod	11	SENT_12	[p1l682t1671r943b1734],
11	individuals	NNS	O	individual	prep_of	8	SENT_12	[p1l963t1671r1337b1734],
12	will	MD	O	will	aux	13	SENT_12	[p1l1357t1671r1481b1734],
13	grow	VB	O	grow	conj_and	13	SENT_12	[p1l1500t1694r1671b1755],
14	to	TO	O	to	_	0	SENT_12	[p1l1687t1683r1752b1734],
15	13-16	CD	NUMBER	13-16	number	16	SENT_12	[p1l1781t1677r1978b1734],
16	million	CD	NUMBER	million	prep_to	13	SENT_12	[p1l1998t1671r2140b1733, p1l8t1774r142b1837],
17	in	IN	O	in	_	0	SENT_12	[p1l165t1780r232b1836],
18	the	DT	O	the	det	20	SENT_12	[p1l254t1774r361b1837],
19	United	NNP	LOCATION	United	nn	20	SENT_12	[p1l384t1774r620b1837],
20	States	NNPS	LOCATION	States	prep_in	13	SENT_12	[p1l643t1778r836b1837],
21	and	CC	O	and	_	0	SENT_12	[p1l861t1774r988b1837],
22	to	TO	O	to	_	0	SENT_12	[p1l1008t1786r1075b1837],
23	>	JJR	O	>	prep_to	13	SENT_12	[p1l1101t1781r1267b1837],
24	100	CD	NUMBER	100	number	25	SENT_12	[p1l1101t1781r1267b1837],
25	million	CD	NUMBER	million	dep	23	SENT_12	[p1l1290t1774r1541b1837],
26	globally	RB	O	globally	dep	13	SENT_12	[p1l1564t1774r1838b1858],
27	by	IN	O	by	_	0	SENT_12	[p1l1855t1774r1940b1858],
28	2050	CD	DATE	2050	prep_by	13	SENT_12	[p1l1959t1781r2139b1837],
29	.	.	O	.	_	0	SENT_12	[p1l1959t1781r2139b1837],

1	The	DT	O	the	det	2	SENT_13	[p1l9t1876r134b1939],
2	cost	NN	O	cost	nsubj	20	SENT_13	[p1l157t1888r292b1939],
3	of	IN	O	of	_	0	SENT_13	[p1l313t1876r387b1939],
4	care	NN	O	care	prep_of	2	SENT_13	[p1l400t1899r536b1939],
5	in	IN	O	in	_	0	SENT_13	[p1l558t1882r625b1938],
6	the	DT	O	the	det	8	SENT_13	[p1l646t1876r752b1939],
7	United	NNP	LOCATION	United	nn	8	SENT_13	[p1l774t1876r1009b1939],
8	States	NNPS	LOCATION	States	prep_in	4	SENT_13	[p1l1031t1880r1222b1939],
9	alone	RB	O	alone	advmod	8	SENT_13	[p1l1246t1876r1427b1939],
10	in	IN	O	in	_	0	SENT_13	[p1l1450t1882r1516b1938],
11	2050	CD	DATE	2050	prep_in	8	SENT_13	[p1l1538t1883r1698b1939],
12	will	MD	O	will	aux	20	SENT_13	[p1l1720t1876r1845b1939],
13	be	VB	O	be	cop	20	SENT_13	[p1l1865t1876r1944b1939],
14	more	JJR	O	more	quantmod	16	SENT_13	[p1l1965t1899r2143b1939],
15	than	IN	O	than	quantmod	16	SENT_13	[p1l9t1978r161b2041],
16	$	$	MONEY	$	num	20	SENT_13	[p1l182t1980r253b2047],
17	1	CD	MONEY	1	number	16	SENT_13	[p1l182t1980r253b2047],
18	trillion	CD	MONEY	trillion	number	16	SENT_13	[p1l278t1970r607b2041],
19	.1	NN	MONEY	.1	nn	20	SENT_13	[p1l278t1970r607b2041],
20	’	NN	O	’	_	0	SENT_13	[p1l278t1970r607b2041],
21	2	CD	NUMBER	2	dep	20	SENT_13	[p1l278t1970r607b2041],
22	The	DT	DATE	the	det	23	SENT_13	[p1l628t1978r751b2041],
23	future	NN	DATE	future	nsubj	29	SENT_13	[p1l772t1978r975b2041],
24	portrayed	VBN	O	portray	partmod	23	SENT_13	[p1l994t1978r1327b2062],
25	by	IN	O	by	_	0	SENT_13	[p1l1344t1978r1427b2062],
26	these	DT	O	these	det	27	SENT_13	[p1l1443t1978r1615b2041],
27	ﬁgures	NNS	O	ﬁgures	agent	24	SENT_13	[p1l1636t1978r1860b2062],
28	is	VBZ	O	be	cop	29	SENT_13	[p1l1881t1984r1930b2041],
29	unacceptable	JJ	O	unacceptable	rcmod	21	SENT_13	[p1l1951t2001r2140b2041, p1l10t2081r311b2164],
30	;	:	O	;	_	0	SENT_13	[p1l1951t2001r2140b2041, p1l10t2081r311b2164],
31	the	DT	O	the	det	36	SENT_13	[p1l335t2081r443b2144],
32	emotional	JJ	O	emotional	amod	36	SENT_13	[p1l467t2081r835b2153],
33	,	,	O	,	_	0	SENT_13	[p1l467t2081r835b2153],
34	social	JJ	O	social	amod	36	SENT_13	[p1l861t2081r1074b2153],
35	,	,	O	,	_	0	SENT_13	[p1l861t2081r1074b2153],
36	economic	JJ	O	economic	nsubjpass	46	SENT_13	[p1l1100t2087r1455b2153],
37	,	,	O	,	_	0	SENT_13	[p1l1100t2087r1455b2153],
38	and	CC	O	and	_	0	SENT_13	[p1l1481t2081r1608b2144],
39	human	JJ	O	human	amod	41	SENT_13	[p1l1629t2081r1874b2144],
40	dignity	NN	O	dignity	nn	41	SENT_13	[p1l1899t2081r2146b2165],
41	costs	NNS	O	cost	conj_and	36	SENT_13	[p1l10t2196r173b2247],
42	involved	VBN	O	involve	partmod	36	SENT_13	[p1l194t2184r482b2247],
43	can	MD	O	can	aux	46	SENT_13	[p1l501t2196r733b2247],
44	not	RB	O	not	neg	46	SENT_13	[p1l501t2196r733b2247],
45	be	VB	O	be	auxpass	46	SENT_13	[p1l750t2184r828b2247],
46	accepted	VBN	O	accept	parataxis	20	SENT_13	[p1l850t2184r1143b2267],
47	without	IN	O	without	_	0	SENT_13	[p1l1160t2184r1425b2247],
48	mounting	VBG	O	mount	prepc_without	46	SENT_13	[p1l1444t2190r1780b2268],
49	a	DT	O	a	det	52	SENT_13	[p1l1799t2207r1833b2247],
50	vigorous	JJ	O	vigorous	amod	52	SENT_13	[p1l1849t2190r2141b2268],
51	scientiﬁc	NN	O	scientiﬁc	nn	52	SENT_13	[p1l10t2286r313b2349],
52	counteroffensive	NN	O	counteroffensive	dobj	48	SENT_13	[p1l335t2286r915b2349],
53	.	.	O	.	_	0	SENT_13	[p1l335t2286r915b2349],

1	Current	JJ	DATE	current	amod	2	SENT_14	[p1l84t2393r359b2452],
2	therapies	NNS	O	therapy	nsubj	14	SENT_14	[p1l379t2389r694b2472],
3	involve	VBP	O	involve	_	0	SENT_14	[p1l718t2389r966b2452],
4	inhibition	NN	O	inhibition	dobj	3	SENT_14	[p1l990t2389r1336b2452],
5	of	IN	O	of	_	0	SENT_14	[p1l1360t2389r1434b2452],
6	acetylcholinesterase	NN	O	acetylcholinesterase	prep_of	4	SENT_14	[p1l1449t2389r2141b2473],
7	or	CC	O	or	_	0	SENT_14	[p1l10t2515r83b2555],
8	antagonism	NN	O	antagonism	prep_of	4	SENT_14	[p1l105t2498r508b2576],
9	of	IN	O	of	_	0	SENT_14	[p1l532t2492r606b2555],
10	the	DT	O	the	det	12	SENT_14	[p1l618t2492r726b2555],
11	N-methyl-D-aspartate	NN	O	n-methyl-d-aspartate	nn	12	SENT_14	[p1l748t2492r1512b2576],
12	receptor	NN	O	receptor	prep_of	4	SENT_14	[p1l1536t2504r1823b2575],
13	and	CC	O	and	_	0	SENT_14	[p1l1846t2492r1973b2555],
14	provide	VB	O	provide	conj_and	3	SENT_14	[p1l1994t2514r2140b2575, p1l7t2595r150b2658],
15	important	JJ	O	important	amod	18	SENT_14	[p1l171t2601r517b2678],
16	but	CC	O	but	_	0	SENT_14	[p1l534t2595r647b2658],
17	temporary	JJ	O	temporary	conj_but	15	SENT_14	[p1l665t2607r1028b2679],
18	improvement	NN	O	improvement	dobj	14	SENT_14	[p1l1046t2601r1506b2678],
19	or	CC	O	or	_	0	SENT_14	[p1l1526t2618r1597b2658],
20	delay	NN	O	delay	conj_or	18	SENT_14	[p1l1617t2595r1795b2679],
21	in	IN	O	in	_	0	SENT_14	[p1l1812t2601r1878b2657],
22	decline	NN	O	decline	prep_in	14	SENT_14	[p1l1899t2595r2141b2658],
23	of	IN	O	of	_	0	SENT_14	[p1l10t2697r86b2760],
24	cognitive	JJ	O	cognitive	amod	27	SENT_14	[p1l102t2703r425b2781],
25	and	CC	O	and	_	0	SENT_14	[p1l452t2697r581b2760],
26	functional	JJ	O	functional	conj_and	24	SENT_14	[p1l605t2697r972b2760],
27	symptoms	NNS	O	symptom	prep_of	22	SENT_14	[p1l997t2689r1461b2781],
28	.3	NN	NUMBER	.3	nsubj	32	SENT_14	[p1l997t2689r1461b2781],
29	=	JJ	O	=	amod	28	SENT_14	[p1l997t2689r1461b2781],
30	4	CD	NUMBER	4	tmod	29	SENT_14	[p1l997t2689r1461b2781],
31	Recently	RB	DATE	recently	advmod	32	SENT_14	[p1l1486t2697r1794b2781],
32	approved	VBD	O	approve	rcmod	27	SENT_14	[p1l1816t2697r2144b2780],
33	higher	JJR	O	higher	dobj	32	SENT_14	[p1l9t2800r434b2884],
34	—	CD	NUMBER	—	num	36	SENT_14	[p1l9t2800r434b2884],
35	dose	NN	O	dose	nn	36	SENT_14	[p1l9t2800r434b2884],
36	alternatives	NNS	O	alternative	nsubj	42	SENT_14	[p1l461t2800r866b2863],
37	of	IN	O	of	_	0	SENT_14	[p1l893t2800r969b2863],
38	donepezil	NN	O	donepezil	prep_of	36	SENT_14	[p1l986t2800r1332b2883],
39	and	CC	O	and	_	0	SENT_14	[p1l1358t2800r1488b2863],
40	rivastigmine	NN	O	rivastigmine	conj_and	38	SENT_14	[p1l1512t2806r1958b2884],
41	have	VBP	O	have	aux	42	SENT_14	[p1l1983t2800r2143b2863],
42	extended	VBN	O	extend	rcmod	33	SENT_14	[p1l10t2903r334b2966],
43	the	DT	O	the	det	44	SENT_14	[p1l357t2903r467b2966],
44	use	NN	O	use	dobj	42	SENT_14	[p1l492t2926r607b2966],
45	of	IN	O	of	_	0	SENT_14	[p1l633t2903r709b2966],
46	these	DT	O	these	det	47	SENT_14	[p1l723t2903r905b2966],
47	agents	NNS	O	agent	prep_of	44	SENT_14	[p1l932t2915r1152b2987],
48	with	IN	O	with	_	0	SENT_14	[p1l1176t2903r1334b2966],
49	improved	VBN	O	improve	amod	50	SENT_14	[p1l1360t2903r1700b2986],
50	eﬂicacy	NN	O	eﬂicacy	prep_with	42	SENT_14	[p1l1725t2903r1991b2987],
51	and	CC	O	and	_	0	SENT_14	[p1l2014t2903r2144b2966],
52	approved	VBD	O	approve	conj_and	32	SENT_14	[p1l10t3006r327b3089],
53	use	NN	O	use	dobj	52	SENT_14	[p1l348t3029r458b3069],
54	in	IN	O	in	_	0	SENT_14	[p1l480t3012r546b3068],
55	more	RBR	O	more	advmod	57	SENT_14	[p1l568t3029r745b3069],
56	severely	RB	O	severely	advmod	57	SENT_14	[p1l768t3006r1041b3090],
57	affected	VBN	O	affect	amod	58	SENT_14	[p1l1059t3006r1323b3069],
58	populations	NNS	O	population	prep_in	52	SENT_14	[p1l1342t2998r1846b3089],
59	.5	CD	NUMBER	.5	number	60	SENT_14	[p1l1342t2998r1846b3089],
60	’	CD	NUMBER	’	num	61	SENT_14	[p1l1342t2998r1846b3089],
61	6	CD	NUMBER	6	dobj	32	SENT_14	[p1l1342t2998r1846b3089],

1	Three	CD	NUMBER	three	num	3	SENT_15	[p1l83t3109r283b3172],
2	major	JJ	O	major	amod	3	SENT_15	[p1l310t3115r519b3193],
3	themes	NNS	O	theme	nsubj	4	SENT_15	[p1l544t3109r798b3172],
4	dominate	VBP	O	dominate	_	0	SENT_15	[p1l826t3109r1162b3172],
5	current	JJ	DATE	current	amod	7	SENT_15	[p1l1190t3121r1452b3172],
6	AD	NN	O	ad	nn	7	SENT_15	[p1l1477t3113r1598b3171],
7	research	NN	O	research	dobj	4	SENT_15	[p1l1627t3109r1941b3172],
8	:	:	O	:	_	0	SENT_15	[p1l1627t3109r1941b3172],
9	early	JJ	O	early	amod	10	SENT_15	[p1l1971t3109r2145b3193],
10	diagnosis	NN	O	diagnosis	dep	7	SENT_15	[p1l10t3212r358b3296],
11	,	,	O	,	_	0	SENT_15	[p1l10t3212r358b3296],
12	biomarkers	NNS	O	biomarker	dep	7	SENT_15	[p1l381t3212r798b3284],
13	,	,	O	,	_	0	SENT_15	[p1l381t3212r798b3284],
14	and	CC	O	and	_	0	SENT_15	[p1l824t3212r953b3275],
15	disease-modifying	JJ	O	disease-modifying	amod	16	SENT_15	[p1l976t3212r1627b3296],
16	therapy	NN	O	therapy	dep	7	SENT_15	[p1l1648t3212r1924b3296],
17	.	.	O	.	_	0	SENT_15	[p1l1648t3212r1924b3296],

1	All	DT	O	all	nsubj	5	SENT_16	[p1l1950t3212r2054b3274],
2	of	IN	O	of	_	0	SENT_16	[p1l2077t3212r2153b3275],
3	these	DT	O	these	det	4	SENT_16	[p1l9t3315r184b3378],
4	themes	NNS	O	theme	prep_of	1	SENT_16	[p1l206t3315r451b3378],
5	relate	VBP	O	relate	_	0	SENT_16	[p1l474t3315r658b3378],
6	to	TO	O	to	_	0	SENT_16	[p1l680t3327r746b3378],
7	the	DT	O	the	det	8	SENT_16	[p1l769t3315r875b3378],
8	development	NN	O	development	prep_to	5	SENT_16	[p1l899t3315r1342b3398],
9	of	IN	O	of	_	0	SENT_16	[p1l1365t3315r1438b3378],
10	new	JJ	O	new	amod	11	SENT_16	[p1l1451t3338r1594b3378],
11	therapies	NNS	O	therapy	prep_of	8	SENT_16	[p1l1613t3315r1940b3398],
12	.	.	O	.	_	0	SENT_16	[p1l1613t3315r1940b3398],

1	Early	RB	O	early	advmod	2	SENT_17	[p1l1966t3315r2146b3399],
2	diagnosis	NN	O	diagnosis	nsubj	3	SENT_17	[p1l10t3418r330b3502],
3	allows	VBZ	O	allow	_	0	SENT_17	[p1l352t3418r563b3481],
4	treatment	NN	O	treatment	dobj	3	SENT_17	[p1l583t3430r918b3481],
5	in	IN	O	in	_	0	SENT_17	[p1l938t3424r1005b3480],
6	stages	NNS	O	stage	prep_in	3	SENT_17	[p1l1026t3430r1224b3502],
7	of	IN	O	of	_	0	SENT_17	[p1l1247t3418r1321b3481],
8	the	DT	O	the	det	9	SENT_17	[p1l1331t3418r1437b3481],
9	illness	NN	O	illness	prep_of	6	SENT_17	[p1l1458t3418r1668b3481],
10	when	WRB	O	when	advmod	14	SENT_17	[p1l1687t3418r1875b3481],
11	pathology	NN	O	pathology	nsubj	14	SENT_17	[p1l1895t3418r2140b3501, p1l10t3544r139b3605],
12	is	VBZ	O	be	cop	14	SENT_17	[p1l159t3527r211b3584],
13	less	RBR	O	less	advmod	14	SENT_17	[p1l234t3521r356b3584],
14	severe	JJ	O	severe	advcl	3	SENT_17	[p1l382t3544r597b3584],
15	and	CC	O	and	_	0	SENT_17	[p1l622t3521r751b3584],
16	possibly	RB	O	possibly	advmod	18	SENT_17	[p1l773t3521r1063b3605],
17	more	RBR	O	more	advmod	18	SENT_17	[p1l1083t3544r1265b3584],
18	amenable	JJ	O	amenable	advcl	3	SENT_17	[p1l1290t3521r1625b3584],
19	to	TO	O	to	_	0	SENT_17	[p1l1648t3533r1716b3584],
20	therapeutic	JJ	O	therapeutic	amod	21	SENT_17	[p1l1740t3521r2141b3604],
21	intervention	NN	O	intervention	prep_to	18	SENT_17	[p1l10t3630r439b3696],
22	;	:	O	;	_	0	SENT_17	[p1l10t3630r439b3696],
23	biomarkers	NNS	O	biomarker	nsubj	25	SENT_17	[p1l458t3624r836b3687],
24	are	VBP	O	be	cop	25	SENT_17	[p1l857t3647r954b3687],
25	critical	JJ	O	critical	parataxis	3	SENT_17	[p1l975t3624r1202b3687],
26	to	TO	O	to	_	0	SENT_17	[p1l1220t3636r1284b3687],
27	early	JJ	O	early	amod	28	SENT_17	[p1l1306t3624r1467b3708],
28	diagnosis	NN	O	diagnosis	prep_to	25	SENT_17	[p1l1484t3624r1794b3708],
29	and	CC	O	and	_	0	SENT_17	[p1l1816t3624r1939b3687],
30	to	TO	O	to	_	0	SENT_17	[p1l1956t3636r2020b3687],
31	the	DT	O	the	det	32	SENT_17	[p1l2040t3624r2144b3687],
32	monitoring	NN	O	monitoring	conj_and	28	SENT_17	[p1l9t3733r401b3811],
33	of	IN	O	of	_	0	SENT_17	[p1l421t3727r494b3790],
34	treatment	NN	O	treatment	prep_of	32	SENT_17	[p1l504t3739r856b3799],
35	;	:	O	;	_	0	SENT_17	[p1l504t3739r856b3799],
36	disease	NN	O	disease	nn	37	SENT_17	[p1l880t3727r1119b3790],
37	modiﬁcation	NN	O	modiﬁcation	nsubj	38	SENT_17	[p1l1140t3727r1580b3790],
38	builds	VBZ	O	build	parataxis	3	SENT_17	[p1l1598t3727r1807b3790],
39	on	IN	O	on	_	0	SENT_17	[p1l1828t3750r1914b3790],
40	recent	JJ	O	recent	amod	41	SENT_17	[p1l1935t3739r2145b3790],
41	advances	NNS	O	advance	prep_on	38	SENT_17	[p2l10t17r317b80],
42	in	IN	O	in	_	0	SENT_17	[p2l340t23r406b79],
43	neuroscience	NN	O	neuroscience	prep_in	41	SENT_17	[p2l429t23r878b80],
44	and	CC	O	and	_	0	SENT_17	[p2l902t17r1028b80],
45	promises	VBZ	O	promise	parataxis	3	SENT_17	[p2l1048t23r1357b100],
46	therapies	NNS	O	therapy	dobj	45	SENT_17	[p2l1380t17r1690b100],
47	that	WDT	O	that	nsubj	48	SENT_17	[p2l1711t17r1845b80],
48	prevent	VBP	O	prevent	rcmod	46	SENT_17	[p2l1866t29r2141b100],
49	,	,	O	,	_	0	SENT_17	[p2l1866t29r2141b100],
50	delay	VBP	O	delay	dep	48	SENT_17	[p2l10t120r190b204],
51	the	DT	O	the	det	52	SENT_17	[p2l206t120r312b183],
52	onset	NN	O	onset	dobj	48	SENT_17	[p2l335t132r534b192],
53	,	,	O	,	_	0	SENT_17	[p2l335t132r534b192],
54	or	CC	O	or	_	0	SENT_17	[p2l557t143r629b183],
55	slow	VB	O	slow	rcmod	46	SENT_17	[p2l650t120r803b183],
56	the	DT	O	the	det	57	SENT_17	[p2l821t120r927b183],
57	progression	NN	O	progression	dobj	55	SENT_17	[p2l948t126r1349b204],
58	of	IN	O	of	_	0	SENT_17	[p2l1371t120r1445b183],
59	AD	NN	O	ad	prep_of	57	SENT_17	[p2l1456t124r1589b183],
60	.	.	O	.	_	0	SENT_17	[p2l1456t124r1589b183],

1	Most	JJS	O	most	amod	2	SENT_18	[p2l81t228r251b286],
2	efforts	NNS	O	effort	nsubj	8	SENT_18	[p2l270t223r477b286],
3	to	TO	O	to	aux	4	SENT_18	[p2l496t235r560b286],
4	develop	VB	O	develop	infmod	2	SENT_18	[p2l581t223r837b306],
5	disease-modifying	JJ	O	disease-modifying	amod	6	SENT_18	[p2l858t223r1474b307],
6	agents	NNS	O	agent	dobj	4	SENT_18	[p2l1492t235r1698b307],
7	have	VBP	O	have	aux	8	SENT_18	[p2l1717t223r1869b286],
8	focused	VBN	O	focus	_	0	SENT_18	[p2l1888t223r2145b286],
9	on	IN	O	on	_	0	SENT_18	[p2l9t349r94b389],
10	the	DT	O	the	det	11	SENT_18	[p2l115t326r220b389],
11	production	NN	O	production	prep_on	8	SENT_18	[p2l241t326r641b409],
12	,	,	O	,	_	0	SENT_18	[p2l241t326r641b409],
13	aggregation	NN	O	aggregation	prep_on	8	SENT_18	[p2l665t332r1078b410],
14	,	,	O	,	_	0	SENT_18	[p2l665t332r1078b410],
15	metabolism	NN	O	metabolism	prep_on	8	SENT_18	[p2l1101t326r1519b398],
16	,	,	O	,	_	0	SENT_18	[p2l1101t326r1519b398],
17	transport	NN	O	transport	prep_on	8	SENT_18	[p2l1541t338r1875b409],
18	,	,	O	,	_	0	SENT_18	[p2l1541t338r1875b409],
19	or	CC	O	or	_	0	SENT_18	[p2l1899t349r1971b389],
20	deposition	NN	O	deposition	prep_on	8	SENT_18	[p2l1992t326r2142b409, p2l9t434r250b491],
21	of	IN	O	of	_	0	SENT_18	[p2l276t428r352b491],
22	amyloid	NN	O	amyloid	nn	23	SENT_18	[p2l368t426r731b512],
23	—	NN	O	—	prep_of	11	SENT_18	[p2l368t426r731b512],
24	[	CD	NUMBER	[	number	25	SENT_18	[p2l368t426r731b512],
25	3	CD	NUMBER	3	num	26	SENT_18	[p2l368t426r731b512],
26	protein	NN	O	protein	dobj	8	SENT_18	[p2l757t434r1013b511],
27	(	CD	NUMBER	(	num	28	SENT_18	[p2l1042t426r1195b509],
28	AI3	NN	O	ai3	dep	26	SENT_18	[p2l1042t426r1195b509],
29	;	:	O	;	_	0	SENT_18	[p2l1042t426r1195b509],
30	Figures	NNS	O	figure	dep	26	SENT_18	[p2l1223t433r1495b511],
31	1	CD	NUMBER	1	num	30	SENT_18	[p2l1525t435r1553b490],
32	and	CC	O	and	_	0	SENT_18	[p2l1585t428r1715b491],
33	2	CD	NUMBER	2	dep	26	SENT_18	[p2l1740t420r1910b505],
34	)	CD	NUMBER	)	number	35	SENT_18	[p2l1740t420r1910b505],
35	.7	CD	NUMBER	.7	num	36	SENT_18	[p2l1740t420r1910b505],
36	’	NN	O	’	dep	30	SENT_18	[p2l1740t420r1910b505],
37	8	CD	NUMBER	8	num	39	SENT_18	[p2l1740t420r1910b505],
38	Other	JJ	O	other	amod	39	SENT_18	[p2l1937t428r2146b491],
39	targets	NNS	O	target	nsubj	40	SENT_18	[p2l7t543r227b615],
40	include	VBP	O	include	rcmod	26	SENT_18	[p2l247t531r491b594],
41	tau	NN	O	tau	nn	42	SENT_18	[p2l510t543r614b594],
42	hyperphosphorylation	NN	O	hyperphosphorylation	dobj	40	SENT_18	[p2l632t531r1381b615],
43	or	CC	O	or	_	0	SENT_18	[p2l1400t554r1471b594],
44	aggregation	NN	O	aggregation	conj_or	42	SENT_18	[p2l1489t537r1895b615],
45	,	,	O	,	_	0	SENT_18	[p2l1489t537r1895b615],
46	microtubule	NN	O	microtubule	nn	47	SENT_18	[p2l1915t537r2142b594, p2l7t634r227b697],
47	stabilization	NN	O	stabilization	dobj	40	SENT_18	[p2l251t634r691b706],
48	,	,	O	,	_	0	SENT_18	[p2l251t634r691b706],
49	neuroprotection	NN	O	neuroprotection	dobj	40	SENT_18	[p2l716t640r1303b717],
50	,	,	O	,	_	0	SENT_18	[p2l716t640r1303b717],
51	and	CC	O	and	_	0	SENT_18	[p2l1328t634r1456b697],
52	neuronal	JJ	O	neuronal	amod	53	SENT_18	[p2l1478t634r1791b697],
53	regeneration	NN	O	regeneration	dobj	40	SENT_18	[p2l1813t657r2141b718, p2l7t728r277b799],
54	.9	CD	NUMBER	.9	number	55	SENT_18	[p2l1813t657r2141b718, p2l7t728r277b799],
55	‘	CD	NUMBER	‘	dep	78	SENT_18	[p2l1813t657r2141b718, p2l7t728r277b799],
56	11	CD	NUMBER	11	dobj	78	SENT_18	[p2l1813t657r2141b718, p2l7t728r277b799],
57	Despite	IN	O	despite	_	0	SENT_18	[p2l301t741r549b819],
58	advances	NNS	O	advance	prep_despite	56	SENT_18	[p2l569t736r865b799],
59	in	IN	O	in	_	0	SENT_18	[p2l885t742r949b798],
60	understanding	VBG	O	understand	prepc_in	78	SENT_18	[p2l968t736r1454b820],
61	the	DT	O	the	det	62	SENT_18	[p2l1470t736r1573b799],
62	requirements	NNS	O	requirement	dobj	60	SENT_18	[p2l1592t742r2031b819],
63	for	IN	O	for	_	0	SENT_18	[p2l2051t736r2145b799],
64	successful	JJ	O	successful	amod	65	SENT_18	[p2l9t839r346b902],
65	pharmacotherapy	NN	O	pharmacotherapy	prep_for	60	SENT_18	[p2l366t839r972b923],
66	of	IN	O	of	_	0	SENT_18	[p2l991t839r1064b902],
67	AD	NN	O	ad	prep_of	65	SENT_18	[p2l1076t843r1210b911],
68	,	,	O	,	_	0	SENT_18	[p2l1076t843r1210b911],
69	all	DT	O	all	det	71	SENT_18	[p2l1234t839r1312b902],
70	clinical	JJ	O	clinical	amod	71	SENT_18	[p2l1334t839r1576b902],
71	trials	NNS	O	trial	nsubj	78	SENT_18	[p2l1596t839r1765b902],
72	of	IN	O	of	_	0	SENT_18	[p2l1788t839r1862b902],
73	diseasemodifying	JJ	O	diseasemodifying	amod	74	SENT_18	[p2l1875t839r2140b902, p2l8t942r374b1026],
74	agents	NNS	O	agent	prep_of	71	SENT_18	[p2l396t954r612b1026],
75	thus	RB	O	thus	advmod	76	SENT_18	[p2l634t942r782b1005],
76	far	RB	O	far	advmod	78	SENT_18	[p2l805t942r899b1005],
77	have	VBP	O	have	aux	78	SENT_18	[p2l920t942r1078b1005],
78	failed	VBN	O	fail	dep	8	SENT_18	[p2l1101t942r1293b1005],
79	to	TO	O	to	aux	80	SENT_18	[p2l1313t954r1380b1005],
80	show	VB	O	show	xcomp	78	SENT_18	[p2l1405t942r1586b1005],
81	a	DT	O	a	det	85	SENT_18	[p2l1607t965r1642b1005],
82	drug	NN	O	drug	nn	85	SENT_18	[p2l1664t942r2143b1026],
83	—	NN	O	—	nn	85	SENT_18	[p2l1664t942r2143b1026],
84	placebo	NN	O	placebo	nn	85	SENT_18	[p2l1664t942r2143b1026],
85	difference	NN	O	difference	dobj	80	SENT_18	[p2l9t1044r340b1107],
86	on	IN	O	on	_	0	SENT_18	[p2l361t1067r446b1107],
87	primary	JJ	O	primary	amod	89	SENT_18	[p2l464t1050r743b1128],
88	outcomes	NNS	O	outcome	nn	89	SENT_18	[p2l760t1056r1083b1107],
89	measures	NNS	O	measure	prep_on	80	SENT_18	[p2l1103t1067r1433b1107],
90	.	.	O	.	_	0	SENT_18	[p2l1103t1067r1433b1107],

1	12	CD	NUMBER	12	number	2	SENT_19	[p2l1446t1036r1594b1078],
2	‘	CD	NUMBER	‘	num	3	SENT_19	[p2l1446t1036r1594b1078],
3	14	CD	NUMBER	14	nsubj	20	SENT_19	[p2l1446t1036r1594b1078],
4	Insuﬂicient	JJ	O	insuﬂicient	amod	7	SENT_19	[p2l1614t1044r1994b1107],
5	eﬂ	NN	O	eﬂ	nn	7	SENT_19	[p2l2014t1044r2141b1107, p2l9t1170r168b1231],
6	°	NN	O	°	nn	7	SENT_19	[p2l2014t1044r2141b1107, p2l9t1170r168b1231],
7	1cacy	NN	O	1cacy	nsubj	18	SENT_19	[p2l2014t1044r2141b1107, p2l9t1170r168b1231],
8	,	,	O	,	_	0	SENT_19	[p2l2014t1044r2141b1107, p2l9t1170r168b1231],
9	excessive	JJ	O	excessive	amod	11	SENT_19	[p2l193t1153r499b1210],
10	adverse	JJ	O	adverse	amod	11	SENT_19	[p2l522t1147r776b1210],
11	effects	NNS	O	effect	nsubj	18	SENT_19	[p2l799t1147r1029b1219],
12	,	,	O	,	_	0	SENT_19	[p2l799t1147r1029b1219],
13	and	CC	O	and	_	0	SENT_19	[p2l1053t1147r1179b1210],
14	poor	JJ	O	poor	amod	17	SENT_19	[p2l1200t1169r1364b1230],
15	clinical	JJ	O	clinical	amod	17	SENT_19	[p2l1386t1147r1629b1210],
16	trial	NN	O	trial	nn	17	SENT_19	[p2l1650t1147r1790b1210],
17	execution	NN	O	execution	conj_and	7	SENT_19	[p2l1812t1153r2143b1210],
18	have	VBP	O	have	rcmod	3	SENT_19	[p2l7t1250r160b1313],
19	all	DT	O	all	dobj	18	SENT_19	[p2l181t1250r258b1313],
20	contributed	VBD	O	contribute	_	0	SENT_19	[p2l277t1250r671b1313],
21	to	TO	O	to	_	0	SENT_19	[p2l689t1262r754b1313],
22	these	DT	O	these	det	26	SENT_19	[p2l773t1250r946b1313],
23	failed	VBN	O	fail	amod	26	SENT_19	[p2l966t1250r1151b1313],
24	drug	NN	O	drug	nn	26	SENT_19	[p2l1170t1250r1330b1334],
25	development	NN	O	development	nn	26	SENT_19	[p2l1348t1250r1785b1333],
26	programs	NNS	O	program	prep_to	20	SENT_19	[p2l1802t1272r2142b1334],
27	.	.	O	.	_	0	SENT_19	[p2l1802t1272r2142b1334],

1	Early	RB	O	early	advmod	2	SENT_20	[p2l82t1353r262b1437],
2	diagnosis	NN	O	diagnosis	nsubj	8	SENT_20	[p2l281t1353r600b1437],
3	and	CC	O	and	_	0	SENT_20	[p2l624t1353r750b1416],
4	treatment	NN	O	treatment	conj_and	2	SENT_20	[p2l770t1365r1106b1416],
5	of	IN	O	of	_	0	SENT_20	[p2l1126t1353r1200b1416],
6	AD	NN	O	ad	prep_of	2	SENT_20	[p2l1211t1357r1330b1415],
7	will	MD	O	will	aux	8	SENT_20	[p2l1352t1353r1478b1416],
8	facilitate	VB	O	facilitate	_	0	SENT_20	[p2l1499t1353r1788b1416],
9	success	NN	O	success	dobj	8	SENT_20	[p2l1811t1376r2056b1416],
10	in	IN	O	in	_	0	SENT_20	[p2l2079t1359r2145b1415],
11	application	NN	O	application	prep_in	8	SENT_20	[p2l9t1456r389b1539],
12	of	IN	O	of	_	0	SENT_20	[p2l413t1456r487b1519],
13	disease-modifying	JJ	O	disease-modifying	amod	14	SENT_20	[p2l500t1456r1136b1540],
14	therapies	NNS	O	therapy	prep_of	11	SENT_20	[p2l1156t1456r1485b1539],
15	.	.	O	.	_	0	SENT_20	[p2l1156t1456r1485b1539],

1	New	NNP	O	New	nn	2	SENT_21	[p2l1509t1461r1668b1519],
2	deﬁnitions	NNS	O	deﬁnitions	nsubj	5	SENT_21	[p2l1689t1456r2054b1519],
3	of	IN	O	of	_	0	SENT_21	[p2l2078t1456r2152b1519],
4	AD	NN	O	ad	prep_of	2	SENT_21	[p2l7t1563r126b1621],
5	allow	VBP	O	allow	_	0	SENT_21	[p2l149t1559r332b1622],
6	identiﬁcation	NN	O	identiﬁcation	dobj	5	SENT_21	[p2l349t1559r806b1622],
7	of	IN	O	of	_	0	SENT_21	[p2l827t1559r901b1622],
8	asymptomatic	JJ	O	asymptomatic	amod	13	SENT_21	[p2l913t1565r1393b1643],
9	and	CC	O	and	_	0	SENT_21	[p2l1415t1559r1541b1622],
10	minimally	RB	O	minimally	advmod	11	SENT_21	[p2l1560t1559r1916b1643],
11	symptomatic	JJ	O	symptomatic	amod	13	SENT_21	[p2l1934t1581r2143b1643, p2l7t1668r262b1725],
12	predementia	NN	O	predementium	nn	13	SENT_21	[p2l280t1662r706b1745],
13	populations	NNS	O	population	prep_of	6	SENT_21	[p2l723t1662r1121b1745],
14	through	IN	O	through	_	0	SENT_21	[p2l1140t1662r1412b1746],
15	the	DT	O	the	det	16	SENT_21	[p2l1431t1662r1535b1725],
16	use	NN	O	use	prep_through	5	SENT_21	[p2l1555t1685r1664b1725],
17	of	IN	O	of	_	0	SENT_21	[p2l1684t1662r1757b1725],
18	biomarkers	NNS	O	biomarker	prep_of	16	SENT_21	[p2l1765t1662r2146b1725],
19	in	IN	O	in	_	0	SENT_21	[p2l8t1770r75b1826],
20	combination	NN	O	combination	prep_in	18	SENT_21	[p2l97t1764r532b1827],
21	with	IN	O	with	_	0	SENT_21	[p2l552t1764r705b1827],
22	clinical	JJ	O	clinical	amod	23	SENT_21	[p2l727t1764r972b1827],
23	assessments	NNS	O	assessment	prep_with	20	SENT_21	[p2l993t1776r1417b1827],
24	.	.	O	.	_	0	SENT_21	[p2l993t1776r1417b1827],

1	Implementation	NN	O	implementation	nsubj	10	SENT_22	[p2l83t1867r638b1950],
2	of	IN	O	of	_	0	SENT_22	[p2l662t1867r736b1930],
3	biomarkers	NNS	O	biomarker	prep_of	1	SENT_22	[p2l747t1867r1138b1930],
4	in	IN	O	in	_	0	SENT_22	[p2l1161t1873r1228b1929],
5	drug	NN	O	drug	nn	6	SENT_22	[p2l1251t1867r1415b1951],
6	discovery	NN	O	discovery	prep_in	3	SENT_22	[p2l1436t1867r1768b1951],
7	and	CC	O	and	_	0	SENT_22	[p2l1788t1867r1914b1930],
8	development	NN	O	development	nn	9	SENT_22	[p2l1937t1867r2142b1930, p2l9t1983r273b2054],
9	programs	NNS	O	program	prep_in	3	SENT_22	[p2l293t1993r622b2055],
10	offers	VBZ	O	offer	_	0	SENT_22	[p2l645t1971r831b2034],
11	an	DT	O	a	det	13	SENT_22	[p2l855t1994r935b2034],
12	important	JJ	O	important	amod	13	SENT_22	[p2l958t1977r1306b2054],
13	means	NNS	O	means	iobj	10	SENT_22	[p2l1328t1994r1547b2034],
14	of	IN	O	of	_	0	SENT_22	[p2l1571t1971r1645b2034],
15	improving	VBG	O	improve	prepc_of	13	SENT_22	[p2l1658t1977r2017b2055],
16	the	DT	O	the	det	17	SENT_22	[p2l2037t1971r2143b2034],
17	likelihood	NN	O	likelihood	dobj	15	SENT_22	[p2l7t2073r356b2136],
18	of	IN	O	of	_	0	SENT_22	[p2l376t2073r450b2136],
19	success	NN	O	success	prep_of	17	SENT_22	[p2l462t2096r706b2136],
20	for	IN	O	for	_	0	SENT_22	[p2l727t2073r824b2136],
21	advancing	VBG	O	advance	prepc_for	15	SENT_22	[p2l845t2073r1195b2157],
22	new	JJ	O	new	amod	24	SENT_22	[p2l1214t2096r1357b2136],
23	AD	NN	O	ad	nn	24	SENT_22	[p2l1373t2077r1492b2135],
24	therapies	NNS	O	therapy	dobj	21	SENT_22	[p2l1513t2065r1981b2156],
25	.15	CD	NUMBER	.15	dobj	10	SENT_22	[p2l1513t2065r1981b2156],
26	=	JJ	O	=	amod	25	SENT_22	[p2l1513t2065r1981b2156],
27	16	CD	NUMBER	16	tmod	26	SENT_22	[p2l1513t2065r1981b2156],
28	This	DT	O	this	det	29	SENT_22	[p2l2001t2073r2144b2136],
29	review	NN	O	review	nsubj	31	SENT_22	[p2l9t2182r244b2239],
30	will	MD	O	will	aux	31	SENT_22	[p2l263t2176r394b2239],
31	present	VB	DATE	present	rcmod	25	SENT_22	[p2l417t2188r677b2259],
32	the	DT	O	the	det	33	SENT_22	[p2l699t2176r810b2239],
33	use	NN	O	use	dobj	31	SENT_22	[p2l834t2199r949b2239],
34	of	IN	O	of	_	0	SENT_22	[p2l974t2176r1050b2239],
35	biomarkers	NNS	O	biomarker	prep_of	33	SENT_22	[p2l1063t2176r1465b2239],
36	in	IN	O	in	_	0	SENT_22	[p2l1490t2182r1558b2238],
37	preclinical	JJ	O	preclinical	amod	39	SENT_22	[p2l1582t2176r1955b2259],
38	drug	NN	O	drug	nn	39	SENT_22	[p2l1980t2176r2147b2260],
39	development	NN	O	development	prep_in	31	SENT_22	[p2l9t2279r470b2362],
40	,	,	O	,	_	0	SENT_22	[p2l9t2279r470b2362],
41	the	DT	O	the	det	42	SENT_22	[p2l492t2279r599b2342],
42	use	NN	O	use	appos	39	SENT_22	[p2l620t2302r731b2342],
43	of	IN	O	of	_	0	SENT_22	[p2l753t2279r827b2342],
44	biomarkers	NNS	O	biomarker	prep_of	42	SENT_22	[p2l837t2279r1225b2342],
45	to	TO	O	to	aux	46	SENT_22	[p2l1246t2291r1312b2342],
46	identify	VB	O	identify	infmod	44	SENT_22	[p2l1335t2279r1603b2363],
47	populations	NNS	O	population	dobj	46	SENT_22	[p2l1620t2279r2026b2362],
48	for	IN	O	for	_	0	SENT_22	[p2l2048t2279r2146b2342],
49	trials	NNS	O	trial	prep_for	47	SENT_22	[p2l7t2382r201b2454],
50	,	,	O	,	_	0	SENT_22	[p2l7t2382r201b2454],
51	the	DT	O	the	det	52	SENT_22	[p2l226t2382r334b2445],
52	role	NN	O	role	appos	39	SENT_22	[p2l358t2382r490b2445],
53	of	IN	O	of	_	0	SENT_22	[p2l514t2382r589b2445],
54	biomarkers	NNS	O	biomarker	prep_of	52	SENT_22	[p2l601t2382r998b2445],
55	in	IN	O	in	_	0	SENT_22	[p2l1022t2388r1090b2444],
56	demonstrating	VBG	O	demonstrate	prepc_in	54	SENT_22	[p2l1114t2382r1628b2466],
57	target	NN	O	target	nn	58	SENT_22	[p2l1649t2394r1850b2466],
58	engagement	NN	O	engagement	dobj	56	SENT_22	[p2l1873t2405r2140b2466, p2l8t2497r203b2557],
59	,	,	O	,	_	0	SENT_22	[p2l1873t2405r2140b2466, p2l8t2497r203b2557],
60	the	DT	O	the	det	61	SENT_22	[p2l226t2485r333b2548],
61	place	NN	O	place	conj_and	42	SENT_22	[p2l355t2485r532b2568],
62	of	IN	O	of	_	0	SENT_22	[p2l555t2485r630b2548],
63	biomarkers	NNS	O	biomarker	prep_of	61	SENT_22	[p2l641t2485r1032b2548],
64	as	IN	O	as	_	0	SENT_22	[p2l1056t2508r1120b2548],
65	outcome	NN	O	outcome	nn	66	SENT_22	[p2l1145t2497r1442b2548],
66	measures	NNS	O	measure	prep_as	63	SENT_22	[p2l1465t2508r1785b2548],
67	in	IN	O	in	_	0	SENT_22	[p2l1809t2491r1876b2547],
68	clinical	JJ	O	clinical	amod	69	SENT_22	[p2l1899t2485r2146b2548],
69	trials	NNS	O	trial	prep_in	66	SENT_22	[p2l7t2588r192b2660],
70	,	,	O	,	_	0	SENT_22	[p2l7t2588r192b2660],
71	and	CC	O	and	_	0	SENT_22	[p2l214t2588r337b2651],
72	the	DT	O	the	det	73	SENT_22	[p2l355t2588r459b2651],
73	utility	NN	O	utility	conj_and	42	SENT_22	[p2l479t2588r679b2672],
74	of	IN	O	of	_	0	SENT_22	[p2l696t2588r768b2651],
75	biomarkers	NNS	O	biomarker	prep_of	73	SENT_22	[p2l776t2588r1155b2651],
76	in	IN	O	in	_	0	SENT_22	[p2l1176t2594r1241b2650],
77	assessing	VBG	O	assess	prepc_in	75	SENT_22	[p2l1261t2594r1562b2672],
78	adverse	JJ	O	adverse	amod	79	SENT_22	[p2l1581t2588r1830b2651],
79	events	NNS	O	event	dobj	77	SENT_22	[p2l1851t2600r2058b2651],
80	in	IN	O	in	_	0	SENT_22	[p2l2078t2594r2143b2650],
81	AD	NN	O	ad	nn	83	SENT_22	[p2l7t2694r125b2752],
82	clinical	JJ	O	clinical	amod	83	SENT_22	[p2l148t2690r391b2753],
83	trials	NNS	O	trial	prep_in	77	SENT_22	[p2l410t2690r596b2753],
84	.	.	O	.	_	0	SENT_22	[p2l410t2690r596b2753],

1	The	DT	O	the	det	2	SENT_23	[p2l620t2690r744b2753],
2	observations	NNS	O	observation	nsubj	3	SENT_23	[p2l765t2690r1196b2753],
3	establish	VBP	O	establish	_	0	SENT_23	[p2l1217t2690r1508b2753],
4	the	DT	O	the	det	5	SENT_23	[p2l1528t2690r1633b2753],
5	foundation	NN	O	foundation	nsubj	12	SENT_23	[p2l1654t2690r2031b2753],
6	for	IN	O	for	_	0	SENT_23	[p2l2051t2690r2147b2753],
7	the	DT	O	the	det	8	SENT_23	[p2l7t2793r114b2856],
8	use	NN	O	use	prep_for	5	SENT_23	[p2l137t2816r248b2856],
9	of	IN	O	of	_	0	SENT_23	[p2l271t2793r345b2856],
10	biomarkers	NNS	O	biomarker	prep_of	8	SENT_23	[p2l356t2793r745b2856],
11	to	TO	O	to	aux	12	SENT_23	[p2l767t2805r833b2856],
12	guide	VB	O	guide	xcomp	3	SENT_23	[p2l857t2793r1045b2877],
13	therapy	NN	O	therapy	dobj	12	SENT_23	[p2l1067t2793r1330b2877],
14	of	IN	O	of	_	0	SENT_23	[p2l1349t2793r1423b2856],
15	AD	NN	O	ad	prep_of	13	SENT_23	[p2l1435t2797r1569b2856],
16	.	.	O	.	_	0	SENT_23	[p2l1435t2797r1569b2856],

1	Codevelopment	NN	O	codevelopment	_	0	SENT_24	[p2l1596t2793r2145b2876],

1	‘	NN	O	‘	_	0	SENT_25	[p2l21t2949r158b2976],
2	Cleveland	NNP	ORGANIZATION	Cleveland	nn	14	SENT_25	[p2l21t2949r158b2976],
3	Clinic	NNP	ORGANIZATION	Clinic	nn	14	SENT_25	[p2l166t2953r236b2976],
4	Lou	NNP	ORGANIZATION	Lou	nn	14	SENT_25	[p2l244t2954r289b2976],
5	Ruvo	NNP	ORGANIZATION	Ruvo	nn	14	SENT_25	[p2l298t2954r361b2976],
6	Centerfor	NNP	ORGANIZATION	Centerfor	nn	14	SENT_25	[p2l368t2952r495b2976],
7	Brain	NNP	ORGANIZATION	Brain	nn	14	SENT_25	[p2l503t2954r566b2976],
8	Health	NNP	ORGANIZATION	Health	nn	14	SENT_25	[p2l575t2953r664b2979],
9	,	,	O	,	_	0	SENT_25	[p2l575t2953r664b2979],
10	Lasvegas	NNP	LOCATION	Lasvegas	appos	14	SENT_25	[p2l673t2954r799b2982],
11	,	,	O	,	_	0	SENT_25	[p2l673t2954r799b2982],
12	NV	NNP	O	NV	appos	14	SENT_25	[p2l808t2954r847b2979],
13	,	,	O	,	_	0	SENT_25	[p2l808t2954r847b2979],
14	USA	NNP	LOCATION	USA	dep	1	SENT_25	[p2l856t2953r914b2976],
15	.	.	O	.	_	0	SENT_25	[p2l856t2953r914b2976],

1	Correspondence	NN	O	correspondence	_	0	SENT_26	[p2l921t2953r1157b2982],
2	:	:	O	:	_	0	SENT_26	[p2l921t2953r1157b2982],
3	J	NNP	PERSON	J	nn	6	SENT_26	[p2l921t2953r1157b2982],
4	Cummings	NNP	PERSON	Cummings	nn	6	SENT_26	[p2l1165t2953r1305b2982],
5	(	NN	O	(	nn	6	SENT_26	[p2l1313t2952r1553b2982],
6	cumminj@ccf.org	NN	O	cumminj@ccf.org	dep	1	SENT_26	[p2l1313t2952r1553b2982],
7	)	CD	NUMBER	)	dep	6	SENT_26	[p2l1313t2952r1553b2982],
8	Received	VBN	O	receive	partmod	6	SENT_26	[p2l21t3007r130b3030],
9	29Ju	NN	O	29ju	nn	11	SENT_26	[p2l139t3007r221b3037],
10	|	NN	O	|	nn	11	SENT_26	[p2l139t3007r221b3037],
11	y	NN	O	y	nsubj	15	SENT_26	[p2l139t3007r221b3037],
12	201	CD	NUMBER	201	number	13	SENT_26	[p2l228t3009r266b3030],
13	3	CD	NUMBER	3	dep	11	SENT_26	[p2l274t3009r292b3034],
14	;	:	O	;	_	0	SENT_26	[p2l274t3009r292b3034],
15	accepted	VBN	O	accept	dep	8	SENT_26	[p2l300t3007r412b3036],
16	20	CD	DATE	20	num	17	SENT_26	[p2l421t3009r450b3030],
17	September	NNP	DATE	September	tmod	15	SENT_26	[p2l457t3007r595b3036],
18	201	CD	NUMBER	201	num	17	SENT_26	[p2l602t3009r640b3030],
19	3	CD	NUMBER	3	dep	17	SENT_26	[p2l647t3009r666b3034],
20	;	:	O	;	_	0	SENT_26	[p2l647t3009r666b3034],
21	advance	NN	O	advance	dep	1	SENT_26	[p2l673t3007r777b3030],
22	online	NN	O	online	prep	21	SENT_26	[p2l784t3007r860b3030],
23	publication	NN	O	publication	dep	22	SENT_26	[p2l869t3007r1007b3036],
24	20	CD	DATE	20	num	23	SENT_26	[p2l1016t3009r1044b3030],
25	November	NNP	DATE	November	tmod	21	SENT_26	[p2l1053t3007r1183b3030],
26	201	CD	NUMBER	201	num	25	SENT_26	[p2l1190t3009r1228b3030],
27	3	CD	NUMBER	3	dep	21	SENT_26	[p2l1236t3009r1254b3030],
28	.	.	O	.	_	0	SENT_26	[p2l1236t3009r1254b3030],

1	doizi	NN	O	doizus	dep	9	SENT_27	[p2l1261t3007r1315b3030],
2	0.1	CD	NUMBER	0.1	num	3	SENT_27	[p2l1322t3009r1351b3030],
3	O38/c	NN	O	o38/c	dep	1	SENT_27	[p2l1358t3007r1506b3036],
4	|	CD	NUMBER	|	num	5	SENT_27	[p2l1358t3007r1506b3036],
5	pt	NN	O	pt	dep	9	SENT_27	[p2l1358t3007r1506b3036],
6	.201	CD	NUMBER	.201	num	9	SENT_27	[p2l1358t3007r1506b3036],
7	3.205	CD	NUMBER	3.205	num	9	SENT_27	[p2l1514t3009r1577b3030],
8	CLINICAL	NNP	O	CLINICAL	nn	9	SENT_27	[p2l20t3057r140b3078],
9	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	17	SENT_27	[p2l149t3057r373b3078],
10	&	CC	O	&	_	0	SENT_27	[p2l380t3057r600b3078],
11	THERAPEUT	NNP	O	THERAPEUT	conj_and	9	SENT_27	[p2l380t3057r600b3078],
12	|	CD	NUMBER	|	num	15	SENT_27	[p2l380t3057r600b3078],
13	CS	NNP	O	CS	nn	15	SENT_27	[p2l380t3057r600b3078],
14	[	CD	NUMBER	[	num	15	SENT_27	[p2l610t3055r728b3085],
15	VOLUME	NNP	O	VOLUME	dep	9	SENT_27	[p2l610t3055r728b3085],
16	95	CD	NUMBER	95	num	17	SENT_27	[p2l736t3057r763b3078],
17	NUMBER	NN	O	number	dep	22	SENT_27	[p2l774t3057r881b3078],
18	1	CD	NUMBER	1	number	19	SENT_27	[p2l891t3058r898b3078],
19	|	CD	NUMBER	|	dep	17	SENT_27	[p2l912t3055r914b3085],
20	JANUARY	NNP	DATE	JANUARY	dep	19	SENT_27	[p2l923t3057r1041b3078],
21	2014	CD	DATE	2014	num	22	SENT_27	[p2l1049t3057r1107b3078],
22	67	CD	DATE	67	_	0	SENT_27	[p2l2108t3057r2139b3078],

1	I	PRP	O	I	_	0	SENT_28	[p3l1651t87r1653b89],
2	`	``	O	`	_	0	SENT_28	[p3l1667t97r1698b115],
3	gj	NN	O	gj	dep	1	SENT_28	[p3l1667t97r1698b115],
4	+	CC	O	+	_	0	SENT_28	[p3l1667t97r1698b115],
5	Astrocyte	NN	O	astrocyte	dep	1	SENT_28	[p3l1711t102r1825b126],
6	'	''	O	'	_	0	SENT_28	[p3l1845t108r1848b115],

1	»	NN	O	»	nsubj	2	SENT_29	[p3l314t540r315b550],
2	=	JJ	O	=	_	0	SENT_29	[p3l362t539r365b550],
3	i	FW	O	i	nn	4	SENT_29	[p3l430t536r431b542],
4	gj	FW	O	gj	dobj	2	SENT_29	[p3l464t531r509b556],
5	+	CC	O	+	_	0	SENT_29	[p3l464t531r509b556],
6	Lj	NNP	O	Lj	dobj	2	SENT_29	[p3l546t525r561b556],
7	:	:	O	:	_	0	SENT_29	[p3l587t537r597b556],
8	‘	CD	NUMBER	‘	num	9	SENT_29	[p3l618t525r626b536],
9	E1	NN	O	e1	dep	4	SENT_29	[p3l648t498r710b610],
10	.	.	O	.	_	0	SENT_29	[p3l648t498r710b610],

1	‘	NN	O	‘	nn	2	SENT_30	[p3l745t531r747b536],
2	HA	NN	O	ha	_	0	SENT_30	[p3l350t577r445b638],
3	I	PRP	O	I	nsubj	4	SENT_30	[p3l513t569r515b572],
4	algal	VBP	O	algal	rcmod	2	SENT_30	[p3l552t532r648b640],
5	‘	RB	O	‘	advmod	4	SENT_30	[p3l552t532r648b640],
6	,	,	O	,	_	0	SENT_30	[p3l552t532r648b640],
7	Lu	NNP	O	Lu	dep	4	SENT_30	[p3l680t556r731b614],
8	*	CD	NUMBER	*	num	7	SENT_30	[p3l484t613r485b628],
9	tit-edreasﬂ	JJ	O	tit-edreasﬂ	amod	10	SENT_30	[p3l536t600r736b689],
10	’	NN	O	’	dep	7	SENT_30	[p3l536t600r736b689],
11	Q	NNP	O	Q	nn	13	SENT_30	[p3l486t659r492b684],
12	9	CD	NUMBER	9	num	13	SENT_30	[p3l543t651r721b689],
13	fj	NN	O	fj	dep	7	SENT_30	[p3l543t651r721b689],
14	+	CC	O	+	rcmod	13	SENT_30	[p3l543t651r721b689],

1	Illustrated	NNP	O	Illustrated	nn	3	SENT_31	[p3l1858t743r1892b848],
2	by-Zina	NNP	O	by-Zina	nn	3	SENT_31	[p3l1858t654r1897b734],
3	Deretsky	NNP	O	Deretsky	_	0	SENT_31	[p3l1873t548r1897b645],

1	Neprilysin	NNP	PERSON	Neprilysin	_	0	SENT_32	[p3l866t1092r973b1116],
2	,	,	O	,	_	0	SENT_32	[p3l1393t1114r1404b1115],
3	3	CD	NUMBER	3	appos	1	SENT_32	[p3l1570t1080r1643b1118],
4	”“	NN	O	”“	dep	3	SENT_32	[p3l1570t1080r1643b1118],
5	2	CD	NUMBER	2	num	4	SENT_32	[p3l1744t1087r1757b1112],
6	'	''	O	'	_	0	SENT_32	[p3l1744t1087r1757b1112],
7	=	JJ	O	=	advmod	4	SENT_32	[p3l1773t1089r1832b1110],
8	fj	NN	O	fj	dep	1	SENT_32	[p3l1773t1089r1832b1110],
9	+	CC	O	+	rcmod	8	SENT_32	[p3l1773t1089r1832b1110],

1	Clearance	NN	O	clearance	_	0	SENT_33	[p3l558t1224r676b1243],
2	f	SYM	O	f	dep	1	SENT_33	[p3l964t1217r1031b1256],

1	G	NN	O	g	_	0	SENT_34	[p3l500t1215r543b1256],
2	across	IN	O	across	_	0	SENT_34	[p3l557t1258r636b1273],
3	J	NNP	O	J	prep_across	1	SENT_34	[p3l874t1242r943b1294],
4	&	CC	O	&	rcmod	3	SENT_34	[p3l1180t1239r1297b1300],
5	,	,	O	,	_	0	SENT_34	[p3l1427t1264r1430b1278],
6	®	CD	NUMBER	®	num	7	SENT_34	[p3l1606t1246r1647b1288],
7	Ingestion	NN	O	ingestion	appos	3	SENT_34	[p3l1665t1251r1773b1275],
8	b	NN	O	b	nn	14	SENT_34	[p3l558t1284r699b1303],
9	|	NN	O	|	nn	14	SENT_34	[p3l558t1284r699b1303],
10	ood	NN	O	ood	nn	14	SENT_34	[p3l558t1284r699b1303],
11	—	CD	NUMBER	—	num	14	SENT_34	[p3l558t1284r699b1303],
12	brain	NN	O	brain	nn	14	SENT_34	[p3l558t1284r699b1303],
13	L	NN	O	l	nn	14	SENT_34	[p3l771t1300r797b1308],
14	fj	NN	O	fj	dep	7	SENT_34	[p3l771t1300r797b1308],
15	+	CC	O	+	rcmod	14	SENT_34	[p3l771t1300r797b1308],
16	,	,	O	,	_	0	SENT_34	[p3l822t1298r830b1303],
17	.	.	O	.	_	0	SENT_34	[p3l822t1298r830b1303],

1	Ins	NNP	O	Ins	nn	2	SENT_35	[p3l1304t1296r1334b1315],
2	I.	NNP	O	I.	_	0	SENT_35	[p3l1350t1296r1359b1314],
3	i	FW	O	i	nn	4	SENT_35	[p3l1419t1278r1426b1291],
4	’	FW	O	’	dep	2	SENT_35	[p3l1419t1278r1426b1291],
5	by	IN	O	by	_	0	SENT_35	[p3l1665t1281r1692b1305],
6	microglia	NNS	O	microglium	prep_by	4	SENT_35	[p3l1700t1281r1809b1305],
7	_	RB	O	_	advmod	6	SENT_35	[p3l607t1314r611b1318],
8	.	.	O	.	_	0	SENT_35	[p3l811t1308r825b1314],

1	~	NN	O	~	nn	3	SENT_36	[p3l811t1308r825b1314],
2	V	NN	O	v	nn	3	SENT_36	[p3l857t1320r859b1322],
3	um	NN	O	um	_	0	SENT_36	[p3l1336t1300r1373b1315],
4	,	,	O	,	_	0	SENT_36	[p3l1577t1312r1580b1313],
5	ba	NN	O	ba	appos	3	SENT_36	[p3l558t1314r636b1333],
6	"	''	O	"	punct	5	SENT_36	[p3l558t1314r636b1333],
7	"	``	O	"	punct	8	SENT_36	[p3l558t1314r636b1333],
8	°	CD	NUMBER	°	dep	3	SENT_36	[p3l558t1314r636b1333],
9	"	``	O	"	punct	8	SENT_36	[p3l558t1314r636b1333],
10	od	NN	O	od	nn	11	SENT_36	[p3l799t1322r810b1344],
11	fj	NN	O	fj	dep	8	SENT_36	[p3l799t1322r810b1344],
12	+	CC	O	+	_	0	SENT_36	[p3l799t1322r810b1344],
13	fj	NN	O	fj	dep	3	SENT_36	[p3l823t1328r860b1348],
14	+	CC	O	+	_	0	SENT_36	[p3l823t1328r860b1348],
15	©	CD	NUMBER	©	num	16	SENT_36	[p3l1001t1312r1043b1354],
16	Metabolism	NN	O	metabolism	conj_+	13	SENT_36	[p3l1057t1324r1192b1343],
17	degrading	JJ	O	degrading	amod	18	SENT_36	[p3l1302t1326r1412b1350],
18	\	NN	O	\	dep	16	SENT_36	[p3l1599t1334r1614b1352],

1	.	.	O	.	_	0	SENT_37	[p3l751t1352r762b1376],
2	'	''	O	'	_	0	SENT_37	[p3l751t1352r762b1376],

1	p	NN	O	p	nn	2	SENT_38	[p3l776t1354r792b1376],
2	fj	NN	O	fj	_	0	SENT_38	[p3l776t1354r792b1376],
3	+	CC	O	+	_	0	SENT_38	[p3l776t1354r792b1376],
4	'	''	O	'	_	0	SENT_38	[p3l799t1356r802b1360],
5	V.	NNP	O	V.	conj_+	2	SENT_38	[p3l809t1354r834b1383],
6	’	SYM	O	’	dep	2	SENT_38	[p3l809t1354r834b1383],
7	-	:	O	-	_	0	SENT_38	[p3l809t1354r834b1383],
8	i	FW	O	i	nn	9	SENT_38	[p3l809t1354r834b1383],
9	__	FW	O	__	dep	2	SENT_38	[p3l843t1376r858b1384],
10	by	IN	O	by	_	0	SENT_38	[p3l1057t1354r1084b1378],
11	enzymes	NNS	O	enzyme	nn	12	SENT_38	[p3l1092t1358r1196b1378],
12	enzyme	NN	O	enzyme	prep_by	9	SENT_38	[p3l1302t1360r1388b1380],

1	Illustrated	NNP	O	Illustrated	_	0	SENT_39	[p3l1879t1683r1897b1788],
2	by	IN	O	by	dep	1	SENT_39	[p3l1879t1649r1902b1674],
3	fine	JJ	O	fine	amod	4	SENT_39	[p3l1865t1594r1897b1644],
4	Deretsky	NN	PERSON	deretsky	pobj	2	SENT_39	[p3l1879t1488r1902b1585],

1	Figure	NN	O	figure	_	0	SENT_40	[p3l7t1900r193b1961],
2	2	CD	NUMBER	2	num	1	SENT_40	[p3l209t1902r241b1947],
3	Metabolism	NN	O	metabolism	nn	6	SENT_40	[p3l280t1899r602b1948],
4	and	CC	O	and	_	0	SENT_40	[p3l621t1899r722b1948],
5	dynamics	NNS	O	dynamics	nn	6	SENT_40	[p3l741t1899r1002b1961],
6	ofamyloid	NN	O	ofamyloid	dep	1	SENT_40	[p3l1019t1898r1320b1961],
7	.	.	O	.	_	0	SENT_40	[p3l1019t1898r1320b1961],

1	of	IN	O	of	_	0	SENT_41	[p3l9t2112r81b2175],
2	therapeutics	NNS	O	therapeutics	prep_of	12	SENT_41	[p3l91t2112r502b2195],
3	and	CC	O	and	_	0	SENT_41	[p3l523t2112r647b2175],
4	biomarkers	NNS	O	biomarker	prep_of	12	SENT_41	[p3l663t2112r1043b2175],
5	in	IN	O	in	_	0	SENT_41	[p3l1064t2118r1129b2174],
6	a	DT	O	a	det	7	SENT_41	[p3l1149t2135r1183b2175],
7	companion	NN	O	companion	prep_in	2	SENT_41	[p3l1202t2118r1583b2195],
8	diagnostic	JJ	O	diagnostic	amod	9	SENT_41	[p3l1603t2112r1947b2196],
9	paradigm	NN	O	paradigm	nsubjpass	12	SENT_41	[p3l1965t2134r2140b2195, p3l9t2215r185b2299],
10	will	MD	O	will	aux	12	SENT_41	[p3l205t2215r331b2278],
11	be	VB	O	be	auxpass	12	SENT_41	[p3l350t2215r429b2278],
12	presented	VBN	O	present	_	0	SENT_41	[p3l450t2215r799b2298],
13	.	.	O	.	_	0	SENT_41	[p3l450t2215r799b2298],

1	The	DT	O	the	det	3	SENT_42	[p3l824t2215r949b2278],
2	speciﬁc	NN	O	speciﬁc	nn	3	SENT_42	[p3l971t2215r1224b2298],
3	perspective	NN	O	perspective	nsubj	10	SENT_42	[p3l1245t2221r1633b2298],
4	of	IN	O	of	_	0	SENT_42	[p3l1655t2215r1729b2278],
5	this	DT	O	this	det	6	SENT_42	[p3l1740t2215r1864b2278],
6	presentation	NN	O	presentation	prep_of	3	SENT_42	[p3l1885t2237r2139b2298, p3l8t2324r211b2381],
7	is	VBZ	O	be	cop	10	SENT_42	[p3l234t2324r285b2381],
8	the	DT	O	the	det	10	SENT_42	[p3l307t2318r415b2381],
9	eventual	JJ	O	eventual	amod	10	SENT_42	[p3l439t2318r731b2381],
10	use	NN	O	use	_	0	SENT_42	[p3l753t2341r865b2381],
11	of	IN	O	of	_	0	SENT_42	[p3l889t2318r964b2381],
12	biomarkers	NNS	O	biomarker	prep_of	10	SENT_42	[p3l975t2318r1368b2381],
13	to	TO	O	to	aux	14	SENT_42	[p3l1392t2330r1458b2381],
14	inform	VB	O	inform	infmod	12	SENT_42	[p3l1483t2318r1724b2381],
15	therapeutic	JJ	O	therapeutic	amod	17	SENT_42	[p3l1745t2318r2141b2401],
16	decision	NN	O	decision	nn	17	SENT_42	[p3l9t2421r286b2484],
17	making	NN	O	making	dobj	14	SENT_42	[p3l305t2421r575b2505],
18	.	.	O	.	_	0	SENT_42	[p3l305t2421r575b2505],

1	Figure	NNP	O	Figure	nsubj	3	SENT_43	[p3l599t2425r825b2504],
2	3	CD	NUMBER	3	num	1	SENT_43	[p3l845t2428r881b2484],
3	summarizes	VBZ	O	summarize	_	0	SENT_43	[p3l903t2427r1305b2484],
4	the	DT	O	the	det	5	SENT_43	[p3l1325t2421r1429b2484],
5	role	NN	O	role	dobj	3	SENT_43	[p3l1450t2421r1576b2484],
6	of	IN	O	of	_	0	SENT_43	[p3l1596t2421r1668b2484],
7	biomarkers	NNS	O	biomarker	prep_of	5	SENT_43	[p3l1677t2421r2057b2484],
8	in	IN	O	in	_	0	SENT_43	[p3l2077t2427r2143b2483],
9	drug	NN	O	drug	nn	11	SENT_43	[p3l9t2524r169b2608],
10	development	NN	O	development	nn	11	SENT_43	[p3l188t2524r626b2607],
11	programs	NNS	O	program	prep_in	7	SENT_43	[p3l644t2546r967b2608],
12	and	CC	O	and	_	0	SENT_43	[p3l989t2524r1113b2587],
13	their	PRP$	O	they	poss	15	SENT_43	[p3l1132t2524r1293b2587],
14	possible	JJ	O	possible	amod	15	SENT_43	[p3l1310t2524r1581b2607],
15	implementation	NN	O	implementation	prep_of	5	SENT_43	[p3l1601t2524r2142b2607],
16	for	IN	O	for	_	0	SENT_43	[p3l8t2627r106b2690],
17	managing	VBG	O	manage	amod	18	SENT_43	[p3l126t2633r467b2711],
18	therapies	NNS	O	therapy	prep_for	15	SENT_43	[p3l486t2627r796b2710],
19	after	IN	O	after	_	0	SENT_43	[p3l819t2627r971b2690],
20	approval	NN	O	approval	prep_after	18	SENT_43	[p3l992t2627r1302b2710],
21	.	.	O	.	_	0	SENT_43	[p3l992t2627r1302b2710],

1	DEFINITION	NN	MISC	definition	nsubjpass	21	SENT_44	[p3l12t2841r430b2897],
2	OF	IN	MISC	of	_	0	SENT_44	[p3l451t2841r544b2897],
3	A	DT	MISC	a	det	6	SENT_44	[p3l564t2842r612b2896],
4	BIOMARKER	NN	MISC	biomarker	nn	6	SENT_44	[p3l633t2841r1067b2897],
5	A	NN	O	a	nn	6	SENT_44	[p3l8t2941r65b2999],
6	biomarker	NN	O	biomarker	prep_of	1	SENT_44	[p3l86t2937r451b3000],
7	(	CD	NUMBER	(	num	10	SENT_44	[p3l477t2937r844b3021],
8	biological	JJ	O	biological	amod	10	SENT_44	[p3l477t2937r844b3021],
9	marker	NN	O	marker	nn	10	SENT_44	[p3l866t2937r1143b3013],
10	)	NN	O	)	nsubjpass	12	SENT_44	[p3l866t2937r1143b3013],
11	is	VBZ	O	be	auxpass	12	SENT_44	[p3l1171t2943r1222b3000],
12	deﬁned	VBN	O	deﬁned	rcmod	6	SENT_44	[p3l1247t2937r1505b3000],
13	as	IN	O	as	_	0	SENT_44	[p3l1529t2960r1594b3000],
14	a	DT	O	a	det	16	SENT_44	[p3l1619t2960r1653b3000],
15	characteristic	JJ	O	characteristic	amod	16	SENT_44	[p3l1676t2937r2143b3000],
16	that	DT	O	that	prep_as	12	SENT_44	[p3l8t3040r146b3103],
17	is	VBZ	O	be	auxpass	19	SENT_44	[p3l170t3046r221b3103],
18	objectively	RB	O	objectively	advmod	19	SENT_44	[p3l247t3040r629b3124],
19	measured	VBN	O	measure	_	0	SENT_44	[p3l650t3040r994b3103],
20	and	CC	O	and	_	0	SENT_44	[p3l1019t3040r1149b3103],
21	evaluated	VBN	O	evaluate	conj_and	19	SENT_44	[p3l1172t3040r1508b3103],
22	as	IN	O	as	_	0	SENT_44	[p3l1533t3063r1599b3103],
23	an	DT	O	a	det	24	SENT_44	[p3l1624t3063r1706b3103],
24	indicator	NN	O	indicator	prep_as	19	SENT_44	[p3l1731t3040r2053b3103],
25	of	IN	O	of	_	0	SENT_44	[p3l2076t3040r2152b3103],
26	normal	JJ	O	normal	amod	28	SENT_44	[p3l8t3143r258b3206],
27	biological	JJ	O	biological	amod	28	SENT_44	[p3l276t3143r612b3227],
28	processes	NNS	O	process	prep_of	24	SENT_44	[p3l631t3165r971b3226],
29	,	,	O	,	_	0	SENT_44	[p3l631t3165r971b3226],
30	pathogenic	JJ	O	pathogenic	amod	31	SENT_44	[p3l993t3143r1372b3227],
31	processes	NNS	O	process	conj_or	28	SENT_44	[p3l1392t3165r1732b3226],
32	,	,	O	,	_	0	SENT_44	[p3l1392t3165r1732b3226],
33	or	CC	O	or	_	0	SENT_44	[p3l1755t3166r1827b3206],
34	pharmacologic	JJ	O	pharmacologic	amod	35	SENT_44	[p3l1845t3143r2139b3226, p3l9t3246r251b3330],
35	responses	NNS	O	response	conj_or	28	SENT_44	[p3l273t3268r603b3329],
36	to	TO	O	to	_	0	SENT_44	[p3l625t3258r690b3309],
37	a	DT	O	a	det	39	SENT_44	[p3l714t3269r748b3309],
38	therapeutic	JJ	O	therapeutic	amod	39	SENT_44	[p3l768t3246r1157b3329],
39	intervention	NN	O	intervention	prep_to	19	SENT_44	[p3l1178t3238r1684b3309],
40	.	.	O	.	_	0	SENT_44	[p3l1178t3238r1684b3309],

1	”	NN	O	”	_	0	SENT_45	[p3l1178t3238r1684b3309],

1	A	DT	O	a	det	4	SENT_46	[p3l81t3353r139b3411],
2	surrogate	JJ	O	surrogate	amod	4	SENT_46	[p3l162t3361r487b3433],
3	end	NN	O	end	nn	4	SENT_46	[p3l512t3349r640b3412],
4	point	NN	O	point	nsubj	12	SENT_46	[p3l661t3355r846b3432],
5	(	CD	NUMBER	(	num	4	SENT_46	[p3l872t3350r972b3426],
6	or	CC	O	or	_	0	SENT_46	[p3l872t3350r972b3426],
7	surrogate	JJ	O	surrogate	amod	9	SENT_46	[p3l996t3361r1321b3433],
8	marker	NN	O	marker	nn	9	SENT_46	[p3l1344t3349r1621b3425],
9	)	NN	O	)	nsubj	12	SENT_46	[p3l1344t3349r1621b3425],
10	is	VBZ	O	be	cop	12	SENT_46	[p3l1649t3355r1699b3412],
11	a	DT	O	a	det	12	SENT_46	[p3l1724t3372r1759b3412],
12	biomarker	NN	O	biomarker	_	0	SENT_46	[p3l1779t3349r2144b3412],
13	used	VBN	O	use	partmod	12	SENT_46	[p3l8t3452r163b3515],
14	as	IN	O	as	_	0	SENT_46	[p3l182t3475r245b3515],
15	a	DT	O	a	det	16	SENT_46	[p3l266t3475r300b3515],
16	substitute	NN	O	substitute	prep_as	13	SENT_46	[p3l319t3452r639b3515],
17	for	IN	O	for	_	0	SENT_46	[p3l659t3452r754b3515],
18	a	DT	O	a	det	21	SENT_46	[p3l773t3475r807b3515],
19	clinical	JJ	O	clinical	amod	21	SENT_46	[p3l825t3452r1064b3515],
20	end	NN	O	end	nn	21	SENT_46	[p3l1083t3452r1206b3515],
21	point	NN	O	point	prep_for	16	SENT_46	[p3l1223t3458r1418b3535],
22	;	:	O	;	_	0	SENT_46	[p3l1223t3458r1418b3535],
23	a	DT	O	a	det	26	SENT_46	[p3l1440t3475r1474b3515],
24	surrogate	JJ	O	surrogate	amod	26	SENT_46	[p3l1493t3464r1804b3536],
25	end	NN	O	end	nn	26	SENT_46	[p3l1824t3452r1947b3515],
26	point	NN	O	point	nsubjpass	28	SENT_46	[p3l1964t3458r2143b3535],
27	is	VBZ	O	be	auxpass	28	SENT_46	[p3l9t3561r58b3618],
28	expected	VBN	O	expect	parataxis	12	SENT_46	[p3l79t3555r378b3638],
29	to	TO	O	to	aux	30	SENT_46	[p3l397t3567r462b3618],
30	predict	VB	O	predict	xcomp	28	SENT_46	[p3l482t3555r722b3638],
31	clinical	JJ	O	clinical	amod	32	SENT_46	[p3l742t3555r983b3618],
32	beneﬁt	NN	O	beneﬁt	dobj	30	SENT_46	[p3l1001t3555r1250b3627],
33	,	,	O	,	_	0	SENT_46	[p3l1001t3555r1250b3627],
34	harm	NN	O	harm	dobj	30	SENT_46	[p3l1271t3555r1470b3627],
35	,	,	O	,	_	0	SENT_46	[p3l1271t3555r1470b3627],
36	or	CC	O	or	_	0	SENT_46	[p3l1492t3578r1563b3618],
37	lack	NN	O	lack	dobj	30	SENT_46	[p3l1581t3555r1720b3618],
38	of	IN	O	of	_	0	SENT_46	[p3l1737t3555r1810b3618],
39	beneﬁt	NN	O	beneﬁt	prep_of	37	SENT_46	[p3l1818t3555r2052b3618],
40	or	CC	O	or	_	0	SENT_46	[p3l2071t3578r2142b3618],
41	harm	NN	O	harm	prep_of	37	SENT_46	[p3l8t3649r274b3720],
42	.	.	O	.	_	0	SENT_46	[p3l8t3649r274b3720],

1	”	NN	O	”	_	0	SENT_47	[p3l8t3649r274b3720],
2	There	EX	O	there	expl	3	SENT_47	[p3l296t3657r488b3720],
3	are	VBP	O	be	rcmod	1	SENT_47	[p3l512t3680r612b3720],
4	no	DT	O	no	nsubj	3	SENT_47	[p3l635t3680r721b3720],
5	validated	VBN	O	validate	partmod	4	SENT_47	[p3l742t3657r1056b3720],
6	surrogate	JJ	O	surrogate	amod	8	SENT_47	[p3l1079t3669r1398b3741],
7	end	NN	O	end	nn	8	SENT_47	[p3l1421t3657r1547b3720],
8	points	NNS	O	point	dobj	5	SENT_47	[p3l1567t3663r1780b3740],
9	in	IN	O	in	_	0	SENT_47	[p3l1803t3663r1870b3719],
10	AD	NN	O	ad	prep_in	5	SENT_47	[p3l1892t3661r2030b3729],
11	;	:	O	;	_	0	SENT_47	[p3l1892t3661r2030b3729],
12	no	DT	O	no	det	13	SENT_47	[p3l2054t3680r2140b3720],
13	biomarker	NN	O	biomarker	nsubjpass	16	SENT_47	[p4l7t16r365b79],
14	has	VBZ	O	have	aux	16	SENT_47	[p4l386t16r498b79],
15	been	VBN	O	be	auxpass	16	SENT_47	[p4l519t16r683b79],
16	shown	VBN	O	show	parataxis	3	SENT_47	[p4l707t16r929b79],
17	to	TO	O	to	aux	19	SENT_47	[p4l950t28r1016b79],
18	reliably	RB	O	reliably	advmod	19	SENT_47	[p4l1040t16r1294b100],
19	predict	VB	O	predict	xcomp	16	SENT_47	[p4l1312t16r1555b99],
20	clinical	JJ	O	clinical	amod	21	SENT_47	[p4l1577t16r1822b79],
21	outcome	NN	O	outcome	dobj	19	SENT_47	[p4l1845t28r2141b79],
22	in	IN	O	in	_	0	SENT_47	[p4l9t125r75b181],
23	AD	NN	O	ad	nn	25	SENT_47	[p4l96t122r214b181],
24	clinical	JJ	O	clinical	amod	25	SENT_47	[p4l238t118r483b182],
25	trials	NNS	O	trial	prep_in	21	SENT_47	[p4l502t110r755b182],
26	.18	CD	NUMBER	.18	tmod	19	SENT_47	[p4l502t110r755b182],

1	The	DT	O	the	det	5	SENT_48	[p4l82t418r209b481],
2	Biomarker	NNP	O	Biomarker	nn	5	SENT_48	[p4l235t418r610b481],
3	Deﬁnitions	NNP	O	Deﬁnitions	nn	5	SENT_48	[p4l635t418r1031b481],
4	Working	NNP	O	Working	nn	5	SENT_48	[p4l1055t418r1367b502],
5	Group	NNP	O	Group	nsubj	20	SENT_48	[p4l1392t422r1618b501],
6	deﬁned	VBD	O	deﬁned	_	0	SENT_48	[p4l1645t418r1907b481],
7	type	NN	O	type	nn	9	SENT_48	[p4l1930t430r2081b502],
8	o	NN	O	o	nn	9	SENT_48	[p4l2106t425r2143b481],
9	biomarkers	NNS	O	biomarker	dobj	6	SENT_48	[p4l6t521r394b584],
10	as	IN	O	as	_	0	SENT_48	[p4l417t544r481b584],
11	those	DT	O	those	prep_as	6	SENT_48	[p4l502t521r684b584],
12	that	WDT	O	that	nsubj	13	SENT_48	[p4l705t521r839b584],
13	measure	VB	O	measure	rcmod	11	SENT_48	[p4l858t544r1144b584],
14	the	DT	O	the	det	16	SENT_48	[p4l1165t521r1271b584],
15	natural	JJ	O	natural	amod	16	SENT_48	[p4l1292t521r1536b584],
16	history	NN	O	history	dobj	13	SENT_48	[p4l1556t521r1800b605],
17	of	IN	O	of	_	0	SENT_48	[p4l1819t521r1892b584],
18	disease	NN	O	disease	prep_of	16	SENT_48	[p4l1905t521r2145b584],
19	and	CC	O	and	_	0	SENT_48	[p4l9t623r138b686],
20	correlate	VBP	O	correlate	conj_and	6	SENT_48	[p4l162t623r466b686],
21	over	IN	O	over	_	0	SENT_48	[p4l492t646r642b686],
22	time	NN	O	time	prep_over	20	SENT_48	[p4l665t629r822b686],
23	with	IN	O	with	_	0	SENT_48	[p4l845t623r1001b686],
24	clinical	JJ	O	clinical	amod	25	SENT_48	[p4l1026t623r1279b686],
25	indicators	NNS	O	indicator	prep_with	22	SENT_48	[p4l1303t615r1737b686],
26	.	.	O	.	_	0	SENT_48	[p4l1303t615r1737b686],

1	”	NN	O	”	nn	2	SENT_49	[p4l1303t615r1737b686],
2	Type	NN	O	type	nsubjpass	6	SENT_49	[p4l1760t626r1930b707],
3	I	CD	NUMBER	i	num	4	SENT_49	[p4l1955t628r1979b685],
4	biomarkers	NNS	O	biomarker	dep	2	SENT_49	[p4l2002t623r2142b686, p4l8t725r288b788],
5	were	VBD	O	be	auxpass	6	SENT_49	[p4l308t748r470b788],
6	identiﬁed	VBN	O	identiﬁed	_	0	SENT_49	[p4l492t725r822b788],
7	as	IN	O	as	_	0	SENT_49	[p4l844t748r908b788],
8	those	DT	O	those	prep_as	6	SENT_49	[p4l930t725r1114b788],
9	that	WDT	O	that	nsubj	10	SENT_49	[p4l1135t725r1270b788],
10	indicate	VBP	O	indicate	rcmod	8	SENT_49	[p4l1291t725r1564b788],
11	the	DT	O	the	det	13	SENT_49	[p4l1586t725r1692b788],
12	intervention	NN	O	intervention	nn	13	SENT_49	[p4l1716t731r2144b788],
13	effects	NNS	O	effect	dobj	10	SENT_49	[p4l9t828r237b891],
14	of	IN	O	of	_	0	SENT_49	[p4l268t828r346b891],
15	a	DT	O	a	det	16	SENT_49	[p4l368t851r403b891],
16	therapy	NN	O	therapy	prep_of	13	SENT_49	[p4l431t828r722b912],
17	.	.	O	.	_	0	SENT_49	[p4l431t828r722b912],

1	Type	NN	O	type	nsubj	7	SENT_50	[p4l756t831r932b912],
2	II	CD	NUMBER	ii	num	3	SENT_50	[p4l963t833r1020b890],
3	biomarkers	NNS	O	biomarker	dep	1	SENT_50	[p4l1049t828r1467b891],
4	are	VBP	O	be	cop	7	SENT_50	[p4l1499t851r1606b891],
5	surrogate	JJ	O	surrogate	amod	7	SENT_50	[p4l1638t840r1982b912],
6	end	NN	O	end	nn	7	SENT_50	[p4l2014t828r2147b891],
7	points	NNS	O	point	_	0	SENT_50	[p4l7t937r253b1014],
8	.	.	O	.	_	0	SENT_50	[p4l7t937r253b1014],

1	In	IN	O	in	_	0	SENT_51	[p4l286t936r360b993],
2	AD	NN	O	ad	nn	3	SENT_51	[p4l388t935r511b993],
3	research	NN	O	research	prep_in	10	SENT_51	[p4l541t931r865b1003],
4	,	,	O	,	_	0	SENT_51	[p4l541t931r865b1003],
5	the	DT	O	the	det	6	SENT_51	[p4l894t931r1006b994],
6	relationship	NN	O	relationship	nsubj	10	SENT_51	[p4l1036t931r1470b1014],
7	of	IN	O	of	_	0	SENT_51	[p4l1501t931r1578b994],
8	magnetic	JJ	O	magnetic	amod	9	SENT_51	[p4l1596t937r1932b1015],
9	resonance	NN	O	resonance	prep_of	6	SENT_51	[p4l1961t954r2140b994, p4l8t1057r212b1097],
10	imaging	NN	O	imaging	_	0	SENT_51	[p4l234t1040r518b1118],
11	(	CD	NUMBER	(	num	12	SENT_51	[p4l543t1035r754b1111],
12	MRI	NNP	O	MRI	nn	14	SENT_51	[p4l543t1035r754b1111],
13	)	CD	NUMBER	)	num	12	SENT_51	[p4l543t1035r754b1111],
14	atrophy	NN	O	atrophy	dobj	10	SENT_51	[p4l781t1034r1050b1118],
15	with	IN	O	with	_	0	SENT_51	[p4l1067t1034r1222b1097],
16	cognitive	JJ	O	cognitive	amod	18	SENT_51	[p4l1244t1040r1561b1118],
17	decline	NN	O	decline	nn	18	SENT_51	[p4l1585t1034r1832b1097],
18	qualiﬁes	NNS	O	qualiﬁes	prep_with	14	SENT_51	[p4l1855t1034r2142b1117],
19	as	IN	O	as	_	0	SENT_51	[p4l9t1160r75b1200],
20	a	DT	O	a	det	23	SENT_51	[p4l100t1160r135b1200],
21	type	NN	O	type	nn	23	SENT_51	[p4l157t1149r307b1221],
22	o	NN	O	o	nn	23	SENT_51	[p4l333t1144r369b1200],
23	biomarker	NN	O	biomarker	prep_as	18	SENT_51	[p4l392t1137r771b1200],
24	.	.	O	.	_	0	SENT_51	[p4l392t1137r771b1200],

1	Reduced	VBN	O	reduce	dep	16	SENT_52	[p4l800t1137r1105b1200],
2	cerebrospinal	JJ	O	cerebrospinal	amod	4	SENT_52	[p4l1129t1137r1604b1220],
3	ﬂuid	JJ	O	ﬂuid	amod	4	SENT_52	[p4l1627t1137r1788b1200],
4	(	NN	O	(	iobj	1	SENT_52	[p4l1815t1138r2011b1214],
5	CSF	NN	O	csf	nn	7	SENT_52	[p4l1815t1138r2011b1214],
6	)	CD	NUMBER	)	num	7	SENT_52	[p4l1815t1138r2011b1214],
7	AB	NNP	ORGANIZATION	AB	dobj	1	SENT_52	[p4l2040t1135r2144b1218],
8	following	VBG	O	follow	_	0	SENT_52	[p4l8t1240r347b1324],
9	treatment	NN	O	treatment	prep_following	7	SENT_52	[p4l370t1252r722b1303],
10	with	IN	O	with	_	0	SENT_52	[p4l744t1240r903b1303],
11	a	DT	O	a	det	12	SENT_52	[p4l929t1263r964b1303],
12	B	NN	O	b	prep_with	9	SENT_52	[p4l992t1238r1390b1321],
13	—	CD	NUMBER	—	num	15	SENT_52	[p4l992t1238r1390b1321],
14	secretase	NN	O	secretase	nn	15	SENT_52	[p4l992t1238r1390b1321],
15	inhibitor	NN	O	inhibitor	nsubj	16	SENT_52	[p4l1416t1240r1735b1303],
16	shows	VBZ	O	show	_	0	SENT_52	[p4l1760t1240r1974b1303],
17	CSF	NN	O	csf	nn	18	SENT_52	[p4l2001t1244r2143b1303],
18	AI3	NN	O	ai3	dobj	16	SENT_52	[p4l8t1341r113b1424],
19	to	TO	O	to	aux	24	SENT_52	[p4l138t1355r205b1406],
20	be	VB	O	be	cop	24	SENT_52	[p4l229t1343r311b1406],
21	a	DT	O	a	det	24	SENT_52	[p4l337t1366r372b1406],
22	type	NN	O	type	nn	24	SENT_52	[p4l394t1355r545b1427],
23	I	CD	NUMBER	i	num	24	SENT_52	[p4l571t1348r595b1405],
24	biomarker	NN	O	biomarker	xcomp	16	SENT_52	[p4l619t1343r1001b1406],
25	.	.	O	.	_	0	SENT_52	[p4l619t1343r1001b1406],

1	There	EX	O	there	expl	2	SENT_53	[p4l1029t1343r1227b1406],
2	are	VBP	O	be	_	0	SENT_53	[p4l1253t1366r1357b1406],
3	no	DT	O	no	det	5	SENT_53	[p4l1381t1366r1469b1406],
4	established	JJ	O	established	amod	5	SENT_53	[p4l1496t1343r1888b1406],
5	type	NN	O	type	iobj	2	SENT_53	[p4l1911t1355r2061b1427],
6	II	CD	NUMBER	ii	num	7	SENT_53	[p4l2087t1348r2142b1405],
7	biomarkers	NNS	O	biomarker	dep	5	SENT_53	[p4l6t1445r402b1508],
8	for	IN	O	for	_	0	SENT_53	[p4l426t1445r525b1508],
9	AD	NN	O	ad	prep_for	7	SENT_53	[p4l547t1449r682b1508],
10	.	.	O	.	_	0	SENT_53	[p4l547t1449r682b1508],

1	Another	DT	O	another	det	3	SENT_54	[p4l81t1548r383b1611],
2	classiﬁcation	NN	O	classiﬁcation	nn	3	SENT_54	[p4l410t1548r869b1611],
3	system	NN	O	system	nsubj	11	SENT_54	[p4l898t1548r1443b1632],
4	—	CD	NUMBER	—	npadvmod	5	SENT_54	[p4l898t1548r1443b1632],
5	useful	JJ	O	useful	amod	3	SENT_54	[p4l898t1548r1443b1632],
6	but	CC	O	but	_	0	SENT_54	[p4l1467t1548r1585b1611],
7	less	RBR	O	less	advmod	8	SENT_54	[p4l1610t1548r1734b1611],
8	commonly	RB	O	commonly	advmod	9	SENT_54	[p4l1762t1548r2149b1632],
9	used	VBN	O	use	amod	3	SENT_54	[p4l8t1651r581b1714],
10	—	NN	O	—	dobj	9	SENT_54	[p4l8t1651r581b1714],
11	describes	VBZ	O	describe	_	0	SENT_54	[p4l8t1651r581b1714],
12	biomarkers	NNS	O	biomarker	dobj	11	SENT_54	[p4l604t1651r1004b1714],
13	along	IN	O	along	_	0	SENT_54	[p4l1030t1651r1223b1735],
14	a	DT	O	a	det	20	SENT_54	[p4l1246t1674r1281b1714],
15	pharmacokinetic	JJ	O	pharmacokinetic	amod	20	SENT_54	[p4l1303t1651r2141b1734],
16	—	NN	O	—	nn	20	SENT_54	[p4l1303t1651r2141b1734],
17	phar	NN	O	phar	nn	20	SENT_54	[p4l1303t1651r2141b1734],
18	—	NN	O	—	nn	20	SENT_54	[p4l1303t1651r2141b1734],
19	macodynamic	JJ	O	macodynamic	amod	20	SENT_54	[p4l8t1754r498b1838],
20	continuum	NN	O	continuum	prep_along	12	SENT_54	[p4l521t1760r902b1817],
21	as	IN	O	as	mark	22	SENT_54	[p4l926t1777r990b1817],
22	follows	VBZ	O	follow	dep	20	SENT_54	[p4l1014t1754r1275b1817],
23	:	:	O	:	_	0	SENT_54	[p4l1014t1754r1275b1817],
24	type	NN	O	type	nn	25	SENT_54	[p4l1299t1766r1446b1838],
25	o	NN	O	o	dep	20	SENT_54	[p4l1470t1761r1524b1817],
26	:	:	O	:	_	0	SENT_54	[p4l1470t1761r1524b1817],
27	genotype/phenotype	NN	O	genotype/phenotype	dep	25	SENT_54	[p4l1551t1754r2141b1838, p4l7t1869r158b1941],
28	that	WDT	O	that	nsubj	29	SENT_54	[p4l181t1857r319b1920],
29	determines	VBZ	O	determine	rcmod	27	SENT_54	[p4l342t1857r736b1920],
30	drug	NN	O	drug	nn	31	SENT_54	[p4l761t1857r928b1941],
31	response	NN	O	response	dobj	29	SENT_54	[p4l951t1879r1278b1940],
32	;	:	O	;	_	0	SENT_54	[p4l951t1879r1278b1940],
33	type	NN	O	type	dep	20	SENT_54	[p4l1303t1869r1453b1941],
34	1	CD	NUMBER	1	dep	33	SENT_54	[p4l1484t1864r1533b1920],
35	:	:	O	:	_	0	SENT_54	[p4l1484t1864r1533b1920],
36	concentration	NN	O	concentration	dep	20	SENT_54	[p4l1561t1863r2053b1920],
37	of	IN	O	of	_	0	SENT_54	[p4l2078t1857r2153b1920],
38	drug	NN	O	drug	prep_of	36	SENT_54	[p4l9t1960r171b2044],
39	or	CC	O	or	_	0	SENT_54	[p4l191t1983r263b2023],
40	metabolite	NN	O	metabolite	prep_of	36	SENT_54	[p4l282t1960r663b2032],
41	;	:	O	;	_	0	SENT_54	[p4l282t1960r663b2032],
42	type	NN	O	type	amod	38	SENT_54	[p4l685t1972r831b2044],
43	2	CD	NUMBER	2	number	42	SENT_54	[p4l852t1967r906b2023],
44	:	:	O	:	_	0	SENT_54	[p4l852t1967r906b2023],
45	molecular	JJ	O	molecular	amod	47	SENT_54	[p4l930t1960r1275b2023],
46	target	NN	O	target	nn	47	SENT_54	[p4l1294t1972r1491b2044],
47	occupancy	NN	O	occupancy	prep_of	36	SENT_54	[p4l1511t1982r1899b2044],
48	;	:	O	;	_	0	SENT_54	[p4l1511t1982r1899b2044],
49	type	NN	O	type	prep_of	36	SENT_54	[p4l1920t1972r2066b2044],
50	3	CD	NUMBER	3	num	49	SENT_54	[p4l2088t1967r2142b2023],
51	:	:	O	:	_	0	SENT_54	[p4l2088t1967r2142b2023],
52	molecular	JJ	O	molecular	amod	54	SENT_54	[p4l8t2063r352b2126],
53	target	NN	O	target	nn	54	SENT_54	[p4l370t2075r566b2147],
54	activation	NN	O	activation	prep_of	36	SENT_54	[p4l586t2069r939b2135],
55	;	:	O	;	_	0	SENT_54	[p4l586t2069r939b2135],
56	type	NN	O	type	prep_of	36	SENT_54	[p4l960t2075r1106b2147],
57	4	CD	NUMBER	4	num	56	SENT_54	[p4l1125t2070r1180b2126],
58	:	:	O	:	_	0	SENT_54	[p4l1125t2070r1180b2126],
59	physiological	JJ	O	physiological	amod	60	SENT_54	[p4l1203t2063r1653b2147],
60	measure	NN	O	measure	prep_of	36	SENT_54	[p4l1672t2086r1976b2135],
61	;	:	O	;	_	0	SENT_54	[p4l1672t2086r1976b2135],
62	type	NN	O	type	prep_of	36	SENT_54	[p4l1997t2075r2142b2147],
63	5	CD	NUMBER	5	num	62	SENT_54	[p4l10t2173r64b2228],
64	:	:	O	:	_	0	SENT_54	[p4l10t2173r64b2228],
65	pathophysiological	JJ	O	pathophysiological	amod	66	SENT_54	[p4l91t2165r763b2249],
66	measure	NN	O	measure	prep_of	36	SENT_54	[p4l787t2188r1101b2237],
67	;	:	O	;	_	0	SENT_54	[p4l787t2188r1101b2237],
68	and	CC	O	and	_	0	SENT_54	[p4l1128t2165r1258b2228],
69	type	NN	O	type	prep_of	36	SENT_54	[p4l1281t2177r1431b2249],
70	6	CD	NUMBER	6	num	69	SENT_54	[p4l1456t2171r1512b2228],
71	:	:	O	:	_	0	SENT_54	[p4l1456t2171r1512b2228],
72	clinical	JJ	O	clinical	amod	73	SENT_54	[p4l1540t2165r1793b2228],
73	ratings	NNS	O	rating	dep	69	SENT_54	[p4l1817t2157r2144b2249],
74	.	.	O	.	_	0	SENT_54	[p4l1817t2157r2144b2249],

1	”	NN	O	”	_	0	SENT_55	[p4l1817t2157r2144b2249],

1	VOLUME	NN	O	volume	nn	3	SENT_56	[p4l542t2383r765b2425],
2	95	CD	NUMBER	95	num	3	SENT_56	[p4l783t2384r839b2425],
3	NUMBER1	NN	O	number1	_	0	SENT_56	[p4l860t2383r1118b2425],
4	|	CD	NUMBER	|	num	5	SENT_56	[p4l1148t2379r1152b2440],
5	JANUARY	NNP	DATE	JANUARY	dep	3	SENT_56	[p4l1171t2383r1416b2425],
6	2014	CD	DATE	2014	num	5	SENT_56	[p4l1432t2384r1553b2425],
7	|	CD	NUMBER	|	num	8	SENT_56	[p4l1571t2379r1576b2440],
8	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_56	[p4l1595t2383r2145b2436],

1	Phase	NN	O	phase	nsubj	9	SENT_57	[p4l1170t2932r1310b2970],
2	|	CD	NUMBER	|	number	3	SENT_57	[p4l1332t2931r1409b2970],
3	|	CD	NUMBER	|	amod	1	SENT_57	[p4l1332t2931r1409b2970],
4	/	:	O	/	punct	6	SENT_57	[p4l1332t2931r1409b2970],
5	|	CD	NUMBER	|	num	6	SENT_57	[p4l1332t2931r1409b2970],
6	|	CD	NUMBER	|	dep	3	SENT_57	[p4l1332t2931r1409b2970],
7	|	NNP	O	|	nn	8	SENT_57	[p4l1332t2931r1409b2970],
8	Post	NNP	O	Post	dep	6	SENT_57	[p4l1647t2932r1954b2980],
9	—	VBD	O	—	_	0	SENT_57	[p4l1647t2932r1954b2980],
10	approva	NN	O	approva	nn	11	SENT_57	[p4l1647t2932r1954b2980],
11	|	NN	O	|	dobj	9	SENT_57	[p4l1647t2932r1954b2980],

1	Relationship	NN	O	relationship	_	0	SENT_58	[p4l73t3352r351b3399],
2	of	IN	O	of	_	0	SENT_58	[p4l370t3351r410b3389],
3	Proof	NNP	O	Proof	prep_of	1	SENT_58	[p4l658t3351r776b3389],
4	of	IN	O	of	_	0	SENT_58	[p4l794t3351r834b3389],
5	biomarkers	NNS	O	biomarker	prep_of	3	SENT_58	[p4l86t3414r337b3451],
6	to	TO	O	to	aux	7	SENT_58	[p4l354t3416r394b3451],
7	pharmaco	VB	O	pharmaco	infmod	5	SENT_58	[p4l577t3413r915b3462],
8	|	JJ	O	|	amod	9	SENT_58	[p4l577t3413r915b3462],
9	ogy	NN	O	ogy	dobj	7	SENT_58	[p4l577t3413r915b3462],
10	/	:	O	/	punct	12	SENT_58	[p4l577t3413r915b3462],
11	Disease	NN	O	disease	nn	12	SENT_58	[p4l1165t3417r1346b3455],
12	behavior	NN	O	behavior	dep	7	SENT_58	[p4l93t3476r288b3514],
13	and	CC	O	and	_	0	SENT_58	[p4l305t3476r386b3514],
14	target	NN	O	target	nn	18	SENT_58	[p4l679t3478r809b3524],
15	modification	NN	O	modification	nn	18	SENT_58	[p4l1120t3479r1389b3517],
16	brain	NN	O	brain	nn	18	SENT_58	[p4l66t3538r174b3576],
17	pathology	NN	O	pathology	nn	18	SENT_58	[p4l196t3538r416b3586],
18	engagement	NN	O	engagement	dep	7	SENT_58	[p4l602t3541r887b3586],

1	Monitoring	VBG	O	monitor	_	0	SENT_59	[p4l1648t3388r1884b3436],
2	linked	VBN	O	link	dep	1	SENT_59	[p4l1609t3450r1736b3488],
3	to	TO	O	to	_	0	SENT_59	[p4l1755t3452r1795b3488],
4	longterm	JJ	O	longterm	amod	5	SENT_59	[p4l1815t3450r1925b3498, p4l1632t3515r1732b3550],
5	effects	NNS	O	effect	prep_to	2	SENT_59	[p4l1752t3512r1899b3550],

1	Figure	NNP	O	Figure	nn	3	SENT_60	[p5l10t65r197b126],
2	3	CD	NUMBER	3	num	3	SENT_60	[p5l212t67r244b113],
3	Role	NN	O	role	nsubj	18	SENT_60	[p5l285t64r400b113],
4	of	IN	O	of	_	0	SENT_60	[p5l417t64r474b113],
5	biomarkers	NNS	O	biomarker	prep_of	3	SENT_60	[p5l488t64r794b113],
6	in	IN	O	in	_	0	SENT_60	[p5l812t67r857b113],
7	the	DT	O	the	det	11	SENT_60	[p5l875t64r964b113],
8	different	JJ	O	different	amod	9	SENT_60	[p5l981t64r1215b113],
9	phases	NNS	O	phase	npadvmod	10	SENT_60	[p5l1233t64r1420b126],
10	ofdrug	JJ	O	ofdrug	amod	11	SENT_60	[p5l1437t64r1633b126],
11	development	NN	O	development	prep_in	5	SENT_60	[p5l1651t64r2022b126],
12	and	CC	O	and	_	0	SENT_60	[p5l2038t64r2139b113],
13	their	PRP$	O	they	poss	15	SENT_60	[p5l7t150r135b199],
14	possible	JJ	O	possible	amod	15	SENT_60	[p5l153t150r376b211],
15	use	NN	O	use	prep_in	5	SENT_60	[p5l395t164r485b199],
16	in	IN	O	in	_	0	SENT_60	[p5l503t152r548b198],
17	management	NN	O	management	prep_in	15	SENT_60	[p5l569t157r940b212],
18	ofapproved	VBD	O	ofapprove	_	0	SENT_60	[p5l956t149r1286b211],
19	therapies	NNS	O	therapy	dobj	18	SENT_60	[p5l1303t150r1573b211],
20	.	.	O	.	_	0	SENT_60	[p5l1303t150r1573b211],

1	This	DT	O	this	det	2	SENT_61	[p5l8t334r152b397],
2	approach	NN	O	approach	nsubj	5	SENT_61	[p5l177t334r496b417],
3	more	RBR	O	more	advmod	4	SENT_61	[p5l519t357r698b397],
4	closely	RB	O	closely	advmod	5	SENT_61	[p5l721t334r955b418],
5	links	VBZ	O	link	_	0	SENT_61	[p5l973t334r1139b397],
6	the	DT	O	the	det	7	SENT_61	[p5l1162t334r1269b397],
7	process	NN	O	process	dobj	5	SENT_61	[p5l1291t356r1547b417],
8	of	IN	O	of	_	0	SENT_61	[p5l1571t334r1645b397],
9	drug	NN	O	drug	nn	10	SENT_61	[p5l1659t334r1823b418],
10	development	NN	O	development	prep_of	7	SENT_61	[p5l1845t334r2140b417, p5l8t448r185b499],
11	to	TO	O	to	_	0	SENT_61	[p5l204t448r270b499],
12	the	DT	O	the	det	15	SENT_61	[p5l292t436r398b499],
13	associated	VBN	O	associate	amod	15	SENT_61	[p5l420t436r768b499],
14	biomarker	NN	O	biomarker	nn	15	SENT_61	[p5l786t436r1145b499],
15	readout	NN	O	readout	prep_to	5	SENT_61	[p5l1166t436r1444b499],
16	.	.	O	.	_	0	SENT_61	[p5l1166t436r1444b499],

1	Biomarkers	NNS	O	biomarker	nsubj	16	SENT_62	[p5l82t539r463b602],
2	may	MD	O	may	aux	16	SENT_62	[p5l483t562r626b623],
3	be	VB	O	be	cop	16	SENT_62	[p5l639t539r717b602],
4	useful	JJ	O	useful	amod	16	SENT_62	[p5l736t539r936b602],
5	in	IN	O	in	_	0	SENT_62	[p5l954t545r1019b601],
6	drug	NN	O	drug	nn	7	SENT_62	[p5l1039t539r1196b623],
7	development	NN	O	development	prep_in	4	SENT_62	[p5l1215t539r1645b622],
8	and	CC	O	and	_	0	SENT_62	[p5l1664t539r1786b602],
9	in	IN	O	in	_	0	SENT_62	[p5l1805t545r1869b601],
10	guiding	VBG	O	guide	amod	11	SENT_62	[p5l1889t539r2144b623],
11	therapy	NN	O	therapy	prep_in	4	SENT_62	[p5l8t642r267b726],
12	without	IN	O	without	_	0	SENT_62	[p5l282t642r548b705],
13	being	VBG	O	be	cop	15	SENT_62	[p5l565t642r755b726],
14	fully	RB	O	fully	advmod	15	SENT_62	[p5l774t642r928b726],
15	qualiﬁed	JJ	O	qualiﬁed	prepc_without	11	SENT_62	[p5l945t642r1241b725],
16	surrogates	NNS	O	surrogate	_	0	SENT_62	[p5l1261t654r1626b726],
17	.	.	O	.	_	0	SENT_62	[p5l1261t654r1626b726],

1	Target	NN	O	target	nn	2	SENT_63	[p5l1649t645r1862b726],
2	engagement	NN	O	engagement	nsubjpass	15	SENT_63	[p5l1881t665r2140b726, p5l8t757r198b817],
3	,	,	O	,	_	0	SENT_63	[p5l1881t665r2140b726, p5l8t757r198b817],
4	proof	NN	O	proof	appos	2	SENT_63	[p5l218t745r411b828],
5	of	IN	O	of	_	0	SENT_63	[p5l422t745r494b808],
6	pharmacology	NN	O	pharmacology	prep_of	4	SENT_63	[p5l503t745r1000b829],
7	,	,	O	,	_	0	SENT_63	[p5l503t745r1000b829],
8	and	CC	O	and	_	0	SENT_63	[p5l1022t745r1146b808],
9	support	NN	O	support	conj_and	4	SENT_63	[p5l1166t757r1426b828],
10	for	IN	O	for	_	0	SENT_63	[p5l1445t745r1540b808],
11	disease	NN	O	disease	nn	12	SENT_63	[p5l1560t745r1795b808],
12	modiﬁcation	NN	O	modiﬁcation	prep_for	9	SENT_63	[p5l1815t745r2138b808, p5l8t854r142b911],
13	can	MD	O	can	aux	15	SENT_63	[p5l163t871r277b911],
14	be	VB	O	be	auxpass	15	SENT_63	[p5l295t848r373b911],
15	accomplished	VBN	O	accomplish	_	0	SENT_63	[p5l394t848r854b931],
16	with	IN	O	with	_	0	SENT_63	[p5l870t848r1020b911],
17	biomarkers	NNS	O	biomarker	prep_with	15	SENT_63	[p5l1038t848r1418b911],
18	not	RB	O	not	neg	19	SENT_63	[p5l1439t860r1551b911],
19	proven	VBN	O	prove	partmod	17	SENT_63	[p5l1568t870r1802b931],
20	to	TO	O	to	aux	21	SENT_63	[p5l1821t860r1885b911],
21	predict	VB	O	predict	xcomp	15	SENT_63	[p5l1905t848r2144b931],
22	clinical	JJ	O	clinical	amod	23	SENT_63	[p5l9t950r254b1013],
23	outcomes	NNS	O	outcome	dobj	21	SENT_63	[p5l275t962r620b1013],
24	.	.	O	.	_	0	SENT_63	[p5l275t962r620b1013],

1	TRAIT	NN	O	trait	dep	132	SENT_64	[p5l8t1165r220b1219],
2	AND	CC	O	and	dep	132	SENT_64	[p5l236t1165r396b1219],
3	STATE	NN	O	state	dep	132	SENT_64	[p5l416t1165r627b1220],
4	BIOMARKERS	NNS	O	biomarker	dep	132	SENT_64	[p5l649t1164r1125b1220],
5	FOR	IN	O	for	dep	132	SENT_64	[p5l1147t1164r1288b1220],
6	AD	NN	O	ad	dep	132	SENT_64	[p5l1305t1165r1409b1219],
7	There	EX	O	there	dep	132	SENT_64	[p5l8t1260r199b1323],
8	are	VBP	O	be	dep	132	SENT_64	[p5l220t1283r320b1323],
9	two	CD	NUMBER	two	dep	132	SENT_64	[p5l339t1272r463b1323],
10	basic	JJ	O	basic	dep	132	SENT_64	[p5l482t1260r653b1323],
11	types	NNS	O	type	dep	132	SENT_64	[p5l671t1272r847b1344],
12	of	IN	O	of	dep	132	SENT_64	[p5l868t1260r942b1323],
13	biomarkers	NNS	O	biomarker	dep	132	SENT_64	[p5l950t1260r1334b1323],
14	in	IN	O	in	dep	132	SENT_64	[p5l1356t1266r1421b1322],
15	AD	NN	O	ad	dep	132	SENT_64	[p5l1441t1264r1577b1323],
16	:	:	O	:	_	0	SENT_64	[p5l1441t1264r1577b1323],
17	trait	NN	O	trait	dep	132	SENT_64	[p5l1599t1266r1740b1323],
18	biomarkers	NNS	O	biomarker	dep	132	SENT_64	[p5l1757t1260r2141b1323],
19	that	WDT	O	that	dep	132	SENT_64	[p5l8t1363r138b1426],
20	deﬁne	VBP	O	deﬁne	dep	132	SENT_64	[p5l157t1363r359b1426],
21	a	DT	O	a	dep	132	SENT_64	[p5l379t1386r413b1426],
22	risk	NN	O	risk	dep	132	SENT_64	[p5l432t1363r558b1426],
23	state	NN	O	state	dep	132	SENT_64	[p5l575t1375r722b1426],
24	for	IN	O	for	dep	132	SENT_64	[p5l742t1363r837b1426],
25	AD	NN	O	ad	dep	132	SENT_64	[p5l854t1367r970b1425],
26	but	CC	O	but	dep	132	SENT_64	[p5l990t1363r1100b1426],
27	do	VBP	O	do	dep	132	SENT_64	[p5l1119t1363r1201b1426],
28	not	RB	O	not	dep	132	SENT_64	[p5l1222t1375r1333b1426],
29	necessarily	RB	O	necessarily	dep	132	SENT_64	[p5l1351t1363r1716b1447],
30	indicate	VBP	O	indicate	dep	132	SENT_64	[p5l1732t1363r1995b1426],
31	that	IN	O	that	dep	132	SENT_64	[p5l2014t1363r2144b1426],
32	the	DT	O	the	dep	132	SENT_64	[p5l8t1466r114b1529],
33	disease	NN	O	disease	dep	132	SENT_64	[p5l137t1466r378b1529],
34	is	VBZ	O	be	dep	132	SENT_64	[p5l401t1472r451b1529],
35	present	JJ	DATE	present	dep	132	SENT_64	[p5l473t1478r725b1549],
36	and	CC	O	and	dep	132	SENT_64	[p5l747t1466r874b1529],
37	state	NN	O	state	dep	132	SENT_64	[p5l896t1478r1048b1529],
38	biomarkers	NNS	O	biomarker	dep	132	SENT_64	[p5l1069t1466r1458b1529],
39	that	WDT	O	that	dep	132	SENT_64	[p5l1480t1466r1614b1529],
40	are	VBP	O	be	dep	132	SENT_64	[p5l1637t1489r1736b1529],
41	indications	NNS	O	indication	dep	132	SENT_64	[p5l1760t1466r2139b1529],
42	of	IN	O	of	dep	132	SENT_64	[p5l9t1569r83b1632],
43	pathological	JJ	O	pathological	dep	132	SENT_64	[p5l94t1569r517b1653],
44	changes	NNS	O	change	dep	132	SENT_64	[p5l540t1569r808b1653],
45	of	IN	O	of	dep	132	SENT_64	[p5l832t1569r906b1632],
46	AD	NN	O	ad	dep	132	SENT_64	[p5l918t1573r1036b1631],
47	(	CD	NUMBER	(	dep	132	SENT_64	[p5l1063t1570r1641b1652],
48	Supplementary	NNP	O	Supplementary	dep	132	SENT_64	[p5l1063t1570r1641b1652],
49	Tables	NNP	O	Tables	dep	132	SENT_64	[p5l1659t1570r1884b1632],
50	S1	NN	O	s1	dep	132	SENT_64	[p5l1906t1573r1982b1632],
51	and	CC	O	and	dep	132	SENT_64	[p5l2010t1570r2144b1632],
52	S2	NN	O	s2	dep	132	SENT_64	[p5l9t1676r91b1736],
53	online	NN	O	online	dep	132	SENT_64	[p5l113t1664r438b1749],
54	)	CD	NUMBER	)	dep	132	SENT_64	[p5l113t1664r438b1749],
55	.20	CD	NUMBER	.20	dep	132	SENT_64	[p5l113t1664r438b1749],
56	Genetic	JJ	O	genetic	dep	132	SENT_64	[p5l461t1676r725b1736],
57	biomarkers	NNS	O	biomarker	dep	132	SENT_64	[p5l743t1672r1150b1744],
58	,	,	O	,	_	0	SENT_64	[p5l743t1672r1150b1744],
59	such	JJ	O	such	dep	132	SENT_64	[p5l1173t1672r1327b1736],
60	as	IN	O	as	dep	132	SENT_64	[p5l1349t1695r1413b1736],
61	autosomal	JJ	O	autosomal	dep	132	SENT_64	[p5l1435t1672r1788b1736],
62	dominant	JJ	O	dominant	dep	132	SENT_64	[p5l1808t1672r2144b1736],
63	AD-causing	NN	O	ad-causing	dep	132	SENT_64	[p5l8t1779r431b1859],
64	mutations	NNS	O	mutation	dep	132	SENT_64	[p5l452t1781r805b1838],
65	and	CC	O	and	dep	132	SENT_64	[p5l830t1775r959b1838],
66	the	DT	O	the	dep	132	SENT_64	[p5l980t1775r1089b1838],
67	apolipoprotein	NN	O	apolipoprotein	dep	132	SENT_64	[p5l1113t1775r1632b1858],
68	E	NN	O	e	dep	132	SENT_64	[p5l1655t1780r1701b1837],
69	e4	NN	O	e4	dep	132	SENT_64	[p5l1726t1782r1801b1838],
70	(	CD	NUMBER	(	dep	132	SENT_64	[p5l1828t1775r2143b1858],
71	ApoE4	NN	O	apoe4	dep	132	SENT_64	[p5l1828t1775r2143b1858],
72	)	NN	O	)	dep	132	SENT_64	[p5l1828t1775r2143b1858],
73	,	,	O	,	_	0	SENT_64	[p5l1828t1775r2143b1858],
74	and	CC	O	and	dep	132	SENT_64	[p5l9t1878r138b1941],
75	other	JJ	O	other	dep	132	SENT_64	[p5l160t1878r345b1941],
76	risk	NN	O	risk	dep	132	SENT_64	[p5l367t1878r499b1941],
77	polymorphisms	NNS	O	polymorphism	dep	132	SENT_64	[p5l517t1878r1068b1962],
78	are	VBP	O	be	dep	132	SENT_64	[p5l1093t1901r1195b1941],
79	examples	NNS	O	example	dep	132	SENT_64	[p5l1219t1878r1538b1961],
80	of	IN	O	of	dep	132	SENT_64	[p5l1563t1878r1638b1941],
81	trait	NN	O	trait	dep	132	SENT_64	[p5l1650t1884r1796b1941],
82	biomarkers	NNS	O	biomarker	dep	132	SENT_64	[p5l1816t1878r2139b1941, p5l9t2004r125b2053],
83	;	:	O	;	_	0	SENT_64	[p5l1816t1878r2139b1941, p5l9t2004r125b2053],
84	their	PRP$	O	they	dep	132	SENT_64	[p5l149t1981r315b2044],
85	presence	NN	O	presence	dep	132	SENT_64	[p5l336t2003r640b2064],
86	increases	VBZ	O	increase	dep	132	SENT_64	[p5l664t1987r978b2044],
87	the	DT	O	the	dep	132	SENT_64	[p5l1001t1981r1109b2044],
88	likelihood	NN	O	likelihood	dep	132	SENT_64	[p5l1132t1981r1488b2044],
89	of	IN	O	of	dep	132	SENT_64	[p5l1510t1981r1585b2044],
90	developing	VBG	O	develop	dep	132	SENT_64	[p5l1600t1981r1982b2065],
91	AD	NN	O	ad	dep	132	SENT_64	[p5l2003t1985r2140b2053],
92	,	,	O	,	_	0	SENT_64	[p5l2003t1985r2140b2053],
93	but	CC	O	but	dep	132	SENT_64	[p5l7t2084r122b2147],
94	they	PRP	O	they	dep	132	SENT_64	[p5l144t2084r298b2168],
95	are	VBP	O	be	dep	132	SENT_64	[p5l319t2107r421b2147],
96	present	JJ	DATE	present	dep	132	SENT_64	[p5l443t2096r701b2167],
97	from	IN	O	from	dep	132	SENT_64	[p5l723t2084r895b2147],
98	conception	NN	O	conception	dep	132	SENT_64	[p5l919t2090r1308b2167],
99	and	CC	O	and	dep	132	SENT_64	[p5l1333t2084r1461b2147],
100	do	VBP	O	do	dep	132	SENT_64	[p5l1485t2084r1570b2147],
101	not	RB	O	not	dep	132	SENT_64	[p5l1595t2096r1711b2147],
102	indicate	VB	O	indicate	dep	132	SENT_64	[p5l1734t2084r2011b2147],
103	the	DT	O	the	dep	132	SENT_64	[p5l2034t2084r2143b2147],
104	presence	NN	O	presence	dep	132	SENT_64	[p5l7t2208r301b2269],
105	or	CC	O	or	dep	132	SENT_64	[p5l322t2209r392b2249],
106	activity	NN	O	activity	dep	132	SENT_64	[p5l412t2192r660b2270],
107	of	IN	O	of	dep	132	SENT_64	[p5l677t2186r749b2249],
108	the	DT	O	the	dep	132	SENT_64	[p5l759t2186r864b2249],
109	disease	NN	O	disease	dep	132	SENT_64	[p5l884t2186r1121b2249],
110	process	NN	O	process	dep	132	SENT_64	[p5l1140t2178r1563b2269],
111	.21	CD	NUMBER	.21	dep	132	SENT_64	[p5l1140t2178r1563b2269],
112	‘	CD	NUMBER	‘	dep	132	SENT_64	[p5l1140t2178r1563b2269],
113	25	CD	NUMBER	25	dep	132	SENT_64	[p5l1140t2178r1563b2269],
114	Trait	NN	O	trait	dep	132	SENT_64	[p5l1584t2189r1743b2249],
115	biomarkers	NNS	O	biomarker	dep	132	SENT_64	[p5l1759t2186r2141b2249],
116	can	MD	O	can	dep	132	SENT_64	[p5l9t2312r127b2352],
117	be	VB	O	be	dep	132	SENT_64	[p5l148t2289r229b2352],
118	used	VBN	O	use	dep	132	SENT_64	[p5l252t2289r412b2352],
119	to	TO	O	to	dep	132	SENT_64	[p5l433t2301r499b2352],
120	choose	VB	O	choose	dep	132	SENT_64	[p5l524t2289r763b2352],
121	patients	NNS	O	patient	dep	132	SENT_64	[p5l785t2295r1057b2372],
122	for	IN	O	for	dep	132	SENT_64	[p5l1081t2289r1180b2352],
123	clinical	JJ	O	clinical	dep	132	SENT_64	[p5l1202t2289r1450b2352],
124	trials	NNS	O	trial	dep	132	SENT_64	[p5l1472t2289r1645b2352],
125	but	CC	O	but	dep	132	SENT_64	[p5l1667t2289r1782b2352],
126	can	MD	O	can	dep	132	SENT_64	[p5l1804t2301r2041b2352],
127	not	RB	O	not	dep	132	SENT_64	[p5l1804t2301r2041b2352],
128	be	VB	O	be	dep	132	SENT_64	[p5l2062t2289r2142b2352],
129	used	VBN	O	use	dep	132	SENT_64	[p5l8t2392r166b2455],
130	as	IN	O	as	dep	132	SENT_64	[p5l186t2415r250b2455],
131	outcome	NN	O	outcome	dep	132	SENT_64	[p5l272t2404r567b2455],
132	measures	NNS	O	measure	_	0	SENT_64	[p5l587t2415r922b2455],
133	.	.	O	.	_	0	SENT_64	[p5l587t2415r922b2455],

1	Trait	NN	O	trait	nn	2	SENT_65	[p5l945t2395r1106b2455],
2	biomarkers	NNS	O	biomarker	nsubj	5	SENT_65	[p5l1123t2392r1510b2455],
3	may	MD	O	may	aux	5	SENT_65	[p5l1531t2415r1677b2476],
4	not	RB	O	not	neg	5	SENT_65	[p5l1694t2404r1808b2455],
5	represent	VB	O	represent	_	0	SENT_65	[p5l1827t2404r2144b2475],
6	targets	NNS	O	target	dobj	5	SENT_65	[p5l8t2507r259b2579],
7	,	,	O	,	_	0	SENT_65	[p5l8t2507r259b2579],
8	but	CC	O	but	_	0	SENT_65	[p5l283t2495r399b2558],
9	they	PRP	O	they	nsubj	10	SENT_65	[p5l420t2495r574b2579],
10	identify	VBP	O	identify	conj_but	5	SENT_65	[p5l595t2495r869b2579],
11	pathways	NNS	O	pathway	dobj	10	SENT_65	[p5l888t2495r1212b2579],
12	that	WDT	O	that	nsubj	14	SENT_65	[p5l1235t2495r1373b2558],
13	may	MD	O	may	aux	14	SENT_65	[p5l1395t2518r1545b2579],
14	indicate	VB	O	indicate	rcmod	11	SENT_65	[p5l1565t2495r1842b2558],
15	avenues	NNS	O	avenue	dobj	14	SENT_65	[p5l1867t2518r2141b2558],
16	for	IN	O	for	_	0	SENT_65	[p5l8t2598r105b2661],
17	therapeutic	JJ	O	therapeutic	amod	18	SENT_65	[p5l123t2598r510b2681],
18	development	NN	O	development	prep_for	15	SENT_65	[p5l531t2598r988b2681],
19	.	.	O	.	_	0	SENT_65	[p5l531t2598r988b2681],

1	Genes	NNS	O	gene	nsubj	8	SENT_66	[p5l1012t2602r1220b2661],
2	that	WDT	O	that	nsubj	5	SENT_66	[p5l1240t2598r1373b2661],
3	are	VBP	O	be	cop	5	SENT_66	[p5l1393t2621r1492b2661],
4	risk	NN	O	risk	nn	5	SENT_66	[p5l1513t2598r1641b2661],
5	factors	NNS	O	factor	rcmod	1	SENT_66	[p5l1658t2598r1885b2661],
6	for	IN	O	for	_	0	SENT_66	[p5l1906t2598r2003b2661],
7	AD	NN	O	ad	prep_for	5	SENT_66	[p5l2021t2602r2139b2660],
8	implicate	VBP	O	implicate	_	0	SENT_66	[p5l9t2701r322b2784],
9	pathways	NNS	O	pathway	dobj	8	SENT_66	[p5l343t2701r659b2785],
10	linked	VBN	O	link	partmod	9	SENT_66	[p5l679t2701r895b2764],
11	to	TO	O	to	_	0	SENT_66	[p5l915t2713r981b2764],
12	immune	JJ	O	immune	amod	14	SENT_66	[p5l1003t2707r1291b2764],
13	system	NN	O	system	nn	14	SENT_66	[p5l1314t2713r1545b2785],
14	function	NN	O	function	prep_to	10	SENT_66	[p5l1566t2701r1876b2773],
15	,	,	O	,	_	0	SENT_66	[p5l1566t2701r1876b2773],
16	cholesterol	NN	O	cholesterol	nn	17	SENT_66	[p5l1900t2701r2139b2764, p5l8t2804r161b2867],
17	metabolism	NN	O	metabolism	prep_to	10	SENT_66	[p5l180t2804r594b2876],
18	,	,	O	,	_	0	SENT_66	[p5l180t2804r594b2876],
19	synaptogenesis	NN	O	synaptogenesis	nn	22	SENT_66	[p5l616t2810r1117b2888],
20	and	CC	O	and	_	0	SENT_66	[p5l1138t2804r1263b2867],
21	synaptic	JJ	O	synaptic	conj_and	19	SENT_66	[p5l1282t2810r1558b2888],
22	integrity	NN	O	integrity	conj_and	14	SENT_66	[p5l1578t2810r1873b2888],
23	,	,	O	,	_	0	SENT_66	[p5l1578t2810r1873b2888],
24	and	CC	O	and	_	0	SENT_66	[p5l1895t2804r2019b2867],
25	AB	NNP	O	AB	nn	26	SENT_66	[p5l2037t2802r2139b2885],
26	metabolism	NN	O	metabolism	conj_and	14	SENT_66	[p5l8t2898r492b2970],
27	.	.	O	.	_	0	SENT_66	[p5l8t2898r492b2970],

1	”	NN	O	”	_	0	SENT_67	[p5l8t2898r492b2970],

1	Trait	NN	O	trait	nn	2	SENT_68	[p5l82t3013r245b3073],
2	biomarkers	NNS	O	biomarker	nsubj	5	SENT_68	[p5l265t3010r658b3073],
3	are	VBP	O	be	cop	5	SENT_68	[p5l682t3033r783b3073],
4	especially	RB	O	especially	advmod	5	SENT_68	[p5l807t3010r1143b3094],
5	relevant	JJ	O	relevant	_	0	SENT_68	[p5l1163t3010r1439b3073],
6	to	TO	O	to	_	0	SENT_68	[p5l1460t3022r1526b3073],
7	prevention	NN	O	prevention	nn	8	SENT_68	[p5l1550t3016r1926b3093],
8	trials	NNS	O	trial	prep_to	5	SENT_68	[p5l1948t3010r2140b3082],
9	,	,	O	,	_	0	SENT_68	[p5l1948t3010r2140b3082],
10	in	IN	O	in	_	0	SENT_68	[p5l9t3119r76b3175],
11	which	WDT	O	which	rel	13	SENT_68	[p5l97t3113r308b3176],
12	they	PRP	O	they	nsubj	13	SENT_68	[p5l329t3113r481b3197],
13	identify	VBP	O	identify	rcmod	8	SENT_68	[p5l500t3113r770b3197],
14	patients	NNS	O	patient	dobj	13	SENT_68	[p5l788t3119r1059b3196],
15	at	IN	O	at	_	0	SENT_68	[p5l1083t3125r1143b3176],
16	high	JJ	O	high	amod	17	SENT_68	[p5l1164t3113r1319b3197],
17	risk	NN	O	risk	prep_at	13	SENT_68	[p5l1341t3113r1472b3176],
18	for	IN	O	for	_	0	SENT_68	[p5l1491t3113r1589b3176],
19	AD	NN	O	ad	prep_for	17	SENT_68	[p5l1610t3117r1744b3176],
20	.	.	O	.	_	0	SENT_68	[p5l1610t3117r1744b3176],

1	Carriers	NNS	O	carrier	nsubjpass	8	SENT_69	[p5l1771t3117r2051b3176],
2	of	IN	O	of	_	0	SENT_69	[p5l2076t3113r2150b3176],
3	presenilin	NN	O	presenilin	nn	5	SENT_69	[p5l7t3216r362b3299],
4	1	CD	NUMBER	1	num	5	SENT_69	[p5l394t3223r419b3278],
5	mutations	NNS	O	mutation	prep_of	1	SENT_69	[p5l450t3222r807b3279],
6	are	VBP	O	be	aux	8	SENT_69	[p5l833t3239r937b3279],
7	being	VBG	O	be	auxpass	8	SENT_69	[p5l960t3216r1158b3300],
8	enrolled	VBN	O	enrol	dep	33	SENT_69	[p5l1182t3216r1474b3279],
9	in	IN	O	in	_	0	SENT_69	[p5l1499t3222r1567b3278],
10	the	DT	O	the	det	11	SENT_69	[p5l1591t3216r1701b3279],
11	Alzheimer	NN	MISC	alzheimer	poss	14	SENT_69	[p5l1725t3216r2141b3279],
12	’s	POS	MISC	’s	_	0	SENT_69	[p5l1725t3216r2141b3279],
13	Prevention	NNP	MISC	Prevention	nn	14	SENT_69	[p5l9t3323r388b3381],
14	Initiative	NNP	MISC	Initiative	prep_in	8	SENT_69	[p5l411t3310r802b3390],
15	,26	CD	NUMBER	,26	dep	14	SENT_69	[p5l411t3310r802b3390],
16	and	CC	O	and	_	0	SENT_69	[p5l826t3318r954b3381],
17	carriers	NNS	O	carrier	conj_and	14	SENT_69	[p5l976t3324r1237b3381],
18	of	IN	O	of	_	0	SENT_69	[p5l1261t3318r1335b3381],
19	presenilin	NN	O	presenilin	prep_of	17	SENT_69	[p5l1347t3318r1693b3401],
20	1	CD	NUMBER	1	num	19	SENT_69	[p5l1723t3325r1773b3390],
21	,	,	O	,	_	0	SENT_69	[p5l1723t3325r1773b3390],
22	presenilin	NN	O	presenilin	prep_of	17	SENT_69	[p5l1796t3318r2142b3401],
23	2	CD	NUMBER	2	num	22	SENT_69	[p5l9t3428r64b3493],
24	,	,	O	,	_	0	SENT_69	[p5l9t3428r64b3493],
25	or	CC	O	or	_	0	SENT_69	[p5l88t3444r160b3484],
26	amyloid	NN	O	amyloid	nn	28	SENT_69	[p5l182t3421r458b3505],
27	precursor	NN	O	precursor	nn	28	SENT_69	[p5l478t3443r810b3504],
28	protein	NN	O	protein	prep_of	17	SENT_69	[p5l830t3427r1078b3504],
29	(	CD	NUMBER	(	num	32	SENT_69	[p5l1104t3422r1308b3497],
30	APP	NN	O	app	nn	32	SENT_69	[p5l1104t3422r1308b3497],
31	)	NN	O	)	nn	32	SENT_69	[p5l1104t3422r1308b3497],
32	mutations	NNS	O	mutation	nsubj	33	SENT_69	[p5l1334t3427r1678b3484],
33	comprise	VBP	O	comprise	_	0	SENT_69	[p5l1702t3427r2014b3504],
34	the	DT	O	the	det	36	SENT_69	[p5l2036t3421r2142b3484],
35	study	NN	O	study	nn	36	SENT_69	[p5l10t3524r204b3608],
36	populations	NNS	O	population	dobj	33	SENT_69	[p5l226t3524r652b3607],
37	for	IN	O	for	_	0	SENT_69	[p5l680t3524r781b3587],
38	the	DT	O	the	det	42	SENT_69	[p5l806t3524r917b3587],
39	Dominantly	NNP	O	Dominantly	nn	42	SENT_69	[p5l945t3524r1381b3608],
40	Inherited	NNP	O	Inherited	nn	42	SENT_69	[p5l1405t3524r1739b3587],
41	Alzheimer	NNP	ORGANIZATION	Alzheimer	nn	42	SENT_69	[p5l1764t3524r2142b3587],
42	Network	NNP	ORGANIZATION	Network	nsubj	48	SENT_69	[p5l8t3626r306b3689],
43	clinical	JJ	O	clinical	amod	44	SENT_69	[p5l324t3626r565b3689],
44	trials	NNS	O	trial	dep	42	SENT_69	[p5l584t3618r835b3689],
45	.27	CD	NUMBER	.27	dep	42	SENT_69	[p5l584t3618r835b3689],
46	A	DT	O	a	det	47	SENT_69	[p5l854t3630r911b3688],
47	trial	NN	O	trial	dep	45	SENT_69	[p5l930t3626r1069b3689],
48	involving	VBG	O	involve	prepc_for	33	SENT_69	[p5l1088t3626r1405b3710],
49	ApoE4	NN	O	apoe4	nn	50	SENT_69	[p5l1423t3630r1654b3709],
50	homozygotes	NNS	O	homozygote	nsubjpass	59	SENT_69	[p5l1673t3626r2139b3710],
51	,	,	O	,	_	0	SENT_69	[p5l1673t3626r2139b3710],
52	another	DT	O	another	det	55	SENT_69	[p5l9t3729r269b3792],
53	genetically	RB	O	genetically	advmod	54	SENT_69	[p5l288t3729r649b3813],
54	identiﬁed	JJ	O	identiﬁed	amod	55	SENT_69	[p5l665t3729r986b3792],
55	population	NN	O	population	appos	50	SENT_69	[p5l1003t3729r1389b3812],
56	,	,	O	,	_	0	SENT_69	[p5l1003t3729r1389b3812],
57	is	VBZ	O	be	auxpass	59	SENT_69	[p5l1411t3735r1460b3792],
58	also	RB	O	also	advmod	59	SENT_69	[p5l1481t3729r1609b3792],
59	planned	VBN	O	plan	ccomp	48	SENT_69	[p5l1629t3729r1903b3812],
60	as	IN	O	as	_	0	SENT_69	[p5l1923t3752r1986b3792],
61	part	NN	O	part	prep_as	59	SENT_69	[p5l2005t3741r2143b3812],
62	of	IN	O	of	_	0	SENT_69	[p6l9t16r83b79],
63	the	DT	O	the	det	64	SENT_69	[p6l94t16r200b79],
64	Alzheimer	NN	O	alzheimer	poss	67	SENT_69	[p6l221t16r622b79],
65	’s	POS	O	’s	_	0	SENT_69	[p6l221t16r622b79],
66	Prevention	NNP	O	Prevention	nn	67	SENT_69	[p6l645t21r1018b79],
67	Initiative	NNP	O	Initiative	prep_of	61	SENT_69	[p6l1040t21r1361b79],
68	.	.	O	.	_	0	SENT_69	[p6l1040t21r1361b79],

1	Persons	NNS	O	person	_	0	SENT_70	[p6l1386t21r1648b79],
2	with	IN	O	with	_	0	SENT_70	[p6l1669t16r1822b79],
3	trait	NN	O	trait	nn	4	SENT_70	[p6l1842t22r1984b79],
4	biomarkers	NNS	O	biomarker	prep_with	1	SENT_70	[p6l2003t16r2139b79, p6l8t119r283b182],

1	may	MD	O	may	aux	2	SENT_71	[p6l304t142r450b203],
2	have	VB	O	have	_	0	SENT_71	[p6l465t119r619b182],
3	no	DT	O	no	det	4	SENT_71	[p6l639t142r725b182],
4	evidence	NN	O	evidence	dobj	2	SENT_71	[p6l747t119r1043b182],
5	of	IN	O	of	_	0	SENT_71	[p6l1064t119r1137b182],
6	any	DT	O	any	det	8	SENT_71	[p6l1149t142r1269b203],
7	AD	NN	O	ad	nn	8	SENT_71	[p6l1285t123r1403b181],
8	pathology	NN	O	pathology	prep_of	4	SENT_71	[p6l1423t119r1768b203],
9	and	CC	O	and	_	0	SENT_71	[p6l1785t119r1911b182],
10	can	MD	O	can	aux	12	SENT_71	[p6l1930t142r2046b182],
11	be	VB	O	be	auxpass	12	SENT_71	[p6l2064t119r2143b182],
12	enrolled	VBN	O	enrol	conj_and	2	SENT_71	[p6l9t222r291b285],
13	in	IN	O	in	_	0	SENT_71	[p6l312t228r378b284],
14	primary	JJ	O	primary	amod	16	SENT_71	[p6l398t228r681b306],
15	prevention	NN	O	prevention	nn	16	SENT_71	[p6l698t228r1070b305],
16	trials	NNS	O	trial	prep_in	12	SENT_71	[p6l1090t222r1278b285],
17	.	.	O	.	_	0	SENT_71	[p6l1090t222r1278b285],

1	State	NNP	O	State	nn	2	SENT_72	[p6l83t329r243b388],
2	biomarkers	NNS	O	biomarker	nsubj	3	SENT_72	[p6l264t325r651b388],
3	indicate	VBP	O	indicate	_	0	SENT_72	[p6l674t325r944b388],
4	the	DT	O	the	det	5	SENT_72	[p6l966t325r1072b388],
5	presence	NN	O	presence	dobj	3	SENT_72	[p6l1093t347r1391b408],
6	and	CC	O	and	_	0	SENT_72	[p6l1414t325r1567b391],
7	/	:	O	/	punct	10	SENT_72	[p6l1414t325r1567b391],
8	or	CC	O	or	dep	10	SENT_72	[p6l1572t348r1644b388],
9	the	DT	O	the	det	10	SENT_72	[p6l1664t325r1770b388],
10	severity	NN	O	severity	dep	5	SENT_72	[p6l1793t331r2059b409],
11	of	IN	O	of	advmod	10	SENT_72	[p6l2078t325r2152b388],
12	AD	NN	O	ad	dobj	3	SENT_72	[p6l8t432r138b491],
13	.	.	O	.	_	0	SENT_72	[p6l8t432r138b491],

1	They	PRP	O	they	nsubjpass	4	SENT_73	[p6l161t428r327b512],
2	can	MD	O	can	aux	4	SENT_73	[p6l344t451r458b491],
3	be	VB	O	be	auxpass	4	SENT_73	[p6l475t428r553b491],
4	used	VBN	O	use	_	0	SENT_73	[p6l573t428r728b491],
5	for	IN	O	for	_	0	SENT_73	[p6l746t428r841b491],
6	diagnosis	NN	O	diagnosis	prep_for	4	SENT_73	[p6l860t428r1190b512],
7	,	,	O	,	_	0	SENT_73	[p6l860t428r1190b512],
8	staging	NN	O	staging	prep_for	4	SENT_73	[p6l1213t434r1467b512],
9	,	,	O	,	_	0	SENT_73	[p6l1213t434r1467b512],
10	or	CC	O	or	_	0	SENT_73	[p6l1488t451r1559b491],
11	outcomes	NNS	O	outcome	nn	12	SENT_73	[p6l1578t440r1898b491],
12	assessment	NN	O	assessment	prep_for	4	SENT_73	[p6l1919t451r2139b491, p6l8t543r201b594],
13	.	.	O	.	_	0	SENT_73	[p6l1919t451r2139b491, p6l8t543r201b594],

1	The	DT	O	the	dep	112	SENT_74	[p6l227t531r352b594],
2	principal	JJ	O	principal	dep	112	SENT_74	[p6l374t531r685b614],
3	state	NN	O	state	dep	112	SENT_74	[p6l709t543r861b594],
4	biomarkers	NNS	O	biomarker	dep	112	SENT_74	[p6l882t531r1272b594],
5	include	VBP	O	include	dep	112	SENT_74	[p6l1295t531r1548b594],
6	atrophy	NN	O	atrophy	dep	112	SENT_74	[p6l1571t531r1837b615],
7	on	IN	O	on	dep	112	SENT_74	[p6l1857t554r1943b594],
8	MRI	NNP	O	MRI	dep	112	SENT_74	[p6l1966t536r2141b603],
9	;	:	O	;	_	0	SENT_74	[p6l1966t536r2141b603],
10	amyloid	NN	O	amyloid	dep	112	SENT_74	[p6l9t634r285b718],
11	deposition	NN	O	deposition	dep	112	SENT_74	[p6l307t634r669b717],
12	on	IN	O	on	dep	112	SENT_74	[p6l691t657r777b697],
13	amyloid	NN	O	amyloid	dep	112	SENT_74	[p6l800t634r1076b718],
14	imaging	NN	O	imaging	dep	112	SENT_74	[p6l1097t640r1393b718],
15	;	:	O	;	_	0	SENT_74	[p6l1097t640r1393b718],
16	changes	NNS	O	change	dep	112	SENT_74	[p6l1417t634r1686b718],
17	in	IN	O	in	dep	112	SENT_74	[p6l1708t640r1775b696],
18	CSF	NN	O	csf	dep	112	SENT_74	[p6l1798t638r1934b697],
19	levels	NNS	O	level	dep	112	SENT_74	[p6l1956t634r2141b697],
20	of	IN	O	of	dep	112	SENT_74	[p6l9t736r83b799],
21	tau	NN	O	tau	dep	112	SENT_74	[p6l94t748r218b808],
22	,	,	O	,	_	0	SENT_74	[p6l94t748r218b808],
23	hyperphosphorylated	VBN	O	hyperphosphorylate	dep	112	SENT_74	[p6l240t736r979b820],
24	tau	FW	O	tau	dep	112	SENT_74	[p6l999t748r1106b799],
25	(	FW	O	(	dep	112	SENT_74	[p6l1131t737r1386b819],
26	p-tau	FW	O	p-tau	dep	112	SENT_74	[p6l1131t737r1386b819],
27	)	FW	O	)	dep	112	SENT_74	[p6l1131t737r1386b819],
28	,	,	O	,	_	0	SENT_74	[p6l1131t737r1386b819],
29	or	CC	O	or	dep	112	SENT_74	[p6l1410t759r1482b799],
30	AB1_42	NN	O	ab1_42	dep	112	SENT_74	[p6l1502t734r1751b827],
31	;	:	O	;	_	0	SENT_74	[p6l1502t734r1751b827],
32	or	CC	O	or	dep	112	SENT_74	[p6l1775t759r1847b799],
33	reduced	VBN	O	reduce	dep	112	SENT_74	[p6l1868t736r2143b799],
34	metabolism	NN	O	metabolism	dep	112	SENT_74	[p6l8t839r419b902],
35	on	IN	O	on	dep	112	SENT_74	[p6l443t862r530b902],
36	ﬂuorodeoxyglucose	NN	O	ﬂuorodeoxyglucose	dep	112	SENT_74	[p6l554t839r1236b923],
37	(	CD	NUMBER	(	dep	112	SENT_74	[p6l1263t839r1488b916],
38	FDG	NN	O	fdg	dep	112	SENT_74	[p6l1263t839r1488b916],
39	)	CD	NUMBER	)	dep	112	SENT_74	[p6l1263t839r1488b916],
40	positron	NN	O	positron	dep	112	SENT_74	[p6l1514t845r1809b922],
41	emission	NN	O	emission	dep	112	SENT_74	[p6l1834t845r2142b902],
42	tomography	NN	O	tomography	dep	112	SENT_74	[p6l8t941r429b1025],
43	(	CD	NUMBER	(	dep	112	SENT_74	[p6l449t933r887b1018],
44	PET	NN	O	pet	dep	112	SENT_74	[p6l449t933r887b1018],
45	)	CD	NUMBER	)	dep	112	SENT_74	[p6l449t933r887b1018],
46	.15	NN	NUMBER	.15	dep	112	SENT_74	[p6l449t933r887b1018],
47	=	JJ	O	=	dep	112	SENT_74	[p6l449t933r887b1018],
48	28	CD	NUMBER	28	dep	112	SENT_74	[p6l449t933r887b1018],
49	’29	CD	NUMBER	’29	dep	112	SENT_74	[p6l449t933r887b1018],
50	These	DT	O	these	dep	112	SENT_74	[p6l908t941r1102b1004],
51	biomarkers	NNS	O	biomarker	dep	112	SENT_74	[p6l1120t941r1508b1004],
52	have	VBP	O	have	dep	112	SENT_74	[p6l1528t941r1683b1004],
53	been	VBN	O	be	dep	112	SENT_74	[p6l1702t941r1866b1004],
54	divided	VBN	O	divide	dep	112	SENT_74	[p6l1887t941r2143b1004],
55	into	IN	O	into	dep	112	SENT_74	[p6l9t1050r142b1107],
56	those	DT	O	those	dep	112	SENT_74	[p6l162t1044r343b1107],
57	indicating	VBG	O	indicate	dep	112	SENT_74	[p6l364t1044r708b1128],
58	abnormalities	NNS	O	abnormality	dep	112	SENT_74	[p6l727t1044r1192b1107],
59	of	IN	O	of	dep	112	SENT_74	[p6l1213t1044r1287b1107],
60	amyloid	NN	O	amyloid	dep	112	SENT_74	[p6l1298t1044r1572b1128],
61	physiology	NN	O	physiology	dep	112	SENT_74	[p6l1590t1044r1963b1128],
62	(	CD	NUMBER	(	dep	112	SENT_74	[p6l1983t1044r2146b1121],
63	CSF	NN	O	csf	dep	112	SENT_74	[p6l1983t1044r2146b1121],
64	amyloid	NN	O	amyloid	dep	112	SENT_74	[p6l10t1147r291b1231],
65	and	CC	O	and	dep	112	SENT_74	[p6l314t1147r442b1210],
66	amyloid	NN	O	amyloid	dep	112	SENT_74	[p6l465t1147r746b1231],
67	imaging	NN	O	imaging	dep	112	SENT_74	[p6l768t1148r1077b1231],
68	)	NN	O	)	dep	112	SENT_74	[p6l768t1148r1077b1231],
69	and	CC	O	and	dep	112	SENT_74	[p6l1105t1147r1233b1210],
70	those	DT	O	those	dep	112	SENT_74	[p6l1254t1147r1440b1210],
71	indicating	VBG	O	indicate	dep	112	SENT_74	[p6l1463t1147r1816b1231],
72	neuronal	JJ	O	neuronal	dep	112	SENT_74	[p6l1838t1147r2150b1210],
73	injury	NN	O	injury	dep	112	SENT_74	[p6l10t1256r228b1334],
74	(	CD	NUMBER	(	dep	112	SENT_74	[p6l253t1251r424b1326],
75	CSF	NN	O	csf	dep	112	SENT_74	[p6l253t1251r424b1326],
76	tau	NN	O	tau	dep	112	SENT_74	[p6l450t1262r561b1313],
77	and	CC	O	and	dep	112	SENT_74	[p6l586t1250r717b1313],
78	p-tau	NN	O	p-tau	dep	112	SENT_74	[p6l740t1262r949b1333],
79	,	,	O	,	_	0	SENT_74	[p6l740t1262r949b1333],
80	MRI	NNP	O	MRI	dep	112	SENT_74	[p6l976t1255r1136b1313],
81	atrophy	NN	O	atrophy	dep	112	SENT_74	[p6l1164t1250r1448b1334],
82	,	,	O	,	_	0	SENT_74	[p6l1164t1250r1448b1334],
83	and	CC	O	and	dep	112	SENT_74	[p6l1477t1250r1607b1313],
84	FDG	NN	O	fdg	dep	112	SENT_74	[p6l1633t1254r1806b1313],
85	hypometabolism	NN	O	hypometabolism	dep	112	SENT_74	[p6l1830t1250r2147b1334, p6l8t1344r424b1430],
86	)	CD	NUMBER	)	dep	112	SENT_74	[p6l1830t1250r2147b1334, p6l8t1344r424b1430],
87	.3	NN	NUMBER	.3	dep	112	SENT_74	[p6l1830t1250r2147b1334, p6l8t1344r424b1430],
88	°	CD	NUMBER	°	dep	112	SENT_74	[p6l1830t1250r2147b1334, p6l8t1344r424b1430],
89	Alternatively	RB	O	alternatively	dep	112	SENT_74	[p6l448t1352r911b1437],
90	,	,	O	,	_	0	SENT_74	[p6l448t1352r911b1437],
91	biomarkers	NNS	O	biomarker	dep	112	SENT_74	[p6l935t1352r1331b1416],
92	have	VBP	O	have	dep	112	SENT_74	[p6l1354t1352r1512b1416],
93	been	VBN	O	be	dep	112	SENT_74	[p6l1534t1352r1701b1416],
94	described	VBN	O	describe	dep	112	SENT_74	[p6l1725t1352r2062b1416],
95	as	IN	O	as	dep	112	SENT_74	[p6l2085t1375r2150b1416],
96	pathophysiological	JJ	O	pathophysiological	dep	112	SENT_74	[p6l8t1456r654b1540],
97	markers	NNS	O	marker	dep	112	SENT_74	[p6l674t1456r950b1519],
98	(	VBP	O	(	dep	112	SENT_74	[p6l974t1456r1138b1533],
99	CSF	NN	O	csf	dep	112	SENT_74	[p6l974t1456r1138b1533],
100	assays	NNS	O	assay	dep	112	SENT_74	[p6l1161t1479r1381b1540],
101	,	,	O	,	_	0	SENT_74	[p6l1161t1479r1381b1540],
102	amyloid	JJ	O	amyloid	dep	112	SENT_74	[p6l1405t1456r1680b1540],
103	imaging	NN	O	imaging	dep	112	SENT_74	[p6l1699t1457r2001b1540],
104	)	NN	O	)	dep	112	SENT_74	[p6l1699t1457r2001b1540],
105	and	CC	O	and	dep	112	SENT_74	[p6l2027t1456r2152b1519],
106	topographic	JJ	O	topographic	dep	112	SENT_74	[p6l8t1559r413b1643],
107	markers	NNS	O	marker	dep	112	SENT_74	[p6l432t1559r702b1622],
108	(	VBP	O	(	dep	112	SENT_74	[p6l726t1560r921b1635],
109	MRI	NNP	O	MRI	dep	112	SENT_74	[p6l726t1560r921b1635],
110	,	,	O	,	_	0	SENT_74	[p6l726t1560r921b1635],
111	FDG-PET	NNP	O	FDG-PET	dep	112	SENT_74	[p6l943t1560r1328b1635],
112	)	CD	NUMBER	)	_	0	SENT_74	[p6l943t1560r1328b1635],
113	.	.	O	.	_	0	SENT_74	[p6l943t1560r1328b1635],

1	Molecular	JJ	O	molecular	amod	2	SENT_75	[p6l1350t1559r1690b1622],
2	markers	NNS	O	marker	dep	3	SENT_75	[p6l1709t1559r1978b1622],
3	have	VBP	O	have	_	0	SENT_75	[p6l1997t1559r2149b1622],
4	greater	JJR	O	greater	amod	6	SENT_75	[p6l9t1674r247b1746],
5	diagnostic	JJ	O	diagnostic	amod	6	SENT_75	[p6l267t1662r620b1746],
6	importance	NN	O	importance	dobj	3	SENT_75	[p6l641t1668r1036b1745],
7	and	CC	O	and	_	0	SENT_75	[p6l1058t1662r1184b1725],
8	topographic	JJ	O	topographic	amod	9	SENT_75	[p6l1203t1662r1620b1746],
9	markers	NNS	O	marker	dobj	3	SENT_75	[p6l1640t1662r1918b1725],
10	reﬂect	JJ	O	reﬂect	amod	12	SENT_75	[p6l1940t1662r2151b1725],
11	disease	NN	O	disease	nn	12	SENT_75	[p6l10t1764r251b1828],
12	progression	NN	O	progression	dep	9	SENT_75	[p6l271t1756r833b1849],
13	.3132	CD	NUMBER	.3132	nsubj	3	SENT_75	[p6l271t1756r833b1849],

1	Biomarkers	NNS	O	biomarker	nsubj	2	SENT_76	[p6l84t1868r494b1931],
2	appear	VBP	O	appear	ccomp	36	SENT_76	[p6l522t1890r761b1951],
3	sequentially	RB	O	sequentially	advmod	2	SENT_76	[p6l788t1868r1220b1952],
4	in	IN	O	in	_	0	SENT_76	[p6l1243t1874r1312b1930],
5	the	DT	O	the	det	6	SENT_76	[p6l1337t1868r1447b1931],
6	course	NN	O	course	prep_in	2	SENT_76	[p6l1475t1891r1706b1931],
7	of	IN	O	of	_	0	SENT_76	[p6l1734t1868r1810b1931],
8	AD	NN	O	ad	prep_of	6	SENT_76	[p6l1825t1872r1965b1940],
9	,	,	O	,	_	0	SENT_76	[p6l1825t1872r1965b1940],
10	with	IN	O	with	_	0	SENT_76	[p6l1992t1868r2151b1931],
11	CSF	NN	ORGANIZATION	csf	nn	12	SENT_76	[p6l11t1975r148b2034],
12	AB	NNP	ORGANIZATION	AB	prep_with	2	SENT_76	[p6l170t1969r273b2052],
13	declining	VBG	O	decline	partmod	12	SENT_76	[p6l297t1971r616b2055],
14	ﬁrst	NN	O	ﬁrst	nn	18	SENT_76	[p6l636t1971r786b2043],
15	,	,	O	,	_	0	SENT_76	[p6l636t1971r786b2043],
16	~	NN	O	~	dep	18	SENT_76	[p6l812t1978r938b2034],
17	20	CD	DURATION	20	num	18	SENT_76	[p6l812t1978r938b2034],
18	years	NNS	NUMBER	year	tmod	13	SENT_76	[p6l959t1994r1134b2055],
19	before	IN	O	before	_	0	SENT_76	[p6l1154t1971r1370b2034],
20	the	DT	O	the	det	21	SENT_76	[p6l1391t1971r1497b2034],
21	onset	NN	O	onset	prep_before	13	SENT_76	[p6l1520t1983r1703b2034],
22	of	IN	O	of	_	0	SENT_76	[p6l1723t1971r1797b2034],
23	dementia	NN	O	dementia	prep_of	21	SENT_76	[p6l1811t1971r2148b2043],
24	;	:	O	;	_	0	SENT_76	[p6l1811t1971r2148b2043],
25	this	DT	O	this	nsubjpass	27	SENT_76	[p6l8t2074r136b2137],
26	is	VBZ	O	be	auxpass	27	SENT_76	[p6l161t2080r212b2137],
27	followed	VBN	O	follow	parataxis	2	SENT_76	[p6l236t2074r539b2137],
28	by	IN	O	by	_	0	SENT_76	[p6l559t2074r645b2158],
29	onset	NN	O	onset	agent	27	SENT_76	[p6l666t2086r853b2137],
30	of	IN	O	of	_	0	SENT_76	[p6l876t2074r952b2137],
31	positive	JJ	O	positive	amod	33	SENT_76	[p6l964t2080r1239b2157],
32	amyloid	NN	O	amyloid	nn	33	SENT_76	[p6l1264t2074r1548b2158],
33	imaging	NN	O	imaging	prep_of	29	SENT_76	[p6l1571t2080r1876b2158],
34	,	,	O	,	_	0	SENT_76	[p6l1571t2080r1876b2158],
35	usually	RB	O	usually	advmod	36	SENT_76	[p6l1901t2074r2153b2158],
36	~	VBP	O	~	_	0	SENT_76	[p6l12t2184r137b2240],
37	15	CD	DURATION	15	num	38	SENT_76	[p6l12t2184r137b2240],
38	years	NNS	NUMBER	year	nsubj	36	SENT_76	[p6l159t2200r335b2261],
39	before	IN	O	before	_	0	SENT_76	[p6l356t2177r572b2240],
40	the	DT	O	the	det	41	SENT_76	[p6l594t2177r701b2240],
41	onset	NN	O	onset	prep_before	38	SENT_76	[p6l724t2189r907b2240],
42	of	IN	O	of	_	0	SENT_76	[p6l929t2177r1003b2240],
43	dementia	NN	O	dementia	prep_of	41	SENT_76	[p6l1017t2177r1355b2249],
44	;	:	O	;	_	0	SENT_76	[p6l1017t2177r1355b2249],
45	CSF	NN	O	csf	nn	47	SENT_76	[p6l1381t2181r1518b2240],
46	tau	NN	O	tau	nn	47	SENT_76	[p6l1541t2189r1648b2240],
47	increase	NN	O	increase	conj_and	38	SENT_76	[p6l1670t2183r1967b2249],
48	,	,	O	,	_	0	SENT_76	[p6l1670t2183r1967b2249],
49	MRI	NNP	O	MRI	nn	50	SENT_76	[p6l1991t2182r2147b2240],
50	atrophy	NN	O	atrophy	appos	47	SENT_76	[p6l10t2280r293b2364],
51	,	,	O	,	_	0	SENT_76	[p6l10t2280r293b2364],
52	and	CC	O	and	_	0	SENT_76	[p6l320t2280r450b2343],
53	FDG	NNP	O	FDG	conj_and	38	SENT_76	[p6l474t2283r834b2343],
54	.	.	O	.	_	0	SENT_76	[p6l474t2283r834b2343],

1	—	NN	O	—	_	0	SENT_77	[p6l474t2283r834b2343],
2	.	.	O	.	_	0	SENT_77	[p6l474t2283r834b2343],

1	PET	NN	O	pet	nn	2	SENT_78	[p6l474t2283r834b2343],
2	hypometabolism	NN	O	hypometabolism	nsubj	4	SENT_78	[p6l858t2280r1455b2364],
3	all	DT	O	all	advmod	4	SENT_78	[p6l1480t2280r1562b2343],
4	have	VBP	O	have	_	0	SENT_78	[p6l1585t2280r1745b2343],
5	their	PRP$	O	they	poss	7	SENT_78	[p6l1769t2280r1937b2343],
6	onset	NN	O	onset	nn	7	SENT_78	[p6l1961t2292r2150b2343],
7	~	NN	O	~	dobj	4	SENT_78	[p6l12t2390r137b2446],
8	10	CD	DURATION	10	num	9	SENT_78	[p6l12t2390r137b2446],
9	years	NNS	NUMBER	year	npadvmod	4	SENT_78	[p6l157t2406r332b2467],
10	before	IN	O	before	_	0	SENT_78	[p6l351t2383r566b2446],
11	dementia	NN	O	dementia	prep_before	4	SENT_78	[p6l587t2383r925b2455],
12	;	:	O	;	_	0	SENT_78	[p6l587t2383r925b2455],
13	memory	NN	O	memory	nn	14	SENT_78	[p6l947t2406r1242b2467],
14	loss	NN	O	loss	nsubj	17	SENT_78	[p6l1258t2383r1383b2446],
15	appears	VBZ	O	appear	cop	17	SENT_78	[p6l1406t2405r1665b2466],
16	5	CD	DURATION	5	num	17	SENT_78	[p6l1688t2391r1722b2446],
17	years	NNS	NUMBER	year	conj_and	4	SENT_78	[p6l1742t2406r1917b2467],
18	before	IN	O	before	_	0	SENT_78	[p6l1936t2383r2151b2446],
19	dementia	NN	O	dementia	nn	20	SENT_78	[p6l10t2486r324b2549],
20	onset	NN	O	onset	prep_before	17	SENT_78	[p6l344t2498r523b2549],
21	(	CD	NUMBER	(	num	20	SENT_78	[p6l545t2486r742b2562],
22	these	DT	O	these	det	23	SENT_78	[p6l545t2486r742b2562],
23	patients	NNS	O	patient	nsubj	24	SENT_78	[p6l761t2492r1026b2569],
24	meet	VBP	O	meet	dep	17	SENT_78	[p6l1046t2498r1212b2549],
25	criteria	NNS	O	criterion	dobj	24	SENT_78	[p6l1231t2492r1471b2549],
26	for	IN	O	for	_	0	SENT_78	[p6l1489t2486r1585b2549],
27	prodromal	JJ	O	prodromal	amod	29	SENT_78	[p6l1603t2486r1965b2569],
28	AD	NN	O	ad	nn	29	SENT_78	[p6l1983t2487r2149b2563],
29	)	NN	O	)	prep_for	25	SENT_78	[p6l1983t2487r2149b2563],
30	;	:	O	;	_	0	SENT_78	[p6l1983t2487r2149b2563],
31	then	RB	O	then	advmod	32	SENT_78	[p6l8t2588r162b2652],
32	functional	JJ	O	functional	amod	33	SENT_78	[p6l182t2588r534b2652],
33	decline	NN	O	decline	nsubj	34	SENT_78	[p6l555t2588r797b2652],
34	occurs	VBZ	O	occur	conj_and	4	SENT_78	[p6l818t2611r1040b2652],
35	and	CC	O	and	_	0	SENT_78	[p6l1062t2588r1188b2652],
36	dementia	NN	O	dementia	nsubjpass	38	SENT_78	[p6l1207t2588r1527b2652],
37	is	VBZ	O	be	auxpass	38	SENT_78	[p6l1546t2595r1596b2652],
38	recognized	VBN	O	recognize	conj_and	4	SENT_78	[p6l1617t2580r2150b2673],
39	.3334	CD	NUMBER	.3334	num	40	SENT_78	[p6l1617t2580r2150b2673],
40	Variations	NNS	O	variation	nsubjpass	47	SENT_78	[p6l8t2697r354b2755],
41	in	IN	O	in	_	0	SENT_78	[p6l375t2698r441b2754],
42	these	DT	O	these	det	44	SENT_78	[p6l460t2692r634b2755],
43	sequential	JJ	O	sequential	amod	44	SENT_78	[p6l656t2692r1000b2775],
44	trajectories	NNS	O	trajectory	prep_in	40	SENT_78	[p6l1018t2698r1396b2776],
45	have	VBP	O	have	aux	47	SENT_78	[p6l1416t2692r1570b2755],
46	been	VBN	O	be	auxpass	47	SENT_78	[p6l1588t2692r1751b2755],
47	reported	VBN	O	report	ccomp	38	SENT_78	[p6l1771t2692r2064b2775],
48	in	IN	O	in	_	0	SENT_78	[p6l2083t2698r2149b2754],
49	up	RB	O	up	quantmod	51	SENT_78	[p6l9t2817r93b2878],
50	to	TO	O	to	dep	51	SENT_78	[p6l114t2807r179b2858],
51	25	CD	PERCENT	25	num	52	SENT_78	[p6l201t2801r342b2860],
52	%	NN	PERCENT	%	prep_in	47	SENT_78	[p6l201t2801r342b2860],
53	of	IN	O	of	_	0	SENT_78	[p6l365t2795r438b2858],
54	patients	NNS	O	patient	prep_of	52	SENT_78	[p6l447t2801r731b2878],
55	.	.	O	.	_	0	SENT_78	[p6l447t2801r731b2878],

1	Delaying	VBG	O	delay	csubj	11	SENT_79	[p6l754t2795r1058b2879],
2	the	DT	O	the	det	3	SENT_79	[p6l1075t2795r1181b2858],
3	time	NN	O	time	dobj	1	SENT_79	[p6l1200t2801r1353b2858],
4	to	TO	O	to	_	0	SENT_79	[p6l1372t2807r1437b2858],
5	onset	NN	O	onset	prep_to	1	SENT_79	[p6l1460t2807r1640b2858],
6	of	IN	O	of	_	0	SENT_79	[p6l1659t2795r1732b2858],
7	a	DT	O	a	det	9	SENT_79	[p6l1744t2818r1778b2858],
8	biomarker	NN	O	biomarker	nn	9	SENT_79	[p6l1795t2795r2150b2858],
9	change	NN	O	change	prep_of	5	SENT_79	[p6l10t2898r248b2982],
10	could	MD	O	could	aux	11	SENT_79	[p6l271t2898r462b2961],
11	play	VB	O	play	_	0	SENT_79	[p6l482t2898r626b2982],
12	a	DT	O	a	det	13	SENT_79	[p6l646t2921r681b2961],
13	role	NN	O	role	dobj	11	SENT_79	[p6l702t2898r831b2961],
14	as	IN	O	as	_	0	SENT_79	[p6l855t2921r919b2961],
15	a	DT	O	a	det	16	SENT_79	[p6l943t2921r978b2961],
16	measure	NN	O	measure	prep_as	11	SENT_79	[p6l999t2921r1286b2961],
17	of	IN	O	of	_	0	SENT_79	[p6l1309t2898r1383b2961],
18	activity	NN	O	activity	prep_of	16	SENT_79	[p6l1397t2904r1650b2982],
19	in	IN	O	in	_	0	SENT_79	[p6l1669t2904r1736b2960],
20	drug	NN	O	drug	nn	22	SENT_79	[p6l1759t2898r1921b2982],
21	development	NN	O	development	nn	22	SENT_79	[p6l1943t2898r2147b2961, p6l10t3013r283b3084],
22	programs	NNS	O	program	prep_in	18	SENT_79	[p6l305t3023r664b3085],
23	.	.	O	.	_	0	SENT_79	[p6l305t3023r664b3085],

1	Individuals	NNS	O	individual	nsubjpass	11	SENT_80	[p6l693t3001r1093b3064],
2	with	IN	O	with	_	0	SENT_80	[p6l1117t3001r1275b3064],
3	evidence	NN	O	evidence	prep_with	1	SENT_80	[p6l1301t3001r1611b3064],
4	of	IN	O	of	_	0	SENT_80	[p6l1638t3001r1713b3064],
5	AD	NN	O	ad	prep_of	3	SENT_80	[p6l1728t3005r1850b3063],
6	on	IN	O	on	_	0	SENT_80	[p6l1877t3024r1966b3064],
7	state	NN	O	state	nn	8	SENT_80	[p6l1992t3013r2150b3064],
8	biomarkers	NNS	O	biomarker	prep_on	5	SENT_80	[p6l7t3105r401b3168],
9	may	MD	O	may	aux	11	SENT_80	[p6l424t3128r573b3189],
10	be	VB	O	be	auxpass	11	SENT_80	[p6l590t3105r671b3168],
11	engaged	VBN	O	engage	_	0	SENT_80	[p6l695t3105r979b3189],
12	in	IN	O	in	_	0	SENT_80	[p6l1001t3111r1068b3167],
13	secondary	JJ	O	secondary	amod	14	SENT_80	[p6l1092t3105r1450b3189],
14	prevention	NN	O	prevention	prep_in	11	SENT_80	[p6l1468t3111r1845b3188],
15	or	CC	O	or	_	0	SENT_80	[p6l1869t3128r1942b3168],
16	treatment	NN	O	treatment	nn	17	SENT_80	[p6l1962t3117r2148b3168, p6l9t3220r187b3271],
17	trials	NNS	O	trial	conj_or	14	SENT_80	[p6l207t3208r380b3271],
18	depending	VBG	O	depend	_	0	SENT_80	[p6l404t3208r772b3292],
19	on	IN	O	on	prepc_depending_on	11	SENT_80	[p6l793t3231r879b3271],
20	whether	IN	O	whether	complm	24	SENT_80	[p6l900t3208r1185b3271],
21	they	PRP	O	they	nsubj	26	SENT_80	[p6l1206t3208r1357b3292],
22	are	VBP	O	be	cop	24	SENT_80	[p6l1377t3231r1478b3271],
23	cognitively	RB	O	cognitively	advmod	24	SENT_80	[p6l1502t3208r1880b3292],
24	normal	JJ	O	normal	pcomp	11	SENT_80	[p6l1899t3208r2151b3271],
25	or	CC	O	or	_	0	SENT_80	[p6l10t3334r82b3374],
26	exhibit	VBP	O	exhibit	pcomp	11	SENT_80	[p6l103t3311r338b3374],
27	cognitive	JJ	O	cognitive	amod	28	SENT_80	[p6l359t3317r672b3395],
28	decline	NN	O	decline	dobj	26	SENT_80	[p6l694t3311r955b3374],
29	.	.	O	.	_	0	SENT_80	[p6l694t3311r955b3374],

1	BIOMARKERS	NNS	O	biomarker	_	0	SENT_81	[p6l13t3526r491b3582],
2	IN	IN	O	in	_	0	SENT_81	[p6l513t3527r582b3581],
3	PRECLINICAL	NNP	O	PRECLINICAL	nn	4	SENT_81	[p6l606t3527r1076b3582],
4	STUDIES	NNPS	O	STUDIES	prep_in	1	SENT_81	[p6l1095t3527r1401b3582],
5	OF	IN	O	of	_	0	SENT_81	[p6l1420t3526r1514b3582],
6	AD	NN	O	ad	prep_of	1	SENT_81	[p6l1533t3527r1637b3581],

1	Animal	NN	O	animal	nn	2	SENT_82	[p7l8t27r267b90],
2	models	NNS	O	model	nsubj	3	SENT_82	[p7l287t27r534b90],
3	play	VBP	O	play	_	0	SENT_82	[p7l554t27r698b111],
4	an	DT	O	a	det	6	SENT_82	[p7l715t50r796b90],
5	important	JJ	O	important	amod	6	SENT_82	[p7l816t33r1164b110],
6	role	NN	O	role	dep	3	SENT_82	[p7l1184t27r1313b90],
7	in	IN	O	in	_	0	SENT_82	[p7l1334t33r1400b89],
8	the	DT	O	the	det	10	SENT_82	[p7l1420t27r1527b90],
9	preclinical	JJ	O	preclinical	amod	10	SENT_82	[p7l1546t27r1906b110],
10	phases	NNS	O	phase	prep_in	6	SENT_82	[p7l1924t27r2151b110],
11	of	IN	O	of	_	0	SENT_82	[p7l10t129r86b193],
12	AD	NN	O	ad	nn	14	SENT_82	[p7l99t133r221b192],
13	drug	NN	O	drug	nn	14	SENT_82	[p7l248t129r416b214],
14	development	NN	O	development	prep_of	10	SENT_82	[p7l439t121r1062b213],
15	.3536	CD	NUMBER	.3536	num	17	SENT_82	[p7l439t121r1062b213],
16	Animal	NNP	O	Animal	nn	17	SENT_82	[p7l1086t129r1353b193],
17	systems	NNS	O	system	nsubj	20	SENT_82	[p7l1378t141r1649b214],
18	do	VBP	O	do	aux	20	SENT_82	[p7l1674t129r1761b193],
19	not	RB	O	not	neg	20	SENT_82	[p7l1787t141r1904b193],
20	model	VB	O	model	rcmod	14	SENT_82	[p7l1927t129r2150b193],
21	the	DT	O	the	det	23	SENT_82	[p7l8t233r114b296],
22	complex	NN	O	complex	nn	23	SENT_82	[p7l136t233r425b316],
23	spectrum	NN	O	spectrum	dobj	20	SENT_82	[p7l445t245r767b316],
24	of	IN	O	of	_	0	SENT_82	[p7l788t233r861b296],
25	changes	NNS	O	change	prep_of	23	SENT_82	[p7l873t233r1140b317],
26	of	IN	O	of	_	0	SENT_82	[p7l1162t233r1236b296],
27	human	JJ	O	human	amod	28	SENT_82	[p7l1246t233r1487b296],
28	AD	NN	O	ad	prep_of	25	SENT_82	[p7l1507t237r1625b295],
29	and	CC	O	and	_	0	SENT_82	[p7l1648t233r1774b296],
30	are	VBP	O	be	conj_and	20	SENT_82	[p7l1794t256r1894b296],
31	mainly	RB	O	mainly	advmod	30	SENT_82	[p7l1914t233r2153b317],
32	of	IN	O	of	_	0	SENT_82	[p7l10t336r86b399],
33	value	NN	O	value	prep_of	30	SENT_82	[p7l100t336r289b399],
34	in	IN	O	in	_	0	SENT_82	[p7l316t342r385b398],
35	representing	VBG	O	represent	prepc_in	20	SENT_82	[p7l411t342r861b420],
36	components	NNS	O	component	dobj	35	SENT_82	[p7l886t348r1325b419],
37	of	IN	O	of	_	0	SENT_82	[p7l1353t336r1429b399],
38	the	DT	O	the	det	40	SENT_82	[p7l1445t336r1555b399],
39	disease	NN	O	disease	nn	40	SENT_82	[p7l1583t336r1834b399],
40	(	NN	O	(	prep_of	36	SENT_82	[p7l1865t336r2055b412],
41	such	JJ	O	such	_	0	SENT_82	[p7l1865t336r2055b412],
42	as	IN	O	as	_	0	SENT_82	[p7l2082t359r2148b399],
43	increased	VBN	O	increase	amod	45	SENT_82	[p7l9t439r337b502],
44	AB	NNP	O	AB	nn	45	SENT_82	[p7l358t437r462b520],
45	production	NN	O	production	prep_such_as	35	SENT_82	[p7l484t439r873b522],
46	or	CC	O	or	_	0	SENT_82	[p7l896t462r968b502],
47	decreased	VBN	O	decrease	amod	50	SENT_82	[p7l991t439r1331b502],
48	AB	NNP	O	AB	nn	50	SENT_82	[p7l1352t437r1455b520],
49	removal	NN	O	removal	nn	50	SENT_82	[p7l1480t439r1806b516],
50	)	NN	O	)	dep	3	SENT_82	[p7l1480t439r1806b516],
51	.	.	O	.	_	0	SENT_82	[p7l1480t439r1806b516],

1	The	DT	O	the	det	6	SENT_83	[p7l1831t439r1957b502],
2	most	RBS	O	most	advmod	4	SENT_83	[p7l1980t451r2151b502],
3	commonly	RB	O	commonly	advmod	4	SENT_83	[p7l10t542r383b626],
4	used	VBN	O	use	amod	6	SENT_83	[p7l401t542r560b605],
5	animal	NN	O	animal	nn	6	SENT_83	[p7l582t542r817b605],
6	models	NNS	O	model	nsubj	12	SENT_83	[p7l839t542r1086b605],
7	are	VBP	O	be	cop	12	SENT_83	[p7l1110t565r1210b605],
8	transgenic	JJ	O	transgenic	amod	12	SENT_83	[p7l1232t548r1588b626],
9	(	NN	O	(	nn	12	SENT_83	[p7l1614t542r1730b626],
10	tg	NN	O	tg	nn	12	SENT_83	[p7l1614t542r1730b626],
11	)	NN	O	)	nn	12	SENT_83	[p7l1614t542r1730b626],
12	species	NNS	O	species	_	0	SENT_83	[p7l1757t548r1995b625],
13	created	VBN	O	create	partmod	12	SENT_83	[p7l2019t565r2147b605, p7l10t645r152b708],
14	with	IN	O	with	_	0	SENT_83	[p7l170t645r323b708],
15	human	JJ	O	human	amod	16	SENT_83	[p7l344t645r587b708],
16	mutations	NNS	O	mutation	prep_with	13	SENT_83	[p7l607t651r971b717],
17	,	,	O	,	_	0	SENT_83	[p7l607t651r971b717],
18	making	VBG	O	make	xcomp	13	SENT_83	[p7l994t645r1255b729],
19	them	PRP	O	they	nsubj	21	SENT_83	[p7l1274t645r1452b708],
20	most	RBS	O	most	advmod	21	SENT_83	[p7l1473t657r1643b708],
21	relevant	JJ	O	relevant	xcomp	18	SENT_83	[p7l1663t645r1937b708],
22	to	TO	O	to	_	0	SENT_83	[p7l1956t657r2022b708],
23	the	DT	O	the	det	26	SENT_83	[p7l2043t645r2150b708],
24	autosomal	JJ	O	autosomal	amod	26	SENT_83	[p7l10t748r362b811],
25	dominant	JJ	O	dominant	amod	26	SENT_83	[p7l382t748r717b811],
26	form	NN	O	form	prep_to	21	SENT_83	[p7l736t748r903b811],
27	of	IN	O	of	_	0	SENT_83	[p7l923t748r997b811],
28	AD	NN	O	ad	prep_of	26	SENT_83	[p7l1007t752r1140b811],
29	.	.	O	.	_	0	SENT_83	[p7l1007t752r1140b811],

1	Single	JJ	O	single	dep	9	SENT_84	[p7l1165t748r1417b832],
2	-	:	O	-	_	0	SENT_84	[p7l1165t748r1417b832],
3	,	,	O	,	_	0	SENT_84	[p7l1165t748r1417b832],
4	double	JJ	O	double	amod	6	SENT_84	[p7l1440t748r1698b811],
5	—	JJ	O	—	amod	6	SENT_84	[p7l1440t748r1698b811],
6	(	NN	O	(	dep	1	SENT_84	[p7l1725t748r1917b825],
7	2	CD	NUMBER	2	number	8	SENT_84	[p7l1725t748r1917b825],
8	>	JJR	O	>	amod	1	SENT_84	[p7l1725t748r1917b825],
9	<	JJR	O	<	_	0	SENT_84	[p7l1725t748r1917b825],
10	-	:	O	-	_	0	SENT_84	[p7l1725t748r1917b825],
11	)	NN	O	)	nn	14	SENT_84	[p7l1725t748r1917b825],
12	,	,	O	,	_	0	SENT_84	[p7l1725t748r1917b825],
13	triple	JJ	O	triple	amod	14	SENT_84	[p7l1939t748r2147b831, p7l13t851r206b928],
14	(	NN	O	(	dep	17	SENT_84	[p7l1939t748r2147b831, p7l13t851r206b928],
15	3	CD	NUMBER	3	num	14	SENT_84	[p7l1939t748r2147b831, p7l13t851r206b928],
16	>	JJR	O	>	npadvmod	17	SENT_84	[p7l1939t748r2147b831, p7l13t851r206b928],
17	<	JJR	O	<	parataxis	9	SENT_84	[p7l1939t748r2147b831, p7l13t851r206b928],
18	.	.	O	.	_	0	SENT_84	[p7l1939t748r2147b831, p7l13t851r206b928],

1	—	NN	O	—	_	0	SENT_85	[p7l1939t748r2147b831, p7l13t851r206b928],
2	.	.	O	.	_	0	SENT_85	[p7l1939t748r2147b831, p7l13t851r206b928],
3	)	SYM	O	)	dep	1	SENT_85	[p7l1939t748r2147b831, p7l13t851r206b928],

1	,	,	O	,	_	0	SENT_86	[p7l1939t748r2147b831, p7l13t851r206b928],
2	and	CC	O	and	nsubj	11	SENT_86	[p7l229t851r356b914],
3	5	CD	NUMBER	5	number	4	SENT_86	[p7l377t859r564b935],
4	>	JJR	O	>	amod	5	SENT_86	[p7l377t859r564b935],
5	<	JJR	O	<	dep	2	SENT_86	[p7l377t859r564b935],
6	-	:	O	-	_	0	SENT_86	[p7l377t859r564b935],
7	tg	NN	O	tg	nn	9	SENT_86	[p7l377t859r564b935],
8	animal	NN	O	animal	nn	9	SENT_86	[p7l583t851r818b914],
9	models	NNS	O	model	dep	5	SENT_86	[p7l838t851r1085b914],
10	are	VBP	O	be	cop	11	SENT_86	[p7l1107t874r1208b914],
11	available	JJ	O	available	_	0	SENT_86	[p7l1229t851r1542b923],
12	,	,	O	,	_	0	SENT_86	[p7l1229t851r1542b923],
13	each	DT	O	each	dobj	11	SENT_86	[p7l1565t851r1718b914],
14	with	IN	O	with	_	0	SENT_86	[p7l1737t851r1890b914],
15	unique	JJ	O	unique	amod	16	SENT_86	[p7l1910t857r2149b934],
16	features	NNS	O	feature	prep_with	13	SENT_86	[p7l9t954r292b1017],
17	.	.	O	.	_	0	SENT_86	[p7l9t954r292b1017],

1	Knockins	NNS	MISC	knockin	nsubjpass	12	SENT_87	[p7l319t954r663b1026],
2	,	,	O	,	_	0	SENT_87	[p7l319t954r663b1026],
3	knockouts	NNS	O	knockout	nsubjpass	12	SENT_87	[p7l686t954r1062b1026],
4	,	,	O	,	_	0	SENT_87	[p7l686t954r1062b1026],
5	and	CC	O	and	_	0	SENT_87	[p7l1087t954r1213b1017],
6	non	JJ	O	non	amod	9	SENT_87	[p7l1235t966r1469b1038],
7	—	NN	O	—	nn	9	SENT_87	[p7l1235t966r1469b1038],
8	tg	NN	O	tg	nn	9	SENT_87	[p7l1235t966r1469b1038],
9	species	NNS	O	species	nsubjpass	12	SENT_87	[p7l1490t960r1729b1037],
10	can	MD	O	can	aux	12	SENT_87	[p7l1752t977r1869b1017],
11	be	VB	O	be	auxpass	12	SENT_87	[p7l1890t954r1970b1017],
12	used	VBN	O	use	_	0	SENT_87	[p7l1993t954r2151b1017],
13	to	TO	O	to	aux	14	SENT_87	[p7l8t1069r74b1120],
14	investigate	VB	O	investigate	xcomp	12	SENT_87	[p7l98t1063r460b1141],
15	speciﬁc	NN	O	speciﬁc	nn	17	SENT_87	[p7l484t1057r738b1140],
16	disease	NN	O	disease	nn	17	SENT_87	[p7l761t1057r1002b1120],
17	pathways	NNS	O	pathway	dobj	14	SENT_87	[p7l1023t1057r1359b1141],
18	.	.	O	.	_	0	SENT_87	[p7l1023t1057r1359b1141],

1	Testing	VBG	O	test	amod	2	SENT_88	[p7l1384t1060r1633b1141],
2	compounds	NNS	O	compound	nsubj	8	SENT_88	[p7l1655t1057r2059b1140],
3	in	IN	O	in	_	0	SENT_88	[p7l2082t1063r2149b1119],
4	multiple	JJ	O	multiple	amod	6	SENT_88	[p7l9t1160r304b1243],
5	tg	NN	O	tg	nn	6	SENT_88	[p7l327t1172r395b1244],
6	models	NNS	O	model	prep_in	2	SENT_88	[p7l418t1160r673b1223],
7	may	MD	O	may	aux	8	SENT_88	[p7l698t1183r849b1244],
8	enhance	VB	O	enhance	_	0	SENT_88	[p7l870t1160r1162b1223],
9	conﬁdence	NN	O	conﬁdence	dobj	8	SENT_88	[p7l1188t1160r1572b1223],
10	in	IN	O	in	_	0	SENT_88	[p7l1596t1166r1665b1222],
11	a	DT	O	a	det	14	SENT_88	[p7l1690t1183r1725b1223],
12	therapeutic	JJ	O	therapeutic	amod	14	SENT_88	[p7l1747t1160r2151b1243],
13	candidate	NN	O	candidate	nn	14	SENT_88	[p7l10t1262r336b1326],
14	agent	NN	O	agent	prep_in	8	SENT_88	[p7l357t1274r538b1347],
15	if	IN	O	if	mark	18	SENT_88	[p7l557t1262r611b1325],
16	beneﬁts	NNS	O	beneﬁts	nsubjpass	18	SENT_88	[p7l619t1262r882b1326],
17	are	VBP	O	be	auxpass	18	SENT_88	[p7l904t1285r1003b1326],
18	observed	VBN	O	observe	advcl	8	SENT_88	[p7l1024t1262r1330b1326],
19	across	IN	O	across	_	0	SENT_88	[p7l1350t1285r1555b1326],
20	model	NN	O	model	nn	21	SENT_88	[p7l1576t1262r1790b1326],
21	systems	NNS	O	system	prep_across	18	SENT_88	[p7l1811t1254r2149b1347],
22	.35	CD	NUMBER	.35	num	23	SENT_88	[p7l1811t1254r2149b1347],
23	Results	NNS	O	result	nsubj	31	SENT_88	[p7l84t1366r319b1429],
24	in	IN	O	in	_	0	SENT_88	[p7l340t1372r405b1428],
25	animal	NN	O	animal	nn	26	SENT_88	[p7l425t1366r654b1429],
26	models	NNS	O	model	prep_in	23	SENT_88	[p7l672t1366r913b1429],
27	have	VBP	O	have	aux	31	SENT_88	[p7l932t1366r1084b1429],
28	so	RB	O	so	advmod	30	SENT_88	[p7l1104t1389r1173b1429],
29	far	RB	O	far	advmod	30	SENT_88	[p7l1194t1366r1284b1429],
30	not	RB	O	not	neg	31	SENT_88	[p7l1302t1378r1413b1429],
31	predicted	VBN	O	predict	rcmod	21	SENT_88	[p7l1430t1366r1748b1449],
32	a	DT	O	a	det	35	SENT_88	[p7l1767t1389r1801b1429],
33	successful	JJ	O	successful	amod	35	SENT_88	[p7l1820t1366r2151b1429],
34	disease-modifying	JJ	O	disease-modifying	amod	35	SENT_88	[p7l10t1469r646b1553],
35	drug	NN	O	drug	dobj	31	SENT_88	[p7l666t1469r829b1553],
36	in	IN	O	in	_	0	SENT_88	[p7l849t1475r916b1531],
37	AD	NN	O	ad	prep_in	35	SENT_88	[p7l937t1473r1070b1532],
38	.	.	O	.	_	0	SENT_88	[p7l937t1473r1070b1532],

1	There	EX	O	there	expl	2	SENT_89	[p7l1095t1469r1288b1532],
2	are	VBP	O	be	_	0	SENT_89	[p7l1310t1492r1411b1532],
3	many	JJ	O	many	amod	5	SENT_89	[p7l1432t1492r1626b1553],
4	possible	JJ	O	possible	amod	5	SENT_89	[p7l1642t1469r1918b1552],
5	explanations	NNS	O	explanation	nsubj	2	SENT_89	[p7l1941t1469r2147b1552, p7l9t1578r270b1635],
6	for	IN	O	for	_	0	SENT_89	[p7l296t1572r397b1635],
7	this	DT	O	this	det	10	SENT_89	[p7l421t1572r550b1635],
8	“	NN	O	“	nn	10	SENT_89	[p7l577t1572r1058b1635],
9	translational	JJ	O	translational	amod	10	SENT_89	[p7l577t1572r1058b1635],
10	gap	NN	O	gap	prep_for	5	SENT_89	[p7l1083t1572r1246b1656],
11	.	.	O	.	_	0	SENT_89	[p7l1083t1572r1246b1656],

1	”	NN	O	”	nn	3	SENT_90	[p7l1083t1572r1246b1656],
2	Animal	NN	O	animal	nn	3	SENT_90	[p7l1273t1572r1541b1635],
3	models	NNS	O	model	nsubj	5	SENT_90	[p7l1565t1572r1821b1635],
4	typically	RB	O	typically	advmod	5	SENT_90	[p7l1847t1572r2153b1656],
5	model	VBP	O	model	_	0	SENT_90	[p7l9t1675r233b1738],
6	one	CD	NUMBER	one	num	7	SENT_90	[p7l258t1698r384b1738],
7	aspect	NN	O	aspect	dobj	5	SENT_90	[p7l409t1687r630b1758],
8	of	IN	O	of	_	0	SENT_90	[p7l654t1675r730b1738],
9	AD	NN	O	ad	prep_of	7	SENT_90	[p7l744t1679r866b1737],
10	and	CC	O	and	dep	11	SENT_90	[p7l894t1675r1024b1738],
11	not	RB	O	not	dep	5	SENT_90	[p7l1048t1687r1165b1738],
12	the	DT	O	the	det	15	SENT_90	[p7l1188t1675r1298b1738],
13	entire	JJ	O	entire	amod	15	SENT_90	[p7l1324t1681r1527b1738],
14	disease	NN	O	disease	nn	15	SENT_90	[p7l1553t1675r1802b1738],
15	complex	NN	O	complex	dep	11	SENT_90	[p7l1828t1675r2144b1758],
16	.	.	O	.	_	0	SENT_90	[p7l1828t1675r2144b1758],

1	Amyloid	JJ	O	amyloid	amod	3	SENT_91	[p7l8t1778r607b1862],
2	—	NN	O	—	nn	3	SENT_91	[p7l8t1778r607b1862],
3	bearing	NN	O	bearing	_	0	SENT_91	[p7l8t1778r607b1862],
4	tg	NN	O	tg	nn	5	SENT_91	[p7l627t1790r694b1862],
5	models	NNS	O	model	dep	3	SENT_91	[p7l714t1778r982b1850],
6	,	,	O	,	_	0	SENT_91	[p7l714t1778r982b1850],
7	for	IN	O	for	_	0	SENT_91	[p7l1006t1778r1105b1841],
8	example	NN	O	example	prep_for	3	SENT_91	[p7l1127t1778r1429b1861],
9	,	,	O	,	_	0	SENT_91	[p7l1127t1778r1429b1861],
10	manifest	JJ	O	manifest	amod	12	SENT_91	[p7l1454t1778r1751b1841],
11	plaque	NN	O	plaque	nn	12	SENT_91	[p7l1772t1778r2001b1861],
12	formation	NN	O	formation	prep_for	3	SENT_91	[p7l2024t1778r2147b1841, p7l9t1887r249b1944],
13	without	IN	O	without	_	0	SENT_91	[p7l267t1881r530b1944],
14	neuroﬁbrillary	JJ	O	neuroﬁbrillary	amod	15	SENT_91	[p7l548t1881r1043b1965],
15	tangles	NNS	O	tangle	prep_without	12	SENT_91	[p7l1059t1881r1293b1965],
16	or	CC	O	or	_	0	SENT_91	[p7l1314t1904r1385b1944],
17	cell	NN	O	cell	nn	18	SENT_91	[p7l1404t1881r1515b1944],
18	death	NN	O	death	prep_for	3	SENT_91	[p7l1535t1881r1736b1944],
19	.	.	O	.	_	0	SENT_91	[p7l1535t1881r1736b1944],

1	In	IN	O	in	_	0	SENT_92	[p7l1760t1886r1829b1943],
2	addition	NN	O	addition	prep_in	6	SENT_92	[p7l1850t1881r2149b1953],
3	,	,	O	,	_	0	SENT_92	[p7l1850t1881r2149b1953],
4	animals	NNS	O	animal	nsubj	6	SENT_92	[p7l10t1984r272b2047],
5	may	MD	O	may	aux	6	SENT_92	[p7l293t2007r439b2068],
6	have	VB	O	have	_	0	SENT_92	[p7l454t1984r608b2047],
7	species-speciﬁc	JJ	O	species-speciﬁc	amod	8	SENT_92	[p7l630t1984r1151b2067],
8	responses	NNS	O	response	dobj	6	SENT_92	[p7l1172t2006r1500b2067],
9	that	WDT	O	that	nsubj	12	SENT_92	[p7l1519t1984r1652b2047],
10	do	VBP	O	do	aux	12	SENT_92	[p7l1672t1984r1755b2047],
11	not	RB	O	not	neg	12	SENT_92	[p7l1776t1996r1890b2047],
12	predict	VB	O	predict	rcmod	8	SENT_92	[p7l1907t1984r2149b2067],
13	human	JJ	O	human	amod	14	SENT_92	[p7l8t2087r256b2150],
14	disease	NN	O	disease	dobj	12	SENT_92	[p7l280t2087r543b2150],
15	.	.	O	.	_	0	SENT_92	[p7l280t2087r543b2150],

1	Finally	RB	O	finally	advmod	7	SENT_93	[p7l570t2087r820b2171],
2	,	,	O	,	_	0	SENT_93	[p7l570t2087r820b2171],
3	many	JJ	O	many	amod	4	SENT_93	[p7l845t2110r1042b2171],
4	experiments	NNS	O	experiment	nsubjpass	7	SENT_93	[p7l1062t2093r1494b2170],
5	are	VBP	O	be	auxpass	7	SENT_93	[p7l1519t2110r1621b2150],
6	not	RB	O	not	neg	7	SENT_93	[p7l1644t2099r1760b2150],
7	conducted	VBN	O	conduct	_	0	SENT_93	[p7l1783t2087r2151b2150],
8	with	IN	O	with	_	0	SENT_93	[p7l8t2190r161b2253],
9	sufficient	JJ	O	sufficient	amod	10	SENT_93	[p7l183t2190r495b2253],
10	rigor	NN	O	rigor	prep_with	7	SENT_93	[p7l515t2196r683b2274],
11	to	TO	O	to	aux	13	SENT_93	[p7l702t2202r768b2253],
12	be	VB	O	be	cop	13	SENT_93	[p7l789t2190r868b2253],
13	reproducible	JJ	O	reproducible	xcomp	7	SENT_93	[p7l890t2190r1343b2273],
14	.	.	O	.	_	0	SENT_93	[p7l890t2190r1343b2273],

1	One	CD	NUMBER	one	num	2	SENT_94	[p7l1369t2194r1512b2253],
2	study	NN	O	study	dep	3	SENT_94	[p7l1534t2190r1721b2274],
3	showed	VBD	O	show	_	0	SENT_94	[p7l1740t2190r1998b2253],
4	that	IN	O	that	complm	12	SENT_94	[p7l2017t2190r2151b2253],
5	only	RB	O	only	quantmod	6	SENT_94	[p7l10t2293r161b2377],
6	25	CD	PERCENT	25	num	7	SENT_94	[p7l177t2299r320b2357],
7	%	NN	PERCENT	%	nsubj	12	SENT_94	[p7l177t2299r320b2357],
8	of	IN	O	of	_	0	SENT_94	[p7l343t2293r417b2356],
9	preclinical	JJ	O	preclinical	amod	11	SENT_94	[p7l426t2293r785b2376],
10	laboratory	NN	O	laboratory	nn	11	SENT_94	[p7l803t2293r1163b2377],
11	studies	NNS	O	study	prep_of	7	SENT_94	[p7l1180t2293r1415b2356],
12	had	VBD	O	have	ccomp	3	SENT_94	[p7l1435t2293r1562b2356],
13	results	NNS	O	result	nsubj	15	SENT_94	[p7l1582t2293r1801b2356],
14	fully	RB	O	fully	advmod	15	SENT_94	[p7l1822t2293r1978b2377],
15	consistent	JJ	O	consistent	xcomp	12	SENT_94	[p7l1995t2316r2147b2356, p7l10t2402r228b2459],
16	with	IN	O	with	_	0	SENT_94	[p7l246t2395r399b2459],
17	validating	VBG	O	validate	prepc_with	15	SENT_94	[p7l418t2395r762b2480],
18	studies	NNS	O	study	dobj	17	SENT_94	[p7l783t2387r1101b2459],
19	.37	CD	NUMBER	.37	nsubj	3	SENT_94	[p7l783t2387r1101b2459],

1	Animal	NN	O	animal	nn	2	SENT_95	[p7l82t2498r343b2561],
2	studies	NNS	O	study	nsubj	4	SENT_95	[p7l366t2498r603b2561],
3	often	RB	O	often	advmod	4	SENT_95	[p7l627t2498r801b2561],
4	use	VBP	O	use	_	0	SENT_95	[p7l824t2521r935b2561],
5	behavioral	JJ	O	behavioral	amod	6	SENT_95	[p7l957t2498r1321b2561],
6	tests	NNS	O	test	dobj	4	SENT_95	[p7l1342t2510r1492b2561],
7	such	JJ	O	such	_	0	SENT_95	[p7l1517t2498r1673b2561],
8	as	IN	O	as	_	0	SENT_95	[p7l1696t2521r1761b2561],
9	the	DT	O	the	det	10	SENT_95	[p7l1784t2498r1891b2561],
10	Morris	NNP	O	Morris	prep_such_as	6	SENT_95	[p7l1914t2503r2149b2561],

1	Water	NN	O	water	nn	2	SENT_96	[p7l8t2606r211b2664],
2	Maze	NN	O	maze	_	0	SENT_96	[p7l229t2606r410b2664],
3	as	IN	O	as	_	0	SENT_96	[p7l431t2624r495b2664],
4	the	DT	O	the	det	5	SENT_96	[p7l515t2601r620b2664],
5	readout	NN	O	readout	prep_as	2	SENT_96	[p7l640t2601r901b2664],
6	for	IN	O	for	_	0	SENT_96	[p7l919t2601r1016b2664],
7	the	DT	O	the	det	8	SENT_96	[p7l1034t2601r1139b2664],
8	intervention	NN	O	intervention	prep_for	5	SENT_96	[p7l1159t2607r1579b2664],
9	in	IN	O	in	_	0	SENT_96	[p7l1599t2607r1665b2663],
10	the	DT	O	the	det	12	SENT_96	[p7l1684t2601r1789b2664],
11	living	NN	O	living	nn	12	SENT_96	[p7l1808t2601r2000b2685],
12	animal	NN	O	animal	prep_in	8	SENT_96	[p7l2019t2607r2148b2664, p7l9t2704r136b2767],
13	and	CC	O	and	_	0	SENT_96	[p7l156t2704r281b2767],
14	brain	NN	O	brain	nn	15	SENT_96	[p7l298t2704r478b2767],
15	pathology	NN	O	pathology	prep_in	8	SENT_96	[p7l497t2704r841b2788],
16	for	IN	O	for	_	0	SENT_96	[p7l857t2704r954b2767],
17	the	DT	O	the	det	18	SENT_96	[p7l972t2704r1077b2767],
18	readout	NN	O	readout	prep_for	2	SENT_96	[p7l1098t2704r1359b2767],
19	of	IN	O	of	_	0	SENT_96	[p7l1379t2704r1452b2767],
20	the	DT	O	the	det	22	SENT_96	[p7l1461t2704r1567b2767],
21	biological	JJ	O	biological	amod	22	SENT_96	[p7l1585t2704r1917b2788],
22	effects	NNS	O	effect	prep_of	18	SENT_96	[p7l1938t2704r2148b2767],
23	of	IN	O	of	_	0	SENT_96	[p7l10t2807r83b2870],
24	the	DT	O	the	det	26	SENT_96	[p7l92t2807r198b2870],
25	candidate	NN	O	candidate	nn	26	SENT_96	[p7l219t2807r546b2870],
26	agent	NN	O	agent	prep_of	22	SENT_96	[p7l567t2819r762b2891],
27	.	.	O	.	_	0	SENT_96	[p7l567t2819r762b2891],

1	Studies	NNS	O	study	nsubj	13	SENT_97	[p7l787t2807r1027b2870],
2	may	MD	O	may	aux	4	SENT_97	[p7l1048t2830r1193b2891],
3	not	RB	O	not	neg	4	SENT_97	[p7l1210t2819r1323b2870],
4	collect	VB	O	collect	_	0	SENT_97	[p7l1342t2807r1561b2870],
5	biomarkers	NNS	O	biomarker	dobj	4	SENT_97	[p7l1579t2807r1963b2870],
6	from	IN	O	from	_	0	SENT_97	[p7l1983t2807r2150b2870],
7	animal	NN	O	animal	nn	8	SENT_97	[p7l10t2910r251b2973],
8	models	NNS	O	model	prep_from	4	SENT_97	[p7l274t2910r527b2973],
9	and	CC	O	and	_	0	SENT_97	[p7l553t2910r682b2973],
10	thus	RB	O	thus	advmod	13	SENT_97	[p7l704t2910r853b2973],
11	do	VBP	O	do	aux	13	SENT_97	[p7l878t2910r964b2973],
12	not	RB	O	not	neg	13	SENT_97	[p7l989t2922r1106b2973],
13	provide	VB	O	provide	conj_and	4	SENT_97	[p7l1127t2910r1396b2993],
14	information	NN	O	information	dobj	13	SENT_97	[p7l1420t2910r1846b2973],
15	that	WDT	O	that	nsubj	17	SENT_97	[p7l1869t2910r2006b2973],
16	can	MD	O	can	aux	17	SENT_97	[p7l2029t2933r2149b2973],
17	translate	VB	O	translate	rcmod	14	SENT_97	[p7l8t3012r301b3075],
18	from	IN	O	from	_	0	SENT_97	[p7l322t3012r490b3075],
19	animal	NN	O	animal	prep_from	17	SENT_97	[p7l512t3012r748b3075],
20	to	TO	O	to	_	0	SENT_97	[p7l767t3024r833b3075],
21	human	JJ	O	human	amod	23	SENT_97	[p7l855t3012r1097b3075],
22	biomarker	NN	O	biomarker	nn	23	SENT_97	[p7l1117t3012r1476b3075],
23	studies	NNS	O	study	prep_to	17	SENT_97	[p7l1498t3012r1750b3075],
24	.	.	O	.	_	0	SENT_97	[p7l1498t3012r1750b3075],

1	This	DT	O	this	det	2	SENT_98	[p7l1774t3012r1917b3075],
2	difference	NN	O	difference	_	0	SENT_98	[p7l1940t3012r2147b3075, p7l10t3138r160b3178],

1	in	IN	O	in	_	0	SENT_99	[p7l180t3121r245b3177],
2	animal	NN	O	animal	nn	5	SENT_99	[p7l266t3115r497b3178],
3	and	CC	O	and	_	0	SENT_99	[p7l517t3115r642b3178],
4	human	JJ	O	human	nn	5	SENT_99	[p7l659t3115r899b3178],
5	studies	NNS	O	study	prep_in	6	SENT_99	[p7l919t3115r1150b3178],
6	creates	VBZ	O	create	_	0	SENT_99	[p7l1171t3127r1398b3178],
7	uncertainty	NN	O	uncertainty	nsubj	6	SENT_99	[p7l1418t3121r1810b3199],
8	regarding	VBG	O	regard	partmod	7	SENT_99	[p7l1826t3115r2151b3199],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_100	[p7l20t3264r139b3285],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_100	[p7l148t3264r373b3285],
3	&	CC	O	&	_	0	SENT_100	[p7l380t3264r600b3285],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_100	[p7l380t3264r600b3285],
5	|	CD	NUMBER	|	num	6	SENT_100	[p7l380t3264r600b3285],
6	CS	NNP	O	CS	conj_and	2	SENT_100	[p7l380t3264r600b3285],
7	|	NNP	O	|	nn	8	SENT_100	[p7l610t3262r612b3292],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_100	[p7l620t3264r728b3285],
9	95	CD	NUMBER	95	num	10	SENT_100	[p7l736t3264r763b3285],
10	NUMBER	NN	O	number	dep	12	SENT_100	[p7l773t3264r881b3285],
11	1	CD	NUMBER	1	num	12	SENT_100	[p7l891t3265r898b3285],
12	|	CD	NUMBER	|	dep	15	SENT_100	[p7l912t3262r914b3292],
13	JANUARY	NNP	DATE	JANUARY	dep	12	SENT_100	[p7l923t3264r1041b3285],
14	2014	CD	DATE	2014	num	15	SENT_100	[p7l1049t3264r1107b3285],
15	69	CD	DATE	69	_	0	SENT_100	[p7l2108t3264r2139b3285],

1	how	WRB	O	how	advmod	4	SENT_101	[p8l7t85r158b148],
2	best	RB	O	best	advmod	4	SENT_101	[p8l177t85r319b148],
3	to	TO	O	to	aux	4	SENT_101	[p8l340t97r408b148],
4	interpret	VB	O	interpret	_	0	SENT_101	[p8l433t91r742b168],
5	efficacy	NN	O	efficacy	dobj	4	SENT_101	[p8l765t85r1029b169],
6	in	IN	O	in	_	0	SENT_101	[p8l1049t91r1117b147],
7	model	NN	O	model	nn	8	SENT_101	[p8l1140t85r1363b148],
8	systems	NNS	O	system	prep_in	4	SENT_101	[p8l1387t97r1656b169],
9	and	CC	O	and	_	0	SENT_101	[p8l1681t85r1810b148],
10	apply	VB	O	apply	conj_and	4	SENT_101	[p8l1834t85r2024b169],
11	the	DT	O	the	det	12	SENT_101	[p8l2043t85r2152b148],
12	observations	NNS	O	observation	dobj	10	SENT_101	[p8l8t188r450b251],
13	to	TO	O	to	_	0	SENT_101	[p8l473t200r540b251],
14	human	JJ	O	human	amod	15	SENT_101	[p8l564t188r811b251],
15	treatment	NN	O	treatment	prep_to	10	SENT_101	[p8l833t200r1191b251],
16	.	.	O	.	_	0	SENT_101	[p8l833t200r1191b251],

1	Parallel	JJ	O	parallel	amod	3	SENT_102	[p8l1218t188r1476b251],
2	animal	NN	O	animal	nn	3	SENT_102	[p8l1500t188r1738b251],
3	system	NN	O	system	nsubj	16	SENT_102	[p8l1762t200r1998b272],
4	and	CC	O	and	_	0	SENT_102	[p8l2022t188r2150b251],
5	human	JJ	O	human	amod	7	SENT_102	[p8l7t291r258b354],
6	trial	NN	O	trial	nn	7	SENT_102	[p8l282t291r429b354],
7	observations	NNS	O	observation	conj_and	3	SENT_102	[p8l454t291r906b354],
8	would	MD	O	would	aux	9	SENT_102	[p8l930t291r1153b354],
9	strengthen	VB	O	strengthen	_	0	SENT_102	[p8l1178t291r1557b375],
10	the	DT	O	the	det	11	SENT_102	[p8l1582t291r1692b354],
11	platform	NN	O	platform	dobj	9	SENT_102	[p8l1716t291r2027b374],
12	for	IN	O	for	_	0	SENT_102	[p8l2052t291r2153b354],
13	drug	NN	O	drug	nn	14	SENT_102	[p8l8t394r168b478],
14	development	NN	O	development	prep_for	11	SENT_102	[p8l187t394r625b477],
15	and	CC	O	and	_	0	SENT_102	[p8l645t394r770b457],
16	facilitate	VB	O	facilitate	conj_and	9	SENT_102	[p8l788t394r1074b457],
17	feedback	NN	O	feedback	dobj	16	SENT_102	[p8l1093t394r1395b457],
18	between	IN	O	between	_	0	SENT_102	[p8l1409t394r1692b457],
19	animal	NN	O	animal	nn	20	SENT_102	[p8l1713t394r1944b457],
20	models	NNS	O	model	prep_between	17	SENT_102	[p8l1963t394r2146b457, p8l8t497r92b560],
21	and	CC	O	and	_	0	SENT_102	[p8l114t497r240b560],
22	human	JJ	O	human	amod	23	SENT_102	[p8l258t497r500b560],
23	disease	NN	O	disease	prep_between	17	SENT_102	[p8l521t497r777b560],
24	.	.	O	.	_	0	SENT_102	[p8l521t497r777b560],

1	Figure	NNP	O	Figure	nn	5	SENT_103	[p8l800t501r1030b580],
2	4	CD	NUMBER	4	num	3	SENT_103	[p8l1048t504r1090b559],
3	shows	NNS	O	show	npadvmod	4	SENT_103	[p8l1110t497r1315b560],
4	translational	JJ	O	translational	amod	5	SENT_103	[p8l1335t497r1763b560],
5	links	NNS	O	link	nsubj	15	SENT_103	[p8l1782t497r1945b560],
6	along	IN	O	along	_	0	SENT_103	[p8l1967t497r2154b581],
7	the	DT	O	the	det	8	SENT_103	[p8l7t601r110b664],
8	continuum	NN	O	continuum	prep_along	5	SENT_103	[p8l131t607r502b664],
9	of	IN	O	of	_	0	SENT_103	[p8l522t601r594b664],
10	animal	NN	O	animal	prep_of	8	SENT_103	[p8l605t601r835b664],
11	to	TO	O	to	_	0	SENT_103	[p8l853t613r918b664],
12	human	JJ	O	human	amod	13	SENT_103	[p8l937t601r1175b664],
13	testing	NN	O	testing	prep_to	10	SENT_103	[p8l1194t607r1435b685],
14	,	,	O	,	_	0	SENT_103	[p8l1194t607r1435b685],
15	emphasizing	VBG	O	emphasize	_	0	SENT_103	[p8l1457t601r1881b685],
16	areas	NNS	O	area	dobj	15	SENT_103	[p8l1899t624r2065b664],
17	in	IN	O	in	_	0	SENT_103	[p8l2086t607r2151b663],
18	which	WDT	O	which	rel	22	SENT_103	[p8l6t704r213b767],
19	additional	JJ	O	additional	amod	20	SENT_103	[p8l234t704r578b767],
20	information	NN	O	information	nsubjpass	22	SENT_103	[p8l597t704r1007b767],
21	is	VBZ	O	be	auxpass	22	SENT_103	[p8l1028t710r1077b767],
22	needed	VBN	O	need	rcmod	16	SENT_103	[p8l1098t704r1357b767],
23	.	.	O	.	_	0	SENT_103	[p8l1098t704r1357b767],

1	Understanding	VBG	O	understand	csubjpass	8	SENT_104	[p8l1381t704r1892b788],
2	predictive	JJ	O	predictive	amod	3	SENT_104	[p8l1909t704r2149b787, p8l7t813r129b870],
3	relationships	NNS	O	relationship	dobj	1	SENT_104	[p8l151t807r589b890],
4	among	IN	O	among	_	0	SENT_104	[p8l612t830r847b891],
5	these	DT	O	these	det	6	SENT_104	[p8l865t807r1041b870],
6	variables	NNS	O	variable	prep_among	1	SENT_104	[p8l1059t807r1363b870],
7	is	VBZ	O	be	auxpass	8	SENT_104	[p8l1384t813r1434b870],
8	required	VBN	O	require	_	0	SENT_104	[p8l1456t807r1748b890],
9	to	TO	O	to	aux	10	SENT_104	[p8l1767t819r1833b870],
10	rationalize	VB	O	rationalize	xcomp	8	SENT_104	[p8l1855t807r2148b870, p8l8t916r100b973],
11	drug	NN	O	drug	nn	12	SENT_104	[p8l121t910r284b994],
12	development	NN	O	development	dobj	10	SENT_104	[p8l304t910r764b993],
13	.	.	O	.	_	0	SENT_104	[p8l304t910r764b993],

1	Exploring	VBG	O	explore	csubj	11	SENT_105	[p8l788t910r1129b994],
2	parallel	JJ	O	parallel	amod	3	SENT_105	[p8l1147t910r1402b993],
3	biomarkers	NNS	O	biomarker	dobj	1	SENT_105	[p8l1419t910r1809b973],
4	in	IN	O	in	_	0	SENT_105	[p8l1830t916r1897b972],
5	animal	NN	O	animal	nn	7	SENT_105	[p8l1918t910r2153b973],
6	model	NN	O	model	nn	7	SENT_105	[p8l7t1013r224b1076],
7	systems	NNS	O	system	prep_in	1	SENT_105	[p8l245t1025r508b1097],
8	and	CC	O	and	_	0	SENT_105	[p8l531t1013r657b1076],
9	humans	NNS	O	human	conj_and	7	SENT_105	[p8l676t1013r950b1076],
10	will	MD	O	will	aux	11	SENT_105	[p8l969t1013r1096b1076],
11	inform	VB	O	inform	dep	35	SENT_105	[p8l1116t1013r1355b1076],
12	drug	NN	O	drug	nn	13	SENT_105	[p8l1377t1013r1539b1097],
13	development	NN	O	development	dobj	11	SENT_105	[p8l1559t1013r2005b1096],
14	and	CC	O	and	_	0	SENT_105	[p8l2025t1013r2152b1076],
15	may	MD	O	may	aux	16	SENT_105	[p8l7t1140r158b1201],
16	play	VB	O	play	conj_and	11	SENT_105	[p8l178t1117r327b1201],
17	a	DT	O	a	det	18	SENT_105	[p8l349t1140r384b1180],
18	role	NN	O	role	dobj	16	SENT_105	[p8l407t1117r541b1180],
19	in	IN	O	in	_	0	SENT_105	[p8l565t1123r634b1179],
20	future	JJ	DATE	future	amod	21	SENT_105	[p8l658t1117r872b1180],
21	prescribing	NN	O	prescribing	prep_in	18	SENT_105	[p8l895t1117r1299b1201],
22	and	CC	O	and	_	0	SENT_105	[p8l1322t1117r1452b1180],
23	treatment	NN	O	treatment	nn	24	SENT_105	[p8l1475t1129r1823b1180],
24	management	NN	O	management	conj_and	21	SENT_105	[p8l1846t1140r2149b1201, p8l7t1232r185b1283],
25	depending	VBG	O	depend	_	0	SENT_105	[p8l206t1220r572b1304],
26	on	IN	O	on	prepc_depending_on	16	SENT_105	[p8l593t1243r679b1283],
27	the	DT	O	the	det	28	SENT_105	[p8l699t1220r806b1283],
28	type	NN	O	type	pobj	16	SENT_105	[p8l827t1232r973b1304],
29	of	IN	O	of	_	0	SENT_105	[p8l996t1220r1070b1283],
30	biomarker	NN	O	biomarker	prep_of	28	SENT_105	[p8l1080t1220r1440b1283],
31	and	CC	O	and	_	0	SENT_105	[p8l1461t1220r1587b1283],
32	the	DT	O	the	det	33	SENT_105	[p8l1607t1220r1714b1283],
33	information	NN	O	information	conj_and	30	SENT_105	[p8l1735t1220r2151b1283],
34	it	PRP	O	it	nsubj	35	SENT_105	[p8l8t1329r53b1386],
35	provides	VBZ	O	provide	_	0	SENT_105	[p8l73t1323r383b1406],
36	.	.	O	.	_	0	SENT_105	[p8l73t1323r383b1406],

1	BIOMARKERS	NNS	O	biomarker	nsubj	3	SENT_106	[p8l11t1538r490b1594],
2	TO	TO	O	to	aux	3	SENT_106	[p8l505t1538r601b1594],
3	DEFINE	VB	O	define	_	0	SENT_106	[p8l622t1539r880b1593],
4	AD	NN	O	ad	nn	6	SENT_106	[p8l899t1539r1004b1593],
5	TRIAL	NN	O	trial	nn	6	SENT_106	[p8l1018t1539r1227b1593],
6	POPULATIONS	NNS	O	population	dobj	3	SENT_106	[p8l1248t1538r1764b1594],

1	AD	NN	O	ad	nsubj	2	SENT_107	[p8l7t1638r128b1696],
2	occurs	VBZ	O	occur	conj_and	2	SENT_107	[p8l155t1657r385b1697],
3	across	IN	O	across	_	0	SENT_107	[p8l411t1657r625b1697],
4	a	DT	O	a	det	5	SENT_107	[p8l651t1657r686b1697],
5	spectrum	NN	O	spectrum	prep_across	2	SENT_107	[p8l710t1646r1044b1717],
6	of	IN	O	of	_	0	SENT_107	[p8l1069t1634r1145b1697],
7	severity	NN	O	severity	prep_of	5	SENT_107	[p8l1160t1640r1435b1718],
8	from	IN	O	from	_	0	SENT_107	[p8l1456t1634r1629b1697],
9	asymptomatic	JJ	O	asymptomatic	amod	11	SENT_107	[p8l1653t1640r2151b1718],
10	brain	NN	O	brain	nn	11	SENT_107	[p8l6t1737r195b1800],
11	changes	NNS	O	change	prep_from	2	SENT_107	[p8l223t1737r524b1821],
12	,	,	O	,	_	0	SENT_107	[p8l223t1737r524b1821],
13	to	TO	O	to	_	0	SENT_107	[p8l552t1749r621b1800],
14	minimally	RB	O	minimally	advmod	15	SENT_107	[p8l649t1737r1022b1821],
15	symptomatic	JJ	O	symptomatic	amod	16	SENT_107	[p8l1046t1743r1511b1821],
16	changes	NNS	O	change	prep_to	2	SENT_107	[p8l1538t1737r1840b1821],
17	,	,	O	,	_	0	SENT_107	[p8l1538t1737r1840b1821],
18	to	TO	O	to	_	0	SENT_107	[p8l1868t1749r1936b1800],
19	more	JJR	O	more	amod	21	SENT_107	[p8l1964t1760r2149b1800],
20	apparent	JJ	O	apparent	amod	21	SENT_107	[p8l8t1852r315b1923],
21	symptoms	NNS	O	symptom	prep_to	2	SENT_107	[p8l339t1852r697b1924],
22	with	IN	O	with	_	0	SENT_107	[p8l719t1840r876b1903],
23	no	DT	O	no	det	24	SENT_107	[p8l899t1863r987b1903],
24	compromise	NN	O	compromise	prep_with	21	SENT_107	[p8l1012t1846r1447b1923],
25	of	IN	O	of	_	0	SENT_107	[p8l1472t1840r1547b1903],
26	activities	NNS	O	activity	prep_of	24	SENT_107	[p8l1561t1846r1869b1903],
27	of	IN	O	of	_	0	SENT_107	[p8l1894t1840r1970b1903],
28	daily	JJ	SET	daily	amod	29	SENT_107	[p8l1984t1840r2154b1924],
29	living	NN	O	living	prep_of	26	SENT_107	[p8l6t1943r224b2027],
30	,	,	O	,	_	0	SENT_107	[p8l6t1943r224b2027],
31	and	CC	O	and	_	0	SENT_107	[p8l251t1943r380b2006],
32	ﬁnally	RB	O	ﬁnally	advmod	2	SENT_107	[p8l403t1943r634b2027],
33	,	,	O	,	_	0	SENT_107	[p8l403t1943r634b2027],
34	to	TO	O	to	_	0	SENT_107	[p8l658t1955r726b2006],
35	mild	JJ	O	mild	prep_to	2	SENT_107	[p8l751t1943r932b2015],
36	,	,	O	,	_	0	SENT_107	[p8l751t1943r932b2015],
37	moderate	JJ	O	moderate	conj_and	35	SENT_107	[p8l958t1943r1312b2015],
38	,	,	O	,	_	0	SENT_107	[p8l958t1943r1312b2015],
39	and	CC	O	and	_	0	SENT_107	[p8l1338t1943r1468b2006],
40	severe	JJ	O	severe	amod	42	SENT_107	[p8l1492t1966r1707b2006],
41	AD	NN	O	ad	nn	42	SENT_107	[p8l1731t1947r1852b2005],
42	dementia	NN	O	dementia	conj_and	35	SENT_107	[p8l1879t1943r2147b2006, p8l7t2052r109b2109],
43	.	.	O	.	_	0	SENT_107	[p8l1879t1943r2147b2006, p8l7t2052r109b2109],

1	Two	CD	NUMBER	two	num	3	SENT_108	[p8l135t2049r281b2109],
2	terminological	JJ	O	terminological	amod	3	SENT_108	[p8l305t2046r814b2130],
3	systems	NNS	O	system	nsubj	13	SENT_108	[p8l838t2058r1102b2130],
4	that	WDT	O	that	nsubj	5	SENT_108	[p8l1125t2046r1259b2109],
5	identify	VBP	O	identify	rcmod	3	SENT_108	[p8l1281t2046r1552b2130],
6	these	DT	O	these	det	7	SENT_108	[p8l1570t2046r1747b2109],
7	stages	NNS	O	stage	nsubj	9	SENT_108	[p8l1771t2058r1972b2130],
8	have	VBP	O	have	aux	9	SENT_108	[p8l1994t2046r2151b2109],
9	evolved	VBN	O	evolve	ccomp	5	SENT_108	[p8l8t2149r269b2212],
10	(	RB	O	(	advmod	9	SENT_108	[p8l294t2150r514b2226],
11	Table	NNP	O	Table	dep	13	SENT_108	[p8l294t2150r514b2226],
12	1	CD	NUMBER	1	num	13	SENT_108	[p8l540t2149r621b2226],
13	)	CD	NUMBER	)	_	0	SENT_108	[p8l540t2149r621b2226],
14	.	.	O	.	_	0	SENT_108	[p8l540t2149r621b2226],

1	The	DT	O	the	det	4	SENT_109	[p8l647t2149r772b2212],
2	International	NNP	ORGANIZATION	International	nn	4	SENT_109	[p8l796t2149r1246b2212],
3	Work	NNP	ORGANIZATION	Work	nn	4	SENT_109	[p8l1267t2149r1461b2212],
4	Group	NNP	ORGANIZATION	Group	nsubj	5	SENT_109	[p8l1482t2153r1702b2232],
5	identiﬁes	VBZ	O	identiﬁes	_	0	SENT_109	[p8l1726t2149r2038b2212],
6	atrisk	NN	O	atrisk	dobj	5	SENT_109	[p8l2062t2161r2148b2212, p8l8t2252r141b2315],
7	cognitively	RB	O	cognitively	advmod	8	SENT_109	[p8l161t2252r549b2336],
8	normal	JJ	O	normal	dep	5	SENT_109	[p8l569t2252r827b2315],
9	populations	NNS	O	population	npadvmod	8	SENT_109	[p8l849t2252r1286b2335],
10	,	,	O	,	_	0	SENT_109	[p8l849t2252r1286b2335],
11	prodromal	JJ	O	prodromal	amod	12	SENT_109	[p8l1311t2252r1690b2335],
12	AD	NN	O	ad	npadvmod	8	SENT_109	[p8l1712t2256r1850b2324],
13	,	,	O	,	_	0	SENT_109	[p8l1712t2256r1850b2324],
14	and	CC	O	and	_	0	SENT_109	[p8l1877t2252r2006b2315],
15	AD	NN	O	ad	nn	16	SENT_109	[p8l2028t2256r2149b2314],
16	dementia	NN	O	dementia	conj_and	9	SENT_109	[p8l8t2346r483b2418],
17	.31	CD	NUMBER	.31	number	18	SENT_109	[p8l8t2346r483b2418],
18	’32	CD	NUMBER	’32	num	20	SENT_109	[p8l8t2346r483b2418],
19	The	DT	O	the	det	20	SENT_109	[p8l504t2354r628b2418],
20	approach	NN	O	approach	dep	16	SENT_109	[p8l650t2354r965b2438],
21	of	IN	O	of	_	0	SENT_109	[p8l985t2354r1059b2418],
22	the	DT	O	the	det	24	SENT_109	[p8l1069t2354r1175b2418],
23	National	NNP	ORGANIZATION	National	dep	24	SENT_109	[p8l1194t2354r1489b2418],
24	Institute	NNP	ORGANIZATION	Institute	prep_of	8	SENT_109	[p8l1510t2360r1792b2418],
25	on	IN	O	on	_	0	SENT_109	[p8l1812t2377r1898b2418],
26	Aging	NNP	O	Aging	prep_on	8	SENT_109	[p8l1918t2358r2151b2439],
27	/	:	O	/	punct	8	SENT_109	[p8l1918t2358r2151b2439],

1	Predictive	JJ	O	predictive	amod	2	SENT_110	[p9l92t131r312b169],
2	relationship	NN	O	relationship	_	0	SENT_110	[p9l333t131r593b179],
3	of	IN	O	of	_	0	SENT_110	[p9l611t131r652b169],
4	changes	NNS	O	change	prep_of	2	SENT_110	[p9l669t131r862b180],
5	in	IN	O	in	_	0	SENT_110	[p9l882t131r916b169],
6	brain	NN	O	brain	nn	7	SENT_110	[p9l937t131r1046b169],
7	pathology	NN	O	pathology	prep_in	4	SENT_110	[p9l90t194r312b243],
8	to	TO	O	to	dep	2	SENT_110	[p9l328t197r369b232],
9	changes	NNS	O	change	pobj	8	SENT_110	[p9l387t194r580b243],
10	in	IN	O	in	_	0	SENT_110	[p9l600t194r634b231],
11	behavior	NN	O	behavior	prep_in	9	SENT_110	[p9l655t194r850b232],
12	in	IN	O	in	dep	2	SENT_110	[p9l868t194r902b231],
13	preclinical	JJ	O	preclinical	amod	14	SENT_110	[p9l923t194r1148b242],
14	models	NNS	O	model	pobj	12	SENT_110	[p9l90t256r253b294],

1	Relationship	NN	O	relationship	_	0	SENT_111	[p9l272t512r552b559],
2	of	IN	O	of	_	0	SENT_111	[p9l570t511r611b549],
3	changes	NNS	O	change	prep_of	1	SENT_111	[p9l628t511r821b560],
4	in	IN	O	in	dep	1	SENT_111	[p9l841t512r875b549],
5	brain	NN	O	brain	nn	6	SENT_111	[p9l896t512r1004b549],
6	pathology	NN	O	pathology	pobj	4	SENT_111	[p9l1026t512r1247b560],
7	to	TO	O	to	dep	1	SENT_111	[p9l1263t514r1304b549],
8	changes	NNS	O	change	pobj	7	SENT_111	[p9l269t574r462b623],
9	in	IN	O	in	_	0	SENT_111	[p9l482t574r515b611],
10	biomarkers	NNS	O	biomarker	prep_in	8	SENT_111	[p9l537t574r789b612],
11	in	IN	O	in	_	0	SENT_111	[p9l809t574r842b611],
12	preclincal	JJ	O	preclincal	amod	13	SENT_111	[p9l863t574r1077b622],
13	models	NNS	O	model	prep_in	10	SENT_111	[p9l1099t574r1260b612],

1	Relationship	NN	O	relationship	_	0	SENT_112	[p9l449t828r728b876],
2	of	IN	O	of	_	0	SENT_112	[p9l747t828r787b866],
3	changes	NNS	O	change	prep_of	1	SENT_112	[p9l805t828r998b877],
4	in	IN	O	in	_	0	SENT_112	[p9l1018t828r1051b866],
5	brain	NN	O	brain	nn	6	SENT_112	[p9l1072t828r1181b866],
6	pathology	NN	O	pathology	prep_in	3	SENT_112	[p9l1202t828r1424b877],
7	or	CC	O	or	_	0	SENT_112	[p9l1441t838r1485b866],
8	biomarkers	NNS	O	biomarker	conj_or	1	SENT_112	[p9l447t891r699b929],
9	in	IN	O	in	_	0	SENT_112	[p9l719t891r753b928],
10	animal	NN	O	animal	nn	11	SENT_112	[p9l773t891r921b929],
11	models	NNS	O	model	prep_in	8	SENT_112	[p9l942t891r1104b929],
12	to	TO	O	to	dep	1	SENT_112	[p9l1122t894r1162b929],
13	biomarker	NN	O	biomarker	nn	14	SENT_112	[p9l1182t891r1410b929],
14	changes	NNS	O	change	pobj	12	SENT_112	[p9l446t953r639b1002],
15	in	IN	O	in	dep	1	SENT_112	[p9l659t953r692b991],
16	humans	NNS	O	human	pobj	15	SENT_112	[p9l714t953r893b991],

1	Relationship	NN	O	relationship	_	0	SENT_113	[p9l624t1213r904b1260],
2	of	IN	O	of	_	0	SENT_113	[p9l923t1212r963b1250],
3	changes	NNS	O	change	prep_of	1	SENT_113	[p9l980t1213r1173b1261],
4	in	IN	O	in	dep	1	SENT_113	[p9l1194t1213r1227b1250],
5	brain	NN	O	brain	nn	6	SENT_113	[p9l1248t1213r1357b1250],
6	pathology	NN	O	pathology	pobj	4	SENT_113	[p9l1378t1213r1600b1261],
7	to	TO	O	to	dep	1	SENT_113	[p9l1616t1215r1657b1250],
8	changes	NNS	O	change	pobj	7	SENT_113	[p9l621t1275r814b1323],
9	in	IN	O	in	_	0	SENT_113	[p9l835t1275r868b1312],
10	biomarkers	NNS	O	biomarker	prep_in	8	SENT_113	[p9l889t1275r1141b1313],
11	in	IN	O	in	_	0	SENT_113	[p9l1161t1275r1195b1312],
12	humans	NNS	O	human	prep_in	10	SENT_113	[p9l1216t1275r1396b1313],

1	Predictive	JJ	O	predictive	amod	2	SENT_114	[p9l794t1538r1014b1576],
2	relationship	NN	O	relationship	_	0	SENT_114	[p9l1035t1538r1295b1586],
3	of	IN	O	of	_	0	SENT_114	[p9l1313t1538r1354b1576],
4	cognitive	JJ	O	cognitive	amod	5	SENT_114	[p9l1371t1538r1572b1587],
5	improvement	NN	O	improvement	prep_of	2	SENT_114	[p9l793t1601r1087b1649],
6	to	TO	O	to	dep	2	SENT_114	[p9l1103t1603r1144b1639],
7	changes	NNS	O	change	pobj	6	SENT_114	[p9l1162t1601r1355b1649],
8	in	IN	O	in	_	0	SENT_114	[p9l1375t1601r1409b1638],
9	biomarkers	NNS	O	biomarker	prep_in	7	SENT_114	[p9l1430t1601r1682b1639],
10	in	IN	O	in	dep	2	SENT_114	[p9l1702t1601r1735b1638],

1	Figure	NNP	O	Figure	nn	3	SENT_115	[p9l9t1883r197b1945],
2	4	CD	NUMBER	4	num	3	SENT_115	[p9l211t1886r246b1931],
3	Linkages	NNS	O	linkage	nsubj	25	SENT_115	[p9l297t1882r537b1945],
4	of	IN	O	of	_	0	SENT_115	[p9l555t1881r612b1931],
5	biomarkers	NNS	O	biomarker	prep_of	3	SENT_115	[p9l626t1882r933b1932],
6	to	TO	O	to	_	0	SENT_115	[p9l949t1889r1004b1931],
7	pathology	NN	O	pathology	prep_to	5	SENT_115	[p9l1023t1882r1307b1946],
8	and	CC	O	and	_	0	SENT_115	[p9l1322t1882r1423b1931],
9	clinical	JJ	O	clinical	amod	10	SENT_115	[p9l1442t1882r1627b1931],
10	outcomes	NNS	O	outcome	prep_of	3	SENT_115	[p9l1646t1889r1920b1932],
11	at	IN	O	at	_	0	SENT_115	[p9l7t1976r58b2018],
12	the	DT	O	the	det	14	SENT_115	[p9l73t1968r163b2018],
13	animal	NN	O	animal	nn	14	SENT_115	[p9l180t1968r362b2018],
14	model	NN	O	model	prep_at	10	SENT_115	[p9l383t1968r555b2018],
15	and	CC	O	and	_	0	SENT_115	[p9l574t1968r675b2018],
16	human	JJ	O	human	amod	18	SENT_115	[p9l696t1968r887b2018],
17	|	NN	O	|	nn	18	SENT_115	[p9l909t1968r1245b2018],
18	eve	NN	O	eve	conj_and	10	SENT_115	[p9l909t1968r1245b2018],
19	|	CD	NUMBER	|	num	20	SENT_115	[p9l909t1968r1245b2018],
20	s.	NN	O	s.	dep	18	SENT_115	[p9l909t1968r1245b2018],
21	These	DT	O	these	det	22	SENT_115	[p9l909t1968r1245b2018],
22	relationships	NNS	O	relationship	dep	18	SENT_115	[p9l1264t1968r1616b2031],
23	are	VBP	O	be	cop	25	SENT_115	[p9l1632t1983r1716b2018],
24	currently	RB	DATE	currently	advmod	25	SENT_115	[p9l1732t1968r1980b2032],
25	underdeveloped	JJ	O	underdeveloped	_	0	SENT_115	[p9l10t2054r467b2117],
26	and	CC	O	and	_	0	SENT_115	[p9l485t2054r586b2104],
27	require	VB	O	require	conj_and	25	SENT_115	[p9l608t2057r801b2117],
28	clarification	NN	O	clarification	dobj	27	SENT_115	[p9l818t2054r1135b2104],
29	to	TO	O	to	aux	30	SENT_115	[p9l1153t2062r1209b2104],
30	rationalize	VB	O	rationalize	xcomp	27	SENT_115	[p9l1228t2054r1512b2104],
31	drug	NN	O	drug	nn	32	SENT_115	[p9l1529t2054r1656b2118],
32	development	NN	O	development	dobj	30	SENT_115	[p9l1675t2054r2061b2117],
33	.	.	O	.	_	0	SENT_115	[p9l1675t2054r2061b2117],

1	Table	NNP	O	Table	nn	3	SENT_116	[p9l6t2275r186b2331],
2	1	CD	NUMBER	1	num	3	SENT_116	[p9l206t2279r229b2330],
3	Classification	NN	O	classification	dep	12	SENT_116	[p9l282t2274r723b2331],
4	of	IN	O	of	_	0	SENT_116	[p9l741t2274r810b2331],
5	the	DT	O	the	det	6	SENT_116	[p9l821t2275r931b2330],
6	spectrum	NN	O	spectrum	prep_of	3	SENT_116	[p9l947t2282r1260b2345],
7	of	IN	O	of	_	0	SENT_116	[p9l1278t2274r1347b2331],
8	AD	NN	O	ad	nn	9	SENT_116	[p9l1358t2277r1457b2330],
9	Alzheimer	NN	O	alzheimer	poss	11	SENT_116	[p9l7t2370r397b2433],
10	’s	POS	O	’s	_	0	SENT_116	[p9l7t2370r397b2433],
11	Association	NNP	O	Association	prep_of	6	SENT_116	[p9l417t2374r806b2433],
12	describes	VBZ	O	describe	_	0	SENT_116	[p9l826t2370r1132b2433],
13	preclinical	JJ	O	preclinical	amod	14	SENT_116	[p9l1151t2370r1499b2453],
14	AD	NN	O	ad	dobj	12	SENT_116	[p9l1517t2374r1649b2442],
15	,	,	O	,	_	0	SENT_116	[p9l1517t2374r1649b2442],
16	mild	JJ	O	mild	amod	18	SENT_116	[p9l1669t2370r1825b2433],
17	cognitive	JJ	O	cognitive	amod	18	SENT_116	[p9l1844t2376r2147b2454],
18	impairment	NN	O	impairment	dobj	12	SENT_116	[p9l8t2479r422b2556],
19	(	CD	NUMBER	(	num	20	SENT_116	[p9l448t2474r663b2550],
20	MCI	NNP	ORGANIZATION	MCI	dep	18	SENT_116	[p9l448t2474r663b2550],
21	)	CD	NUMBER	)	num	20	SENT_116	[p9l448t2474r663b2550],
22	of	IN	O	of	_	0	SENT_116	[p9l691t2473r766b2536],
23	the	DT	O	the	det	25	SENT_116	[p9l778t2473r886b2536],
24	AD	NN	O	ad	nn	25	SENT_116	[p9l909t2477r1029b2535],
25	type	NN	O	type	prep_of	20	SENT_116	[p9l1053t2485r1201b2557],
26	(	CD	NUMBER	(	dep	20	SENT_116	[p9l1228t2473r1408b2550],
27	with	IN	O	with	_	0	SENT_116	[p9l1228t2473r1408b2550],
28	intermediate	JJ	O	intermediate	amod	31	SENT_116	[p9l1431t2473r1874b2536],
29	or	CC	O	or	_	0	SENT_116	[p9l1898t2496r1971b2536],
30	high	JJ	O	high	conj_or	28	SENT_116	[p9l1992t2473r2149b2557],
31	likelihood	NN	O	likelihood	prep_with	26	SENT_116	[p9l7t2576r351b2639],
32	of	IN	O	of	_	0	SENT_116	[p9l371t2576r443b2639],
33	AD	NN	O	ad	nn	34	SENT_116	[p9l453t2577r619b2652],
34	)	NN	O	)	prep_of	31	SENT_116	[p9l453t2577r619b2652],
35	,	,	O	,	_	0	SENT_116	[p9l453t2577r619b2652],
36	and	CC	O	and	_	0	SENT_116	[p9l642t2576r766b2639],
37	AD	NN	O	ad	nn	39	SENT_116	[p9l784t2580r902b2638],
38	dementia	NN	O	dementia	nn	39	SENT_116	[p9l924t2576r1240b2639],
39	(	NN	O	(	dobj	12	SENT_116	[p9l1262t2576r1437b2652],
40	with	IN	O	with	_	0	SENT_116	[p9l1262t2576r1437b2652],
41	intermediate	JJ	O	intermediate	prep_with	12	SENT_116	[p9l1457t2576r1887b2639],
42	or	CC	O	or	_	0	SENT_116	[p9l1907t2599r1978b2639],
43	high	JJ	O	high	amod	44	SENT_116	[p9l1996t2576r2148b2660],
44	likelihood	NN	O	likelihood	conj_or	41	SENT_116	[p9l7t2679r357b2743],
45	of	IN	O	of	_	0	SENT_116	[p9l378t2679r452b2743],
46	AD	NN	O	ad	prep_of	44	SENT_116	[p9l463t2671r869b2756],
47	)	CD	NUMBER	)	number	48	SENT_116	[p9l463t2671r869b2756],
48	.30	CD	NUMBER	.30	num	49	SENT_116	[p9l463t2671r869b2756],
49	’	NN	O	’	dep	41	SENT_116	[p9l463t2671r869b2756],
50	38	CD	NUMBER	38	num	53	SENT_116	[p9l463t2671r869b2756],
51	‘	NN	O	‘	nn	53	SENT_116	[p9l463t2671r869b2756],
52	4	CD	NUMBER	4	num	53	SENT_116	[p9l463t2671r869b2756],
53	°	NN	O	°	nsubj	12	SENT_116	[p9l463t2671r869b2756],

1	Both	DT	O	both	det	2	SENT_117	[p9l83t2782r252b2845],
2	approaches	NNS	O	approach	nsubj	3	SENT_117	[p9l277t2782r673b2865],
3	emphasize	VBP	O	emphasize	_	0	SENT_117	[p9l699t2782r1067b2865],
4	the	DT	O	the	det	5	SENT_117	[p9l1091t2782r1200b2845],
5	importance	NN	O	importance	dobj	3	SENT_117	[p9l1225t2788r1632b2865],
6	of	IN	O	of	_	0	SENT_117	[p9l1657t2782r1733b2845],
7	biomarkers	NNS	O	biomarker	prep_of	5	SENT_117	[p9l1745t2782r2147b2845],
8	as	IN	O	as	_	0	SENT_117	[p9l9t2908r74b2948],
9	a	DT	O	a	det	10	SENT_117	[p9l98t2908r132b2948],
10	means	NN	O	means	prep_as	3	SENT_117	[p9l154t2908r374b2948],
11	of	IN	O	of	_	0	SENT_117	[p9l398t2885r472b2948],
12	identifying	VBG	O	identify	prepc_of	10	SENT_117	[p9l485t2885r864b2969],
13	the	DT	O	the	det	14	SENT_117	[p9l884t2885r991b2948],
14	presence	NN	O	presence	dobj	12	SENT_117	[p9l1013t2907r1314b2968],
15	of	IN	O	of	_	0	SENT_117	[p9l1337t2885r1411b2948],
16	AD	NN	O	ad	nn	17	SENT_117	[p9l1424t2889r1543b2947],
17	pathology	NN	O	pathology	prep_of	14	SENT_117	[p9l1566t2885r1916b2969],
18	before	IN	O	before	_	0	SENT_117	[p9l1933t2885r2149b2948],
19	the	DT	O	the	det	20	SENT_117	[p9l7t2988r114b3051],
20	emergence	NN	O	emergence	prep_before	12	SENT_117	[p9l138t3011r506b3072],
21	of	IN	O	of	_	0	SENT_117	[p9l529t2988r603b3051],
22	dementia	NN	O	dementia	prep_of	20	SENT_117	[p9l617t2988r954b3051],
23	.	.	O	.	_	0	SENT_117	[p9l617t2988r954b3051],

1	In	IN	O	in	_	0	SENT_118	[p9l980t2993r1051b3050],
2	the	DT	O	the	det	3	SENT_118	[p9l1073t2988r1179b3051],
3	case	NN	O	case	prep_in	17	SENT_118	[p9l1203t3011r1342b3051],
4	of	IN	O	of	_	0	SENT_118	[p9l1366t2988r1440b3051],
5	the	DT	O	the	det	6	SENT_118	[p9l1452t2988r1558b3051],
6	AD	NN	O	ad	prep_of	3	SENT_118	[p9l1581t2992r1699b3050],
7	at-risk	JJ	O	at-risk	amod	8	SENT_118	[p9l1724t2988r1947b3051],
8	state	NN	O	state	nsubj	17	SENT_118	[p9l1967t2992r2148b3054],
9	/	:	O	/	punct	11	SENT_118	[p9l1967t2992r2148b3054],
10	preclinical	JJ	O	preclinical	amod	11	SENT_118	[p9l7t3091r378b3174],
11	AD	NN	O	ad	dep	8	SENT_118	[p9l400t3095r538b3163],
12	,	,	O	,	_	0	SENT_118	[p9l400t3095r538b3163],
13	biomarkers	NNS	O	biomarker	appos	11	SENT_118	[p9l561t3091r961b3154],
14	are	VBP	O	be	cop	17	SENT_118	[p9l987t3114r1089b3154],
15	the	DT	O	the	det	17	SENT_118	[p9l1113t3091r1222b3154],
16	only	JJ	O	only	amod	17	SENT_118	[p9l1247t3091r1402b3175],
17	means	NNS	O	means	_	0	SENT_118	[p9l1422t3114r1647b3154],
18	of	IN	O	of	_	0	SENT_118	[p9l1672t3091r1747b3154],
19	identifying	VBG	O	identify	prepc_of	17	SENT_118	[p9l1762t3091r2150b3175],
20	the	DT	O	the	det	21	SENT_118	[p9l7t3194r116b3257],
21	syndrome	NN	O	syndrome	dobj	19	SENT_118	[p9l140t3194r507b3278],
22	;	:	O	;	_	0	SENT_118	[p9l140t3194r507b3278],
23	cognition	NN	O	cognition	nsubj	30	SENT_118	[p9l532t3200r866b3278],
24	and	CC	O	and	_	0	SENT_118	[p9l891t3194r1019b3257],
25	activities	NNS	O	activity	nsubj	30	SENT_118	[p9l1043t3200r1349b3257],
26	of	IN	O	of	_	0	SENT_118	[p9l1374t3194r1449b3257],
27	daily	JJ	SET	daily	amod	28	SENT_118	[p9l1464t3194r1634b3278],
28	living	NN	O	living	prep_of	23	SENT_118	[p9l1652t3194r1851b3278],
29	are	VBP	O	be	cop	30	SENT_118	[p9l1873t3217r1975b3257],
30	normal	JJ	O	normal	parataxis	17	SENT_118	[p9l1999t3217r2146b3257, p9l8t3297r150b3360],
31	.	.	O	.	_	0	SENT_118	[p9l1999t3217r2146b3257, p9l8t3297r150b3360],

1	The	DT	O	the	det	3	SENT_119	[p9l173t3297r297b3360],
2	prodromal	JJ	O	prodromal	amod	3	SENT_119	[p9l316t3297r681b3380],
3	AD	NN	O	ad	_	0	SENT_119	[p9l700t3301r847b3363],
4	/	:	O	/	punct	3	SENT_119	[p9l700t3301r847b3363],
5	MCI	NNP	ORGANIZATION	MCI	nsubjpass	11	SENT_119	[p9l851t3301r1008b3360],
6	due	JJ	O	due	_	0	SENT_119	[p9l1030t3297r1152b3360],
7	to	TO	O	to	_	0	SENT_119	[p9l1171t3309r1236b3360],
8	AD	NN	O	ad	nn	9	SENT_119	[p9l1257t3301r1374b3359],
9	syndrome	NN	O	syndrome	prep_due_to	5	SENT_119	[p9l1397t3297r1735b3381],
10	is	VBZ	O	be	auxpass	11	SENT_119	[p9l1755t3303r1805b3360],
11	identiﬁed	VBN	O	identiﬁed	dep	3	SENT_119	[p9l1825t3297r2150b3360],
12	by	IN	O	by	_	0	SENT_119	[p9l6t3400r90b3484],
13	a	DT	O	a	det	14	SENT_119	[p9l110t3423r145b3463],
14	combination	NN	O	combination	agent	11	SENT_119	[p9l167t3400r603b3463],
15	of	IN	O	of	_	0	SENT_119	[p9l626t3400r700b3463],
16	cognitive	JJ	O	cognitive	amod	17	SENT_119	[p9l714t3406r1027b3484],
17	decline	NN	O	decline	prep_of	14	SENT_119	[p9l1050t3400r1294b3463],
18	not	RB	O	not	neg	20	SENT_119	[p9l1317t3412r1431b3463],
19	sufficiently	RB	O	sufficiently	advmod	20	SENT_119	[p9l1454t3400r1830b3484],
20	severe	JJ	O	severe	amod	17	SENT_119	[p9l1850t3423r2059b3463],
21	to	TO	O	to	aux	22	SENT_119	[p9l2081t3412r2147b3463],
22	interfere	VB	O	interfere	xcomp	20	SENT_119	[p9l8t3503r298b3566],
23	with	IN	O	with	_	0	SENT_119	[p9l317t3503r470b3566],
24	daily	JJ	SET	daily	amod	25	SENT_119	[p9l491t3503r658b3587],
25	functions	NNS	O	function	prep_with	22	SENT_119	[p9l675t3503r998b3566],
26	and	CC	O	and	_	0	SENT_119	[p9l1020t3503r1147b3566],
27	biomarkers	NNS	O	biomarker	prep_with	22	SENT_119	[p9l1164t3503r1553b3566],
28	indicative	JJ	O	indicative	acomp	22	SENT_119	[p9l1574t3503r1908b3566],
29	of	IN	O	of	_	0	SENT_119	[p9l1929t3503r2003b3566],
30	AD	NN	O	ad	prep_of	17	SENT_119	[p9l2013t3507r2147b3566],
31	.	.	O	.	_	0	SENT_119	[p9l2013t3507r2147b3566],

1	AD	NN	O	ad	nn	2	SENT_120	[p9l7t3610r124b3668],
2	dementia	NN	O	dementia	nsubjpass	4	SENT_120	[p9l146t3606r459b3669],
3	is	VBZ	O	be	auxpass	4	SENT_120	[p9l477t3612r526b3669],
4	diagnosed	VBN	O	diagnose	_	0	SENT_120	[p9l547t3606r889b3690],
5	when	WRB	O	when	advmod	13	SENT_120	[p9l906t3606r1090b3669],
6	cognition	NN	O	cognition	nsubj	13	SENT_120	[p9l1111t3612r1430b3690],
7	and	CC	O	and	_	0	SENT_120	[p9l1450t3606r1574b3669],
8	activities	NNS	O	activity	nsubj	13	SENT_120	[p9l1593t3612r1886b3669],
9	of	IN	O	of	_	0	SENT_120	[p9l1906t3606r1979b3669],
10	daily	JJ	SET	daily	amod	11	SENT_120	[p9l1990t3606r2152b3690],
11	living	NN	O	living	prep_of	6	SENT_120	[p9l7t3709r202b3793],
12	are	VBP	O	be	cop	13	SENT_120	[p9l222t3732r322b3772],
13	abnormal	JJ	O	abnormal	advcl	4	SENT_120	[p9l345t3709r675b3772],
14	and	CC	O	and	_	0	SENT_120	[p9l697t3709r824b3772],
15	biomarkers	NNS	O	biomarker	nsubj	19	SENT_120	[p9l842t3709r1231b3772],
16	of	IN	O	of	_	0	SENT_120	[p9l1254t3709r1328b3772],
17	AD	NN	O	ad	prep_of	15	SENT_120	[p9l1339t3713r1458b3771],
18	are	VBP	O	be	cop	19	SENT_120	[p9l1482t3732r1582b3772],
19	present	JJ	DATE	present	conj_and	13	SENT_120	[p9l1603t3721r1871b3792],
20	.	.	O	.	_	0	SENT_120	[p9l1603t3721r1871b3792],

1	These	DT	O	these	det	2	SENT_121	[p10l82t16r282b79],
2	criteria	NNS	O	criterion	nsubj	3	SENT_121	[p10l307t22r561b79],
3	allow	VBP	O	allow	_	0	SENT_121	[p10l585t16r774b79],
4	recruitment	NN	O	recruitment	dobj	3	SENT_121	[p10l796t22r1219b79],
5	of	IN	O	of	_	0	SENT_121	[p10l1243t16r1319b79],
6	populations	NNS	O	population	prep_of	4	SENT_121	[p10l1333t16r1754b99],
7	of	IN	O	of	_	0	SENT_121	[p10l1779t16r1855b79],
8	patients	NNS	O	patient	prep_of	6	SENT_121	[p10l1869t22r2148b99],
9	who	WP	O	who	nsubj	10	SENT_121	[p10l7t119r150b182],
10	meet	VBP	O	meet	rcmod	8	SENT_121	[p10l170t131r335b182],
11	speciﬁc	NN	O	speciﬁc	dep	12	SENT_121	[p10l354t119r601b202],
12	clinical	JJ	O	clinical	dobj	10	SENT_121	[p10l621t119r859b182],
13	and	CC	O	and	_	0	SENT_121	[p10l879t119r1002b182],
14	biomarker	NN	O	biomarker	nn	15	SENT_121	[p10l1019t119r1369b182],
15	criteria	NNS	O	criterion	conj_and	12	SENT_121	[p10l1388t125r1626b182],
16	for	IN	O	for	_	0	SENT_121	[p10l1644t119r1739b182],
17	AD	NN	O	ad	prep_for	10	SENT_121	[p10l1757t123r1889b191],
18	,	,	O	,	_	0	SENT_121	[p10l1757t123r1889b191],
19	including	VBG	O	include	_	0	SENT_121	[p10l1910t119r2147b182, p10l8t228r114b306],
20	patients	NNS	O	patient	prep_including	10	SENT_121	[p10l131t228r394b305],
21	who	WP	O	who	nsubj	24	SENT_121	[p10l413t221r556b285],
22	do	VBP	O	do	aux	24	SENT_121	[p10l578t221r660b285],
23	not	RB	O	not	neg	24	SENT_121	[p10l681t233r793b285],
24	have	VB	O	have	rcmod	20	SENT_121	[p10l810t221r962b285],
25	dementia	NN	O	dementia	dobj	24	SENT_121	[p10l983t213r1372b285],
26	.	.	O	.	_	0	SENT_121	[p10l983t213r1372b285],

1	“	RB	O	“	advmod	2	SENT_122	[p10l983t213r1372b285],
2	Preventing	VBG	O	prevent	csubjpass	26	SENT_122	[p10l1396t227r1760b306],
3	or	CC	O	or	_	0	SENT_122	[p10l1779t244r1849b285],
4	delaying	VBG	O	delay	csubjpass	26	SENT_122	[p10l1869t221r2150b306],
5	the	DT	O	the	det	6	SENT_122	[p10l7t325r114b388],
6	onset	NN	O	onset	dobj	4	SENT_122	[p10l137t337r319b388],
7	of	IN	O	of	_	0	SENT_122	[p10l341t325r415b388],
8	dementia	NN	O	dementia	prep_of	6	SENT_122	[p10l429t325r767b397],
9	,	,	O	,	_	0	SENT_122	[p10l429t325r767b397],
10	deferring	VBG	O	defer	csubjpass	26	SENT_122	[p10l791t325r1109b409],
11	the	DT	O	the	det	12	SENT_122	[p10l1128t325r1235b388],
12	onset	NN	O	onset	dobj	10	SENT_122	[p10l1258t337r1441b388],
13	of	IN	O	of	_	0	SENT_122	[p10l1463t325r1536b388],
14	cognitive	JJ	O	cognitive	amod	15	SENT_122	[p10l1550t331r1863b409],
15	decline	NN	O	decline	prep_of	12	SENT_122	[p10l1886t325r2147b397],
16	,	,	O	,	_	0	SENT_122	[p10l1886t325r2147b397],
17	or	CC	O	or	_	0	SENT_122	[p10l9t451r81b491],
18	slowing	VBG	O	slow	csubjpass	26	SENT_122	[p10l101t428r364b512],
19	the	DT	O	the	det	20	SENT_122	[p10l382t428r488b491],
20	rate	NN	O	rate	dobj	18	SENT_122	[p10l509t440r636b491],
21	of	IN	O	of	_	0	SENT_122	[p10l658t428r732b491],
22	cognitive	JJ	O	cognitive	amod	23	SENT_122	[p10l743t434r1056b512],
23	deterioration	NN	O	deterioration	prep_of	20	SENT_122	[p10l1077t428r1526b491],
24	can	MD	O	can	aux	26	SENT_122	[p10l1547t451r1664b491],
25	be	VB	O	be	auxpass	26	SENT_122	[p10l1683t428r1762b491],
26	assessed	VBN	O	assess	_	0	SENT_122	[p10l1784t428r2065b491],
27	as	IN	O	as	_	0	SENT_122	[p10l2085t451r2150b491],
28	clinical	JJ	O	clinical	amod	29	SENT_122	[p10l9t531r250b594],
29	outcomes	NNS	O	outcome	prep_as	26	SENT_122	[p10l269t543r610b603],
30	;	:	O	;	_	0	SENT_122	[p10l269t543r610b603],
31	biomarkers	NNS	O	biomarker	nsubj	32	SENT_122	[p10l629t531r1011b594],
32	provide	VBP	O	provide	parataxis	26	SENT_122	[p10l1031t531r1288b614],
33	insight	NN	O	insight	dobj	32	SENT_122	[p10l1308t531r1538b615],
34	into	IN	O	into	_	0	SENT_122	[p10l1557t537r1688b594],
35	the	DT	O	the	det	36	SENT_122	[p10l1708t531r1813b594],
36	effects	NNS	O	effect	prep_into	32	SENT_122	[p10l1834t531r2042b594],
37	on	IN	O	on	_	0	SENT_122	[p10l2063t554r2148b594],
38	the	DT	O	the	det	40	SENT_122	[p10l7t634r113b697],
39	underlying	JJ	O	underlying	amod	40	SENT_122	[p10l133t634r507b718],
40	biology	NN	O	biology	prep_on	36	SENT_122	[p10l524t634r788b718],
41	.	.	O	.	_	0	SENT_122	[p10l524t634r788b718],

1	Biomarkers	NNS	O	biomarker	nsubj	4	SENT_123	[p10l812t634r1202b697],
2	will	MD	O	will	aux	4	SENT_123	[p10l1222t634r1346b697],
3	be	VB	O	be	cop	4	SENT_123	[p10l1364t634r1443b697],
4	critical	JJ	O	critical	_	0	SENT_123	[p10l1464t634r1697b697],
5	to	TO	O	to	_	0	SENT_123	[p10l1715t646r1781b697],
6	identiﬁcation	NN	O	identiﬁcation	prep_to	4	SENT_123	[p10l1802t634r2146b697, p10l7t743r145b800],
7	of	IN	O	of	_	0	SENT_123	[p10l167t737r241b800],
8	patients	NNS	O	patient	prep_of	6	SENT_123	[p10l252t743r522b820],
9	for	IN	O	for	_	0	SENT_123	[p10l544t737r642b800],
10	the	DT	O	the	det	12	SENT_123	[p10l661t737r768b800],
11	candidate	NN	O	candidate	nn	12	SENT_123	[p10l790t737r1121b800],
12	therapies	NNS	O	therapy	prep_for	8	SENT_123	[p10l1142t737r1452b820],
13	in	IN	O	in	_	0	SENT_123	[p10l1475t743r1542b799],
14	clinical	JJ	O	clinical	amod	15	SENT_123	[p10l1564t737r1809b800],
15	trials	NNS	O	trial	prep_in	12	SENT_123	[p10l1829t737r2000b800],
16	and	CC	O	and	_	0	SENT_123	[p10l2024t737r2150b800],
17	when	WRB	O	when	advmod	21	SENT_123	[p10l7t841r194b904],
18	disease-modifying	JJ	O	disease-modifying	amod	19	SENT_123	[p10l217t841r853b925],
19	agents	NNS	O	agent	nsubjpass	21	SENT_123	[p10l873t853r1087b925],
20	are	VBP	O	be	auxpass	21	SENT_123	[p10l1110t864r1210b904],
21	approved	VBN	O	approve	conj_and	6	SENT_123	[p10l1232t841r1565b924],
22	.	.	O	.	_	0	SENT_123	[p10l1232t841r1565b924],

1	In	IN	O	in	_	0	SENT_124	[p10l83t949r154b1006],
2	recent	JJ	O	recent	amod	3	SENT_124	[p10l177t956r388b1007],
3	trials	NNS	O	trial	prep_in	19	SENT_124	[p10l408t944r579b1007],
4	of	IN	O	of	_	0	SENT_124	[p10l604t944r677b1007],
5	immunotherapies	NNS	O	immunotherapy	prep_of	3	SENT_124	[p10l690t944r1300b1027],
6	of	IN	O	of	_	0	SENT_124	[p10l1324t944r1398b1007],
7	AD	NN	O	ad	prep_of	5	SENT_124	[p10l1410t948r1546b1016],
8	,	,	O	,	_	0	SENT_124	[p10l1410t948r1546b1016],
9	amyloid	NN	O	amyloid	nn	10	SENT_124	[p10l1571t944r1848b1028],
10	imaging	NN	O	imaging	nsubj	19	SENT_124	[p10l1870t950r2151b1028],
11	of	IN	O	of	_	0	SENT_124	[p10l9t1047r84b1110],
12	patients	NNS	O	patient	prep_of	10	SENT_124	[p10l97t1053r375b1130],
13	meeting	VBG	O	meet	partmod	12	SENT_124	[p10l399t1053r687b1131],
14	clinical	JJ	O	clinical	amod	15	SENT_124	[p10l710t1047r962b1110],
15	criteria	NNS	O	criterion	dobj	13	SENT_124	[p10l986t1053r1239b1110],
16	for	IN	O	for	_	0	SENT_124	[p10l1261t1047r1361b1110],
17	AD	NN	O	ad	nn	18	SENT_124	[p10l1383t1051r1504b1109],
18	dementia	NN	O	dementia	prep_for	15	SENT_124	[p10l1531t1047r1860b1110],
19	showed	VBD	O	show	_	0	SENT_124	[p10l1884t1047r2148b1110],
20	that	IN	O	that	complm	26	SENT_124	[p10l7t1150r138b1213],
21	~	NN	O	~	nsubj	26	SENT_124	[p10l159t1156r345b1214],
22	20	CD	PERCENT	20	number	23	SENT_124	[p10l159t1156r345b1214],
23	%	NN	PERCENT	%	amod	21	SENT_124	[p10l159t1156r345b1214],
24	did	VBD	O	do	aux	26	SENT_124	[p10l368t1150r476b1213],
25	not	RB	O	not	neg	26	SENT_124	[p10l495t1162r606b1213],
26	have	VB	O	have	ccomp	19	SENT_124	[p10l624t1150r776b1213],
27	a	DT	O	a	det	30	SENT_124	[p10l796t1173r830b1213],
28	cortical	JJ	O	cortical	amod	30	SENT_124	[p10l849t1150r1099b1213],
29	amyloid	NN	O	amyloid	nn	30	SENT_124	[p10l1119t1150r1390b1234],
30	burden	NN	O	burden	dobj	26	SENT_124	[p10l1406t1150r1649b1213],
31	and	CC	O	and	_	0	SENT_124	[p10l1669t1150r1792b1213],
32	would	MD	O	would	aux	34	SENT_124	[p10l1809t1150r2020b1213],
33	not	RB	O	not	neg	34	SENT_124	[p10l2038t1162r2149b1213],
34	meet	VB	O	meet	ccomp	19	SENT_124	[p10l8t1265r178b1316],
35	biomarker	NN	O	biomarker	nn	36	SENT_124	[p10l197t1253r558b1316],
36	criteria	NNS	O	criterion	dobj	34	SENT_124	[p10l581t1259r827b1316],
37	for	IN	O	for	_	0	SENT_124	[p10l849t1253r947b1316],
38	AD	NN	O	ad	prep_for	34	SENT_124	[p10l968t1257r1102b1316],
39	.	.	O	.	_	0	SENT_124	[p10l968t1257r1102b1316],

1	This	DT	O	this	nsubj	2	SENT_125	[p10l1128t1253r1272b1316],
2	indicates	VBZ	O	indicate	_	0	SENT_125	[p10l1295t1253r1600b1316],
3	the	DT	O	the	det	4	SENT_125	[p10l1622t1253r1729b1316],
4	importance	NN	O	importance	dobj	2	SENT_125	[p10l1752t1259r2150b1336],
5	of	IN	O	of	_	0	SENT_125	[p10l9t1356r82b1419],
6	using	VBG	O	use	prepc_of	4	SENT_125	[p10l92t1362r277b1440],
7	biomarkers	NNS	O	biomarker	dobj	6	SENT_125	[p10l293t1356r677b1419],
8	to	TO	O	to	aux	9	SENT_125	[p10l697t1368r762b1419],
9	support	VB	O	support	xcomp	6	SENT_125	[p10l785t1368r1048b1439],
10	and	CC	O	and	_	0	SENT_125	[p10l1068t1356r1193b1419],
11	validate	VB	O	validate	conj_and	9	SENT_125	[p10l1209t1356r1473b1419],
12	a	DT	O	a	det	14	SENT_125	[p10l1494t1379r1529b1419],
13	clinical	JJ	O	clinical	amod	14	SENT_125	[p10l1548t1356r1791b1419],
14	diagnosis	NN	O	diagnosis	dobj	9	SENT_125	[p10l1811t1356r2145b1440],
15	.	.	O	.	_	0	SENT_125	[p10l1811t1356r2145b1440],

1	BIOMARKERS	NNS	O	biomarker	_	0	SENT_126	[p10l12t1571r490b1627],
2	OF	IN	O	of	_	0	SENT_126	[p10l509t1571r603b1627],
3	TARGET	NN	O	target	nn	4	SENT_126	[p10l619t1572r900b1626],
4	ENGAGEMENT	NN	O	engagement	prep_of	1	SENT_126	[p10l920t1572r1431b1626],

1	When	WRB	O	when	advmod	4	SENT_127	[p10l7t1667r226b1730],
2	drugs	NNS	O	drug	nsubj	4	SENT_127	[p10l255t1667r456b1751],
3	are	VBP	O	be	cop	4	SENT_127	[p10l485t1690r590b1730],
4	ﬁrst	JJ	O	ﬁrst	advcl	19	SENT_127	[p10l618t1667r758b1730],
5	introduced	VBN	O	introduce	conj_or	5	SENT_127	[p10l786t1667r1184b1730],
6	into	IN	O	into	_	0	SENT_127	[p10l1212t1673r1352b1730],
7	normal	JJ	O	normal	amod	8	SENT_127	[p10l1381t1667r1644b1730],
8	volunteers	NNS	O	volunteer	prep_into	5	SENT_127	[p10l1668t1667r2045b1730],
9	or	CC	O	or	_	0	SENT_127	[p10l2075t1690r2149b1730],
10	in	IN	O	in	_	0	SENT_127	[p10l9t1776r77b1832],
11	early	JJ	O	early	amod	12	SENT_127	[p10l104t1770r278b1854],
12	trials	NNS	O	trial	prep_in	5	SENT_127	[p10l299t1770r478b1833],
13	with	IN	O	with	_	0	SENT_127	[p10l503t1770r662b1833],
14	AD	NN	O	ad	nn	15	SENT_127	[p10l687t1774r809b1832],
15	patients	NNS	O	patient	prep_with	12	SENT_127	[p10l836t1776r1138b1853],
16	,	,	O	,	_	0	SENT_127	[p10l836t1776r1138b1853],
17	it	PRP	O	it	nsubj	19	SENT_127	[p10l1166t1776r1213b1833],
18	is	VBZ	O	be	cop	19	SENT_127	[p10l1238t1776r1290b1833],
19	necessary	JJ	O	necessary	_	0	SENT_127	[p10l1317t1793r1664b1854],
20	to	TO	O	to	aux	21	SENT_127	[p10l1686t1782r1754b1833],
21	determine	VB	O	determine	xcomp	19	SENT_127	[p10l1782t1770r2147b1833],
22	whether	IN	O	whether	complm	33	SENT_127	[p10l7t1873r288b1936],
23	the	DT	O	the	det	24	SENT_127	[p10l306t1873r412b1936],
24	effects	NNS	O	effect	nsubjpass	33	SENT_127	[p10l433t1873r644b1936],
25	observed	VBN	O	observe	partmod	24	SENT_127	[p10l666t1873r975b1936],
26	in	IN	O	in	_	0	SENT_127	[p10l994t1879r1060b1935],
27	cell	NN	O	cell	nn	28	SENT_127	[p10l1081t1873r1194b1936],
28	assays	NNS	O	assay	prep_in	25	SENT_127	[p10l1214t1896r1417b1957],
29	or	CC	O	or	_	0	SENT_127	[p10l1439t1896r1510b1936],
30	animal	NN	O	animal	nn	31	SENT_127	[p10l1530t1873r1764b1936],
31	models	NNS	O	model	conj_or	28	SENT_127	[p10l1783t1873r2028b1936],
32	are	VBP	O	be	auxpass	33	SENT_127	[p10l2050t1896r2150b1936],
33	recapitulated	VBN	O	recapitulate	ccomp	21	SENT_127	[p10l9t1976r457b2059],
34	in	IN	O	in	_	0	SENT_127	[p10l479t1982r546b2038],
35	humans	NNS	O	human	prep_in	33	SENT_127	[p10l568t1976r861b2039],
36	.	.	O	.	_	0	SENT_127	[p10l568t1976r861b2039],

1	Demonstrating	VBG	O	demonstrate	csubj	7	SENT_128	[p10l888t1981r1415b2060],
2	target	NN	O	target	nn	3	SENT_128	[p10l1435t1988r1634b2060],
3	engagement	NN	O	engagement	dobj	1	SENT_128	[p10l1657t1988r2074b2060],
4	is	VBZ	O	be	cop	7	SENT_128	[p10l2097t1982r2147b2039],
5	the	DT	O	the	det	7	SENT_128	[p10l7t2079r113b2142],
6	ﬁrst	JJ	O	ﬁrst	amod	7	SENT_128	[p10l133t2079r264b2142],
7	step	NN	O	step	_	0	SENT_128	[p10l285t2091r416b2162],
8	in	IN	O	in	_	0	SENT_128	[p10l438t2085r504b2141],
9	deciding	VBG	O	decide	prepc_in	7	SENT_128	[p10l525t2079r817b2163],
10	whether	IN	O	whether	complm	12	SENT_128	[p10l834t2079r1114b2142],
11	to	TO	O	to	aux	12	SENT_128	[p10l1132t2091r1198b2142],
12	advance	VB	O	advance	ccomp	9	SENT_128	[p10l1220t2079r1493b2142],
13	a	DT	O	a	det	14	SENT_128	[p10l1514t2102r1549b2142],
14	compound	NN	O	compound	dobj	12	SENT_128	[p10l1568t2079r1938b2162],
15	in	IN	O	in	_	0	SENT_128	[p10l1957t2085r2023b2141],
16	the	DT	O	the	det	19	SENT_128	[p10l2042t2079r2148b2142],
17	drug	NN	O	drug	nn	19	SENT_128	[p10l9t2182r174b2266],
18	development	NN	O	development	nn	19	SENT_128	[p10l196t2182r646b2265],
19	process	NN	O	process	prep_in	14	SENT_128	[p10l667t2204r941b2265],
20	.	.	O	.	_	0	SENT_128	[p10l667t2204r941b2265],

1	Target	NN	O	target	nn	3	SENT_129	[p10l968t2185r1185b2266],
2	engagement	NN	O	engagement	nn	3	SENT_129	[p10l1208t2194r1628b2266],
3	trials	NNS	O	trial	nsubjpass	7	SENT_129	[p10l1649t2182r1822b2245],
4	may	MD	O	may	aux	7	SENT_129	[p10l1846t2205r1995b2266],
5	also	RB	O	also	advmod	7	SENT_129	[p10l2015t2182r2147b2245],
6	be	VB	O	be	auxpass	7	SENT_129	[p10l6t2285r87b2348],
7	viewed	VBN	O	view	_	0	SENT_129	[p10l108t2285r355b2348],
8	as	IN	O	as	_	0	SENT_129	[p10l378t2308r444b2348],
9	proof-of-pharmacology	NN	O	proof-of-pharmacology	nn	12	SENT_129	[p10l467t2285r1302b2369],
10	or	CC	O	or	_	0	SENT_129	[p10l1323t2308r1396b2348],
11	proof	NN	O	proof	nn	12	SENT_129	[p10l1417t2285r2149b2368],
12	—	NN	O	—	prep_as	7	SENT_129	[p10l1417t2285r2149b2368],
13	of	IN	O	of	_	0	SENT_129	[p10l1417t2285r2149b2368],
14	—	CD	NUMBER	—	num	16	SENT_129	[p10l1417t2285r2149b2368],
15	mechanism	NN	O	mechanism	nn	16	SENT_129	[p10l1417t2285r2149b2368],
16	trials	NNS	O	trial	prep_of	12	SENT_129	[p10l7t2387r178b2450],
17	if	IN	O	if	mark	24	SENT_129	[p10l200t2387r254b2449],
18	the	DT	O	the	det	19	SENT_129	[p10l264t2387r371b2450],
19	effects	NNS	O	effect	nsubjpass	24	SENT_129	[p10l392t2387r604b2450],
20	on	IN	O	on	_	0	SENT_129	[p10l626t2410r712b2450],
21	downstream	JJ	O	downstream	amod	22	SENT_129	[p10l733t2387r1158b2450],
22	events	NNS	O	event	prep_on	19	SENT_129	[p10l1179t2399r1391b2450],
23	are	VBP	O	be	auxpass	24	SENT_129	[p10l1413t2410r1513b2450],
24	used	VBN	O	use	advcl	7	SENT_129	[p10l1534t2387r1692b2450],
25	to	TO	O	to	aux	26	SENT_129	[p10l1711t2399r1777b2450],
26	determine	VB	O	determine	xcomp	24	SENT_129	[p10l1800t2387r2150b2450],
27	target	NN	O	target	nn	28	SENT_129	[p10l7t2501r205b2574],
28	engagement	NN	O	engagement	dobj	26	SENT_129	[p10l225t2501r656b2574],
29	.	.	O	.	_	0	SENT_129	[p10l225t2501r656b2574],

1	Stable	JJ	O	stable	amod	3	SENT_130	[p10l83t2593r286b2656],
2	isotope	NN	O	isotope	nn	3	SENT_130	[p10l309t2593r853b2676],
3	—	NN	O	—	nsubj	8	SENT_130	[p10l309t2593r853b2676],
4	labeled	VBN	O	label	partmod	3	SENT_130	[p10l309t2593r853b2676],
5	kinetics	NNS	O	kinetics	dobj	4	SENT_130	[p10l873t2593r1142b2656],
6	is	VBZ	O	be	cop	8	SENT_130	[p10l1166t2599r1216b2656],
7	a	DT	O	a	det	8	SENT_130	[p10l1240t2616r1275b2656],
8	technique	NN	O	technique	_	0	SENT_130	[p10l1296t2593r1638b2676],
9	for	IN	O	for	_	0	SENT_130	[p10l1662t2593r1760b2656],
10	measuring	VBG	O	measure	prepc_for	8	SENT_130	[p10l1781t2599r2150b2677],
11	the	DT	O	the	det	12	SENT_130	[p10l7t2696r118b2759],
12	dynamics	NNS	O	dynamics	dobj	10	SENT_130	[p10l147t2696r488b2780],
13	of	IN	O	of	_	0	SENT_130	[p10l518t2696r594b2759],
14	CSF	NN	O	csf	nn	15	SENT_130	[p10l613t2700r755b2759],
15	constituents	NNS	O	constituent	prep_of	12	SENT_130	[p10l785t2702r1219b2759],
16	using	VBG	O	use	dep	10	SENT_130	[p10l1248t2702r1442b2780],
17	mass	NN	O	mass	nn	18	SENT_130	[p10l1467t2719r1641b2759],
18	spectrometry	NN	O	spectrometry	dobj	16	SENT_130	[p10l1671t2708r2153b2780],
19	and	CC	O	and	_	0	SENT_130	[p10l9t2799r135b2862],
20	assaying	VBG	O	assay	conj_and	10	SENT_130	[p10l158t2805r442b2883],
21	their	PRP$	O	they	poss	22	SENT_130	[p10l462t2799r624b2862],
22	synthesis	NN	O	synthesis	dobj	20	SENT_130	[p10l647t2799r954b2883],
23	and	CC	O	and	_	0	SENT_130	[p10l977t2799r1104b2862],
24	clearance	NN	O	clearance	dobj	20	SENT_130	[p10l1126t2799r1459b2862],
25	.	.	O	.	_	0	SENT_130	[p10l1126t2799r1459b2862],

1	Studies	NNS	O	study	nsubjpass	14	SENT_131	[p10l1485t2799r1728b2862],
2	of	IN	O	of	_	0	SENT_131	[p10l1751t2799r1825b2862],
3	synthesis	NN	O	synthesis	nn	11	SENT_131	[p10l1839t2799r2147b2883],
4	and	CC	O	and	_	0	SENT_131	[p10l9t2902r136b2965],
5	clearance	NN	O	clearance	nn	11	SENT_131	[p10l158t2902r477b2965],
6	of	IN	O	of	_	0	SENT_131	[p10l501t2902r575b2965],
7	AB	NNP	O	AB	prep_of	3	SENT_131	[p10l586t2900r691b2983],
8	and	CC	O	and	_	0	SENT_131	[p10l715t2902r843b2965],
9	of	IN	O	of	nn	11	SENT_131	[p10l864t2902r939b2965],
10	ApoE	NN	O	apoe	pobj	9	SENT_131	[p10l950t2906r1144b2985],
11	isoforms	NNS	O	isoform	prep_of	1	SENT_131	[p10l1167t2902r1465b2965],
12	have	VBP	O	have	aux	14	SENT_131	[p10l1487t2902r1643b2965],
13	been	VBN	O	be	auxpass	14	SENT_131	[p10l1664t2902r1829b2965],
14	reported	VBN	O	report	_	0	SENT_131	[p10l1852t2902r2149b2985],
15	with	IN	O	with	_	0	SENT_131	[p10l7t3005r159b3069],
16	this	DT	O	this	det	17	SENT_131	[p10l180t3005r304b3069],
17	approach	NN	O	approach	prep_with	14	SENT_131	[p10l327t2997r799b3089],
18	.42	CD	NUMBER	.42	number	19	SENT_131	[p10l327t2997r799b3089],
19	’43	CD	NUMBER	’43	num	17	SENT_131	[p10l327t2997r799b3089],
20	Reduced	VBN	O	reduce	partmod	17	SENT_131	[p10l823t3005r1120b3069],
21	clearance	NN	O	clearance	dobj	20	SENT_131	[p10l1142t3006r1458b3069],
22	of	IN	O	of	_	0	SENT_131	[p10l1481t3005r1555b3069],
23	AB	NNP	O	AB	prep_of	21	SENT_131	[p10l1566t3003r1670b3087],
24	from	IN	O	from	_	0	SENT_131	[p10l1693t3005r1860b3069],
25	the	DT	O	the	det	26	SENT_131	[p10l1881t3005r1987b3069],
26	CSF	NN	O	csf	prep_from	20	SENT_131	[p10l2011t3009r2148b3069],

1	International	NNP	O	International	nn	2	SENT_132	[p10l658t3187r842b3212],
2	Work	NNP	O	Work	_	0	SENT_132	[p10l849t3187r924b3212],

1	Features	NNP	O	Features	dep	111	SENT_133	[p10l21t3227r141b3251],
2	Group	NNP	O	Group	dep	111	SENT_133	[p10l692t3227r781b3257],
3	criteria	NNS	O	criterion	dep	111	SENT_133	[p10l789t3227r887b3251],
4	National	NNP	ORGANIZATION	National	dep	111	SENT_133	[p10l1052t3226r1170b3251],
5	Institute	NNP	ORGANIZATION	Institute	dep	111	SENT_133	[p10l1180t3227r1299b3251],
6	on	IN	ORGANIZATION	on	dep	111	SENT_133	[p10l1306t3233r1341b3251],
7	Aging/Alzheimer	NNP	ORGANIZATION	Aging/Alzheimer	dep	111	SENT_133	[p10l1349t3226r1612b3257],
8	's	POS	O	's	dep	111	SENT_133	[p10l1349t3226r1612b3257],
9	Association	NNP	O	Association	dep	111	SENT_133	[p10l1619t3227r1782b3251],
10	criteria	NNS	O	criterion	dep	111	SENT_133	[p10l1791t3227r1889b3251],
11	Normal	JJ	O	normal	dep	111	SENT_133	[p10l21t3284r120b3308],
12	cognition	NN	O	cognition	dep	111	SENT_133	[p10l129t3285r267b3315],
13	;	:	O	;	_	0	SENT_133	[p10l129t3285r267b3315],
14	intact	JJ	O	intact	dep	111	SENT_133	[p10l276t3285r353b3308],
15	ADLs	NNS	O	adl	dep	111	SENT_133	[p10l360t3285r437b3312],
16	;	:	O	;	_	0	SENT_133	[p10l360t3285r437b3312],
17	biomarker	NN	O	biomarker	dep	111	SENT_133	[p10l445t3284r586b3308],
18	At-risk	JJ	MISC	at-risk	dep	111	SENT_133	[p10l656t3284r744b3308],
19	state	NN	O	state	dep	111	SENT_133	[p10l751t3288r817b3308],
20	with	IN	O	with	dep	111	SENT_133	[p10l824t3284r883b3308],
21	Preclinical	JJ	O	preclinical	dep	111	SENT_133	[p10l1052t3284r1188b3308],
22	AD	NN	O	ad	dep	111	SENT_133	[p10l1196t3285r1237b3308],
23	evidence	NN	O	evidence	dep	111	SENT_133	[p10l20t3323r144b3348],
24	of	IN	O	of	dep	111	SENT_133	[p10l152t3323r180b3348],
25	AD	NN	O	ad	dep	111	SENT_133	[p10l185t3324r226b3348],
26	AD	NN	O	ad	dep	111	SENT_133	[p10l656t3324r697b3348],
27	pathology	NN	O	pathology	dep	111	SENT_133	[p10l706t3323r847b3355],
28	Abnormal	JJ	O	abnormal	dep	111	SENT_133	[p10l20t3381r156b3405],
29	cognition	NN	O	cognition	dep	111	SENT_133	[p10l165t3382r303b3412],
30	;	:	O	;	_	0	SENT_133	[p10l165t3382r303b3412],
31	normal	JJ	O	normal	dep	111	SENT_133	[p10l312t3381r407b3405],
32	ADLs	NNS	O	adl	dep	111	SENT_133	[p10l416t3382r492b3409],
33	;	:	O	;	_	0	SENT_133	[p10l416t3382r492b3409],
34	Prodromal	JJ	O	prodromal	dep	111	SENT_133	[p10l658t3381r799b3405],
35	AD	NN	O	ad	dep	111	SENT_133	[p10l807t3382r848b3405],
36	MCI	NNP	ORGANIZATION	MCI	dep	111	SENT_133	[p10l1051t3383r1101b3406],
37	due	JJ	O	due	dep	111	SENT_133	[p10l1110t3382r1162b3406],
38	to	TO	O	to	dep	111	SENT_133	[p10l1169t3385r1197b3406],
39	AD	NN	O	ad	dep	111	SENT_133	[p10l1204t3383r1252b3410],
40	;	:	O	;	_	0	SENT_133	[p10l1204t3383r1252b3410],
41	intermediate	JJ	O	intermediate	dep	111	SENT_133	[p10l1261t3382r1437b3406],
42	likelihood	NN	O	likelihood	dep	111	SENT_133	[p10l1446t3382r1587b3406],
43	:	:	O	:	_	0	SENT_133	[p10l1446t3382r1587b3406],
44	one	CD	NUMBER	one	dep	111	SENT_133	[p10l1595t3389r1647b3406],
45	biomarker	NN	O	biomarker	dep	111	SENT_133	[p10l1655t3382r1796b3406],
46	present	JJ	DATE	present	dep	111	SENT_133	[p10l1804t3386r1907b3412],
47	(	CD	NUMBER	(	dep	111	SENT_133	[p10l1915t3381r1960b3413],
48	AB	NNP	O	AB	dep	111	SENT_133	[p10l1915t3381r1960b3413],
49	or	CC	O	or	dep	111	SENT_133	[p10l1968t3389r1996b3406],
50	neuronal	JJ	O	neuronal	dep	111	SENT_133	[p10l2004t3382r2124b3406],
51	biomarker	NN	O	biomarker	dep	111	SENT_133	[p10l21t3419r162b3444],
52	evidence	NN	O	evidence	dep	111	SENT_133	[p10l169t3419r293b3444],
53	ofAD	NN	O	ofad	dep	111	SENT_133	[p10l301t3419r375b3444],
54	injury	NN	O	injury	dep	111	SENT_133	[p10l1052t3421r1145b3452],
55	)	NN	O	)	dep	111	SENT_133	[p10l1052t3421r1145b3452],
56	;	:	O	;	_	0	SENT_133	[p10l1052t3421r1145b3452],
57	high	JJ	O	high	dep	111	SENT_133	[p10l1154t3420r1213b3452],
58	likelihood	NN	O	likelihood	dep	111	SENT_133	[p10l1223t3420r1364b3445],
59	:	:	O	:	_	0	SENT_133	[p10l1223t3420r1364b3445],
60	two	CD	NUMBER	two	dep	111	SENT_133	[p10l1371t3424r1424b3445],
61	biomarkers	NNS	O	biomarker	dep	111	SENT_133	[p10l1433t3420r1586b3445],
62	present	JJ	DATE	present	dep	111	SENT_133	[p10l1595t3424r1697b3451],
63	(	CD	NUMBER	(	dep	111	SENT_133	[p10l1706t3419r1751b3452],
64	AB	NNP	O	AB	dep	111	SENT_133	[p10l1706t3419r1751b3452],
65	plus	CC	O	plus	dep	111	SENT_133	[p10l1759t3420r1815b3451],
66	neuronal	JJ	O	neuronal	dep	111	SENT_133	[p10l1823t3420r1944b3445],
67	injury	NN	O	injury	dep	111	SENT_133	[p10l1954t3421r2040b3452],
68	)	CD	NUMBER	)	dep	111	SENT_133	[p10l1954t3421r2040b3452],
69	Abnormal	JJ	O	abnormal	dep	111	SENT_133	[p10l20t3484r156b3509],
70	cognition	NN	O	cognition	dep	111	SENT_133	[p10l165t3485r303b3516],
71	;	:	O	;	_	0	SENT_133	[p10l165t3485r303b3516],
72	abnormal	JJ	O	abnormal	dep	111	SENT_133	[p10l311t3484r442b3509],
73	ADLs	NNS	O	adl	dep	111	SENT_133	[p10l451t3485r527b3513],
74	;	:	O	;	_	0	SENT_133	[p10l451t3485r527b3513],
75	AD	NN	O	ad	dep	111	SENT_133	[p10l656t3485r697b3509],
76	dementia	NN	O	dementia	dep	111	SENT_133	[p10l705t3484r835b3509],
77	AD	NN	O	ad	dep	111	SENT_133	[p10l1051t3486r1091b3510],
78	dementia	NN	O	dementia	dep	111	SENT_133	[p10l1099t3485r1237b3514],
79	;	:	O	;	_	0	SENT_133	[p10l1099t3485r1237b3514],
80	intermediate	JJ	O	intermediate	dep	111	SENT_133	[p10l1246t3485r1422b3510],
81	likelihood	NN	O	likelihood	dep	111	SENT_133	[p10l1431t3485r1564b3510],
82	zone	NN	O	zone	dep	111	SENT_133	[p10l1573t3492r1637b3510],
83	biomarker	NN	O	biomarker	dep	111	SENT_133	[p10l1646t3485r1787b3510],
84	present	JJ	DATE	present	dep	111	SENT_133	[p10l1795t3489r1897b3516],
85	(	CD	NUMBER	(	dep	111	SENT_133	[p10l1906t3484r1951b3517],
86	AB	NNP	O	AB	dep	111	SENT_133	[p10l1906t3484r1951b3517],
87	or	CC	O	or	dep	111	SENT_133	[p10l1958t3492r1986b3510],
88	neuronal	JJ	O	neuronal	dep	111	SENT_133	[p10l1994t3485r2115b3510],
89	biomarker	NN	O	biomarker	dep	111	SENT_133	[p10l21t3523r162b3548],
90	evidence	NN	O	evidence	dep	111	SENT_133	[p10l169t3523r293b3548],
91	ofAD	NN	O	ofad	dep	111	SENT_133	[p10l301t3523r375b3548],
92	injury	NN	O	injury	dep	111	SENT_133	[p10l1052t3525r1145b3556],
93	)	NN	O	)	dep	111	SENT_133	[p10l1052t3525r1145b3556],
94	;	:	O	;	_	0	SENT_133	[p10l1052t3525r1145b3556],
95	high	JJ	O	high	dep	111	SENT_133	[p10l1154t3524r1213b3556],
96	likelihood	NN	O	likelihood	dep	111	SENT_133	[p10l1223t3524r1364b3549],
97	:	:	O	:	_	0	SENT_133	[p10l1223t3524r1364b3549],
98	two	CD	NUMBER	two	dep	111	SENT_133	[p10l1371t3528r1424b3549],
99	biomarkers	NNS	O	biomarker	dep	111	SENT_133	[p10l1433t3524r1586b3549],
100	present	JJ	DATE	present	dep	111	SENT_133	[p10l1595t3528r1698b3555],
101	(	CD	NUMBER	(	dep	111	SENT_133	[p10l1706t3523r1751b3556],
102	AB	NNP	O	AB	dep	111	SENT_133	[p10l1706t3523r1751b3556],
103	plus	CC	O	plus	dep	111	SENT_133	[p10l1759t3524r1815b3555],
104	neuronal	JJ	O	neuronal	dep	111	SENT_133	[p10l1823t3524r1944b3549],
105	injury	NN	O	injury	dep	111	SENT_133	[p10l1954t3525r2040b3556],
106	)	CD	NUMBER	)	dep	111	SENT_133	[p10l1954t3525r2040b3556],
107	AB	NNP	ORGANIZATION	AB	dep	111	SENT_133	[p10l20t3582r58b3611],
108	,	,	O	,	_	0	SENT_133	[p10l20t3582r58b3611],
109	amy	NNP	O	amy	dep	111	SENT_133	[p10l65t3582r192b3611],
110	|	NNP	O	|	dep	111	SENT_133	[p10l65t3582r192b3611],
111	oid	NN	O	oid	_	0	SENT_133	[p10l65t3582r192b3611],
112	.	.	O	.	_	0	SENT_133	[p10l65t3582r192b3611],

1	—	NN	O	—	_	0	SENT_134	[p10l65t3582r192b3611],
2	.	.	O	.	_	0	SENT_134	[p10l65t3582r192b3611],

1	B	NN	O	b	_	0	SENT_135	[p10l65t3582r192b3611],
2	;	:	O	;	_	0	SENT_135	[p10l65t3582r192b3611],
3	AD	NN	O	ad	dep	1	SENT_135	[p10l199t3584r239b3608],
4	,	,	O	,	_	0	SENT_135	[p10l199t3584r239b3608],
5	Alzheimer	NN	O	alzheimer	poss	7	SENT_135	[p10l246t3583r384b3605],
6	's	POS	O	's	_	0	SENT_135	[p10l246t3583r384b3605],
7	disease	NN	O	disease	appos	3	SENT_135	[p10l391t3583r485b3608],
8	;	:	O	;	_	0	SENT_135	[p10l391t3583r485b3608],
9	ADLs	NNS	O	adl	dep	3	SENT_135	[p10l491t3584r558b3608],
10	,	,	O	,	_	0	SENT_135	[p10l491t3584r558b3608],
11	activities	NNS	O	activity	appos	9	SENT_135	[p10l564t3584r670b3605],
12	ofdaily	RB	O	ofdaily	advmod	13	SENT_135	[p10l677t3583r763b3611],
13	living	VBG	O	live	partmod	11	SENT_135	[p10l770t3583r841b3611],
14	;	:	O	;	_	0	SENT_135	[p10l770t3583r841b3611],
15	MCI	NNP	ORGANIZATION	MCI	dep	1	SENT_135	[p10l848t3584r899b3608],
16	,	,	O	,	_	0	SENT_135	[p10l848t3584r899b3608],
17	mild	JJ	O	mild	amod	19	SENT_135	[p10l907t3583r957b3605],
18	cognitive	JJ	O	cognitive	amod	19	SENT_135	[p10l965t3584r1076b3611],
19	impairment	NN	O	impairment	appos	15	SENT_135	[p10l1084t3584r1230b3610],
20	.	.	O	.	_	0	SENT_135	[p10l1084t3584r1230b3610],

1	70	CD	NUMBER	70	num	2	SENT_136	[p10l20t3688r51b3709],
2	VOLUME	NN	O	volume	nsubjpass	17	SENT_136	[p10l1367t3688r1475b3709],
3	95	CD	NUMBER	95	num	4	SENT_136	[p10l1483t3688r1510b3709],
4	NUMBER	NN	O	number	dep	2	SENT_136	[p10l1520t3688r1628b3709],
5	1	CD	NUMBER	1	number	6	SENT_136	[p10l1638t3689r1645b3709],
6	|	CD	NUMBER	|	num	15	SENT_136	[p10l1659t3686r1661b3716],
7	JANUARY	NNP	DATE	JANUARY	nn	15	SENT_136	[p10l1670t3688r1788b3709],
8	2014	CD	DATE	2014	num	15	SENT_136	[p10l1796t3688r1854b3709],
9	|	CD	NUMBER	|	num	10	SENT_136	[p10l1863t3686r1865b3716],
10	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	15	SENT_136	[p10l1874t3688r2139b3714],
11	in	IN	O	in	_	0	SENT_136	[p11l9t323r77b379],
12	late	JJ	O	late	amod	14	SENT_136	[p11l102t317r449b380],
13	—	NN	O	—	nn	14	SENT_136	[p11l102t317r449b380],
14	onset	NN	O	onset	prep_in	10	SENT_136	[p11l102t317r449b380],
15	AD	NN	O	ad	dep	4	SENT_136	[p11l473t321r594b379],
16	was	VBD	O	be	auxpass	17	SENT_136	[p11l621t340r750b380],
17	demonstrated	VBN	O	demonstrate	_	0	SENT_136	[p11l777t317r1268b380],
18	using	VBG	O	use	xcomp	17	SENT_136	[p11l1292t323r1484b401],
19	this	DT	O	this	det	20	SENT_136	[p11l1507t317r1635b380],
20	technique	NN	O	technique	dobj	18	SENT_136	[p11l1661t317r2030b400],
21	,	,	O	,	_	0	SENT_136	[p11l1661t317r2030b400],
22	an	DT	O	a	det	23	SENT_136	[p11l2058t340r2140b380],
23	observation	NN	O	observation	appos	20	SENT_136	[p11l9t420r397b483],
24	of	IN	O	of	_	0	SENT_136	[p11l417t420r488b483],
25	importance	NN	O	importance	prep_of	23	SENT_136	[p11l498t426r878b503],
26	in	IN	O	in	_	0	SENT_136	[p11l897t426r961b482],
27	deciphering	VBG	O	decipher	prepc_in	18	SENT_136	[p11l981t420r1374b504],
28	the	DT	O	the	det	31	SENT_136	[p11l1390t420r1493b483],
29	etio	FW	O	etio	nn	30	SENT_136	[p11l1512t420r1915b504],
30	—	FW	O	—	amod	31	SENT_136	[p11l1512t420r1915b504],
31	biology	NN	O	biology	dobj	27	SENT_136	[p11l1512t420r1915b504],
32	of	IN	O	of	_	0	SENT_136	[p11l1930t420r2002b483],
33	AD	NN	O	ad	prep_of	31	SENT_136	[p11l2011t424r2140b483],
34	.	.	O	.	_	0	SENT_136	[p11l2011t424r2140b483],

1	Stable	JJ	O	stable	amod	3	SENT_137	[p11l9t523r205b586],
2	isotope	NN	O	isotope	nn	3	SENT_137	[p11l225t523r749b606],
3	—	NN	O	—	nsubjpass	8	SENT_137	[p11l225t523r749b606],
4	labeled	VBN	O	label	partmod	3	SENT_137	[p11l225t523r749b606],
5	kinetics	NNS	O	kinetics	dobj	4	SENT_137	[p11l766t523r1024b586],
6	can	MD	O	can	aux	8	SENT_137	[p11l1045t546r1159b586],
7	be	VB	O	be	auxpass	8	SENT_137	[p11l1176t523r1254b586],
8	used	VBN	O	use	_	0	SENT_137	[p11l1274t523r1429b586],
9	in	IN	O	in	_	0	SENT_137	[p11l1447t529r1512b585],
10	drug	NN	O	drug	nn	11	SENT_137	[p11l1532t523r1691b607],
11	development	NN	O	development	prep_in	8	SENT_137	[p11l1709t523r2143b606],
12	to	TO	O	to	aux	13	SENT_137	[p11l7t638r71b689],
13	assess	VB	O	assess	xcomp	8	SENT_137	[p11l92t649r280b689],
14	the	DT	O	the	det	15	SENT_137	[p11l298t626r401b689],
15	effects	NNS	O	effect	dobj	13	SENT_137	[p11l420t626r624b689],
16	of	IN	O	of	_	0	SENT_137	[p11l644t626r715b689],
17	pharmaceuticals	NNS	O	pharmaceutical	prep_of	15	SENT_137	[p11l724t626r1264b709],
18	on	IN	O	on	_	0	SENT_137	[p11l1284t649r1367b689],
19	AB	NNP	O	AB	nn	20	SENT_137	[p11l1385t624r1486b707],
20	synthesis	NN	O	synthesis	prep_on	13	SENT_137	[p11l1505t626r1801b710],
21	and	CC	O	and	_	0	SENT_137	[p11l1821t626r1943b689],
22	clearance	NN	O	clearance	conj_and	20	SENT_137	[p11l1961t626r2139b689, p11l9t752r173b792],
23	.	.	O	.	_	0	SENT_137	[p11l1961t626r2139b689, p11l9t752r173b792],

1	A	DT	O	a	det	3	SENT_138	[p11l194t733r251b791],
2	y-secretase	NN	O	y-secretase	nn	3	SENT_138	[p11l267t741r628b810],
3	inhibitor	NN	O	inhibitor	nsubjpass	5	SENT_138	[p11l647t729r941b792],
4	was	VBD	O	be	auxpass	5	SENT_138	[p11l957t752r1080b792],
5	shown	VBN	O	show	_	0	SENT_138	[p11l1101t729r1317b792],
6	to	TO	O	to	aux	7	SENT_138	[p11l1335t741r1399b792],
7	decrease	VB	O	decrease	xcomp	5	SENT_138	[p11l1420t729r1701b792],
8	AB	NNP	O	AB	nn	9	SENT_138	[p11l1720t727r1821b810],
9	synthesis	NN	O	synthesis	nsubj	13	SENT_138	[p11l1843t729r2141b813],
10	in	IN	O	in	_	0	SENT_138	[p11l9t837r75b893],
11	healthy	JJ	O	healthy	amod	12	SENT_138	[p11l95t831r347b915],
12	controls	NNS	O	control	prep_in	9	SENT_138	[p11l366t823r720b903],
13	,44	CD	NUMBER	,44	xcomp	7	SENT_138	[p11l366t823r720b903],
14	demonstrating	VBG	O	demonstrate	partmod	13	SENT_138	[p11l742t831r1241b915],
15	proof	NN	O	proof	dobj	14	SENT_138	[p11l1259t831r1454b914],
16	of	IN	O	of	_	0	SENT_138	[p11l1467t831r1540b894],
17	pharmacology	NN	O	pharmacology	prep_of	15	SENT_138	[p11l1551t831r2044b915],
18	by	IN	O	by	_	0	SENT_138	[p11l2061t831r2144b915],
19	measuring	VBG	O	measure	agent	14	SENT_138	[p11l8t940r364b1018],
20	the	DT	O	the	det	22	SENT_138	[p11l381t934r485b997],
21	synthetic	JJ	O	synthetic	amod	22	SENT_138	[p11l505t934r807b1018],
22	product	NN	O	product	dobj	19	SENT_138	[p11l825t934r1092b1017],
23	of	IN	O	of	_	0	SENT_138	[p11l1110t934r1183b997],
24	the	DT	O	the	det	25	SENT_138	[p11l1191t934r1296b997],
25	enzyme	NN	O	enzyme	prep_of	22	SENT_138	[p11l1315t956r1573b1018],
26	that	WDT	O	that	nsubj	27	SENT_138	[p11l1592t934r1723b997],
27	cleaves	VBZ	O	cleave	rcmod	25	SENT_138	[p11l1741t934r1970b997],
28	APP	NN	O	app	dobj	27	SENT_138	[p11l1989t938r2139b996],
29	to	TO	O	to	aux	30	SENT_138	[p11l8t1049r71b1100],
30	produce	VB	O	produce	xcomp	27	SENT_138	[p11l90t1037r360b1120],
31	AB	NNP	O	AB	dobj	30	SENT_138	[p11l377t1035r493b1118],
32	.	.	O	.	_	0	SENT_138	[p11l377t1035r493b1118],

1	As	IN	O	as	mark	2	SENT_139	[p11l514t1041r598b1100],
2	predicted	VBN	O	predict	advcl	9	SENT_139	[p11l615t1037r943b1120],
3	,	,	O	,	_	0	SENT_139	[p11l615t1037r943b1120],
4	inhibition	NN	O	inhibition	nsubjpass	9	SENT_139	[p11l963t1037r1289b1100],
5	of	IN	O	of	_	0	SENT_139	[p11l1308t1037r1380b1100],
6	the	DT	O	the	det	7	SENT_139	[p11l1388t1037r1490b1100],
7	enzyme	NN	O	enzyme	prep_of	4	SENT_139	[p11l1509t1059r1762b1121],
8	was	VBD	O	be	auxpass	9	SENT_139	[p11l1779t1060r1900b1100],
9	associated	VBN	O	associate	_	0	SENT_139	[p11l1920t1043r2139b1100, p11l9t1140r147b1203],
10	with	IN	O	with	_	0	SENT_139	[p11l164t1140r314b1203],
11	decreased	VBN	O	decrease	amod	12	SENT_139	[p11l333t1140r662b1203],
12	production	NN	O	production	prep_with	9	SENT_139	[p11l680t1140r1056b1223],
13	of	IN	O	of	_	0	SENT_139	[p11l1076t1140r1149b1203],
14	AB	NNP	O	AB	prep_of	12	SENT_139	[p11l1157t1138r1259b1221],
15	without	IN	O	without	_	0	SENT_139	[p11l1278t1140r1540b1203],
16	an	DT	O	a	det	17	SENT_139	[p11l1559t1163r1637b1203],
17	effect	NN	O	effect	prep_without	14	SENT_139	[p11l1657t1140r1835b1203],
18	on	IN	O	on	_	0	SENT_139	[p11l1853t1163r1938b1203],
19	clearance	NN	O	clearance	prep_on	17	SENT_139	[p11l1958t1140r2139b1203, p11l9t1266r176b1306],
20	.	.	O	.	_	0	SENT_139	[p11l1958t1140r2139b1203, p11l9t1266r176b1306],

1	A	DT	O	a	det	3	SENT_140	[p11l201t1247r257b1305],
2	3-month	JJ	DURATION	3-month	amod	3	SENT_140	[p11l280t1243r577b1306],
3	trial	NN	O	trial	nsubj	20	SENT_140	[p11l598t1243r737b1306],
4	of	IN	O	of	_	0	SENT_140	[p11l758t1243r831b1306],
5	the	DT	O	the	det	10	SENT_140	[p11l843t1243r948b1306],
6	same	JJ	O	same	amod	10	SENT_140	[p11l971t1266r1141b1306],
7	agent	NN	O	agent	nn	10	SENT_140	[p11l1164t1255r1345b1327],
8	(	NN	O	(	nn	10	SENT_140	[p11l1369t1243r1860b1327],
9	semagecestat	NN	O	semagecestat	nn	10	SENT_140	[p11l1369t1243r1860b1327],
10	)	NN	O	)	prep_of	3	SENT_140	[p11l1369t1243r1860b1327],
11	showed	VBD	O	show	_	0	SENT_140	[p11l1887t1243r2142b1306],
12	a	DT	O	a	det	15	SENT_140	[p11l9t1369r44b1409],
13	58	CD	PERCENT	58	number	14	SENT_140	[p11l71t1351r215b1411],
14	%	NN	PERCENT	%	amod	15	SENT_140	[p11l71t1351r215b1411],
15	reduction	NN	O	reduction	dobj	11	SENT_140	[p11l244t1346r587b1409],
16	in	IN	O	in	_	0	SENT_140	[p11l613t1352r681b1408],
17	plasma	NN	O	plasma	nn	18	SENT_140	[p11l706t1346r957b1429],
18	AB	NNP	O	AB	prep_in	11	SENT_140	[p11l981t1344r1086b1427],
19	and	CC	O	and	_	0	SENT_140	[p11l1114t1346r1244b1409],
20	had	VBD	O	have	conj_and	11	SENT_140	[p11l1268t1346r1399b1409],
21	no	DT	O	no	det	22	SENT_140	[p11l1424t1369r1512b1409],
22	effect	NN	O	effect	dobj	20	SENT_140	[p11l1540t1346r1728b1409],
23	on	IN	O	on	_	0	SENT_140	[p11l1753t1369r1841b1409],
24	CSF	NN	ORGANIZATION	csf	nn	26	SENT_140	[p11l1868t1350r2009b1409],
25	AB	NNP	ORGANIZATION	AB	nn	26	SENT_140	[p11l2035t1344r2141b1427],
26	levels	NNS	O	level	prep_on	22	SENT_140	[p11l7t1440r270b1520],
27	,45	CD	NUMBER	,45	dobj	11	SENT_140	[p11l7t1440r270b1520],
28	suggesting	VBG	O	suggest	partmod	27	SENT_140	[p11l294t1454r651b1532],
29	that	IN	O	that	complm	37	SENT_140	[p11l669t1448r802b1511],
30	synthesis	NN	O	synthesis	nsubj	37	SENT_140	[p11l824t1448r1128b1532],
31	in	IN	O	in	_	0	SENT_140	[p11l1150t1454r1216b1510],
32	the	DT	O	the	det	35	SENT_140	[p11l1237t1448r1342b1511],
33	central	JJ	O	central	amod	35	SENT_140	[p11l1365t1448r1597b1511],
34	nervous	JJ	O	nervous	amod	35	SENT_140	[p11l1618t1471r1889b1511],
35	system	NN	O	system	prep_in	30	SENT_140	[p11l1912t1460r2142b1532],
36	may	MD	O	may	aux	37	SENT_140	[p11l8t1574r153b1635],
37	accommodate	VB	O	accommodate	ccomp	28	SENT_140	[p11l170t1551r642b1614],
38	to	TO	O	to	_	0	SENT_140	[p11l661t1563r726b1614],
39	chronic	JJ	O	chronic	amod	40	SENT_140	[p11l747t1551r1001b1614],
40	inhibition	NN	O	inhibition	prep_to	37	SENT_140	[p11l1021t1551r1356b1614],
41	or	CC	O	or	_	0	SENT_140	[p11l1375t1574r1446b1614],
42	that	IN	O	that	complm	47	SENT_140	[p11l1463t1551r1595b1614],
43	the	DT	O	the	det	44	SENT_140	[p11l1613t1551r1717b1614],
44	dynamics	NNS	O	dynamics	nsubj	47	SENT_140	[p11l1737t1551r2058b1635],
45	of	IN	O	of	_	0	SENT_140	[p11l2079t1551r2152b1614],
46	AB	NNP	O	AB	prep_of	44	SENT_140	[p11l8t1652r110b1735],
47	differ	VBP	O	differ	conj_or	37	SENT_140	[p11l131t1654r310b1717],
48	between	IN	O	between	_	0	SENT_140	[p11l326t1654r608b1717],
49	AD	NN	O	ad	nn	50	SENT_140	[p11l627t1658r744b1716],
50	patients	NNS	O	patient	prep_between	47	SENT_140	[p11l764t1660r1028b1737],
51	and	CC	O	and	_	0	SENT_140	[p11l1049t1654r1174b1717],
52	healthy	JJ	O	healthy	amod	53	SENT_140	[p11l1191t1654r1441b1738],
53	controls	NNS	O	control	conj_and	50	SENT_140	[p11l1457t1654r1744b1717],
54	.	.	O	.	_	0	SENT_140	[p11l1457t1654r1744b1717],

1	Short	JJ	O	short	amod	5	SENT_141	[p11l1767t1654r2141b1717],
2	—	NN	O	—	nn	5	SENT_141	[p11l1767t1654r2141b1717],
3	term	NN	O	term	nn	5	SENT_141	[p11l1767t1654r2141b1717],
4	pharmacologic	JJ	O	pharmacologic	amod	5	SENT_141	[p11l7t1757r515b1841],
5	effects	NNS	O	effect	nsubj	8	SENT_141	[p11l536t1757r745b1820],
6	may	MD	O	may	aux	8	SENT_141	[p11l766t1780r912b1841],
7	not	RB	O	not	neg	8	SENT_141	[p11l929t1769r1042b1820],
8	predict	VB	O	predict	_	0	SENT_141	[p11l1060t1757r1301b1840],
9	long-term	JJ	O	long-term	amod	10	SENT_141	[p11l1319t1757r1661b1841],
10	effects	NNS	O	effect	dobj	8	SENT_141	[p11l1682t1757r1909b1820],
11	.	.	O	.	_	0	SENT_141	[p11l1682t1757r1909b1820],

1	Altered	JJ	O	altered	amod	2	SENT_142	[p11l81t1860r331b1923],
2	processing	NN	O	processing	_	0	SENT_142	[p11l349t1866r707b1944],
3	of	IN	O	of	_	0	SENT_142	[p11l725t1860r798b1923],
4	APP	NN	O	app	prep_of	2	SENT_142	[p11l807t1864r957b1922],
5	by	IN	O	by	dep	2	SENT_142	[p11l976t1860r1059b1944],
6	a	DT	O	a	pobj	5	SENT_142	[p11l1076t1883r1109b1923],
7	'	''	O	'	_	0	SENT_142	[p11l1126t1872r1490b1941],
8	y	JJ	O	y	dep	6	SENT_142	[p11l1126t1872r1490b1941],
9	—	CD	NUMBER	—	num	11	SENT_142	[p11l1126t1872r1490b1941],
10	secretase	NN	O	secretase	nn	11	SENT_142	[p11l1126t1872r1490b1941],
11	inhibitor	NN	O	inhibitor	nsubj	12	SENT_142	[p11l1510t1860r1806b1923],
12	increased	VBD	O	increase	ccomp	8	SENT_142	[p11l1825t1860r2143b1923],
13	the	DT	O	the	det	15	SENT_142	[p11l8t1963r118b2026],
14	1	CD	NUMBER	1	num	15	SENT_142	[p11l151t1967r344b2029],
15	—	CD	NUMBER	—	dep	12	SENT_142	[p11l151t1967r344b2029],
16	15	CD	NUMBER	15	dep	15	SENT_142	[p11l151t1967r344b2029],
17	/	:	O	/	punct	15	SENT_142	[p11l151t1967r344b2029],
18	16	CD	NUMBER	16	num	21	SENT_142	[p11l357t1969r430b2026],
19	amino	NN	O	amino	nn	21	SENT_142	[p11l458t1969r682b2026],
20	acid	NN	O	acid	nn	21	SENT_142	[p11l710t1963r855b2026],
21	fragment	NN	O	fragment	dep	15	SENT_142	[p11l880t1963r1206b2047],
22	of	IN	O	of	_	0	SENT_142	[p11l1231t1963r1307b2026],
23	AB	NNP	O	AB	prep_of	21	SENT_142	[p11l1322t1961r1428b2044],
24	in	IN	O	in	_	0	SENT_142	[p11l1455t1969r1523b2025],
25	the	DT	O	the	det	26	SENT_142	[p11l1548t1963r1658b2026],
26	CSF	NN	O	csf	prep_in	8	SENT_142	[p11l1686t1967r1838b2035],
27	,	,	O	,	_	0	SENT_142	[p11l1686t1967r1838b2035],
28	offering	VBG	O	offer	partmod	6	SENT_142	[p11l1866t1963r2144b2047],
29	another	DT	O	another	det	30	SENT_142	[p11l9t2066r276b2129],
30	means	NN	O	means	iobj	28	SENT_142	[p11l298t2089r518b2129],
31	of	IN	O	of	_	0	SENT_142	[p11l542t2066r616b2129],
32	detecting	VBG	O	detect	prepc_of	30	SENT_142	[p11l630t2066r949b2150],
33	and	CC	O	and	_	0	SENT_142	[p11l971t2066r1098b2129],
34	characterizing	VBG	O	characterize	prepc_of	30	SENT_142	[p11l1120t2066r1612b2150],
35	the	DT	O	the	det	37	SENT_142	[p11l1632t2066r1739b2129],
36	pharmacologic	JJ	O	pharmacologic	amod	37	SENT_142	[p11l1761t2066r2138b2149, p11l7t2168r171b2252],
37	effect	NN	O	effect	dobj	32	SENT_142	[p11l193t2168r375b2231],
38	of	IN	O	of	_	0	SENT_142	[p11l396t2168r470b2231],
39	y-secretase	NN	O	y-secretase	nn	40	SENT_142	[p11l479t2180r851b2249],
40	inhibitors	NNS	O	inhibitor	prep_of	37	SENT_142	[p11l873t2160r1287b2231],
41	.46	CD	NUMBER	.46	dobj	28	SENT_142	[p11l873t2160r1287b2231],

1	Target	NN	O	target	nn	2	SENT_143	[p11l82t2274r300b2355],
2	engagement	NN	O	engagement	nsubjpass	6	SENT_143	[p11l323t2283r744b2355],
3	has	VBZ	O	have	aux	6	SENT_143	[p11l766t2271r879b2334],
4	also	RB	O	also	advmod	6	SENT_143	[p11l904t2271r1037b2334],
5	been	VBN	O	be	auxpass	6	SENT_143	[p11l1059t2271r1226b2334],
6	studied	VBN	O	study	_	0	SENT_143	[p11l1251t2271r1506b2334],
7	for	IN	O	for	_	0	SENT_143	[p11l1528t2271r1628b2334],
8	the	DT	O	the	det	12	SENT_143	[p11l1649t2271r1757b2334],
9	B-amyloid	JJ	MISC	b-amyloid	amod	12	SENT_143	[p11l1784t2269r2143b2355],
10	precursor	NN	O	precursor	nn	12	SENT_143	[p11l7t2396r332b2457],
11	protein	NN	O	protein	nn	12	SENT_143	[p11l350t2380r593b2457],
12	site	NN	O	site	prep_for	6	SENT_143	[p11l613t2380r722b2437],
13	cleaving	VBG	O	cleave	partmod	12	SENT_143	[p11l742t2374r1015b2458],
14	enzyme	NN	O	enzyme	nn	17	SENT_143	[p11l1033t2396r1290b2458],
15	(	CD	NUMBER	(	num	17	SENT_143	[p11l1313t2375r1590b2450],
16	BACE	NN	O	bace	nn	17	SENT_143	[p11l1313t2375r1590b2450],
17	)	NN	O	)	dobj	13	SENT_143	[p11l1313t2375r1590b2450],
18	,	,	O	,	_	0	SENT_143	[p11l1313t2375r1590b2450],
19	the	DT	O	the	det	20	SENT_143	[p11l1611t2374r1715b2437],
20	enzyme	NN	O	enzyme	appos	17	SENT_143	[p11l1735t2396r1992b2458],
21	that	WDT	O	that	nsubj	22	SENT_143	[p11l2011t2374r2142b2437],
22	ﬁrst	VBD	O	ﬁrst	rcmod	20	SENT_143	[p11l8t2477r140b2540],
23	cleaves	NNS	O	cleave	nn	24	SENT_143	[p11l159t2477r391b2540],
24	APP	NN	O	app	dobj	22	SENT_143	[p11l410t2481r561b2539],
25	in	IN	O	in	_	0	SENT_143	[p11l583t2483r648b2539],
26	the	DT	O	the	det	28	SENT_143	[p11l667t2477r772b2540],
27	sequential	JJ	O	sequential	amod	28	SENT_143	[p11l794t2477r1137b2560],
28	proteolysis	NN	O	proteolysis	prep_in	24	SENT_143	[p11l1155t2477r1520b2561],
29	that	WDT	O	that	nsubj	30	SENT_143	[p11l1539t2477r1671b2540],
30	produces	VBZ	O	produce	rcmod	28	SENT_143	[p11l1689t2477r1998b2560],
31	AB	NNP	O	AB	dobj	30	SENT_143	[p11l2018t2475r2139b2558],
32	.	.	O	.	_	0	SENT_143	[p11l2018t2475r2139b2558],

1	BACE	NN	ORGANIZATION	bace	nn	2	SENT_144	[p11l9t2584r216b2644],
2	inhibitors	NNS	O	inhibitor	nsubjpass	5	SENT_144	[p11l237t2580r567b2643],
3	have	VBP	O	have	aux	5	SENT_144	[p11l587t2580r741b2643],
4	been	VBN	O	be	auxpass	5	SENT_144	[p11l760t2580r923b2643],
5	shown	VBN	O	show	_	0	SENT_144	[p11l944t2580r1165b2643],
6	to	TO	O	to	aux	7	SENT_144	[p11l1184t2592r1250b2643],
7	reduce	VB	O	reduce	xcomp	5	SENT_144	[p11l1272t2580r1498b2643],
8	CSF	NN	ORGANIZATION	csf	nn	9	SENT_144	[p11l1519t2584r1656b2644],
9	AB	NNP	ORGANIZATION	AB	dobj	7	SENT_144	[p11l1676t2578r1779b2661],
10	in	IN	O	in	_	0	SENT_144	[p11l1802t2586r1868b2642],
11	nonhuman	JJ	O	nonhuman	amod	12	SENT_144	[p11l1888t2580r2139b2643, p11l8t2705r159b2745],
12	primates	NNS	O	primate	prep_in	9	SENT_144	[p11l179t2688r476b2765],
13	and	CC	O	and	_	0	SENT_144	[p11l498t2682r624b2745],
14	in	IN	O	in	_	0	SENT_144	[p11l644t2688r710b2744],
15	wild-type	JJ	O	wild-type	amod	16	SENT_144	[p11l729t2682r1057b2766],
16	rats	NNS	O	rat	prep_in	24	SENT_144	[p11l1078t2674r1358b2745],
17	.47	CD	NUMBER	.47	number	18	SENT_144	[p11l1078t2674r1358b2745],
18	’48	CD	NUMBER	’48	dep	16	SENT_144	[p11l1078t2674r1358b2745],
19	BACE	NN	O	bace	nn	21	SENT_144	[p11l1380t2686r1588b2745],
20	enzyme	NN	O	enzyme	nn	21	SENT_144	[p11l1610t2704r1872b2766],
21	activity	NN	O	activity	nsubjpass	24	SENT_144	[p11l1894t2688r2146b2766],
22	can	MD	O	can	aux	24	SENT_144	[p11l9t2808r126b2848],
23	be	VB	O	be	auxpass	24	SENT_144	[p11l146t2785r225b2848],
24	measured	VBN	O	measure	conj_and	5	SENT_144	[p11l248t2785r581b2848],
25	in	IN	O	in	_	0	SENT_144	[p11l603t2791r669b2847],
26	plasma	NN	O	plasma	prep_in	24	SENT_144	[p11l690t2785r933b2868],
27	and	CC	O	and	_	0	SENT_144	[p11l955t2785r1081b2848],
28	CSF	NN	O	csf	prep_in	24	SENT_144	[p11l1104t2789r1250b2857],
29	,	,	O	,	_	0	SENT_144	[p11l1104t2789r1250b2857],
30	and	CC	O	and	_	0	SENT_144	[p11l1275t2785r1401b2848],
31	it	PRP	O	it	nsubj	32	SENT_144	[p11l1422t2791r1468b2848],
32	represents	VBZ	O	represent	conj_and	5	SENT_144	[p11l1489t2797r1837b2868],
33	a	DT	O	a	det	39	SENT_144	[p11l1860t2808r1895b2848],
34	potential	JJ	O	potential	amod	39	SENT_144	[p11l1915t2797r2139b2868, p11l8t2887r116b2950],
35	pharmacodynamic	JJ	O	pharmacodynamic	amod	39	SENT_144	[p11l134t2887r781b2971],
36	proof	NN	O	proof	nn	39	SENT_144	[p11l800t2887r1616b2971],
37	—	CD	NUMBER	—	num	39	SENT_144	[p11l800t2887r1616b2971],
38	of-pharmacology	JJ	O	of-pharmacology	amod	39	SENT_144	[p11l800t2887r1616b2971],
39	biomarker	NN	O	biomarker	nsubj	54	SENT_144	[p11l1631t2879r2142b2950],
40	.49	CD	NUMBER	.49	npadvmod	41	SENT_144	[p11l1631t2879r2142b2950],
41	>	JJR	O	>	dep	54	SENT_144	[p11l1631t2879r2142b2950],
42	50	CD	NUMBER	50	num	44	SENT_144	[p11l1631t2879r2142b2950],
43	BACE	NN	O	bace	nn	44	SENT_144	[p11l9t2994r212b3053],
44	inhibition	NN	O	inhibition	nsubj	45	SENT_144	[p11l232t2990r564b3053],
45	decreases	VBZ	O	decrease	dep	54	SENT_144	[p11l585t2990r897b3053],
46	the	DT	O	the	det	48	SENT_144	[p11l916t2990r1020b3053],
47	APP	NN	O	app	nn	48	SENT_144	[p11l1039t2994r1188b3052],
48	cleavage	NN	O	cleavage	dobj	45	SENT_144	[p11l1209t2990r1483b3074],
49	by	IN	O	by	_	0	SENT_144	[p11l1501t2990r1878b3074],
50	—	NN	O	—	nn	52	SENT_144	[p11l1501t2990r1878b3074],
51	product	NN	O	product	nn	52	SENT_144	[p11l1501t2990r1878b3074],
52	sAPPB	NN	O	sappb	prep_by	45	SENT_144	[p11l1897t2988r2140b3071],
53	,	,	O	,	_	0	SENT_144	[p11l1897t2988r2140b3071],
54	providing	VBG	O	provide	xcomp	32	SENT_144	[p11l7t3092r343b3176],
55	another	DT	O	another	det	57	SENT_144	[p11l364t3092r629b3155],
56	possible	JJ	O	possible	amod	57	SENT_144	[p11l648t3092r923b3175],
57	biomarker	NN	O	biomarker	dobj	54	SENT_144	[p11l943t3092r1301b3155],
58	of	IN	O	of	_	0	SENT_144	[p11l1322t3092r1396b3155],
59	BACE	NN	O	bace	nn	60	SENT_144	[p11l1408t3096r1616b3155],
60	inhibition	NN	O	inhibition	prep_of	57	SENT_144	[p11l1638t3084r2061b3155],
61	.47	CD	NUMBER	.47	num	60	SENT_144	[p11l1638t3084r2061b3155],

1	No	DT	O	no	det	6	SENT_145	[p11l81t3200r185b3258],
2	pharmacologic	JJ	O	pharmacologic	amod	6	SENT_145	[p11l209t3195r766b3279],
3	/	:	O	/	punct	4	SENT_145	[p11l209t3195r766b3279],
4	target	NN	O	target	dep	2	SENT_145	[p11l771t3207r973b3279],
5	engagement	NN	O	engagement	dep	4	SENT_145	[p11l997t3207r1422b3279],
6	biomarker	NN	O	biomarker	nsubjpass	9	SENT_145	[p11l1443t3195r1812b3258],
7	has	VBZ	O	have	aux	9	SENT_145	[p11l1834t3195r1949b3258],
8	been	VBN	O	be	auxpass	9	SENT_145	[p11l1971t3195r2140b3258],
9	linked	VBN	O	link	_	0	SENT_145	[p11l7t3297r222b3360],
10	to	TO	O	to	_	0	SENT_145	[p11l240t3309r305b3360],
11	disease-modiﬁcation	JJ	O	disease-modiﬁcation	amod	12	SENT_145	[p11l328t3297r1037b3360],
12	biomarkers	NNS	O	biomarker	prep_to	9	SENT_145	[p11l1056t3297r1441b3360],
13	or	CC	O	or	_	0	SENT_145	[p11l1462t3320r1534b3360],
14	clinical	JJ	O	clinical	amod	15	SENT_145	[p11l1554t3297r1797b3360],
15	outcomes	NNS	O	outcome	conj_or	12	SENT_145	[p11l1817t3309r2142b3360],
16	in	IN	O	in	_	0	SENT_145	[p12l9t33r73b89],
17	AD	NN	O	ad	prep_in	9	SENT_145	[p12l92t31r223b90],
18	.	.	O	.	_	0	SENT_145	[p12l92t31r223b90],

1	Biomarkers	NNS	O	biomarker	nsubj	2	SENT_146	[p12l246t27r629b90],
2	represent	VBP	O	represent	_	0	SENT_146	[p12l650t39r960b110],
3	a	DT	O	a	det	5	SENT_146	[p12l979t50r1013b90],
4	valuable	JJ	O	valuable	amod	5	SENT_146	[p12l1028t27r1304b90],
5	means	NNS	O	means	dobj	2	SENT_146	[p12l1324t50r1538b90],
6	of	IN	O	of	_	0	SENT_146	[p12l1559t27r1631b90],
7	assessing	VBG	O	assess	prepc_of	5	SENT_146	[p12l1642t33r1942b111],
8	pharmacologic	JJ	O	pharmacologic	amod	9	SENT_146	[p12l1959t27r2139b110, p12l8t130r353b214],
9	activity	NN	O	activity	dobj	7	SENT_146	[p12l373t136r627b214],
10	,	,	O	,	_	0	SENT_146	[p12l373t136r627b214],
11	and	CC	O	and	_	0	SENT_146	[p12l650t130r773b193],
12	molecules	NNS	O	molecule	nsubj	24	SENT_146	[p12l792t130r1127b193],
13	that	WDT	O	that	nsubj	16	SENT_146	[p12l1146t130r1277b193],
14	do	VBP	O	do	aux	16	SENT_146	[p12l1297t130r1379b193],
15	not	RB	O	not	neg	16	SENT_146	[p12l1400t142r1512b193],
16	achieve	VB	O	achieve	rcmod	12	SENT_146	[p12l1531t130r1778b193],
17	minimally	RB	O	minimally	advmod	18	SENT_146	[p12l1797t130r2147b214],
18	deﬁned	JJ	O	deﬁned	amod	19	SENT_146	[p12l9t233r274b296],
19	levels	NNS	O	level	dobj	16	SENT_146	[p12l298t233r491b296],
20	of	IN	O	of	_	0	SENT_146	[p12l519t233r595b296],
21	effect	NN	O	effect	prep_of	19	SENT_146	[p12l613t233r802b296],
22	are	VBP	O	be	cop	24	SENT_146	[p12l828t256r932b296],
23	not	RB	O	not	neg	24	SENT_146	[p12l958t245r1076b296],
24	likely	JJ	O	likely	conj_and	2	SENT_146	[p12l1100t233r1295b317],
25	to	TO	O	to	aux	27	SENT_146	[p12l1316t245r1384b296],
26	be	VB	O	be	auxpass	27	SENT_146	[p12l1410t233r1492b296],
27	advanced	VBN	O	advance	xcomp	24	SENT_146	[p12l1519t233r1855b296],
28	for	IN	O	for	_	0	SENT_146	[p12l1880t233r1982b296],
29	further	JJ	O	further	amod	30	SENT_146	[p12l2007t233r2139b296, p12l8t336r147b399],
30	testing	NN	O	testing	prep_for	27	SENT_146	[p12l165t342r409b420],
31	.	.	O	.	_	0	SENT_146	[p12l165t342r409b420],

1	They	PRP	O	they	nsubj	5	SENT_147	[p12l433t336r602b420],
2	have	VBP	O	have	aux	5	SENT_147	[p12l618t336r773b399],
3	not	RB	O	not	neg	5	SENT_147	[p12l793t348r907b399],
4	yet	RB	O	yet	advmod	5	SENT_147	[p12l924t348r1025b420],
5	predicted	VBN	O	predict	_	0	SENT_147	[p12l1043t336r1368b419],
6	efﬁcacy	NN	O	efﬁcacy	dobj	5	SENT_147	[p12l1388t336r1645b420],
7	of	IN	O	of	_	0	SENT_147	[p12l1662t336r1736b399],
8	either	CC	O	either	preconj	10	SENT_147	[p12l1747t336r1944b399],
9	other	JJ	O	other	amod	10	SENT_147	[p12l1964t336r2145b399],
10	biomarker	NN	O	biomarker	prep_of	6	SENT_147	[p12l7t438r376b501],
11	or	CC	O	or	_	0	SENT_147	[p12l400t461r474b501],
12	clinical	JJ	O	clinical	amod	13	SENT_147	[p12l497t438r751b501],
13	outcomes	NNS	O	outcome	conj_or	10	SENT_147	[p12l775t450r1130b501],
14	.	.	O	.	_	0	SENT_147	[p12l775t450r1130b501],

1	If	IN	O	if	mark	12	SENT_148	[p12l1158t438r1219b500],
2	measures	NNS	O	measure	nsubjpass	12	SENT_148	[p12l1233t461r1560b501],
3	such	JJ	O	such	_	0	SENT_148	[p12l1587t438r1746b501],
4	as	IN	O	as	_	0	SENT_148	[p12l1770t461r1836b501],
5	levels	NNS	O	level	prep_such_as	2	SENT_148	[p12l1860t438r2051b501],
6	of	IN	O	of	_	0	SENT_148	[p12l2077t438r2152b501],
7	plasma	NN	O	plasma	nn	9	SENT_148	[p12l7t541r248b624],
8	drug	NN	O	drug	nn	9	SENT_148	[p12l267t541r428b625],
9	activity	NN	O	activity	prep_of	5	SENT_148	[p12l447t547r696b625],
10	are	VBP	O	be	auxpass	12	SENT_148	[p12l713t564r812b604],
11	eventually	RB	O	eventually	advmod	12	SENT_148	[p12l833t541r1180b625],
12	linked	VBN	O	link	advcl	20	SENT_148	[p12l1195t541r1409b604],
13	with	IN	O	with	_	0	SENT_148	[p12l1426t541r1577b604],
14	clinical	JJ	O	clinical	amod	15	SENT_148	[p12l1598t541r1839b604],
15	beneﬁts	NNS	O	beneﬁts	prep_with	12	SENT_148	[p12l1857t541r2138b613],
16	,	,	O	,	_	0	SENT_148	[p12l1857t541r2138b613],
17	they	PRP	O	they	nsubjpass	20	SENT_148	[p12l8t644r161b728],
18	can	MD	O	can	aux	20	SENT_148	[p12l181t667r300b707],
19	be	VB	O	be	auxpass	20	SENT_148	[p12l321t644r401b707],
20	integrated	VBN	O	integrate	_	0	SENT_148	[p12l425t644r778b728],
21	into	IN	O	into	_	0	SENT_148	[p12l801t650r936b707],
22	later-stage	JJ	O	later-stage	amod	23	SENT_148	[p12l960t644r1318b728],
23	trials	NNS	O	trial	prep_into	20	SENT_148	[p12l1340t644r1515b707],
24	and	CC	O	and	_	0	SENT_148	[p12l1540t644r1668b707],
25	postapproval	JJ	O	postapproval	amod	28	SENT_148	[p12l1689t644r2143b727],
26	clinical	JJ	O	clinical	amod	28	SENT_148	[p12l9t748r254b811],
27	management	NN	O	management	nn	28	SENT_148	[p12l274t760r720b832],
28	approaches	NNS	O	approach	prep_into	20	SENT_148	[p12l741t748r1141b831],
29	.	.	O	.	_	0	SENT_148	[p12l741t748r1141b831],

1	BIOMARKERS	NNS	O	biomarker	_	0	SENT_149	[p12l12t962r488b1018],
2	OF	IN	O	of	_	0	SENT_149	[p12l508t962r601b1018],
3	DISEASE	NN	O	disease	nn	4	SENT_149	[p12l624t963r924b1018],
4	MODIFICATION	NN	O	modification	prep_of	1	SENT_149	[p12l944t962r1485b1018],

1	Disease	NN	O	disease	nn	3	SENT_150	[p12l11t1064r274b1121],
2	state	NN	O	state	nn	3	SENT_150	[p12l291t1071r460b1121],
3	biomarkers	NNS	O	biomarker	nsubj	16	SENT_150	[p12l479t1064r872b1121],
4	in	IN	O	in	_	0	SENT_150	[p12l891t1064r950b1120],
5	drug	NN	O	drug	nn	7	SENT_150	[p12l970t1064r1132b1137],
6	development	NN	O	development	nn	7	SENT_150	[p12l1151t1064r1614b1136],
7	programs	NNS	O	program	prep_in	16	SENT_150	[p12l1633t1080r1967b1137],
8	The	DT	O	the	det	9	SENT_150	[p12l8t1161r133b1224],
9	goal	NN	O	goal	nsubj	16	SENT_150	[p12l154t1161r295b1245],
10	of	IN	O	of	_	0	SENT_150	[p12l316t1161r389b1224],
11	many	JJ	O	many	amod	15	SENT_150	[p12l400t1184r593b1245],
12	current	JJ	DATE	current	amod	15	SENT_150	[p12l610t1173r862b1224],
13	drug	NN	O	drug	nn	15	SENT_150	[p12l882t1161r1044b1245],
14	development	NN	O	development	nn	15	SENT_150	[p12l1063t1161r1507b1244],
15	programs	NNS	O	program	prep_of	9	SENT_150	[p12l1525t1183r1853b1245],
16	is	VBZ	O	be	_	0	SENT_150	[p12l1874t1167r1924b1224],
17	to	TO	O	to	aux	18	SENT_150	[p12l1944t1173r2010b1224],
18	use	VB	O	use	xcomp	16	SENT_150	[p12l2031t1184r2142b1224],
19	the	DT	O	the	det	22	SENT_150	[p12l8t1264r116b1327],
20	increasingly	RB	O	increasingly	advmod	21	SENT_150	[p12l141t1264r568b1348],
21	well-characterized	JJ	O	well-characterized	amod	22	SENT_150	[p12l586t1264r1236b1327],
22	biology	NN	O	biology	dobj	18	SENT_150	[p12l1256t1264r1523b1348],
23	of	IN	O	of	_	0	SENT_150	[p12l1543t1264r1619b1327],
24	AD	NN	O	ad	prep_of	22	SENT_150	[p12l1632t1268r1753b1326],
25	to	TO	O	to	aux	26	SENT_150	[p12l1777t1276r1845b1327],
26	identify	VB	O	identify	xcomp	18	SENT_150	[p12l1870t1264r2145b1348],
27	pharmacologically	RB	O	pharmacologically	advmod	28	SENT_150	[p12l7t1367r628b1451],
28	manipulable	JJ	O	manipulable	amod	29	SENT_150	[p12l643t1367r1057b1450],
29	steps	NNS	O	step	dobj	26	SENT_150	[p12l1078t1379r1239b1450],
30	in	IN	O	in	_	0	SENT_150	[p12l1259t1373r1324b1429],
31	Vulnerable	JJ	O	vulnerable	amod	33	SENT_150	[p12l1340t1367r1692b1430],
32	disease	NN	O	disease	nn	33	SENT_150	[p12l1713t1367r1946b1430],
33	pathways	NNS	O	pathway	prep_in	29	SENT_150	[p12l1965t1367r2140b1450, p12l7t1493r171b1554],
34	and	CC	O	and	_	0	SENT_150	[p12l196t1470r322b1533],
35	develop	VB	O	develop	xcomp	18	SENT_150	[p12l345t1470r608b1553],
36	new	JJ	O	new	amod	37	SENT_150	[p12l632t1493r775b1533],
37	drugs	NNS	O	drug	dobj	35	SENT_150	[p12l796t1470r988b1554],
38	that	WDT	O	that	nsubj	40	SENT_150	[p12l1010t1470r1144b1533],
39	will	MD	O	will	aux	40	SENT_150	[p12l1164t1470r1290b1533],
40	prevent	VB	O	prevent	rcmod	37	SENT_150	[p12l1311t1482r1588b1553],
41	,	,	O	,	_	0	SENT_150	[p12l1311t1482r1588b1553],
42	delay	VB	O	delay	conj_and	26	SENT_150	[p12l1613t1470r1793b1554],
43	the	DT	O	the	det	44	SENT_150	[p12l1811t1470r1918b1533],
44	onset	NN	O	onset	dobj	42	SENT_150	[p12l1941t1482r2140b1542],
45	,	,	O	,	_	0	SENT_150	[p12l1941t1482r2140b1542],
46	or	CC	O	or	_	0	SENT_150	[p12l9t1596r80b1636],
47	slow	VB	O	slow	conj_or	26	SENT_150	[p12l99t1573r249b1636],
48	the	DT	O	the	det	50	SENT_150	[p12l265t1573r369b1636],
49	disease	NN	O	disease	nn	50	SENT_150	[p12l389t1573r625b1636],
50	progression	NN	O	progression	dobj	47	SENT_150	[p12l643t1579r1052b1657],
51	.	.	O	.	_	0	SENT_150	[p12l643t1579r1052b1657],

1	Supporting	VBG	O	support	csubj	6	SENT_151	[p12l1076t1577r1453b1657],
2	a	DT	O	a	det	4	SENT_151	[p12l1472t1596r1505b1636],
3	disease-modifying	JJ	O	disease-modifying	amod	4	SENT_151	[p12l1525t1573r2145b1657],
4	claim	NN	O	claim	dobj	1	SENT_151	[p12l9t1676r191b1739],
5	will	MD	O	will	aux	6	SENT_151	[p12l209t1676r333b1739],
6	involve	VB	O	involve	_	0	SENT_151	[p12l353t1676r593b1739],
7	demonstrating	VBG	O	demonstrate	xcomp	6	SENT_151	[p12l614t1676r1126b1760],
8	,	,	O	,	_	0	SENT_151	[p12l614t1676r1126b1760],
9	in	IN	O	in	_	0	SENT_151	[p12l1148t1682r1214b1738],
10	well-conducted	JJ	O	well-conducted	amod	12	SENT_151	[p12l1231t1676r1755b1739],
11	clinical	JJ	O	clinical	amod	12	SENT_151	[p12l1775t1676r2016b1739],
12	trials	NNS	O	trial	prep_in	7	SENT_151	[p12l2034t1682r2140b1739, p12l9t1779r114b1851],
13	,	,	O	,	_	0	SENT_151	[p12l2034t1682r2140b1739, p12l9t1779r114b1851],
14	a	DT	O	a	det	16	SENT_151	[p12l139t1802r174b1842],
15	clinical	JJ	O	clinical	amod	16	SENT_151	[p12l196t1779r440b1842],
16	beneﬁt	NN	O	beneﬁt	prep_in	7	SENT_151	[p12l460t1779r696b1842],
17	and	CC	O	and	_	0	SENT_151	[p12l718t1779r844b1842],
18	a	DT	O	a	det	20	SENT_151	[p12l866t1802r901b1842],
19	corresponding	JJ	O	corresponding	amod	20	SENT_151	[p12l922t1779r1422b1863],
20	effect	NN	O	effect	prep_in	7	SENT_151	[p12l1444t1779r1625b1842],
21	on	IN	O	on	_	0	SENT_151	[p12l1648t1802r1733b1842],
22	biomarkers	NNS	O	biomarker	prep_on	7	SENT_151	[p12l1754t1779r2142b1842],
23	indicative	JJ	O	indicative	amod	22	SENT_151	[p12l9t1882r339b1945],
24	of	IN	O	of	_	0	SENT_151	[p12l360t1882r433b1945],
25	changes	NNS	O	change	prep_of	23	SENT_151	[p12l444t1882r711b1966],
26	in	IN	O	in	_	0	SENT_151	[p12l732t1888r798b1944],
27	the	DT	O	the	det	29	SENT_151	[p12l817t1882r922b1945],
28	underlying	VBG	O	underlie	amod	29	SENT_151	[p12l943t1882r1316b1966],
29	processes	NNS	O	process	prep_in	25	SENT_151	[p12l1333t1904r1652b1965],
30	of	IN	O	of	_	0	SENT_151	[p12l1674t1882r1747b1945],
31	AD	NN	O	ad	prep_of	29	SENT_151	[p12l1757t1886r1874b1944],
32	leading	VBG	O	lead	partmod	31	SENT_151	[p12l1895t1882r2145b1966],
33	to	TO	O	to	_	0	SENT_151	[p12l8t1996r74b2048],
34	cell	NN	O	cell	nn	35	SENT_151	[p12l98t1984r212b2048],
35	death	NN	O	death	prep_to	32	SENT_151	[p12l235t1976r503b2048],
36	.51	CD	NUMBER	.51	num	37	SENT_151	[p12l235t1976r503b2048],
37	Biomarkers	NNS	O	biomarker	nsubj	41	SENT_151	[p12l530t1984r926b2048],
38	of	IN	O	of	_	0	SENT_151	[p12l949t1984r1023b2048],
39	disease	NN	O	disease	nn	40	SENT_151	[p12l1037t1984r1279b2048],
40	modiﬁcation	NN	O	modiﬁcation	prep_of	37	SENT_151	[p12l1302t1984r1745b2048],
41	differ	VBP	O	differ	rcmod	35	SENT_151	[p12l1769t1984r1952b2048],
42	from	IN	O	from	_	0	SENT_151	[p12l1973t1984r2142b2048],
43	those	DT	O	those	prep_from	41	SENT_151	[p12l8t2088r186b2151],
44	of	IN	O	of	_	0	SENT_151	[p12l206t2088r278b2151],
45	target	NN	O	target	nn	46	SENT_151	[p12l287t2100r479b2172],
46	engagement	NN	O	engagement	prep_of	43	SENT_151	[p12l498t2100r917b2172],
47	;	:	O	;	_	0	SENT_151	[p12l498t2100r917b2172],
48	the	DT	O	the	det	49	SENT_151	[p12l937t2088r1041b2151],
49	latter	JJ	O	latter	nsubj	52	SENT_151	[p12l1059t2088r1232b2151],
50	are	VBP	O	be	cop	52	SENT_151	[p12l1251t2111r1349b2151],
51	near-term	JJ	O	near-term	amod	52	SENT_151	[p12l1368t2100r1704b2151],
52	markers	NNS	O	marker	parataxis	6	SENT_151	[p12l1723t2088r1993b2151],
53	that	WDT	O	that	nsubj	54	SENT_151	[p12l2013t2088r2143b2151],
54	show	VBP	O	show	rcmod	52	SENT_151	[p12l9t2191r187b2254],
55	proof	NN	O	proof	dobj	54	SENT_151	[p12l204t2191r399b2274],
56	of	IN	O	of	_	0	SENT_151	[p12l411t2191r484b2254],
57	pharmacology	NN	O	pharmacology	prep_of	55	SENT_151	[p12l494t2191r992b2275],
58	but	CC	O	but	_	0	SENT_151	[p12l1007t2191r1121b2254],
59	do	VBP	O	do	aux	61	SENT_151	[p12l1141t2191r1225b2254],
60	not	RB	O	not	neg	61	SENT_151	[p12l1247t2203r1361b2254],
61	establish	VB	O	establish	conj_but	54	SENT_151	[p12l1381t2191r1674b2254],
62	the	DT	O	the	det	63	SENT_151	[p12l1694t2191r1801b2254],
63	relevance	NN	O	relevance	dobj	61	SENT_151	[p12l1822t2191r2142b2254],
64	to	TO	O	to	_	0	SENT_151	[p12l7t2306r72b2357],
65	disease	NN	O	disease	nn	66	SENT_151	[p12l93t2294r326b2357],
66	progression	NN	O	progression	prep_to	61	SENT_151	[p12l345t2300r753b2378],
67	,	,	O	,	_	0	SENT_151	[p12l345t2300r753b2378],
68	whereas	IN	O	whereas	mark	71	SENT_151	[p12l772t2294r1042b2357],
69	the	DT	O	the	det	70	SENT_151	[p12l1061t2294r1164b2357],
70	former	JJ	O	former	nsubj	71	SENT_151	[p12l1184t2294r1415b2357],
71	demonstrate	VBP	O	demonstrate	advcl	61	SENT_151	[p12l1434t2294r1849b2357],
72	an	DT	O	a	det	73	SENT_151	[p12l1870t2317r1947b2357],
73	effect	NN	O	effect	dobj	71	SENT_151	[p12l1967t2294r2144b2357],
74	on	IN	O	on	_	0	SENT_151	[p12l9t2421r95b2461],
75	disease	NN	O	disease	nn	76	SENT_151	[p12l117t2398r357b2461],
76	progression	NN	O	progression	prep_on	73	SENT_151	[p12l378t2404r796b2482],
77	.	.	O	.	_	0	SENT_151	[p12l378t2404r796b2482],

1	Biomarkers	NNS	O	biomarker	nsubj	3	SENT_152	[p12l82t2501r466b2564],
2	might	MD	O	might	aux	3	SENT_152	[p12l486t2501r685b2585],
3	play	VB	O	play	_	0	SENT_152	[p12l702t2501r842b2585],
4	several	JJ	O	several	amod	5	SENT_152	[p12l859t2501r1087b2564],
5	roles	NNS	O	role	dobj	3	SENT_152	[p12l1107t2501r1263b2564],
6	in	IN	O	in	_	0	SENT_152	[p12l1283t2507r1348b2563],
7	drug	NN	O	drug	nn	9	SENT_152	[p12l1368t2501r1527b2585],
8	development	NN	O	development	nn	9	SENT_152	[p12l1545t2501r1979b2584],
9	programs	NNS	O	program	prep_in	5	SENT_152	[p12l1996t2523r2137b2584, p12l8t2627r216b2688],
10	(	CD	NUMBER	(	num	11	SENT_152	[p12l241t2604r500b2687],
11	Figure	NN	O	figure	tmod	3	SENT_152	[p12l241t2604r500b2687],
12	3	CD	NUMBER	3	num	13	SENT_152	[p12l520t2605r605b2680],
13	)	NN	O	)	dep	11	SENT_152	[p12l520t2605r605b2680],
14	.	.	O	.	_	0	SENT_152	[p12l520t2605r605b2680],

1	They	PRP	O	they	nsubjpass	4	SENT_153	[p12l629t2604r798b2688],
2	can	MD	O	can	aux	4	SENT_153	[p12l816t2627r933b2667],
3	be	VB	O	be	auxpass	4	SENT_153	[p12l952t2604r1031b2667],
4	used	VBN	O	use	_	0	SENT_153	[p12l1053t2604r1211b2667],
5	to	TO	O	to	aux	6	SENT_153	[p12l1229t2616r1295b2667],
6	establish	VB	O	establish	xcomp	4	SENT_153	[p12l1318t2604r1612b2667],
7	the	DT	O	the	det	8	SENT_153	[p12l1631t2604r1738b2667],
8	presence	NN	O	presence	dobj	6	SENT_153	[p12l1758t2626r2056b2687],
9	of	IN	O	of	_	0	SENT_153	[p12l2078t2604r2152b2667],
10	the	DT	O	the	det	12	SENT_153	[p12l7t2707r116b2770],
11	disease	NN	O	disease	nn	12	SENT_153	[p12l140t2707r385b2770],
12	process	NN	O	process	prep_of	8	SENT_153	[p12l407t2729r665b2790],
13	in	IN	O	in	_	0	SENT_153	[p12l690t2713r757b2769],
14	trial	NN	O	trial	nn	15	SENT_153	[p12l780t2707r923b2770],
15	participants	NNS	O	participant	prep_in	6	SENT_153	[p12l945t2713r1380b2790],
16	,	,	O	,	_	0	SENT_153	[p12l945t2713r1380b2790],
17	including	VBG	O	include	_	0	SENT_153	[p12l1405t2707r1739b2791],
18	cognitively	RB	O	cognitively	advmod	19	SENT_153	[p12l1761t2707r2145b2791],
19	normal	JJ	O	normal	amod	20	SENT_153	[p12l8t2810r268b2873],
20	individuals	NNS	O	individual	prep_including	6	SENT_153	[p12l294t2810r710b2882],
21	,	,	O	,	_	0	SENT_153	[p12l294t2810r710b2882],
22	patients	NNS	O	patient	prep_including	6	SENT_153	[p12l738t2816r1019b2893],
23	with	IN	O	with	_	0	SENT_153	[p12l1044t2810r1202b2873],
24	very	RB	O	very	advmod	25	SENT_153	[p12l1226t2833r1384b2894],
25	mild	JJ	O	mild	amod	26	SENT_153	[p12l1407t2810r1572b2873],
26	symptoms	NNS	O	symptom	prep_with	22	SENT_153	[p12l1598t2822r1982b2894],
27	,	,	O	,	_	0	SENT_153	[p12l1598t2822r1982b2894],
28	and	CC	O	and	_	0	SENT_153	[p12l2011t2810r2142b2873],
29	those	DT	O	those	conj_and	20	SENT_153	[p12l7t2913r194b2976],
30	with	IN	O	with	_	0	SENT_153	[p12l215t2913r371b2976],
31	dementia	NN	O	dementia	prep_with	29	SENT_153	[p12l395t2913r737b2976],
32	.	.	O	.	_	0	SENT_153	[p12l395t2913r737b2976],

1	Cognitively	RB	O	cognitively	advmod	2	SENT_154	[p12l765t2913r1171b2997],
2	normal	JJ	O	normal	amod	3	SENT_154	[p12l1191t2913r1446b2976],
3	participants	NNS	O	participant	nsubjpass	9	SENT_154	[p12l1467t2919r1884b2996],
4	in	IN	O	in	_	0	SENT_154	[p12l1908t2919r1976b2975],
5	prevention	NN	O	prevention	nn	6	SENT_154	[p12l1998t2935r2137b2996, p12l6t3022r261b3079],
6	trials	NNS	O	trial	prep_in	3	SENT_154	[p12l281t3016r448b3079],
7	can	MD	O	can	aux	9	SENT_154	[p12l469t3039r584b3079],
8	be	VB	O	be	auxpass	9	SENT_154	[p12l602t3016r680b3079],
9	identiﬁed	VBN	O	identiﬁed	_	0	SENT_154	[p12l700t3016r1021b3079],
10	only	RB	O	only	advmod	9	SENT_154	[p12l1041t3016r1189b3100],
11	by	IN	O	by	_	0	SENT_154	[p12l1203t3016r1285b3100],
12	biomarkers	NNS	O	biomarker	agent	9	SENT_154	[p12l1300t3016r1681b3079],
13	because	IN	O	because	mark	17	SENT_154	[p12l1699t3016r1962b3079],
14	their	PRP$	O	they	poss	15	SENT_154	[p12l1981t3016r2141b3079],
15	cognition	NN	O	cognition	nsubj	17	SENT_154	[p12l9t3125r346b3203],
16	is	VBZ	O	be	cop	17	SENT_154	[p12l371t3125r422b3182],
17	intact	JJ	O	intact	advcl	9	SENT_154	[p12l448t3125r665b3182],
18	.	.	O	.	_	0	SENT_154	[p12l448t3125r665b3182],

1	Low	JJ	O	low	amod	3	SENT_155	[p12l693t3124r845b3182],
2	CSF	NN	O	csf	nn	3	SENT_155	[p12l867t3123r1008b3182],
3	AB	NNP	O	AB	nsubjpass	9	SENT_155	[p12l1033t3117r1138b3200],
4	or	CC	O	or	_	0	SENT_155	[p12l1166t3142r1240b3182],
5	abnormal	JJ	O	abnormal	amod	7	SENT_155	[p12l1263t3119r1603b3182],
6	amyloid	NN	O	amyloid	nn	7	SENT_155	[p12l1628t3119r1913b3203],
7	imaging	NN	O	imaging	conj_or	3	SENT_155	[p12l1936t3125r2138b3203, p12l9t3228r120b3306],
8	is	VBZ	O	be	auxpass	9	SENT_155	[p12l143t3228r194b3285],
9	used	VBN	O	use	_	0	SENT_155	[p12l219t3222r383b3285],
10	to	TO	O	to	aux	11	SENT_155	[p12l405t3234r473b3285],
11	show	VB	O	show	xcomp	9	SENT_155	[p12l500t3222r682b3285],
12	that	IN	O	that	complm	15	SENT_155	[p12l703t3222r842b3285],
13	the	DT	O	the	det	14	SENT_155	[p12l864t3222r973b3285],
14	amyloid	NN	O	amyloid	nsubj	15	SENT_155	[p12l999t3222r1285b3306],
15	processes	VBZ	O	process	ccomp	11	SENT_155	[p12l1307t3244r1641b3305],
16	characteristic	NN	O	characteristic	nsubj	20	SENT_155	[p12l1667t3222r2142b3285],
17	of	IN	O	of	_	0	SENT_155	[p12l9t3325r84b3388],
18	AD	NN	O	ad	prep_of	16	SENT_155	[p12l97t3329r218b3387],
19	are	VBP	O	be	cop	20	SENT_155	[p12l244t3348r346b3388],
20	present	JJ	DATE	present	ccomp	15	SENT_155	[p12l369t3337r643b3408],
21	.	.	O	.	_	0	SENT_155	[p12l369t3337r643b3408],

1	Within	IN	O	within	_	0	SENT_156	[p12l669t3325r918b3388],
2	the	DT	O	the	det	4	SENT_156	[p12l941t3325r1049b3388],
3	MCI	NNP	ORGANIZATION	MCI	nn	4	SENT_156	[p12l1073t3329r1235b3388],
4	population	NN	O	population	prep_within	11	SENT_156	[p12l1258t3325r1663b3408],
5	,	,	O	,	_	0	SENT_156	[p12l1258t3325r1663b3408],
6	patients	NNS	O	patient	nsubjpass	11	SENT_156	[p12l1687t3331r1963b3408],
7	with	IN	O	with	_	0	SENT_156	[p12l1985t3325r2142b3388],
8	prodromal	JJ	O	prodromal	amod	9	SENT_156	[p12l7t3428r383b3511],
9	AD	NN	O	ad	prep_with	6	SENT_156	[p12l405t3432r525b3490],
10	are	VBP	O	be	auxpass	11	SENT_156	[p12l551t3451r653b3491],
11	distinguished	VBN	O	distinguish	_	0	SENT_156	[p12l678t3428r1150b3512],
12	from	IN	O	from	_	0	SENT_156	[p12l1171t3428r1342b3491],
13	those	DT	O	those	prep_from	11	SENT_156	[p12l1365t3428r1551b3491],
14	with	IN	O	with	_	0	SENT_156	[p12l1573t3428r1729b3491],
15	other	JJ	O	other	amod	16	SENT_156	[p12l1753t3428r1938b3491],
16	types	NNS	O	type	prep_with	13	SENT_156	[p12l1959t3440r2140b3512],
17	of	IN	O	of	_	0	SENT_156	[p12l9t3530r84b3593],
18	MCI	NNP	ORGANIZATION	MCI	prep_of	16	SENT_156	[p12l98t3534r260b3593],
19	through	IN	O	through	_	0	SENT_156	[p12l284t3530r569b3614],
20	the	DT	O	the	det	21	SENT_156	[p12l591t3530r700b3593],
21	use	NN	O	use	prep_through	11	SENT_156	[p12l724t3553r837b3593],
22	of	IN	O	of	_	0	SENT_156	[p12l862t3530r937b3593],
23	biomarkers	NNS	O	biomarker	prep_of	21	SENT_156	[p12l949t3522r1511b3593],
24	.31	CD	NUMBER	.31	number	25	SENT_156	[p12l949t3522r1511b3593],
25	’32	CD	NUMBER	’32	num	28	SENT_156	[p12l949t3522r1511b3593],
26	The	DT	O	the	det	28	SENT_156	[p12l1536t3530r1664b3593],
27	clinical	JJ	O	clinical	amod	28	SENT_156	[p12l1688t3530r1940b3593],
28	diagnosis	NN	O	diagnosis	nsubj	33	SENT_156	[p12l1964t3530r2138b3614, p12l8t3638r185b3695],
29	of	IN	O	of	_	0	SENT_156	[p12l209t3632r284b3695],
30	AD	NN	O	ad	nn	31	SENT_156	[p12l297t3636r418b3694],
31	dementia	NN	O	dementia	prep_of	28	SENT_156	[p12l443t3632r770b3695],
32	has	VBZ	O	have	aux	33	SENT_156	[p12l792t3632r905b3695],
33	limited	VBN	O	limit	rcmod	23	SENT_156	[p12l928t3632r1178b3695],
34	sensitivity	NN	O	sensitivity	dobj	33	SENT_156	[p12l1202t3638r1556b3716],
35	and	CC	O	and	_	0	SENT_156	[p12l1576t3632r1705b3695],
36	speciﬁcity52	NN	O	speciﬁcity52	conj_and	34	SENT_156	[p12l1728t3624r2141b3716],
37	and	CC	O	and	_	0	SENT_156	[p12l9t3735r140b3798],
38	can	MD	O	can	aux	40	SENT_156	[p12l167t3758r289b3798],
39	be	VB	O	be	auxpass	40	SENT_156	[p12l314t3735r396b3798],
40	improved	VBN	O	improve	rcmod	23	SENT_156	[p12l425t3735r769b3818],
41	by	IN	O	by	_	0	SENT_156	[p12l793t3735r880b3819],
42	using	VBG	O	use	agent	40	SENT_156	[p12l904t3741r1098b3819],
43	biomarkers	NNS	O	biomarker	dobj	42	SENT_156	[p12l1121t3735r1547b3798],
44	.	.	O	.	_	0	SENT_156	[p12l1121t3735r1547b3798],

1	Biomarkers	NNS	O	biomarker	nsubjpass	4	SENT_157	[p12l1578t3735r1990b3798],
2	can	MD	O	can	aux	4	SENT_157	[p12l2019t3758r2141b3798],
3	be	VB	O	be	auxpass	4	SENT_157	[p13l6t18r87b81],
4	used	VBN	O	use	_	0	SENT_157	[p13l111t18r273b81],
5	as	IN	O	as	_	0	SENT_157	[p13l297t41r362b81],
6	outcomes	NNS	O	outcome	prep_as	4	SENT_157	[p13l387t30r723b81],
7	of	IN	O	of	_	0	SENT_157	[p13l748t18r823b81],
8	disease-modifying	JJ	O	disease-modifying	amod	9	SENT_157	[p13l838t18r1490b102],
9	interventions	NNS	O	intervention	prep_of	6	SENT_157	[p13l1511t24r1996b81],
10	.	.	O	.	_	0	SENT_157	[p13l1511t24r1996b81],

1	For	IN	O	for	_	0	SENT_158	[p13l2024t23r2142b81],
2	example	NN	O	example	prep_for	10	SENT_158	[p13l9t121r313b204],
3	,	,	O	,	_	0	SENT_158	[p13l9t121r313b204],
4	tau	FW	O	tau	nn	5	SENT_158	[p13l337t121r714b184],
5	—	FW	O	—	nsubjpass	10	SENT_158	[p13l337t121r714b184],
6	related	JJ	O	related	amod	7	SENT_158	[p13l337t121r714b184],
7	agents	NNS	O	agent	dep	5	SENT_158	[p13l738t133r953b205],
8	might	MD	O	might	aux	10	SENT_158	[p13l976t121r1182b205],
9	be	VB	O	be	auxpass	10	SENT_158	[p13l1202t121r1282b184],
10	tested	VBN	O	test	_	0	SENT_158	[p13l1305t121r1508b184],
11	in	IN	O	in	_	0	SENT_158	[p13l1530t127r1598b183],
12	trials	NNS	O	trial	prep_in	10	SENT_158	[p13l1620t121r1793b184],
13	requiring	VBG	O	require	partmod	12	SENT_158	[p13l1817t127r2143b205],
14	positive	JJ	O	positive	amod	16	SENT_158	[p13l7t230r275b307],
15	amyloid	NN	O	amyloid	nn	16	SENT_158	[p13l299t224r577b308],
16	imaging	NN	O	imaging	dobj	13	SENT_158	[p13l599t230r881b308],
17	at	IN	O	at	_	0	SENT_158	[p13l903t236r962b287],
18	baseline	NN	O	baseline	prep_at	13	SENT_158	[p13l981t224r1261b287],
19	to	TO	O	to	aux	20	SENT_158	[p13l1283t236r1349b287],
20	ensure	VB	O	ensure	xcomp	13	SENT_158	[p13l1374t247r1599b287],
21	the	DT	O	the	det	22	SENT_158	[p13l1621t224r1727b287],
22	accuracy	NN	O	accuracy	dobj	20	SENT_158	[p13l1751t247r2057b308],
23	of	IN	O	of	_	0	SENT_158	[p13l2077t224r2151b287],
24	diagnosis	NN	O	diagnosis	prep_of	22	SENT_158	[p13l9t327r351b411],
25	,	,	O	,	_	0	SENT_158	[p13l9t327r351b411],
26	but	CC	O	but	_	0	SENT_158	[p13l374t327r489b390],
27	tau	FW	O	tau	nsubj	30	SENT_158	[p13l510t339r618b390],
28	biomarkers	NNS	O	biomarker	dep	27	SENT_158	[p13l638t327r1031b390],
29	would	MD	O	would	aux	30	SENT_158	[p13l1053t327r1270b390],
30	function	VB	O	function	conj_but	10	SENT_158	[p13l1291t327r1588b390],
31	as	IN	O	as	_	0	SENT_158	[p13l1612t350r1676b390],
32	the	DT	O	the	det	35	SENT_158	[p13l1699t327r1807b390],
33	principal	JJ	O	principal	amod	35	SENT_158	[p13l1828t327r2142b410],
34	biomarker	NN	O	biomarker	nn	35	SENT_158	[p13l6t430r376b493],
35	outcomes	NNS	O	outcome	prep_as	30	SENT_158	[p13l400t442r755b493],
36	.	.	O	.	_	0	SENT_158	[p13l400t442r755b493],

1	Linkage	NN	O	linkage	nsubjpass	7	SENT_159	[p13l783t430r1062b514],
2	to	TO	O	to	_	0	SENT_159	[p13l1086t442r1153b493],
3	clinical	JJ	O	clinical	amod	4	SENT_159	[p13l1179t430r1433b493],
4	outcomes	NNS	O	outcome	prep_to	1	SENT_159	[p13l1457t442r1794b493],
5	would	MD	O	would	aux	7	SENT_159	[p13l1818t430r2038b493],
6	be	VB	O	be	auxpass	7	SENT_159	[p13l2060t430r2141b493],
7	required	VBN	O	require	_	0	SENT_159	[p13l9t533r299b616],
8	to	TO	O	to	aux	9	SENT_159	[p13l318t545r383b596],
9	show	VB	O	show	xcomp	7	SENT_159	[p13l406t533r583b596],
10	that	IN	O	that	complm	16	SENT_159	[p13l600t533r734b596],
11	changes	NNS	O	change	nsubj	16	SENT_159	[p13l753t533r1022b617],
12	in	IN	O	in	_	0	SENT_159	[p13l1043t539r1109b595],
13	tau	NN	O	tau	nn	14	SENT_159	[p13l1129t545r1236b596],
14	biomarkers	NNS	O	biomarker	prep_in	11	SENT_159	[p13l1254t533r1641b596],
15	are	VBP	O	be	cop	16	SENT_159	[p13l1663t556r1763b596],
16	relevant	JJ	O	relevant	ccomp	9	SENT_159	[p13l1785t533r2057b596],
17	to	TO	O	to	_	0	SENT_159	[p13l2075t545r2141b596],
18	disease	NN	O	disease	nn	19	SENT_159	[p13l9t635r249b698],
19	modiﬁcation	NN	O	modiﬁcation	prep_to	16	SENT_159	[p13l270t635r727b698],
20	.	.	O	.	_	0	SENT_159	[p13l270t635r727b698],

1	In	IN	O	in	_	0	SENT_160	[p13l82t743r154b800],
2	phase	NN	O	phase	prep_in	16	SENT_160	[p13l176t738r372b821],
3	II	CD	NUMBER	ii	num	2	SENT_160	[p13l396t743r469b810],
4	,	,	O	,	_	0	SENT_160	[p13l396t743r469b810],
5	effects	NNS	O	effect	nsubjpass	16	SENT_160	[p13l494t738r708b801],
6	on	IN	O	on	_	0	SENT_160	[p13l733t761r819b801],
7	disease	NN	O	disease	nn	8	SENT_160	[p13l843t738r1085b801],
8	biomarkers	NNS	O	biomarker	prep_on	5	SENT_160	[p13l1107t738r1499b801],
9	without	IN	O	without	_	0	SENT_160	[p13l1521t738r1791b801],
10	a	DT	O	a	det	13	SENT_160	[p13l1814t761r1848b801],
11	demonstrated	VBN	O	demonstrate	amod	13	SENT_160	[p13l1871t738r2140b801, p13l9t841r246b904],
12	clinical	JJ	O	clinical	amod	13	SENT_160	[p13l269t841r520b904],
13	beneﬁt	NN	O	beneﬁt	prep_without	8	SENT_160	[p13l541t841r783b904],
14	might	MD	O	might	aux	16	SENT_160	[p13l805t841r1013b925],
15	be	VB	O	be	auxpass	16	SENT_160	[p13l1033t841r1114b904],
16	accepted	VBN	O	accept	_	0	SENT_160	[p13l1139t841r1443b924],
17	as	IN	O	as	_	0	SENT_160	[p13l1466t864r1531b904],
18	proofofmechanism	NN	O	proofofmechanism	prep_as	16	SENT_160	[p13l1555t841r2140b924, p13l8t950r175b1007],
19	to	TO	O	to	aux	20	SENT_160	[p13l194t956r259b1007],
20	assist	VB	O	assist	xcomp	16	SENT_160	[p13l282t950r457b1007],
21	in	IN	O	in	_	0	SENT_160	[p13l476t950r542b1006],
22	decision	NN	O	decision	prep_in	20	SENT_160	[p13l563t944r843b1007],
23	making	VBG	O	make	partmod	22	SENT_160	[p13l862t944r1120b1028],
24	regarding	VBG	O	regard	xcomp	23	SENT_160	[p13l1139t944r1465b1028],
25	whether	IN	O	whether	complm	27	SENT_160	[p13l1481t944r1761b1007],
26	to	TO	O	to	aux	27	SENT_160	[p13l1779t956r1844b1007],
27	advance	VB	O	advance	ccomp	24	SENT_160	[p13l1867t944r2139b1007],
28	a	DT	O	a	det	29	SENT_160	[p13l9t1070r43b1110],
29	candidate	NN	O	candidate	dobj	27	SENT_160	[p13l63t1047r389b1110],
30	to	TO	O	to	_	0	SENT_160	[p13l408t1059r473b1110],
31	phase	NN	O	phase	prep_to	27	SENT_160	[p13l493t1047r685b1130],
32	III	CD	NUMBER	iii	num	31	SENT_160	[p13l707t1052r806b1110],
33	.	.	O	.	_	0	SENT_160	[p13l707t1052r806b1110],

1	They	PRP	O	they	nsubjpass	4	SENT_161	[p13l829t1047r996b1131],
2	can	MD	O	can	aux	4	SENT_161	[p13l1014t1070r1129b1110],
3	be	VB	O	be	auxpass	4	SENT_161	[p13l1147t1047r1226b1110],
4	used	VBN	O	use	_	0	SENT_161	[p13l1246t1047r1403b1110],
5	in	IN	O	in	_	0	SENT_161	[p13l1422t1053r1488b1109],
6	phases	NNS	O	phase	prep_in	4	SENT_161	[p13l1506t1047r1729b1130],
7	II	CD	NUMBER	ii	num	6	SENT_161	[p13l1751t1052r1804b1109],
8	and	CC	O	and	_	0	SENT_161	[p13l1826t1047r1951b1110],
9	III	CD	NUMBER	iii	prep_in	4	SENT_161	[p13l1970t1052r2052b1109],
10	in	IN	O	in	_	0	SENT_161	[p13l2073t1053r2139b1109],
11	conjunction	NN	O	conjunction	prep_in	6	SENT_161	[p13l9t1156r420b1234],
12	with	IN	O	with	_	0	SENT_161	[p13l438t1150r591b1213],
13	clinical	JJ	O	clinical	amod	14	SENT_161	[p13l611t1150r855b1213],
14	measures	NNS	O	measure	prep_with	4	SENT_161	[p13l875t1173r1191b1213],
15	to	TO	O	to	aux	16	SENT_161	[p13l1211t1162r1277b1213],
16	develop	VB	O	develop	xcomp	4	SENT_161	[p13l1300t1150r1562b1233],
17	clinical	JJ	O	clinical	amod	20	SENT_161	[p13l1584t1150r2138b1234, p13l9t1252r101b1315],
18	—	NN	O	—	nn	20	SENT_161	[p13l1584t1150r2138b1234, p13l9t1252r101b1315],
19	biological	JJ	O	biological	amod	20	SENT_161	[p13l1584t1150r2138b1234, p13l9t1252r101b1315],
20	data	NNS	O	datum	nsubj	35	SENT_161	[p13l121t1252r262b1315],
21	supportive	JJ	O	supportive	dep	35	SENT_161	[p13l282t1258r640b1335],
22	of	IN	O	of	_	0	SENT_161	[p13l660t1252r733b1315],
23	disease	NN	O	disease	nn	24	SENT_161	[p13l744t1252r981b1315],
24	modiﬁcation	NN	O	modiﬁcation	prep_of	21	SENT_161	[p13l1001t1244r1513b1315],
25	.53	CD	NUMBER	.53	num	26	SENT_161	[p13l1001t1244r1513b1315],
26	Use	NN	O	use	nsubj	35	SENT_161	[p13l1535t1257r1657b1315],
27	of	IN	O	of	_	0	SENT_161	[p13l1678t1252r1750b1315],
28	biomarkers	NNS	O	biomarker	prep_of	26	SENT_161	[p13l1759t1252r2141b1315],
29	in	IN	O	in	_	0	SENT_161	[p13l8t1361r73b1417],
30	phase	NN	O	phase	nn	33	SENT_161	[p13l92t1355r282b1438],
31	II	CD	NUMBER	ii	num	33	SENT_161	[p13l303t1360r355b1417],
32	decision	NN	O	decision	nn	33	SENT_161	[p13l376t1355r653b1418],
33	making	NN	O	making	prep_in	28	SENT_161	[p13l672t1355r927b1439],
34	is	VBZ	O	be	cop	35	SENT_161	[p13l945t1361r994b1418],
35	attractive	JJ	O	attractive	xcomp	16	SENT_161	[p13l1015t1361r1324b1418],
36	because	IN	O	because	mark	44	SENT_161	[p13l1341t1355r1603b1418],
37	sample	NN	O	sample	nn	38	SENT_161	[p13l1624t1355r1856b1438],
38	sizes	NNS	O	size	nsubj	44	SENT_161	[p13l1876t1361r2027b1418],
39	for	IN	O	for	_	0	SENT_161	[p13l2047t1355r2142b1418],
40	biomarker	NN	O	biomarker	nn	41	SENT_161	[p13l6t1458r361b1521],
41	outcomes	NNS	O	outcome	prep_for	38	SENT_161	[p13l380t1470r704b1521],
42	are	VBP	O	be	cop	44	SENT_161	[p13l725t1481r824b1521],
43	considerably	RB	O	considerably	advmod	44	SENT_161	[p13l845t1458r1276b1542],
44	smaller	JJR	O	smaller	advcl	35	SENT_161	[p13l1293t1458r1540b1521],
45	than	IN	O	than	_	0	SENT_161	[p13l1558t1458r1711b1521],
46	sample	NN	O	sample	nn	47	SENT_161	[p13l1732t1458r1966b1541],
47	sizes	NNS	O	size	prep_than	44	SENT_161	[p13l1987t1464r2139b1521],
48	required	VBN	O	require	partmod	47	SENT_161	[p13l9t1561r306b1644],
49	to	TO	O	to	aux	50	SENT_161	[p13l327t1573r394b1624],
50	show	VB	O	show	xcomp	48	SENT_161	[p13l420t1561r601b1624],
51	clinical	JJ	O	clinical	amod	52	SENT_161	[p13l622t1561r872b1624],
52	effects	NNS	O	effect	dobj	50	SENT_161	[p13l896t1561r1130b1624],
53	.	.	O	.	_	0	SENT_161	[p13l896t1561r1130b1624],

1	The	DT	O	the	det	2	SENT_162	[p13l1156t1561r1283b1624],
2	risk	NN	O	risk	nsubj	21	SENT_162	[p13l1307t1561r1439b1624],
3	of	IN	O	of	_	0	SENT_162	[p13l1460t1561r1535b1624],
4	making	VBG	O	make	prepc_of	2	SENT_162	[p13l1548t1561r1814b1645],
5	the	DT	O	the	det	6	SENT_162	[p13l1835t1561r1943b1624],
6	decision	NN	O	decision	dobj	4	SENT_162	[p13l1967t1561r2137b1624, p13l9t1670r148b1727],
7	to	TO	O	to	_	0	SENT_162	[p13l167t1676r232b1727],
8	advance	NN	O	advance	prep_to	4	SENT_162	[p13l254t1664r526b1727],
9	to	TO	O	to	_	0	SENT_162	[p13l546t1676r611b1727],
10	phase	NN	O	phase	prep_to	4	SENT_162	[p13l631t1664r823b1747],
11	III	CD	NUMBER	iii	num	10	SENT_162	[p13l844t1669r926b1726],
12	on	IN	O	on	_	0	SENT_162	[p13l948t1687r1033b1727],
13	the	DT	O	the	det	14	SENT_162	[p13l1052t1664r1157b1727],
14	basis	NN	O	basis	prep_on	10	SENT_162	[p13l1175t1664r1339b1727],
15	of	IN	O	of	_	0	SENT_162	[p13l1361t1664r1434b1727],
16	biomarker	NN	O	biomarker	nn	17	SENT_162	[p13l1442t1664r1796b1727],
17	outcomes	NNS	O	outcome	prep_of	14	SENT_162	[p13l1816t1676r2140b1727],
18	in	IN	O	in	_	0	SENT_162	[p13l9t1773r76b1829],
19	phase	NN	O	phase	prep_in	17	SENT_162	[p13l99t1767r299b1850],
20	II	CD	NUMBER	ii	num	19	SENT_162	[p13l323t1772r377b1829],
21	is	VBZ	O	be	_	0	SENT_162	[p13l403t1773r454b1830],
22	that	IN	O	that	complm	27	SENT_162	[p13l478t1767r615b1830],
23	biomarker	NN	O	biomarker	nn	24	SENT_162	[p13l635t1767r1004b1830],
24	effects	NNS	O	effect	nsubjpass	27	SENT_162	[p13l1027t1767r1245b1830],
25	are	VBP	O	be	auxpass	27	SENT_162	[p13l1270t1790r1372b1830],
26	not	RB	O	not	neg	27	SENT_162	[p13l1396t1779r1513b1830],
27	known	VBN	O	know	ccomp	21	SENT_162	[p13l1534t1767r1777b1830],
28	to	TO	O	to	aux	29	SENT_162	[p13l1800t1779r1867b1830],
29	predict	VB	O	predict	xcomp	27	SENT_162	[p13l1891t1767r2141b1850],
30	clinical	JJ	O	clinical	amod	31	SENT_162	[p13l9t1870r251b1933],
31	beneﬁt	NN	O	beneﬁt	dobj	29	SENT_162	[p13l268t1870r516b1933],
32	.	.	O	.	_	0	SENT_162	[p13l268t1870r516b1933],

1	The	DT	O	the	det	2	SENT_163	[p13l540t1870r663b1933],
2	alternative	NN	O	alternative	nsubj	10	SENT_163	[p13l685t1870r1038b1933],
3	of	IN	O	of	_	0	SENT_163	[p13l1059t1870r1132b1933],
4	assessing	VBG	O	assess	prepc_of	2	SENT_163	[p13l1144t1876r1448b1954],
5	clinical	JJ	O	clinical	amod	6	SENT_163	[p13l1467t1870r1709b1933],
6	outcomes	NNS	O	outcome	dobj	4	SENT_163	[p13l1729t1882r2053b1933],
7	in	IN	O	in	_	0	SENT_163	[p13l2073t1876r2140b1932],
8	phase	NN	O	phase	prep_in	4	SENT_163	[p13l7t1973r203b2056],
9	II	CD	NUMBER	ii	num	8	SENT_163	[p13l227t1978r280b2035],
10	requires	VBZ	O	require	_	0	SENT_163	[p13l305t1979r582b2056],
11	sample	NN	O	sample	nn	12	SENT_163	[p13l607t1973r845b2056],
12	sizes	NNS	O	size	nsubj	13	SENT_163	[p13l869t1979r1025b2036],
13	comparable	JJ	O	comparable	xcomp	10	SENT_163	[p13l1049t1973r1450b2056],
14	with	IN	O	with	_	0	SENT_163	[p13l1472t1973r1625b2036],
15	those	DT	O	those	prep_with	13	SENT_163	[p13l1647t1973r1832b2036],
16	in	IN	O	in	_	0	SENT_163	[p13l1854t1979r1921b2035],
17	phase	NN	O	phase	nn	19	SENT_163	[p13l1943t1973r2139b2056],
18	III	CD	NUMBER	iii	num	19	SENT_163	[p13l9t2082r91b2139],
19	programs	NNS	O	program	prep_in	15	SENT_163	[p13l113t2099r458b2161],
20	.	.	O	.	_	0	SENT_163	[p13l113t2099r458b2161],

1	Disease-modification	NN	O	disease-modification	nn	2	SENT_164	[p13l82t2179r886b2242],
2	biomarkers	NNS	O	biomarker	nsubj	5	SENT_164	[p13l919t2179r1340b2242],
3	are	VBP	O	be	cop	5	SENT_164	[p13l1376t2202r1484b2242],
4	state	NN	O	state	nn	5	SENT_164	[p13l1520t2191r1686b2242],
5	biomarkers	NNS	O	biomarker	_	0	SENT_164	[p13l1719t2179r2140b2242],

1	(	NN	O	(	nn	3	SENT_165	[p13l12t2283r601b2365],
2	Supplementary	NNP	O	Supplementary	nn	3	SENT_165	[p13l12t2283r601b2365],
3	Table	NNP	O	Table	nsubj	5	SENT_165	[p13l620t2283r816b2345],
4	S2	NN	O	s2	dep	3	SENT_165	[p13l839t2286r922b2345],
5	online	NN	O	online	_	0	SENT_165	[p13l947t2282r1193b2358],
6	)	NN	O	)	dobj	5	SENT_165	[p13l947t2282r1193b2358],
7	that	WDT	O	that	nsubj	16	SENT_165	[p13l1220t2282r1356b2345],
8	reﬂect	VBP	O	reﬂect	rcmod	6	SENT_165	[p13l1378t2282r1594b2345],
9	the	DT	O	the	det	10	SENT_165	[p13l1616t2282r1724b2345],
10	presence	NN	O	presence	dobj	8	SENT_165	[p13l1746t2304r2051b2365],
11	of	IN	O	of	_	0	SENT_165	[p13l2075t2282r2150b2345],
12	the	DT	O	the	det	13	SENT_165	[p13l7t2385r118b2448],
13	disease	NN	O	disease	prep_of	10	SENT_165	[p13l146t2385r398b2448],
14	and	CC	O	and	_	0	SENT_165	[p13l426t2385r557b2448],
15	can	MD	O	can	aux	16	SENT_165	[p13l584t2408r705b2448],
16	show	VB	O	show	rcmod	6	SENT_165	[p13l733t2385r917b2448],
17	the	DT	O	the	det	18	SENT_165	[p13l941t2385r1051b2448],
18	effect	NN	O	effect	dobj	16	SENT_165	[p13l1080t2385r1269b2448],
19	of	IN	O	of	_	0	SENT_165	[p13l1296t2385r1372b2448],
20	pharmacotherapy	NN	O	pharmacotherapy	prep_of	18	SENT_165	[p13l1389t2385r2027b2469],
21	on	IN	O	on	_	0	SENT_165	[p13l2051t2408r2140b2448],
22	biological	JJ	O	biological	amod	23	SENT_165	[p13l6t2488r360b2572],
23	outcomes	NNS	O	outcome	prep_on	16	SENT_165	[p13l388t2500r750b2551],
24	.	.	O	.	_	0	SENT_165	[p13l388t2500r750b2551],

1	Successful	JJ	O	successful	amod	3	SENT_166	[p13l782t2488r1149b2551],
2	disease-modifying	JJ	O	disease-modifying	amod	3	SENT_166	[p13l1177t2488r1845b2572],
3	therapy	NN	O	therapy	nsubj	5	SENT_166	[p13l1870t2488r2145b2572],
4	will	MD	O	will	aux	5	SENT_166	[p13l7t2590r137b2653],
5	reduce	VB	O	reduce	_	0	SENT_166	[p13l162t2590r398b2653],
6	the	DT	O	the	det	7	SENT_166	[p13l423t2590r533b2653],
7	rate	NN	O	rate	dobj	5	SENT_166	[p13l559t2602r690b2653],
8	of	IN	O	of	_	0	SENT_166	[p13l716t2590r792b2653],
9	clinical	JJ	O	clinical	amod	10	SENT_166	[p13l809t2590r1064b2653],
10	decline	NN	O	decline	prep_of	7	SENT_166	[p13l1089t2590r1341b2653],
11	and	CC	O	and	_	0	SENT_166	[p13l1368t2590r1498b2653],
12	reduce	VB	O	reduce	conj_and	5	SENT_166	[p13l1523t2590r1759b2653],
13	the	DT	O	the	det	14	SENT_166	[p13l1784t2590r1893b2653],
14	rate	NN	O	rate	dobj	12	SENT_166	[p13l1919t2602r2051b2653],
15	of	IN	O	of	_	0	SENT_166	[p13l2077t2590r2153b2653],
16	biological	JJ	O	biological	amod	17	SENT_166	[p13l6t2693r343b2777],
17	change	NN	O	change	prep_of	14	SENT_166	[p13l366t2693r604b2777],
18	(	CD	NUMBER	(	dobj	5	SENT_166	[p13l631t2693r788b2777],
19	e.g.	FW	O	e.g.	dep	18	SENT_166	[p13l631t2693r788b2777],
20	,	,	O	,	_	0	SENT_166	[p13l631t2693r788b2777],
21	atrophy	NN	O	atrophy	conj_and	18	SENT_166	[p13l813t2693r1087b2777],
22	,	,	O	,	_	0	SENT_166	[p13l813t2693r1087b2777],
23	metabolism	NN	O	metabolism	appos	21	SENT_166	[p13l1111t2693r1534b2765],
24	,	,	O	,	_	0	SENT_166	[p13l1111t2693r1534b2765],
25	and	CC	O	and	_	0	SENT_166	[p13l1560t2693r1686b2756],
26	levels	NNS	O	level	conj_and	18	SENT_166	[p13l1706t2693r1892b2756],
27	of	IN	O	of	_	0	SENT_166	[p13l1916t2693r1990b2756],
28	CSF	NN	O	csf	nn	29	SENT_166	[p13l2005t2697r2142b2756],
29	tau	NN	O	tau	prep_of	26	SENT_166	[p13l7t2808r133b2868],
30	,	,	O	,	_	0	SENT_166	[p13l7t2808r133b2868],
31	CSF	NN	O	csf	nn	32	SENT_166	[p13l159t2800r297b2859],
32	p	NN	O	p	conj_and	18	SENT_166	[p13l320t2808r522b2879],
33	—	CD	NUMBER	—	num	34	SENT_166	[p13l320t2808r522b2879],
34	tau	NN	O	tau	dep	32	SENT_166	[p13l320t2808r522b2879],
35	,	,	O	,	_	0	SENT_166	[p13l320t2808r522b2879],
36	and	CC	O	and	_	0	SENT_166	[p13l548t2796r676b2859],
37	possibly	RB	O	possibly	advmod	38	SENT_166	[p13l697t2796r982b2880],
38	CSF	NN	ORGANIZATION	csf	conj_and	18	SENT_166	[p13l1002t2800r1141b2859],
39	AB	NNP	ORGANIZATION	AB	dep	38	SENT_166	[p13l1164t2794r1296b2877],
40	)	CD	NUMBER	)	num	39	SENT_166	[p13l1164t2794r1296b2877],
41	as	IN	O	as	mark	76	SENT_166	[p13l1324t2819r1389b2859],
42	compared	VBN	O	compare	_	0	SENT_166	[p13l1413t2796r1759b2879],
43	with	IN	O	with	prepc_compared_with	76	SENT_166	[p13l1780t2796r1934b2859],
44	those	DT	O	those	pobj	76	SENT_166	[p13l1956t2796r2141b2859],
45	observed	VBN	O	observe	partmod	44	SENT_166	[p13l9t2899r327b2962],
46	in	IN	O	in	_	0	SENT_166	[p13l349t2905r417b2961],
47	the	DT	O	the	det	49	SENT_166	[p13l439t2899r548b2962],
48	control	NN	O	control	nn	49	SENT_166	[p13l573t2899r824b2962],
49	group	NN	O	group	prep_in	45	SENT_166	[p13l846t2921r1069b2983],
50	,	,	O	,	_	0	SENT_166	[p13l846t2921r1069b2983],
51	although	IN	O	although	mark	57	SENT_166	[p13l1095t2899r1406b2983],
52	relationships	NNS	O	relationship	nsubj	57	SENT_166	[p13l1430t2899r1878b2982],
53	among	IN	O	among	_	0	SENT_166	[p13l1904t2922r2144b2983],
54	these	DT	O	these	det	55	SENT_166	[p13l7t3002r182b3065],
55	measures	NNS	O	measure	prep_among	52	SENT_166	[p13l205t3025r522b3065],
56	may	MD	O	may	aux	57	SENT_166	[p13l545t3025r691b3086],
57	differ	VB	O	differ	dep	49	SENT_166	[p13l711t3002r893b3065],
58	for	IN	O	for	_	0	SENT_166	[p13l914t3002r1011b3065],
59	natural	JJ	O	natural	amod	60	SENT_166	[p13l1032t3002r1276b3065],
60	history	NN	O	history	prep_for	57	SENT_166	[p13l1297t3002r1540b3086],
61	and	CC	O	and	_	0	SENT_166	[p13l1560t3002r1686b3065],
62	for	IN	O	for	mark	65	SENT_166	[p13l1707t3002r1804b3065],
63	intervention	NN	O	intervention	nn	64	SENT_166	[p13l1826t3008r2138b3065, p13l7t3111r145b3168],
64	studies	NNS	O	study	nsubj	65	SENT_166	[p13l169t3105r404b3168],
65	(	VBP	O	(	conj_and	57	SENT_166	[p13l431t3106r589b3189],
66	e.g.	FW	O	e.g.	dobj	65	SENT_166	[p13l431t3106r589b3189],
67	,	,	O	,	_	0	SENT_166	[p13l431t3106r589b3189],
68	CSF	NN	O	csf	nn	69	SENT_166	[p13l614t3109r752b3168],
69	levels	NNS	O	level	nsubj	76	SENT_166	[p13l774t3105r960b3168],
70	of	IN	O	of	_	0	SENT_166	[p13l984t3105r1058b3168],
71	AB	NNP	O	AB	nn	72	SENT_166	[p13l1071t3103r1174b3186],
72	decline	NN	O	decline	prep_of	69	SENT_166	[p13l1198t3105r1442b3168],
73	and	CC	O	and	_	0	SENT_166	[p13l1465t3105r1592b3168],
74	tau/p-tau	NN	O	tau/p-tau	nn	75	SENT_166	[p13l1613t3109r1935b3188],
75	levels	NNS	O	level	conj_and	72	SENT_166	[p13l1956t3105r2142b3168],
76	increase	VBP	O	increase	advcl	5	SENT_166	[p13l8t3214r279b3271],
77	in	IN	O	in	_	0	SENT_166	[p13l299t3214r364b3270],
78	the	DT	O	the	det	80	SENT_166	[p13l382t3208r486b3271],
79	natural	JJ	O	natural	amod	80	SENT_166	[p13l506t3208r744b3271],
80	history	NN	O	history	prep_in	76	SENT_166	[p13l762t3208r1000b3292],
81	of	IN	O	of	_	0	SENT_166	[p13l1017t3208r1088b3271],
82	AD	NN	O	ad	prep_of	80	SENT_166	[p13l1098t3212r1230b3280],
83	,	,	O	,	_	0	SENT_166	[p13l1098t3212r1230b3280],
84	but	CC	O	but	_	0	SENT_166	[p13l1249t3208r1360b3271],
85	these	DT	O	these	det	86	SENT_166	[p13l1377t3208r1549b3271],
86	two	CD	NUMBER	two	nsubj	88	SENT_166	[p13l1567t3220r1690b3271],
87	may	MD	O	may	aux	88	SENT_166	[p13l1710t3231r1854b3292],
88	respond	VB	O	respond	conj_but	5	SENT_166	[p13l1870t3208r2141b3291],
89	differentially	RB	O	differentially	advmod	88	SENT_166	[p13l9t3311r458b3395],
90	to	TO	O	to	_	0	SENT_166	[p13l478t3323r545b3374],
91	treatment	NN	O	treatment	nn	92	SENT_166	[p13l569t3312r960b3388],
92	)	NN	O	)	prep_to	88	SENT_166	[p13l569t3312r960b3388],
93	.	.	O	.	_	0	SENT_166	[p13l569t3312r960b3388],

1	Conﬁdence	NN	O	conﬁdence	nsubjpass	11	SENT_167	[p13l988t3311r1390b3374],
2	that	WDT	O	that	dobj	8	SENT_167	[p13l1413t3311r1551b3374],
3	clinical	JJ	O	clinical	amod	6	SENT_167	[p13l1573t3311r1825b3374],
4	and	CC	O	and	_	0	SENT_167	[p13l1849t3311r1978b3374],
5	biomarker	NN	O	biomarker	conj_and	3	SENT_167	[p13l1998t3311r2138b3374, p13l8t3414r256b3477],
6	effects	NNS	O	effect	nsubj	8	SENT_167	[p13l278t3414r489b3477],
7	are	VBP	O	be	cop	8	SENT_167	[p13l514t3437r614b3477],
8	related	JJ	O	related	rcmod	1	SENT_167	[p13l636t3414r868b3477],
9	will	MD	O	will	aux	11	SENT_167	[p13l887t3414r1014b3477],
10	be	VB	O	be	auxpass	11	SENT_167	[p13l1033t3414r1112b3477],
11	increased	VBN	O	increase	_	0	SENT_167	[p13l1136t3414r1460b3477],
12	by	IN	O	by	_	0	SENT_167	[p13l1480t3414r1564b3498],
13	demonstrating	VBG	O	demonstrate	agent	11	SENT_167	[p13l1583t3414r2086b3498],
14	a	DT	O	a	det	16	SENT_167	[p13l2108t3437r2142b3477],
15	consistent	JJ	O	consistent	amod	16	SENT_167	[p13l9t3523r341b3580],
16	association	NN	O	association	dobj	13	SENT_167	[p13l360t3523r727b3580],
17	between	IN	O	between	_	0	SENT_167	[p13l744t3517r1021b3580],
18	the	DT	O	the	det	20	SENT_167	[p13l1040t3517r1143b3580],
19	two	CD	NUMBER	two	num	20	SENT_167	[p13l1162t3529r1283b3580],
20	outcomes	NNS	O	outcome	prep_between	16	SENT_167	[p13l1305t3529r1622b3580],
21	across	IN	O	across	_	0	SENT_167	[p13l1643t3540r1844b3580],
22	multiple	JJ	O	multiple	amod	23	SENT_167	[p13l1864t3517r2139b3600],
23	trials	NNS	O	trial	prep_across	13	SENT_167	[p13l7t3620r178b3683],
24	and	CC	O	and	_	0	SENT_167	[p13l201t3620r327b3683],
25	multiple	JJ	O	multiple	amod	27	SENT_167	[p13l347t3620r632b3703],
26	pharmacologic	JJ	O	pharmacologic	amod	27	SENT_167	[p13l653t3620r1165b3704],
27	mechanisms	NNS	O	mechanism	prep_across	13	SENT_167	[p13l1186t3620r1629b3683],
28	.	.	O	.	_	0	SENT_167	[p13l1186t3620r1629b3683],

1	MRI	NNP	O	MRI	nsubj	2	SENT_168	[p14l10t73r137b127],
2	measures	VBZ	O	measure	_	0	SENT_168	[p14l158t87r487b128],
3	Three	CD	NUMBER	three	num	4	SENT_168	[p14l8t168r219b231],
4	measures	NNS	O	measure	dobj	2	SENT_168	[p14l249t191r585b231],
5	of	IN	O	of	_	0	SENT_168	[p14l616t168r692b231],
6	atrophy	NN	O	atrophy	prep_of	4	SENT_168	[p14l713t168r993b252],
7	on	IN	O	on	_	0	SENT_168	[p14l1020t191r1109b231],
8	MRI	NNP	O	MRI	prep_on	6	SENT_168	[p14l1138t173r1300b231],
9	have	VBP	O	have	aux	11	SENT_168	[p14l1330t168r1494b231],
10	been	VBN	O	be	auxpass	11	SENT_168	[p14l1521t168r1694b231],
11	used	VBN	O	use	rcmod	4	SENT_168	[p14l1723t168r1890b231],
12	in	IN	O	in	_	0	SENT_168	[p14l1919t174r1988b230],
13	AD	NN	O	ad	nn	15	SENT_168	[p14l2017t172r2139b230],
14	clinical	JJ	O	clinical	amod	15	SENT_168	[p14l9t271r247b334],
15	trials	NNS	O	trial	prep_in	11	SENT_168	[p14l264t271r447b334],
16	:	:	O	:	_	0	SENT_168	[p14l264t271r447b334],
17	whole	JJ	O	whole	amod	20	SENT_168	[p14l467t271r875b334],
18	—	JJ	O	—	amod	20	SENT_168	[p14l467t271r875b334],
19	brain	NN	O	brain	nn	20	SENT_168	[p14l467t271r875b334],
20	atrophy	NN	O	atrophy	dep	11	SENT_168	[p14l895t271r1161b355],
21	,	,	O	,	_	0	SENT_168	[p14l895t271r1161b355],
22	Ventricular	JJ	O	ventricular	amod	23	SENT_168	[p14l1179t271r1548b334],
23	enlargement	NN	O	enlargement	dep	11	SENT_168	[p14l1567t271r1999b355],
24	,	,	O	,	_	0	SENT_168	[p14l1567t271r1999b355],
25	and	CC	O	and	_	0	SENT_168	[p14l2021t271r2144b334],
26	hippocampal	JJ	O	hippocampal	amod	28	SENT_168	[p14l7t373r466b456],
27	atrophy	NN	O	atrophy	nn	28	SENT_168	[p14l489t365r832b457],
28	.54	NN	NUMBER	.54	dep	11	SENT_168	[p14l489t365r832b457],
29	For	IN	O	for	dep	20	SENT_168	[p14l856t378r973b436],
30	example	NN	O	example	pobj	29	SENT_168	[p14l996t373r1302b456],
31	,	,	O	,	_	0	SENT_168	[p14l996t373r1302b456],
32	in	IN	O	in	_	0	SENT_168	[p14l1327t379r1394b435],
33	patients	NNS	O	patient	prep_in	30	SENT_168	[p14l1416t379r1690b456],
34	with	IN	O	with	_	0	SENT_168	[p14l1712t373r1868b436],
35	mild	JJ	O	mild	amod	37	SENT_168	[p14l1891t373r2053b436],
36	to	TO	O	to	dep	37	SENT_168	[p14l2074t385r2141b436],
37	moderate	JJ	O	moderate	amod	38	SENT_168	[p14l8t476r330b539],
38	AD	NN	O	ad	prep_with	33	SENT_168	[p14l350t480r468b538],
39	included	VBD	O	include	rcmod	38	SENT_168	[p14l490t476r786b539],
40	in	IN	O	in	_	0	SENT_168	[p14l806t482r872b538],
41	a	DT	O	a	det	43	SENT_168	[p14l893t499r927b539],
42	clinical	JJ	O	clinical	amod	43	SENT_168	[p14l947t476r1190b539],
43	trial	NN	O	trial	prep_in	49	SENT_168	[p14l1208t476r1348b539],
44	of	IN	O	of	_	0	SENT_168	[p14l1368t476r1442b539],
45	divalproex	NN	O	divalproex	prep_of	43	SENT_168	[p14l1453t476r1829b559],
46	,	,	O	,	_	0	SENT_168	[p14l1453t476r1829b559],
47	placebotreated	JJ	O	placebotreated	amod	48	SENT_168	[p14l1849t476r2139b559, p14l7t579r241b642],
48	patients	NNS	O	patient	nsubj	49	SENT_168	[p14l258t585r522b662],
49	exhibited	VBD	O	exhibit	ccomp	39	SENT_168	[p14l543t579r853b642],
50	a	DT	O	a	det	54	SENT_168	[p14l873t602r907b642],
51	6	CD	PERCENT	6	number	52	SENT_168	[p14l926t584r1025b643],
52	%	NN	PERCENT	%	amod	54	SENT_168	[p14l926t584r1025b643],
53	annualized	VBN	O	annualize	amod	54	SENT_168	[p14l1048t579r1415b642],
54	change	NN	O	change	dobj	49	SENT_168	[p14l1435t579r1668b663],
55	in	IN	O	in	_	0	SENT_168	[p14l1688t585r1753b641],
56	hippocampal	JJ	O	hippocampal	amod	57	SENT_168	[p14l1772t579r2138b662, p14l7t682r112b765],
57	Volume	NN	O	volume	prep_in	54	SENT_168	[p14l131t682r405b754],
58	,	,	O	,	_	0	SENT_168	[p14l131t682r405b754],
59	a	DT	O	a	quantmod	60	SENT_168	[p14l431t705r465b745],
60	1.5	CD	PERCENT	1.5	num	61	SENT_168	[p14l494t687r650b746],
61	%	NN	PERCENT	%	dep	4	SENT_168	[p14l494t687r650b746],
62	annualized	VBN	O	annualize	amod	63	SENT_168	[p14l675t682r1052b745],
63	change	NN	O	change	dep	4	SENT_168	[p14l1075t682r1314b766],
64	in	IN	O	in	_	0	SENT_168	[p14l1337t688r1404b744],
65	whole	JJ	O	whole	amod	68	SENT_168	[p14l1424t682r1845b745],
66	—	NN	O	—	nn	68	SENT_168	[p14l1424t682r1845b745],
67	brain	NN	O	brain	nn	68	SENT_168	[p14l1424t682r1845b745],
68	volume	NN	O	volume	prep_in	63	SENT_168	[p14l1866t682r2140b754],
69	,	,	O	,	_	0	SENT_168	[p14l1866t682r2140b754],
70	and	CC	O	and	_	0	SENT_168	[p14l9t784r140b847],
71	a	DT	O	a	det	74	SENT_168	[p14l168t807r203b847],
72	10	CD	PERCENT	10	number	73	SENT_168	[p14l237t790r377b849],
73	%	NN	PERCENT	%	amod	74	SENT_168	[p14l237t790r377b849],
74	change	NN	O	change	conj_and	4	SENT_168	[p14l408t784r657b868],
75	in	IN	O	in	_	0	SENT_168	[p14l685t790r754b846],
76	Ventricular	JJ	O	ventricular	amod	79	SENT_168	[p14l779t784r1179b847],
77	volume	NN	O	volume	nn	79	SENT_168	[p14l1203t777r1555b847],
78	.55	CD	NUMBER	.55	num	79	SENT_168	[p14l1203t777r1555b847],
79	Rates	NNS	O	rate	prep_in	74	SENT_168	[p14l1585t789r1774b847],
80	of	IN	O	of	_	0	SENT_168	[p14l1803t784r1880b847],
81	annual	JJ	SET	annual	prep_of	79	SENT_168	[p14l1899t784r2142b847],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_169	[p14l22t933r141b954],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_169	[p14l150t933r375b954],
3	&	CC	O	&	_	0	SENT_169	[p14l382t933r602b954],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_169	[p14l382t933r602b954],
5	|	CD	NUMBER	|	num	6	SENT_169	[p14l382t933r602b954],
6	CS	NNP	O	CS	conj_and	2	SENT_169	[p14l382t933r602b954],
7	|	NNP	O	|	nn	8	SENT_169	[p14l612t931r614b961],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_169	[p14l622t933r730b954],
9	95	CD	NUMBER	95	num	10	SENT_169	[p14l738t933r765b954],
10	NUMBER	NN	O	number	dep	12	SENT_169	[p14l775t933r883b954],
11	1	CD	NUMBER	1	num	12	SENT_169	[p14l893t934r900b954],
12	|	CD	NUMBER	|	dep	15	SENT_169	[p14l914t931r916b961],
13	JANUARY	NNP	DATE	JANUARY	dep	12	SENT_169	[p14l925t933r1043b954],
14	2014	CD	DATE	2014	num	15	SENT_169	[p14l1051t933r1109b954],
15	71	CD	DATE	71	_	0	SENT_169	[p14l2111t934r2137b954],

1	change	NN	O	change	nsubjpass	4	SENT_170	[p14l9t1309r254b1393],
2	can	MD	O	can	aux	4	SENT_170	[p14l279t1332r399b1372],
3	be	VB	O	be	auxpass	4	SENT_170	[p14l421t1309r503b1372],
4	used	VBN	O	use	_	0	SENT_170	[p14l527t1309r689b1372],
5	to	TO	O	to	_	0	SENT_170	[p14l712t1321r779b1372],
6	the	DT	O	the	prep_to	4	SENT_170	[p14l804t1309r913b1372],
7	predict	VBP	O	predict	rcmod	6	SENT_170	[p14l937t1309r1188b1392],
8	the	DT	O	the	det	10	SENT_170	[p14l1210t1309r1319b1372],
9	sample	NN	O	sample	nn	10	SENT_170	[p14l1344t1309r1588b1392],
10	sizes	NNS	O	size	dobj	7	SENT_170	[p14l1614t1315r1773b1372],
11	needed	VBN	O	need	partmod	10	SENT_170	[p14l1798t1309r2052b1372],
12	to	TO	O	to	aux	13	SENT_170	[p14l2074t1321r2142b1372],
13	show	VB	O	show	xcomp	11	SENT_170	[p14l9t1412r185b1475],
14	drug	NN	O	drug	nn	17	SENT_170	[p14l204t1412r671b1496],
15	—	NN	O	—	nn	17	SENT_170	[p14l204t1412r671b1496],
16	placebo	NN	O	placebo	nn	17	SENT_170	[p14l204t1412r671b1496],
17	differences	NNS	O	difference	dobj	13	SENT_170	[p14l693t1412r1058b1475],
18	for	IN	O	for	_	0	SENT_170	[p14l1079t1412r1176b1475],
19	speciﬁc	NN	O	speciﬁc	prep_for	17	SENT_170	[p14l1196t1412r1446b1495],
20	expected	VBN	O	expect	partmod	19	SENT_170	[p14l1467t1412r1768b1495],
21	effect	NN	O	effect	nn	22	SENT_170	[p14l1788t1412r1969b1475],
22	sizes	NNS	O	size	dobj	20	SENT_170	[p14l1988t1418r2142b1475],
23	for	IN	O	for	_	0	SENT_170	[p14l8t1515r105b1578],
24	clinical	JJ	O	clinical	amod	25	SENT_170	[p14l124t1515r366b1578],
25	trials	NNS	O	trial	prep_for	20	SENT_170	[p14l384t1515r569b1578],
26	.	.	O	.	_	0	SENT_170	[p14l384t1515r569b1578],

1	In	IN	O	in	_	0	SENT_171	[p14l593t1520r663b1577],
2	one	CD	NUMBER	one	num	3	SENT_171	[p14l684t1538r804b1578],
3	study	NN	O	study	prep_in	18	SENT_171	[p14l826t1515r1017b1599],
4	,	,	O	,	_	0	SENT_171	[p14l826t1515r1017b1599],
5	detection	NN	O	detection	nsubjpass	18	SENT_171	[p14l1040t1515r1354b1578],
6	of	IN	O	of	_	0	SENT_171	[p14l1375t1515r1447b1578],
7	25	CD	PERCENT	25	number	8	SENT_171	[p14l1458t1520r1599b1579],
8	%	NN	PERCENT	%	amod	9	SENT_171	[p14l1458t1520r1599b1579],
9	slowing	NN	O	slowing	prep_of	5	SENT_171	[p14l1622t1515r1881b1599],
10	in	IN	O	in	_	0	SENT_171	[p14l1900t1521r1965b1577],
11	mild	JJ	O	mild	amod	12	SENT_171	[p14l1985t1515r2142b1578],
12	AD	NN	O	ad	prep_in	9	SENT_171	[p14l8t1622r126b1680],
13	with	IN	O	with	_	0	SENT_171	[p14l149t1618r302b1681],
14	80	CD	PERCENT	80	number	15	SENT_171	[p14l325t1624r467b1683],
15	%	NN	PERCENT	%	amod	16	SENT_171	[p14l325t1624r467b1683],
16	power	NN	O	power	prep_with	12	SENT_171	[p14l490t1640r705b1701],
17	was	VBD	O	be	auxpass	18	SENT_171	[p14l725t1641r851b1681],
18	shown	VBN	O	show	_	0	SENT_171	[p14l875t1618r1097b1681],
19	to	TO	O	to	aux	20	SENT_171	[p14l1119t1630r1185b1681],
20	require	VB	O	require	xcomp	18	SENT_171	[p14l1209t1624r1453b1701],
21	81	CD	NUMBER	81	num	22	SENT_171	[p14l1477t1625r1549b1681],
22	patients	NNS	O	patient	dobj	20	SENT_171	[p14l1576t1624r1846b1701],
23	per	IN	O	per	_	0	SENT_171	[p14l1868t1640r1982b1701],
24	arm	NN	O	arm	prep_per	22	SENT_171	[p14l2004t1641r2140b1681],
25	if	IN	O	if	mark	32	SENT_171	[p14l9t1721r63b1783],
26	whole	JJ	O	whole	amod	29	SENT_171	[p14l71t1721r487b1784],
27	—	NN	O	—	nn	29	SENT_171	[p14l71t1721r487b1784],
28	brain	NN	O	brain	nn	29	SENT_171	[p14l71t1721r487b1784],
29	atrophy	NN	O	atrophy	nsubj	32	SENT_171	[p14l509t1721r772b1805],
30	is	VBZ	O	be	cop	32	SENT_171	[p14l788t1727r838b1784],
31	the	DT	O	the	det	32	SENT_171	[p14l858t1721r964b1784],
32	outcome	NN	O	outcome	advcl	20	SENT_171	[p14l985t1733r1296b1793],
33	,	,	O	,	_	0	SENT_171	[p14l985t1733r1296b1793],
34	88	CD	NUMBER	88	num	35	SENT_171	[p14l1319t1728r1395b1784],
35	patients	NNS	O	patient	appos	32	SENT_171	[p14l1416t1727r1683b1804],
36	if	IN	O	if	mark	41	SENT_171	[p14l1704t1721r1758b1783],
37	hippocampal	JJ	O	hippocampal	amod	38	SENT_171	[p14l1768t1721r2139b1804, p14l7t1824r111b1907],
38	Volume	NN	O	volume	nsubj	41	SENT_171	[p14l130t1824r386b1887],
39	is	VBZ	O	be	cop	41	SENT_171	[p14l409t1830r459b1887],
40	the	DT	O	the	det	41	SENT_171	[p14l482t1824r588b1887],
41	outcome	NN	O	outcome	dep	35	SENT_171	[p14l611t1836r925b1896],
42	,	,	O	,	_	0	SENT_171	[p14l611t1836r925b1896],
43	and	CC	O	and	_	0	SENT_171	[p14l950t1824r1077b1887],
44	118	CD	NUMBER	118	num	45	SENT_171	[p14l1105t1831r1217b1887],
45	patients	NNS	O	patient	advcl	20	SENT_171	[p14l1240t1830r1509b1907],
46	if	IN	O	if	mark	50	SENT_171	[p14l1533t1824r1587b1886],
47	ventricular	JJ	O	ventricular	amod	48	SENT_171	[p14l1598t1824r1977b1887],
48	outcome	NN	O	outcome	nsubjpass	50	SENT_171	[p14l1999t1836r2137b1887, p14l9t1949r190b1989],
49	is	VBZ	O	be	auxpass	50	SENT_171	[p14l211t1932r260b1989],
50	used	VBN	O	use	dep	45	SENT_171	[p14l281t1926r438b1989],
51	as	IN	O	as	_	0	SENT_171	[p14l459t1949r522b1989],
52	the	DT	O	the	det	54	SENT_171	[p14l542t1926r648b1989],
53	trial	NN	O	trial	nn	54	SENT_171	[p14l667t1926r808b1989],
54	outcome	NN	O	outcome	prep_as	50	SENT_171	[p14l828t1918r1203b1989],
55	.56	CD	NUMBER	.56	tmod	50	SENT_171	[p14l828t1918r1203b1989],
56	The	DT	O	the	det	59	SENT_171	[p14l1223t1926r1348b1989],
57	sample	NN	O	sample	nn	59	SENT_171	[p14l1369t1926r1605b2009],
58	size	NN	O	size	nn	59	SENT_171	[p14l1626t1932r1748b1989],
59	calculation	NN	O	calculation	nsubj	60	SENT_171	[p14l1769t1926r2142b1989],
60	depends	VBZ	O	depend	rcmod	55	SENT_171	[p14l9t2029r293b2112],
61	on	IN	O	on	_	0	SENT_171	[p14l317t2052r402b2092],
62	the	DT	O	the	det	63	SENT_171	[p14l424t2029r531b2092],
63	size	NN	O	size	prep_on	60	SENT_171	[p14l554t2035r677b2092],
64	of	IN	O	of	_	0	SENT_171	[p14l700t2029r774b2092],
65	the	DT	O	the	det	66	SENT_171	[p14l786t2029r892b2092],
66	effect	NN	O	effect	prep_of	63	SENT_171	[p14l916t2029r1098b2092],
67	and	CC	O	and	_	0	SENT_171	[p14l1120t2029r1246b2092],
68	the	DT	O	the	det	70	SENT_171	[p14l1266t2029r1373b2092],
69	measurement	NN	O	measurement	nn	70	SENT_171	[p14l1395t2041r1862b2092],
70	error	NN	O	error	conj_and	63	SENT_171	[p14l1884t2052r2056b2092],
71	of	IN	O	of	_	0	SENT_171	[p14l2078t2029r2152b2092],
72	the	DT	O	the	det	73	SENT_171	[p14l8t2131r114b2194],
73	biomarker	NN	O	biomarker	prep_of	70	SENT_171	[p14l133t2131r502b2194],
74	.	.	O	.	_	0	SENT_171	[p14l133t2131r502b2194],

1	If	IN	O	if	mark	5	SENT_172	[p14l83t2234r142b2296],
2	MRI	NNP	O	MRI	nn	3	SENT_172	[p14l154t2239r311b2297],
3	atrophy	NN	O	atrophy	nsubjpass	5	SENT_172	[p14l335t2234r604b2318],
4	is	VBZ	O	be	auxpass	5	SENT_172	[p14l623t2240r673b2297],
5	used	VBN	O	use	advcl	20	SENT_172	[p14l696t2234r856b2297],
6	in	IN	O	in	_	0	SENT_172	[p14l878t2240r944b2296],
7	clinical	JJ	O	clinical	amod	8	SENT_172	[p14l967t2234r1217b2297],
8	trials	NNS	O	trial	prep_in	5	SENT_172	[p14l1237t2234r1412b2297],
9	of	IN	O	of	_	0	SENT_172	[p14l1436t2234r1510b2297],
10	patients	NNS	O	patient	prep_of	8	SENT_172	[p14l1521t2240r1796b2317],
11	with	IN	O	with	_	0	SENT_172	[p14l1816t2234r1971b2297],
12	prodromal	JJ	O	prodromal	amod	13	SENT_172	[p14l1992t2256r2139b2317, p14l9t2337r268b2400],
13	AD	NN	O	ad	prep_with	10	SENT_172	[p14l293t2341r433b2409],
14	,	,	O	,	_	0	SENT_172	[p14l293t2341r433b2409],
15	then	RB	O	then	advmod	20	SENT_172	[p14l461t2337r622b2400],
16	152	CD	NUMBER	152	num	17	SENT_172	[p14l656t2344r773b2400],
17	patients	NNS	O	patient	nsubjpass	20	SENT_172	[p14l800t2343r1085b2420],
18	would	MD	O	would	aux	20	SENT_172	[p14l1110t2337r1335b2400],
19	be	VB	O	be	auxpass	20	SENT_172	[p14l1359t2337r1441b2400],
20	required	VBN	O	require	_	0	SENT_172	[p14l1468t2337r1775b2420],
21	to	TO	O	to	aux	22	SENT_172	[p14l1800t2349r1868b2400],
22	show	VB	O	show	xcomp	20	SENT_172	[p14l1897t2337r2082b2400],
23	a	DT	O	a	det	26	SENT_172	[p14l2107t2360r2142b2400],
24	25	CD	PERCENT	25	number	25	SENT_172	[p14l9t2445r152b2504],
25	%	NN	PERCENT	%	amod	26	SENT_172	[p14l9t2445r152b2504],
26	slowing	NN	O	slowing	dobj	22	SENT_172	[p14l179t2440r447b2524],
27	in	IN	O	in	_	0	SENT_172	[p14l469t2446r536b2502],
28	hippocampal	JJ	O	hippocampal	amod	29	SENT_172	[p14l559t2440r1018b2523],
29	atrophy	NN	O	atrophy	prep_in	26	SENT_172	[p14l1042t2440r1311b2524],
30	and	CC	O	and	_	0	SENT_172	[p14l1332t2440r1460b2503],
31	284	CD	NUMBER	284	num	32	SENT_172	[p14l1483t2447r1605b2503],
32	patients	NNS	O	patient	nsubjpass	35	SENT_172	[p14l1628t2446r1903b2523],
33	would	MD	O	would	aux	35	SENT_172	[p14l1925t2440r2143b2503],
34	be	VB	O	be	auxpass	35	SENT_172	[p14l7t2543r87b2606],
35	required	VBN	O	require	conj_and	20	SENT_172	[p14l112t2543r411b2626],
36	to	TO	O	to	aux	37	SENT_172	[p14l434t2555r500b2606],
37	show	VB	O	show	xcomp	35	SENT_172	[p14l527t2543r708b2606],
38	a	DT	O	a	det	40	SENT_172	[p14l730t2566r765b2606],
39	25	CD	PERCENT	25	number	40	SENT_172	[p14l788t2548r933b2608],
40	%	NN	PERCENT	%	dobj	37	SENT_172	[p14l788t2548r933b2608],
41	slowing	VBG	O	slow	amod	40	SENT_172	[p14l961t2543r1230b2627],
42	on	IN	O	on	_	0	SENT_172	[p14l1253t2566r1340b2606],
43	the	DT	O	the	det	46	SENT_172	[p14l1364t2543r1473b2606],
44	Clinical	JJ	O	clinical	amod	46	SENT_172	[p14l1499t2543r1773b2606],
45	Dementia	NNP	O	Dementia	nn	46	SENT_172	[p14l1796t2548r2143b2606],
46	Rating	NNP	O	Rating	prep_on	40	SENT_172	[p14l9t2650r447b2730],
47	.	.	O	.	_	0	SENT_172	[p14l9t2650r447b2730],

1	—	NN	O	—	_	0	SENT_173	[p14l9t2650r447b2730],
2	.	.	O	.	_	0	SENT_173	[p14l9t2650r447b2730],

1	Sum	NN	O	sum	_	0	SENT_174	[p14l9t2650r447b2730],
2	of	IN	O	of	_	0	SENT_174	[p14l472t2646r548b2709],
3	Boxes	NNPS	O	Boxes	prep_of	1	SENT_174	[p14l563t2651r786b2709],
4	.	.	O	.	_	0	SENT_174	[p14l563t2651r786b2709],

1	If	IN	O	if	mark	7	SENT_175	[p14l815t2646r875b2708],
2	low	JJ	O	low	amod	4	SENT_175	[p14l889t2646r1016b2709],
3	CSF	NN	O	csf	nn	4	SENT_175	[p14l1038t2650r1179b2709],
4	AB	NNP	O	AB	nsubj	7	SENT_175	[p14l1203t2644r1308b2727],
5	is	VBZ	O	be	cop	7	SENT_175	[p14l1334t2652r1385b2709],
6	also	RB	O	also	advmod	7	SENT_175	[p14l1412t2646r1546b2709],
7	present	JJ	DATE	present	advcl	17	SENT_175	[p14l1571t2658r1831b2729],
8	with	IN	O	with	_	0	SENT_175	[p14l1852t2646r2009b2709],
9	the	DT	O	the	det	11	SENT_175	[p14l2033t2646r2142b2709],
10	MRI	NNP	MISC	MRI	nn	11	SENT_175	[p14l8t2754r168b2812],
11	atrophy	NN	O	atrophy	prep_with	7	SENT_175	[p14l195t2749r479b2833],
12	,	,	O	,	_	0	SENT_175	[p14l195t2749r479b2833],
13	125	CD	NUMBER	125	num	14	SENT_175	[p14l513t2756r628b2812],
14	patients	NNS	O	patient	nsubjpass	17	SENT_175	[p14l654t2755r934b2832],
15	would	MD	O	would	aux	17	SENT_175	[p14l958t2749r1180b2812],
16	be	VB	O	be	auxpass	17	SENT_175	[p14l1201t2749r1283b2812],
17	required	VBN	O	require	_	0	SENT_175	[p14l1309t2749r1611b2832],
18	to	TO	O	to	aux	19	SENT_175	[p14l1634t2761r1702b2812],
19	show	VB	O	show	xcomp	17	SENT_175	[p14l1729t2749r1912b2812],
20	a	DT	O	a	det	23	SENT_175	[p14l1935t2772r1970b2812],
21	25	CD	PERCENT	25	number	22	SENT_175	[p14l1994t2754r2140b2814],
22	%	NN	PERCENT	%	amod	23	SENT_175	[p14l1994t2754r2140b2814],
23	slowing	NN	O	slowing	dobj	19	SENT_175	[p14l9t2852r284b2936],
24	in	IN	O	in	_	0	SENT_175	[p14l307t2858r376b2914],
25	hippocampal	JJ	O	hippocampal	amod	26	SENT_175	[p14l401t2852r871b2935],
26	atrophy	NN	O	atrophy	prep_in	23	SENT_175	[p14l896t2852r1172b2936],
27	and	CC	O	and	_	0	SENT_175	[p14l1195t2852r1326b2915],
28	246	CD	NUMBER	246	num	29	SENT_175	[p14l1350t2858r1474b2915],
29	patients	NNS	O	patient	prep_in	23	SENT_175	[p14l1499t2858r1781b2935],
30	to	TO	O	to	aux	31	SENT_175	[p14l1806t2864r1874b2915],
31	show	VB	O	show	xcomp	19	SENT_175	[p14l1902t2852r2086b2915],
32	a	DT	O	a	det	34	SENT_175	[p14l2109t2875r2144b2915],
33	25	CD	PERCENT	25	number	34	SENT_175	[p14l9t2960r152b3019],
34	%	NN	PERCENT	%	dobj	31	SENT_175	[p14l9t2960r152b3019],
35	slowing	VBG	O	slow	amod	34	SENT_175	[p14l179t2955r447b3039],
36	on	IN	O	on	_	0	SENT_175	[p14l468t2978r555b3018],
37	the	DT	O	the	det	40	SENT_175	[p14l578t2955r685b3018],
38	Clinical	JJ	O	clinical	amod	40	SENT_175	[p14l710t2955r982b3018],
39	Dementia	NNP	O	Dementia	nn	40	SENT_175	[p14l1005t2960r1350b3018],
40	Rating	NNP	O	Rating	prep_on	34	SENT_175	[p14l1372t2959r1806b3039],
41	.	.	O	.	_	0	SENT_175	[p14l1372t2959r1806b3039],

1	—	NN	O	—	_	0	SENT_176	[p14l1372t2959r1806b3039],
2	.	.	O	.	_	0	SENT_176	[p14l1372t2959r1806b3039],

1	Sum	NN	O	sum	_	0	SENT_177	[p14l1372t2959r1806b3039],
2	of	IN	O	of	_	0	SENT_177	[p14l1829t2955r1904b3018],
3	Boxes	NNPS	O	Boxes	prep_of	1	SENT_177	[p14l1919t2960r2139b3018],
4	.	.	O	.	_	0	SENT_177	[p14l1919t2960r2139b3018],

1	This	DT	O	this	nsubj	2	SENT_178	[p14l8t3058r158b3121],
2	compares	VBZ	O	compare	_	0	SENT_178	[p14l190t3080r539b3141],
3	with	IN	O	with	_	0	SENT_178	[p14l568t3058r730b3121],
4	a	DT	O	a	det	6	SENT_178	[p14l761t3081r796b3121],
5	sample	NN	O	sample	nn	6	SENT_178	[p14l827t3058r1079b3141],
6	size	NN	O	size	prep_with	2	SENT_178	[p14l1111t3064r1243b3121],
7	of	IN	O	of	_	0	SENT_178	[p14l1274t3058r1352b3121],
8	392	CD	NUMBER	392	num	9	SENT_178	[p14l1374t3065r1498b3121],
9	patients	NNS	O	patient	prep_of	6	SENT_178	[p14l1529t3064r1819b3141],
10	and	CC	O	and	_	0	SENT_178	[p14l1851t3058r1984b3121],
11	583	CD	NUMBER	583	num	12	SENT_178	[p14l2015t3065r2138b3121],
12	patients	NNS	O	patient	prep_of	6	SENT_178	[p14l7t3167r282b3244],
13	to	TO	O	to	aux	14	SENT_178	[p14l305t3173r372b3224],
14	show	VB	O	show	xcomp	2	SENT_178	[p14l398t3161r577b3224],
15	25	CD	PERCENT	25	number	16	SENT_178	[p14l598t3167r742b3225],
16	%	NN	PERCENT	%	amod	17	SENT_178	[p14l598t3167r742b3225],
17	slowing	NN	O	slowing	dobj	14	SENT_178	[p14l768t3161r1036b3245],
18	of	IN	O	of	_	0	SENT_178	[p14l1058t3161r1133b3224],
19	the	DT	O	the	det	20	SENT_178	[p14l1145t3161r1253b3224],
20	hippocampus	NN	O	hippocampus	prep_of	14	SENT_178	[p14l1276t3161r1749b3244],
21	and	CC	O	and	_	0	SENT_178	[p14l1774t3161r1902b3224],
22	on	IN	O	on	_	0	SENT_178	[p14l1925t3184r2011b3224],
23	the	DT	O	the	det	26	SENT_178	[p14l2034t3161r2142b3224],
24	Clinical	JJ	O	clinical	amod	26	SENT_178	[p14l10t3264r290b3327],
25	Dementia	NNP	O	Dementia	nn	26	SENT_178	[p14l316t3269r670b3327],
26	Rating	NNP	O	Rating	prep_on	14	SENT_178	[p14l695t3268r1141b3348],
27	.	.	O	.	_	0	SENT_178	[p14l695t3268r1141b3348],

1	—	NN	O	—	_	0	SENT_179	[p14l695t3268r1141b3348],
2	.	.	O	.	_	0	SENT_179	[p14l695t3268r1141b3348],

1	Sum	NN	O	sum	nsubj	32	SENT_180	[p14l695t3268r1141b3348],
2	of	IN	O	of	_	0	SENT_180	[p14l1167t3264r1244b3327],
3	Boxes	NNPS	O	Boxes	prep_of	1	SENT_180	[p14l1260t3269r1488b3336],
4	,	,	O	,	_	0	SENT_180	[p14l1260t3269r1488b3336],
5	respectively	RB	O	respectively	advmod	32	SENT_180	[p14l1516t3264r1953b3348],
6	,	,	O	,	_	0	SENT_180	[p14l1516t3264r1953b3348],
7	if	IN	O	if	mark	13	SENT_180	[p14l1980t3264r2037b3326],
8	no	DT	O	no	det	11	SENT_180	[p14l2052t3287r2142b3327],
9	biomarker	NN	O	biomarker	nn	11	SENT_180	[p14l7t3366r379b3429],
10	enrichment	NN	O	enrichment	nn	11	SENT_180	[p14l403t3366r816b3429],
11	strategy	NN	O	strategy	nsubjpass	13	SENT_180	[p14l841t3378r1123b3450],
12	is	VBZ	O	be	auxpass	13	SENT_180	[p14l1144t3372r1196b3429],
13	used	VBN	O	use	dep	32	SENT_180	[p14l1221t3359r1470b3429],
14	.57	CD	NUMBER	.57	dobj	13	SENT_180	[p14l1221t3359r1470b3429],
15	The	DT	O	the	det	17	SENT_180	[p14l1494t3366r1621b3429],
16	greater	JJR	O	greater	amod	17	SENT_180	[p14l1647t3378r1894b3450],
17	rate	NN	O	rate	npadvmod	24	SENT_180	[p14l1918t3378r2050b3429],
18	of	IN	O	of	_	0	SENT_180	[p14l2076t3366r2151b3429],
19	change	NN	O	change	prep_of	17	SENT_180	[p14l9t3469r257b3553],
20	in	IN	O	in	_	0	SENT_180	[p14l283t3475r352b3531],
21	moderate	JJ	O	moderate	amod	23	SENT_180	[p14l377t3469r717b3532],
22	AD	NN	O	ad	nn	23	SENT_180	[p14l742t3473r863b3531],
23	dementia	NN	O	dementia	prep_in	19	SENT_180	[p14l891t3469r1226b3532],
24	as	IN	O	as	advmod	13	SENT_180	[p14l1251t3492r1318b3532],
25	compared	VBN	O	compare	_	0	SENT_180	[p14l1344t3469r1701b3552],
26	with	IN	O	with	prepc_compared_with	13	SENT_180	[p14l1724t3469r1883b3532],
27	that	DT	O	that	pobj	13	SENT_180	[p14l1907t3469r2048b3532],
28	in	IN	O	in	_	0	SENT_180	[p14l2072t3475r2141b3531],
29	mild	JJ	O	mild	amod	30	SENT_180	[p14l8t3572r174b3635],
30	AD	NN	O	ad	prep_in	27	SENT_180	[p14l198t3576r319b3634],
31	dementia	NN	O	dementia	nsubj	32	SENT_180	[p14l347t3572r682b3635],
32	allows	VBZ	O	allow	_	0	SENT_180	[p14l707t3572r928b3635],
33	the	DT	O	the	det	34	SENT_180	[p14l953t3572r1064b3635],
34	use	NN	O	use	dobj	32	SENT_180	[p14l1089t3595r1204b3635],
35	of	IN	O	of	_	0	SENT_180	[p14l1230t3572r1307b3635],
36	smaller	JJR	O	smaller	amod	38	SENT_180	[p14l1324t3572r1585b3635],
37	sample	NN	O	sample	nn	38	SENT_180	[p14l1611t3572r1858b3655],
38	sizes	NNS	O	size	prep_of	34	SENT_180	[p14l1884t3578r2046b3635],
39	in	IN	O	in	_	0	SENT_180	[p14l2073t3578r2142b3634],
40	this	DT	O	this	det	41	SENT_180	[p14l8t3675r134b3738],
41	phase	NN	O	phase	prep_in	38	SENT_180	[p14l157t3675r355b3758],
42	of	IN	O	of	_	0	SENT_180	[p14l379t3675r453b3738],
43	the	DT	O	the	det	44	SENT_180	[p14l466t3675r574b3738],
44	disease	NN	O	disease	prep_of	41	SENT_180	[p14l598t3675r860b3738],
45	.	.	O	.	_	0	SENT_180	[p14l598t3675r860b3738],

1	Although	IN	O	although	mark	4	SENT_181	[p15l81t17r420b101],
2	MRI	NNP	O	MRI	nsubj	4	SENT_181	[p15l445t22r605b80],
3	has	VBZ	O	have	aux	4	SENT_181	[p15l631t17r746b80],
4	shown	VBN	O	show	advcl	25	SENT_181	[p15l773t17r1002b80],
5	a	DT	O	a	det	10	SENT_181	[p15l1029t40r1064b80],
6	relatively	RB	O	relatively	advmod	7	SENT_181	[p15l1088t17r1413b101],
7	regular	JJ	O	regular	amod	10	SENT_181	[p15l1435t17r1687b101],
8	and	CC	O	and	_	0	SENT_181	[p15l1712t17r1842b80],
9	consistent	JJ	O	consistent	conj_and	7	SENT_181	[p15l1868t23r2140b80, p15l9t132r118b183],
10	relationship	NN	O	relationship	dobj	4	SENT_181	[p15l141t120r560b203],
11	to	TO	O	to	_	0	SENT_181	[p15l584t132r652b183],
12	cognitive	JJ	O	cognitive	amod	13	SENT_181	[p15l678t126r1000b204],
13	decline	NN	O	decline	prep_to	4	SENT_181	[p15l1026t120r1276b183],
14	and	CC	O	and	_	0	SENT_181	[p15l1302t120r1432b183],
15	disease	NN	O	disease	nn	16	SENT_181	[p15l1455t120r1703b183],
16	progression	NN	O	progression	prep_to	4	SENT_181	[p15l1727t126r2142b204],
17	in	IN	O	in	_	0	SENT_181	[p15l9t229r76b285],
18	natural	JJ	O	natural	amod	20	SENT_181	[p15l100t223r350b286],
19	history	NN	O	history	nn	20	SENT_181	[p15l372t223r622b307],
20	studies	NNS	O	study	prep_in	13	SENT_181	[p15l643t223r902b295],
21	,	,	O	,	_	0	SENT_181	[p15l643t223r902b295],
22	this	DT	O	this	det	23	SENT_181	[p15l926t223r1054b286],
23	measure	NN	O	measure	nsubj	25	SENT_181	[p15l1078t246r1371b286],
24	has	VBZ	O	have	aux	25	SENT_181	[p15l1393t223r1507b286],
25	performed	VBN	O	perform	_	0	SENT_181	[p15l1531t223r1907b306],
26	somewhat	RB	O	somewhat	advmod	25	SENT_181	[p15l1930t246r2140b286, p15l7t326r174b389],
27	unpredictably	RB	O	unpredictably	advmod	25	SENT_181	[p15l193t326r670b410],
28	in	IN	O	in	_	0	SENT_181	[p15l687t332r754b388],
29	clinical	JJ	O	clinical	amod	30	SENT_181	[p15l774t326r1019b389],
30	trials	NNS	O	trial	prep_in	25	SENT_181	[p15l1037t326r1225b389],
31	.	.	O	.	_	0	SENT_181	[p15l1037t326r1225b389],

1	Atrophy	NN	O	atrophy	nsubj	3	SENT_182	[p15l1248t326r1533b410],
2	was	VBD	O	be	cop	3	SENT_182	[p15l1548t349r1674b389],
3	greater	JJR	O	greater	_	0	SENT_182	[p15l1695t338r1932b410],
4	in	IN	O	in	_	0	SENT_182	[p15l1952t332r2018b388],
5	the	DT	O	the	det	8	SENT_182	[p15l2037t326r2143b389],
6	active	JJ	O	active	amod	8	SENT_182	[p15l9t434r201b491],
7	treatment	NN	O	treatment	nn	8	SENT_182	[p15l220t440r549b491],
8	arm	NN	O	arm	prep_in	3	SENT_182	[p15l569t451r702b491],
9	of	IN	O	of	_	0	SENT_182	[p15l723t428r795b491],
10	a	DT	O	a	det	12	SENT_182	[p15l806t451r841b491],
11	placebo	NN	O	placebo	nn	12	SENT_182	[p15l858t428r1494b511],
12	—	NN	O	—	prep_of	8	SENT_182	[p15l858t428r1494b511],
13	controlled	VBN	O	control	partmod	12	SENT_182	[p15l858t428r1494b511],
14	divalproex	NN	O	divalproex	nn	15	SENT_182	[p15l1514t428r1869b511],
15	study	NN	O	study	dobj	13	SENT_182	[p15l1888t421r2141b512],
16	,55	CD	NUMBER	,55	num	15	SENT_182	[p15l1888t421r2141b512],
17	and	CC	O	and	_	0	SENT_182	[p15l9t531r136b594],
18	there	EX	O	there	expl	19	SENT_182	[p15l154t531r328b594],
19	was	VBD	O	be	conj_and	3	SENT_182	[p15l348t554r473b594],
20	greater	JJR	O	greater	amod	23	SENT_182	[p15l495t543r732b615],
21	brain	NN	O	brain	nn	23	SENT_182	[p15l750t531r931b594],
22	volume	NN	O	volume	nn	23	SENT_182	[p15l949t531r1204b594],
23	loss	NN	O	loss	nsubj	19	SENT_182	[p15l1224t531r1350b594],
24	in	IN	O	in	_	0	SENT_182	[p15l1371t537r1438b593],
25	patients	NNS	O	patient	prep_in	23	SENT_182	[p15l1458t537r1727b614],
26	who	WP	O	who	nsubj	27	SENT_182	[p15l1746t531r1893b594],
27	had	VBD	O	have	rcmod	25	SENT_182	[p15l1914t531r2041b594],
28	an	DT	O	a	det	30	SENT_182	[p15l2063t554r2142b594],
29	antibody	NN	O	antibody	nn	30	SENT_182	[p15l9t634r322b718],
30	response	NN	O	response	dobj	27	SENT_182	[p15l343t656r649b717],
31	to	TO	O	to	_	0	SENT_182	[p15l672t646r739b697],
32	vaccination	NN	O	vaccination	prep_to	30	SENT_182	[p15l761t640r1167b697],
33	with	IN	O	with	_	0	SENT_182	[p15l1189t634r1346b697],
34	AN1792	NN	O	an1792	prep_with	27	SENT_182	[p15l1368t638r1660b697],
35	than	IN	O	than	dep	27	SENT_182	[p15l1684t634r1842b697],
36	in	IN	O	in	_	0	SENT_182	[p15l1866t640r1933b696],
37	those	DT	O	those	prep_in	27	SENT_182	[p15l1956t634r2143b697],
38	who	WP	O	who	nsubj	39	SENT_182	[p15l7t736r156b799],
39	failed	VBD	O	fail	rcmod	37	SENT_182	[p15l181t736r374b799],
40	to	TO	O	to	aux	41	SENT_182	[p15l396t748r463b799],
41	respond	VB	O	respond	xcomp	39	SENT_182	[p15l488t728r854b819],
42	.58	CD	NUMBER	.58	dobj	41	SENT_182	[p15l488t728r854b819],
43	Although	IN	O	although	mark	48	SENT_182	[p15l878t736r1213b820],
44	various	JJ	O	various	amod	45	SENT_182	[p15l1234t742r1492b799],
45	explanations	NNS	O	explanation	nsubjpass	48	SENT_182	[p15l1517t736r1959b819],
46	have	VBP	O	have	aux	48	SENT_182	[p15l1983t736r2142b799],
47	been	VBN	O	be	auxpass	48	SENT_182	[p15l7t839r168b902],
48	offered	VBN	O	offer	advcl	58	SENT_182	[p15l188t839r421b902],
49	for	IN	O	for	_	0	SENT_182	[p15l440t839r535b902],
50	these	DT	O	these	det	52	SENT_182	[p15l553t839r725b902],
51	unanticipated	JJ	O	unanticipated	amod	52	SENT_182	[p15l745t839r1208b922],
52	responses	NNS	O	response	prep_for	48	SENT_182	[p15l1227t861r1569b922],
53	,	,	O	,	_	0	SENT_182	[p15l1227t861r1569b922],
54	their	PRP$	O	they	poss	55	SENT_182	[p15l1590t839r1750b902],
55	occurrence	NN	O	occurrence	nsubjpass	58	SENT_182	[p15l1769t862r2142b902],
56	was	VBD	O	be	auxpass	58	SENT_182	[p15l7t965r132b1005],
57	not	RB	O	not	neg	58	SENT_182	[p15l155t954r269b1005],
58	expected	VBN	O	expect	rcmod	42	SENT_182	[p15l292t942r611b1025],
59	;	:	O	;	_	0	SENT_182	[p15l292t942r611b1025],
60	they	PRP	O	they	nsubj	61	SENT_182	[p15l635t942r785b1026],
61	indicate	VBP	O	indicate	parataxis	3	SENT_182	[p15l804t942r1074b1005],
62	that	IN	O	that	complm	68	SENT_182	[p15l1096t942r1230b1005],
63	biomarker	NN	O	biomarker	nn	64	SENT_182	[p15l1249t942r1608b1005],
64	performance	NN	O	performance	nsubj	68	SENT_182	[p15l1628t942r2069b1025],
65	is	VBZ	O	be	cop	68	SENT_182	[p15l2092t948r2141b1005],
66	not	RB	O	not	neg	68	SENT_182	[p15l8t1057r121b1108],
67	yet	RB	O	yet	advmod	68	SENT_182	[p15l138t1057r239b1129],
68	predictable	JJ	O	predictable	ccomp	61	SENT_182	[p15l258t1045r637b1128],
69	and	CC	O	and	_	0	SENT_182	[p15l658t1045r784b1108],
70	that	IN	O	that	complm	74	SENT_182	[p15l802t1045r935b1108],
71	greater	JJR	O	greater	amod	72	SENT_182	[p15l954t1057r1190b1129],
72	experience	NN	O	experience	nsubjpass	74	SENT_182	[p15l1210t1051r1576b1128],
73	is	VBZ	O	be	auxpass	74	SENT_182	[p15l1597t1051r1647b1108],
74	needed	VBN	O	need	conj_and	68	SENT_182	[p15l1668t1045r1913b1108],
75	across	IN	O	across	_	0	SENT_182	[p15l1933t1068r2140b1108],
76	populations	NNS	O	population	prep_across	74	SENT_182	[p15l7t1148r413b1231],
77	and	CC	O	and	_	0	SENT_182	[p15l436t1148r562b1211],
78	treatment	NN	O	treatment	nn	79	SENT_182	[p15l582t1160r917b1211],
79	types	NNS	O	type	conj_and	76	SENT_182	[p15l937t1160r1131b1232],
80	.	.	O	.	_	0	SENT_182	[p15l937t1160r1131b1232],

1	Amyloid	JJ	O	amyloid	amod	2	SENT_183	[p15l8t1361r296b1434],
2	measures	NNS	O	measure	_	0	SENT_183	[p15l317t1377r646b1418],
3	Current	JJ	DATE	current	amod	4	SENT_183	[p15l10t1462r289b1521],
4	modeling	NN	O	modeling	nsubj	5	SENT_183	[p15l313t1458r652b1542],
5	suggests	VBZ	O	suggest	rcmod	2	SENT_183	[p15l676t1470r965b1542],
6	that	IN	O	that	complm	9	SENT_183	[p15l991t1458r1129b1521],
7	AB	NNP	O	AB	nsubjpass	9	SENT_183	[p15l1152t1456r1257b1539],
8	is	VBZ	O	be	auxpass	9	SENT_183	[p15l1283t1464r1335b1521],
9	deposited	VBN	O	deposit	ccomp	5	SENT_183	[p15l1362t1458r1705b1541],
10	in	IN	O	in	_	0	SENT_183	[p15l1730t1464r1798b1520],
11	the	DT	O	the	det	12	SENT_183	[p15l1822t1458r1931b1521],
12	brain	NN	O	brain	prep_in	9	SENT_183	[p15l1955t1458r2142b1521],
13	during	IN	O	during	_	0	SENT_183	[p15l9t1561r242b1645],
14	an	DT	O	a	det	17	SENT_183	[p15l263t1584r343b1624],
15	~	NN	O	~	nn	17	SENT_183	[p15l368t1568r523b1624],
16	17	CD	NUMBER	17	num	17	SENT_183	[p15l368t1568r523b1624],
17	—	NN	O	—	prep_during	9	SENT_183	[p15l368t1568r523b1624],
18	to	TO	O	to	_	0	SENT_183	[p15l548t1573r614b1624],
19	20-year	JJ	DURATION	20-year	amod	20	SENT_183	[p15l637t1568r897b1645],
20	period	NN	O	period	prep_to	17	SENT_183	[p15l917t1561r1147b1644],
21	before	IN	O	before	mark	25	SENT_183	[p15l1166t1561r1383b1624],
22	AD	NN	O	ad	nn	23	SENT_183	[p15l1404t1565r1523b1623],
23	dementia	NN	O	dementia	nsubjpass	25	SENT_183	[p15l1548t1561r1870b1624],
24	is	VBZ	O	be	auxpass	25	SENT_183	[p15l1892t1567r1942b1624],
25	diagnosed	VBN	O	diagnose	advcl	9	SENT_183	[p15l1966t1561r2138b1645, p15l8t1655r294b1726],
26	.34	CD	NUMBER	.34	num	27	SENT_183	[p15l1966t1561r2138b1645, p15l8t1655r294b1726],
27	CSF	NN	O	csf	dobj	25	SENT_183	[p15l317t1667r454b1726],
28	AB	NNP	O	AB	nn	29	SENT_183	[p15l476t1661r578b1744],
29	levels	NNS	O	level	nsubj	30	SENT_183	[p15l601t1663r788b1726],
30	decline	VBP	O	decline	rcmod	27	SENT_183	[p15l811t1663r1055b1726],
31	a	DT	DURATION	a	det	33	SENT_183	[p15l1079t1686r1112b1726],
32	few	JJ	DURATION	few	amod	33	SENT_183	[p15l1134t1663r1254b1726],
33	years	NNS	DURATION	year	tmod	30	SENT_183	[p15l1271t1686r1446b1747],
34	before	IN	O	before	_	0	SENT_183	[p15l1467t1663r1683b1726],
35	cortical	JJ	O	cortical	amod	36	SENT_183	[p15l1706t1663r1964b1726],
36	deposition	NN	O	deposition	prep_before	30	SENT_183	[p15l1986t1663r2137b1746, p15l9t1757r338b1828],
37	.33	CD	NUMBER	.33	num	36	SENT_183	[p15l1986t1663r2137b1746, p15l9t1757r338b1828],
38	There	EX	O	there	expl	39	SENT_183	[p15l364t1765r562b1828],
39	is	VBZ	O	be	rcmod	36	SENT_183	[p15l588t1771r640b1828],
40	a	DT	O	a	det	43	SENT_183	[p15l666t1788r701b1828],
41	signiﬁcant	JJ	O	signiﬁcant	amod	43	SENT_183	[p15l726t1765r1096b1849],
42	inverse	JJ	O	inverse	amod	43	SENT_183	[p15l1120t1771r1371b1828],
43	relationship	NN	O	relationship	nsubj	39	SENT_183	[p15l1397t1765r1819b1848],
44	between	IN	O	between	_	0	SENT_183	[p15l1844t1765r2140b1828],
45	CSF	NN	O	csf	prep_between	43	SENT_183	[p15l10t1871r149b1930],
46	AB	NNP	O	AB	dep	2	SENT_183	[p15l172t1865r277b1948],
47	and	CC	O	and	_	0	SENT_183	[p15l301t1867r430b1930],
48	cortical	JJ	O	cortical	amod	52	SENT_183	[p15l453t1867r716b1930],
49	ﬁbrillar	NN	O	ﬁbrillar	nn	52	SENT_183	[p15l739t1867r1003b1930],
50	amyloid	NN	O	amyloid	nn	52	SENT_183	[p15l1026t1867r1310b1951],
51	AB	NNP	O	AB	nn	52	SENT_183	[p15l1331t1865r1435b1948],
52	deposition	NN	O	deposition	conj_and	46	SENT_183	[p15l1459t1859r1916b1950],
53	;	:	O	;	_	0	SENT_183	[p15l1459t1859r1916b1950],
54	59	CD	NUMBER	59	dep	2	SENT_183	[p15l1459t1859r1916b1950],
55	this	DT	O	this	nsubjpass	57	SENT_183	[p15l1939t1867r2066b1930],
56	is	VBZ	O	be	auxpass	57	SENT_183	[p15l2090t1873r2142b1930],
57	interpreted	VBN	O	interpret	rcmod	54	SENT_183	[p15l9t1970r401b2053],
58	as	IN	O	as	_	0	SENT_183	[p15l424t1993r489b2033],
59	indicating	VBG	O	indicate	prepc_as	57	SENT_183	[p15l513t1970r869b2054],
60	that	IN	O	that	complm	73	SENT_183	[p15l889t1970r1025b2033],
61	as	IN	O	as	mark	65	SENT_183	[p15l1048t1993r1113b2033],
62	ﬁbrillar	NN	O	ﬁbrillar	nn	63	SENT_183	[p15l1136t1970r1400b2033],
63	amyloid	NN	O	amyloid	nsubjpass	65	SENT_183	[p15l1422t1970r1705b2054],
64	is	VBZ	O	be	auxpass	65	SENT_183	[p15l1727t1976r1778b2033],
65	deposited	VBN	O	deposit	advcl	73	SENT_183	[p15l1802t1970r2142b2053],
66	in	IN	O	in	_	0	SENT_183	[p15l9t2079r76b2135],
67	the	DT	O	the	det	68	SENT_183	[p15l97t2073r205b2136],
68	cortex	NN	O	cortex	prep_in	65	SENT_183	[p15l229t2085r462b2145],
69	,	,	O	,	_	0	SENT_183	[p15l229t2085r462b2145],
70	monomeric	JJ	O	monomeric	amod	71	SENT_183	[p15l487t2079r892b2136],
71	AB	NNP	O	AB	nsubjpass	73	SENT_183	[p15l913t2071r1017b2154],
72	is	VBZ	O	be	auxpass	73	SENT_183	[p15l1041t2079r1092b2136],
73	incorporated	VBN	O	incorporate	ccomp	59	SENT_183	[p15l1115t2073r1569b2156],
74	into	IN	O	into	_	0	SENT_183	[p15l1591t2079r1727b2136],
75	the	DT	O	the	det	77	SENT_183	[p15l1750t2073r1857b2136],
76	cortical	JJ	O	cortical	amod	77	SENT_183	[p15l1881t2073r2142b2136],
77	plaques	NNS	O	plaque	prep_into	73	SENT_183	[p15l7t2176r272b2259],
78	and	CC	O	and	_	0	SENT_183	[p15l296t2176r424b2239],
79	CSF	NN	O	csf	nn	80	SENT_183	[p15l447t2180r586b2239],
80	levels	NNS	O	level	nsubj	81	SENT_183	[p15l608t2176r799b2239],
81	decline	VBP	O	decline	ccomp	59	SENT_183	[p15l823t2176r1089b2239],
82	.	.	O	.	_	0	SENT_183	[p15l823t2176r1089b2239],

1	Rates	NNS	O	rate	nsubj	6	SENT_184	[p15l1115t2181r1300b2239],
2	of	IN	O	of	_	0	SENT_184	[p15l1324t2176r1398b2239],
3	AB	NNP	O	AB	nn	4	SENT_184	[p15l1411t2174r1515b2257],
4	accumulation	NN	O	accumulation	prep_of	1	SENT_184	[p15l1539t2176r2016b2239],
5	are	VBP	O	be	cop	6	SENT_184	[p15l2040t2199r2142b2239],
6	low	JJ	O	low	_	0	SENT_184	[p15l7t2279r135b2342],
7	at	IN	O	at	_	0	SENT_184	[p15l159t2291r220b2342],
8	baseline	NN	O	baseline	prep_at	6	SENT_184	[p15l242t2279r532b2342],
9	(	CD	NUMBER	(	number	10	SENT_184	[p15l561t2280r668b2355],
10	15	CD	DURATION	15	num	11	SENT_184	[p15l561t2280r668b2355],
11	years	NNS	NUMBER	year	npadvmod	6	SENT_184	[p15l694t2302r876b2363],
12	before	IN	O	before	_	0	SENT_184	[p15l900t2279r1124b2342],
13	onset	NN	O	onset	prep_before	6	SENT_184	[p15l1150t2291r1339b2342],
14	of	IN	O	of	_	0	SENT_184	[p15l1365t2279r1440b2342],
15	dementia	NN	O	dementia	nn	16	SENT_184	[p15l1457t2279r1840b2355],
16	)	NN	O	)	prep_of	13	SENT_184	[p15l1457t2279r1840b2355],
17	,	,	O	,	_	0	SENT_184	[p15l1457t2279r1840b2355],
18	accelerate	VB	O	accelerate	dep	16	SENT_184	[p15l1868t2279r2139b2342, p15l9t2394r108b2445],
19	as	IN	O	as	_	0	SENT_184	[p15l134t2405r201b2445],
20	deposition	NN	O	deposition	nn	21	SENT_184	[p15l228t2382r609b2465],
21	increases	NNS	O	increase	prep_as	18	SENT_184	[p15l635t2388r980b2454],
22	,	,	O	,	_	0	SENT_184	[p15l635t2388r980b2454],
23	and	CC	O	and	_	0	SENT_184	[p15l1009t2382r1139b2445],
24	then	RB	O	then	advmod	18	SENT_184	[p15l1164t2382r1324b2445],
25	decrease	VB	O	decrease	conj_and	18	SENT_184	[p15l1350t2382r1654b2445],
26	as	IN	O	as	mark	31	SENT_184	[p15l1681t2405r1748b2445],
27	maximum	JJ	O	maximum	amod	29	SENT_184	[p15l1774t2388r2143b2445],
28	cortical	JJ	O	cortical	amod	29	SENT_184	[p15l9t2484r288b2547],
29	accumulation	NN	O	accumulation	nsubjpass	31	SENT_184	[p15l318t2484r822b2547],
30	is	VBZ	O	be	auxpass	31	SENT_184	[p15l853t2490r906b2547],
31	reached	VBN	O	reach	advcl	25	SENT_184	[p15l937t2476r1313b2547],
32	.60	CD	NUMBER	.60	dobj	31	SENT_184	[p15l937t2476r1313b2547],
33	This	DT	O	this	det	35	SENT_184	[p15l1342t2484r1493b2547],
34	time	NN	O	time	nn	35	SENT_184	[p15l1523t2490r1688b2547],
35	course	NN	O	course	nsubj	36	SENT_184	[p15l1718t2507r1957b2547],
36	suggests	VBZ	O	suggest	dep	31	SENT_184	[p15l1988t2507r2139b2568, p15l8t2599r177b2671],
37	a	DT	O	a	det	39	SENT_184	[p15l205t2610r239b2650],
38	long	JJ	O	long	amod	39	SENT_184	[p15l263t2587r420b2671],
39	period	NN	O	period	dobj	36	SENT_184	[p15l442t2587r679b2670],
40	during	IN	O	during	_	0	SENT_184	[p15l705t2587r945b2671],
41	which	WDT	O	which	rel	46	SENT_184	[p15l967t2587r1185b2650],
42	antiamyloid	JJ	O	antiamyloid	amod	43	SENT_184	[p15l1211t2587r1639b2671],
43	interventions	NNS	O	intervention	nsubj	46	SENT_184	[p15l1664t2593r2140b2650],
44	might	MD	O	might	aux	46	SENT_184	[p15l8t2690r226b2774],
45	be	VB	O	be	cop	46	SENT_184	[p15l253t2690r336b2753],
46	effective	JJ	O	effective	rcmod	39	SENT_184	[p15l368t2690r691b2762],
47	,	,	O	,	_	0	SENT_184	[p15l368t2690r691b2762],
48	followed	VBN	O	follow	_	0	SENT_184	[p15l723t2690r1040b2753],
49	by	IN	O	by	prepc_followed_by	31	SENT_184	[p15l1067t2690r1156b2774],
50	a	DT	O	a	det	52	SENT_184	[p15l1183t2713r1218b2753],
51	dementia	NN	O	dementia	nn	52	SENT_184	[p15l1248t2690r1592b2753],
52	period	NN	O	period	pobj	31	SENT_184	[p15l1620t2690r1864b2773],
53	during	IN	O	during	_	0	SENT_184	[p15l1895t2690r2142b2774],
54	which	WDT	O	which	rel	59	SENT_184	[p15l7t2793r226b2856],
55	decreasing	VBG	O	decrease	csubj	59	SENT_184	[p15l253t2793r638b2877],
56	amyloid	NN	O	amyloid	nn	57	SENT_184	[p15l663t2793r954b2877],
57	production	NN	O	production	dobj	55	SENT_184	[p15l978t2793r1385b2876],
58	might	MD	O	might	aux	59	SENT_184	[p15l1411t2793r1624b2877],
59	have	VB	O	have	rcmod	52	SENT_184	[p15l1648t2793r1810b2856],
60	minimal	JJ	O	minimal	amod	61	SENT_184	[p15l1837t2793r2144b2856],
61	effect	NN	O	effect	dobj	59	SENT_184	[p15l9t2896r211b2959],
62	.	.	O	.	_	0	SENT_184	[p15l9t2896r211b2959],

1	The	DT	O	the	det	2	SENT_185	[p15l237t2896r363b2959],
2	validity	NN	O	validity	nsubj	6	SENT_185	[p15l383t2896r651b2980],
3	of	IN	O	of	_	0	SENT_185	[p15l671t2896r745b2959],
4	these	DT	O	these	det	5	SENT_185	[p15l757t2896r937b2959],
5	interpretations	NNS	O	interpretation	prep_of	2	SENT_185	[p15l960t2902r1481b2979],
6	requires	VBZ	O	require	_	0	SENT_185	[p15l1505t2902r1787b2979],
7	empirical	JJ	O	empirical	amod	8	SENT_185	[p15l1812t2896r2142b2979],
8	demonstration	NN	O	demonstration	dobj	6	SENT_185	[p15l9t2998r547b3061],
9	.	.	O	.	_	0	SENT_185	[p15l9t2998r547b3061],

1	Amyloid	JJ	O	amyloid	amod	2	SENT_186	[p15l81t3101r401b3185],
2	abnormalities	NNS	O	abnormality	nsubj	3	SENT_186	[p15l432t3101r937b3164],
3	have	VBP	O	have	_	0	SENT_186	[p15l968t3101r1133b3164],
4	value	NN	O	value	dobj	3	SENT_186	[p15l1162t3101r1355b3164],
5	for	IN	O	for	_	0	SENT_186	[p15l1386t3101r1490b3164],
6	diagnosis	NN	O	diagnosis	prep_for	4	SENT_186	[p15l1520t3101r1865b3185],
7	of	IN	O	of	_	0	SENT_186	[p15l1897t3101r1975b3164],
8	AD	NN	O	ad	prep_of	6	SENT_186	[p15l1995t3105r2140b3173],
9	;	:	O	;	_	0	SENT_186	[p15l1995t3105r2140b3173],
10	the	DT	O	the	det	11	SENT_186	[p15l8t3204r116b3267],
11	presence	NN	O	presence	nsubj	34	SENT_186	[p15l140t3226r446b3287],
12	of	IN	O	of	_	0	SENT_186	[p15l471t3204r546b3267],
13	low	JJ	O	low	amod	15	SENT_186	[p15l560t3204r687b3267],
14	CSF	NN	O	csf	nn	15	SENT_186	[p15l709t3208r849b3267],
15	AB	NNP	O	AB	prep_of	11	SENT_186	[p15l874t3202r979b3285],
16	or	CC	O	or	_	0	SENT_186	[p15l1004t3227r1077b3267],
17	positive	JJ	O	positive	amod	19	SENT_186	[p15l1099t3210r1374b3287],
18	amyloid	NN	O	amyloid	nn	19	SENT_186	[p15l1399t3204r1683b3288],
19	imaging	NN	O	imaging	conj_or	11	SENT_186	[p15l1706t3210r1993b3288],
20	in	IN	O	in	_	0	SENT_186	[p15l2016t3210r2084b3266],
21	a	DT	O	a	det	22	SENT_186	[p15l2109t3227r2144b3267],
22	patient	NN	O	patient	prep_in	19	SENT_186	[p16l7t33r246b110],
23	with	IN	O	with	_	0	SENT_186	[p16l264t27r417b90],
24	dementia	NN	O	dementia	prep_with	22	SENT_186	[p16l438t27r758b90],
25	and	CC	O	and	_	0	SENT_186	[p16l778t27r904b90],
26	no	DT	O	no	det	28	SENT_186	[p16l924t50r1009b90],
27	other	JJ	O	other	amod	28	SENT_186	[p16l1033t27r1213b90],
28	causes	NNS	O	cause	conj_and	22	SENT_186	[p16l1234t50r1448b90],
29	of	IN	O	of	_	0	SENT_186	[p16l1470t27r1544b90],
30	cognitive	JJ	O	cognitive	amod	31	SENT_186	[p16l1556t33r1867b111],
31	impairment	NN	O	impairment	prep_of	28	SENT_186	[p16l1889t33r2142b110, p16l8t142r182b193],
32	is	VBZ	O	be	cop	34	SENT_186	[p16l201t136r251b193],
33	strong	JJ	O	strong	amod	34	SENT_186	[p16l273t142r486b214],
34	evidence	NN	O	evidence	parataxis	3	SENT_186	[p16l505t130r799b193],
35	in	IN	O	in	_	0	SENT_186	[p16l820t136r886b192],
36	support	NN	O	support	prep_in	34	SENT_186	[p16l907t142r1169b213],
37	of	IN	O	of	_	0	SENT_186	[p16l1188t130r1261b193],
38	a	DT	O	a	det	39	SENT_186	[p16l1273t153r1307b193],
39	diagnosis	NN	O	diagnosis	prep_of	36	SENT_186	[p16l1327t130r1642b214],
40	of	IN	O	of	_	0	SENT_186	[p16l1663t130r1736b193],
41	AD	NN	O	ad	nn	42	SENT_186	[p16l1746t134r1862b192],
42	dementia	NN	O	dementia	prep_of	39	SENT_186	[p16l1886t130r2142b193, p16l7t239r97b296],
43	(	CD	NUMBER	(	num	42	SENT_186	[p16l124t233r393b316],
44	Figure	NNP	O	Figure	nsubj	46	SENT_186	[p16l124t233r393b316],
45	1	CD	NUMBER	1	num	44	SENT_186	[p16l422t240r451b295],
46	shows	VBZ	O	show	rcmod	34	SENT_186	[p16l482t233r696b296],
47	the	DT	O	the	det	48	SENT_186	[p16l720t233r830b296],
48	relationship	NN	O	relationship	dobj	46	SENT_186	[p16l856t233r1279b316],
49	of	IN	O	of	_	0	SENT_186	[p16l1306t233r1382b296],
50	AB	NNP	O	AB	nn	51	SENT_186	[p16l1396t231r1502b314],
51	biology	NN	O	biology	prep_of	48	SENT_186	[p16l1525t233r1795b317],
52	to	TO	O	to	_	0	SENT_186	[p16l1815t245r1883b296],
53	plaque	NN	O	plaque	nn	55	SENT_186	[p16l1908t233r2145b316],
54	deposition	NN	O	deposition	nn	55	SENT_186	[p16l9t336r430b419],
55	)	NN	O	)	prep_to	46	SENT_186	[p16l9t336r430b419],
56	.	.	O	.	_	0	SENT_186	[p16l9t336r430b419],

1	Similarly	RB	O	similarly	advmod	27	SENT_187	[p16l458t336r785b420],
2	,	,	O	,	_	0	SENT_187	[p16l458t336r785b420],
3	these	DT	O	these	det	4	SENT_187	[p16l809t336r990b399],
4	ﬁndings	NNS	O	ﬁndings	nsubj	27	SENT_187	[p16l1014t336r1298b420],
5	in	IN	O	in	_	0	SENT_187	[p16l1322t342r1391b398],
6	a	DT	O	a	det	7	SENT_187	[p16l1416t359r1450b399],
7	patient	NN	O	patient	prep_in	4	SENT_187	[p16l1472t342r1718b419],
8	with	IN	O	with	_	0	SENT_187	[p16l1739t336r1896b399],
9	cognitive	JJ	O	cognitive	amod	10	SENT_187	[p16l1920t342r2142b420, p16l7t445r133b502],
10	impairment	NN	O	impairment	prep_with	7	SENT_187	[p16l157t445r591b522],
11	,	,	O	,	_	0	SENT_187	[p16l157t445r591b522],
12	intact	JJ	O	intact	amod	13	SENT_187	[p16l617t445r816b502],
13	activities	NNS	O	activity	conj_and	7	SENT_187	[p16l840t445r1148b502],
14	of	IN	O	of	_	0	SENT_187	[p16l1173t439r1248b502],
15	daily	JJ	SET	daily	amod	16	SENT_187	[p16l1263t439r1434b523],
16	living	NN	O	living	prep_of	13	SENT_187	[p16l1453t439r1669b523],
17	,	,	O	,	_	0	SENT_187	[p16l1453t439r1669b523],
18	and	CC	O	and	_	0	SENT_187	[p16l1696t439r1824b502],
19	no	DT	O	no	det	21	SENT_187	[p16l1847t462r1934b502],
20	other	JJ	O	other	amod	21	SENT_187	[p16l1960t439r2146b502],
21	cause	NN	O	cause	prep_in	4	SENT_187	[p16l9t565r195b605],
22	of	IN	O	of	_	0	SENT_187	[p16l220t542r294b605],
23	cognitive	JJ	O	cognitive	amod	24	SENT_187	[p16l309t548r627b626],
24	decline	NN	O	decline	prep_of	21	SENT_187	[p16l651t542r898b605],
25	would	MD	O	would	aux	27	SENT_187	[p16l920t542r1138b605],
26	strongly	RB	O	strongly	advmod	27	SENT_187	[p16l1162t542r1446b626],
27	support	VB	O	support	_	0	SENT_187	[p16l1468t554r1737b625],
28	a	DT	O	a	det	29	SENT_187	[p16l1761t565r1795b605],
29	diagnosis	NN	O	diagnosis	dobj	27	SENT_187	[p16l1819t542r2144b626],
30	of	IN	O	of	_	0	SENT_187	[p16l9t644r83b707],
31	prodromal	JJ	O	prodromal	amod	32	SENT_187	[p16l94t644r466b727],
32	AD	NN	O	ad	prep_of	29	SENT_187	[p16l486t636r683b707],
33	.31	CD	NUMBER	.31	num	32	SENT_187	[p16l486t636r683b707],
34	The	DT	O	the	det	35	SENT_187	[p16l708t644r834b707],
35	role	NN	O	role	nsubj	46	SENT_187	[p16l856t644r986b707],
36	of	IN	O	of	_	0	SENT_187	[p16l1009t644r1083b707],
37	these	DT	O	these	det	38	SENT_187	[p16l1094t644r1272b707],
38	measures	NNS	O	measure	prep_of	35	SENT_187	[p16l1293t667r1614b707],
39	as	IN	O	as	_	0	SENT_187	[p16l1637t667r1702b707],
40	outcomes	NNS	O	outcome	prep_as	38	SENT_187	[p16l1725t656r2055b707],
41	in	IN	O	in	_	0	SENT_187	[p16l2078t650r2145b706],
42	clinical	JJ	O	clinical	amod	43	SENT_187	[p16l9t747r250b810],
43	trials	NNS	O	trial	prep_in	40	SENT_187	[p16l269t747r438b810],
44	is	VBZ	O	be	cop	46	SENT_187	[p16l459t753r509b810],
45	less	RBR	O	less	advmod	46	SENT_187	[p16l528t747r645b810],
46	clear	JJ	O	clear	rcmod	32	SENT_187	[p16l667t747r836b810],
47	.	.	O	.	_	0	SENT_187	[p16l667t747r836b810],

1	CSF	NN	O	csf	nsubjpass	6	SENT_188	[p16l860t751r995b811],
2	AB	NNP	O	AB	nn	3	SENT_188	[p16l1016t745r1117b828],
3	monomers	NNS	O	monomer	dep	1	SENT_188	[p16l1139t770r1503b810],
4	are	VBP	O	be	auxpass	6	SENT_188	[p16l1526t770r1624b810],
5	not	RB	O	not	neg	6	SENT_188	[p16l1644t759r1757b810],
6	considered	VBN	O	consider	_	0	SENT_188	[p16l1777t747r2145b810],
7	toxic	JJ	O	toxic	acomp	6	SENT_188	[p16l7t856r193b922],
8	,	,	O	,	_	0	SENT_188	[p16l7t856r193b922],
9	and	CC	O	and	_	0	SENT_188	[p16l217t850r344b913],
10	ﬁbrillar	NN	O	ﬁbrillar	nn	11	SENT_188	[p16l364t850r624b913],
11	amyloid	NN	O	amyloid	nsubj	18	SENT_188	[p16l645t850r923b934],
12	deposited	VBN	O	deposit	partmod	11	SENT_188	[p16l944t850r1279b933],
13	in	IN	O	in	_	0	SENT_188	[p16l1300t856r1366b912],
14	plaques	NNS	O	plaque	prep_in	12	SENT_188	[p16l1387t850r1648b933],
15	may	MD	O	may	aux	18	SENT_188	[p16l1670t873r1818b934],
16	also	RB	O	also	advmod	18	SENT_188	[p16l1836t850r1968b913],
17	have	VB	O	have	aux	18	SENT_188	[p16l1990t850r2146b913],
18	limited	VBN	O	limit	conj_and	6	SENT_188	[p16l7t953r255b1016],
19	toxicity	NN	O	toxicity	dobj	18	SENT_188	[p16l276t959r554b1037],
20	;	:	O	;	_	0	SENT_188	[p16l276t959r554b1037],
21	most	RBS	O	most	advmod	22	SENT_188	[p16l579t965r750b1016],
22	studies	NNS	O	study	nsubj	23	SENT_188	[p16l773t953r1010b1016],
23	point	VBP	O	point	conj_and	6	SENT_188	[p16l1032t959r1217b1036],
24	toward	IN	O	toward	_	0	SENT_188	[p16l1237t953r1479b1016],
25	amyloid	NN	O	amyloid	nn	26	SENT_188	[p16l1502t953r1781b1037],
26	oligomers	NNS	O	oligomer	prep_toward	23	SENT_188	[p16l1804t953r2144b1037],
27	as	IN	O	as	_	0	SENT_188	[p16l9t1079r74b1119],
28	the	DT	O	the	det	31	SENT_188	[p16l97t1056r204b1119],
29	most	RBS	O	most	advmod	30	SENT_188	[p16l227t1068r399b1119],
30	neurotoxic	JJ	O	neurotoxic	amod	31	SENT_188	[p16l421t1062r794b1119],
31	form	NN	O	form	prep_as	23	SENT_188	[p16l817t1056r986b1119],
32	of	IN	O	of	_	0	SENT_188	[p16l1010t1056r1085b1119],
33	the	DT	O	the	det	34	SENT_188	[p16l1097t1056r1204b1119],
34	peptide	NN	O	peptide	prep_of	31	SENT_188	[p16l1227t1056r1504b1139],
35	,	,	O	,	_	0	SENT_188	[p16l1227t1056r1504b1139],
36	and	CC	O	and	_	0	SENT_188	[p16l1531t1056r1658b1119],
37	this	DT	O	this	det	38	SENT_188	[p16l1679t1056r1804b1119],
38	species	NNS	O	species	nsubjpass	41	SENT_188	[p16l1830t1062r2070b1139],
39	is	VBZ	O	be	auxpass	41	SENT_188	[p16l2094t1062r2144b1119],
40	not	RB	O	not	neg	41	SENT_188	[p16l8t1171r122b1222],
41	measured	VBN	O	measure	conj_and	6	SENT_188	[p16l142t1159r477b1222],
42	by	IN	O	by	_	0	SENT_188	[p16l495t1159r578b1243],
43	the	DT	O	the	det	44	SENT_188	[p16l595t1159r702b1222],
44	two	CD	NUMBER	two	agent	41	SENT_188	[p16l722t1171r847b1222],
45	commonly	RB	O	commonly	advmod	46	SENT_188	[p16l871t1159r1243b1243],
46	used	VBN	O	use	partmod	44	SENT_188	[p16l1261t1159r1419b1222],
47	amyloid	NN	O	amyloid	nn	48	SENT_188	[p16l1440t1159r1717b1243],
48	biomarkers	NNS	O	biomarker	dobj	46	SENT_188	[p16l1735t1159r2142b1222],
49	.	.	O	.	_	0	SENT_188	[p16l1735t1159r2142b1222],

1	Alterations	NNS	O	alteration	nsubj	7	SENT_189	[p16l7t1262r391b1325],
2	of	IN	O	of	_	0	SENT_189	[p16l414t1262r489b1325],
3	these	DT	O	these	prep_of	1	SENT_189	[p16l499t1262r677b1325],
4	might	MD	O	might	aux	7	SENT_189	[p16l698t1262r904b1346],
5	not	RB	O	not	neg	7	SENT_189	[p16l924t1274r1039b1325],
6	be	VB	O	be	cop	7	SENT_189	[p16l1057t1262r1137b1325],
7	relevant	JJ	O	relevant	_	0	SENT_189	[p16l1159t1262r1435b1325],
8	to	TO	O	to	_	0	SENT_189	[p16l1454t1274r1521b1325],
9	disease	NN	O	disease	nn	10	SENT_189	[p16l1544t1262r1787b1325],
10	modiﬁcation	NN	O	modiﬁcation	prep_to	7	SENT_189	[p16l1809t1262r2141b1325, p16l7t1371r163b1428],
11	.	.	O	.	_	0	SENT_189	[p16l1809t1262r2141b1325, p16l7t1371r163b1428],

1	One	CD	NUMBER	one	num	2	SENT_190	[p16l189t1369r332b1428],
2	study	NN	O	study	nsubj	3	SENT_190	[p16l355t1365r543b1449],
3	showed	VBD	O	show	_	0	SENT_190	[p16l562t1365r821b1428],
4	reduction	NN	O	reduction	dobj	3	SENT_190	[p16l843t1365r1178b1428],
5	in	IN	O	in	_	0	SENT_190	[p16l1200t1371r1266b1427],
6	cortical	JJ	O	cortical	amod	8	SENT_190	[p16l1288t1365r1547b1428],
7	AB	NNP	O	AB	nn	8	SENT_190	[p16l1567t1363r1671b1446],
8	levels	NNS	O	level	prep_in	3	SENT_190	[p16l1692t1365r1879b1428],
9	following	VBG	O	follow	_	0	SENT_190	[p16l1901t1365r2142b1428, p16l9t1474r119b1552],
10	treatment	NN	O	treatment	prep_following	3	SENT_190	[p16l141t1480r487b1531],
11	with	IN	O	with	_	0	SENT_190	[p16l508t1468r665b1531],
12	the	DT	O	the	det	15	SENT_190	[p16l688t1468r797b1531],
13	monoclonal	JJ	O	monoclonal	amod	15	SENT_190	[p16l821t1468r1244b1531],
14	antibody	NN	O	antibody	nn	15	SENT_190	[p16l1268t1468r1583b1552],
15	bapineuzumab	NN	O	bapineuzumab	prep_with	10	SENT_190	[p16l1602t1468r2143b1551],
16	,	,	O	,	_	0	SENT_190	[p16l1602t1468r2143b1551],
17	and	CC	O	and	_	0	SENT_190	[p16l9t1571r136b1634],
18	there	EX	O	there	expl	19	SENT_190	[p16l158t1571r334b1634],
19	was	VBD	O	be	conj_and	3	SENT_190	[p16l356t1594r483b1634],
20	no	DT	O	no	det	22	SENT_190	[p16l507t1594r593b1634],
21	corresponding	JJ	O	corresponding	amod	22	SENT_190	[p16l619t1571r1125b1655],
22	improvement	NN	O	improvement	nsubj	19	SENT_190	[p16l1147t1577r1615b1654],
23	in	IN	O	in	_	0	SENT_190	[p16l1638t1577r1705b1633],
24	cognition	NN	O	cognition	prep_in	22	SENT_190	[p16l1729t1563r2141b1655],
25	.	.	O	.	_	0	SENT_190	[p16l1729t1563r2141b1655],

1	“	NN	O	“	nsubj	3	SENT_191	[p16l1729t1563r2141b1655],
2	This	DT	O	this	dep	1	SENT_191	[p16l8t1674r152b1737],
3	suggests	VBZ	O	suggest	_	0	SENT_191	[p16l175t1686r457b1758],
4	that	IN	O	that	complm	15	SENT_191	[p16l477t1674r613b1737],
5	plaque	NN	O	plaque	nn	6	SENT_191	[p16l632t1674r862b1757],
6	removal	NN	O	removal	nsubj	15	SENT_191	[p16l884t1674r1164b1737],
7	by	IN	O	by	_	0	SENT_191	[p16l1183t1674r1267b1758],
8	itself	PRP	O	itself	prep_by	6	SENT_191	[p16l1285t1674r1458b1737],
9	may	MD	O	may	aux	15	SENT_191	[p16l1470t1697r1617b1758],
10	not	RB	O	not	neg	15	SENT_191	[p16l1635t1686r1749b1737],
11	be	VB	O	be	cop	15	SENT_191	[p16l1768t1674r1847b1737],
12	a	DT	O	a	det	15	SENT_191	[p16l1870t1697r1904b1737],
13	meaningful	JJ	O	meaningful	amod	15	SENT_191	[p16l1924t1697r2142b1737, p16l8t1777r208b1861],
14	therapeutic	JJ	O	therapeutic	amod	15	SENT_191	[p16l227t1777r614b1860],
15	outcome	NN	O	outcome	ccomp	3	SENT_191	[p16l635t1789r928b1840],
16	in	IN	O	in	_	0	SENT_191	[p16l949t1783r1015b1839],
17	AD	NN	O	ad	prep_in	15	SENT_191	[p16l1035t1781r1167b1840],
18	.	.	O	.	_	0	SENT_191	[p16l1035t1781r1167b1840],

1	Measures	NNS	O	measure	nsubj	11	SENT_192	[p16l1190t1782r1509b1840],
2	of	IN	O	of	_	0	SENT_192	[p16l1531t1777r1604b1840],
3	neuronal	JJ	O	neuronal	amod	4	SENT_192	[p16l1615t1777r1920b1840],
4	injury	NN	O	injury	prep_of	1	SENT_192	[p16l1940t1783r2149b1861],
5	or	CC	O	or	_	0	SENT_192	[p16l9t1903r81b1943],
6	loss	NN	O	loss	prep_of	1	SENT_192	[p16l101t1880r228b1943],
7	may	MD	O	may	aux	11	SENT_192	[p16l251t1903r399b1964],
8	be	VB	O	be	cop	11	SENT_192	[p16l415t1880r495b1943],
9	more	RBR	O	more	advmod	10	SENT_192	[p16l518t1903r696b1943],
10	direct	JJ	O	direct	amod	11	SENT_192	[p16l720t1880r919b1943],
11	measures	NNS	O	measure	_	0	SENT_192	[p16l940t1903r1261b1943],
12	of	IN	O	of	_	0	SENT_192	[p16l1285t1880r1359b1943],
13	disease	NN	O	disease	nn	14	SENT_192	[p16l1372t1880r1615b1943],
14	modiﬁcation	NN	O	modiﬁcation	prep_of	11	SENT_192	[p16l1638t1880r2100b1943],
15	.	.	O	.	_	0	SENT_192	[p16l1638t1880r2100b1943],

1	Tau	NN	O	tau	nn	2	SENT_193	[p16l7t2095r127b2150],
2	measures	NNS	O	measure	_	0	SENT_193	[p16l148t2109r478b2150],

1	Spinal	JJ	O	spinal	amod	3	SENT_194	[p16l9t2190r224b2273],
2	ﬂuid	NN	O	ﬂuid	nn	3	SENT_194	[p16l248t2190r408b2253],
3	measures	NNS	O	measure	_	0	SENT_194	[p16l431t2213r755b2253],
4	of	IN	O	of	_	0	SENT_194	[p16l781t2190r855b2253],
5	tau	NN	O	tau	prep_of	3	SENT_194	[p16l869t2202r978b2253],
6	and	CC	O	and	_	0	SENT_194	[p16l1002t2190r1130b2253],
7	p	NN	O	p	nn	10	SENT_194	[p16l1153t2202r1340b2273],
8	—	CD	NUMBER	—	num	10	SENT_194	[p16l1153t2202r1340b2273],
9	tau	NN	O	tau	nn	10	SENT_194	[p16l1153t2202r1340b2273],
10	increase	NN	O	increase	prep_of	3	SENT_194	[p16l1364t2196r1648b2253],
11	with	IN	O	with	_	0	SENT_194	[p16l1670t2190r1826b2253],
12	AD	NN	O	ad	nn	13	SENT_194	[p16l1849t2194r1968b2252],
13	progression	NN	O	progression	prep_with	3	SENT_194	[p16l1994t2212r2141b2273, p16l8t2299r321b2377],
14	.	.	O	.	_	0	SENT_194	[p16l1994t2212r2141b2273, p16l8t2299r321b2377],

1	Total	JJ	O	total	amod	2	SENT_195	[p16l349t2293r529b2356],
2	tau	NN	O	tau	nsubjpass	4	SENT_195	[p16l553t2305r664b2356],
3	is	VBZ	O	be	auxpass	4	SENT_195	[p16l689t2299r741b2356],
4	thought	VBN	O	think	_	0	SENT_195	[p16l766t2293r1050b2377],
5	to	TO	O	to	aux	6	SENT_195	[p16l1073t2305r1141b2356],
6	reﬂect	VB	O	reﬂect	xcomp	4	SENT_195	[p16l1168t2293r1389b2356],
7	neuronal	JJ	O	neuronal	amod	8	SENT_195	[p16l1413t2293r1735b2356],
8	injury	NN	O	injury	dobj	6	SENT_195	[p16l1760t2299r1989b2377],
9	,	,	O	,	_	0	SENT_195	[p16l1760t2299r1989b2377],
10	and	CC	O	and	_	0	SENT_195	[p16l2017t2293r2147b2356],
11	p	NN	O	p	nsubjpass	15	SENT_195	[p16l7t2408r200b2479],
12	—	CD	NUMBER	—	num	13	SENT_195	[p16l7t2408r200b2479],
13	tau	NN	O	tau	dep	11	SENT_195	[p16l7t2408r200b2479],
14	is	VBZ	O	be	auxpass	15	SENT_195	[p16l225t2402r277b2459],
15	hypothesized	VBN	O	hypothesize	conj_and	4	SENT_195	[p16l303t2396r783b2480],
16	to	TO	O	to	aux	17	SENT_195	[p16l807t2408r875b2459],
17	reﬂect	VB	O	reﬂect	xcomp	15	SENT_195	[p16l903t2396r1126b2459],
18	a	DT	O	a	det	21	SENT_195	[p16l1152t2419r1187b2459],
19	more	RBR	O	more	advmod	20	SENT_195	[p16l1211t2419r1396b2459],
20	speciﬁc	JJ	O	speciﬁc	amod	21	SENT_195	[p16l1424t2396r1690b2479],
21	relationship	NN	O	relationship	dobj	17	SENT_195	[p16l1716t2396r2145b2479],
22	with	IN	O	with	_	0	SENT_195	[p16l7t2499r158b2562],
23	neuroﬁbrillary	JJ	O	neuroﬁbrillary	amod	24	SENT_195	[p16l179t2499r681b2583],
24	tangles	NNS	O	tangle	prep_with	17	SENT_195	[p16l698t2499r935b2583],
25	composed	VBN	O	compose	partmod	24	SENT_195	[p16l958t2499r1306b2582],
26	of	IN	O	of	_	0	SENT_195	[p16l1327t2499r1400b2562],
27	hyperphosphorylated	VBN	O	hyperphosphorylate	prepc_of	25	SENT_195	[p16l1411t2499r2146b2583],
28	tau	NN	O	tau	dobj	27	SENT_195	[p16l7t2593r202b2664],
29	.62	CD	NUMBER	.62	num	32	SENT_195	[p16l7t2593r202b2664],
30	Total	JJ	O	total	amod	32	SENT_195	[p16l228t2601r407b2664],
31	tau	NN	O	tau	nn	32	SENT_195	[p16l431t2613r541b2664],
32	elevation	NN	O	elevation	nsubj	35	SENT_195	[p16l566t2601r888b2664],
33	is	VBZ	O	be	cop	35	SENT_195	[p16l913t2607r965b2664],
34	not	RB	O	not	neg	35	SENT_195	[p16l991t2613r1109b2664],
35	speciﬁc	JJ	O	speciﬁc	rcmod	28	SENT_195	[p16l1134t2601r1397b2684],
36	to	TO	O	to	_	0	SENT_195	[p16l1421t2613r1489b2664],
37	AD	NN	O	ad	prep_to	35	SENT_195	[p16l1514t2605r1635b2663],
38	and	CC	O	and	_	0	SENT_195	[p16l1663t2601r1794b2664],
39	occurs	VBZ	O	occur	rcmod	28	SENT_195	[p16l1818t2624r2050b2664],
40	in	IN	O	in	_	0	SENT_195	[p16l2076t2607r2145b2663],
41	traumatic	JJ	O	traumatic	amod	43	SENT_195	[p16l7t2710r346b2767],
42	brain	NN	O	brain	nn	43	SENT_195	[p16l366t2704r550b2767],
43	injury	NN	O	injury	prep_in	39	SENT_195	[p16l572t2710r795b2788],
44	,	,	O	,	_	0	SENT_195	[p16l572t2710r795b2788],
45	stroke	NN	O	stroke	prep_in	39	SENT_195	[p16l820t2704r1049b2776],
46	,	,	O	,	_	0	SENT_195	[p16l820t2704r1049b2776],
47	and	CC	O	and	_	0	SENT_195	[p16l1074t2704r1201b2767],
48	Creutzfeldt	NNP	O	Creutzfeldt	prep_in	39	SENT_195	[p16l1224t2704r1857b2780],
49	—	CD	NUMBER	—	number	50	SENT_195	[p16l1224t2704r1857b2780],
50	]	CD	NUMBER	]	num	52	SENT_195	[p16l1224t2704r1857b2780],
51	akob	NN	O	akob	nn	52	SENT_195	[p16l1224t2704r1857b2780],
52	disease	NN	O	disease	dobj	39	SENT_195	[p16l1881t2704r2145b2776],
53	,	,	O	,	_	0	SENT_195	[p16l1881t2704r2145b2776],
54	in	IN	O	in	_	0	SENT_195	[p16l8t2812r75b2868],
55	addition	NN	O	addition	_	0	SENT_195	[p16l97t2806r384b2869],
56	to	TO	O	to	_	0	SENT_195	[p16l405t2818r470b2869],
57	AD	NN	O	ad	prep_in_addition_to	27	SENT_195	[p16l492t2810r625b2869],
58	.	.	O	.	_	0	SENT_195	[p16l492t2810r625b2869],

1	P-tau	NN	O	p-tau	nsubjpass	3	SENT_196	[p16l651t2811r831b2869],
2	is	VBZ	O	be	auxpass	3	SENT_196	[p16l852t2812r902b2869],
3	correlated	VBN	O	correlate	_	0	SENT_196	[p16l925t2806r1269b2869],
4	with	IN	O	with	_	0	SENT_196	[p16l1288t2806r1440b2869],
5	neocortical	JJ	O	neocortical	amod	6	SENT_196	[p16l1461t2806r1848b2869],
6	neuroﬁbrillary	NN	O	neuroﬁbrillary	prep_with	3	SENT_196	[p16l1868t2806r2142b2869, p16l6t2909r262b2993],

1	tangle	NN	O	tangle	nn	2	SENT_197	[p16l279t2909r485b2993],
2	burden	NN	O	burden	nsubj	4	SENT_197	[p16l504t2909r750b2972],
3	and	CC	O	and	dep	4	SENT_197	[p16l772t2909r897b2972],
4	with	IN	O	with	_	0	SENT_197	[p16l916t2909r1067b2972],
5	faster	JJR	O	faster	amod	6	SENT_197	[p16l1088t2909r1274b2972],
6	progression	NN	O	progression	pobj	4	SENT_197	[p16l1293t2915r1693b2993],
7	from	IN	O	from	_	0	SENT_197	[p16l1714t2909r1880b2972],
8	MCI	NNP	ORGANIZATION	MCI	prep_from	6	SENT_197	[p16l1901t2913r2058b2972],
9	to	TO	O	to	_	0	SENT_197	[p16l2079t2921r2144b2972],
10	AD	NN	O	ad	nn	11	SENT_197	[p16l7t3015r127b3073],
11	dementia	NN	O	dementia	prep_to	4	SENT_197	[p16l154t3003r565b3074],
12	.	.	O	.	_	0	SENT_197	[p16l154t3003r565b3074],

1	“	NN	O	“	nsubj	2	SENT_198	[p16l154t3003r565b3074],
2	Lowered	VBD	O	lower	dep	9	SENT_198	[p16l592t3011r895b3074],
3	levels	NNS	O	level	dobj	2	SENT_198	[p16l917t3011r1108b3074],
4	of	IN	O	of	_	0	SENT_198	[p16l1133t3011r1208b3074],
5	CSF	NN	ORGANIZATION	csf	nn	6	SENT_198	[p16l1225t3015r1364b3075],
6	AB	NNP	ORGANIZATION	AB	prep_of	3	SENT_198	[p16l1389t3009r1494b3092],
7	are	VBP	O	be	auxpass	9	SENT_198	[p16l1520t3034r1623b3074],
8	not	RB	O	not	neg	9	SENT_198	[p16l1647t3023r1764b3074],
9	associated	VBN	O	associate	_	0	SENT_198	[p16l1788t3011r2146b3074],
10	with	IN	O	with	_	0	SENT_198	[p17l7t18r167b81],
11	cognitive	JJ	O	cognitive	amod	12	SENT_198	[p17l195t24r525b102],
12	decline	NN	O	decline	prep_with	9	SENT_198	[p17l553t18r810b81],
13	unless	IN	O	unless	mark	17	SENT_198	[p17l837t18r1061b81],
14	the	DT	O	the	det	15	SENT_198	[p17l1087t18r1199b81],
15	decline	NN	O	decline	nsubjpass	17	SENT_198	[p17l1227t18r1484b81],
16	is	VBZ	O	be	auxpass	17	SENT_198	[p17l1511t24r1564b81],
17	associated	VBN	O	associate	advcl	9	SENT_198	[p17l1592t18r1961b81],
18	with	IN	O	with	_	0	SENT_198	[p17l1985t18r2146b81],
19	elevated	JJ	O	elevated	amod	22	SENT_198	[p17l9t120r292b183],
20	p	NN	O	p	nn	22	SENT_198	[p17l313t112r584b203],
21	—	CD	NUMBER	—	num	22	SENT_198	[p17l313t112r584b203],
22	tau	NN	O	tau	prep_with	17	SENT_198	[p17l313t112r584b203],
23	.64	CD	NUMBER	.64	nsubjpass	9	SENT_198	[p17l313t112r584b203],

1	These	DT	O	these	det	2	SENT_199	[p17l82t223r281b286],
2	observations	NNS	O	observation	nsubj	3	SENT_199	[p17l307t223r756b286],
3	indicate	VBP	O	indicate	_	0	SENT_199	[p17l781t223r1061b286],
4	that	IN	O	that	complm	9	SENT_199	[p17l1084t223r1222b286],
5	tau	NN	O	tau	nn	8	SENT_199	[p17l1245t235r1355b286],
6	and	CC	O	and	_	0	SENT_199	[p17l1379t223r1509b286],
7	p-tau	NN	O	p-tau	nn	8	SENT_199	[p17l1532t235r1721b306],
8	levels	NNS	O	level	nsubj	9	SENT_199	[p17l1743t223r1935b286],
9	comprise	VBP	O	comprise	ccomp	3	SENT_199	[p17l1961t246r2142b286, p17l7t332r181b409],
10	evidence	NN	O	evidence	dobj	9	SENT_199	[p17l208t326r521b389],
11	of	IN	O	of	_	0	SENT_199	[p17l549t326r625b389],
12	brain	NN	O	brain	nn	13	SENT_199	[p17l639t326r828b389],
13	injury	NN	O	injury	prep_of	10	SENT_199	[p17l855t332r1075b410],
14	or	CC	O	or	_	0	SENT_199	[p17l1098t349r1173b389],
15	neurodegeneration	NN	O	neurodegeneration	prep_of	10	SENT_199	[p17l1198t326r1881b410],
16	in	IN	O	in	_	0	SENT_199	[p17l1909t332r1977b388],
17	AD	NN	O	ad	prep_in	9	SENT_199	[p17l2003t330r2142b389],
18	.	.	O	.	_	0	SENT_199	[p17l2003t330r2142b389],

1	They	PRP	O	they	nsubj	3	SENT_200	[p17l8t429r174b513],
2	might	MD	O	might	aux	3	SENT_200	[p17l191t429r391b513],
3	function	VB	O	function	_	0	SENT_200	[p17l409t429r697b492],
4	as	IN	O	as	_	0	SENT_200	[p17l717t452r780b492],
5	“	NN	O	“	prep_as	3	SENT_200	[p17l802t429r1270b492],
6	downstream	JJ	O	downstream	amod	8	SENT_200	[p17l802t429r1270b492],
7	”	NN	O	”	nn	8	SENT_200	[p17l802t429r1270b492],
8	markers	NNS	O	marker	dobj	3	SENT_200	[p17l1291t429r1563b492],
9	for	IN	O	for	_	0	SENT_200	[p17l1584t429r1680b492],
10	interventions	NNS	O	intervention	prep_for	8	SENT_200	[p17l1698t435r2144b492],
11	successfully	RB	O	successfully	advmod	12	SENT_200	[p17l9t532r413b616],
12	affecting	VBG	O	affect	partmod	10	SENT_200	[p17l430t532r723b616],
13	temporally	RB	O	temporally	advmod	14	SENT_200	[p17l741t532r1115b616],
14	antecedent	JJ	O	antecedent	amod	15	SENT_200	[p17l1133t532r1502b595],
15	factors	NNS	O	factor	dobj	12	SENT_200	[p17l1522t532r1749b595],
16	or	CC	O	or	_	0	SENT_200	[p17l1771t555r1843b595],
17	as	IN	O	as	amod	26	SENT_200	[p17l1863t555r1927b595],
18	direct	JJ	O	direct	amod	19	SENT_200	[p17l1949t532r2145b595],
19	markers	NNS	O	marker	dep	17	SENT_200	[p17l8t635r285b698],
20	for	IN	O	for	_	0	SENT_200	[p17l308t635r405b698],
21	tau	FW	O	tau	nn	22	SENT_200	[p17l424t635r797b698],
22	—	FW	O	—	prep_for	19	SENT_200	[p17l424t635r797b698],
23	related	JJ	O	related	amod	22	SENT_200	[p17l424t635r797b698],
24	or	CC	O	or	_	0	SENT_200	[p17l818t658r890b698],
25	neuroprotective	JJ	O	neuroprotective	amod	22	SENT_200	[p17l910t641r1454b718],
26	therapies	NNS	O	therapy	dobj	12	SENT_200	[p17l1475t635r1803b718],
27	.	.	O	.	_	0	SENT_200	[p17l1475t635r1803b718],

1	A	DT	O	a	det	2	SENT_201	[p17l81t742r138b800],
2	challenge	NN	O	challenge	nsubj	9	SENT_201	[p17l159t738r477b822],
3	in	IN	O	in	_	0	SENT_201	[p17l498t744r564b800],
4	the	DT	O	the	det	5	SENT_201	[p17l583t738r689b801],
5	use	NN	O	use	prep_in	2	SENT_201	[p17l710t761r820b801],
6	of	IN	O	of	_	0	SENT_201	[p17l842t738r915b801],
7	tau	FW	O	tau	nn	8	SENT_201	[p17l925t738r1296b801],
8	—	FW	O	—	prep_of	5	SENT_201	[p17l925t738r1296b801],
9	related	JJ	O	related	_	0	SENT_201	[p17l925t738r1296b801],
10	CSF	NN	O	csf	nn	11	SENT_201	[p17l1316t742r1453b801],
11	measures	NNS	O	measure	dobj	9	SENT_201	[p17l1474t761r1791b801],
12	in	IN	O	in	_	0	SENT_201	[p17l1812t744r1878b800],
13	clinical	JJ	O	clinical	amod	14	SENT_201	[p17l1899t738r2143b801],
14	trials	NNS	O	trial	prep_in	11	SENT_201	[p17l7t841r181b904],
15	and	CC	O	and	_	0	SENT_201	[p17l205t841r333b904],
16	in	IN	O	in	_	0	SENT_201	[p17l356t847r423b903],
17	following	VBG	O	follow	conj_and	14	SENT_201	[p17l446t841r774b925],
18	the	DT	O	the	det	20	SENT_201	[p17l794t841r902b904],
19	natural	JJ	O	natural	amod	20	SENT_201	[p17l925t841r1173b904],
20	history	NN	O	history	nsubj	25	SENT_201	[p17l1194t841r1442b925],
21	of	IN	O	of	_	0	SENT_201	[p17l1463t841r1537b904],
22	AD	NN	O	ad	prep_of	20	SENT_201	[p17l1550t845r1669b903],
23	is	VBZ	O	be	cop	25	SENT_201	[p17l1695t847r1745b904],
24	the	DT	O	the	det	25	SENT_201	[p17l1768t841r1876b904],
25	level	NN	O	level	ccomp	17	SENT_201	[p17l1898t841r2056b904],
26	of	IN	O	of	_	0	SENT_201	[p17l2079t841r2153b904],
27	inter	NN	O	inter	prep_of	25	SENT_201	[p17l8t949r189b1006],
28	-	:	O	-	_	0	SENT_201	[p17l8t949r189b1006],
29	and	CC	O	and	_	0	SENT_201	[p17l212t943r335b1006],
30	intralaboratory	JJ	O	intralaboratory	amod	31	SENT_201	[p17l355t943r866b1027],
31	variability	NN	O	variability	dobj	9	SENT_201	[p17l879t943r1220b1027],
32	in	IN	O	in	_	0	SENT_201	[p17l1236t949r1301b1005],
33	these	DT	O	these	det	34	SENT_201	[p17l1320t943r1492b1006],
34	measures	NNS	O	measure	prep_in	31	SENT_201	[p17l1511t935r1902b1006],
35	.	.	O	.	_	0	SENT_201	[p17l1511t935r1902b1006],

1	“	NN	O	“	nn	2	SENT_202	[p17l1511t935r1902b1006],
2	Efforts	NNS	O	effort	nsubjpass	11	SENT_202	[p17l1923t943r2144b1006],
3	to	TO	O	to	aux	4	SENT_202	[p17l7t1058r73b1109],
4	establish	VB	O	establish	infmod	2	SENT_202	[p17l96t1046r390b1109],
5	standards	NNS	O	standard	dobj	4	SENT_202	[p17l413t1046r740b1109],
6	for	IN	O	for	_	0	SENT_202	[p17l763t1046r860b1109],
7	reliable	JJ	O	reliable	amod	8	SENT_202	[p17l881t1046r1128b1109],
8	assays	NNS	O	assay	prep_for	5	SENT_202	[p17l1151t1069r1355b1130],
9	are	VBP	O	be	aux	11	SENT_202	[p17l1378t1069r1478b1109],
10	being	VBG	O	be	auxpass	11	SENT_202	[p17l1498t1046r1689b1130],
11	pursued	VBN	O	pursue	_	0	SENT_202	[p17l1708t1046r2003b1129],
12	.	.	O	.	_	0	SENT_202	[p17l1708t1046r2003b1129],

1	Tau	NN	O	tau	nn	2	SENT_203	[p17l82t1152r207b1212],
2	imaging	NN	O	imaging	nsubj	4	SENT_203	[p17l229t1155r512b1233],
3	would	MD	O	would	aux	4	SENT_203	[p17l531t1149r747b1212],
4	provide	VB	O	provide	_	0	SENT_203	[p17l768t1149r1031b1232],
5	an	DT	O	a	det	7	SENT_203	[p17l1054t1172r1135b1212],
6	important	JJ	O	important	amod	7	SENT_203	[p17l1158t1155r1508b1232],
7	alternative	NN	O	alternative	dobj	4	SENT_203	[p17l1530t1149r1892b1212],
8	to	TO	O	to	_	0	SENT_203	[p17l1914t1161r1980b1212],
9	CSF	NN	O	csf	nn	10	SENT_203	[p17l2005t1153r2143b1212],
10	measures	NNS	O	measure	prep_to	4	SENT_203	[p17l8t1275r330b1315],
11	of	IN	O	of	_	0	SENT_203	[p17l354t1252r429b1315],
12	tau	NN	O	tau	prep_of	10	SENT_203	[p17l441t1264r549b1315],
13	and	CC	O	and	_	0	SENT_203	[p17l572t1252r700b1315],
14	p-tau	NN	O	p-tau	conj_and	12	SENT_203	[p17l720t1264r923b1335],
15	,	,	O	,	_	0	SENT_203	[p17l720t1264r923b1335],
16	and	CC	O	and	_	0	SENT_203	[p17l949t1252r1076b1315],
17	the	DT	O	the	det	19	SENT_203	[p17l1097t1252r1205b1315],
18	technical	JJ	O	technical	amod	19	SENT_203	[p17l1227t1252r1542b1315],
19	requirements	NNS	O	requirement	nsubjpass	25	SENT_203	[p17l1564t1258r2024b1335],
20	for	IN	O	for	_	0	SENT_203	[p17l2048t1252r2147b1315],
21	such	JJ	O	such	amod	22	SENT_203	[p17l9t1354r169b1417],
22	imaging	NN	O	imaging	prep_for	19	SENT_203	[p17l193t1360r482b1438],
23	are	VBP	O	be	aux	25	SENT_203	[p17l505t1377r608b1417],
24	being	VBG	O	be	auxpass	25	SENT_203	[p17l631t1354r829b1438],
25	assessed	VBN	O	assess	conj_and	4	SENT_203	[p17l852t1346r1307b1417],
26	.66	NN	NUMBER	.66	dobj	25	SENT_203	[p17l852t1346r1307b1417],
27	=	JJ	O	=	amod	26	SENT_203	[p17l852t1346r1307b1417],
28	67	CD	NUMBER	67	tmod	27	SENT_203	[p17l852t1346r1307b1417],
29	This	DT	O	this	det	30	SENT_203	[p17l1331t1354r1477b1417],
30	measure	NN	O	measure	nsubj	33	SENT_203	[p17l1502t1377r1798b1417],
31	would	MD	O	would	aux	33	SENT_203	[p17l1821t1354r2041b1417],
32	be	VB	O	be	cop	33	SENT_203	[p17l2063t1354r2144b1417],
33	useful	JJ	O	useful	rcmod	26	SENT_203	[p17l8t1457r215b1520],
34	in	IN	O	in	_	0	SENT_203	[p17l237t1463r304b1519],
35	AD	NN	O	ad	prep_in	33	SENT_203	[p17l326t1461r444b1519],
36	and	CC	O	and	_	0	SENT_203	[p17l469t1457r596b1520],
37	in	IN	O	in	_	0	SENT_203	[p17l618t1463r684b1519],
38	tau-opathies	NNS	O	tau-opathy	conj_and	35	SENT_203	[p17l706t1457r1134b1540],
39	such	JJ	O	such	_	0	SENT_203	[p17l1158t1457r1313b1520],
40	as	IN	O	as	_	0	SENT_203	[p17l1337t1480r1401b1520],
41	progressive	JJ	O	progressive	amod	43	SENT_203	[p17l1423t1463r1811b1541],
42	supranuclear	JJ	O	supranuclear	amod	43	SENT_203	[p17l1835t1479r2142b1540, p17l9t1560r166b1623],
43	palsy	NN	O	palsy	prep_such_as	38	SENT_203	[p17l183t1560r364b1644],
44	,	,	O	,	_	0	SENT_203	[p17l183t1560r364b1644],
45	frontotemporal	JJ	O	frontotemporal	amod	46	SENT_203	[p17l386t1560r898b1643],
46	dementia	NN	O	dementia	prep_such_as	38	SENT_203	[p17l917t1560r1246b1632],
47	,	,	O	,	_	0	SENT_203	[p17l917t1560r1246b1632],
48	corticobasal	JJ	O	corticobasal	amod	49	SENT_203	[p17l1268t1560r1671b1623],
49	degeneration	NN	O	degeneration	prep_such_as	38	SENT_203	[p17l1690t1560r2143b1644],
50	,	,	O	,	_	0	SENT_203	[p17l1690t1560r2143b1644],
51	and	CC	O	and	_	0	SENT_203	[p17l9t1663r135b1726],
52	chronic	JJ	O	chronic	amod	54	SENT_203	[p17l156t1663r415b1726],
53	traumatic	JJ	O	traumatic	amod	54	SENT_203	[p17l436t1669r768b1726],
54	encephalopathy	NN	O	encephalopathy	prep_such_as	38	SENT_203	[p17l790t1663r1340b1747],
55	.	.	O	.	_	0	SENT_203	[p17l790t1663r1340b1747],

1	Hypometabolism	NN	O	hypometabolism	nsubj	6	SENT_204	[p17l11t1876r607b1949],
2	on	IN	O	on	_	0	SENT_204	[p17l627t1892r711b1933],
3	FDG-PET	NNP	O	FDG-PET	nn	5	SENT_204	[p17l734t1878r1035b1933],
4	Cerebral	NNP	MISC	Cerebral	nn	5	SENT_204	[p17l10t1973r296b2036],
5	metabolism	NN	O	metabolism	prep_on	1	SENT_204	[p17l313t1973r706b2036],
6	correlates	VBZ	O	correlate	_	0	SENT_204	[p17l726t1973r1043b2036],
7	with	IN	O	with	_	0	SENT_204	[p17l1061t1973r1210b2036],
8	cognitive	JJ	O	cognitive	amod	9	SENT_204	[p17l1229t1979r1532b2057],
9	function	NN	O	function	prep_with	6	SENT_204	[p17l1551t1973r1853b2045],
10	,	,	O	,	_	0	SENT_204	[p17l1551t1973r1853b2045],
11	suggesting	VBG	O	suggest	xcomp	6	SENT_204	[p17l1874t1985r2142b2057, p17l8t2082r115b2160],
12	that	IN	O	that	complm	15	SENT_204	[p17l132t2076r264b2139],
13	FDG-PET	NN	O	fdg-pet	nsubj	15	SENT_204	[p17l284t2079r628b2139],
14	might	MD	O	might	aux	15	SENT_204	[p17l648t2076r848b2160],
15	function	VB	O	function	ccomp	11	SENT_204	[p17l868t2076r1154b2139],
16	as	IN	O	as	mark	43	SENT_204	[p17l1176t2099r1239b2139],
17	a	DT	O	a	det	18	SENT_204	[p17l1261t2099r1295b2139],
18	measure	NN	O	measure	nsubj	43	SENT_204	[p17l1314t2099r1596b2139],
19	of	IN	O	of	_	0	SENT_204	[p17l1617t2076r1690b2139],
20	drug	NN	O	drug	nn	21	SENT_204	[p17l1702t2076r1861b2160],
21	effect	NN	O	effect	prep_of	18	SENT_204	[p17l1881t2076r2059b2139],
22	in	IN	O	in	_	0	SENT_204	[p17l2079t2082r2145b2138],
23	clinical	JJ	O	clinical	amod	24	SENT_204	[p17l9t2178r248b2241],
24	trials	NNS	O	trial	prep_in	21	SENT_204	[p17l267t2170r515b2241],
25	.68	CD	NUMBER	.68	num	27	SENT_204	[p17l267t2170r515b2241],
26	Sample	NN	O	sample	nn	27	SENT_204	[p17l538t2178r780b2261],
27	size	NN	O	size	nsubj	28	SENT_204	[p17l801t2184r922b2241],
28	estimates	VBZ	O	estimate	rcmod	24	SENT_204	[p17l944t2184r1252b2241],
29	to	TO	O	to	aux	30	SENT_204	[p17l1272t2190r1337b2241],
30	detect	VB	O	detect	xcomp	28	SENT_204	[p17l1361t2178r1562b2241],
31	a	DT	O	a	det	34	SENT_204	[p17l1583t2201r1617b2241],
32	25	CD	PERCENT	25	number	33	SENT_204	[p17l1637t2184r1778b2243],
33	%	NN	PERCENT	%	amod	34	SENT_204	[p17l1637t2184r1778b2243],
34	slowing	NN	O	slowing	dobj	30	SENT_204	[p17l1802t2178r2060b2262],
35	of	IN	O	of	_	0	SENT_204	[p17l2080t2178r2153b2241],
36	progression	NN	O	progression	prep_of	34	SENT_204	[p17l7t2287r413b2365],
37	with	IN	O	with	_	0	SENT_204	[p17l433t2281r588b2344],
38	80	CD	PERCENT	80	number	39	SENT_204	[p17l611t2287r754b2346],
39	%	NN	PERCENT	%	amod	40	SENT_204	[p17l611t2287r754b2346],
40	power	NN	O	power	prep_with	30	SENT_204	[p17l778t2303r995b2364],
41	are	VBP	O	be	cop	43	SENT_204	[p17l1017t2304r1118b2344],
42	roughly	RB	O	roughly	advmod	43	SENT_204	[p17l1141t2281r1412b2365],
43	comparable	JJ	O	comparable	advcl	15	SENT_204	[p17l1431t2281r1833b2364],
44	between	IN	O	between	_	0	SENT_204	[p17l1854t2281r2143b2344],
45	FDG-PET	NN	O	fdg-pet	prep_between	43	SENT_204	[p17l9t2387r364b2447],
46	and	CC	O	and	_	0	SENT_204	[p17l389t2384r517b2447],
47	MRI	NNP	O	MRI	prep_between	43	SENT_204	[p17l539t2389r715b2447],
48	.	.	O	.	_	0	SENT_204	[p17l539t2389r715b2447],

1	It	PRP	O	it	nsubjpass	3	SENT_205	[p17l742t2389r792b2447],
2	is	VBZ	O	be	auxpass	3	SENT_205	[p17l814t2390r865b2447],
3	calculated	VBN	O	calculate	_	0	SENT_205	[p17l890t2384r1240b2447],
4	that	IN	O	that	complm	19	SENT_205	[p17l1261t2384r1397b2447],
5	~	NN	O	~	nsubj	19	SENT_205	[p17l1421t2391r1549b2447],
6	70	CD	NUMBER	70	num	7	SENT_205	[p17l1421t2391r1549b2447],
7	patients	NNS	O	patient	nsubjpass	12	SENT_205	[p17l1572t2390r1846b2467],
8	per	IN	O	per	_	0	SENT_205	[p17l1869t2406r1984b2467],
9	arm	NN	O	arm	prep_per	7	SENT_205	[p17l2007t2407r2145b2447],
10	would	MD	O	would	aux	12	SENT_205	[p17l7t2487r216b2550],
11	be	VB	O	be	auxpass	12	SENT_205	[p17l232t2487r310b2550],
12	required	VBN	O	require	rcmod	5	SENT_205	[p17l329t2487r613b2570],
13	in	IN	O	in	_	0	SENT_205	[p17l630t2493r696b2549],
14	clinical	JJ	O	clinical	amod	15	SENT_205	[p17l715t2487r952b2550],
15	trials	NNS	O	trial	prep_in	12	SENT_205	[p17l969t2487r1135b2550],
16	in	IN	O	in	_	0	SENT_205	[p17l1154t2493r1219b2549],
17	which	WDT	O	which	dep	18	SENT_205	[p17l1236t2487r1441b2550],
18	FD	NN	O	fd	prep_in	15	SENT_205	[p17l1460t2492r1561b2549],
19	G	NN	O	g	ccomp	3	SENT_205	[p17l1569t2490r1802b2550],
20	.	.	O	.	_	0	SENT_205	[p17l1569t2490r1802b2550],

1	—	NN	O	—	_	0	SENT_206	[p17l1569t2490r1802b2550],
2	.	.	O	.	_	0	SENT_206	[p17l1569t2490r1802b2550],

1	PET	NN	O	pet	nsubj	5	SENT_207	[p17l1569t2490r1802b2550],
2	is	VBZ	O	be	cop	5	SENT_207	[p17l1821t2493r1870b2550],
3	the	DT	O	the	det	5	SENT_207	[p17l1888t2487r1992b2550],
4	biomarker	NN	O	biomarker	nn	5	SENT_207	[p17l2009t2487r2142b2550, p17l8t2590r259b2653],
5	outcome	NN	O	outcome	_	0	SENT_207	[p17l281t2582r662b2653],
6	.69	CD	NUMBER	.69	num	5	SENT_207	[p17l281t2582r662b2653],
7	This	DT	O	this	nsubj	8	SENT_207	[p17l685t2590r830b2653],
8	compares	VBZ	O	compare	dep	5	SENT_207	[p17l854t2612r1183b2673],
9	with	IN	O	with	_	0	SENT_207	[p17l1204t2590r1359b2653],
10	~	NN	O	~	nn	12	SENT_207	[p17l1384t2596r1553b2653],
11	6OO	NN	O	6oo	nn	12	SENT_207	[p17l1384t2596r1553b2653],
12	patients	NNS	O	patient	prep_with	8	SENT_207	[p17l1575t2596r1847b2673],
13	per	IN	O	per	_	0	SENT_207	[p17l1868t2612r1983b2673],
14	arm	NN	O	arm	prep_per	12	SENT_207	[p17l2005t2613r2143b2653],

1	VOLUME	NN	O	volume	nn	3	SENT_208	[p17l542t2808r765b2850],
2	95	CD	NUMBER	95	num	3	SENT_208	[p17l783t2809r839b2850],
3	NUMBER	NN	O	number	_	0	SENT_208	[p17l860t2808r1084b2850],
4	1	CD	NUMBER	1	number	5	SENT_208	[p17l1105t2810r1118b2850],
5	|	CD	NUMBER	|	num	3	SENT_208	[p17l1148t2804r1152b2865],
6	JANUARY	NNP	DATE	JANUARY	amod	3	SENT_208	[p17l1171t2808r1416b2850],
7	2014	CD	DATE	2014	num	6	SENT_208	[p17l1432t2809r1553b2850],
8	|	CD	NUMBER	|	num	9	SENT_208	[p17l1571t2804r1576b2865],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	6	SENT_208	[p17l1595t2808r2145b2861],
10	to	TO	O	to	aux	11	SENT_208	[p18l8t97r73b148],
11	detect	VB	O	detect	infmod	9	SENT_208	[p18l96t85r301b148],
12	a	DT	O	a	det	14	SENT_208	[p18l321t108r356b148],
13	25	CD	PERCENT	25	number	14	SENT_208	[p18l376t90r519b150],
14	%	NN	PERCENT	%	dobj	11	SENT_208	[p18l376t90r519b150],
15	slowing	VBG	O	slow	amod	14	SENT_208	[p18l543t85r804b169],
16	on	IN	O	on	_	0	SENT_208	[p18l824t108r910b148],
17	the	DT	O	the	det	18	SENT_208	[p18l930t85r1036b148],
18	Alzheimer	NN	O	alzheimer	poss	22	SENT_208	[p18l1057t85r1455b148],
19	’s	POS	O	’s	_	0	SENT_208	[p18l1057t85r1455b148],
20	Disease	NN	O	disease	nn	22	SENT_208	[p18l1478t90r1734b148],
21	Assessment	NNP	O	Assessment	nn	22	SENT_208	[p18l1755t89r2151b148],
22	Scale	NNP	O	Scale	prep_on	14	SENT_208	[p18l10t188r549b272],
23	.	.	O	.	_	0	SENT_208	[p18l10t188r549b272],

1	—	NN	O	—	_	0	SENT_209	[p18l10t188r549b272],
2	.	.	O	.	_	0	SENT_209	[p18l10t188r549b272],

1	Cognitive	JJ	MISC	cognitive	amod	2	SENT_210	[p18l10t188r549b272],
2	Subscale	NN	MISC	subscale	_	0	SENT_210	[p18l569t188r868b251],
3	.	.	O	.	_	0	SENT_210	[p18l569t188r868b251],

1	Similar	JJ	O	similar	amod	2	SENT_211	[p18l891t188r1130b251],
2	approaches	NNS	O	approach	nsubj	3	SENT_211	[p18l1148t188r1522b271],
3	suggested	VBD	O	suggest	_	0	SENT_211	[p18l1542t188r1865b272],
4	that	IN	O	that	complm	7	SENT_211	[p18l1881t188r2012b251],
5	one	CD	NUMBER	one	nsubj	7	SENT_211	[p18l2030t211r2150b251],
6	could	MD	O	could	aux	7	SENT_211	[p18l9t291r200b354],
7	detect	VB	O	detect	ccomp	3	SENT_211	[p18l221t291r426b354],
8	a	DT	O	a	det	11	SENT_211	[p18l448t314r483b354],
9	25	CD	PERCENT	25	number	10	SENT_211	[p18l503t297r646b356],
10	%	NN	PERCENT	%	amod	11	SENT_211	[p18l503t297r646b356],
11	slowing	NN	O	slowing	dobj	7	SENT_211	[p18l671t291r934b375],
12	of	IN	O	of	_	0	SENT_211	[p18l954t291r1028b354],
13	progression	NN	O	progression	prep_of	11	SENT_211	[p18l1039t297r1441b375],
14	with	IN	O	with	_	0	SENT_211	[p18l1460t291r1613b354],
15	200	CD	NUMBER	200	nn	19	SENT_211	[p18l1635t298r1755b354],
16	cognitively	RB	O	cognitively	advmod	17	SENT_211	[p18l1778t291r2154b375],
17	normal	JJ	O	normal	amod	19	SENT_211	[p18l8t395r255b458],
18	ApoE	NN	O	apoe	nn	19	SENT_211	[p18l273t399r534b478],
19	—	NN	O	—	prep_with	13	SENT_211	[p18l273t399r534b478],
20	4	CD	NUMBER	4	num	21	SENT_211	[p18l273t399r534b478],
21	homozygotes	NNS	O	homozygote	xcomp	7	SENT_211	[p18l553t395r998b479],
22	per	IN	O	per	_	0	SENT_211	[p18l1018t417r1130b478],
23	arm	NN	O	arm	prep_per	21	SENT_211	[p18l1149t418r1284b458],
24	in	IN	O	in	_	0	SENT_211	[p18l1304t401r1369b457],
25	a	DT	O	a	det	27	SENT_211	[p18l1390t418r1425b458],
26	prevention	NN	O	prevention	nn	27	SENT_211	[p18l1442t401r1807b478],
27	trial	NN	O	trial	prep_in	7	SENT_211	[p18l1826t395r1978b458],
28	.	.	O	.	_	0	SENT_211	[p18l1826t395r1978b458],

1	There	EX	O	there	expl	2	SENT_212	[p18l82t498r278b561],
2	is	VBZ	O	be	_	0	SENT_212	[p18l300t504r351b561],
3	less	JJR	O	less	amod	4	SENT_212	[p18l373t498r492b561],
4	experience	NN	O	experience	nsubj	2	SENT_212	[p18l516t504r888b581],
5	in	IN	O	in	_	0	SENT_212	[p18l911t504r979b560],
6	the	DT	O	the	det	8	SENT_212	[p18l999t498r1107b561],
7	multisite	JJ	O	multisite	amod	8	SENT_212	[p18l1129t498r1431b561],
8	application	NN	O	application	prep_in	2	SENT_212	[p18l1455t498r1838b581],
9	of	IN	O	of	_	0	SENT_212	[p18l1861t498r1936b561],
10	FDG	NN	O	fdg	prep_of	8	SENT_212	[p18l1949t502r2147b561],
11	—	CD	NUMBER	—	num	12	SENT_212	[p18l1949t502r2147b561],
12	PET	NN	O	pet	npadvmod	13	SENT_212	[p18l9t604r158b663],
13	than	IN	O	than	advmod	2	SENT_212	[p18l181t601r339b664],
14	in	IN	O	in	_	0	SENT_212	[p18l363t607r431b663],
15	the	DT	O	the	det	16	SENT_212	[p18l453t601r562b664],
16	application	NN	O	application	prep_in	2	SENT_212	[p18l587t601r974b684],
17	of	IN	O	of	_	0	SENT_212	[p18l998t601r1073b664],
18	MRI	NNP	MISC	MRI	prep_of	16	SENT_212	[p18l1087t606r1246b664],
19	and	CC	O	and	_	0	SENT_212	[p18l1272t601r1401b664],
20	CSF	NN	O	csf	prep_in	2	SENT_212	[p18l1425t605r1564b664],
21	in	IN	O	in	_	0	SENT_212	[p18l1590t607r1658b663],
22	clinical	JJ	O	clinical	amod	23	SENT_212	[p18l1682t601r1932b664],
23	trials	NNS	O	trial	prep_in	20	SENT_212	[p18l1954t601r2146b664],
24	.	.	O	.	_	0	SENT_212	[p18l1954t601r2146b664],

1	Methods	NNS	O	method	nsubj	3	SENT_213	[p18l8t704r311b767],
2	are	VBP	O	be	aux	3	SENT_213	[p18l334t727r434b767],
3	advancing	VBG	O	advance	_	0	SENT_213	[p18l457t704r808b788],
4	to	TO	O	to	aux	5	SENT_213	[p18l827t716r893b767],
5	allow	VB	O	allow	xcomp	3	SENT_213	[p18l917t704r1100b767],
6	standardization	NN	O	standardization	dobj	5	SENT_213	[p18l1120t704r1652b767],
7	of	IN	O	of	_	0	SENT_213	[p18l1674t704r1749b767],
8	data	NNS	O	datum	nn	9	SENT_213	[p18l1761t704r1905b767],
9	collection	NN	O	collection	prep_of	6	SENT_213	[p18l1926t704r2147b767, p18l8t814r140b871],
10	and	CC	O	and	_	0	SENT_213	[p18l159t807r282b871],
11	interpretation	NN	O	interpretation	prep_of	6	SENT_213	[p18l299t814r756b891],
12	relevant	JJ	O	relevant	amod	9	SENT_213	[p18l774t808r1037b871],
13	to	TO	O	to	_	0	SENT_213	[p18l1052t819r1116b871],
14	application	NN	O	application	prep_to	12	SENT_213	[p18l1137t807r1501b891],
15	in	IN	O	in	_	0	SENT_213	[p18l1519t814r1584b870],
16	multisite	JJ	O	multisite	amod	17	SENT_213	[p18l1602t807r1889b871],
17	trials	NNS	O	trial	prep_in	14	SENT_213	[p18l1906t799r2148b871],
18	.68	CD	NUMBER	.68	tmod	12	SENT_213	[p18l1906t799r2148b871],

1	Novel	JJ	O	novel	amod	2	SENT_214	[p18l11t1022r205b1079],
2	biomarkers	NNS	O	biomarker	_	0	SENT_214	[p18l226t1022r621b1079],

1	The	DT	O	the	det	3	SENT_215	[p18l8t1119r135b1182],
2	current	JJ	DATE	current	amod	3	SENT_215	[p18l160t1131r417b1182],
3	repertoire	NN	O	repertoire	nsubj	8	SENT_215	[p18l439t1125r784b1202],
4	of	IN	O	of	_	0	SENT_215	[p18l809t1119r883b1182],
5	biomarkers	NNS	O	biomarker	prep_of	3	SENT_215	[p18l895t1119r1291b1182],
6	is	VBZ	O	be	cop	8	SENT_215	[p18l1314t1125r1366b1182],
7	very	RB	O	very	advmod	8	SENT_215	[p18l1386t1142r1542b1203],
8	limited	JJ	O	limited	_	0	SENT_215	[p18l1560t1119r1810b1182],
9	given	VBN	O	give	prep	8	SENT_215	[p18l1832t1125r2019b1203],
10	the	DT	O	the	det	12	SENT_215	[p18l2041t1119r2149b1182],
11	complex	JJ	O	complex	amod	12	SENT_215	[p18l9t1222r310b1305],
12	range	NN	O	range	dep	9	SENT_215	[p18l332t1245r526b1306],
13	of	IN	O	of	_	0	SENT_215	[p18l552t1222r628b1285],
14	cellular	JJ	O	cellular	amod	15	SENT_215	[p18l644t1222r904b1285],
15	processes	NNS	O	process	prep_of	12	SENT_215	[p18l926t1244r1260b1305],
16	involved	VBN	O	involve	partmod	15	SENT_215	[p18l1285t1222r1587b1285],
17	in	IN	O	in	_	0	SENT_215	[p18l1611t1228r1679b1284],
18	AD	NN	O	ad	prep_in	16	SENT_215	[p18l1703t1226r1841b1285],
19	.	.	O	.	_	0	SENT_215	[p18l1703t1226r1841b1285],

1	Reliable	JJ	O	reliable	amod	2	SENT_216	[p18l1869t1222r2149b1285],
2	measures	NNS	O	measure	nsubj	26	SENT_216	[p18l8t1348r326b1388],
3	of	IN	O	of	_	0	SENT_216	[p18l348t1325r421b1388],
4	AB	NNP	O	AB	nn	5	SENT_216	[p18l431t1323r535b1406],
5	oligomers	NNS	O	oligomer	prep_of	2	SENT_216	[p18l557t1325r912b1409],
6	,	,	O	,	_	0	SENT_216	[p18l557t1325r912b1409],
7	inﬂammation	NN	O	inﬂammation	nn	14	SENT_216	[p18l934t1325r1420b1397],
8	,	,	O	,	_	0	SENT_216	[p18l934t1325r1420b1397],
9	oxidation	NN	O	oxidation	dep	14	SENT_216	[p18l1443t1325r1786b1397],
10	,	,	O	,	_	0	SENT_216	[p18l1443t1325r1786b1397],
11	apoptosis	NN	O	apoptosis	dep	14	SENT_216	[p18l1809t1331r2148b1408],
12	,	,	O	,	_	0	SENT_216	[p18l1809t1331r2148b1408],
13	mitochondrial	JJ	O	mitochondrial	amod	14	SENT_216	[p18l8t1428r499b1491],
14	function	NN	O	function	conj_and	2	SENT_216	[p18l519t1428r828b1500],
15	,	,	O	,	_	0	SENT_216	[p18l519t1428r828b1500],
16	integrity	NN	O	integrity	conj_and	2	SENT_216	[p18l850t1434r1141b1512],
17	of	IN	O	of	_	0	SENT_216	[p18l1158t1428r1231b1491],
18	cellular	JJ	O	cellular	amod	19	SENT_216	[p18l1243t1428r1491b1491],
19	organelles	NNS	O	organelle	prep_of	16	SENT_216	[p18l1511t1428r1870b1512],
20	,	,	O	,	_	0	SENT_216	[p18l1511t1428r1870b1512],
21	and	CC	O	and	_	0	SENT_216	[p18l1893t1428r2018b1491],
22	cell	NN	O	cell	nn	23	SENT_216	[p18l2038t1428r2150b1491],
23	death	NN	O	death	nsubj	26	SENT_216	[p18l9t1531r196b1594],
24	would	MD	O	would	aux	26	SENT_216	[p18l214t1531r428b1594],
25	usefully	RB	O	usefully	advmod	26	SENT_216	[p18l447t1531r716b1615],
26	expand	VB	O	expand	_	0	SENT_216	[p18l733t1531r981b1614],
27	the	DT	O	the	det	28	SENT_216	[p18l999t1531r1105b1594],
28	ability	NN	O	ability	dobj	26	SENT_216	[p18l1126t1531r1338b1615],
29	to	TO	O	to	aux	30	SENT_216	[p18l1353t1543r1419b1594],
30	monitor	VB	O	monitor	infmod	28	SENT_216	[p18l1440t1537r1720b1594],
31	the	DT	O	the	det	32	SENT_216	[p18l1738t1531r1844b1594],
32	progression	NN	O	progression	dobj	30	SENT_216	[p18l1863t1553r2146b1615, p18l9t1640r147b1697],
33	of	IN	O	of	_	0	SENT_216	[p18l167t1634r239b1697],
34	AD	NN	O	ad	prep_of	32	SENT_216	[p18l249t1638r381b1706],
35	,	,	O	,	_	0	SENT_216	[p18l249t1638r381b1706],
36	comprehend	VBP	O	comprehend	conj_and	34	SENT_216	[p18l403t1634r826b1717],
37	its	PRP$	O	its	poss	38	SENT_216	[p18l845t1640r918b1697],
38	pathophysiology	NN	O	pathophysiology	dobj	36	SENT_216	[p18l938t1634r1506b1718],
39	,	,	O	,	_	0	SENT_216	[p18l938t1634r1506b1718],
40	and	CC	O	and	_	0	SENT_216	[p18l1529t1634r1652b1697],
41	monitor	NN	O	monitor	nn	42	SENT_216	[p18l1670t1640r1946b1697],
42	interventions	NNS	O	intervention	conj_and	34	SENT_216	[p18l1965t1640r2146b1697, p18l6t1743r317b1800],
43	.	.	O	.	_	0	SENT_216	[p18l1965t1640r2146b1697, p18l6t1743r317b1800],

1	Many	JJ	O	many	dep	124	SENT_217	[p18l343t1742r542b1821],
2	measures	NNS	O	measure	dep	124	SENT_217	[p18l561t1760r882b1800],
3	have	VBP	O	have	dep	124	SENT_217	[p18l904t1737r1061b1800],
4	been	VBN	O	be	dep	124	SENT_217	[p18l1081t1737r1247b1800],
5	nominated	VBN	O	nominate	dep	124	SENT_217	[p18l1270t1737r1647b1800],
6	as	IN	O	as	dep	124	SENT_217	[p18l1669t1760r1734b1800],
7	biomarkers	NNS	O	biomarker	dep	124	SENT_217	[p18l1755t1737r2147b1800],
8	for	IN	O	for	dep	124	SENT_217	[p18l9t1839r108b1903],
9	AD	NN	O	ad	dep	124	SENT_217	[p18l129t1843r266b1912],
10	,	,	O	,	_	0	SENT_217	[p18l129t1843r266b1912],
11	but	CC	O	but	dep	124	SENT_217	[p18l290t1840r406b1903],
12	consensus	NN	O	consensus	dep	124	SENT_217	[p18l428t1862r781b1903],
13	has	VBZ	O	have	dep	124	SENT_217	[p18l804t1839r918b1903],
14	been	VBN	O	be	dep	124	SENT_217	[p18l940t1839r1108b1903],
15	reached	VBN	O	reach	dep	124	SENT_217	[p18l1131t1839r1404b1903],
16	for	IN	O	for	dep	124	SENT_217	[p18l1427t1839r1526b1903],
17	only	RB	O	only	dep	124	SENT_217	[p18l1549t1839r1703b1924],
18	a	DT	O	a	dep	124	SENT_217	[p18l1723t1862r1758b1903],
19	few	JJ	O	few	dep	124	SENT_217	[p18l1780t1831r1977b1903],
20	.53	CD	NUMBER	.53	dep	124	SENT_217	[p18l1780t1831r1977b1903],
21	One	CD	NUMBER	one	dep	124	SENT_217	[p18l2003t1843r2149b1903],
22	analyte	NN	O	analyte	dep	124	SENT_217	[p18l9t1943r251b2027],
23	panel	NN	O	panel	dep	124	SENT_217	[p18l273t1943r459b2026],
24	that	WDT	O	that	dep	124	SENT_217	[p18l480t1943r615b2006],
25	has	VBZ	O	have	dep	124	SENT_217	[p18l634t1943r747b2006],
26	undergone	VBN	O	undergo	dep	124	SENT_217	[p18l770t1943r1141b2027],
27	two	CD	NUMBER	two	dep	124	SENT_217	[p18l1162t1955r1288b2006],
28	validations	NNS	O	validation	dep	124	SENT_217	[p18l1309t1943r1685b2006],
29	with	IN	O	with	dep	124	SENT_217	[p18l1706t1943r1860b2006],
30	support	NN	O	support	dep	124	SENT_217	[p18l1883t1955r2149b2026],
31	for	IN	O	for	dep	124	SENT_217	[p18l8t2046r104b2109],
32	accuracy	NN	O	accuracy	dep	124	SENT_217	[p18l123t2069r428b2130],
33	,	,	O	,	_	0	SENT_217	[p18l123t2069r428b2130],
34	sensitivity	NN	O	sensitivity	dep	124	SENT_217	[p18l450t2052r795b2130],
35	,	,	O	,	_	0	SENT_217	[p18l450t2052r795b2130],
36	and	CC	O	and	dep	124	SENT_217	[p18l817t2046r941b2109],
37	speciﬁcity	NN	O	speciﬁcity	dep	124	SENT_217	[p18l961t2046r1296b2130],
38	in	IN	O	in	dep	124	SENT_217	[p18l1312t2052r1377b2108],
39	AD	NN	O	ad	dep	124	SENT_217	[p18l1396t2050r1513b2108],
40	includes	VBZ	O	include	dep	124	SENT_217	[p18l1534t2046r1810b2109],
41	increased	VBN	O	increase	dep	124	SENT_217	[p18l1830t2046r2148b2109],
42	levels	NNS	O	level	dep	124	SENT_217	[p18l7t2149r187b2212],
43	of	IN	O	of	dep	124	SENT_217	[p18l208t2149r280b2212],
44	cortisol	NN	O	cortisol	dep	124	SENT_217	[p18l290t2149r555b2221],
45	,	,	O	,	_	0	SENT_217	[p18l290t2149r555b2221],
46	pancreatic	JJ	O	pancreatic	dep	124	SENT_217	[p18l575t2155r920b2232],
47	polypeptide	NN	O	polypeptide	dep	124	SENT_217	[p18l938t2149r1350b2233],
48	,	,	O	,	_	0	SENT_217	[p18l938t2149r1350b2233],
49	insulin	NN	O	insulin	dep	124	SENT_217	[p18l1371t2149r1750b2212],
50	—	NN	O	—	dep	124	SENT_217	[p18l1371t2149r1750b2212],
51	like	IN	O	like	dep	124	SENT_217	[p18l1371t2149r1750b2212],
52	growth	NN	O	growth	dep	124	SENT_217	[p18l1770t2149r2007b2233],
53	factor	NN	O	factor	dep	124	SENT_217	[p18l2026t2149r2146b2212, p18l8t2264r107b2315],
54	binding	NN	O	binding	dep	124	SENT_217	[p18l126t2252r394b2336],
55	protein	NN	O	protein	dep	124	SENT_217	[p18l414t2258r662b2335],
56	2	CD	NUMBER	2	dep	124	SENT_217	[p18l684t2259r740b2324],
57	,	,	O	,	_	0	SENT_217	[p18l684t2259r740b2324],
58	B2	NN	O	b2	dep	124	SENT_217	[p18l766t2250r847b2333],
59	microglobulin	NN	O	microglobulin	dep	124	SENT_217	[p18l870t2252r1379b2336],
60	,	,	O	,	_	0	SENT_217	[p18l870t2252r1379b2336],
61	vascular	JJ	O	vascular	dep	124	SENT_217	[p18l1400t2252r1685b2315],
62	cell	NN	O	cell	dep	124	SENT_217	[p18l1706t2252r1819b2315],
63	adhesion	NN	O	adhesion	dep	124	SENT_217	[p18l1842t2252r2149b2315],
64	molecule	NN	O	molecule	dep	124	SENT_217	[p18l8t2355r311b2418],
65	1	CD	NUMBER	1	dep	124	SENT_217	[p18l337t2362r384b2427],
66	,	,	O	,	_	0	SENT_217	[p18l337t2362r384b2427],
67	carcinoembryonic	JJ	O	carcinoembryonic	dep	124	SENT_217	[p18l405t2355r1012b2439],
68	antigen	NN	O	antigen	dep	124	SENT_217	[p18l1032t2361r1294b2439],
69	,	,	O	,	_	0	SENT_217	[p18l1032t2361r1294b2439],
70	matrix	NN	O	matrix	dep	124	SENT_217	[p18l1314t2361r1536b2418],
71	metalloproteinase	NN	O	metalloproteinase	dep	124	SENT_217	[p18l1553t2355r2148b2438],
72	2	CD	NUMBER	2	dep	124	SENT_217	[p18l9t2465r63b2530],
73	,	,	O	,	_	0	SENT_217	[p18l9t2465r63b2530],
74	CD40	NN	O	cd40	dep	124	SENT_217	[p18l86t2462r300b2530],
75	,	,	O	,	_	0	SENT_217	[p18l86t2462r300b2530],
76	macrophage	NN	O	macrophage	dep	124	SENT_217	[p18l322t2458r736b2542],
77	inﬂammatory	NN	O	inﬂammatory	dep	124	SENT_217	[p18l756t2458r1224b2542],
78	protein	NN	O	protein	dep	124	SENT_217	[p18l1240t2464r1485b2541],
79	lot	NN	O	lot	dep	124	SENT_217	[p18l1511t2465r1613b2530],
80	,	,	O	,	_	0	SENT_217	[p18l1511t2465r1613b2530],
81	superoxide	NN	O	superoxide	dep	124	SENT_217	[p18l1635t2458r2004b2541],
82	dismutase	NN	O	dismutase	dep	124	SENT_217	[p18l2025t2458r2146b2521, p18l8t2573r269b2633],
83	,	,	O	,	_	0	SENT_217	[p18l2025t2458r2146b2521, p18l8t2573r269b2633],
84	and	CC	O	and	dep	124	SENT_217	[p18l292t2561r417b2624],
85	homocysteine	NN	O	homocysteine	dep	124	SENT_217	[p18l436t2561r931b2645],
86	;	:	O	;	_	0	SENT_217	[p18l436t2561r931b2645],
87	and	CC	O	and	dep	124	SENT_217	[p18l954t2561r1080b2624],
88	decreased	VBD	O	decrease	dep	124	SENT_217	[p18l1100t2561r1435b2624],
89	levels	NNS	O	level	dep	124	SENT_217	[p18l1453t2561r1637b2624],
90	of	IN	O	of	dep	124	SENT_217	[p18l1659t2561r1733b2624],
91	apolipopro	NN	O	apolipopro	dep	124	SENT_217	[p18l1744t2561r2144b2644],
92	—	CD	NUMBER	—	dep	124	SENT_217	[p18l1744t2561r2144b2644],
93	tein	NN	O	tein	dep	124	SENT_217	[p18l8t2670r137b2727],
94	E	NN	O	e	dep	124	SENT_217	[p18l158t2669r221b2736],
95	,	,	O	,	_	0	SENT_217	[p18l158t2669r221b2736],
96	epidermal	JJ	O	epidermal	dep	124	SENT_217	[p18l244t2664r590b2747],
97	growth	NN	O	growth	dep	124	SENT_217	[p18l610t2664r853b2748],
98	factor	NN	O	factor	dep	124	SENT_217	[p18l873t2664r1072b2727],
99	receptor	NN	O	receptor	dep	124	SENT_217	[p18l1092t2676r1387b2747],
100	,	,	O	,	_	0	SENT_217	[p18l1092t2676r1387b2747],
101	hemoglobin	NN	O	hemoglobin	dep	124	SENT_217	[p18l1408t2664r1840b2748],
102	,	,	O	,	_	0	SENT_217	[p18l1408t2664r1840b2748],
103	calcium	NN	O	calcium	dep	124	SENT_217	[p18l1863t2664r2149b2736],
104	,	,	O	,	_	0	SENT_217	[p18l1863t2664r2149b2736],
105	zinc	NN	O	zinc	dep	124	SENT_217	[p18l9t2774r166b2840],
106	,	,	O	,	_	0	SENT_217	[p18l9t2774r166b2840],
107	interleukin	NN	O	interleukin	dep	124	SENT_217	[p18l188t2767r566b2831],
108	17	CD	NUMBER	17	dep	124	SENT_217	[p18l594t2774r684b2840],
109	,	,	O	,	_	0	SENT_217	[p18l594t2774r684b2840],
110	and	CC	O	and	dep	124	SENT_217	[p18l707t2767r834b2831],
111	albumin	NN	O	albumin	dep	124	SENT_217	[p18l854t2759r1221b2831],
112	.7	CD	NUMBER	.7	dep	124	SENT_217	[p18l854t2759r1221b2831],
113	°	CD	NUMBER	°	dep	124	SENT_217	[p18l854t2759r1221b2831],
114	Conﬁrmation	NN	O	conﬁrmation	dep	124	SENT_217	[p18l1244t2767r1714b2831],
115	of	IN	O	of	dep	124	SENT_217	[p18l1735t2767r1809b2831],
116	this	DT	O	this	dep	124	SENT_217	[p18l1819t2767r1943b2831],
117	panel	NN	O	panel	dep	124	SENT_217	[p18l1963t2767r2150b2851],
118	or	CC	O	or	dep	124	SENT_217	[p18l9t2894r81b2934],
119	nomination	NN	O	nomination	dep	124	SENT_217	[p18l101t2877r505b2934],
120	of	IN	O	of	dep	124	SENT_217	[p18l527t2871r601b2934],
121	alternative	JJ	O	alternative	dep	124	SENT_217	[p18l614t2871r972b2934],
122	panels	NNS	O	panel	dep	124	SENT_217	[p18l993t2871r1209b2954],
123	is	VBZ	O	be	dep	124	SENT_217	[p18l1231t2877r1281b2934],
124	required	VBN	O	require	_	0	SENT_217	[p18l1303t2871r1610b2954],
125	.	.	O	.	_	0	SENT_217	[p18l1303t2871r1610b2954],

1	“	NN	O	“	nn	2	SENT_218	[p18l83t2974r385b3046],
2	Omics	NNS	O	omic	nsubjpass	18	SENT_218	[p18l83t2974r385b3046],
3	,	,	O	,	_	0	SENT_218	[p18l83t2974r385b3046],
4	”	NN	O	”	appos	2	SENT_218	[p18l83t2974r385b3046],
5	including	VBG	O	include	_	0	SENT_218	[p18l410t2974r745b3058],
6	genomics	NNS	O	genomic	prep_including	4	SENT_218	[p18l766t2980r1118b3058],
7	,	,	O	,	_	0	SENT_218	[p18l766t2980r1118b3058],
8	transcriptomics	NNS	O	transcriptomic	prep_including	4	SENT_218	[p18l1142t2980r1713b3057],
9	,	,	O	,	_	0	SENT_218	[p18l1142t2980r1713b3057],
10	proteomics	NNS	O	proteomic	prep_including	4	SENT_218	[p18l1737t2980r2149b3057],
11	,	,	O	,	_	0	SENT_218	[p18l1737t2980r2149b3057],
12	and	CC	O	and	_	0	SENT_218	[p18l9t3077r134b3140],
13	metabolomics	NNS	O	metabolomic	prep_including	4	SENT_218	[p18l153t3077r647b3149],
14	,	,	O	,	_	0	SENT_218	[p18l153t3077r647b3149],
15	are	VBP	O	be	aux	18	SENT_218	[p18l669t3100r768b3140],
16	being	VBG	O	be	auxpass	18	SENT_218	[p18l786t3077r975b3161],
17	intensively	RB	O	intensively	advmod	18	SENT_218	[p18l993t3077r1356b3161],
18	studied	VBN	O	study	_	0	SENT_218	[p18l1373t3077r1620b3140],
19	to	TO	O	to	aux	20	SENT_218	[p18l1638t3089r1703b3140],
20	identify	VB	O	identify	xcomp	18	SENT_218	[p18l1724t3077r1988b3161],
21	proﬁles	NNS	O	proﬁles	dobj	20	SENT_218	[p18l2002t3099r2145b3160, p18l8t3180r137b3243],
22	of	IN	O	of	prep	21	SENT_218	[p18l158t3180r230b3243],
23	over	IN	O	over	pobj	22	SENT_218	[p18l240t3203r407b3243],
24	-	:	O	-	_	0	SENT_218	[p18l240t3203r407b3243],
25	and	CC	O	and	_	0	SENT_218	[p18l429t3180r552b3243],
26	underexpressed	JJ	O	underexpressed	amod	27	SENT_218	[p18l570t3180r1094b3263],
27	molecules	NNS	O	molecule	dobj	20	SENT_218	[p18l1112t3180r1445b3243],
28	that	WDT	O	that	nsubjpass	44	SENT_218	[p18l1463t3180r1593b3243],
29	comprise	VBP	O	comprise	rcmod	27	SENT_218	[p18l1612t3186r1916b3263],
30	an	DT	O	a	det	32	SENT_218	[p18l1936t3203r2014b3243],
31	AD	NN	O	ad	nn	32	SENT_218	[p18l2032t3184r2148b3242],
32	signature	NN	O	signature	dobj	29	SENT_218	[p18l10t3274r473b3367],
33	.16	CD	NUMBER	.16	number	34	SENT_218	[p18l10t3274r473b3367],
34	’71	CD	NUMBER	’71	num	36	SENT_218	[p18l10t3274r473b3367],
35	Several	JJ	O	several	amod	36	SENT_218	[p18l499t3282r741b3346],
36	proﬁles	NNS	O	proﬁles	nsubjpass	39	SENT_218	[p18l760t3282r1010b3366],
37	have	VBP	O	have	aux	39	SENT_218	[p18l1030t3282r1185b3346],
38	been	VBN	O	be	auxpass	39	SENT_218	[p18l1203t3282r1367b3346],
39	identiﬁed	VBN	O	identiﬁed	rcmod	32	SENT_218	[p18l1388t3282r1712b3346],
40	but	CC	O	but	_	0	SENT_218	[p18l1730t3282r1843b3346],
41	have	VBP	O	have	aux	44	SENT_218	[p18l1862t3282r2016b3346],
42	not	RB	O	not	neg	44	SENT_218	[p18l2037t3294r2150b3346],
43	been	VBN	O	be	auxpass	44	SENT_218	[p18l7t3386r171b3449],
44	validated	VBN	O	validate	conj_but	29	SENT_218	[p18l190t3386r505b3449],
45	in	IN	O	in	_	0	SENT_218	[p18l527t3392r593b3448],
46	independent	JJ	O	independent	amod	47	SENT_218	[p18l616t3386r1051b3469],
47	laboratories	NNS	O	laboratory	prep_in	44	SENT_218	[p18l1070t3386r1495b3458],
48	,	,	O	,	_	0	SENT_218	[p18l1070t3386r1495b3458],
49	and	CC	O	and	_	0	SENT_218	[p18l1519t3386r1646b3449],
50	consensus	NN	O	consensus	nsubjpass	55	SENT_218	[p18l1668t3409r2015b3449],
51	has	VBZ	O	have	aux	55	SENT_218	[p18l2036t3386r2149b3449],
52	not	RB	O	not	neg	55	SENT_218	[p18l8t3501r121b3552],
53	yet	RB	O	yet	advmod	55	SENT_218	[p18l137t3501r238b3573],
54	been	VBN	O	be	auxpass	55	SENT_218	[p18l254t3489r416b3552],
55	reached	VBN	O	reach	conj_and	18	SENT_218	[p18l436t3489r701b3552],
56	on	IN	O	on	_	0	SENT_218	[p18l720t3512r805b3552],
57	this	DT	O	this	det	58	SENT_218	[p18l823t3489r946b3552],
58	approach	NN	O	approach	prep_on	55	SENT_218	[p18l967t3489r1279b3572],
59	to	TO	O	to	_	0	SENT_218	[p18l1298t3501r1363b3552],
60	biomarker	NN	O	biomarker	nn	61	SENT_218	[p18l1382t3489r1736b3552],
61	application	NN	O	application	prep_to	55	SENT_218	[p18l1755t3489r2145b3572],
62	.	.	O	.	_	0	SENT_218	[p18l1755t3489r2145b3572],

1	Particularly	RB	O	particularly	advmod	3	SENT_219	[p18l83t3592r483b3676],
2	urgently	RB	O	urgently	advmod	3	SENT_219	[p18l501t3592r788b3676],
3	needed	VBN	O	need	dep	4	SENT_219	[p18l806t3592r1053b3655],
4	are	VBP	O	be	_	0	SENT_219	[p18l1074t3615r1174b3655],
5	biomarkers	NNS	O	biomarker	nsubj	4	SENT_219	[p18l1195t3592r1582b3655],
6	that	WDT	O	that	nsubj	7	SENT_219	[p18l1604t3592r1737b3655],
7	deﬁne	VBP	O	deﬁne	ccomp	5	SENT_219	[p18l1759t3592r1966b3655],
8	populations	NNS	O	population	nsubj	9	SENT_219	[p18l1987t3614r2147b3675, p18l8t3695r289b3758],
9	responsive	JJ	O	responsive	xcomp	7	SENT_219	[p18l315t3701r686b3778],
10	to	TO	O	to	_	0	SENT_219	[p18l710t3707r778b3758],
11	speciﬁc	NN	O	speciﬁc	nn	12	SENT_219	[p18l805t3695r1065b3778],
12	interventions	NNS	O	intervention	prep_to	9	SENT_219	[p18l1090t3701r1576b3758],
13	.	.	O	.	_	0	SENT_219	[p18l1090t3701r1576b3758],

1	These	DT	O	these	nsubjpass	11	SENT_220	[p18l1604t3695r1804b3758],
2	would	MD	O	would	aux	4	SENT_220	[p18l1826t3695r2047b3758],
3	be	VB	O	be	auxpass	4	SENT_220	[p18l2069t3695r2150b3758],
4	used	VBN	O	use	_	0	SENT_220	[p19l8t17r171b80],
5	for	IN	O	for	_	0	SENT_220	[p19l193t17r293b80],
6	clinical	JJ	O	clinical	amod	7	SENT_220	[p19l317t17r568b80],
7	trials	NNS	O	trial	prep_for	4	SENT_220	[p19l590t17r766b80],
8	and	CC	O	and	_	0	SENT_220	[p19l791t17r920b80],
9	could	MD	O	could	aux	11	SENT_220	[p19l944t17r1139b80],
10	be	VB	O	be	auxpass	11	SENT_220	[p19l1159t17r1241b80],
11	incorporated	VBN	O	incorporate	conj_and	4	SENT_220	[p19l1265t17r1723b100],
12	as	IN	O	as	_	0	SENT_220	[p19l1746t40r1812b80],
13	companion	NN	O	companion	nn	14	SENT_220	[p19l1837t39r2147b100, p19l9t126r119b183],
14	diagnostics	NNS	O	diagnostic	prep_as	11	SENT_220	[p19l142t120r527b204],
15	after	IN	O	after	_	0	SENT_220	[p19l551t120r704b183],
16	approval	NN	O	approval	prep_after	11	SENT_220	[p19l726t120r1038b203],
17	.	.	O	.	_	0	SENT_220	[p19l726t120r1038b203],

1	The	DT	O	the	det	2	SENT_221	[p19l1064t120r1190b183],
2	companions	NNS	O	companion	nsubjpass	19	SENT_221	[p19l1213t126r1634b203],
3	might	MD	O	might	aux	4	SENT_221	[p19l1657t120r1862b204],
4	identify	VB	O	identify	_	0	SENT_221	[p19l1883t120r2152b204],
5	appropriate	JJ	O	appropriate	amod	6	SENT_221	[p19l9t229r398b306],
6	patients	NNS	O	patient	dobj	4	SENT_221	[p19l416t229r682b306],
7	for	IN	O	for	_	0	SENT_221	[p19l702t223r799b286],
8	treatment	NN	O	treatment	prep_for	6	SENT_221	[p19l816t235r1149b286],
9	by	IN	O	by	_	0	SENT_221	[p19l1165t223r1248b307],
10	practitioners	NNS	O	practitioner	prep_by	4	SENT_221	[p19l1263t229r1695b306],
11	and	CC	O	and	_	0	SENT_221	[p19l1716t223r1857b295],
12	,	,	O	,	_	0	SENT_221	[p19l1716t223r1857b295],
13	in	IN	O	in	dep	19	SENT_221	[p19l1879t229r1945b285],
14	some	DT	O	some	det	15	SENT_221	[p19l1965t246r2142b286],
15	cases	NNS	O	case	pobj	13	SENT_221	[p19l9t349r190b398],
16	,	,	O	,	_	0	SENT_221	[p19l9t349r190b398],
17	might	MD	O	might	aux	19	SENT_221	[p19l209t326r405b410],
18	be	VB	O	be	auxpass	19	SENT_221	[p19l421t326r498b389],
19	used	VBN	O	use	conj_and	4	SENT_221	[p19l516t326r669b389],
20	to	TO	O	to	aux	21	SENT_221	[p19l685t338r748b389],
21	monitor	VB	O	monitor	xcomp	19	SENT_221	[p19l768t332r1039b389],
22	therapeutic	JJ	O	therapeutic	amod	23	SENT_221	[p19l1055t326r1428b409],
23	responses	NNS	O	response	dobj	21	SENT_221	[p19l1447t348r1780b409],
24	.	.	O	.	_	0	SENT_221	[p19l1447t348r1780b409],

1	Candidate	NN	O	candidate	nn	2	SENT_222	[p19l1802t326r2139b389],
2	paradigms	NNS	O	paradigm	nsubj	3	SENT_222	[p19l7t429r383b513],
3	include	VBP	O	include	_	0	SENT_222	[p19l411t429r673b492],
4	use	NN	O	use	nsubj	9	SENT_222	[p19l700t452r815b492],
5	of	IN	O	of	_	0	SENT_222	[p19l843t429r919b492],
6	inﬂammatory	JJ	O	inﬂammatory	amod	7	SENT_222	[p19l938t429r1431b513],
7	markers	NNS	O	marker	prep_of	4	SENT_222	[p19l1454t429r1743b492],
8	to	TO	O	to	aux	9	SENT_222	[p19l1769t441r1838b492],
9	identify	VB	O	identify	xcomp	3	SENT_222	[p19l1867t429r2146b513],
10	patients	NNS	O	patient	dobj	9	SENT_222	[p19l7t538r277b615],
11	for	IN	O	for	_	0	SENT_222	[p19l299t532r397b595],
12	anti-inﬂammatory	JJ	O	anti-inﬂammatory	amod	13	SENT_222	[p19l419t532r1058b616],
13	agents	NNS	O	agent	prep_for	10	SENT_222	[p19l1078t544r1290b616],
14	or	CC	O	or	_	0	SENT_222	[p19l1314t555r1386b595],
15	use	NN	O	use	dobj	9	SENT_222	[p19l1407t555r1518b595],
16	of	IN	O	of	_	0	SENT_222	[p19l1541t532r1615b595],
17	isoprostanes	NNS	O	isoprostane	prep_of	15	SENT_222	[p19l1628t538r2053b615],
18	to	TO	O	to	aux	19	SENT_222	[p19l2075t544r2141b595],
19	identify	VB	O	identify	xcomp	9	SENT_222	[p19l9t634r278b718],
20	patients	NNS	O	patient	nsubjpass	23	SENT_222	[p19l295t640r567b717],
21	to	TO	O	to	aux	23	SENT_222	[p19l589t646r655b697],
22	be	VB	O	be	auxpass	23	SENT_222	[p19l677t634r757b697],
23	treated	VBN	O	treat	xcomp	19	SENT_222	[p19l778t634r1018b697],
24	with	IN	O	with	_	0	SENT_222	[p19l1038t634r1192b697],
25	antioXidants	NNS	O	antioxidant	prep_with	23	SENT_222	[p19l1215t626r1720b697],
26	.53	CD	NUMBER	.53	num	27	SENT_222	[p19l1215t626r1720b697],
27	Biomarkers	NNS	O	biomarker	nsubj	40	SENT_222	[p19l1745t634r2141b697],
28	that	WDT	O	that	nsubj	29	SENT_222	[p19l7t737r142b800],
29	bridge	VBP	O	bridge	rcmod	27	SENT_222	[p19l161t737r381b821],
30	disease	NN	O	disease	nn	31	SENT_222	[p19l405t737r647b800],
31	biology	NN	O	biology	dobj	29	SENT_222	[p19l667t737r928b821],
32	to	TO	O	to	_	0	SENT_222	[p19l946t749r1012b800],
33	mechanism	NN	O	mechanism	prep_to	29	SENT_222	[p19l1035t737r1435b800],
34	of	IN	O	of	_	0	SENT_222	[p19l1457t737r1532b800],
35	action	NN	O	action	prep_of	33	SENT_222	[p19l1545t743r1757b800],
36	of	IN	O	of	_	0	SENT_222	[p19l1781t737r1855b800],
37	putative	JJ	O	putative	amod	38	SENT_222	[p19l1867t743r2143b820],
38	therapies	NNS	O	therapy	prep_of	35	SENT_222	[p19l7t840r309b923],
39	will	MD	O	will	aux	40	SENT_222	[p19l327t840r450b903],
40	advance	VB	O	advance	rcmod	25	SENT_222	[p19l469t840r738b903],
41	the	DT	O	the	det	42	SENT_222	[p19l756t840r860b903],
42	ﬁeld	NN	O	ﬁeld	dobj	40	SENT_222	[p19l880t840r1039b912],
43	,	,	O	,	_	0	SENT_222	[p19l880t840r1039b912],
44	allow	VBP	O	allow	rcmod	25	SENT_222	[p19l1061t840r1239b903],
45	use	NN	O	use	dobj	44	SENT_222	[p19l1255t863r1363b903],
46	of	IN	O	of	_	0	SENT_222	[p19l1384t840r1456b903],
47	smaller	JJR	O	smaller	amod	49	SENT_222	[p19l1466t840r1710b903],
48	trial	NN	O	trial	nn	49	SENT_222	[p19l1727t840r1864b903],
49	populations	NNS	O	population	prep_of	45	SENT_222	[p19l1881t840r2140b923, p19l7t949r191b1015],
50	,	,	O	,	_	0	SENT_222	[p19l1881t840r2140b923, p19l7t949r191b1015],
51	and	CC	O	and	_	0	SENT_222	[p19l214t943r340b1006],
52	move	VB	O	move	rcmod	25	SENT_222	[p19l359t966r543b1006],
53	AD	NN	O	ad	nn	54	SENT_222	[p19l563t947r681b1005],
54	therapies	NNS	O	therapy	dobj	52	SENT_222	[p19l702t943r1009b1026],
55	toward	IN	O	toward	_	0	SENT_222	[p19l1029t943r1267b1006],
56	personalized	JJ	O	personalized	amod	57	SENT_222	[p19l1285t943r1718b1026],
57	medicine	NN	O	medicine	prep_toward	52	SENT_222	[p19l1737t943r2066b1006],
58	.	.	O	.	_	0	SENT_222	[p19l1737t943r2066b1006],

1	One	CD	NUMBER	one	num	3	SENT_223	[p19l83t1050r225b1109],
2	possible	JJ	O	possible	amod	3	SENT_223	[p19l244t1046r517b1129],
3	approach	NN	O	approach	nsubj	6	SENT_223	[p19l539t1046r852b1129],
4	is	VBZ	O	be	cop	6	SENT_223	[p19l872t1052r922b1109],
5	the	DT	O	the	det	6	SENT_223	[p19l942t1046r1048b1109],
6	identiﬁcation	NN	O	identiﬁcation	_	0	SENT_223	[p19l1068t1046r1522b1109],
7	of	IN	O	of	_	0	SENT_223	[p19l1542t1046r1615b1109],
8	small	JJ	O	small	amod	9	SENT_223	[p19l1627t1046r1807b1109],
9	groups	NNS	O	group	prep_of	6	SENT_223	[p19l1826t1068r2057b1130],
10	of	IN	O	of	_	0	SENT_223	[p19l2078t1046r2152b1109],
11	AD	NN	O	ad	nn	12	SENT_223	[p19l7t1153r124b1211],
12	patients	NNS	O	patient	prep_of	9	SENT_223	[p19l145t1155r410b1232],
13	that	WDT	O	that	nsubj	19	SENT_223	[p19l430t1149r562b1212],
14	have	VBP	O	have	rcmod	6	SENT_223	[p19l580t1149r734b1212],
15	unique	JJ	O	unique	amod	17	SENT_223	[p19l753t1155r989b1232],
16	biological	JJ	O	biological	amod	17	SENT_223	[p19l1007t1149r1338b1233],
17	features	NNS	O	feature	dobj	14	SENT_223	[p19l1357t1149r1618b1212],
18	and	CC	O	and	_	0	SENT_223	[p19l1640t1149r1764b1212],
19	respond	VBP	O	respond	conj_and	14	SENT_223	[p19l1784t1149r2058b1232],
20	to	TO	O	to	_	0	SENT_223	[p19l2075t1161r2141b1212],
21	therapies	NNS	O	therapy	prep_to	19	SENT_223	[p19l7t1252r311b1335],
22	with	IN	O	with	_	0	SENT_223	[p19l330t1252r480b1315],
23	linked	VBN	O	link	amod	24	SENT_223	[p19l499t1252r711b1315],
24	mechanisms	NNS	O	mechanism	prep_with	19	SENT_223	[p19l729t1252r1148b1315],
25	of	IN	O	of	_	0	SENT_223	[p19l1169t1252r1242b1315],
26	action	NN	O	action	prep_of	24	SENT_223	[p19l1253t1258r1477b1324],
27	;	:	O	;	_	0	SENT_223	[p19l1253t1258r1477b1324],
28	these	DT	O	these	nsubj	30	SENT_223	[p19l1498t1252r1670b1315],
29	might	MD	O	might	aux	30	SENT_223	[p19l1690t1252r1890b1336],
30	qualify	VB	O	qualify	parataxis	6	SENT_223	[p19l1909t1252r2144b1336],
31	as	IN	O	as	_	0	SENT_223	[p19l9t1377r72b1418],
32	rare	JJ	O	rare	amod	33	SENT_223	[p19l93t1377r225b1418],
33	diseases	NNS	O	disease	prep_as	30	SENT_223	[p19l245t1354r514b1418],
34	if	IN	O	if	mark	36	SENT_223	[p19l535t1354r588b1417],
35	there	EX	O	there	expl	36	SENT_223	[p19l598t1354r770b1418],
36	are	VBP	O	be	advcl	30	SENT_223	[p19l791t1377r890b1418],
37	<	JJR	O	<	acomp	36	SENT_223	[p19l913t1361r1218b1426],
38	200,000	CD	NUMBER	200,000	num	39	SENT_223	[p19l913t1361r1218b1426],
39	cases	NNS	O	case	npadvmod	36	SENT_223	[p19l1240t1377r1408b1418],
40	with	IN	O	with	_	0	SENT_223	[p19l1427t1354r1578b1418],
41	these	DT	O	these	det	42	SENT_223	[p19l1597t1354r1771b1418],
42	features	NNS	O	feature	prep_with	36	SENT_223	[p19l1791t1354r2053b1418],
43	in	IN	O	in	_	0	SENT_223	[p19l2074t1360r2139b1417],
44	the	DT	O	the	det	46	SENT_223	[p19l7t1458r111b1521],
45	United	NNP	LOCATION	United	nn	46	SENT_223	[p19l130t1458r359b1521],
46	States	NNPS	LOCATION	States	prep_in	42	SENT_223	[p19l379t1462r582b1521],
47	.	.	O	.	_	0	SENT_223	[p19l379t1462r582b1521],

1	This	DT	O	this	det	2	SENT_224	[p19l604t1458r743b1521],
2	approach	NN	O	approach	nsubj	4	SENT_224	[p19l764t1458r1072b1541],
3	might	MD	O	might	aux	4	SENT_224	[p19l1091t1458r1289b1542],
4	allow	VB	O	allow	_	0	SENT_224	[p19l1308t1458r1486b1521],
5	the	DT	O	the	det	6	SENT_224	[p19l1501t1458r1605b1521],
6	sponsor	NN	O	sponsor	dobj	4	SENT_224	[p19l1625t1480r1889b1541],
7	to	TO	O	to	aux	8	SENT_224	[p19l1906t1470r1971b1521],
8	beneﬁt	JJ	O	beneﬁt	infmod	6	SENT_224	[p19l1989t1458r2140b1521, p19l9t1561r114b1624],
9	from	IN	O	from	_	0	SENT_224	[p19l134t1561r302b1624],
10	the	DT	O	the	det	11	SENT_224	[p19l323t1561r429b1624],
11	incentives	NNS	O	incentive	prep_from	8	SENT_224	[p19l452t1567r793b1624],
12	of	IN	O	of	_	0	SENT_224	[p19l816t1561r890b1624],
13	the	DT	O	the	det	16	SENT_224	[p19l901t1561r1008b1624],
14	Orphan	NNP	MISC	Orphan	nn	16	SENT_224	[p19l1031t1561r1298b1644],
15	Drug	NNP	MISC	Drug	nn	16	SENT_224	[p19l1321t1566r1501b1645],
16	Act	NNP	MISC	Act	prep_of	11	SENT_224	[p19l1520t1565r1655b1624],
17	.	.	O	.	_	0	SENT_224	[p19l1520t1565r1655b1624],

1	Development	NN	O	development	nsubj	11	SENT_225	[p19l1680t1561r2143b1644],
2	of	IN	O	of	_	0	SENT_225	[p19l9t1664r85b1727],
3	“	NN	O	“	nn	6	SENT_225	[p19l103t1664r328b1727],
4	niche	NN	O	niche	nn	6	SENT_225	[p19l103t1664r328b1727],
5	therapies	NNS	O	therapy	nn	6	SENT_225	[p19l354t1664r711b1747],
6	”	NN	O	”	prep_of	1	SENT_225	[p19l354t1664r711b1747],
7	within	IN	O	within	_	0	SENT_225	[p19l738t1664r970b1727],
8	AD	NN	O	ad	prep_within	6	SENT_225	[p19l996t1668r1118b1726],
9	is	VBZ	O	be	cop	11	SENT_225	[p19l1147t1670r1199b1727],
10	biologically	RB	O	biologically	advmod	11	SENT_225	[p19l1224t1664r1643b1748],
11	plausible	JJ	O	plausible	_	0	SENT_225	[p19l1666t1664r1982b1747],
12	and	CC	O	and	_	0	SENT_225	[p19l2010t1664r2141b1727],
13	commercially	RB	O	commercially	advmod	14	SENT_225	[p19l9t1767r478b1851],
14	attractive	JJ	O	attractive	conj_and	11	SENT_225	[p19l496t1773r829b1830],
15	.	.	O	.	_	0	SENT_225	[p19l496t1773r829b1830],

1	BIOMARKERS	NNS	O	biomarker	_	0	SENT_226	[p19l12t1981r488b2037],
2	OF	IN	O	of	_	0	SENT_226	[p19l508t1981r601b2037],
3	CURRENT	JJ	DATE	current	amod	6	SENT_226	[p19l621t1982r961b2037],
4	SYMPTOMATIC	JJ	O	symptomatic	amod	6	SENT_226	[p19l978t1981r1510b2037],
5	TH	NN	O	th	nn	6	SENT_226	[p19l1525t1982r1617b2036],
6	ERAPIES	NNS	O	erapy	prep_of	1	SENT_226	[p19l1629t1982r1924b2037],

1	FOR	IN	O	for	_	0	SENT_227	[p19l12t2084r153b2140],
2	AD	NN	O	ad	prep_for	4	SENT_227	[p19l170t2085r274b2139],
3	Biomarkers	NNS	O	biomarker	nsubj	4	SENT_227	[p19l9t2180r401b2243],
4	played	VBD	O	play	_	0	SENT_227	[p19l422t2180r645b2264],
5	a	DT	O	a	det	8	SENT_227	[p19l665t2203r700b2243],
6	relatively	RB	O	relatively	advmod	7	SENT_227	[p19l720t2180r1031b2264],
7	small	JJ	O	small	amod	8	SENT_227	[p19l1049t2180r1229b2243],
8	role	NN	O	role	dobj	4	SENT_227	[p19l1250t2180r1378b2243],
9	in	IN	O	in	_	0	SENT_227	[p19l1400t2186r1466b2242],
10	the	DT	O	the	det	11	SENT_227	[p19l1486t2180r1592b2243],
11	development	NN	O	development	prep_in	4	SENT_227	[p19l1614t2180r2058b2263],
12	of	IN	O	of	_	0	SENT_227	[p19l2078t2180r2151b2243],
13	current	JJ	DATE	current	amod	14	SENT_227	[p19l9t2295r261b2346],
14	therapies	NNS	O	therapy	prep_of	11	SENT_227	[p19l282t2283r593b2366],
15	of	IN	O	of	_	0	SENT_227	[p19l617t2283r691b2346],
16	AD	NN	O	ad	prep_of	14	SENT_227	[p19l703t2287r837b2346],
17	.	.	O	.	_	0	SENT_227	[p19l703t2287r837b2346],

1	Studies	NNS	O	study	nsubj	6	SENT_228	[p19l863t2283r1107b2346],
2	of	IN	O	of	_	0	SENT_228	[p19l1131t2283r1205b2346],
3	serum	NN	O	serum	nn	5	SENT_228	[p19l1219t2306r1433b2346],
4	acetylcholinesterase	NN	O	acetylcholinesterase	nn	5	SENT_228	[p19l1456t2283r2141b2367],
5	inhibition	NN	O	inhibition	prep_of	1	SENT_228	[p19l9t2386r363b2449],
6	showed	VBD	O	show	_	0	SENT_228	[p19l390t2386r656b2449],
7	that	IN	O	that	complm	12	SENT_228	[p19l680t2386r818b2449],
8	5	CD	NUMBER	5	num	9	SENT_228	[p19l844t2394r879b2449],
9	mg	NN	O	mg	nsubj	12	SENT_228	[p19l897t2409r1009b2470],
10	of	IN	O	of	_	0	SENT_228	[p19l1033t2386r1109b2449],
11	donepezil	NN	O	donepezil	prep_of	9	SENT_228	[p19l1126t2386r1472b2469],
12	produced	VBD	O	produce	ccomp	6	SENT_228	[p19l1496t2386r1836b2469],
13	62-71	CD	PERCENT	62-71	num	14	SENT_228	[p19l1861t2391r2140b2451],
14	%	NN	PERCENT	%	dobj	12	SENT_228	[p19l1861t2391r2140b2451],
15	inhibition	NN	O	inhibition	dep	14	SENT_228	[p19l9t2489r381b2561],
16	,	,	O	,	_	0	SENT_228	[p19l9t2489r381b2561],
17	and	CC	O	and	_	0	SENT_228	[p19l408t2489r538b2552],
18	10	CD	NUMBER	10	num	19	SENT_228	[p19l568t2496r641b2552],
19	mg	NN	O	mg	nsubj	20	SENT_228	[p19l658t2512r769b2573],
20	produced	VBD	O	produce	conj_and	6	SENT_228	[p19l791t2489r1130b2572],
21	74-83	CD	PERCENT	74-83	num	23	SENT_228	[p19l1155t2495r1432b2554],
22	%	NN	PERCENT	%	nn	23	SENT_228	[p19l1155t2495r1432b2554],
23	inhibition	NN	O	inhibition	dobj	20	SENT_228	[p19l1459t2489r1812b2552],
24	at	IN	O	at	_	0	SENT_228	[p19l1838t2501r1899b2552],
25	steady	JJ	O	steady	amod	26	SENT_228	[p19l1924t2489r2147b2573],
26	state	NN	O	state	prep_at	23	SENT_228	[p19l9t2583r245b2654],
27	.72	CD	NUMBER	.72	num	26	SENT_228	[p19l9t2583r245b2654],
28	However	RB	O	however	advmod	26	SENT_228	[p19l269t2596r592b2663],
29	,	,	O	,	_	0	SENT_228	[p19l269t2596r592b2663],
30	studies	NNS	O	study	appos	23	SENT_228	[p19l617t2591r854b2654],
31	that	WDT	O	that	nsubj	32	SENT_228	[p19l877t2591r1013b2654],
32	measured	VBD	O	measure	rcmod	30	SENT_228	[p19l1034t2591r1372b2654],
33	brain	NN	O	brain	nn	35	SENT_228	[p19l1391t2591r1574b2654],
34	acetylcholinesterase	NN	O	acetylcholinesterase	nn	35	SENT_228	[p19l1598t2591r2139b2675, p19l9t2717r179b2757],
35	inhibition	NN	O	inhibition	nsubj	38	SENT_228	[p19l201t2694r541b2757],
36	with	IN	O	with	_	0	SENT_228	[p19l559t2694r712b2757],
37	PET	NN	O	pet	prep_with	35	SENT_228	[p19l733t2697r878b2756],
38	showed	VBD	O	show	ccomp	32	SENT_228	[p19l900t2694r1157b2757],
39	that	IN	O	that	complm	45	SENT_228	[p19l1176t2694r1309b2757],
40	substantially	RB	O	substantially	advmod	41	SENT_228	[p19l1330t2694r1761b2778],
41	less	JJR	O	less	amod	43	SENT_228	[p19l1777t2694r1895b2757],
42	acetylcholinesterase	NN	O	acetylcholinesterase	nn	43	SENT_228	[p19l1917t2694r2140b2778, p19l9t2796r501b2859],
43	inhibition	NN	O	inhibition	nsubjpass	45	SENT_228	[p19l525t2796r873b2859],
44	was	VBD	O	be	auxpass	45	SENT_228	[p19l895t2819r1023b2859],
45	achieved	VBN	O	achieve	ccomp	38	SENT_228	[p19l1048t2796r1354b2859],
46	in	IN	O	in	_	0	SENT_228	[p19l1376t2802r1444b2858],
47	the	DT	O	the	det	50	SENT_228	[p19l1466t2796r1575b2859],
48	central	JJ	O	central	amod	50	SENT_228	[p19l1599t2796r1838b2859],
49	nervous	JJ	O	nervous	amod	50	SENT_228	[p19l1860t2819r2140b2859],
50	system	NN	O	system	prep_in	45	SENT_228	[p19l9t2911r263b2983],
51	.	.	O	.	_	0	SENT_228	[p19l9t2911r263b2983],

1	Brain	NN	O	brain	nn	3	SENT_229	[p19l291t2904r481b2962],
2	acetylcholinesterase	NN	O	acetylcholinesterase	nn	3	SENT_229	[p19l505t2899r1205b2983],
3	inhibition	NN	O	inhibition	nsubj	4	SENT_229	[p19l1229t2899r1579b2962],
4	ranged	VBD	O	range	_	0	SENT_229	[p19l1603t2899r1844b2983],
5	from	IN	O	from	_	0	SENT_229	[p19l1866t2899r2038b2962],
6	20	CD	NUMBER	20	number	8	SENT_229	[p19l2062t2906r2141b2962],
7	to	TO	O	to	dep	8	SENT_229	[p19l7t3014r73b3065],
8	40	CD	PERCENT	40	num	9	SENT_229	[p19l96t3008r239b3066],
9	%	NN	PERCENT	%	prep_from	4	SENT_229	[p19l96t3008r239b3066],
10	following	VBG	O	follow	_	0	SENT_229	[p19l263t3002r586b3086],
11	administration	NN	O	administration	prep_following	9	SENT_229	[p19l606t3002r1116b3065],
12	of	IN	O	of	_	0	SENT_229	[p19l1139t3002r1213b3065],
13	10	CD	NUMBER	10	num	14	SENT_229	[p19l1232t3009r1303b3065],
14	mg	NN	O	mg	prep_of	11	SENT_229	[p19l1318t3025r1427b3086],
15	of	IN	O	of	_	0	SENT_229	[p19l1448t3002r1522b3065],
16	donepezil	NN	O	donepezil	prep_of	14	SENT_229	[p19l1535t3002r1868b3085],
17	or	CC	O	or	_	0	SENT_229	[p19l1890t3025r1962b3065],
18	9	CD	NUMBER	9	num	19	SENT_229	[p19l1984t3009r2019b3065],
19	mg	NN	O	mg	conj_or	14	SENT_229	[p19l2035t3025r2144b3086],
20	of	IN	O	of	_	0	SENT_229	[p19l9t3104r82b3167],
21	rivastigmine	NN	O	rivastigmine	prep_of	19	SENT_229	[p19l93t3096r671b3188],
22	.73	CD	NUMBER	.73	number	23	SENT_229	[p19l93t3096r671b3188],
23	’74	CD	NUMBER	’74	dobj	4	SENT_229	[p19l93t3096r671b3188],
24	These	DT	O	these	det	25	SENT_229	[p19l690t3104r882b3167],
25	observations	NNS	O	observation	nsubj	26	SENT_229	[p19l903t3104r1331b3167],
26	contributed	VBD	O	contribute	rcmod	23	SENT_229	[p19l1352t3104r1747b3167],
27	to	TO	O	to	_	0	SENT_229	[p19l1765t3116r1830b3167],
28	the	DT	O	the	det	29	SENT_229	[p19l1850t3104r1955b3167],
29	decision	NN	O	decision	prep_to	26	SENT_229	[p19l1976t3104r2139b3167, p19l9t3213r149b3270],
30	to	TO	O	to	aux	31	SENT_229	[p19l170t3219r235b3270],
31	develop	VB	O	develop	infmod	29	SENT_229	[p19l259t3207r521b3290],
32	high	JJ	O	high	amod	35	SENT_229	[p19l543t3207r885b3291],
33	—	NN	O	—	nn	35	SENT_229	[p19l543t3207r885b3291],
34	dose	NN	O	dose	nn	35	SENT_229	[p19l543t3207r885b3291],
35	forms	NNS	O	form	dobj	31	SENT_229	[p19l907t3207r1104b3270],
36	of	IN	O	of	_	0	SENT_229	[p19l1127t3207r1201b3270],
37	donepezil	NN	O	donepezil	prep_of	35	SENT_229	[p19l1213t3207r1546b3290],
38	and	CC	O	and	_	0	SENT_229	[p19l1567t3207r1693b3270],
39	rivastigmine	NN	O	rivastigmine	prep_of	35	SENT_229	[p19l1714t3213r2142b3291],
40	that	WDT	O	that	nsubj	41	SENT_229	[p19l7t3310r144b3373],
41	achieve	VBP	O	achieve	rcmod	35	SENT_229	[p19l168t3310r426b3373],
42	higher	JJR	O	higher	amod	43	SENT_229	[p19l449t3310r679b3394],
43	levels	NNS	O	level	dobj	41	SENT_229	[p19l700t3310r890b3373],
44	of	IN	O	of	_	0	SENT_229	[p19l915t3310r991b3373],
45	central	JJ	O	central	amod	47	SENT_229	[p19l1005t3310r1246b3373],
46	cholinesterase	NN	O	cholinesterase	nn	47	SENT_229	[p19l1270t3310r1765b3373],
47	inhibition	NN	O	inhibition	prep_of	43	SENT_229	[p19l1790t3310r2140b3373],
48	and	CC	O	and	_	0	SENT_229	[p19l9t3412r135b3475],
49	improve	VB	O	improve	infmod	29	SENT_229	[p19l155t3418r437b3495],
50	clinical	JJ	O	clinical	amod	51	SENT_229	[p19l459t3412r703b3475],
51	outcomes	NNS	O	outcome	nsubj	53	SENT_229	[p19l724t3404r1256b3475],
52	.5	CD	NUMBER	.5	npadvmod	53	SENT_229	[p19l724t3404r1256b3475],
53	>	JJR	O	>	xcomp	49	SENT_229	[p19l724t3404r1256b3475],
54	75	CD	NUMBER	75	num	55	SENT_229	[p19l724t3404r1256b3475],
55	>	JJR	O	>	dobj	31	SENT_229	[p19l724t3404r1256b3475],
56	76	CD	NUMBER	76	dobj	26	SENT_229	[p19l724t3404r1256b3475],
57	This	DT	O	this	nsubj	60	SENT_229	[p19l1278t3412r1420b3475],
58	is	VBZ	O	be	cop	60	SENT_229	[p19l1442t3418r1492b3475],
59	an	DT	O	a	det	60	SENT_229	[p19l1514t3435r1594b3475],
60	example	NN	O	example	rcmod	56	SENT_229	[p19l1616t3412r1898b3495],
61	of	IN	O	of	_	0	SENT_229	[p19l1920t3412r1993b3475],
62	biomarker-informed	JJ	O	biomarker-informed	amod	63	SENT_229	[p19l2003t3412r2138b3475, p19l8t3515r608b3578],
63	decisions	NNS	O	decision	prep_of	60	SENT_229	[p19l629t3515r942b3578],
64	in	IN	O	in	_	0	SENT_229	[p19l965t3521r1031b3577],
65	drug	NN	O	drug	nn	66	SENT_229	[p19l1053t3515r1215b3599],
66	development	NN	O	development	prep_in	63	SENT_229	[p19l1236t3515r1695b3598],
67	.	.	O	.	_	0	SENT_229	[p19l1236t3515r1695b3598],

1	BIOMARKERS	NNS	O	biomarker	_	0	SENT_230	[p19l12t3729r488b3785],
2	OF	IN	O	of	_	0	SENT_230	[p19l508t3729r601b3785],
3	ADVERSE	JJ	O	adverse	amod	4	SENT_230	[p19l620t3730r955b3785],
4	EVENTS	NNS	O	event	prep_of	1	SENT_230	[p19l976t3730r1250b3785],

1	Amyloid	JJ	O	amyloid	amod	5	SENT_231	[p20l7t27r608b111],
2	—	NN	O	—	nn	5	SENT_231	[p20l7t27r608b111],
3	related	JJ	O	related	amod	5	SENT_231	[p20l7t27r608b111],
4	imaging	NN	O	imaging	nn	5	SENT_231	[p20l639t33r936b111],
5	abnormalities	NNS	O	abnormality	nsubj	6	SENT_231	[p20l967t27r1466b90],
6	(	VBP	O	(	_	0	SENT_231	[p20l1502t28r1796b104],
7	ARIAS	NNP	O	ARIAS	nsubj	27	SENT_231	[p20l1502t28r1796b104],
8	)	CD	NUMBER	)	num	7	SENT_231	[p20l1502t28r1796b104],
9	of	IN	O	of	_	0	SENT_231	[p20l1833t27r1910b90],
10	either	CC	O	either	preconj	14	SENT_231	[p20l1933t27r2143b90],
11	the	DT	O	the	det	14	SENT_231	[p20l7t130r115b193],
12	hemorrhagic	JJ	O	hemorrhagic	amod	14	SENT_231	[p20l138t130r591b214],
13	(	NN	O	(	nn	14	SENT_231	[p20l619t131r846b206],
14	ARIA	NN	ORGANIZATION	aria	prep_of	7	SENT_231	[p20l619t131r846b206],
15	-	:	O	-	_	0	SENT_231	[p20l873t131r992b207],
16	H	NN	O	h	dep	14	SENT_231	[p20l873t131r992b207],
17	)	CD	NUMBER	)	num	16	SENT_231	[p20l873t131r992b207],
18	or	CC	O	or	_	0	SENT_231	[p20l1021t153r1095b193],
19	effusion	NN	O	effusion	nn	21	SENT_231	[p20l1118t130r1397b193],
20	(	CD	NUMBER	(	num	21	SENT_231	[p20l1425t131r1653b206],
21	ARIA	NN	ORGANIZATION	aria	conj_or	14	SENT_231	[p20l1425t131r1653b206],
22	-	:	O	-	_	0	SENT_231	[p20l1679t131r1781b207],
23	E	NN	O	e	nn	25	SENT_231	[p20l1679t131r1781b207],
24	)	CD	NUMBER	)	num	25	SENT_231	[p20l1679t131r1781b207],
25	type	NN	O	type	conj_or	14	SENT_231	[p20l1809t142r1958b214],
26	have	VBP	O	have	aux	27	SENT_231	[p20l1982t130r2141b193],
27	emerged	VBN	O	emerge	ccomp	6	SENT_231	[p20l9t232r302b316],
28	in	IN	O	in	_	0	SENT_231	[p20l323t238r389b294],
29	some	DT	O	some	det	31	SENT_231	[p20l410t255r586b295],
30	clinical	JJ	O	clinical	amod	31	SENT_231	[p20l608t232r847b295],
31	trials	NNS	O	trial	prep_in	27	SENT_231	[p20l867t232r1034b295],
32	of	IN	O	of	_	0	SENT_231	[p20l1056t232r1129b295],
33	antiamyloid	JJ	O	antiamyloid	amod	34	SENT_231	[p20l1142t232r1544b316],
34	agents	NNS	O	agent	prep_of	31	SENT_231	[p20l1565t224r1927b316],
35	.77	CD	NUMBER	.77	number	36	SENT_231	[p20l1565t224r1927b316],
36	’78	CD	NUMBER	’78	dep	34	SENT_231	[p20l1565t224r1927b316],
37	These	DT	O	these	dep	36	SENT_231	[p20l1949t232r2142b295],

1	Table	NNP	O	Table	nsubj	9	SENT_232	[p20l19t391r106b418],
2	2	CD	NUMBER	2	num	4	SENT_232	[p20l114t393r131b418],
3	Enrichment	NN	O	enrichment	nn	4	SENT_232	[p20l153t391r337b418],
4	strategies	NNS	O	strategy	npadvmod	8	SENT_232	[p20l344t392r502b426],
5	for	IN	O	for	_	0	SENT_232	[p20l509t391r555b418],
6	clinical	JJ	O	clinical	amod	7	SENT_232	[p20l562t391r672b418],
7	trials	NNS	O	trial	prep_for	4	SENT_232	[p20l680t391r760b418],
8	as	IN	O	as	advmod	9	SENT_232	[p20l768t399r801b418],
9	described	VBN	O	describe	_	0	SENT_232	[p20l809t391r965b418],
10	by	IN	O	by	_	0	SENT_232	[p20l975t391r1013b426],
11	the	DT	O	the	det	12	SENT_232	[p20l1019t391r1072b418],
12	FDA	NNP	ORGANIZATION	FDA	prep_by	9	SENT_232	[p20l1081t392r1145b418],
13	(	CD	NUMBER	(	num	12	SENT_232	[p20l1154t392r1253b422],
14	2012	CD	DATE	2012	num	15	SENT_232	[p20l1154t392r1253b422],
15	)	NN	O	)	dep	12	SENT_232	[p20l1154t392r1253b422],

1	Example	NN	O	example	_	0	SENT_233	[p20l1637t452r1758b483],
2	in	IN	O	in	_	0	SENT_233	[p20l1767t453r1790b476],
3	Alzheimer	NNP	O	Alzheimer	poss	5	SENT_233	[p20l1799t452r1963b477],
4	's	POS	O	's	_	0	SENT_233	[p20l1799t452r1963b477],
5	disease	NN	O	disease	prep_in	1	SENT_233	[p20l1971t452r2076b477],

1	Strategy	NNP	O	Strategy	nn	4	SENT_234	[p20l20t492r140b522],
2	Description	NN	O	description	nn	4	SENT_234	[p20l369t492r532b522],
3	clinicaltrials	NNS	O	clinicaltrial	nn	4	SENT_234	[p20l1768t491r1944b515],
4	Strategies	NNS	O	strategy	nsubj	6	SENT_234	[p20l21t569r156b600],
5	to	TO	O	to	aux	6	SENT_234	[p20l163t572r190b593],
6	decrease	VB	O	decrease	_	0	SENT_234	[p20l198t568r320b593],
7	Selecting	VBG	O	select	ccomp	6	SENT_234	[p20l368t568r494b600],
8	patients	NNS	O	patient	dobj	7	SENT_234	[p20l504t569r614b599],
9	with	IN	O	with	_	0	SENT_234	[p20l621t568r680b593],
10	baseline	NN	O	baseline	nn	11	SENT_234	[p20l690t568r803b593],
11	measurements	NNS	O	measurement	prep_with	7	SENT_234	[p20l812t572r1015b593],
12	in	IN	O	in	_	0	SENT_234	[p20l1024t569r1046b593],
13	a	DT	O	a	det	15	SENT_234	[p20l1055t575r1068b593],
14	narrow	JJ	O	narrow	amod	15	SENT_234	[p20l1077t575r1174b593],
15	range	NN	O	range	prep_in	11	SENT_234	[p20l1182t575r1259b600],
16	and	CC	O	and	_	0	SENT_234	[p20l1267t568r1317b593],
17	Narrowing	VBG	O	narrow	conj_and	7	SENT_234	[p20l1587t569r1730b600],
18	the	DT	O	the	det	19	SENT_234	[p20l1738t568r1783b593],
19	range	NN	O	range	dobj	17	SENT_234	[p20l1792t575r1869b600],
20	of	IN	O	of	_	0	SENT_234	[p20l1877t568r1905b593],
21	the	DT	O	the	det	23	SENT_234	[p20l1910t568r1955b593],
22	severity	NN	O	severity	nn	23	SENT_234	[p20l1963t569r2069b600],
23	heterogeneity	NN	O	heterogeneity	prep_of	17	SENT_234	[p20l21t607r216b639],
24	excluding	VBG	O	exclude	_	0	SENT_234	[p20l368t607r501b639],
25	patients	NNS	O	patient	prep_excluding	23	SENT_234	[p20l511t609r621b639],
26	whose	WP$	O	whose	poss	27	SENT_234	[p20l628t607r718b632],
27	disease	NN	O	disease	nsubj	30	SENT_234	[p20l726t607r826b632],
28	or	CC	O	or	_	0	SENT_234	[p20l834t615r862b632],
29	symptoms	NNS	O	symptom	nsubj	30	SENT_234	[p20l869t611r1012b639],
30	improve	VBP	O	improve	rcmod	25	SENT_234	[p20l1021t609r1134b639],
31	spontaneously	RB	O	spontaneously	advmod	30	SENT_234	[p20l1142t607r1345b639],
32	or	CC	O	or	_	0	SENT_234	[p20l1352t615r1380b632],
33	of	IN	O	of	_	0	SENT_234	[p20l1586t607r1614b632],
34	cognitive	JJ	O	cognitive	amod	35	SENT_234	[p20l1620t609r1747b639],
35	impairment	NN	O	impairment	conj_or	23	SENT_234	[p20l1755t609r1916b639],
36	of	IN	O	of	_	0	SENT_234	[p20l1923t607r1952b632],
37	patients	NNS	O	patient	prep_of	35	SENT_234	[p20l1958t609r2068b639],
38	whose	WP$	O	whose	poss	39	SENT_234	[p20l368t647r457b671],
39	measurements	NNS	O	measurement	nsubj	42	SENT_234	[p20l466t651r669b671],
40	are	VBP	O	be	cop	42	SENT_234	[p20l677t654r718b671],
41	highly	RB	O	highly	advmod	42	SENT_234	[p20l727t647r812b678],
42	variable	JJ	O	variable	rcmod	37	SENT_234	[p20l818t647r927b671],
43	included	VBN	O	include	prep	42	SENT_234	[p20l1587t647r1704b671],
44	in	IN	O	in	pcomp	43	SENT_234	[p20l1714t648r1736b671],
45	the	DT	O	the	det	46	SENT_234	[p20l1745t647r1790b671],
46	trial	NN	O	trial	pobj	44	SENT_234	[p20l1796t647r1855b675],
47	,	,	O	,	_	0	SENT_234	[p20l1796t647r1855b675],
48	such	JJ	O	such	_	0	SENT_234	[p20l1863t647r1925b671],
49	as	IN	O	as	_	0	SENT_234	[p20l1934t654r1961b671],
50	limiting	VBG	O	limit	prepc_such_as	37	SENT_234	[p20l1970t647r2073b678],
51	the	DT	O	the	det	52	SENT_234	[p20l2081t647r2126b671],
52	population	NN	O	population	dobj	50	SENT_234	[p20l1587t686r1737b717],
53	to	TO	O	to	_	0	SENT_234	[p20l1745t690r1773b711],
54	those	DT	O	those	prep_to	50	SENT_234	[p20l1780t686r1856b711],
55	with	IN	O	with	_	0	SENT_234	[p20l1863t686r1922b711],
56	prodromal	JJ	O	prodromal	amod	57	SENT_234	[p20l1932t686r2075b717],
57	AD	NN	O	ad	prep_with	54	SENT_234	[p20l2084t687r2125b711],

1	Prognostic	JJ	O	prognostic	amod	2	SENT_235	[p20l21t764r166b794],
2	enrichment	NN	O	enrichment	_	0	SENT_235	[p20l174t763r334b788],
3	Choosing	VBG	O	choose	partmod	2	SENT_235	[p20l368t763r497b794],
4	patients	NNS	O	patient	dobj	3	SENT_235	[p20l507t764r617b794],
5	with	IN	O	with	_	0	SENT_235	[p20l624t763r684b788],
6	a	DT	O	a	det	8	SENT_235	[p20l692t770r706b788],
7	greater	JJR	O	greater	amod	8	SENT_235	[p20l714t767r813b794],
8	likelihood	NN	O	likelihood	prep_with	3	SENT_235	[p20l821t763r954b788],
9	of	IN	O	of	_	0	SENT_235	[p20l963t763r992b788],
10	having	VBG	O	have	prepc_of	8	SENT_235	[p20l998t763r1089b794],
11	a	DT	O	a	det	13	SENT_235	[p20l1098t770r1111b788],
12	disease	NN	O	disease	nn	13	SENT_235	[p20l1119t763r1327b788],
13	—	NN	O	—	nsubj	15	SENT_235	[p20l1119t763r1327b788],
14	related	JJ	O	related	amod	15	SENT_235	[p20l1119t763r1327b788],
15	end	NN	O	end	xcomp	10	SENT_235	[p20l1336t763r1387b788],
16	Choosing	VBG	O	choose	partmod	15	SENT_235	[p20l1586t763r1715b794],
17	prodromal	JJ	O	prodromal	amod	19	SENT_235	[p20l1725t763r1868b794],
18	AD	NN	O	ad	nn	19	SENT_235	[p20l1877t764r1918b787],
19	patients	NNS	O	patient	dobj	16	SENT_235	[p20l1926t764r2036b794],
20	strategies	NNS	O	strategy	nn	21	SENT_235	[p20l20t804r153b834],
21	point	NN	O	point	tmod	16	SENT_235	[p20l369t804r441b834],
22	or	CC	O	or	_	0	SENT_235	[p20l448t810r476b827],
23	a	DT	O	a	det	24	SENT_235	[p20l483t810r496b827],
24	substantial	JJ	O	substantial	conj_or	21	SENT_235	[p20l505t802r653b827],
25	worsening	VBG	O	worsen	amod	24	SENT_235	[p20l662t804r806b834],
26	in	IN	O	in	_	0	SENT_235	[p20l816t804r838b827],
27	condition	NN	O	condition	prep_in	2	SENT_235	[p20l847t802r977b827],
28	with	IN	O	with	_	0	SENT_235	[p20l1585t802r1645b827],
29	more	RBR	O	more	advmod	30	SENT_235	[p20l1655t810r1725b827],
30	severe	JJ	O	severe	amod	32	SENT_235	[p20l1733t810r1820b827],
31	cognitive	JJ	O	cognitive	amod	32	SENT_235	[p20l1828t804r1955b834],
32	deﬁcits	NNS	O	deﬁcits	prep_with	27	SENT_235	[p20l1962t802r2060b827],
33	to	TO	O	to	aux	34	SENT_235	[p20l2067t806r2095b827],
34	enhance	VB	O	enhance	infmod	27	SENT_235	[p20l1586t842r1704b866],
35	the	DT	O	the	det	36	SENT_235	[p20l1711t842r1756b866],
36	numbers	NNS	O	number	dobj	34	SENT_235	[p20l1764t842r1885b866],
37	who	WP	O	who	nsubj	38	SENT_235	[p20l1893t842r1952b866],
38	progress	VBP	O	progress	rcmod	36	SENT_235	[p20l1961t849r2078b873],
39	to	TO	O	to	_	0	SENT_235	[p20l2085t846r2113b866],
40	AD	NN	O	ad	nn	41	SENT_235	[p20l1586t881r1626b905],
41	dementia	NN	O	dementia	prep_to	38	SENT_235	[p20l1634t880r1764b905],
42	in	IN	O	in	_	0	SENT_235	[p20l1774t882r1796b905],
43	the	DT	O	the	det	46	SENT_235	[p20l1804t880r1849b905],
44	course	NN	O	course	nn	46	SENT_235	[p20l1857t888r1947b905],
45	ofthe	NN	O	ofthe	nn	46	SENT_235	[p20l1955t880r2033b905],
46	trial	NN	O	trial	prep_in	41	SENT_235	[p20l2040t880r2091b905],

1	Predictive	JJ	O	predictive	amod	2	SENT_236	[p20l21t944r156b968],
2	enrichment	NN	O	enrichment	_	0	SENT_236	[p20l163t944r323b968],
3	Choosing	VBG	O	choose	partmod	2	SENT_236	[p20l368t944r497b975],
4	patients	NNS	O	patient	nsubj	6	SENT_236	[p20l507t945r617b975],
5	more	RBR	O	more	advmod	6	SENT_236	[p20l626t951r696b968],
6	likely	JJ	O	likely	xcomp	3	SENT_236	[p20l705t944r774b975],
7	to	TO	O	to	aux	8	SENT_236	[p20l780t948r808b968],
8	respond	VB	O	respond	xcomp	6	SENT_236	[p20l817t944r928b975],
9	to	TO	O	to	_	0	SENT_236	[p20l936t948r964b968],
10	the	DT	O	the	det	12	SENT_236	[p20l971t944r1016b968],
11	drug	NN	O	drug	nn	12	SENT_236	[p20l1023t944r1087b975],
12	treatment	NN	O	treatment	prep_to	8	SENT_236	[p20l1095t948r1233b968],
13	than	IN	O	than	_	0	SENT_236	[p20l1240t944r1301b968],
14	other	JJ	O	other	amod	17	SENT_236	[p20l1310t944r1384b968],
15	Requiring	VBG	O	require	amod	17	SENT_236	[p20l1587t945r1718b975],
16	amyloid	NN	O	amyloid	nn	17	SENT_236	[p20l1727t944r1836b975],
17	abnormalities	NNS	O	abnormality	prep_than	8	SENT_236	[p20l1845t944r2034b968],
18	strategies	NNS	O	strategy	nn	19	SENT_236	[p20l20t984r153b1014],
19	patients	NNS	O	patient	dep	17	SENT_236	[p20l369t984r479b1014],
20	with	IN	O	with	_	0	SENT_236	[p20l486t982r545b1007],
21	the	DT	O	the	det	22	SENT_236	[p20l554t982r599b1007],
22	condition	NN	O	condition	prep_with	6	SENT_236	[p20l606t982r737b1007],
23	being	VBG	O	be	auxpass	24	SENT_236	[p20l747t982r823b1014],
24	treated	VBN	O	treat	partmod	22	SENT_236	[p20l831t982r937b1007],
25	.	.	O	.	_	0	SENT_236	[p20l831t982r937b1007],

1	Selection	NN	O	selection	nsubj	7	SENT_237	[p20l945t982r1070b1007],
2	of	IN	O	of	_	0	SENT_237	[p20l1079t982r1108b1007],
3	patients	NNS	O	patient	prep_of	1	SENT_237	[p20l1114t984r1224b1014],
4	could	MD	O	could	aux	7	SENT_237	[p20l1232t982r1306b1007],
5	be	VB	O	be	cop	7	SENT_237	[p20l1316t982r1349b1007],
6	(	JJ	O	(	amod	7	SENT_237	[p20l1587t983r1715b1014],
7	imaging	NN	O	imaging	dep	55	SENT_237	[p20l1587t983r1715b1014],
8	,	,	O	,	_	0	SENT_237	[p20l1587t983r1715b1014],
9	CSF	NN	O	csf	nn	10	SENT_237	[p20l1722t983r1781b1011],
10	)	NN	O	)	dep	55	SENT_237	[p20l1722t983r1781b1011],
11	at	IN	O	at	_	0	SENT_237	[p20l1790t986r1815b1007],
12	baseline	NN	O	baseline	prep_at	10	SENT_237	[p20l1823t982r1936b1007],
13	in	IN	O	in	_	0	SENT_237	[p20l1944t984r1967b1007],
14	trials	NNS	O	trial	prep_in	12	SENT_237	[p20l1975t982r2040b1007],
15	based	VBN	O	base	partmod	14	SENT_237	[p20l369t1021r449b1046],
16	on	IN	O	on	_	0	SENT_237	[p20l457t1029r491b1046],
17	a	DT	O	a	det	21	SENT_237	[p20l500t1029r513b1046],
18	specific	JJ	O	specific	amod	21	SENT_237	[p20l522t1021r624b1053],
19	aspect	NN	O	aspect	nn	21	SENT_237	[p20l631t1025r721b1053],
20	ofa	NN	O	ofa	nn	21	SENT_237	[p20l728t1021r775b1046],
21	patient	NN	O	patient	poss	23	SENT_237	[p20l785t1022r900b1053],
22	’s	POS	O	’s	_	0	SENT_237	[p20l785t1022r900b1053],
23	physiology	NN	O	physiology	prep_on	15	SENT_237	[p20l909t1021r1059b1053],
24	or	CC	O	or	_	0	SENT_237	[p20l1066t1029r1094b1046],
25	a	DT	O	a	det	26	SENT_237	[p20l1100t1029r1114b1046],
26	disease	NN	O	disease	dep	41	SENT_237	[p20l1122t1021r1223b1046],
27	characteristic	JJ	O	characteristic	dep	28	SENT_237	[p20l1230t1021r1413b1046],
28	targeting	VBG	O	target	dep	26	SENT_237	[p20l1585t1023r1712b1053],
29	amyloid-related	JJ	O	amyloid-related	amod	30	SENT_237	[p20l1720t1021r1937b1053],
30	mechanisms	NNS	O	mechanism	dobj	28	SENT_237	[p20l1947t1021r2118b1046],
31	that	WDT	O	that	nsubjpass	33	SENT_237	[p20l367t1061r423b1086],
32	is	VBZ	O	be	auxpass	33	SENT_237	[p20l431t1062r449b1086],
33	related	VBN	O	relate	rcmod	30	SENT_237	[p20l458t1061r551b1086],
34	in	IN	O	in	_	0	SENT_237	[p20l561t1062r583b1086],
35	some	DT	O	some	det	36	SENT_237	[p20l592t1068r666b1086],
36	mannerto	NN	O	mannerto	prep_in	33	SENT_237	[p20l675t1065r815b1086],
37	the	DT	O	the	det	39	SENT_237	[p20l822t1061r867b1086],
38	study	NN	O	study	nn	39	SENT_237	[p20l875t1061r950b1093],
39	drug	NN	O	drug	poss	41	SENT_237	[p20l957t1061r1039b1093],
40	's	POS	O	's	_	0	SENT_237	[p20l957t1061r1039b1093],
41	mechanism	NN	O	mechanism	dep	55	SENT_237	[p20l1047t1061r1213b1090],
42	,	,	O	,	_	0	SENT_237	[p20l1047t1061r1213b1090],
43	or	CC	O	or	_	0	SENT_237	[p20l1220t1068r1248b1086],
44	it	PRP	O	it	nsubj	48	SENT_237	[p20l1256t1062r1272b1086],
45	could	MD	O	could	aux	48	SENT_237	[p20l1280t1061r1355b1086],
46	be	VB	O	be	cop	48	SENT_237	[p20l1364t1061r1397b1086],
47	empiric	JJ	O	empiric	amod	48	SENT_237	[p20l368t1101r471b1131],
48	(	NN	O	(	dep	55	SENT_237	[p20l480t1101r541b1131],
49	e.g.	FW	O	e.g.	dep	48	SENT_237	[p20l480t1101r541b1131],
50	,	,	O	,	_	0	SENT_237	[p20l480t1101r541b1131],
51	the	DT	O	the	det	52	SENT_237	[p20l548t1100r593b1124],
52	patient	NN	O	patient	appos	49	SENT_237	[p20l602t1101r699b1131],
53	has	VBZ	O	have	aux	55	SENT_237	[p20l707t1100r752b1124],
54	previously	RB	DATE	previously	advmod	55	SENT_237	[p20l761t1100r902b1131],
55	responded	VBN	O	respond	_	0	SENT_237	[p20l910t1100r1056b1131],
56	to	TO	O	to	_	0	SENT_237	[p20l1064t1104r1092b1124],
57	a	DT	O	a	det	58	SENT_237	[p20l1100t1107r1113b1124],
58	drug	NN	O	drug	prep_to	55	SENT_237	[p20l1121t1100r1185b1131],
59	in	IN	O	in	_	0	SENT_237	[p20l1195t1101r1217b1124],
60	the	DT	O	the	det	62	SENT_237	[p20l1225t1100r1270b1124],
61	same	JJ	O	same	amod	62	SENT_237	[p20l1278t1107r1349b1124],
62	class	NN	O	class	prep_in	58	SENT_237	[p20l1357t1100r1429b1128],
63	)	CD	NUMBER	)	nsubj	55	SENT_237	[p20l1357t1100r1429b1128],

1	Biomarkers	NNS	O	biomarker	nsubjpass	3	SENT_238	[p20l21t1162r154b1184],
2	are	VBP	O	be	auxpass	3	SENT_238	[p20l161t1168r197b1184],
3	used	VBN	O	use	_	0	SENT_238	[p20l205t1162r260b1184],
4	primarily	RB	O	primarily	advmod	3	SENT_238	[p20l268t1162r375b1190],
5	as	IN	O	as	_	0	SENT_238	[p20l381t1168r405b1184],
6	a	DT	O	a	det	9	SENT_238	[p20l411t1168r423b1184],
7	predictive	JJ	O	predictive	amod	9	SENT_238	[p20l431t1162r551b1189],
8	enrichment	NN	O	enrichment	nn	9	SENT_238	[p20l558t1162r697b1184],
9	strategy	NN	O	strategy	prep_as	3	SENT_238	[p20l704t1165r805b1190],
10	.	.	O	.	_	0	SENT_238	[p20l704t1165r805b1190],

1	AD	NN	O	ad	_	0	SENT_239	[p20l20t1207r60b1231],
2	,	,	O	,	_	0	SENT_239	[p20l20t1207r60b1231],
3	Alzheimer	NN	O	alzheimer	poss	5	SENT_239	[p20l67t1206r205b1228],
4	's	POS	O	's	_	0	SENT_239	[p20l67t1206r205b1228],
5	disease	NN	O	disease	appos	1	SENT_239	[p20l212t1206r306b1231],
6	;	:	O	;	_	0	SENT_239	[p20l212t1206r306b1231],
7	CSF	NN	O	csf	dep	1	SENT_239	[p20l312t1207r359b1231],
8	,	,	O	,	_	0	SENT_239	[p20l312t1207r359b1231],
9	cerebrospinal	JJ	O	cerebrospinal	amod	10	SENT_239	[p20l366t1206r529b1234],
10	fluid	NN	O	fluid	appos	7	SENT_239	[p20l536t1206r596b1231],
11	;	:	O	;	_	0	SENT_239	[p20l536t1206r596b1231],
12	FDA	NNP	ORGANIZATION	FDA	dep	1	SENT_239	[p20l603t1207r657b1231],
13	,	,	O	,	_	0	SENT_239	[p20l603t1207r657b1231],
14	US	NNP	ORGANIZATION	US	nn	15	SENT_239	[p20l665t1207r695b1228],
15	Food	NNP	ORGANIZATION	Food	conj_and	12	SENT_239	[p20l703t1206r762b1228],
16	and	CC	ORGANIZATION	and	_	0	SENT_239	[p20l769t1206r813b1228],
17	Drug	NNP	ORGANIZATION	Drug	nn	18	SENT_239	[p20l822t1207r879b1234],
18	Administration	NNP	ORGANIZATION	Administration	dep	1	SENT_239	[p20l887t1206r1073b1228],
19	.	.	O	.	_	0	SENT_239	[p20l887t1206r1073b1228],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_240	[p20l20t1304r140b1325],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_240	[p20l149t1304r373b1325],
3	&	CC	O	&	_	0	SENT_240	[p20l380t1304r600b1325],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_240	[p20l380t1304r600b1325],
5	|	CD	NUMBER	|	num	6	SENT_240	[p20l380t1304r600b1325],
6	CS	NNP	O	CS	conj_and	2	SENT_240	[p20l380t1304r600b1325],
7	[	CD	NUMBER	[	num	8	SENT_240	[p20l610t1302r728b1332],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_240	[p20l610t1302r728b1332],
9	95	CD	NUMBER	95	num	8	SENT_240	[p20l736t1304r763b1325],
10	NUMBER	NN	O	number	dep	12	SENT_240	[p20l774t1304r881b1325],
11	1	CD	NUMBER	1	num	10	SENT_240	[p20l891t1305r898b1325],
12	|	CD	NUMBER	|	dep	15	SENT_240	[p20l912t1302r914b1332],
13	JANUARY	NNP	DATE	JANUARY	dep	12	SENT_240	[p20l923t1304r1041b1325],
14	2014	CD	DATE	2014	num	15	SENT_240	[p20l1049t1304r1107b1325],
15	73	CD	DATE	73	_	0	SENT_240	[p20l2109t1304r2139b1325],

1	Table	NNP	O	Table	nn	3	SENT_241	[p20l7t1681r187b1737],
2	3	CD	NUMBER	3	num	3	SENT_241	[p20l204t1685r239b1737],
3	Types	NNS	O	type	_	0	SENT_241	[p20l290t1684r483b1752],
4	of	IN	O	of	_	0	SENT_241	[p20l499t1680r568b1737],
5	heterogeneity	NN	O	heterogeneity	prep_of	3	SENT_241	[p20l583t1681r1059b1752],
6	observed	VBN	O	observe	partmod	5	SENT_241	[p20l1073t1681r1382b1737],
7	in	IN	O	in	_	0	SENT_241	[p20l1403t1682r1459b1736],
8	AD	NN	O	ad	nn	9	SENT_241	[p20l1477t1683r1576b1736],
9	Pathology	NN	O	pathology	prep_in	6	SENT_241	[p20l11t1806r300b1872],

1	Neurofibrillary	JJ	O	neurofibrillary	amod	6	SENT_242	[p20l81t1928r493b1994],
2	tangle	NN	O	tangle	nn	6	SENT_242	[p20l506t1929r688b1993],
3	burden	NN	O	burden	nn	6	SENT_242	[p20l707t1929r910b1980],
4	Amyloid	NN	O	amyloid	nn	6	SENT_242	[p20l78t2051r313b2116],
5	burden	NN	O	burden	nn	6	SENT_242	[p20l334t2051r537b2102],
6	(	NN	O	(	_	0	SENT_242	[p20l558t2051r856b2116],
7	especially	RB	O	especially	advmod	9	SENT_242	[p20l558t2051r856b2116],
8	soluble	JJ	O	soluble	amod	9	SENT_242	[p20l871t2051r1077b2102],
9	amyloid	NN	O	amyloid	dep	6	SENT_242	[p20l1093t2051r1340b2116],
10	)	NN	O	)	nn	12	SENT_242	[p20l1093t2051r1340b2116],
11	Cell	NN	O	cell	nn	12	SENT_242	[p20l78t2173r178b2224],
12	death	NN	O	death	dep	6	SENT_242	[p20l197t2173r359b2224],

1	Synaptic	JJ	O	synaptic	amod	3	SENT_243	[p20l79t2296r323b2360],
2	dysfunction	NN	O	dysfunction	nn	3	SENT_243	[p20l338t2294r676b2360],
3	Inflammation	NN	O	inflammation	_	0	SENT_243	[p20l81t2416r462b2467],

1	Co	NNP	O	Co	_	0	SENT_244	[p20l9t2538r381b2601],
2	—	CD	NUMBER	—	num	1	SENT_244	[p20l9t2538r381b2601],
3	occurring	VBG	O	occur	partmod	1	SENT_244	[p20l9t2538r381b2601],
4	proteins	NNS	O	protein	dobj	3	SENT_244	[p20l402t2539r634b2601],
5	or-Synuclein	JJ	O	or-synuclein	amod	7	SENT_244	[p20l79t2659r417b2724],
6	TD	NN	O	td	nn	7	SENT_244	[p20l76t2783r154b2831],
7	P-43	NN	O	p-43	dep	4	SENT_244	[p20l162t2783r281b2832],

1	Vascular	JJ	O	vascular	amod	2	SENT_245	[p20l7t2901r245b2952],
2	pathology	NN	O	pathology	_	0	SENT_245	[p20l262t2901r556b2966],

1	Amyloid	JJ	O	amyloid	amod	3	SENT_246	[p20l78t3023r313b3089],
2	angiopathy	NN	O	angiopathy	nn	3	SENT_246	[p20l332t3023r660b3089],
3	Arteriosclerosis	NN	MISC	arteriosclerosis	_	0	SENT_246	[p20l78t3146r516b3196],
4	lschemic	JJ	O	lschemic	amod	6	SENT_246	[p20l81t3267r328b3318],
5	brain	NN	O	brain	nn	6	SENT_246	[p20l346t3267r487b3318],
6	injury	NN	O	injury	dep	3	SENT_246	[p20l508t3269r670b3332],

1	Topography	NN	O	topography	_	0	SENT_247	[p20l6t3388r355b3453],

1	Typical	JJ	O	typical	amod	3	SENT_248	[p20l76t3510r272b3575],
2	Hippocampal	JJ	O	hippocampal	amod	3	SENT_248	[p20l81t3632r462b3696],
3	sparing	NN	O	sparing	_	0	SENT_248	[p20l482t3635r692b3697],

1	Limbic	JJ	MISC	limbic	_	0	SENT_249	[p21l81t25r268b76],
2	predominant	JJ	O	predominant	dep	1	SENT_249	[p21l286t25r661b89],

1	Clinical	JJ	O	clinical	amod	2	SENT_250	[p21l9t145r210b196],
2	variant	NN	O	variant	_	0	SENT_250	[p21l228t148r426b196],

1	Typical	JJ	O	typical	amod	3	SENT_251	[p21l76t267r272b332],
2	Amnestic	JJ	MISC	amnestic	amod	3	SENT_251	[p21l78t391r346b439],
3	variant	NN	O	variant	_	0	SENT_251	[p21l360t391r558b439],

1	Logopenic	JJ	MISC	logopenic	amod	2	SENT_252	[p21l81t513r381b575],
2	aphasia	NN	O	aphasia	_	0	SENT_252	[p21l397t510r613b574],
3	Frontal	JJ	MISC	frontal	amod	4	SENT_252	[p21l81t633r275b683],
4	variant	NN	O	variant	dep	2	SENT_252	[p21l292t635r490b683],

1	Posterior	JJ	O	posterior	amod	3	SENT_253	[p21l81t756r333b805],
2	cortical	JJ	O	cortical	amod	3	SENT_253	[p21l348t754r555b805],
3	atrophy	NN	O	atrophy	_	0	SENT_253	[p21l573t754r797b819],

1	Genetics	NNP	O	Genetics	_	0	SENT_254	[p21l9t877r255b925],

1	ApoE4	NN	O	apoe4	nn	2	SENT_255	[p21l78t998r265b1059],
2	carrier	NN	O	carrier	dep	7	SENT_255	[p21l280t998r461b1046],
3	or	CC	O	or	_	0	SENT_255	[p21l476t1010r533b1046],
4	not	RB	O	not	neg	6	SENT_255	[p21l551t1003r645b1046],
5	Other	JJ	O	other	amod	6	SENT_255	[p21l78t1117r243b1168],
6	genotypes	NNS	O	genotype	conj_or	2	SENT_255	[p21l258t1125r561b1182],
7	relevant	JJ	O	relevant	_	0	SENT_255	[p21l581t1117r810b1168],
8	to	TO	O	to	_	0	SENT_255	[p21l825t1125r882b1168],
9	AB	NNP	O	AB	prep_to	7	SENT_255	[p21l898t1115r989b1183],
10	,	,	O	,	_	0	SENT_255	[p21l898t1115r989b1183],
11	tau	NN	O	tau	prep_to	7	SENT_255	[p21l1004t1125r1109b1176],
12	,	,	O	,	_	0	SENT_255	[p21l1004t1125r1109b1176],
13	immune	JJ	O	immune	amod	14	SENT_255	[p21l1128t1120r1365b1168],
14	function	NN	O	function	prep_to	7	SENT_255	[p21l1379t1117r1636b1176],
15	,	,	O	,	_	0	SENT_255	[p21l1379t1117r1636b1176],
16	cholesterol	NN	O	cholesterol	nn	17	SENT_255	[p21l1653t1117r1966b1168],
17	metabolism	NN	O	metabolism	prep_to	7	SENT_255	[p21l81t1208r433b1267],
18	,	,	O	,	_	0	SENT_255	[p21l81t1208r433b1267],
19	and	CC	O	and	_	0	SENT_255	[p21l449t1208r554b1259],
20	synaptic	JJ	O	synaptic	amod	21	SENT_255	[p21l573t1211r810b1274],
21	integrity	NN	O	integrity	conj_and	9	SENT_255	[p21l828t1211r1069b1274],

1	Host	NN	O	host	nn	2	SENT_256	[p21l11t1331r139b1380],
2	characteristics	NNS	O	characteristic	_	0	SENT_256	[p21l155t1329r563b1380],
3	that	WDT	O	that	nsubj	5	SENT_256	[p21l578t1329r693b1380],
4	may	MD	O	may	aux	5	SENT_256	[p21l711t1344r829b1394],
5	influence	VB	O	influence	rcmod	2	SENT_256	[p21l846t1328r1108b1380],
6	disease	NN	O	disease	nn	7	SENT_256	[p21l1125t1329r1333b1380],
7	phenotype	NN	O	phenotype	dobj	5	SENT_256	[p21l1352t1329r1665b1394],

1	Age	NNP	O	Age	nn	2	SENT_257	[p21l78t1454r189b1515],
2	Age	NNP	O	Age	_	0	SENT_257	[p21l78t1575r189b1636],
3	at	IN	O	at	_	0	SENT_257	[p21l205t1580r258b1623],
4	onset	NN	O	onset	nn	5	SENT_257	[p21l273t1580r431b1623],
5	Gender	NN	O	gender	prep_at	2	SENT_257	[p21l78t1694r291b1745],

1	Educational	NNP	O	Educational	nn	2	SENT_258	[p21l81t1815r412b1866],
2	level	NN	O	level	nsubj	7	SENT_258	[p21l434t1815r559b1866],
3	and	CC	O	and	_	0	SENT_258	[p21l578t1815r682b1866],
4	cognitive	JJ	O	cognitive	amod	6	SENT_258	[p21l701t1818r966b1880],
5	reserve	NN	O	reserve	nn	6	SENT_258	[p21l984t1831r1188b1866],
6	Medications	NNS	MISC	medication	nsubj	7	SENT_258	[p21l80t1938r428b1988],
7	taken	VBN	O	take	_	0	SENT_258	[p21l443t1938r600b1988],
8	in	IN	O	in	_	0	SENT_258	[p21l620t1940r666b1987],
9	life	NN	O	life	prep_in	7	SENT_258	[p21l687t1937r767b1988],

1	These	DT	O	these	nsubj	3	SENT_259	[p21l6t2057r153b2102],
2	may	MD	O	may	aux	3	SENT_259	[p21l169t2070r273b2114],
3	influence	VB	O	influence	_	0	SENT_259	[p21l287t2057r517b2102],
4	response	NN	O	response	dobj	3	SENT_259	[p21l533t2070r757b2113],
5	to	TO	O	to	_	0	SENT_259	[p21l770t2064r820b2102],
6	pharmacologic	JJ	O	pharmacologic	amod	7	SENT_259	[p21l837t2057r1212b2113],
7	intervention	NN	O	intervention	prep_to	3	SENT_259	[p21l1227t2059r1548b2102],
8	.	.	O	.	_	0	SENT_259	[p21l1227t2059r1548b2102],

1	AB	NNP	O	AB	_	0	SENT_260	[p21l8t2135r88b2194],
2	,	,	O	,	_	0	SENT_260	[p21l8t2135r88b2194],
3	amyloid-B	NN	O	amyloid-b	appos	1	SENT_260	[p21l102t2135r367b2194],
4	;	:	O	;	_	0	SENT_260	[p21l102t2135r367b2194],
5	AD	NN	O	ad	dep	1	SENT_260	[p21l381t2139r465b2188],
6	,	,	O	,	_	0	SENT_260	[p21l381t2139r465b2188],
7	Alzheimer	NN	O	alzheimer	poss	9	SENT_260	[p21l479t2137r766b2181],
8	's	POS	O	's	_	0	SENT_260	[p21l479t2137r766b2181],
9	disease	NN	O	disease	appos	5	SENT_260	[p21l781t2137r976b2188],
10	;	:	O	;	_	0	SENT_260	[p21l781t2137r976b2188],
11	ApoE4	NN	O	apoe4	dep	1	SENT_260	[p21l990t2139r1165b2192],
12	,	,	O	,	_	0	SENT_260	[p21l990t2139r1165b2192],
13	apolipoprotein	NN	O	apolipoprotein	nn	14	SENT_260	[p21l1179t2137r1552b2192],
14	E4	NN	O	e4	appos	11	SENT_260	[p21l1571t2139r1842b2188],
15	;	:	O	;	_	0	SENT_260	[p21l1571t2139r1842b2188],
16	TDP-43	NN	O	tdp-43	dep	1	SENT_260	[p21l1571t2139r1842b2188],
17	,	,	O	,	_	0	SENT_260	[p21l1571t2139r1842b2188],
18	transactive	JJ	O	transactive	amod	21	SENT_260	[p21l1855t2139r2129b2181],
19	response	NN	O	response	nn	21	SENT_260	[p21l10t2228r234b2271],
20	DNA-binding	JJ	O	dna-binding	amod	21	SENT_260	[p21l251t2216r578b2272],
21	protein	NN	O	protein	appos	16	SENT_260	[p21l596t2218r773b2271],
22	43	CD	NUMBER	43	dep	21	SENT_260	[p21l788t2218r860b2260],
23	.	.	O	.	_	0	SENT_260	[p21l788t2218r860b2260],

1	were	VBD	O	be	auxpass	2	SENT_261	[p21l8t2397r162b2438],
2	seen	VBN	O	see	_	0	SENT_261	[p21l181t2397r323b2438],
3	in	IN	O	in	_	0	SENT_261	[p21l341t2381r405b2437],
4	up	RB	O	up	advmod	15	SENT_261	[p21l422t2397r505b2458],
5	to	TO	O	to	_	0	SENT_261	[p21l523t2386r586b2438],
6	17	CD	PERCENT	17	num	7	SENT_261	[p21l611t2380r742b2439],
7	%	NN	PERCENT	%	prep_to	4	SENT_261	[p21l611t2380r742b2439],
8	of	IN	O	of	_	0	SENT_261	[p21l762t2374r833b2438],
9	patients	NNS	O	patient	prep_of	7	SENT_261	[p21l840t2381r1097b2458],
10	in	IN	O	in	_	0	SENT_261	[p21l1115t2381r1179b2437],
11	trials	NNS	O	trial	prep_in	9	SENT_261	[p21l1195t2374r1357b2438],
12	with	IN	O	with	_	0	SENT_261	[p21l1373t2374r1520b2438],
13	bapineuzumab4	NN	O	bapineuzumab4	prep_with	11	SENT_261	[p21l1535t2366r2153b2458],
14	°	CD	NUMBER	°	num	13	SENT_261	[p21l1535t2366r2153b2458],
15	’79	CD	NUMBER	’79	prep_in	2	SENT_261	[p21l1535t2366r2153b2458],
16	and	CC	O	and	_	0	SENT_261	[p21l10t2478r136b2541],
17	have	VBP	O	have	aux	19	SENT_261	[p21l156t2478r310b2541],
18	been	VBN	O	be	auxpass	19	SENT_261	[p21l330t2478r493b2541],
19	observed	VBN	O	observe	conj_and	2	SENT_261	[p21l515t2478r823b2541],
20	in	IN	O	in	_	0	SENT_261	[p21l843t2484r909b2540],
21	smaller	JJR	O	smaller	amod	22	SENT_261	[p21l931t2478r1179b2541],
22	numbers	NNS	O	number	prep_in	19	SENT_261	[p21l1199t2478r1500b2541],
23	of	IN	O	of	_	0	SENT_261	[p21l1522t2478r1596b2541],
24	patients	NNS	O	patient	prep_of	22	SENT_261	[p21l1606t2484r1873b2561],
25	in	IN	O	in	_	0	SENT_261	[p21l1895t2484r1961b2540],
26	trials	NNS	O	trial	prep_in	24	SENT_261	[p21l1982t2478r2150b2541],
27	of	IN	O	of	_	0	SENT_261	[p21l10t2581r83b2644],
28	other	JJ	O	other	amod	29	SENT_261	[p21l94t2581r273b2644],
29	agents	NNS	O	agent	prep_of	26	SENT_261	[p21l291t2593r517b2665],
30	.	.	O	.	_	0	SENT_261	[p21l291t2593r517b2665],

1	Approximately	RB	O	approximately	quantmod	2	SENT_262	[p21l539t2581r1044b2665],
2	80	CD	PERCENT	80	num	3	SENT_262	[p21l1061t2586r1201b2646],
3	%	NN	PERCENT	%	nsubj	8	SENT_262	[p21l1061t2586r1201b2646],
4	of	IN	O	of	_	0	SENT_262	[p21l1223t2581r1296b2644],
5	patients	NNS	O	patient	prep_of	3	SENT_262	[p21l1305t2587r1569b2664],
6	with	IN	O	with	_	0	SENT_262	[p21l1587t2581r1738b2644],
7	ARIAS	NNP	O	ARIAS	prep_with	5	SENT_262	[p21l1757t2585r1980b2644],
8	have	VBP	O	have	_	0	SENT_262	[p21l2000t2581r2153b2644],
9	no	DT	O	no	det	11	SENT_262	[p21l9t2707r95b2747],
10	associated	JJ	O	associated	amod	11	SENT_262	[p21l118t2684r459b2747],
11	symptoms	NNS	O	symptom	dobj	8	SENT_262	[p21l480t2696r843b2768],
12	.	.	O	.	_	0	SENT_262	[p21l480t2696r843b2768],

1	ARIAS	NNP	O	ARIAS	nsubjpass	3	SENT_263	[p21l866t2688r1090b2747],
2	are	VBP	O	be	auxpass	3	SENT_263	[p21l1112t2707r1210b2747],
3	detected	VBN	O	detect	_	0	SENT_263	[p21l1233t2684r1516b2747],
4	by	IN	O	by	_	0	SENT_263	[p21l1533t2684r1617b2768],
5	MRI	NNP	MISC	MRI	agent	3	SENT_263	[p21l1634t2689r1807b2756],
6	,	,	O	,	_	0	SENT_263	[p21l1634t2689r1807b2756],
7	and	CC	O	and	_	0	SENT_263	[p21l1830t2684r1955b2747],
8	serial	NN	O	serial	nsubjpass	12	SENT_263	[p21l1976t2684r2153b2747],
9	MRI	NNP	O	MRI	nn	10	SENT_263	[p21l9t2792r163b2850],
10	assessment	NN	O	assessment	dep	8	SENT_263	[p21l186t2799r557b2850],
11	is	VBZ	O	be	auxpass	12	SENT_263	[p21l577t2793r626b2850],
12	required	VBN	O	require	conj_and	3	SENT_263	[p21l647t2787r933b2870],
13	in	IN	O	in	_	0	SENT_263	[p21l954t2793r1019b2849],
14	trials	NNS	O	trial	prep_in	12	SENT_263	[p21l1039t2787r1206b2850],
15	of	IN	O	of	_	0	SENT_263	[p21l1228t2787r1301b2850],
16	antiamyloid	JJ	O	antiamyloid	amod	17	SENT_263	[p21l1313t2787r1716b2871],
17	compounds	NNS	O	compound	prep_of	14	SENT_263	[p21l1736t2787r2150b2870],
18	.	.	O	.	_	0	SENT_263	[p21l1736t2787r2150b2870],

1	Monitoring	VBG	O	monitor	amod	3	SENT_264	[p21l9t2895r405b2974],
2	side	JJ	O	side	amod	3	SENT_264	[p21l426t2890r557b2953],
3	effects	NNS	O	effect	nsubjpass	15	SENT_264	[p21l580t2890r791b2953],
4	is	VBZ	O	be	cop	7	SENT_264	[p21l813t2896r863b2953],
5	a	DT	O	a	det	7	SENT_264	[p21l886t2913r921b2953],
6	critical	JJ	O	critical	amod	7	SENT_264	[p21l941t2890r1174b2953],
7	application	NN	O	application	_	0	SENT_264	[p21l1195t2890r1572b2973],
8	of	IN	O	of	_	0	SENT_264	[p21l1594t2890r1668b2953],
9	biomarkers	NNS	O	biomarker	prep_of	7	SENT_264	[p21l1678t2890r2065b2953],
10	in	IN	O	in	_	0	SENT_264	[p21l2087t2896r2153b2952],
11	trials	NNS	O	trial	prep_in	9	SENT_264	[p21l9t2993r176b3056],
12	and	CC	O	and	_	0	SENT_264	[p21l197t2993r322b3056],
13	may	MD	O	may	aux	15	SENT_264	[p21l341t3016r486b3077],
14	be	VB	O	be	auxpass	15	SENT_264	[p21l501t2993r579b3056],
15	required	VBN	O	require	conj_and	7	SENT_264	[p21l600t2993r886b3076],
16	when	WRB	O	when	advmod	17	SENT_264	[p21l903t2993r1089b3056],
17	treating	VBG	O	treat	advcl	15	SENT_264	[p21l1108t2999r1370b3077],
18	patients	NNS	O	patient	dobj	17	SENT_264	[p21l1387t2999r1651b3076],
19	with	IN	O	with	_	0	SENT_264	[p21l1670t2993r1821b3056],
20	approved	VBN	O	approve	amod	24	SENT_264	[p21l1842t2993r2154b3076],
21	disease	NN	O	disease	nn	24	SENT_264	[p21l10t3096r631b3180],
22	—	NN	O	—	nn	24	SENT_264	[p21l10t3096r631b3180],
23	modifying	VBG	O	modify	amod	24	SENT_264	[p21l10t3096r631b3180],
24	agents	NNS	O	agent	prep_with	17	SENT_264	[p21l648t3108r856b3180],
25	if	IN	O	if	mark	29	SENT_264	[p21l876t3096r929b3158],
26	these	DT	O	these	det	27	SENT_264	[p21l937t3096r1109b3159],
27	effects	NNS	O	effect	nsubjpass	29	SENT_264	[p21l1129t3096r1336b3159],
28	are	VBP	O	be	auxpass	29	SENT_264	[p21l1356t3119r1455b3159],
29	deemed	VBN	O	deem	advcl	15	SENT_264	[p21l1474t3096r1739b3159],
30	to	TO	O	to	aux	31	SENT_264	[p21l1756t3108r1821b3159],
31	represent	VB	O	represent	xcomp	29	SENT_264	[p21l1841t3108r2152b3179],
32	important	JJ	O	important	amod	34	SENT_264	[p21l10t3205r352b3282],
33	safety	NN	O	safety	nn	34	SENT_264	[p21l371t3199r564b3283],
34	signals	NNS	O	signal	dobj	31	SENT_264	[p21l581t3199r823b3283],
35	.	.	O	.	_	0	SENT_264	[p21l581t3199r823b3283],

1	In	IN	O	in	_	0	SENT_265	[p21l84t3307r157b3364],
2	addition	NN	O	addition	_	0	SENT_265	[p21l182t3302r479b3365],
3	to	TO	O	to	_	0	SENT_265	[p21l502t3314r570b3365],
4	monitoring	VBG	O	monitor	prepc_in_addition_to	30	SENT_265	[p21l595t3308r1001b3386],
5	effects	NNS	O	effect	dobj	4	SENT_265	[p21l1024t3302r1243b3365],
6	such	JJ	O	such	_	0	SENT_265	[p21l1268t3302r1428b3365],
7	as	IN	O	as	_	0	SENT_265	[p21l1453t3325r1519b3365],
8	ARIAS	NNP	O	ARIAS	nn	9	SENT_265	[p21l1543t3306r1776b3365],
9	speciﬁc	NN	O	speciﬁc	prep_such_as	5	SENT_265	[p21l1802t3302r2063b3385],
10	to	TO	O	to	_	0	SENT_265	[p21l2086t3314r2154b3365],
11	amyloid	NN	O	amyloid	nn	12	SENT_265	[p21l10t3405r286b3489],
12	therapies	NNS	O	therapy	prep_to	4	SENT_265	[p21l305t3405r614b3488],
13	in	IN	O	in	_	0	SENT_265	[p21l635t3411r701b3467],
14	AD	NN	O	ad	prep_in	12	SENT_265	[p21l721t3409r855b3477],
15	,	,	O	,	_	0	SENT_265	[p21l721t3409r855b3477],
16	biomarkers	NNS	O	biomarker	nsubjpass	30	SENT_265	[p21l876t3405r1263b3468],
17	indicative	JJ	O	indicative	amod	16	SENT_265	[p21l1284t3405r1617b3468],
18	of	IN	O	of	_	0	SENT_265	[p21l1638t3405r1711b3468],
19	liver	NN	O	liver	prep_of	17	SENT_265	[p21l1721t3405r1872b3468],
20	or	CC	O	or	_	0	SENT_265	[p21l1892t3428r1963b3468],
21	renal	JJ	O	renal	amod	22	SENT_265	[p21l1983t3405r2154b3468],
22	injury	NN	O	injury	conj_or	19	SENT_265	[p21l10t3514r214b3592],
23	or	CC	O	or	_	0	SENT_265	[p21l231t3531r301b3571],
24	of	IN	O	of	amod	16	SENT_265	[p21l320t3508r392b3571],
25	adverse	JJ	O	adverse	amod	27	SENT_265	[p21l403t3508r651b3571],
26	cardiac	JJ	O	cardiac	amod	27	SENT_265	[p21l671t3508r909b3571],
27	events	NNS	O	event	pobj	24	SENT_265	[p21l929t3520r1135b3571],
28	are	VBP	O	be	auxpass	30	SENT_265	[p21l1157t3531r1254b3571],
29	routinely	RB	O	routinely	advmod	30	SENT_265	[p21l1274t3508r1578b3592],
30	collected	VBN	O	collect	_	0	SENT_265	[p21l1595t3508r1891b3571],
31	in	IN	O	in	_	0	SENT_265	[p21l1909t3514r1974b3570],
32	drug	NN	O	drug	nn	34	SENT_265	[p21l1994t3508r2152b3592],
33	development	NN	O	development	nn	34	SENT_265	[p21l10t3610r456b3694],
34	programs	NNS	O	program	prep_in	30	SENT_265	[p21l475t3602r886b3695],
35	.	.	O	.	_	0	SENT_265	[p21l475t3602r886b3695],

1	”	NN	O	”	_	0	SENT_266	[p21l475t3602r886b3695],

1	BIOMARKER	NN	O	biomarker	nn	2	SENT_267	[p22l12t271r448b327],
2	COMBINATIONS	NNS	O	combination	nn	4	SENT_267	[p22l466t271r1036b327],
3	Simultaneous	JJ	O	simultaneous	amod	4	SENT_267	[p22l9t367r467b430],
4	acquisition	NN	O	acquisition	nsubj	8	SENT_267	[p22l489t373r860b450],
5	of	IN	O	of	_	0	SENT_267	[p22l881t367r954b430],
6	multiple	JJ	O	multiple	amod	7	SENT_267	[p22l964t367r1246b450],
7	biomarkers	NNS	O	biomarker	prep_of	4	SENT_267	[p22l1264t367r1648b430],
8	provides	VBZ	O	provide	_	0	SENT_267	[p22l1667t367r1956b450],
9	more	JJR	O	more	amod	10	SENT_267	[p22l1977t390r2152b430],
10	information	NN	O	information	dobj	8	SENT_267	[p22l8t470r424b533],
11	than	IN	O	than	_	0	SENT_267	[p22l444t470r600b533],
12	any	DT	O	any	det	14	SENT_267	[p22l622t493r744b554],
13	single	JJ	O	single	amod	14	SENT_267	[p22l762t470r959b554],
14	biomarker	NN	O	biomarker	prep_than	8	SENT_267	[p22l979t470r1349b533],
15	.	.	O	.	_	0	SENT_267	[p22l979t470r1349b533],

1	In	IN	O	in	dep	12	SENT_268	[p22l1375t475r1446b532],
2	one	CD	NUMBER	one	num	3	SENT_268	[p22l1468t493r1591b533],
3	study	NN	O	study	pobj	1	SENT_268	[p22l1613t470r1800b554],
4	of	IN	O	of	_	0	SENT_268	[p22l1818t470r1893b533],
5	the	DT	O	the	det	9	SENT_268	[p22l1904t470r2010b533],
6	AD	NN	O	ad	nn	9	SENT_268	[p22l2031t474r2150b532],
7	Neuroimaging	NNP	O	Neuroimaging	nn	9	SENT_268	[p22l7t578r509b657],
8	Initiative	NNP	O	Initiative	nn	9	SENT_268	[p22l530t578r836b636],
9	sample	NN	O	sample	prep_of	3	SENT_268	[p22l859t573r1115b656],
10	,	,	O	,	_	0	SENT_268	[p22l859t573r1115b656],
11	the	DT	O	the	det	12	SENT_268	[p22l1138t573r1245b636],
12	combination	NN	O	combination	_	0	SENT_268	[p22l1267t573r1704b636],
13	of	IN	O	of	_	0	SENT_268	[p22l1727t573r1801b636],
14	MRI	NNP	O	MRI	prep_of	12	SENT_268	[p22l1813t578r1988b645],
15	,	,	O	,	_	0	SENT_268	[p22l1813t578r1988b645],
16	CSF	NN	O	csf	nn	17	SENT_268	[p22l2013t577r2150b636],
17	measures	NNS	O	measure	prep_of	12	SENT_268	[p22l8t699r337b748],
18	,	,	O	,	_	0	SENT_268	[p22l8t699r337b748],
19	and	CC	O	and	_	0	SENT_268	[p22l359t676r483b739],
20	FDG	NNP	O	FDG	prep_of	12	SENT_268	[p22l502t679r844b739],
21	.	.	O	.	_	0	SENT_268	[p22l502t679r844b739],

1	—	NN	O	—	_	0	SENT_269	[p22l502t679r844b739],
2	.	.	O	.	_	0	SENT_269	[p22l502t679r844b739],

1	PET	NN	O	pet	nsubj	2	SENT_270	[p22l502t679r844b739],
2	resulted	VBD	O	result	dep	49	SENT_270	[p22l864t676r1130b739],
3	in	IN	O	in	_	0	SENT_270	[p22l1148t682r1213b738],
4	a	DT	O	a	det	7	SENT_270	[p22l1234t699r1268b739],
5	93.2	CD	PERCENT	93.2	num	7	SENT_270	[p22l1287t682r1485b740],
6	%	NN	PERCENT	%	nn	7	SENT_270	[p22l1287t682r1485b740],
7	accuracy	NN	O	accuracy	prep_in	2	SENT_270	[p22l1508t699r1806b760],
8	(	CD	PERCENT	(	number	9	SENT_270	[p22l1825t677r1991b752],
9	93	CD	PERCENT	93	dep	10	SENT_270	[p22l1825t677r1991b752],
10	%	NN	PERCENT	%	dep	16	SENT_270	[p22l1825t677r1991b752],
11	sensitivity	NN	O	sensitivity	nn	16	SENT_270	[p22l2013t699r2149b739, p22l9t785r249b863],
12	,	,	O	,	_	0	SENT_270	[p22l2013t699r2149b739, p22l9t785r249b863],
13	93.3	CD	PERCENT	93.3	number	14	SENT_270	[p22l272t785r475b844],
14	%	NN	PERCENT	%	amod	16	SENT_270	[p22l272t785r475b844],
15	speciﬁcity	NN	O	speciﬁcity	nn	16	SENT_270	[p22l499t779r867b863],
16	)	NN	O	)	npadvmod	7	SENT_270	[p22l499t779r867b863],
17	in	IN	O	in	_	0	SENT_270	[p22l891t785r958b841],
18	the	DT	O	the	det	19	SENT_270	[p22l978t779r1084b842],
19	classiﬁcation	NN	O	classiﬁcation	prep_in	7	SENT_270	[p22l1106t779r1545b842],
20	of	IN	O	of	_	0	SENT_270	[p22l1566t779r1640b842],
21	AD	NN	O	ad	prep_of	19	SENT_270	[p22l1650t783r1769b841],
22	and	CC	O	and	_	0	SENT_270	[p22l1792t779r1919b842],
23	in	IN	O	in	_	0	SENT_270	[p22l1938t785r2005b841],
24	distinguishing	JJ	O	distinguishing	amod	25	SENT_270	[p22l2027t779r2150b842, p22l7t882r401b966],
25	AD	NN	O	ad	prep_in	7	SENT_270	[p22l420t886r539b944],
26	from	IN	O	from	_	0	SENT_270	[p22l562t882r731b945],
27	healthy	JJ	O	healthy	amod	28	SENT_270	[p22l751t882r1006b966],
28	controls	NNS	O	control	prep_from	2	SENT_270	[p22l1025t882r1319b954],
29	,	,	O	,	_	0	SENT_270	[p22l1025t882r1319b954],
30	whereas	IN	O	whereas	mark	33	SENT_270	[p22l1341t882r1619b945],
31	MRI	NNP	O	MRI	nsubj	33	SENT_270	[p22l1641t887r1797b945],
32	alone	RB	O	alone	advmod	33	SENT_270	[p22l1821t882r2004b945],
33	had	VBD	O	have	advcl	2	SENT_270	[p22l2025t882r2153b945],
34	86.2	CD	PERCENT	86.2	num	36	SENT_270	[p22l10t990r214b1049],
35	%	NN	PERCENT	%	nn	36	SENT_270	[p22l10t990r214b1049],
36	accuracy	NN	O	accuracy	dobj	33	SENT_270	[p22l240t1008r548b1069],
37	(	CD	PERCENT	(	number	38	SENT_270	[p22l571t986r742b1061],
38	86	CD	PERCENT	86	dep	39	SENT_270	[p22l571t986r742b1061],
39	%	NN	PERCENT	%	dep	40	SENT_270	[p22l571t986r742b1061],
40	sensitivity	NN	O	sensitivity	dep	36	SENT_270	[p22l767t991r1127b1069],
41	,	,	O	,	_	0	SENT_270	[p22l767t991r1127b1069],
42	86.3	CD	PERCENT	86.3	num	45	SENT_270	[p22l1153t991r1357b1050],
43	%	NN	PERCENT	%	nn	45	SENT_270	[p22l1153t991r1357b1050],
44	speciﬁcity	NN	O	speciﬁcity	nn	45	SENT_270	[p22l1383t985r1777b1069],
45	)	NN	O	)	appos	36	SENT_270	[p22l1383t985r1777b1069],
46	,	,	O	,	_	0	SENT_270	[p22l1383t985r1777b1069],
47	CSF	NN	O	csf	appos	45	SENT_270	[p22l1803t989r1941b1048],
48	alone	RB	O	alone	advmod	49	SENT_270	[p22l1966t985r2150b1048],
49	exhibited	VBD	O	exhibit	_	0	SENT_270	[p22l9t1088r327b1151],
50	82.1	CD	PERCENT	82.1	num	51	SENT_270	[p22l348t1093r551b1153],
51	%	NN	PERCENT	%	dobj	49	SENT_270	[p22l348t1093r551b1153],
52	accuracy	NN	O	accuracy	nsubj	49	SENT_270	[p22l574t1111r879b1172],
53	(	CD	PERCENT	(	number	54	SENT_270	[p22l900t1089r1131b1164],
54	81.9	CD	PERCENT	81.9	dep	55	SENT_270	[p22l900t1089r1131b1164],
55	%	NN	PERCENT	%	dep	56	SENT_270	[p22l900t1089r1131b1164],
56	sensitivity	NN	O	sensitivity	dep	52	SENT_270	[p22l1155t1094r1510b1172],
57	,	,	O	,	_	0	SENT_270	[p22l1155t1094r1510b1172],
58	82.3	CD	PERCENT	82.3	num	61	SENT_270	[p22l1534t1093r1737b1152],
59	%	NN	PERCENT	%	nn	61	SENT_270	[p22l1534t1093r1737b1152],
60	speciﬁcity	NN	O	speciﬁcity	nn	61	SENT_270	[p22l1761t1088r2151b1172],
61	)	NN	O	)	nsubj	49	SENT_270	[p22l1761t1088r2151b1172],
62	,	,	O	,	_	0	SENT_270	[p22l1761t1088r2151b1172],
63	and	CC	O	and	_	0	SENT_270	[p22l9t1191r139b1254],
64	FDG	NNP	O	FDG	nsubj	49	SENT_270	[p22l163t1194r524b1254],
65	.	.	O	.	_	0	SENT_270	[p22l163t1194r524b1254],

1	—	NN	O	—	_	0	SENT_271	[p22l163t1194r524b1254],
2	.	.	O	.	_	0	SENT_271	[p22l163t1194r524b1254],

1	PET	NN	O	pet	nsubj	2	SENT_272	[p22l163t1194r524b1254],
2	had	VBD	O	have	_	0	SENT_272	[p22l548t1191r679b1254],
3	86.5	CD	PERCENT	86.5	num	5	SENT_272	[p22l704t1197r913b1255],
4	%	NN	PERCENT	%	nn	5	SENT_272	[p22l704t1197r913b1255],
5	accuracy	NN	O	accuracy	dobj	2	SENT_272	[p22l940t1214r1256b1275],
6	(	CD	PERCENT	(	number	7	SENT_272	[p22l1280t1192r1518b1267],
7	86.3	CD	PERCENT	86.3	dep	8	SENT_272	[p22l1280t1192r1518b1267],
8	%	NN	PERCENT	%	dep	9	SENT_272	[p22l1280t1192r1518b1267],
9	sensitivity	NN	O	sensitivity	dep	5	SENT_272	[p22l1546t1197r1915b1275],
10	,	,	O	,	_	0	SENT_272	[p22l1546t1197r1915b1275],
11	86.6	CD	PERCENT	86.6	num	12	SENT_272	[p22l1942t1196r2151b1256],
12	%	NN	PERCENT	%	appos	5	SENT_272	[p22l1942t1196r2151b1256],
13	sensitivity	NN	O	sensitivity	num	12	SENT_272	[p22l9t1285r465b1378],
14	)	CD	NUMBER	)	number	13	SENT_272	[p22l9t1285r465b1378],
15	.8	CD	NUMBER	.8	number	13	SENT_272	[p22l9t1285r465b1378],
16	°	CD	NUMBER	°	number	13	SENT_272	[p22l9t1285r465b1378],
17	There	EX	O	there	expl	18	SENT_272	[p22l486t1293r680b1357],
18	was	VBD	O	be	rcmod	12	SENT_272	[p22l699t1316r825b1357],
19	an	DT	O	a	det	24	SENT_272	[p22l848t1316r927b1357],
20	~	NN	O	~	nn	24	SENT_272	[p22l951t1299r1142b1358],
21	10	CD	PERCENT	10	num	24	SENT_272	[p22l951t1299r1142b1358],
22	%	NN	PERCENT	%	nn	24	SENT_272	[p22l951t1299r1142b1358],
23	accuracy	NN	O	accuracy	nn	24	SENT_272	[p22l1165t1316r1470b1378],
24	advantage	NN	O	advantage	nsubj	18	SENT_272	[p22l1488t1293r1831b1378],
25	of	IN	O	of	_	0	SENT_272	[p22l1853t1293r1927b1357],
26	multiple	JJ	O	multiple	amod	27	SENT_272	[p22l1938t1293r2149b1357, p22l7t1397r108b1480],
27	biomarkers	NNS	O	biomarker	prep_of	24	SENT_272	[p22l128t1397r518b1460],
28	relative	JJ	O	relative	advmod	27	SENT_272	[p22l540t1397r788b1460],
29	to	TO	O	to	_	0	SENT_272	[p22l809t1409r875b1460],
30	single	JJ	O	single	amod	31	SENT_272	[p22l899t1397r1096b1481],
31	biomarkers	NNS	O	biomarker	prep_to	28	SENT_272	[p22l1115t1397r1522b1460],
32	.	.	O	.	_	0	SENT_272	[p22l1115t1397r1522b1460],

1	Incorporating	VBG	O	incorporate	csubj	9	SENT_273	[p22l83t1505r572b1584],
2	multiple	JJ	O	multiple	amod	3	SENT_273	[p22l592t1500r882b1583],
3	biomarkers	NNS	O	biomarker	dobj	1	SENT_273	[p22l904t1500r1300b1563],
4	in	IN	O	in	_	0	SENT_273	[p22l1324t1506r1391b1562],
5	a	DT	O	a	det	6	SENT_273	[p22l1415t1523r1450b1563],
6	trial	NN	O	trial	prep_in	1	SENT_273	[p22l1471t1500r1615b1563],
7	could	MD	O	could	aux	9	SENT_273	[p22l1638t1500r1832b1563],
8	substantially	RB	O	substantially	advmod	9	SENT_273	[p22l1855t1500r2147b1563, p22l7t1603r183b1687],
9	reduce	VB	O	reduce	_	0	SENT_273	[p22l203t1603r434b1666],
10	the	DT	O	the	det	11	SENT_273	[p22l457t1603r565b1666],
11	number	NN	O	number	dobj	9	SENT_273	[p22l588t1603r866b1666],
12	of	IN	O	of	_	0	SENT_273	[p22l888t1603r963b1666],
13	patients	NNS	O	patient	prep_of	11	SENT_273	[p22l976t1609r1249b1686],
14	required	VBN	O	require	partmod	13	SENT_273	[p22l1274t1603r1570b1686],
15	to	TO	O	to	aux	16	SENT_273	[p22l1591t1615r1658b1666],
16	show	VB	O	show	xcomp	14	SENT_273	[p22l1684t1603r1864b1666],
17	a	DT	O	a	det	19	SENT_273	[p22l1885t1626r1920b1666],
18	drugplacebo	NN	O	drugplacebo	nn	19	SENT_273	[p22l1943t1603r2149b1687, p22l7t1706r271b1789],
19	difference	NN	O	difference	dobj	16	SENT_273	[p22l295t1706r633b1769],
20	in	IN	O	in	_	0	SENT_273	[p22l655t1712r722b1768],
21	clinical	JJ	O	clinical	amod	22	SENT_273	[p22l745t1706r991b1769],
22	trials	NNS	O	trial	prep_in	16	SENT_273	[p22l1011t1706r1200b1769],
23	.	.	O	.	_	0	SENT_273	[p22l1011t1706r1200b1769],

1	Selecting	VBG	O	select	csubj	26	SENT_274	[p22l1227t1706r1536b1790],
2	mild	JJ	O	mild	amod	4	SENT_274	[p22l1557t1706r1717b1769],
3	AD	NN	O	ad	nn	4	SENT_274	[p22l1737t1710r1856b1768],
4	subjects	NNS	O	subject	dobj	1	SENT_274	[p22l1881t1706r2151b1790],
5	on	IN	O	on	_	0	SENT_274	[p22l9t1832r98b1872],
6	the	DT	O	the	det	7	SENT_274	[p22l126t1809r238b1872],
7	basis	NN	O	basis	prep_on	1	SENT_274	[p22l265t1809r441b1872],
8	of	IN	O	of	_	0	SENT_274	[p22l471t1809r549b1872],
9	complementary	JJ	O	complementary	amod	10	SENT_274	[p22l568t1809r1142b1893],
10	biomarkers	NNS	O	biomarker	prep_of	7	SENT_274	[p22l1165t1809r1597b1881],
11	,	,	O	,	_	0	SENT_274	[p22l1165t1809r1597b1881],
12	including	VBG	O	include	_	0	SENT_274	[p22l1628t1809r1974b1893],
13	hippocampal	JJ	O	hippocampal	amod	14	SENT_274	[p22l2000t1809r2149b1892, p22l7t1912r340b1995],
14	volume	NN	O	volume	prep_including	10	SENT_274	[p22l357t1912r626b1984],
15	,	,	O	,	_	0	SENT_274	[p22l357t1912r626b1984],
16	ApoE	NN	O	apoe	nn	17	SENT_274	[p22l647t1916r837b1995],
17	genotype	NN	O	genotype	conj_and	14	SENT_274	[p22l857t1924r1181b1996],
18	,	,	O	,	_	0	SENT_274	[p22l857t1924r1181b1996],
19	age	NN	O	age	prep_including	10	SENT_274	[p22l1204t1935r1328b1996],
20	,	,	O	,	_	0	SENT_274	[p22l1204t1935r1328b1996],
21	and	CC	O	and	_	0	SENT_274	[p22l1351t1912r1475b1975],
22	ventricular	JJ	O	ventricular	amod	23	SENT_274	[p22l1491t1912r1865b1975],
23	volume	NN	O	volume	prep_including	10	SENT_274	[p22l1881t1912r2150b1984],
24	,	,	O	,	_	0	SENT_274	[p22l1881t1912r2150b1984],
25	could	MD	O	could	aux	26	SENT_274	[p22l9t2015r204b2078],
26	reduce	VB	O	reduce	_	0	SENT_274	[p22l227t2015r461b2078],
27	the	DT	O	the	det	29	SENT_274	[p22l484t2015r593b2078],
28	sample	NN	O	sample	nn	29	SENT_274	[p22l618t2015r861b2098],
29	size	NN	O	size	dobj	26	SENT_274	[p22l886t2021r1013b2078],
30	to	TO	O	to	aux	31	SENT_274	[p22l1035t2027r1103b2078],
31	~	VB	O	~	xcomp	26	SENT_274	[p22l1131t2022r1259b2078],
32	40	CD	NUMBER	40	num	33	SENT_274	[p22l1131t2022r1259b2078],
33	patients	NNS	O	patient	dobj	31	SENT_274	[p22l1283t2021r1560b2098],
34	per	IN	O	per	_	0	SENT_274	[p22l1583t2037r1700b2098],
35	arm	NN	O	arm	prep_per	33	SENT_274	[p22l1723t2038r1862b2078],
36	in	IN	O	in	_	0	SENT_274	[p22l1886t2021r1954b2077],
37	trials	NNS	O	trial	prep_in	31	SENT_274	[p22l1977t2015r2153b2078],
38	designed	VBN	O	design	partmod	37	SENT_274	[p22l9t2117r326b2202],
39	to	TO	O	to	aux	40	SENT_274	[p22l349t2129r417b2181],
40	show	VB	O	show	xcomp	38	SENT_274	[p22l445t2117r628b2181],
41	a	DT	O	a	det	43	SENT_274	[p22l651t2140r686b2181],
42	25	CD	PERCENT	25	number	43	SENT_274	[p22l711t2123r858b2182],
43	%	NN	PERCENT	%	dobj	40	SENT_274	[p22l711t2123r858b2182],
44	slowing	VBG	O	slow	amod	43	SENT_274	[p22l886t2117r1159b2202],
45	per	IN	O	per	_	0	SENT_274	[p22l1182t2140r1299b2201],
46	year	NN	DURATION	year	prep_per	43	SENT_274	[p22l1320t2140r1471b2202],
47	with	IN	O	with	_	0	SENT_274	[p22l1493t2117r1652b2181],
48	80	CD	PERCENT	80	number	49	SENT_274	[p22l1679t2123r1824b2182],
49	%	NN	PERCENT	%	amod	50	SENT_274	[p22l1679t2123r1824b2182],
50	power	NN	O	power	prep_with	46	SENT_274	[p22l1851t2109r2148b2201],
51	.	.	O	.	_	0	SENT_274	[p22l1851t2109r2148b2201],

1	“	RB	O	“	advmod	2	SENT_275	[p22l1851t2109r2148b2201],
2	Identifying	VBG	O	identify	csubj	15	SENT_275	[p22l9t2221r390b2305],
3	populations	NNS	O	population	dobj	2	SENT_275	[p22l410t2221r818b2304],
4	highly	RB	O	highly	advmod	5	SENT_275	[p22l839t2221r1059b2305],
5	likely	JJ	O	likely	amod	3	SENT_275	[p22l1077t2221r1263b2305],
6	to	TO	O	to	aux	7	SENT_275	[p22l1281t2233r1347b2284],
7	decline	VB	O	decline	xcomp	2	SENT_275	[p22l1371t2221r1615b2284],
8	or	CC	O	or	_	0	SENT_275	[p22l1638t2244r1710b2284],
9	using	VBG	O	use	csubj	15	SENT_275	[p22l1731t2227r1918b2305],
10	multiple	JJ	O	multiple	amod	11	SENT_275	[p22l1938t2221r2149b2284, p22l7t2324r107b2407],
11	biomarkers	NNS	O	biomarker	dobj	9	SENT_275	[p22l126t2324r512b2387],
12	as	IN	O	as	_	0	SENT_275	[p22l534t2347r598b2387],
13	outcomes	NNS	O	outcome	prep_as	9	SENT_275	[p22l620t2336r946b2387],
14	could	MD	O	could	aux	15	SENT_275	[p22l968t2324r1157b2387],
15	allow	VB	O	allow	_	0	SENT_275	[p22l1178t2324r1359b2387],
16	development	NN	O	development	nn	17	SENT_275	[p22l1378t2324r1820b2407],
17	decisions	NNS	O	decision	dobj	15	SENT_275	[p22l1840t2324r2152b2387],
18	based	VBN	O	base	_	0	SENT_275	[p22l6t2427r203b2490],
19	on	IN	O	on	prepc_based_on	15	SENT_275	[p22l225t2450r311b2490],
20	trials	NNS	O	trial	pobj	15	SENT_275	[p22l332t2427r503b2490],
21	with	IN	O	with	_	0	SENT_275	[p22l524t2427r677b2490],
22	relatively	RB	O	relatively	advmod	23	SENT_275	[p22l699t2427r1011b2511],
23	small	JJ	O	small	amod	25	SENT_275	[p22l1030t2427r1211b2490],
24	sample	NN	O	sample	nn	25	SENT_275	[p22l1233t2427r1471b2510],
25	sizes	NNS	O	size	prep_with	20	SENT_275	[p22l1494t2433r1666b2490],
26	.	.	O	.	_	0	SENT_275	[p22l1494t2433r1666b2490],

1	QUALIFICATION	NNP	O	QUALIFICATION	nsubj	11	SENT_276	[p22l9t2642r578b2706],
2	OF	IN	O	of	_	0	SENT_276	[p22l600t2642r694b2698],
3	BIOMARKERS	NNP	O	BIOMARKERS	nn	4	SENT_276	[p22l716t2642r1195b2698],
4	Integration	NN	O	integration	prep_of	1	SENT_276	[p22l9t2744r408b2823],
5	of	IN	O	of	_	0	SENT_276	[p22l435t2739r511b2802],
6	biomarkers	NNS	O	biomarker	prep_of	4	SENT_276	[p22l526t2739r931b2802],
7	into	IN	O	into	_	0	SENT_276	[p22l959t2745r1098b2802],
8	drug	NN	O	drug	nn	10	SENT_276	[p22l1126t2739r1295b2823],
9	development	NN	O	development	nn	10	SENT_276	[p22l1320t2739r1783b2822],
10	programs	NNS	O	program	prep_into	6	SENT_276	[p22l1807t2761r2149b2823],
11	requires	VBZ	O	require	_	0	SENT_276	[p22l9t2848r299b2925],
12	regulatory	JJ	O	regulatory	amod	13	SENT_276	[p22l328t2842r703b2926],
13	review	NN	O	review	dobj	11	SENT_276	[p22l727t2848r966b2905],
14	if	IN	O	if	mark	17	SENT_276	[p22l991t2842r1048b2904],
15	the	DT	O	the	det	16	SENT_276	[p22l1064t2842r1176b2905],
16	biomarker	NN	O	biomarker	nsubj	17	SENT_276	[p22l1202t2842r1579b2905],
17	is	VBZ	O	be	advcl	11	SENT_276	[p22l1606t2848r1658b2905],
18	to	TO	O	to	aux	20	SENT_276	[p22l1685t2854r1754b2905],
19	be	VB	O	be	auxpass	20	SENT_276	[p22l1781t2842r1863b2905],
20	used	VBN	O	use	dep	17	SENT_276	[p22l1891t2842r2056b2905],
21	to	TO	O	to	aux	22	SENT_276	[p22l2082t2854r2151b2905],
22	deﬁne	VB	O	deﬁne	xcomp	20	SENT_276	[p22l9t2945r221b3008],
23	a	DT	O	a	det	25	SENT_276	[p22l245t2968r280b3008],
24	trial	NN	O	trial	nn	25	SENT_276	[p22l302t2945r446b3008],
25	population	NN	O	population	dobj	22	SENT_276	[p22l467t2945r852b3028],
26	or	CC	O	or	_	0	SENT_276	[p22l876t2968r949b3008],
27	as	IN	O	as	conj_or	20	SENT_276	[p22l972t2968r1037b3008],
28	an	DT	O	a	det	29	SENT_276	[p22l1062t2968r1143b3008],
29	outcome	NN	O	outcome	pobj	27	SENT_276	[p22l1167t2957r1470b3008],
30	of	IN	O	of	_	0	SENT_276	[p22l1494t2945r1569b3008],
31	the	DT	O	the	det	32	SENT_276	[p22l1582t2945r1690b3008],
32	trial	NN	O	trial	prep_of	29	SENT_276	[p22l1713t2945r1873b3008],
33	.	.	O	.	_	0	SENT_276	[p22l1713t2945r1873b3008],

1	The	DT	O	the	det	3	SENT_277	[p22l1900t2945r2027b3008],
2	US	NNP	ORGANIZATION	US	nn	3	SENT_277	[p22l2051t2949r2152b3008],
3	Food	NNP	ORGANIZATION	Food	nsubj	8	SENT_277	[p22l9t3048r182b3111],
4	and	CC	ORGANIZATION	and	_	0	SENT_277	[p22l201t3048r325b3111],
5	Drug	NNP	ORGANIZATION	Drug	nn	6	SENT_277	[p22l344t3053r521b3132],
6	Administration	NNP	ORGANIZATION	Administration	nsubj	8	SENT_277	[p22l538t3048r1058b3111],
7	has	VBZ	O	have	aux	8	SENT_277	[p22l1077t3048r1187b3111],
8	articulated	VBN	O	articulate	_	0	SENT_277	[p22l1208t3048r1568b3111],
9	a	DT	O	a	det	10	SENT_277	[p22l1587t3071r1621b3111],
10	policy	NN	O	policy	dobj	8	SENT_277	[p22l1638t3048r1847b3132],
11	for	IN	O	for	_	0	SENT_277	[p22l1863t3048r1958b3111],
12	qualifying	VBG	O	qualify	prepc_for	8	SENT_277	[p22l1978t3048r2147b3131, p22l8t3151r204b3235],
13	biomarkers	NNS	O	biomarker	dobj	12	SENT_277	[p22l220t3151r603b3214],
14	whereby	IN	O	whereby	mark	19	SENT_277	[p22l622t3151r912b3235],
15	the	DT	O	the	det	16	SENT_277	[p22l927t3151r1032b3214],
16	biomarker	NN	O	biomarker	nsubjpass	19	SENT_277	[p22l1050t3151r1404b3214],
17	can	MD	O	can	aux	19	SENT_277	[p22l1424t3174r1539b3214],
18	be	VB	O	be	auxpass	19	SENT_277	[p22l1557t3151r1636b3214],
19	integrated	VBN	O	integrate	advcl	12	SENT_277	[p22l1656t3151r1998b3235],
20	into	IN	O	into	_	0	SENT_277	[p22l2017t3157r2148b3214],
21	a	DT	O	a	det	24	SENT_277	[p22l9t3277r43b3317],
22	clinical	JJ	O	clinical	amod	24	SENT_277	[p22l62t3254r302b3317],
23	development	NN	O	development	nn	24	SENT_277	[p22l321t3254r756b3337],
24	program	NN	O	program	prep_into	19	SENT_277	[p22l774t3276r1066b3338],
25	and	CC	O	and	_	0	SENT_277	[p22l1086t3254r1210b3317],
26	the	DT	O	the	det	27	SENT_277	[p22l1227t3254r1332b3317],
27	results	NNS	O	result	prep_into	19	SENT_277	[p22l1352t3254r1567b3317],
28	presented	VBN	O	present	partmod	27	SENT_277	[p22l1586t3254r1913b3337],
29	as	IN	O	as	_	0	SENT_277	[p22l1932t3277r1995b3317],
30	part	NN	O	part	prep_as	28	SENT_277	[p22l2014t3266r2152b3337],
31	of	IN	O	of	_	0	SENT_277	[p22l9t3356r82b3420],
32	a	DT	O	a	det	35	SENT_277	[p22l93t3379r128b3420],
33	New	NNP	MISC	New	nn	35	SENT_277	[p22l146t3362r303b3420],
34	Drug	NNP	MISC	Drug	nn	35	SENT_277	[p22l321t3362r499b3441],
35	Application	NN	MISC	application	prep_of	30	SENT_277	[p22l517t3348r994b3440],
36	.82	CD	NUMBER	.82	num	35	SENT_277	[p22l517t3348r994b3440],
37	A	DT	O	a	det	39	SENT_277	[p22l1014t3361r1071b3419],
38	qualiﬁed	JJ	O	qualiﬁed	amod	39	SENT_277	[p22l1091t3356r1387b3440],
39	biomarker	NN	O	biomarker	nsubj	41	SENT_277	[p22l1404t3356r1759b3420],
40	can	MD	O	can	aux	41	SENT_277	[p22l1779t3379r1895b3420],
41	play	VB	O	play	rcmod	35	SENT_277	[p22l1913t3356r2056b3441],
42	an	DT	O	a	det	44	SENT_277	[p22l2073t3379r2152b3420],
43	important	JJ	O	important	amod	44	SENT_277	[p22l8t3466r356b3543],
44	role	NN	O	role	dobj	41	SENT_277	[p22l375t3460r504b3523],
45	in	IN	O	in	_	0	SENT_277	[p22l525t3466r591b3522],
46	providing	VBG	O	provide	prepc_in	41	SENT_277	[p22l610t3460r947b3544],
47	data	NNS	O	datum	nsubj	48	SENT_277	[p22l966t3460r1109b3523],
48	acceptable	JJ	O	acceptable	xcomp	46	SENT_277	[p22l1129t3460r1482b3543],
49	to	TO	O	to	_	0	SENT_277	[p22l1502t3472r1568b3523],
50	regulatory	JJ	O	regulatory	amod	51	SENT_277	[p22l1590t3460r1945b3544],
51	agencies	NNS	O	agency	prep_to	48	SENT_277	[p22l1963t3483r2147b3544, p22l9t3569r133b3626],
52	in	IN	O	in	_	0	SENT_277	[p22l157t3569r224b3625],
53	support	NN	O	support	prep_in	51	SENT_277	[p22l248t3575r517b3646],
54	of	IN	O	of	_	0	SENT_277	[p22l539t3563r614b3626],
55	indication	NN	O	indication	nn	56	SENT_277	[p22l627t3563r980b3626],
56	claims	NNS	O	claim	prep_of	53	SENT_277	[p22l1004t3563r1221b3626],
57	and	CC	O	and	_	0	SENT_277	[p22l1246t3563r1373b3626],
58	labeling	NN	O	labeling	prep_of	53	SENT_277	[p22l1394t3563r1684b3647],
59	.	.	O	.	_	0	SENT_277	[p22l1394t3563r1684b3647],

1	This	DT	O	this	det	2	SENT_278	[p22l1710t3563r1855b3626],
2	labeling	NN	O	labeling	nsubj	4	SENT_278	[p22l1877t3563r2152b3647],
3	would	MD	O	would	aux	4	SENT_278	[p22l7t3666r230b3729],
4	play	VB	O	play	_	0	SENT_278	[p22l254t3666r403b3750],
5	a	DT	O	a	det	7	SENT_278	[p22l427t3689r462b3729],
6	key	JJ	O	key	amod	7	SENT_278	[p22l486t3666r611b3750],
7	role	NN	O	role	dobj	4	SENT_278	[p22l633t3666r768b3729],
8	in	IN	O	in	_	0	SENT_278	[p22l794t3672r863b3728],
9	how	WRB	O	how	advmod	14	SENT_278	[p22l888t3666r1042b3729],
10	the	DT	O	the	det	11	SENT_278	[p22l1064t3666r1175b3729],
11	biomarkers	NNS	O	biomarker	nsubjpass	14	SENT_278	[p22l1199t3666r1604b3729],
12	would	MD	O	would	aux	14	SENT_278	[p22l1630t3666r1853b3729],
13	be	VB	O	be	auxpass	14	SENT_278	[p22l1876t3666r1958b3729],
14	integrated	VBN	O	integrate	prepc_in	4	SENT_278	[p22l1985t3672r2149b3729, p23l8t16r220b100],

1	into	IN	O	into	_	0	SENT_279	[p23l239t22r371b79],
2	clinical	JJ	O	clinical	amod	3	SENT_279	[p23l393t16r634b79],
3	practice	NN	O	practice	pobj	1	SENT_279	[p23l652t22r936b99],
4	.	.	O	.	_	0	SENT_279	[p23l652t22r936b99],

1	Qualiﬁcation	NN	O	qualiﬁcation	nsubj	2	SENT_280	[p23l960t16r1403b92],
2	establishes	VBZ	O	establish	_	0	SENT_280	[p23l1424t16r1779b79],
3	biomarker	NN	O	biomarker	dobj	2	SENT_280	[p23l1798t16r2151b79],
4	as	IN	O	as	_	0	SENT_280	[p23l9t142r73b182],
5	being	VBG	O	be	cop	7	SENT_280	[p23l91t119r281b203],
6	“	JJ	O	“	amod	7	SENT_280	[p23l300t119r399b182],
7	ﬁt	NN	O	ﬁt	prepc_as	2	SENT_280	[p23l300t119r399b182],
8	for	IN	O	for	_	0	SENT_280	[p23l417t119r514b182],
9	purpose	NN	O	purpose	nn	10	SENT_280	[p23l532t119r836b202],
10	”	NN	O	”	prep_for	7	SENT_280	[p23l532t119r836b202],
11	within	IN	O	within	_	0	SENT_280	[p23l856t119r1077b182],
12	the	DT	O	the	det	15	SENT_280	[p23l1096t119r1201b182],
13	drug	NN	O	drug	nn	15	SENT_280	[p23l1222t119r1382b203],
14	development	NN	O	development	nn	15	SENT_280	[p23l1402t119r1841b202],
15	program	NN	O	program	prep_within	7	SENT_280	[p23l1859t141r2153b203],
16	but	CC	O	but	_	0	SENT_280	[p23l6t222r123b285],
17	does	VBZ	O	do	aux	19	SENT_280	[p23l147t222r305b285],
18	not	RB	O	not	neg	19	SENT_280	[p23l330t234r447b285],
19	address	VB	O	address	conj_but	2	SENT_280	[p23l471t222r734b285],
20	wider	JJR	O	wider	amod	21	SENT_280	[p23l757t222r959b285],
21	applications	NNS	O	application	dobj	19	SENT_280	[p23l983t222r1407b305],
22	of	IN	O	of	_	0	SENT_280	[p23l1433t222r1508b285],
23	the	DT	O	the	det	24	SENT_280	[p23l1521t222r1631b285],
24	biomarkers	NNS	O	biomarker	prep_of	21	SENT_280	[p23l1654t222r2055b285],
25	or	CC	O	or	_	0	SENT_280	[p23l2080t245r2154b285],
26	their	PRP$	O	they	poss	27	SENT_280	[p23l7t325r171b389],
27	readiness	NN	O	readiness	conj_or	21	SENT_280	[p23l191t325r510b389],
28	for	IN	O	for	_	0	SENT_280	[p23l532t325r629b389],
29	commercialization	NN	O	commercialization	prep_for	27	SENT_280	[p23l651t325r1310b389],
30	.	.	O	.	_	0	SENT_280	[p23l651t325r1310b389],

1	The	DT	ORGANIZATION	the	det	5	SENT_281	[p23l82t429r211b492],
2	Food	NNP	ORGANIZATION	Food	nn	5	SENT_281	[p23l238t429r422b492],
3	and	CC	ORGANIZATION	and	_	0	SENT_281	[p23l448t429r580b492],
4	Drug	NNP	ORGANIZATION	Drug	conj_and	2	SENT_281	[p23l605t434r794b513],
5	Administration	NNP	ORGANIZATION	Administration	nsubj	6	SENT_281	[p23l817t429r1379b492],
6	recognizes	VBZ	O	recognize	dep	18	SENT_281	[p23l1405t435r1786b513],
7	strategies	NNS	O	strategy	dobj	6	SENT_281	[p23l1814t435r2150b513],
8	that	WDT	O	that	nsubjpass	11	SENT_281	[p23l7t532r150b595],
9	can	MD	O	can	aux	11	SENT_281	[p23l177t555r301b595],
10	be	VB	O	be	auxpass	11	SENT_281	[p23l326t532r409b595],
11	used	VBN	O	use	rcmod	7	SENT_281	[p23l437t532r605b595],
12	for	IN	O	for	_	0	SENT_281	[p23l631t532r735b595],
13	population	NN	O	population	nn	14	SENT_281	[p23l760t532r1163b615],
14	enrichment	NN	O	enrichment	prep_for	11	SENT_281	[p23l1191t532r1616b595],
15	in	IN	O	in	_	0	SENT_281	[p23l1643t538r1712b594],
16	clinical	JJ	O	clinical	amod	17	SENT_281	[p23l1741t532r2005b595],
17	trials	NNS	O	trial	prep_in	14	SENT_281	[p23l2031t538r2147b595, p23l9t635r99b699],
18	(	VBP	O	(	_	0	SENT_281	[p23l129t636r356b712],
19	Table	NNP	O	Table	dobj	18	SENT_281	[p23l129t636r356b712],
20	2	CD	NUMBER	2	num	19	SENT_281	[p23l381t627r537b713],
21	)	CD	NUMBER	)	number	22	SENT_281	[p23l381t627r537b713],
22	.83	CD	NUMBER	.83	nsubj	18	SENT_281	[p23l381t627r537b713],
23	There	EX	O	there	expl	24	SENT_281	[p23l564t635r762b699],
24	are	VBP	O	be	rcmod	22	SENT_281	[p23l789t658r893b699],
25	means	VBZ	O	mean	dep	24	SENT_281	[p23l918t658r1145b699],
26	to	TO	O	to	aux	27	SENT_281	[p23l1170t647r1238b699],
27	decrease	VB	O	decrease	xcomp	25	SENT_281	[p23l1266t635r1568b699],
28	population	NN	O	population	nn	29	SENT_281	[p23l1592t635r1984b719],
29	heterogeneity	NN	O	heterogeneity	dobj	27	SENT_281	[p23l2009t635r2148b699, p23l9t765r393b843],
30	,	,	O	,	_	0	SENT_281	[p23l2009t635r2148b699, p23l9t765r393b843],
31	prognostic	JJ	O	prognostic	amod	33	SENT_281	[p23l419t765r801b843],
32	enrichment	NN	O	enrichment	nn	33	SENT_281	[p23l827t759r1240b822],
33	strategies	NNS	O	strategy	dobj	27	SENT_281	[p23l1265t765r1616b843],
34	,	,	O	,	_	0	SENT_281	[p23l1265t765r1616b843],
35	and	CC	O	and	_	0	SENT_281	[p23l1644t759r1774b822],
36	predictive	JJ	O	predictive	amod	38	SENT_281	[p23l1797t759r2153b842],
37	enrichment	NN	O	enrichment	nn	38	SENT_281	[p23l9t862r408b925],
38	approaches	NNS	O	approach	dobj	27	SENT_281	[p23l430t862r832b945],
39	.	.	O	.	_	0	SENT_281	[p23l430t862r832b945],

1	In	IN	O	in	_	0	SENT_282	[p23l858t867r929b924],
2	AD	NN	O	ad	nn	4	SENT_282	[p23l950t866r1067b924],
3	drug	NN	O	drug	nn	4	SENT_282	[p23l1092t862r1254b946],
4	development	NN	O	development	prep_in	8	SENT_282	[p23l1275t862r1738b945],
5	,	,	O	,	_	0	SENT_282	[p23l1275t862r1738b945],
6	biomarkers	NNS	O	biomarker	nsubjpass	8	SENT_282	[p23l1759t862r2149b925],
7	are	VBP	O	be	auxpass	8	SENT_282	[p23l9t989r112b1029],
8	used	VBN	O	use	_	0	SENT_282	[p23l137t966r300b1029],
9	primarily	RB	O	primarily	advmod	8	SENT_282	[p23l322t966r659b1050],
10	as	IN	O	as	_	0	SENT_282	[p23l682t989r747b1029],
11	a	DT	O	a	det	13	SENT_282	[p23l774t989r808b1029],
12	putative	JJ	O	putative	amod	13	SENT_282	[p23l830t972r1116b1049],
13	means	NNS	O	means	prep_as	8	SENT_282	[p23l1140t989r1365b1029],
14	of	IN	O	of	_	0	SENT_282	[p23l1391t966r1467b1029],
15	improving	VBG	O	improve	prepc_of	13	SENT_282	[p23l1482t972r1852b1050],
16	the	DT	O	the	det	17	SENT_282	[p23l1874t966r1983b1029],
17	predictability	NN	O	predictability	dobj	15	SENT_282	[p23l2007t988r2149b1049, p23l9t1069r366b1153],
18	of	IN	O	of	_	0	SENT_282	[p23l386t1069r461b1132],
19	a	DT	O	a	det	20	SENT_282	[p23l475t1092r509b1132],
20	response	NN	O	response	prep_of	17	SENT_282	[p23l532t1091r839b1152],
21	by	IN	O	by	_	0	SENT_282	[p23l860t1069r945b1153],
22	identifying	VBG	O	identify	prepc_by	15	SENT_282	[p23l965t1069r1352b1153],
23	patients	NNS	O	patient	nsubj	25	SENT_282	[p23l1373t1075r1649b1152],
24	more	RBR	O	more	advmod	25	SENT_282	[p23l1673t1092r1853b1132],
25	likely	JJ	O	likely	xcomp	22	SENT_282	[p23l1875t1069r2067b1153],
26	to	TO	O	to	aux	27	SENT_282	[p23l2085t1081r2152b1132],
27	harbor	VB	O	harbor	dep	25	SENT_282	[p23l7t1172r248b1235],
28	the	DT	O	the	det	30	SENT_282	[p23l271t1172r380b1235],
29	target	NN	O	target	nn	30	SENT_282	[p23l405t1184r609b1256],
30	pathology	NN	O	pathology	dobj	27	SENT_282	[p23l632t1172r991b1256],
31	and	CC	O	and	_	0	SENT_282	[p23l1013t1172r1142b1235],
32	to	TO	O	to	aux	33	SENT_282	[p23l1165t1184r1232b1235],
33	respond	VB	O	respond	conj_and	27	SENT_282	[p23l1259t1172r1546b1255],
34	to	TO	O	to	_	0	SENT_282	[p23l1569t1184r1636b1235],
35	the	DT	O	the	det	37	SENT_282	[p23l1662t1172r1771b1235],
36	test	NN	O	test	nn	37	SENT_282	[p23l1796t1184r1919b1235],
37	agent	NN	O	agent	prep_to	33	SENT_282	[p23l1943t1184r2149b1256],
38	.	.	O	.	_	0	SENT_282	[p23l1943t1184r2149b1256],

1	Amyloid	JJ	O	amyloid	amod	2	SENT_283	[p23l7t1275r317b1359],
2	biomarkers	NNS	O	biomarker	nsubj	3	SENT_283	[p23l337t1275r739b1338],
3	(	VBP	O	(	ccomp	19	SENT_283	[p23l767t1276r931b1359],
4	e.g.	FW	O	e.g.	dobj	3	SENT_283	[p23l767t1276r931b1359],
5	,	,	O	,	_	0	SENT_283	[p23l767t1276r931b1359],
6	deposition	NN	O	deposition	nsubjpass	19	SENT_283	[p23l957t1275r1332b1358],
7	of	IN	O	of	_	0	SENT_283	[p23l1357t1275r1432b1338],
8	amyloid	NN	O	amyloid	prep_of	6	SENT_283	[p23l1447t1275r1732b1359],
9	on	IN	O	on	_	0	SENT_283	[p23l1755t1298r1843b1338],
10	amyloid	NN	O	amyloid	nn	11	SENT_283	[p23l1867t1275r2153b1359],
11	imaging	NN	O	imaging	prep_on	8	SENT_283	[p23l9t1384r301b1462],
12	or	CC	O	or	_	0	SENT_283	[p23l326t1401r400b1441],
13	low	JJ	O	low	amod	16	SENT_283	[p23l423t1378r552b1441],
14	CSF	NN	O	csf	nn	16	SENT_283	[p23l576t1382r717b1441],
15	AB	NNP	O	AB	nn	16	SENT_283	[p23l743t1376r878b1459],
16	)	NNP	O	)	prep_on	8	SENT_283	[p23l743t1376r878b1459],
17	can	MD	O	can	aux	19	SENT_283	[p23l909t1401r1030b1441],
18	be	VB	O	be	auxpass	19	SENT_283	[p23l1054t1378r1135b1441],
19	used	VBN	O	use	_	0	SENT_283	[p23l1161t1378r1326b1441],
20	to	TO	O	to	aux	21	SENT_283	[p23l1349t1390r1418b1441],
21	enrich	VB	O	enrich	xcomp	19	SENT_283	[p23l1445t1378r1673b1441],
22	a	DT	O	a	det	23	SENT_283	[p23l1700t1401r1734b1441],
23	population	NN	O	population	dobj	21	SENT_283	[p23l1758t1378r2152b1461],
24	of	IN	O	of	_	0	SENT_283	[p23l9t1481r84b1544],
25	patients	NNS	O	patient	prep_of	23	SENT_283	[p23l97t1487r376b1564],
26	in	IN	O	in	_	0	SENT_283	[p23l401t1487r469b1543],
27	whom	WP	O	whom	rel	34	SENT_283	[p23l490t1481r712b1544],
28	the	DT	O	the	det	29	SENT_283	[p23l735t1481r844b1544],
29	efﬁcacy	NN	O	efﬁcacy	nsubj	34	SENT_283	[p23l869t1481r1133b1565],
30	of	IN	O	of	_	0	SENT_283	[p23l1154t1481r1229b1544],
31	an	DT	O	a	det	33	SENT_283	[p23l1244t1504r1326b1544],
32	antiamyloid	JJ	O	antiamyloid	amod	33	SENT_283	[p23l1350t1481r1774b1565],
33	agent	NN	O	agent	prep_of	29	SENT_283	[p23l1797t1493r1986b1565],
34	is	VBZ	O	be	rcmod	25	SENT_283	[p23l2008t1487r2060b1544],
35	to	TO	O	to	aux	37	SENT_283	[p23l2083t1493r2150b1544],
36	be	VB	O	be	auxpass	37	SENT_283	[p23l6t1584r86b1647],
37	assessed	VBN	O	assess	xcomp	34	SENT_283	[p23l110t1584r414b1647],
38	.	.	O	.	_	0	SENT_283	[p23l110t1584r414b1647],

1	This	DT	O	this	nsubj	3	SENT_284	[p23l440t1584r584b1647],
2	will	MD	O	will	aux	3	SENT_284	[p23l606t1584r735b1647],
3	ensure	VB	O	ensure	dep	29	SENT_284	[p23l757t1607r986b1647],
4	that	IN	O	that	complm	9	SENT_284	[p23l1008t1584r1144b1647],
5	the	DT	O	the	det	7	SENT_284	[p23l1165t1584r1273b1647],
6	target	NN	O	target	nn	7	SENT_284	[p23l1295t1596r1497b1668],
7	biology	NN	O	biology	nsubj	9	SENT_284	[p23l1516t1584r1781b1668],
8	is	VBZ	O	be	cop	9	SENT_284	[p23l1801t1590r1851b1647],
9	present	JJ	DATE	present	ccomp	3	SENT_284	[p23l1874t1596r2149b1667],
10	,	,	O	,	_	0	SENT_284	[p23l1874t1596r2149b1667],
11	although	IN	O	although	advcl	9	SENT_284	[p23l9t1687r335b1771],
12	the	DT	O	the	det	13	SENT_284	[p23l363t1687r477b1750],
13	effect	NN	O	effect	dep	24	SENT_284	[p23l506t1687r701b1750],
14	of	IN	O	of	_	0	SENT_284	[p23l729t1687r807b1750],
15	this	DT	O	this	det	16	SENT_284	[p23l825t1687r958b1750],
16	strategy	NN	O	strategy	prep_of	13	SENT_284	[p23l989t1699r1281b1771],
17	on	IN	O	on	_	0	SENT_284	[p23l1307t1710r1397b1750],
18	the	DT	O	the	det	19	SENT_284	[p23l1425t1687r1538b1750],
19	€	NN	O	€	prep_on	16	SENT_284	[p23l1567t1687r1917b1771],
20	ﬂ	NN	O	ﬂ	dep	24	SENT_284	[p23l1567t1687r1917b1771],
21	‘	CD	NUMBER	‘	num	20	SENT_284	[p23l1567t1687r1917b1771],
22	lCi	NNP	O	lCi	nn	24	SENT_284	[p23l1567t1687r1917b1771],
23	€	CD	NUMBER	€	num	24	SENT_284	[p23l1567t1687r1917b1771],
24	I1CY	NN	O	i1cy	dep	11	SENT_284	[p23l1567t1687r1917b1771],
25	of	IN	O	of	_	0	SENT_284	[p23l1942t1687r2020b1750],
26	the	DT	O	the	det	27	SENT_284	[p23l2038t1687r2151b1750],
27	study	NN	O	study	prep_of	24	SENT_284	[p23l9t1789r201b1874],
28	is	VBZ	O	be	cop	29	SENT_284	[p23l222t1796r274b1853],
29	subject	JJ	O	subject	_	0	SENT_284	[p23l300t1789r548b1874],
30	to	TO	O	to	aux	31	SENT_284	[p23l570t1801r637b1853],
31	debate	VB	O	debate	xcomp	29	SENT_284	[p23l663t1781r1056b1853],
32	.84	CD	NUMBER	.84	num	33	SENT_284	[p23l663t1781r1056b1853],
33	>	JJR	O	>	dobj	31	SENT_284	[p23l663t1781r1056b1853],
34	85	CD	NUMBER	85	nsubj	29	SENT_284	[p23l663t1781r1056b1853],

1	BIOMARKERS	NNS	O	biomarker	nsubj	11	SENT_285	[p23l12t2005r491b2061],
2	AND	CC	O	and	_	0	SENT_285	[p23l509t2006r670b2060],
3	BIOLOGICAL	JJ	O	biological	amod	4	SENT_285	[p23l691t2005r1136b2061],
4	HETEROGENEITY	NN	O	heterogeneity	conj_and	1	SENT_285	[p23l1157t2005r1763b2061],
5	OF	IN	O	of	_	0	SENT_285	[p23l1781t2005r1874b2061],
6	AD	NN	O	ad	nn	7	SENT_285	[p23l1894t2006r1998b2060],
7	AD	NN	O	ad	prep_of	1	SENT_285	[p23l7t2105r123b2163],
8	is	VBZ	O	be	cop	11	SENT_285	[p23l144t2107r193b2164],
9	a	DT	O	a	det	11	SENT_285	[p23l213t2124r247b2164],
10	heterogeneous	JJ	O	heterogeneous	amod	11	SENT_285	[p23l264t2101r746b2185],
11	disease	NN	O	disease	_	0	SENT_285	[p23l766t2101r999b2164],
12	with	IN	O	with	_	0	SENT_285	[p23l1016t2101r1165b2164],
13	multiple	JJ	O	multiple	amod	15	SENT_285	[p23l1183t2101r1459b2184],
14	contributing	VBG	O	contribute	amod	15	SENT_285	[p23l1479t2101r1895b2185],
15	pathologies	NNS	O	pathology	prep_with	11	SENT_285	[p23l1910t2101r2148b2184, p23l9t2210r195b2288],
16	.	.	O	.	_	0	SENT_285	[p23l1910t2101r2148b2184, p23l9t2210r195b2288],

1	Neuroﬁbrillary	JJ	O	neuroﬁbrillary	amod	2	SENT_286	[p23l217t2204r731b2288],
2	tangles	NNS	O	tangle	nsubjpass	5	SENT_286	[p23l746t2204r982b2288],
3	have	VBP	O	have	aux	5	SENT_286	[p23l1001t2204r1155b2267],
4	been	VBN	O	be	auxpass	5	SENT_286	[p23l1173t2204r1336b2267],
5	found	VBN	O	find	_	0	SENT_286	[p23l1355t2204r1557b2267],
6	to	TO	O	to	aux	7	SENT_286	[p23l1575t2216r1640b2267],
7	correlate	VB	O	correlate	xcomp	5	SENT_286	[p23l1662t2204r1954b2267],
8	more	JJR	O	more	dobj	7	SENT_286	[p23l1973t2227r2149b2267],

1	VOLUME	NN	O	volume	nn	3	SENT_287	[p23l543t2423r768b2465],
2	95	CD	NUMBER	95	num	3	SENT_287	[p23l785t2424r842b2465],
3	NUMBER	NN	O	number	dep	13	SENT_287	[p23l863t2423r1087b2465],
4	1	CD	NUMBER	1	number	5	SENT_287	[p23l1109t2425r1122b2465],
5	|	CD	NUMBER	|	dep	3	SENT_287	[p23l1151t2419r1156b2480],
6	JANUARY	NNP	DATE	JANUARY	dep	5	SENT_287	[p23l1175t2423r1421b2465],
7	2014	CD	DATE	2014	num	6	SENT_287	[p23l1437t2424r1558b2465],
8	|	CD	NUMBER	|	dep	13	SENT_287	[p23l1577t2419r1581b2480],
9	www.nature.com/cpt	JJ	O	www.nature.com/cpt	amod	13	SENT_287	[p23l1600t2423r2152b2476],
10	strongly	RB	O	strongly	advmod	12	SENT_287	[p23l10t2828r299b2912],
11	than	IN	O	than	dep	12	SENT_287	[p23l319t2828r479b2891],
12	neuritic	JJ	O	neuritic	amod	13	SENT_287	[p23l505t2834r781b2891],
13	plaques	NNS	O	plaque	dep	23	SENT_287	[p23l805t2828r1073b2911],
14	with	IN	O	with	_	0	SENT_287	[p23l1098t2828r1255b2891],
15	cognitive	JJ	O	cognitive	amod	16	SENT_287	[p23l1282t2834r1604b2912],
16	impairment	NN	O	impairment	prep_with	13	SENT_287	[p23l1630t2834r2051b2911],
17	in	IN	O	in	_	0	SENT_287	[p23l2076t2834r2144b2890],
18	AD	NN	O	ad	prep_in	16	SENT_287	[p23l8t2935r145b3003],
19	,	,	O	,	_	0	SENT_287	[p23l8t2935r145b3003],
20	but	CC	O	but	_	0	SENT_287	[p23l168t2931r283b2994],
21	correlation	NN	O	correlation	nn	22	SENT_287	[p23l306t2931r686b2994],
22	studies	NNS	O	study	ccomp	63	SENT_287	[p23l710t2931r949b2994],
23	show	VBP	O	show	ccomp	63	SENT_287	[p23l973t2931r1154b2994],
24	that	IN	O	that	complm	41	SENT_287	[p23l1173t2931r1309b2994],
25	tangle	NN	O	tangle	nn	27	SENT_287	[p23l1330t2931r1541b3015],
26	burden	NN	O	burden	nn	27	SENT_287	[p23l1562t2931r1814b2994],
27	accounts	NNS	O	account	nsubj	41	SENT_287	[p23l1838t2943r2142b2994],
28	for	IN	O	for	_	0	SENT_287	[p23l8t3034r109b3097],
29	only	RB	O	only	quantmod	30	SENT_287	[p23l135t3034r290b3118],
30	26.5	CD	PERCENT	26.5	num	31	SENT_287	[p23l313t3040r523b3099],
31	%	NN	PERCENT	%	prep_for	27	SENT_287	[p23l313t3040r523b3099],
32	of	IN	O	of	_	0	SENT_287	[p23l552t3034r628b3097],
33	the	DT	O	the	det	34	SENT_287	[p23l643t3034r753b3097],
34	variability	NN	O	variability	prep_of	31	SENT_287	[p23l776t3034r1139b3118],
35	in	IN	O	in	_	0	SENT_287	[p23l1162t3040r1230b3096],
36	clinical	JJ	O	clinical	amod	40	SENT_287	[p23l1257t3034r1511b3097],
37	severity	NN	O	severity	nn	40	SENT_287	[p23l1537t3040r1813b3118],
38	(	NN	O	(	nn	40	SENT_287	[p23l1839t3034r2144b3111],
39	neuritic	JJ	O	neuritic	amod	40	SENT_287	[p23l1839t3034r2144b3111],
40	plaques	NNS	O	plaque	prep_in	34	SENT_287	[p23l7t3136r257b3219],
41	account	VBP	O	account	ccomp	23	SENT_287	[p23l278t3148r537b3199],
42	for	IN	O	for	_	0	SENT_287	[p23l554t3136r649b3199],
43	13	CD	PERCENT	13	num	44	SENT_287	[p23l673t3142r805b3201],
44	%	NN	PERCENT	%	prep_for	41	SENT_287	[p23l673t3142r805b3201],
45	and	CC	O	and	_	0	SENT_287	[p23l826t3136r949b3199],
46	age	NN	O	age	nn	47	SENT_287	[p23l967t3159r1072b3220],
47	accounts	NNS	O	account	prep_for	41	SENT_287	[p23l1093t3148r1381b3199],
48	for	IN	O	for	_	0	SENT_287	[p23l1400t3136r1494b3199],
49	4.4	CD	PERCENT	4.4	num	50	SENT_287	[p23l1510t3128r1777b3212],
50	%	NN	PERCENT	%	prep_for	41	SENT_287	[p23l1510t3128r1777b3212],
51	)	CD	NUMBER	)	number	52	SENT_287	[p23l1510t3128r1777b3212],
52	.86	CD	NUMBER	.86	num	50	SENT_287	[p23l1510t3128r1777b3212],
53	Thus	RB	O	thus	advmod	50	SENT_287	[p23l1796t3136r1973b3208],
54	,	,	O	,	_	0	SENT_287	[p23l1796t3136r1973b3208],
55	even	RB	O	even	advmod	57	SENT_287	[p23l1994t3159r2145b3199],
56	the	DT	O	the	det	57	SENT_287	[p23l8t3239r114b3302],
57	pathologies	NNS	O	pathology	nsubj	63	SENT_287	[p23l136t3239r530b3323],
58	with	IN	O	with	_	0	SENT_287	[p23l552t3239r705b3302],
59	the	DT	O	the	det	61	SENT_287	[p23l726t3239r833b3302],
60	highest	JJS	O	highest	amod	61	SENT_287	[p23l855t3239r1105b3323],
61	correlations	NNS	O	correlation	prep_with	57	SENT_287	[p23l1126t3239r1532b3302],
62	still	RB	O	still	advmod	63	SENT_287	[p23l1556t3239r1678b3302],
63	account	VBP	O	account	_	0	SENT_287	[p23l1700t3251r1970b3302],
64	for	IN	O	for	_	0	SENT_287	[p23l1991t3239r2089b3302],
65	a	DT	O	a	det	67	SENT_287	[p23l2111t3262r2146b3302],
66	limited	JJ	O	limited	amod	67	SENT_287	[p23l7t3342r250b3405],
67	amount	NN	O	amount	prep_for	63	SENT_287	[p23l270t3354r533b3405],
68	of	IN	O	of	_	0	SENT_287	[p23l553t3342r626b3405],
69	the	DT	O	the	det	71	SENT_287	[p23l636t3342r741b3405],
70	cognitive	JJ	O	cognitive	amod	71	SENT_287	[p23l763t3348r1071b3426],
71	change	NN	O	change	prep_of	67	SENT_287	[p23l1093t3342r1328b3426],
72	observed	VBN	O	observe	partmod	71	SENT_287	[p23l1349t3342r1656b3405],
73	in	IN	O	in	_	0	SENT_287	[p23l1676t3348r1742b3404],
74	the	DT	O	the	det	75	SENT_287	[p23l1761t3342r1867b3405],
75	disease	NN	O	disease	prep_in	72	SENT_287	[p23l1888t3342r2142b3405],
76	.	.	O	.	_	0	SENT_287	[p23l1888t3342r2142b3405],

1	Subtypes	NNS	O	subtype	nsubjpass	7	SENT_288	[p23l83t3445r404b3529],
2	of	IN	O	of	_	0	SENT_288	[p23l434t3445r510b3508],
3	AD	NN	O	ad	prep_of	1	SENT_288	[p23l528t3449r651b3507],
4	also	RB	O	also	advmod	7	SENT_288	[p23l682t3445r820b3508],
5	have	VBP	O	have	aux	7	SENT_288	[p23l849t3445r1012b3508],
6	been	VBN	O	be	auxpass	7	SENT_288	[p23l1039t3445r1211b3508],
7	recognized	VBN	O	recognize	_	0	SENT_288	[p23l1240t3445r1654b3529],
8	.	.	O	.	_	0	SENT_288	[p23l1240t3445r1654b3529],

1	Typical	JJ	O	typical	amod	4	SENT_289	[p23l1686t3445r1967b3529],
2	,	,	O	,	_	0	SENT_289	[p23l1686t3445r1967b3529],
3	hippocampal	JJ	O	hippocampal	amod	4	SENT_289	[p23l1996t3445r2142b3528, p23l7t3549r343b3632],
4	sparing	NN	O	sparing	nsubjpass	12	SENT_289	[p23l364t3555r632b3633],
5	,	,	O	,	_	0	SENT_289	[p23l364t3555r632b3633],
6	and	CC	O	and	_	0	SENT_289	[p23l655t3549r780b3612],
7	limbic	JJ	O	limbic	amod	9	SENT_289	[p23l798t3549r1012b3612],
8	predominant	JJ	O	predominant	amod	9	SENT_289	[p23l1031t3549r1477b3632],
9	subtypes	NNS	O	subtype	nsubjpass	12	SENT_289	[p23l1498t3549r1791b3633],
10	have	VBP	O	have	aux	12	SENT_289	[p23l1811t3549r1965b3612],
11	been	VBN	O	be	auxpass	12	SENT_289	[p23l1984t3549r2147b3612],
12	described	VBN	O	describe	_	0	SENT_289	[p23l9t3652r331b3715],
13	based	VBN	O	base	_	0	SENT_289	[p23l347t3652r539b3715],
14	on	IN	O	on	prepc_based_on	12	SENT_289	[p23l558t3675r642b3715],
15	autopsy	NN	O	autopsy	nn	16	SENT_289	[p23l662t3664r921b3736],
16	features	NNS	O	feature	pobj	12	SENT_289	[p23l937t3652r1195b3715],
17	of	IN	O	of	_	0	SENT_289	[p23l1215t3652r1287b3715],
18	the	DT	O	the	det	19	SENT_289	[p23l1296t3652r1400b3715],
19	disease	NN	O	disease	prep_of	16	SENT_289	[p23l1421t3652r1670b3715],
20	.	.	O	.	_	0	SENT_289	[p23l1421t3652r1670b3715],

1	The	DT	O	the	det	4	SENT_290	[p23l1693t3652r1815b3715],
2	latter	JJ	O	latter	amod	4	SENT_290	[p23l1833t3652r2006b3715],
3	two	CD	NUMBER	two	num	4	SENT_290	[p23l2023t3664r2145b3715],
4	forms	NNS	O	form	nsubj	5	SENT_290	[p24l8t20r211b83],
5	account	VBP	O	account	_	0	SENT_290	[p24l235t32r510b83],
6	for	IN	O	for	_	0	SENT_290	[p24l532t20r631b83],
7	~	NN	O	~	prep_for	5	SENT_290	[p24l656t26r850b85],
8	25	CD	PERCENT	25	num	9	SENT_290	[p24l656t26r850b85],
9	%	NN	PERCENT	%	dobj	5	SENT_290	[p24l656t26r850b85],
10	of	IN	O	of	_	0	SENT_290	[p24l876t20r951b83],
11	cases	NNS	O	case	prep_of	9	SENT_290	[p24l966t12r1225b83],
12	.87	CD	NUMBER	.87	num	14	SENT_290	[p24l966t12r1225b83],
13	Pathological	JJ	O	pathological	amod	14	SENT_290	[p24l1250t20r1681b104],
14	features	NNS	O	feature	nsubj	17	SENT_290	[p24l1704t20r1975b83],
15	may	MD	O	may	aux	17	SENT_290	[p24l1998t43r2148b104],
16	also	RB	O	also	advmod	17	SENT_290	[p24l9t123r137b186],
17	vary	VB	O	vary	rcmod	11	SENT_290	[p24l155t146r306b207],
18	by	IN	O	by	_	0	SENT_290	[p24l320t123r403b207],
19	age	NN	O	age	prep_by	17	SENT_290	[p24l420t146r543b207],
20	.	.	O	.	_	0	SENT_290	[p24l420t146r543b207],

1	In	IN	O	in	_	0	SENT_291	[p24l566t128r636b185],
2	postmortem	NN	O	postmortem	nn	3	SENT_291	[p24l655t135r1087b206],
3	studies	NNS	O	study	prep_in	11	SENT_291	[p24l1108t123r1356b195],
4	,	,	O	,	_	0	SENT_291	[p24l1108t123r1356b195],
5	patients	NNS	O	patient	nsubjpass	11	SENT_291	[p24l1376t129r1639b206],
6	aged	JJ	O	aged	amod	5	SENT_291	[p24l1661t123r1814b207],
7	>	JJR	O	>	dep	6	SENT_291	[p24l1835t130r1956b186],
8	80	CD	DURATION	80	num	9	SENT_291	[p24l1835t130r1956b186],
9	years	NNS	NUMBER	year	tmod	6	SENT_291	[p24l1975t146r2146b207],
10	were	VBD	O	be	auxpass	11	SENT_291	[p24l7t249r167b289],
11	found	VBN	O	find	_	0	SENT_291	[p24l188t226r391b289],
12	to	TO	O	to	aux	13	SENT_291	[p24l410t238r476b289],
13	have	VB	O	have	xcomp	11	SENT_291	[p24l497t226r652b289],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	15	SENT_291	[p24l673t226r1092b310],
15	fewer	JJR	O	fewer	amod	16	SENT_291	[p24l1109t226r1296b289],
16	microglia	NNS	O	microglium	dobj	13	SENT_291	[p24l1314t226r1642b310],
17	and	CC	O	and	_	0	SENT_291	[p24l1662t226r1788b289],
18	astrocytes	NNS	O	astrocyte	dobj	13	SENT_291	[p24l1808t238r2146b310],
19	as	IN	O	as	mark	27	SENT_291	[p24l9t351r75b391],
20	compared	VBN	O	compare	prep	27	SENT_291	[p24l100t328r451b411],
21	with	IN	O	with	pcomp	20	SENT_291	[p24l472t328r629b391],
22	younger	JJR	O	younger	amod	23	SENT_291	[p24l650t351r941b412],
23	patients	NNS	O	patient	pobj	21	SENT_291	[p24l962t320r1324b411],
24	.88	CD	NUMBER	.88	dep	23	SENT_291	[p24l962t320r1324b411],
25	This	DT	DATE	this	nsubj	27	SENT_291	[p24l1348t328r1495b391],
26	may	MD	DATE	may	aux	27	SENT_291	[p24l1519t351r1669b412],
27	contribute	VB	O	contribute	advcl	13	SENT_291	[p24l1690t328r2053b391],
28	to	TO	O	to	_	0	SENT_291	[p24l2076t340r2143b391],
29	the	DT	O	the	det	31	SENT_291	[p24l8t431r115b494],
30	slower	JJR	O	slower	amod	31	SENT_291	[p24l140t431r364b494],
31	rate	NN	O	rate	prep_to	27	SENT_291	[p24l386t443r515b494],
32	of	IN	O	of	_	0	SENT_291	[p24l539t431r614b494],
33	decline	NN	O	decline	prep_of	31	SENT_291	[p24l629t431r876b494],
34	observed	VBN	O	observe	partmod	33	SENT_291	[p24l901t431r1216b494],
35	in	IN	O	in	_	0	SENT_291	[p24l1238t437r1306b493],
36	older	JJR	O	older	prep_in	34	SENT_291	[p24l1330t431r1510b494],
37	as	IN	O	as	mark	51	SENT_291	[p24l1533t454r1598b494],
38	compared	VBN	O	compare	_	0	SENT_291	[p24l1622t431r1970b514],
39	with	IN	O	with	prepc_compared_with	51	SENT_291	[p24l1991t431r2146b494],
40	younger	JJR	O	younger	amod	41	SENT_291	[p24l6t556r301b617],
41	patients	NNS	O	patient	pobj	51	SENT_291	[p24l325t525r692b616],
42	.89	CD	NUMBER	.89	num	43	SENT_291	[p24l325t525r692b616],
43	CSF	NN	O	csf	nsubj	51	SENT_291	[p24l720t537r873b605],
44	,	,	O	,	_	0	SENT_291	[p24l720t537r873b605],
45	MRI	NNP	O	MRI	nn	46	SENT_291	[p24l901t538r1061b596],
46	measures	NNS	O	measure	nsubj	51	SENT_291	[p24l1089t556r1439b605],
47	,	,	O	,	_	0	SENT_291	[p24l1089t556r1439b605],
48	and	CC	O	and	_	0	SENT_291	[p24l1469t533r1599b596],
49	amyloid	NN	O	amyloid	nn	50	SENT_291	[p24l1625t533r1913b617],
50	imaging	NN	O	imaging	nsubj	51	SENT_291	[p24l1939t539r2142b617, p24l9t642r118b720],
51	correlate	VBP	O	correlate	dep	36	SENT_291	[p24l141t636r442b699],
52	with	IN	O	with	_	0	SENT_291	[p24l464t636r620b699],
53	the	DT	O	the	det	54	SENT_291	[p24l642t636r750b699],
54	pathology	NN	O	pathology	prep_with	51	SENT_291	[p24l772t636r1126b720],
55	of	IN	O	of	_	0	SENT_291	[p24l1147t636r1222b699],
56	AD	NN	O	ad	prep_of	54	SENT_291	[p24l1234t640r1354b698],
57	as	IN	O	as	mark	58	SENT_291	[p24l1380t659r1445b699],
58	found	VBN	O	find	advcl	51	SENT_291	[p24l1469t636r1677b699],
59	at	IN	O	at	_	0	SENT_291	[p24l1700t648r1760b699],
60	autopsy	NN	O	autopsy	prep_at	58	SENT_291	[p24l1783t648r2054b720],
61	or	CC	O	or	_	0	SENT_291	[p24l2074t659r2147b699],
62	biopsy9091	NN	O	biopsy9091	prep_at	58	SENT_291	[p24l7t730r372b822],
63	and	CC	O	and	_	0	SENT_291	[p24l400t738r528b801],
64	can	MD	O	can	aux	66	SENT_291	[p24l551t761r669b801],
65	be	VB	O	be	auxpass	66	SENT_291	[p24l690t738r770b801],
66	expected	VBN	O	expect	advcl	51	SENT_291	[p24l795t738r1102b821],
67	to	TO	O	to	aux	68	SENT_291	[p24l1124t750r1190b801],
68	reﬂect	VB	O	reﬂect	xcomp	66	SENT_291	[p24l1215t738r1430b801],
69	the	DT	O	the	det	70	SENT_291	[p24l1451t738r1559b801],
70	heterogeneity	NN	O	heterogeneity	dobj	68	SENT_291	[p24l1581t738r2058b822],
71	of	IN	O	of	_	0	SENT_291	[p24l2078t738r2153b801],
72	the	DT	O	the	det	74	SENT_291	[p24l8t841r115b904],
73	underlying	VBG	O	underlie	amod	74	SENT_291	[p24l139t841r521b925],
74	disease	NN	O	disease	prep_of	70	SENT_291	[p24l543t841r804b904],
75	.	.	O	.	_	0	SENT_291	[p24l543t841r804b904],

1	Differing	VBG	O	differ	_	0	SENT_292	[p24l831t841r1147b925],
2	genotypes	NNS	O	genotype	dobj	1	SENT_292	[p24l1169t853r1536b925],
3	,	,	O	,	_	0	SENT_292	[p24l1169t853r1536b925],
4	variable	JJ	O	variable	amod	6	SENT_292	[p24l1558t841r1833b904],
5	vascular	JJ	O	vascular	amod	6	SENT_292	[p24l1854t841r2144b904],
6	pathology	NN	O	pathology	dep	26	SENT_292	[p24l7t944r363b1028],
7	,	,	O	,	_	0	SENT_292	[p24l7t944r363b1028],
8	and	CC	O	and	_	0	SENT_292	[p24l388t944r514b1007],
9	variable	JJ	O	variable	amod	10	SENT_292	[p24l533t944r804b1007],
10	amounts	NNS	O	amount	dep	26	SENT_292	[p24l827t956r1122b1007],
11	of	IN	O	of	_	0	SENT_292	[p24l1146t944r1220b1007],
12	comorbid	JJ	O	comorbid	amod	13	SENT_292	[p24l1234t944r1567b1007],
13	changes	NNS	O	change	prep_of	10	SENT_292	[p24l1589t944r1877b1028],
14	,	,	O	,	_	0	SENT_292	[p24l1589t944r1877b1028],
15	such	JJ	O	such	_	0	SENT_292	[p24l1902t944r2057b1007],
16	as	IN	O	as	_	0	SENT_292	[p24l2080t967r2144b1007],
17	Lewy	NNP	PERSON	Lewy	nn	19	SENT_292	[p24l9t1052r195b1131],
18	body	NN	O	body	nn	19	SENT_292	[p24l213t1047r391b1131],
19	pathology	NN	O	pathology	prep_such_as	6	SENT_292	[p24l410t1047r762b1131],
20	and	CC	O	and	_	0	SENT_292	[p24l783t1047r910b1110],
21	transactive	JJ	O	transactive	amod	22	SENT_292	[p24l932t1053r1310b1110],
22	response	NN	O	response	prep_such_as	6	SENT_292	[p24l1334t1069r1637b1130],
23	DNA-binding	JJ	O	dna-binding	amod	24	SENT_292	[p24l1662t1047r2146b1131],
24	protein	NN	O	protein	dep	26	SENT_292	[p24l7t1155r252b1232],
25	(	NN	O	(	nn	26	SENT_292	[p24l275t1150r614b1226],
26	TDP	NN	O	tdp	dep	32	SENT_292	[p24l275t1150r614b1226],
27	—	CD	NUMBER	—	num	28	SENT_292	[p24l275t1150r614b1226],
28	43	CD	NUMBER	43	dep	26	SENT_292	[p24l275t1150r614b1226],
29	)	NN	O	)	nn	32	SENT_292	[p24l275t1150r614b1226],
30	,	,	O	,	_	0	SENT_292	[p24l275t1150r614b1226],
31	further	JJ	O	further	amod	32	SENT_292	[p24l635t1149r875b1212],
32	increase	NN	O	increase	dep	48	SENT_292	[p24l894t1155r1166b1212],
33	the	DT	O	the	det	34	SENT_292	[p24l1185t1149r1290b1212],
34	heterogeneity	NN	O	heterogeneity	dep	40	SENT_292	[p24l1309t1149r1770b1233],
35	of	IN	O	of	_	0	SENT_292	[p24l1787t1149r1860b1212],
36	AD9192	NNP	O	AD9192	nn	37	SENT_292	[p24l1869t1141r2144b1212],
37	Table	NNP	O	Table	prep_of	34	SENT_292	[p24l8t1253r201b1315],
38	3	CD	NUMBER	3	num	39	SENT_292	[p24l221t1259r258b1315],
39	lists	NNS	O	list	dep	40	SENT_292	[p24l280t1252r411b1315],
40	sources	NNS	O	source	dep	48	SENT_292	[p24l433t1275r685b1315],
41	of	IN	O	of	_	0	SENT_292	[p24l708t1252r782b1315],
42	pathological	JJ	O	pathological	amod	45	SENT_292	[p24l792t1252r1216b1336],
43	and	CC	O	and	_	0	SENT_292	[p24l1237t1252r1363b1315],
44	clinical	JJ	O	clinical	amod	45	SENT_292	[p24l1383t1252r1628b1315],
45	variability	NN	O	variability	prep_of	40	SENT_292	[p24l1646t1252r1996b1336],
46	that	WDT	O	that	nsubj	48	SENT_292	[p24l2013t1252r2146b1315],
47	may	MD	O	may	aux	48	SENT_292	[p24l8t1378r159b1439],
48	inﬂuence	VB	O	inﬂuence	ccomp	1	SENT_292	[p24l179t1355r503b1418],
49	AD	NN	O	ad	nn	50	SENT_292	[p24l527t1359r648b1417],
50	phenotype	NN	O	phenotype	dobj	48	SENT_292	[p24l673t1355r1064b1439],
51	.	.	O	.	_	0	SENT_292	[p24l673t1355r1064b1439],

1	Use	NN	O	use	nsubj	14	SENT_293	[p24l1092t1360r1219b1418],
2	of	IN	O	of	_	0	SENT_293	[p24l1244t1355r1320b1418],
3	multiple	JJ	O	multiple	amod	4	SENT_293	[p24l1334t1355r1628b1438],
4	biomarkers	NNS	O	biomarker	prep_of	1	SENT_293	[p24l1650t1355r2050b1418],
5	to	TO	O	to	aux	6	SENT_293	[p24l2074t1367r2142b1418],
6	deﬁne	VB	O	deﬁne	infmod	1	SENT_293	[p24l9t1458r223b1521],
7	more	JJR	O	more	dep	8	SENT_293	[p24l247t1481r429b1521],
8	homogeneous	JJ	O	homogeneous	amod	10	SENT_293	[p24l452t1458r948b1542],
9	pathological	JJ	O	pathological	amod	10	SENT_293	[p24l971t1458r1408b1542],
10	subtypes	NNS	O	subtype	dobj	6	SENT_293	[p24l1432t1458r1737b1542],
11	of	IN	O	of	_	0	SENT_293	[p24l1762t1458r1838b1521],
12	AD	NN	O	ad	prep_of	10	SENT_293	[p24l1851t1462r1972b1520],
13	may	MD	O	may	aux	14	SENT_293	[p24l1998t1481r2149b1542],
14	allow	VB	O	allow	_	0	SENT_293	[p24l9t1561r188b1624],
15	selection	NN	O	selection	dobj	14	SENT_293	[p24l206t1561r500b1624],
16	of	IN	O	of	_	0	SENT_293	[p24l520t1561r593b1624],
17	patients	NNS	O	patient	prep_of	15	SENT_293	[p24l602t1567r865b1644],
18	for	IN	O	for	_	0	SENT_293	[p24l885t1561r980b1624],
19	trials	NNS	O	trial	prep_for	14	SENT_293	[p24l998t1561r1165b1624],
20	and	CC	O	and	_	0	SENT_293	[p24l1186t1561r1326b1633],
21	,	,	O	,	_	0	SENT_293	[p24l1186t1561r1326b1633],
22	eventually	RB	O	eventually	dep	14	SENT_293	[p24l1348t1561r1700b1645],
23	,	,	O	,	_	0	SENT_293	[p24l1348t1561r1700b1645],
24	for	IN	O	for	_	0	SENT_293	[p24l1721t1561r1817b1624],
25	approved	VBN	O	approve	amod	26	SENT_293	[p24l1836t1561r2146b1644],
26	therapy	NN	O	therapy	conj_and	19	SENT_293	[p24l8t1664r270b1748],
27	that	WDT	O	that	nsubj	28	SENT_293	[p24l287t1664r421b1727],
28	responds	VBZ	O	respond	ccomp	26	SENT_293	[p24l441t1664r749b1747],
29	preferentially	RB	O	preferentially	advmod	28	SENT_293	[p24l770t1664r1230b1748],
30	to	TO	O	to	_	0	SENT_293	[p24l1247t1676r1312b1727],
31	unique	JJ	O	unique	amod	32	SENT_293	[p24l1336t1670r1574b1747],
32	treatments	NNS	O	treatment	prep_to	28	SENT_293	[p24l1594t1676r1978b1727],
33	.	.	O	.	_	0	SENT_293	[p24l1594t1676r1978b1727],

1	CONCLUSION	NN	O	conclusion	_	0	SENT_294	[p24l9t1878r486b1934],

1	Biomarkers	NNS	O	biomarker	nsubj	4	SENT_295	[p24l9t1974r412b2037],
2	are	VBP	O	be	cop	4	SENT_295	[p24l437t1997r540b2037],
3	increasingly	RB	O	increasingly	advmod	4	SENT_295	[p24l564t1974r991b2058],
4	important	JJ	O	important	_	0	SENT_295	[p24l1011t1980r1367b2057],
5	in	IN	O	in	_	0	SENT_295	[p24l1390t1980r1458b2036],
6	drug	NN	O	drug	nn	7	SENT_295	[p24l1482t1974r1648b2058],
7	development	NN	O	development	prep_in	4	SENT_295	[p24l1671t1974r2144b2057],
8	,	,	O	,	_	0	SENT_295	[p24l1671t1974r2144b2057],
9	with	IN	O	with	_	0	SENT_295	[p24l7t2077r166b2140],
10	application	NN	O	application	prep_with	4	SENT_295	[p24l194t2077r592b2160],
11	in	IN	O	in	_	0	SENT_295	[p24l619t2083r688b2139],
12	decision	NN	O	decision	nn	13	SENT_295	[p24l716t2077r1013b2140],
13	making	NN	O	making	prep_in	10	SENT_295	[p24l1039t2077r1329b2161],
14	,	,	O	,	_	0	SENT_295	[p24l1039t2077r1329b2161],
15	patient	NN	O	patient	nn	16	SENT_295	[p24l1357t2083r1608b2160],
16	selection	NN	O	selection	conj_and	13	SENT_295	[p24l1635t2077r1970b2149],
17	,	,	O	,	_	0	SENT_295	[p24l1635t2077r1970b2149],
18	outcome	NN	O	outcome	nn	19	SENT_295	[p24l1999t2089r2143b2140, p24l9t2203r197b2243],
19	measurement	NN	O	measurement	prep_in	10	SENT_295	[p24l221t2192r721b2252],
20	,	,	O	,	_	0	SENT_295	[p24l221t2192r721b2252],
21	and	CC	O	and	_	0	SENT_295	[p24l748t2180r878b2243],
22	side-effect	JJ	O	side-effect	amod	23	SENT_295	[p24l902t2180r1264b2243],
23	monitoring	NN	O	monitoring	prep_in	10	SENT_295	[p24l1287t2186r1709b2264],
24	.	.	O	.	_	0	SENT_295	[p24l1287t2186r1709b2264],

1	Biomarkers	NNS	O	biomarker	nsubj	2	SENT_296	[p24l1737t2180r2143b2243],
2	provide	VBP	O	provide	_	0	SENT_296	[p24l7t2283r282b2366],
3	insight	NN	O	insight	dobj	2	SENT_296	[p24l312t2283r560b2367],
4	into	IN	O	into	_	0	SENT_296	[p24l587t2289r728b2346],
5	the	DT	O	the	det	8	SENT_296	[p24l757t2283r869b2346],
6	underlying	VBG	O	underlie	amod	8	SENT_296	[p24l898t2283r1295b2367],
7	disease	NN	O	disease	nn	8	SENT_296	[p24l1323t2283r1577b2346],
8	process	NN	O	process	prep_into	2	SENT_296	[p24l1605t2305r1873b2366],
9	and	CC	O	and	_	0	SENT_296	[p24l1903t2283r2035b2346],
10	its	PRP$	O	its	poss	11	SENT_296	[p24l2063t2289r2143b2346],
11	progression	NN	O	progression	prep_into	2	SENT_296	[p24l7t2393r426b2471],
12	.	.	O	.	_	0	SENT_296	[p24l7t2393r426b2471],

1	Biomarker	NN	O	biomarker	nn	2	SENT_297	[p24l452t2387r816b2450],
2	abnormalities	NNS	O	abnormality	_	0	SENT_297	[p24l839t2387r1308b2450],
3	in	IN	O	in	_	0	SENT_297	[p24l1332t2393r1398b2449],
4	patients	NNS	O	patient	prep_in	2	SENT_297	[p24l1420t2393r1689b2470],
5	with	IN	O	with	_	0	SENT_297	[p24l1711t2387r1864b2450],
6	no	DT	O	no	det	7	SENT_297	[p24l1886t2410r1972b2450],
7	cognitive	JJ	O	cognitive	prep_with	2	SENT_297	[p24l1997t2410r2141b2471, p24l8t2520r201b2577],

1	symptoms	NNS	O	symptom	nsubj	2	SENT_298	[p24l225t2526r578b2598],
2	allow	VBP	O	allow	ccomp	22	SENT_298	[p24l603t2514r787b2577],
3	primary	JJ	O	primary	amod	7	SENT_298	[p24l806t2520r1091b2598],
4	and	CC	O	and	_	0	SENT_298	[p24l1111t2514r1238b2577],
5	secondary	JJ	O	secondary	conj_and	3	SENT_298	[p24l1261t2514r1617b2598],
6	prevention	NN	O	prevention	nn	7	SENT_298	[p24l1635t2520r2010b2597],
7	trials	NNS	O	trial	dobj	2	SENT_298	[p24l2032t2520r2140b2577, p24l9t2617r117b2689],
8	;	:	O	;	_	0	SENT_298	[p24l2032t2520r2140b2577, p24l9t2617r117b2689],
9	biomarker	NN	O	biomarker	nn	10	SENT_298	[p24l141t2617r510b2680],
10	changes	NNS	O	change	nsubj	16	SENT_298	[p24l533t2617r810b2701],
11	in	IN	O	in	_	0	SENT_298	[p24l834t2623r902b2679],
12	patients	NNS	O	patient	prep_in	10	SENT_298	[p24l925t2623r1202b2700],
13	with	IN	O	with	_	0	SENT_298	[p24l1224t2617r1381b2680],
14	mild	JJ	O	mild	amod	15	SENT_298	[p24l1404t2617r1568b2680],
15	symptoms	NNS	O	symptom	prep_with	12	SENT_298	[p24l1592t2629r1952b2701],
16	(	VBP	O	(	dep	7	SENT_298	[p24l1980t2618r2142b2701],
17	e.g.	FW	O	e.g.	dobj	16	SENT_298	[p24l1980t2618r2142b2701],
18	,	,	O	,	_	0	SENT_298	[p24l1980t2618r2142b2701],
19	prodromal	JJ	O	prodromal	amod	21	SENT_298	[p24l7t2720r377b2803],
20	AD	NN	O	ad	nn	21	SENT_298	[p24l398t2720r544b2797],
21	)	NN	O	)	nsubj	22	SENT_298	[p24l398t2720r544b2797],
22	facilitate	VBP	O	facilitate	_	0	SENT_298	[p24l571t2720r861b2783],
23	trials	NNS	O	trial	dobj	22	SENT_298	[p24l883t2720r1054b2783],
24	aimed	VBN	O	aim	partmod	23	SENT_298	[p24l1078t2720r1289b2783],
25	at	IN	O	at	_	0	SENT_298	[p24l1311t2732r1371b2783],
26	prevention	NN	O	prevention	prep_at	24	SENT_298	[p24l1391t2726r1764b2803],
27	or	CC	O	or	_	0	SENT_298	[p24l1787t2743r1859b2783],
28	slowing	NN	O	slowing	conj_or	26	SENT_298	[p24l1882t2720r2145b2804],
29	of	IN	O	of	_	0	SENT_298	[p24l9t2823r83b2886],
30	cognitive	JJ	O	cognitive	amod	31	SENT_298	[p24l95t2829r407b2907],
31	decline	NN	O	decline	prep_of	26	SENT_298	[p24l429t2823r672b2886],
32	and	CC	O	and	_	0	SENT_298	[p24l694t2823r820b2886],
33	development	NN	O	development	prep_of	26	SENT_298	[p24l840t2823r1284b2906],
34	of	IN	O	of	_	0	SENT_298	[p24l1305t2823r1379b2886],
35	dementia	NN	O	dementia	prep_of	26	SENT_298	[p24l1391t2823r1726b2886],
36	.	.	O	.	_	0	SENT_298	[p24l1391t2823r1726b2886],

1	Biomarkers	NNS	O	biomarker	nsubj	2	SENT_299	[p24l1751t2823r2144b2886],
2	play	VBP	O	play	conj_and	2	SENT_299	[p24l7t2926r151b3010],
3	a	DT	O	a	det	4	SENT_299	[p24l171t2949r205b2989],
4	role	NN	O	role	dobj	2	SENT_299	[p24l227t2926r355b2989],
5	in	IN	O	in	_	0	SENT_299	[p24l379t2932r445b2988],
6	safety	NN	O	safety	nn	7	SENT_299	[p24l468t2926r664b3010],
7	monitoring	NN	O	monitoring	prep_in	4	SENT_299	[p24l683t2932r1076b3010],
8	and	CC	O	and	_	0	SENT_299	[p24l1097t2926r1224b2989],
9	in	IN	O	in	_	0	SENT_299	[p24l1245t2932r1311b2988],
10	stratiﬁcation	NN	O	stratiﬁcation	prep_in	4	SENT_299	[p24l1335t2926r1767b2989],
11	of	IN	O	of	_	0	SENT_299	[p24l1790t2926r1864b2989],
12	patients	NNS	O	patient	prep_of	10	SENT_299	[p24l1875t2932r2144b3009],
13	for	IN	O	for	_	0	SENT_299	[p24l8t3029r104b3092],
14	enrollment	NN	O	enrollment	prep_for	12	SENT_299	[p24l123t3029r495b3092],
15	in	IN	O	in	_	0	SENT_299	[p24l514t3035r579b3091],
16	trials	NNS	O	trial	prep_in	2	SENT_299	[p24l598t3029r765b3092],
17	and	CC	O	and	_	0	SENT_299	[p24l787t3029r911b3092],
18	for	IN	O	for	_	0	SENT_299	[p24l930t3029r1025b3092],
19	interpretation	NN	O	interpretation	prep_for	2	SENT_299	[p24l1044t3035r1510b3112],
20	of	IN	O	of	_	0	SENT_299	[p24l1531t3029r1604b3092],
21	data	NNS	O	datum	prep_of	19	SENT_299	[p24l1614t3029r1756b3092],
22	from	IN	O	from	_	0	SENT_299	[p24l1774t3029r1939b3092],
23	trials	NNS	O	trial	prep_from	21	SENT_299	[p24l1958t3029r2142b3092],
24	.	.	O	.	_	0	SENT_299	[p24l1958t3029r2142b3092],

1	Surrogate	NN	O	surrogate	nn	2	SENT_300	[p24l10t3136r340b3216],
2	markers	NNS	O	marker	nsubjpass	8	SENT_300	[p24l363t3132r642b3195],
3	that	WDT	O	that	nsubj	4	SENT_300	[p24l665t3132r799b3195],
4	predict	VBP	O	predict	rcmod	2	SENT_300	[p24l820t3132r1065b3215],
5	drug	NN	O	drug	nn	6	SENT_300	[p24l1088t3132r1251b3216],
6	beneﬁt	NN	O	beneﬁt	dobj	4	SENT_300	[p24l1270t3132r1508b3195],
7	are	VBP	O	be	auxpass	8	SENT_300	[p24l1530t3155r1631b3195],
8	needed	VBN	O	need	_	0	SENT_300	[p24l1654t3132r1918b3195],
9	.	.	O	.	_	0	SENT_300	[p24l1654t3132r1918b3195],

1	Novel	JJ	O	novel	amod	2	SENT_301	[p24l1943t3132r2145b3195],
2	biomarkers	NNS	O	biomarker	nsubjpass	32	SENT_301	[p24l7t3235r397b3298],
3	that	WDT	O	that	nsubj	4	SENT_301	[p24l420t3235r554b3298],
4	provide	VBP	O	provide	rcmod	2	SENT_301	[p24l575t3235r837b3318],
5	more	JJR	O	more	amod	6	SENT_301	[p24l860t3258r1038b3298],
6	insight	NN	O	insight	dobj	4	SENT_301	[p24l1062t3235r1297b3319],
7	into	IN	O	into	_	0	SENT_301	[p24l1318t3241r1453b3298],
8	the	DT	O	the	det	10	SENT_301	[p24l1476t3235r1583b3298],
9	disease	NN	O	disease	nn	10	SENT_301	[p24l1607t3235r1848b3298],
10	process	NN	O	process	prep_into	4	SENT_301	[p24l1870t3257r2144b3318],
11	,	,	O	,	_	0	SENT_301	[p24l1870t3257r2144b3318],
12	identify	VBP	O	identify	dep	4	SENT_301	[p24l9t3338r279b3422],
13	subpopulations	NNS	O	subpopulation	dobj	4	SENT_301	[p24l300t3338r830b3421],
14	of	IN	O	of	_	0	SENT_301	[p24l855t3338r929b3401],
15	treatment	NN	O	treatment	nn	18	SENT_301	[p24l942t3344r1681b3421],
16	—	NN	O	—	nn	18	SENT_301	[p24l942t3344r1681b3421],
17	responsive	JJ	O	responsive	amod	18	SENT_301	[p24l942t3344r1681b3421],
18	patients	NNS	O	patient	prep_of	13	SENT_301	[p24l1703t3344r1994b3421],
19	,	,	O	,	_	0	SENT_301	[p24l1703t3344r1994b3421],
20	and	CC	O	and	_	0	SENT_301	[p24l2020t3338r2148b3401],
21	help	VB	O	help	conj_and	4	SENT_301	[p24l8t3441r157b3524],
22	match	VB	O	match	xcomp	21	SENT_301	[p24l182t3441r401b3504],
23	disease	NN	O	disease	nn	24	SENT_301	[p24l426t3441r675b3504],
24	biology	NN	O	biology	dobj	22	SENT_301	[p24l698t3441r966b3525],
25	to	TO	O	to	_	0	SENT_301	[p24l987t3453r1055b3504],
26	mechanism	NN	O	mechanism	prep_to	22	SENT_301	[p24l1080t3441r1489b3504],
27	of	IN	O	of	_	0	SENT_301	[p24l1515t3441r1590b3504],
28	drug	NN	O	drug	nn	29	SENT_301	[p24l1606t3441r1773b3525],
29	action	NN	O	action	prep_of	26	SENT_301	[p24l1798t3447r2016b3504],
30	are	VBP	O	be	auxpass	32	SENT_301	[p24l2041t3464r2145b3504],
31	also	RB	O	also	advmod	32	SENT_301	[p24l9t3544r138b3607],
32	needed	VBN	O	need	_	0	SENT_301	[p24l159t3544r418b3607],
33	.	.	O	.	_	0	SENT_301	[p24l159t3544r418b3607],

1	Biomarkers	NNS	O	biomarker	nsubj	12	SENT_302	[p24l442t3544r830b3607],
2	may	MD	O	may	aux	3	SENT_302	[p24l851t3567r996b3628],
3	emerge	VB	O	emerge	_	0	SENT_302	[p24l1013t3567r1257b3628],
4	as	IN	O	as	_	0	SENT_302	[p24l1278t3567r1341b3607],
5	companion	NN	O	companion	nn	6	SENT_302	[p24l1363t3550r1746b3627],
6	diagnostics	NNS	O	diagnostic	prep_as	3	SENT_302	[p24l1767t3544r2145b3628],
7	for	IN	O	for	_	0	SENT_302	[p24l8t3647r105b3710],
8	disease-modifying	JJ	O	disease-modifying	amod	9	SENT_302	[p24l125t3647r756b3731],
9	compounds	NNS	O	compound	prep_for	6	SENT_302	[p24l775t3647r1176b3730],
10	and	CC	O	and	_	0	SENT_302	[p24l1198t3647r1323b3710],
11	may	MD	O	may	aux	12	SENT_302	[p24l1342t3670r1488b3731],
12	have	VB	O	have	conj_and	3	SENT_302	[p24l1504t3647r1658b3710],
13	major	JJ	O	major	amod	14	SENT_302	[p24l1678t3653r1879b3731],
14	roles	NNS	O	role	dobj	12	SENT_302	[p24l1899t3647r2058b3710],
15	in	IN	O	in	_	0	SENT_302	[p24l2079t3653r2145b3709],
16	treatment	NN	O	treatment	nn	17	SENT_302	[p25l8t28r344b79],
17	application	NN	O	application	prep_in	14	SENT_302	[p25l365t16r744b99],
18	and	CC	O	and	_	0	SENT_302	[p25l766t16r893b79],
19	management	NN	O	management	prep_in	14	SENT_302	[p25l913t28r1374b100],
20	.	.	O	.	_	0	SENT_302	[p25l913t28r1374b100],

1	SUPPLEMENTARY	NNP	O	SUPPLEMENTARY	nn	2	SENT_303	[p25l10t176r559b225],
2	MATERIAL	NN	O	material	nsubjpass	4	SENT_303	[p25l575t177r892b224],
3	is	VBZ	O	be	auxpass	4	SENT_303	[p25l909t177r946b225],
4	linked	VBN	O	link	_	0	SENT_303	[p25l964t175r1130b225],
5	to	TO	O	to	_	0	SENT_303	[p25l1147t182r1203b225],
6	the	DT	O	the	det	10	SENT_303	[p25l1218t175r1310b225],
7	online	JJ	O	online	amod	10	SENT_303	[p25l1326t175r1501b225],
8	version	NN	O	version	nn	10	SENT_303	[p25l1516t177r1718b225],
9	ofthe	NN	O	ofthe	nn	10	SENT_303	[p25l1736t174r1896b225],
10	paper	NN	O	paper	prep_to	4	SENT_303	[p25l1913t189r2076b238],
11	at	IN	O	at	_	0	SENT_303	[p25l2090t182r2143b225],
12	http://www.nature.com/cpt	JJ	O	http://www.nature.com/cpt	prep_at	4	SENT_303	[p25l11t260r794b323],

1	CONFLICT	NN	O	conflict	_	0	SENT_304	[p25l9t408r322b457],
2	OF	IN	O	of	_	0	SENT_304	[p25l336t408r418b457],
3	INTEREST	NN	O	interest	prep_of	1	SENT_304	[p25l438t408r736b457],

1	J.C.	NNP	ORGANIZATION	J.C.	nsubj	3	SENT_305	[p25l6t494r97b542],
2	has	VBZ	O	have	aux	3	SENT_305	[p25l115t492r206b542],
3	provided	VBN	O	provide	_	0	SENT_305	[p25l224t492r473b555],
4	consultation	NN	O	consultation	dobj	3	SENT_305	[p25l492t492r841b542],
5	to	TO	O	to	_	0	SENT_305	[p25l857t500r915b542],
6	Acadia	NNP	ORGANIZATION	Acadia	nn	12	SENT_305	[p25l930t492r1133b550],
7	,	,	O	,	_	0	SENT_305	[p25l930t492r1133b550],
8	Adamas	NNP	O	Adamas	appos	12	SENT_305	[p25l1148t492r1388b550],
9	,	,	O	,	_	0	SENT_305	[p25l1148t492r1388b550],
10	Avanir	NNP	ORGANIZATION	Avanir	appos	12	SENT_305	[p25l1402t494r1591b550],
11	,	,	O	,	_	0	SENT_305	[p25l1402t494r1591b550],
12	Boehringer	NNP	O	Boehringer	prep_to	3	SENT_305	[p25l1610t492r1943b556],
13	—	CD	NUMBER	—	num	12	SENT_305	[p25l1610t492r1943b556],
14	lngelheim	NN	O	lngelheim	dep	12	SENT_305	[p25l11t579r307b643],
15	,	,	O	,	_	0	SENT_305	[p25l11t579r307b643],
16	Bristol	NNP	LOCATION	Bristol	appos	12	SENT_305	[p25l326t579r689b644],
17	.	.	O	.	_	0	SENT_305	[p25l326t579r689b644],

1	—	NN	O	—	_	0	SENT_306	[p25l326t579r689b644],
2	.	.	O	.	_	0	SENT_306	[p25l326t579r689b644],

1	Myers	NNP	PERSON	Myers	nn	12	SENT_307	[p25l326t579r689b644],
2	Squibb	NNP	PERSON	Squibb	nn	12	SENT_307	[p25l706t579r918b642],
3	,	,	O	,	_	0	SENT_307	[p25l706t579r918b642],
4	Eisai	NNP	ORGANIZATION	Eisai	appos	12	SENT_307	[p25l936t582r1068b637],
5	,	,	O	,	_	0	SENT_307	[p25l936t582r1068b637],
6	EnVivo	NNP	O	EnVivo	appos	12	SENT_307	[p25l1087t582r1287b637],
7	,	,	O	,	_	0	SENT_307	[p25l1087t582r1287b637],
8	Genentech	NNP	ORGANIZATION	Genentech	appos	12	SENT_307	[p25l1303t579r1627b637],
9	,	,	O	,	_	0	SENT_307	[p25l1303t579r1627b637],
10	G	NNP	O	G	appos	12	SENT_307	[p25l1642t579r2123b637],
11	|	CD	NUMBER	|	num	12	SENT_307	[p25l1642t579r2123b637],
12	axoSmithK	NNP	O	axoSmithK	_	0	SENT_307	[p25l1642t579r2123b637],
13	|	CD	NUMBER	|	num	14	SENT_307	[p25l1642t579r2123b637],
14	ine	NN	O	ine	dep	12	SENT_307	[p25l1642t579r2123b637],
15	,	,	O	,	_	0	SENT_307	[p25l1642t579r2123b637],
16	Lilly	NNP	ORGANIZATION	Lilly	nn	39	SENT_307	[p25l11t666r128b730],
17	,	,	O	,	_	0	SENT_307	[p25l11t666r128b730],
18	Lundbeck	NNP	PERSON	Lundbeck	appos	39	SENT_307	[p25l146t666r436b723],
19	,	,	O	,	_	0	SENT_307	[p25l146t666r436b723],
20	Merck	NNP	PERSON	Merck	appos	39	SENT_307	[p25l453t666r637b723],
21	,	,	O	,	_	0	SENT_307	[p25l453t666r637b723],
22	Novartis	NNP	ORGANIZATION	Novartis	appos	39	SENT_307	[p25l656t668r899b723],
23	,	,	O	,	_	0	SENT_307	[p25l656t668r899b723],
24	Otsuka	NNP	PERSON	Otsuka	appos	39	SENT_307	[p25l915t666r1127b723],
25	,	,	O	,	_	0	SENT_307	[p25l915t666r1127b723],
26	Pfizer	NNP	ORGANIZATION	Pfizer	appos	39	SENT_307	[p25l1145t665r1306b723],
27	,	,	O	,	_	0	SENT_307	[p25l1145t665r1306b723],
28	Prana	NNP	ORGANIZATION	Prana	appos	39	SENT_307	[p25l1324t668r1493b723],
29	,	,	O	,	_	0	SENT_307	[p25l1324t668r1493b723],
30	QR	NNP	ORGANIZATION	QR	appos	39	SENT_307	[p25l1509t667r1589b722],
31	Pharma	NNP	ORGANIZATION	Pharma	nn	39	SENT_307	[p25l1607t666r1834b723],
32	,	,	O	,	_	0	SENT_307	[p25l1607t666r1834b723],
33	Resverlogix	NNP	O	Resverlogix	appos	39	SENT_307	[p25l11t750r345b814],
34	,	,	O	,	_	0	SENT_307	[p25l11t750r345b814],
35	Servier	NNP	ORGANIZATION	Servier	appos	39	SENT_307	[p25l361t752r565b808],
36	,	,	O	,	_	0	SENT_307	[p25l361t752r565b808],
37	Sonexa	NNP	LOCATION	Sonexa	appos	39	SENT_307	[p25l581t752r799b808],
38	,	,	O	,	_	0	SENT_307	[p25l581t752r799b808],
39	Suven	NNP	O	Suven	conj_and	14	SENT_307	[p25l815t752r1000b808],
40	,	,	O	,	_	0	SENT_307	[p25l815t752r1000b808],
41	and	CC	O	and	_	0	SENT_307	[p25l1016t750r1119b800],
42	Takeda	NNP	PERSON	Takeda	nn	44	SENT_307	[p25l1132t750r1329b800],
43	pharmaceutical	JJ	O	pharmaceutical	amod	44	SENT_307	[p25l1349t750r1784b813],
44	companies	NNS	O	company	dep	12	SENT_307	[p25l1802t752r2123b813],
45	.	.	O	.	_	0	SENT_307	[p25l1802t752r2123b813],

1	K.Z.	NNP	O	K.Z.	nsubj	2	SENT_308	[p25l11t839r109b887],
2	reported	VBD	O	report	_	0	SENT_308	[p25l126t836r370b899],
3	no	DT	O	no	det	4	SENT_308	[p25l389t851r459b887],
4	conflict	NN	O	conflict	dobj	2	SENT_308	[p25l474t836r683b887],
5	of	IN	O	of	_	0	SENT_308	[p25l698t836r756b887],
6	interest	NN	O	interest	prep_of	4	SENT_308	[p25l768t839r992b887],
7	.	.	O	.	_	0	SENT_308	[p25l768t839r992b887],

1	©	RB	O	©	advmod	2	SENT_309	[p25l8t1024r48b1065],
2	2014	CD	DATE	2014	_	0	SENT_309	[p25l64t1024r193b1068],
3	American	NNP	ORGANIZATION	American	nn	4	SENT_309	[p25l207t1023r460b1068],
4	Society	NNP	ORGANIZATION	Society	dep	2	SENT_309	[p25l478t1022r673b1081],
5	for	IN	ORGANIZATION	for	_	0	SENT_309	[p25l685t1020r758b1068],
6	Clinical	JJ	ORGANIZATION	clinical	amod	7	SENT_309	[p25l772t1020r960b1068],
7	Pharmacology	NN	ORGANIZATION	pharmacology	prep_for	4	SENT_309	[p25l981t1020r1366b1081],
8	and	CC	ORGANIZATION	and	_	0	SENT_309	[p25l1379t1020r1477b1068],
9	Therapeutics	NNS	ORGANIZATION	therapeutics	prep_for	4	SENT_309	[p25l1489t1020r1836b1080],
10	1	CD	NUMBER	1	num	9	SENT_309	[p25l14t1100r51b1145],
11	.	.	O	.	_	0	SENT_309	[p25l14t1100r51b1145],

1	Alzheimer	NNP	O	Alzheimer	_	0	SENT_310	[p25l130t1096r432b1145],
2	's	POS	O	's	possessive	1	SENT_310	[p25l130t1096r432b1145],
3	Association	NNP	O	Association	dep	1	SENT_310	[p25l446t1098r760b1145],
4	.	.	O	.	_	0	SENT_310	[p25l446t1098r760b1145],

1	2012	CD	DATE	2012	num	2	SENT_311	[p25l776t1099r901b1145],
2	Alzheimer	NN	O	alzheimer	poss	4	SENT_311	[p25l916t1096r1218b1145],
3	's	POS	O	's	_	0	SENT_311	[p25l916t1096r1218b1145],
4	disease	NN	O	disease	_	0	SENT_311	[p25l1233t1096r1425b1145],
5	facts	NNS	O	fact	dep	4	SENT_311	[p25l1438t1095r1560b1145],
6	and	CC	O	and	_	0	SENT_311	[p25l1575t1096r1672b1145],
7	ﬁgures	NNS	O	ﬁgures	dep	4	SENT_311	[p25l1686t1095r1878b1159],
8	.	.	O	.	_	0	SENT_311	[p25l1686t1095r1878b1159],

1	Alzheimers	NNPS	O	Alzheimers	_	0	SENT_312	[p25l128t1173r408b1222],
2	Dement	NNP	O	Dement	dep	1	SENT_312	[p25l421t1175r636b1222],
3	.	.	O	.	_	0	SENT_312	[p25l421t1175r636b1222],

1	8	CD	NUMBER	8	_	0	SENT_313	[p25l650t1176r695b1229],
2	,	,	O	,	_	0	SENT_313	[p25l650t1176r695b1229],
3	1	CD	NUMBER	1	number	4	SENT_313	[p25l714t1177r728b1221],
4	31-168	CD	NUMBER	31-168	appos	1	SENT_313	[p25l743t1176r934b1222],
5	(	CD	NUMBER	(	num	7	SENT_313	[p25l950t1174r1125b1229],
6	2012	CD	DATE	2012	num	7	SENT_313	[p25l950t1174r1125b1229],
7	)	NN	O	)	dep	4	SENT_313	[p25l950t1174r1125b1229],
8	.	.	O	.	_	0	SENT_313	[p25l950t1174r1125b1229],

1	2	LS	NUMBER	2	_	0	SENT_314	[p25l9t1253r51b1299],
2	.	.	O	.	_	0	SENT_314	[p25l9t1253r51b1299],

1	Thies	NNP	PERSON	Thies	nn	7	SENT_315	[p25l128t1250r278b1306],
2	,	,	O	,	_	0	SENT_315	[p25l128t1250r278b1306],
3	W.	NNP	O	W.	nn	7	SENT_315	[p25l289t1252r350b1299],
4	&	CC	O	&	_	0	SENT_315	[p25l364t1251r401b1299],
5	Bleiler	NNP	PERSON	Bleiler	nn	7	SENT_315	[p25l416t1250r584b1306],
6	,	,	O	,	_	0	SENT_315	[p25l416t1250r584b1306],
7	L.	NNP	O	L.	_	0	SENT_315	[p25l601t1252r651b1306],
8	;	:	O	;	_	0	SENT_315	[p25l601t1252r651b1306],
9	Alzheimer	NNP	ORGANIZATION	Alzheimer	poss	11	SENT_315	[p25l664t1250r966b1299],
10	's	POS	ORGANIZATION	's	_	0	SENT_315	[p25l664t1250r966b1299],
11	Association	NNP	ORGANIZATION	Association	dep	7	SENT_315	[p25l980t1252r1295b1299],
12	.	.	O	.	_	0	SENT_315	[p25l980t1252r1295b1299],

1	2013	CD	DATE	2013	num	2	SENT_316	[p25l1310t1253r1435b1299],
2	Alzheimer	NN	O	alzheimer	poss	4	SENT_316	[p25l1450t1250r1752b1299],
3	's	POS	O	's	_	0	SENT_316	[p25l1450t1250r1752b1299],
4	disease	NN	O	disease	_	0	SENT_316	[p25l1767t1250r1959b1299],
5	facts	NNS	O	fact	dep	4	SENT_316	[p25l1972t1249r2095b1299],
6	and	CC	O	and	_	0	SENT_316	[p25l132t1328r229b1377],
7	ﬁgures	NNS	O	ﬁgures	dep	4	SENT_316	[p25l244t1327r436b1391],
8	.	.	O	.	_	0	SENT_316	[p25l244t1327r436b1391],

1	Alzheimers	NNPS	O	Alzheimers	_	0	SENT_317	[p25l446t1328r726b1377],
2	Dement	NNP	O	Dement	dep	1	SENT_317	[p25l738t1330r954b1377],
3	.	.	O	.	_	0	SENT_317	[p25l738t1330r954b1377],

1	9	CD	NUMBER	9	_	0	SENT_318	[p25l967t1331r1012b1385],
2	,	,	O	,	_	0	SENT_318	[p25l967t1331r1012b1385],
3	208-245	CD	NUMBER	208-245	number	4	SENT_318	[p25l1028t1331r1250b1377],
4	(	CD	NUMBER	(	appos	1	SENT_318	[p25l1268t1329r1442b1385],
5	2013	CD	DATE	2013	num	6	SENT_318	[p25l1268t1329r1442b1385],
6	)	NN	O	)	dep	4	SENT_318	[p25l1268t1329r1442b1385],
7	.	.	O	.	_	0	SENT_318	[p25l1268t1329r1442b1385],

1	3	LS	NUMBER	3	_	0	SENT_319	[p25l9t1409r51b1455],
2	.	.	O	.	_	0	SENT_319	[p25l9t1409r51b1455],

1	Cummings	NNP	PERSON	Cummings	nn	4	SENT_320	[p25l131t1407r518b1469],
2	,	,	O	,	_	0	SENT_320	[p25l131t1407r518b1469],
3	J.L.	NNP	PERSON	J.L.	appos	4	SENT_320	[p25l131t1407r518b1469],
4	Use	NNP	PERSON	Use	_	0	SENT_320	[p25l536t1408r628b1455],
5	of	IN	O	of	_	0	SENT_320	[p25l642t1405r697b1455],
6	cholinesterase	NN	O	cholinesterase	nn	7	SENT_320	[p25l706t1406r1085b1455],
7	inhibitors	NNS	O	inhibitor	prep_of	4	SENT_320	[p25l1101t1406r1349b1455],
8	in	IN	O	in	dep	4	SENT_320	[p25l1365t1408r1408b1455],
9	clinical	JJ	O	clinical	amod	10	SENT_320	[p25l1425t1406r1601b1455],
10	practice	NN	O	practice	pobj	8	SENT_320	[p25l1620t1408r1840b1468],
11	:	:	O	:	_	0	SENT_320	[p25l1620t1408r1840b1468],
12	evidencebased	VBN	O	evidencebase	partmod	10	SENT_320	[p25l1855t1406r2114b1455, p25l134t1484r287b1533],

1	recommendations	NNS	O	recommendation	_	0	SENT_321	[p25l305t1484r910b1533],
2	.	.	O	.	_	0	SENT_321	[p25l305t1484r910b1533],

1	Am	NNP	O	Am	_	0	SENT_322	[p25l305t1484r910b1533],
2	.	.	O	.	_	0	SENT_322	[p25l305t1484r910b1533],

1	J.	NNP	PERSON	J.	nn	2	SENT_323	[p25l921t1486r956b1533],
2	Geriatr	NNP	PERSON	Geriatr	_	0	SENT_323	[p25l972t1486r1153b1533],
3	.	.	O	.	_	0	SENT_323	[p25l972t1486r1153b1533],

1	Psychiatry	NNP	O	Psychiatry	_	0	SENT_324	[p25l1168t1484r1429b1548],
2	1	CD	NUMBER	1	number	3	SENT_324	[p25l1443t1488r1463b1533],
3	1	CD	NUMBER	1	dep	1	SENT_324	[p25l1479t1488r1520b1541],
4	,	,	O	,	_	0	SENT_324	[p25l1479t1488r1520b1541],
5	131-145	CD	NUMBER	131-145	number	6	SENT_324	[p25l1539t1487r1757b1533],
6	(	CD	NUMBER	(	appos	1	SENT_324	[p25l1776t1485r1950b1541],
7	2003	CD	DATE	2003	num	8	SENT_324	[p25l1776t1485r1950b1541],
8	)	NN	O	)	dep	6	SENT_324	[p25l1776t1485r1950b1541],
9	.	.	O	.	_	0	SENT_324	[p25l1776t1485r1950b1541],

1	4	LS	NUMBER	4	_	0	SENT_325	[p25l7t1566r51b1611],
2	.	.	O	.	_	0	SENT_325	[p25l7t1566r51b1611],

1	Massoud	NNP	PERSON	Massoud	_	0	SENT_326	[p25l132t1562r379b1619],
2	,	,	O	,	_	0	SENT_326	[p25l132t1562r379b1619],
3	F.	NNP	ORGANIZATION	F.	conj_and	1	SENT_326	[p25l396t1564r427b1611],
4	&	CC	ORGANIZATION	&	_	0	SENT_326	[p25l441t1563r478b1611],
5	Léger	NNP	ORGANIZATION	Léger	conj_and	1	SENT_326	[p25l494t1563r647b1625],
6	,	,	O	,	_	0	SENT_326	[p25l494t1563r647b1625],
7	G.C.	NNP	O	G.C.	nn	9	SENT_326	[p25l661t1563r762b1611],
8	Pharmacological	JJ	O	pharmacological	amod	9	SENT_326	[p25l779t1562r1213b1625],
9	treatment	NN	O	treatment	appos	1	SENT_326	[p25l1228t1569r1493b1611],
10	of	IN	O	of	_	0	SENT_326	[p25l1507t1561r1562b1611],
11	Alzheimer	NN	O	alzheimer	nn	12	SENT_326	[p25l1571t1562r1839b1611],
12	disease	NN	O	disease	prep_of	9	SENT_326	[p25l1852t1562r2056b1611],
13	.	.	O	.	_	0	SENT_326	[p25l1852t1562r2056b1611],

1	Can	MD	O	can	_	0	SENT_327	[p25l133t1641r242b1689],
2	.	.	O	.	_	0	SENT_327	[p25l133t1641r242b1689],

1	J.	NNP	O	J.	nn	2	SENT_328	[p25l253t1642r287b1689],
2	Psychiatry	NNP	O	Psychiatry	_	0	SENT_328	[p25l302t1640r573b1703],
3	.	.	O	.	_	0	SENT_328	[p25l302t1640r573b1703],

1	56	CD	NUMBER	56	_	0	SENT_329	[p25l588t1643r668b1697],
2	,	,	O	,	_	0	SENT_329	[p25l588t1643r668b1697],
3	579-588	CD	NUMBER	579-588	num	4	SENT_329	[p25l683t1643r907b1689],
4	(	NN	O	(	appos	1	SENT_329	[p25l923t1641r1024b1697],
5	201	CD	NUMBER	201	number	6	SENT_329	[p25l923t1641r1024b1697],
6	1	CD	NUMBER	1	num	7	SENT_329	[p25l1042t1641r1098b1697],
7	)	NN	O	)	dep	4	SENT_329	[p25l1042t1641r1098b1697],
8	.	.	O	.	_	0	SENT_329	[p25l1042t1641r1098b1697],

1	5	CD	NUMBER	5	_	0	SENT_330	[p25l9t1722r51b1767],
2	.	.	O	.	_	0	SENT_330	[p25l9t1722r51b1767],

1	Cummings	NNP	PERSON	Cummings	_	0	SENT_331	[p25l131t1719r429b1781],
2	,	,	O	,	_	0	SENT_331	[p25l131t1719r429b1781],
3	J.	NNP	O	J.	nn	4	SENT_331	[p25l441t1720r475b1767],
4	etal	NNP	O	etal	appos	1	SENT_331	[p25l490t1718r605b1767],
5	.	.	O	.	_	0	SENT_331	[p25l490t1718r605b1767],

1	Randomized	NNP	O	Randomized	_	0	SENT_332	[p25l622t1718r964b1775],
2	,	,	O	,	_	0	SENT_332	[p25l622t1718r964b1775],
3	doub	NN	O	doub	nn	4	SENT_332	[p25l978t1718r1335b1775],
4	|	NN	O	|	appos	1	SENT_332	[p25l978t1718r1335b1775],
5	e	SYM	O	e	dep	6	SENT_332	[p25l978t1718r1335b1775],
6	—	CD	NUMBER	—	dep	7	SENT_332	[p25l978t1718r1335b1775],
7	b	NN	O	b	dep	14	SENT_332	[p25l978t1718r1335b1775],
8	|	CD	NUMBER	|	num	7	SENT_332	[p25l978t1718r1335b1775],
9	ind	NN	O	ind	nn	14	SENT_332	[p25l978t1718r1335b1775],
10	,	,	O	,	_	0	SENT_332	[p25l978t1718r1335b1775],
11	parallel-group	NN	O	parallel-group	dep	14	SENT_332	[p25l1352t1718r1735b1781],
12	,	,	O	,	_	0	SENT_332	[p25l1352t1718r1735b1781],
13	48-week	JJ	DURATION	48-week	amod	14	SENT_332	[p25l1748t1718r1973b1767],
14	study	NN	O	study	dep	25	SENT_332	[p25l1986t1718r2131b1781],
15	for	IN	O	for	_	0	SENT_332	[p25l131t1794r204b1845],
16	efﬁcacy	NN	O	efﬁcacy	prep_for	14	SENT_332	[p25l217t1794r418b1858],
17	and	CC	O	and	_	0	SENT_332	[p25l430t1795r527b1845],
18	safety	NN	O	safety	conj_and	16	SENT_332	[p25l544t1794r699b1858],
19	of	IN	O	of	_	0	SENT_332	[p25l711t1794r766b1845],
20	a	DT	O	a	det	23	SENT_332	[p25l776t1810r801b1845],
21	higher-dose	JJ	O	higher-dose	amod	23	SENT_332	[p25l820t1795r1136b1858],
22	rivastigmine	NN	O	rivastigmine	nn	23	SENT_332	[p25l1153t1797r1476b1858],
23	patch	NN	O	patch	prep_of	16	SENT_332	[p25l1493t1795r1636b1857],
24	(	CD	NUMBER	(	number	25	SENT_332	[p25l1654t1796r1730b1852],
25	15	CD	NUMBER	15	dep	1	SENT_332	[p25l1654t1796r1730b1852],
26	vs.	IN	O	vs.	_	0	SENT_332	[p25l1746t1810r1811b1845],
27	10	CD	NUMBER	10	num	29	SENT_332	[p25l1830t1798r1887b1845],
28	cm2	NN	O	cm2	nn	29	SENT_332	[p25l1902t1786r2016b1852],
29	)	NN	O	)	prep_vs.	25	SENT_332	[p25l1902t1786r2016b1852],
30	in	IN	O	in	_	0	SENT_332	[p25l2034t1797r2076b1844],
31	Alzheimer	NNP	O	Alzheimer	poss	33	SENT_332	[p25l131t1873r433b1922],
32	's	POS	O	's	_	0	SENT_332	[p25l131t1873r433b1922],
33	disease	NN	O	disease	prep_in	29	SENT_332	[p25l448t1873r653b1922],
34	.	.	O	.	_	0	SENT_332	[p25l448t1873r653b1922],

1	Dement	NNP	PERSON	Dement	_	0	SENT_333	[p25l667t1875r880b1922],
2	.	.	O	.	_	0	SENT_333	[p25l667t1875r880b1922],

1	Geriatr	NNP	O	Geriatr	_	0	SENT_334	[p25l896t1875r1077b1922],
2	.	.	O	.	_	0	SENT_334	[p25l896t1875r1077b1922],

1	Cogn	NNP	O	Cogn	_	0	SENT_335	[p25l1093t1874r1236b1936],
2	.	.	O	.	_	0	SENT_335	[p25l1093t1874r1236b1936],

1	Disord	NNP	O	Disord	_	0	SENT_336	[p25l1250t1873r1427b1922],
2	.	.	O	.	_	0	SENT_336	[p25l1250t1873r1427b1922],

1	33	CD	NUMBER	33	_	0	SENT_337	[p25l1441t1876r1521b1930],
2	,	,	O	,	_	0	SENT_337	[p25l1441t1876r1521b1930],
3	341	CD	NUMBER	341	number	4	SENT_337	[p25l1536t1876r1620b1922],
4	-353	CD	NUMBER	-353	appos	1	SENT_337	[p25l1634t1876r1758b1922],
5	(	CD	NUMBER	(	num	7	SENT_337	[p25l1777t1874r1951b1930],
6	2012	CD	DATE	2012	num	7	SENT_337	[p25l1777t1874r1951b1930],
7	)	NN	O	)	dep	4	SENT_337	[p25l1777t1874r1951b1930],
8	.	.	O	.	_	0	SENT_337	[p25l1777t1874r1951b1930],

1	6	CD	NUMBER	6	_	0	SENT_338	[p25l9t1954r51b2000],
2	.	.	O	.	_	0	SENT_338	[p25l9t1954r51b2000],

1	Farlow	NNP	PERSON	Farlow	_	0	SENT_339	[p25l133t1951r314b2008],
2	,	,	O	,	_	0	SENT_339	[p25l133t1951r314b2008],
3	M.	NNP	O	M.	nn	4	SENT_339	[p25l330t1953r389b2000],
4	etal	NNP	O	etal	appos	1	SENT_339	[p25l404t1951r519b2000],
5	.	.	O	.	_	0	SENT_339	[p25l404t1951r519b2000],

1	Safety	NN	O	safety	_	0	SENT_340	[p25l533t1950r695b2014],
2	and	CC	O	and	_	0	SENT_340	[p25l708t1951r804b2000],
3	tolerability	NN	O	tolerability	conj_and	1	SENT_340	[p25l819t1951r1105b2014],
4	of	IN	O	of	_	0	SENT_340	[p25l1118t1950r1172b2000],
5	donepezil	NN	O	donepezil	nn	7	SENT_340	[p25l1182t1951r1440b2013],
6	23	CD	NUMBER	23	num	7	SENT_340	[p25l1457t1954r1516b2000],
7	mg	NN	O	mg	prep_of	1	SENT_340	[p25l1531t1965r1613b2014],
8	in	IN	O	in	_	0	SENT_340	[p25l1631t1953r1674b2000],
9	moderate	JJ	O	moderate	prep_in	1	SENT_340	[p25l1692t1951r1947b2000],
10	to	TO	O	to	_	0	SENT_340	[p25l1960t1958r2013b2000],
11	severe	JJ	O	severe	amod	12	SENT_340	[p25l132t2042r300b2077],
12	Alzheimer	NN	O	alzheimer	poss	14	SENT_340	[p25l314t2028r615b2077],
13	's	POS	O	's	_	0	SENT_340	[p25l314t2028r615b2077],
14	disease	NN	O	disease	prep_to	9	SENT_340	[p25l630t2028r835b2077],
15	.	.	O	.	_	0	SENT_340	[p25l630t2028r835b2077],

1	BMCNeurol	NN	O	bmcneurol	_	0	SENT_341	[p25l849t2028r1156b2077],
2	.	.	O	.	_	0	SENT_341	[p25l849t2028r1156b2077],

1	11,57	CD	NUMBER	11,57	num	2	SENT_342	[p25l1174t2032r1327b2084],
2	(	NN	O	(	_	0	SENT_342	[p25l1343t2029r1444b2084],
3	201	CD	NUMBER	201	number	4	SENT_342	[p25l1343t2029r1444b2084],
4	1	CD	NUMBER	1	dep	2	SENT_342	[p25l1462t2029r1518b2084],
5	)	NN	O	)	dep	4	SENT_342	[p25l1462t2029r1518b2084],
6	.	.	O	.	_	0	SENT_342	[p25l1462t2029r1518b2084],

1	7	CD	NUMBER	7	_	0	SENT_343	[p25l10t2110r51b2156],
2	.	.	O	.	_	0	SENT_343	[p25l10t2110r51b2156],

1	Huang	NNP	PERSON	Huang	_	0	SENT_344	[p25l133t2108r318b2169],
2	,	,	O	,	_	0	SENT_344	[p25l133t2108r318b2169],
3	Y.	NNP	ORGANIZATION	Y.	conj_and	1	SENT_344	[p25l328t2108r367b2156],
4	&	CC	ORGANIZATION	&	_	0	SENT_344	[p25l381t2107r418b2156],
5	Mucke	NNP	ORGANIZATION	Mucke	conj_and	1	SENT_344	[p25l432t2106r617b2163],
6	,	,	O	,	_	0	SENT_344	[p25l432t2106r617b2163],
7	L.	NNP	PERSON	L.	nn	9	SENT_344	[p25l634t2108r671b2156],
8	Alzheimer	NNP	PERSON	Alzheimer	nn	9	SENT_344	[p25l685t2106r952b2156],
9	mechanisms	NNS	O	mechanism	appos	1	SENT_344	[p25l967t2106r1296b2156],
10	and	CC	O	and	_	0	SENT_344	[p25l1311t2106r1407b2156],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_344	[p25l1422t2106r1728b2168],
12	strategies	NNS	O	strategy	appos	1	SENT_344	[p25l1742t2108r2008b2169],
13	.	.	O	.	_	0	SENT_344	[p25l1742t2108r2008b2169],

1	Cell	NN	O	cell	_	0	SENT_345	[p25l2023t2106r2115b2156],

1	8	CD	NUMBER	8	_	0	SENT_346	[p25l9t2264r51b2311],
2	.	.	O	.	_	0	SENT_346	[p25l9t2264r51b2311],

1	Katsuno	NNP	PERSON	Katsuno	_	0	SENT_347	[p25l133t2263r357b2318],
2	,	,	O	,	_	0	SENT_347	[p25l133t2263r357b2318],
3	M.	NNP	O	M.	conj_and	1	SENT_347	[p25l372t2261r653b2318],
4	,	,	O	,	_	0	SENT_347	[p25l372t2261r653b2318],
5	Tanaka	NNP	PERSON	Tanaka	conj_and	1	SENT_347	[p25l372t2261r653b2318],
6	,	,	O	,	_	0	SENT_347	[p25l372t2261r653b2318],
7	F.	NNP	ORGANIZATION	F.	conj_and	1	SENT_347	[p25l669t2263r701b2311],
8	&	CC	ORGANIZATION	&	_	0	SENT_347	[p25l715t2262r752b2311],
9	Sobue	NNP	ORGANIZATION	Sobue	conj_and	1	SENT_347	[p25l765t2261r944b2318],
10	,	,	O	,	_	0	SENT_347	[p25l765t2261r944b2318],
11	G.	NNP	O	G.	nn	12	SENT_347	[p25l958t2263r1009b2311],
12	Perspectives	NNS	O	perspective	appos	1	SENT_347	[p25l1026t2263r1351b2323],
13	on	IN	O	on	_	0	SENT_347	[p25l1365t2276r1430b2311],
14	moleculartargeted	JJ	O	moleculartargeted	amod	15	SENT_347	[p25l1448t2261r1945b2324],
15	therapies	NNS	O	therapy	prep_on	12	SENT_347	[p25l131t2339r376b2401],
16	and	CC	O	and	_	0	SENT_347	[p25l391t2339r487b2389],
17	clinical	JJ	O	clinical	amod	18	SENT_347	[p25l504t2339r680b2389],
18	trials	NNS	O	trial	conj_and	12	SENT_347	[p25l696t2339r821b2389],
19	for	IN	O	for	_	0	SENT_347	[p25l834t2338r907b2389],
20	neurodegenerative	JJ	O	neurodegenerative	amod	21	SENT_347	[p25l922t2339r1426b2402],
21	diseases	NNS	O	disease	prep_for	18	SENT_347	[p25l1441t2339r1670b2389],
22	.	.	O	.	_	0	SENT_347	[p25l1441t2339r1670b2389],

1	J.	NNP	PERSON	J.	nn	2	SENT_348	[p25l1681t2341r1715b2389],
2	Neurol	NNP	PERSON	Neurol	_	0	SENT_348	[p25l1730t2339r1907b2389],
3	.	.	O	.	_	0	SENT_348	[p25l1730t2339r1907b2389],

1	Neurosurg	NNP	LOCATION	Neurosurg	_	0	SENT_349	[p25l132t2419r405b2480],
2	.	.	O	.	_	0	SENT_349	[p25l132t2419r405b2480],

1	Psychiatr	NN	O	psychiatr	_	0	SENT_350	[p25l420t2417r661b2481],
2	.	.	O	.	_	0	SENT_350	[p25l420t2417r661b2481],

1	83	CD	NUMBER	83	_	0	SENT_351	[p25l676t2420r756b2474],
2	,	,	O	,	_	0	SENT_351	[p25l676t2420r756b2474],
3	329-335	CD	NUMBER	329-335	num	4	SENT_351	[p25l771t2420r993b2466],
4	(	NN	O	(	appos	1	SENT_351	[p25l1012t2418r1112b2474],
5	201	CD	NUMBER	201	number	6	SENT_351	[p25l1012t2418r1112b2474],
6	2	CD	NUMBER	2	num	7	SENT_351	[p25l1127t2418r1186b2474],
7	)	NN	O	)	dep	4	SENT_351	[p25l1127t2418r1186b2474],
8	.	.	O	.	_	0	SENT_351	[p25l1127t2418r1186b2474],

1	9	CD	NUMBER	9	_	0	SENT_352	[p25l9t2498r51b2544],
2	.	.	O	.	_	0	SENT_352	[p25l9t2498r51b2544],

1	Salloway	NNP	PERSON	Salloway	_	0	SENT_353	[p25l131t2495r372b2559],
2	,	,	O	,	_	0	SENT_353	[p25l131t2495r372b2559],
3	5.	LS	NUMBER	5.	dep	1	SENT_353	[p25l386t2496r440b2552],
4	,	,	O	,	_	0	SENT_353	[p25l386t2496r440b2552],
5	Mintzer	NNP	PERSON	Mintzer	conj_and	1	SENT_353	[p25l455t2497r663b2552],
6	,	,	O	,	_	0	SENT_353	[p25l455t2497r663b2552],
7	J.	NNP	O	J.	conj_and	1	SENT_353	[p25l675t2497r928b2552],
8	,	,	O	,	_	0	SENT_353	[p25l675t2497r928b2552],
9	Weiner	NNP	PERSON	Weiner	conj_and	1	SENT_353	[p25l675t2497r928b2552],
10	,	,	O	,	_	0	SENT_353	[p25l675t2497r928b2552],
11	M.F.	NNP	ORGANIZATION	M.F.	conj_and	1	SENT_353	[p25l943t2497r1040b2544],
12	&	CC	ORGANIZATION	&	_	0	SENT_353	[p25l1055t2497r1091b2544],
13	Cummings	NNP	ORGANIZATION	Cummings	conj_and	1	SENT_353	[p25l1104t2496r1403b2558],
14	,	,	O	,	_	0	SENT_353	[p25l1104t2496r1403b2558],
15	J.L.	NNP	O	J.L.	nn	17	SENT_353	[p25l1415t2497r1492b2545],
16	Disease-modifying	NNP	O	Disease-modifying	nn	17	SENT_353	[p25l1509t2494r1999b2559],
17	therapies	NNS	O	therapy	appos	1	SENT_353	[p25l131t2573r376b2635],
18	in	IN	O	in	_	0	SENT_353	[p25l392t2575r435b2622],
19	Alzheimer	NN	O	alzheimer	poss	21	SENT_353	[p25l451t2573r753b2623],
20	's	POS	O	's	_	0	SENT_353	[p25l451t2573r753b2623],
21	disease	NN	O	disease	prep_in	17	SENT_353	[p25l768t2573r972b2623],
22	.	.	O	.	_	0	SENT_353	[p25l768t2573r972b2623],

1	Alzheimers	NNPS	O	Alzheimers	_	0	SENT_354	[p25l983t2573r1263b2623],
2	Dement	NNP	O	Dement	dep	1	SENT_354	[p25l1275t2575r1490b2623],
3	.	.	O	.	_	0	SENT_354	[p25l1275t2575r1490b2623],

1	4	CD	NUMBER	4	_	0	SENT_355	[p25l1503t2577r1549b2630],
2	,	,	O	,	_	0	SENT_355	[p25l1503t2577r1549b2630],
3	65-79	CD	NUMBER	65-79	number	4	SENT_355	[p25l1563t2576r1723b2623],
4	(	CD	NUMBER	(	appos	1	SENT_355	[p25l1739t2574r1913b2630],
5	2008	CD	DATE	2008	num	6	SENT_355	[p25l1739t2574r1913b2630],
6	)	NN	O	)	dep	4	SENT_355	[p25l1739t2574r1913b2630],
7	.	.	O	.	_	0	SENT_355	[p25l1739t2574r1913b2630],

1	10	CD	NUMBER	10	_	0	SENT_356	[p25l13t2654r83b2701],
2	.	.	O	.	_	0	SENT_356	[p25l13t2654r83b2701],

1	Brunden	NNP	LOCATION	Brunden	_	0	SENT_357	[p25l133t2651r370b2708],
2	,	,	O	,	_	0	SENT_357	[p25l133t2651r370b2708],
3	K.R.	NNP	LOCATION	K.R.	conj_and	1	SENT_357	[p25l386t2651r828b2714],
4	,	,	O	,	_	0	SENT_357	[p25l386t2651r828b2714],
5	Trojanowski	NNP	PERSON	Trojanowski	conj_and	1	SENT_357	[p25l386t2651r828b2714],
6	,	,	O	,	_	0	SENT_357	[p25l386t2651r828b2714],
7	J.Q.	NNP	PERSON	J.Q.	conj_and	1	SENT_357	[p25l841t2653r930b2706],
8	&	CC	PERSON	&	_	0	SENT_357	[p25l944t2653r981b2701],
9	Lee	NNP	PERSON	Lee	conj_and	1	SENT_357	[p25l996t2653r1213b2708],
10	,	,	O	,	_	0	SENT_357	[p25l996t2653r1213b2708],
11	V.M.	NNP	O	V.M.	nn	12	SENT_357	[p25l996t2653r1213b2708],
12	Advances	NNS	O	advance	appos	1	SENT_357	[p25l1227t2651r1480b2701],
13	in	IN	O	in	_	0	SENT_357	[p25l1497t2653r1539b2700],
14	tau-focused	JJ	O	tau-focused	amod	16	SENT_357	[p25l1555t2650r1867b2701],
15	drug	NN	O	drug	nn	16	SENT_357	[p25l1883t2651r2005b2714],
16	discovery	NN	O	discovery	prep_in	12	SENT_357	[p25l132t2729r383b2793],
17	for	IN	O	for	_	0	SENT_357	[p25l394t2728r467b2779],
18	Alzheimer	NN	O	alzheimer	poss	20	SENT_357	[p25l480t2729r781b2779],
19	's	POS	O	's	_	0	SENT_357	[p25l480t2729r781b2779],
20	disease	NN	O	disease	prep_for	16	SENT_357	[p25l796t2729r988b2778],
21	and	CC	O	and	_	0	SENT_357	[p25l1003t2729r1099b2778],
22	related	JJ	O	related	amod	23	SENT_357	[p25l1118t2729r1296b2779],
23	tauopathies	NNS	O	tauopathy	prep_for	16	SENT_357	[p25l1312t2729r1639b2791],
24	.	.	O	.	_	0	SENT_357	[p25l1312t2729r1639b2791],

1	Nat	NN	PERSON	nat	_	0	SENT_358	[p25l1653t2731r1754b2779],
2	.	.	O	.	_	0	SENT_358	[p25l1653t2731r1754b2779],

1	Rev.	NNP	O	Rev.	nn	3	SENT_359	[p25l1769t2731r1865b2778],
2	Drug	NNP	PERSON	Drug	nn	3	SENT_359	[p25l1880t2731r2006b2792],
3	Discov	NNP	PERSON	Discov	_	0	SENT_359	[p25l132t2808r310b2855],
4	.	.	O	.	_	0	SENT_359	[p25l132t2808r310b2855],

1	8	CD	NUMBER	8	_	0	SENT_360	[p25l324t2809r369b2862],
2	,	,	O	,	_	0	SENT_360	[p25l324t2809r369b2862],
3	783-793	CD	NUMBER	783-793	number	4	SENT_360	[p25l384t2809r606b2855],
4	(	CD	NUMBER	(	appos	1	SENT_360	[p25l624t2807r799b2862],
5	2009	CD	DATE	2009	num	6	SENT_360	[p25l624t2807r799b2862],
6	)	NN	O	)	dep	4	SENT_360	[p25l624t2807r799b2862],
7	.	.	O	.	_	0	SENT_360	[p25l624t2807r799b2862],

1	11	CD	NUMBER	11	_	0	SENT_361	[p25l13t2888r83b2933],
2	.	.	O	.	_	0	SENT_361	[p25l13t2888r83b2933],

1	Tuszynski	NNP	PERSON	Tuszynski	_	0	SENT_362	[p25l128t2884r395b2947],
2	,	,	O	,	_	0	SENT_362	[p25l128t2884r395b2947],
3	M.H.	NNP	O	M.H.	nn	4	SENT_362	[p25l410t2886r524b2933],
4	etal	NNP	O	etal	appos	1	SENT_362	[p25l539t2884r654b2933],
5	.	.	O	.	_	0	SENT_362	[p25l539t2884r654b2933],

1	A	DT	O	a	det	2	SENT_363	[p25l668t2886r704b2933],
2	phase	NN	O	phase	_	0	SENT_363	[p25l720t2884r874b2946],
3	1	CD	NUMBER	1	num	5	SENT_363	[p25l893t2888r908b2933],
4	clinical	JJ	O	clinical	amod	5	SENT_363	[p25l932t2884r1108b2933],
5	trial	NN	O	trial	dep	2	SENT_363	[p25l1124t2884r1222b2933],
6	of	IN	O	of	_	0	SENT_363	[p25l1239t2883r1293b2933],
7	nerve	NN	O	nerve	nn	11	SENT_363	[p25l1305t2899r1451b2934],
8	growth	NN	O	growth	nn	11	SENT_363	[p25l1465t2884r1653b2947],
9	factor	NN	O	factor	nn	11	SENT_363	[p25l1668t2883r1823b2933],
10	gene	NN	O	gene	nn	11	SENT_363	[p25l1836t2899r1967b2947],
11	therapy	NN	O	therapy	prep_of	5	SENT_363	[p25l131t2962r335b3026],
12	for	IN	O	for	_	0	SENT_363	[p25l347t2961r420b3011],
13	Alzheimer	NN	O	alzheimer	nn	14	SENT_363	[p25l432t2962r700b3011],
14	disease	NN	O	disease	prep_for	11	SENT_363	[p25l713t2962r917b3012],
15	.	.	O	.	_	0	SENT_363	[p25l713t2962r917b3012],

1	Nat	NN	PERSON	nat	_	0	SENT_364	[p25l931t2964r1033b3011],
2	.	.	O	.	_	0	SENT_364	[p25l931t2964r1033b3011],

1	Med	NNP	O	Med	_	0	SENT_365	[p25l1046t2962r1170b3011],
2	.	.	O	.	_	0	SENT_365	[p25l1046t2962r1170b3011],

1	1	CD	NUMBER	1	num	2	SENT_366	[p25l1187t2966r1207b3011],
2	1	CD	NUMBER	1	_	0	SENT_366	[p25l1223t2966r1264b3019],
3	,	,	O	,	_	0	SENT_366	[p25l1223t2966r1264b3019],
4	551	CD	NUMBER	551	number	5	SENT_366	[p25l1279t2966r1363b3011],
5	-555	CD	NUMBER	-555	appos	2	SENT_366	[p25l1377t2966r1501b3012],
6	(	CD	NUMBER	(	num	8	SENT_366	[p25l1520t2963r1694b3019],
7	2005	CD	DATE	2005	num	8	SENT_366	[p25l1520t2963r1694b3019],
8	)	NN	O	)	dep	5	SENT_366	[p25l1520t2963r1694b3019],
9	.	.	O	.	_	0	SENT_366	[p25l1520t2963r1694b3019],

1	12	CD	NUMBER	12	_	0	SENT_367	[p25l13t3043r83b3090],
2	.	.	O	.	_	0	SENT_367	[p25l13t3043r83b3090],

1	Cummings	NNP	PERSON	Cummings	_	0	SENT_368	[p25l130t3042r429b3103],
2	,	,	O	,	_	0	SENT_368	[p25l130t3042r429b3103],
3	J.	NNP	O	J.	appos	1	SENT_368	[p25l441t3040r625b3090],
4	What	WDT	O	what	nsubjpass	7	SENT_368	[p25l441t3040r625b3090],
5	can	MD	O	can	aux	7	SENT_368	[p25l639t3055r728b3090],
6	be	VB	O	be	auxpass	7	SENT_368	[p25l747t3040r809b3090],
7	inferred	VBN	O	infer	rcmod	3	SENT_368	[p25l825t3039r1027b3090],
8	from	IN	O	from	_	0	SENT_368	[p25l1042t3039r1165b3090],
9	the	DT	O	the	det	10	SENT_368	[p25l1180t3040r1266b3090],
10	interruption	NN	O	interruption	prep_from	7	SENT_368	[p25l1282t3042r1597b3102],
11	of	IN	O	of	_	0	SENT_368	[p25l1613t3039r1668b3090],
12	the	DT	O	the	det	14	SENT_368	[p25l1676t3040r1762b3090],
13	semagacestat	NN	O	semagacestat	nn	14	SENT_368	[p25l1777t3047r2140b3103],
14	trial	NN	O	trial	prep_of	10	SENT_368	[p25l131t3118r228b3168],
15	for	IN	O	for	_	0	SENT_368	[p25l243t3117r316b3167],
16	treatment	NN	O	treatment	prep_for	7	SENT_368	[p25l328t3125r593b3167],
17	of	IN	O	of	_	0	SENT_368	[p25l606t3117r661b3167],
18	Alzheimer	NN	O	alzheimer	poss	20	SENT_368	[p25l670t3118r972b3167],
19	's	POS	O	's	_	0	SENT_368	[p25l670t3118r972b3167],
20	disease	NN	O	disease	prep_of	16	SENT_368	[p25l987t3118r1204b3168],
21	?	.	O	?	_	0	SENT_368	[p25l987t3118r1204b3168],

1	Biol	NNP	O	Biol	_	0	SENT_369	[p25l1219t3118r1321b3167],
2	.	.	O	.	_	0	SENT_369	[p25l1219t3118r1321b3167],

1	Psychiatry	NNP	O	Psychiatry	_	0	SENT_370	[p25l1336t3118r1597b3182],
2	68	CD	NUMBER	68	num	1	SENT_370	[p25l1607t3121r1688b3175],
3	,	,	O	,	_	0	SENT_370	[p25l1607t3121r1688b3175],
4	876-878	CD	NUMBER	876-878	num	1	SENT_370	[p25l1703t3121r1927b3167],
5	(	CD	NUMBER	(	num	7	SENT_370	[p25l1943t3119r2118b3175],
6	2010	CD	DATE	2010	num	7	SENT_370	[p25l1943t3119r2118b3175],
7	)	NN	O	)	dep	1	SENT_370	[p25l1943t3119r2118b3175],
8	.	.	O	.	_	0	SENT_370	[p25l1943t3119r2118b3175],

1	13	CD	NUMBER	13	_	0	SENT_371	[p25l13t3199r83b3246],
2	.	.	O	.	_	0	SENT_371	[p25l13t3199r83b3246],

1	Becker	NNP	PERSON	Becker	_	0	SENT_372	[p25l133t3196r314b3253],
2	,	,	O	,	_	0	SENT_372	[p25l133t3196r314b3253],
3	R.E.	NNP	ORGANIZATION	R.E.	conj_and	1	SENT_372	[p25l331t3198r417b3246],
4	&	CC	ORGANIZATION	&	_	0	SENT_372	[p25l431t3198r468b3246],
5	Greig	NNP	ORGANIZATION	Greig	conj_and	1	SENT_372	[p25l480t3198r633b3259],
6	,	,	O	,	_	0	SENT_372	[p25l480t3198r633b3259],
7	N.H.	NNP	LOCATION	N.H.	appos	1	SENT_372	[p25l650t3198r753b3246],
8	Increasing	VBG	O	increase	partmod	7	SENT_372	[p25l770t3198r1036b3259],
9	the	DT	O	the	det	11	SENT_372	[p25l1051t3196r1137b3246],
10	success	NN	O	success	nn	11	SENT_372	[p25l1152t3211r1347b3246],
11	rate	NN	O	rate	dobj	8	SENT_372	[p25l1363t3203r1461b3246],
12	for	IN	O	for	_	0	SENT_372	[p25l1474t3195r1547b3246],
13	Alzheimer	NN	O	alzheimer	poss	17	SENT_372	[p25l1559t3196r1861b3246],
14	's	POS	O	's	_	0	SENT_372	[p25l1559t3196r1861b3246],
15	disease	NN	O	disease	nn	17	SENT_372	[p25l1876t3196r2068b3246],
16	drug	NN	O	drug	nn	17	SENT_372	[p25l132t3274r254b3337],
17	discovery	NN	O	discovery	prep_for	11	SENT_372	[p25l270t3274r521b3338],
18	and	CC	O	and	_	0	SENT_372	[p25l534t3274r631b3323],
19	development	NN	O	development	conj_and	17	SENT_372	[p25l647t3274r1014b3336],
20	.	.	O	.	_	0	SENT_372	[p25l647t3274r1014b3336],

1	Expert	NN	O	expert	_	0	SENT_373	[p25l1029t3276r1192b3336],
2	Opin	NN	PERSON	opin	dep	1	SENT_373	[p25l1201t3275r1333b3336],
3	.	.	O	.	_	0	SENT_373	[p25l1201t3275r1333b3336],

1	Drug	NN	O	drug	_	0	SENT_374	[p25l1348t3276r1474b3337],
2	Discov	NNP	O	Discov	dep	1	SENT_374	[p25l1486t3276r1664b3323],
3	.	.	O	.	_	0	SENT_374	[p25l1486t3276r1664b3323],

1	7	CD	NUMBER	7	_	0	SENT_375	[p25l1679t3278r1723b3331],
2	,	,	O	,	_	0	SENT_375	[p25l1679t3278r1723b3331],
3	367-370	CD	NUMBER	367-370	number	4	SENT_375	[p25l1738t3277r1962b3323],
4	(	CD	NUMBER	(	appos	1	SENT_375	[p25l1978t3275r2153b3331],
5	2012	CD	DATE	2012	num	6	SENT_375	[p25l1978t3275r2153b3331],
6	)	NN	O	)	dep	4	SENT_375	[p25l1978t3275r2153b3331],
7	.	.	O	.	_	0	SENT_375	[p25l1978t3275r2153b3331],

1	14	CD	NUMBER	14	_	0	SENT_376	[p25l13t3356r83b3401],
2	.	.	O	.	_	0	SENT_376	[p25l13t3356r83b3401],

1	Fillit	NNP	PERSON	Fillit	nn	3	SENT_377	[p25l133t3352r250b3409],
2	,	,	O	,	_	0	SENT_377	[p25l133t3352r250b3409],
3	H.M.	NNP	O	H.M.	_	0	SENT_377	[p25l266t3354r379b3402],
4	et	FW	O	et	nn	5	SENT_377	[p25l393t3359r442b3401],
5	al.	FW	O	al.	dep	3	SENT_377	[p25l451t3352r509b3401],
6	.	.	O	.	_	0	SENT_377	[p25l451t3352r509b3401],

1	Barriers	NNS	O	barrier	_	0	SENT_378	[p25l525t3354r719b3401],
2	to	TO	O	to	_	0	SENT_378	[p25l733t3359r786b3401],
3	drug	NN	O	drug	nn	4	SENT_378	[p25l800t3352r922b3415],
4	discovery	NN	O	discovery	prep_to	1	SENT_378	[p25l939t3352r1190b3416],
5	and	CC	O	and	_	0	SENT_378	[p25l1203t3352r1299b3401],
6	development	NN	O	development	conj_and	4	SENT_378	[p25l1316t3352r1671b3414],
7	for	IN	O	for	_	0	SENT_378	[p25l1683t3351r1756b3401],
8	Alzheimer	NN	O	alzheimer	nn	9	SENT_378	[p25l1768t3352r2036b3401],
9	disease	NN	O	disease	prep_for	1	SENT_378	[p25l132t3430r336b3480],
10	.	.	O	.	_	0	SENT_378	[p25l132t3430r336b3480],

1	Alzheimer	NN	O	alzheimer	_	0	SENT_379	[p25l347t3430r607b3480],
2	Dis	NN	O	di	dep	1	SENT_379	[p25l615t3432r702b3480],
3	.	.	O	.	_	0	SENT_379	[p25l615t3432r702b3480],

1	Assoc	NNP	O	Assoc	_	0	SENT_380	[p25l713t3432r868b3480],
2	.	.	O	.	_	0	SENT_380	[p25l713t3432r868b3480],

1	Disord	NNP	O	Disord	_	0	SENT_381	[p25l883t3430r1059b3480],
2	.	.	O	.	_	0	SENT_381	[p25l883t3430r1059b3480],

1	16	CD	NUMBER	16	num	2	SENT_382	[p25l1077t3433r1142b3480],
2	(	CD	NUMBER	(	_	0	SENT_382	[p25l1157t3430r1330b3492],
3	suppl	NN	O	suppl	dep	2	SENT_382	[p25l1157t3430r1330b3492],
4	.	.	O	.	_	0	SENT_382	[p25l1157t3430r1330b3492],

1	1	CD	NUMBER	1	num	2	SENT_383	[p25l1349t3431r1405b3487],
2	)	NN	O	)	_	0	SENT_383	[p25l1349t3431r1405b3487],
3	,	,	O	,	_	0	SENT_383	[p25l1349t3431r1405b3487],
4	51-58	CD	NUMBER	51-58	number	5	SENT_383	[p25l1419t3431r1576b3480],
5	(	CD	NUMBER	(	appos	2	SENT_383	[p25l1592t3431r1767b3487],
6	2002	CD	DATE	2002	num	7	SENT_383	[p25l1592t3431r1767b3487],
7	)	NN	O	)	dep	5	SENT_383	[p25l1592t3431r1767b3487],
8	.	.	O	.	_	0	SENT_383	[p25l1592t3431r1767b3487],

1	15	CD	NUMBER	15	_	0	SENT_384	[p25l13t3512r83b3558],
2	.	.	O	.	_	0	SENT_384	[p25l13t3512r83b3558],

1	Cummings	NNP	PERSON	Cummings	_	0	SENT_385	[p25l130t3509r428b3571],
2	,	,	O	,	_	0	SENT_385	[p25l130t3509r428b3571],
3	J.L.	NNP	O	J.L.	nn	4	SENT_385	[p25l441t3510r518b3558],
4	Biomarkers	NNS	O	biomarker	appos	1	SENT_385	[p25l535t3508r826b3558],
5	in	IN	O	in	_	0	SENT_385	[p25l843t3510r885b3557],
6	Alzheimer	NN	O	alzheimer	poss	10	SENT_385	[p25l901t3508r1203b3558],
7	's	POS	O	's	_	0	SENT_385	[p25l901t3508r1203b3558],
8	disease	NN	O	disease	nn	10	SENT_385	[p25l1218t3508r1410b3558],
9	drug	NN	O	drug	nn	10	SENT_385	[p25l1425t3508r1546b3571],
10	development	NN	O	development	prep_in	4	SENT_385	[p25l1563t3508r1930b3570],
11	.	.	O	.	_	0	SENT_385	[p25l1563t3508r1930b3570],

1	Alzheimers	NNPS	O	Alzheimers	_	0	SENT_386	[p25l128t3584r408b3633],
2	Dement	NNP	O	Dement	dep	1	SENT_386	[p25l420t3586r635b3633],
3	.	.	O	.	_	0	SENT_386	[p25l420t3586r635b3633],

1	7	CD	NUMBER	7	_	0	SENT_387	[p25l650t3588r694b3641],
2	,	,	O	,	_	0	SENT_387	[p25l650t3588r694b3641],
3	e13-e44	JJ	O	e13-e44	amod	4	SENT_387	[p25l709t3587r934b3633],
4	(	NN	O	(	appos	1	SENT_387	[p25l949t3585r1050b3641],
5	201	CD	NUMBER	201	number	6	SENT_387	[p25l949t3585r1050b3641],
6	1	CD	NUMBER	1	num	7	SENT_387	[p25l1068t3585r1124b3640],
7	)	NN	O	)	dep	4	SENT_387	[p25l1068t3585r1124b3640],
8	.	.	O	.	_	0	SENT_387	[p25l1068t3585r1124b3640],

1	Cummings	NNP	PERSON	Cummings	_	0	SENT_388	[p26l130t19r428b80],
2	,	,	O	,	_	0	SENT_388	[p26l130t19r428b80],
3	J.L.	NNP	PERSON	J.L.	nn	4	SENT_388	[p26l441t19r518b67],
4	etal	NNP	O	etal	appos	1	SENT_388	[p26l532t17r648b67],
5	.	.	O	.	_	0	SENT_388	[p26l532t17r648b67],

1	Alzheimer	NN	O	alzheimer	poss	5	SENT_389	[p26l661t17r963b67],
2	's	POS	O	's	_	0	SENT_389	[p26l661t17r963b67],
3	disease	NN	O	disease	nn	5	SENT_389	[p26l978t17r1170b67],
4	drug	NN	O	drug	nn	5	SENT_389	[p26l1184t17r1306b80],
5	development	NN	O	development	_	0	SENT_389	[p26l1323t17r2029b79],
6	:	:	O	:	_	0	SENT_389	[p26l1323t17r2029b79],
7	translational	JJ	O	translational	amod	9	SENT_389	[p26l1323t17r2029b79],
8	neuroscience	NN	O	neuroscience	nn	9	SENT_389	[p26l134t97r482b145],
9	strategies	NNS	O	strategy	dep	5	SENT_389	[p26l497t97r762b158],
10	.	.	O	.	_	0	SENT_389	[p26l497t97r762b158],

1	CNS	NN	O	cn	_	0	SENT_390	[p26l778t97r881b145],
2	Spectr	NN	O	spectr	dep	1	SENT_390	[p26l890t97r1060b157],
3	.	.	O	.	_	0	SENT_390	[p26l890t97r1060b157],

1	11	CD	NUMBER	11	_	0	SENT_391	[p26l1078t99r1155b152],
2	,	,	O	,	_	0	SENT_391	[p26l1078t99r1155b152],
3	1-1	CD	NUMBER	1-1	number	4	SENT_391	[p26l1174t99r1253b144],
4	1	CD	NUMBER	1	appos	1	SENT_391	[p26l1271t99r1286b144],
5	(	CD	NUMBER	(	num	7	SENT_391	[p26l1312t96r1487b152],
6	2013	CD	DATE	2013	num	7	SENT_391	[p26l1312t96r1487b152],
7	)	NN	O	)	dep	4	SENT_391	[p26l1312t96r1487b152],
8	.	.	O	.	_	0	SENT_391	[p26l1312t96r1487b152],

1	Biomarkers	NNS	O	biomarker	nn	2	SENT_392	[p26l133t173r424b223],
2	Deﬁnitions	NNS	O	deﬁnitions	_	0	SENT_392	[p26l441t172r725b223],
3	Working	VBG	O	work	partmod	2	SENT_392	[p26l736t173r957b236],
4	Group	NNP	O	Group	dobj	3	SENT_392	[p26l973t175r1149b235],
5	.	.	O	.	_	0	SENT_392	[p26l973t175r1149b235],

1	Biomarkers	NNS	O	biomarker	_	0	SENT_393	[p26l1166t173r1457b223],
2	and	CC	O	and	_	0	SENT_393	[p26l1472t173r1568b223],
3	surrogate	JJ	O	surrogate	amod	4	SENT_393	[p26l1585t181r1837b236],
4	endpoints	NNS	O	endpoint	conj_and	1	SENT_393	[p26l1851t173r2131b235],
5	:	:	O	:	_	0	SENT_393	[p26l1851t173r2131b235],
6	preferred	JJ	O	preferred	amod	7	SENT_393	[p26l134t250r373b313],
7	deﬁnitions	NNS	O	deﬁnitions	dep	1	SENT_393	[p26l390t250r669b301],
8	and	CC	O	and	_	0	SENT_393	[p26l684t251r780b301],
9	conceptual	JJ	O	conceptual	amod	10	SENT_393	[p26l797t251r1088b313],
10	framework	NN	O	framework	conj_and	7	SENT_393	[p26l1103t250r1403b301],
11	.	.	O	.	_	0	SENT_393	[p26l1103t250r1403b301],

1	Clin	NNP	O	Clin	_	0	SENT_394	[p26l1418t251r1523b301],
2	.	.	O	.	_	0	SENT_394	[p26l1418t251r1523b301],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_395	[p26l1538t251r1823b301],
2	.	.	O	.	_	0	SENT_395	[p26l1538t251r1823b301],

1	Ther	NNP	O	Ther	_	0	SENT_396	[p26l1840t251r1961b301],
2	.	.	O	.	_	0	SENT_396	[p26l1840t251r1961b301],

1	69	CD	NUMBER	69	_	0	SENT_397	[p26l1975t254r2056b308],
2	,	,	O	,	_	0	SENT_397	[p26l1975t254r2056b308],
3	89-95	CD	NUMBER	89-95	number	4	SENT_397	[p26l132t331r289b377],
4	(	CD	NUMBER	(	appos	1	SENT_397	[p26l307t329r482b384],
5	2001	CD	DATE	2001	num	6	SENT_397	[p26l307t329r482b384],
6	)	NN	O	)	dep	4	SENT_397	[p26l307t329r482b384],
7	.	.	O	.	_	0	SENT_397	[p26l307t329r482b384],

1	Coley	NNP	PERSON	Coley	_	0	SENT_398	[p26l130t406r285b470],
2	,	,	O	,	_	0	SENT_398	[p26l130t406r285b470],
3	N.	NNP	O	N.	conj_and	1	SENT_398	[p26l302t408r364b463],
4	,	,	O	,	_	0	SENT_398	[p26l302t408r364b463],
5	Andrieu	NNP	PERSON	Andrieu	conj_and	1	SENT_398	[p26l378t406r601b463],
6	,	,	O	,	_	0	SENT_398	[p26l378t406r601b463],
7	S.	NNP	O	S.	conj_and	1	SENT_398	[p26l616t408r669b463],
8	,	,	O	,	_	0	SENT_398	[p26l616t408r669b463],
9	Delrieu	NNP	LOCATION	Delrieu	conj_and	1	SENT_398	[p26l686t406r885b463],
10	,	,	O	,	_	0	SENT_398	[p26l686t406r885b463],
11	J.	NNP	O	J.	conj_and	1	SENT_398	[p26l897t408r1173b463],
12	,	,	O	,	_	0	SENT_398	[p26l897t408r1173b463],
13	Voisin	NNP	PERSON	Voisin	conj_and	1	SENT_398	[p26l897t408r1173b463],
14	,	,	O	,	_	0	SENT_398	[p26l897t408r1173b463],
15	T.	NNP	O	T.	conj_and	1	SENT_398	[p26l897t408r1173b463],
16	&	CC	O	&	_	0	SENT_398	[p26l1188t406r1395b463],
17	Ve	NNP	O	Ve	conj_and	1	SENT_398	[p26l1188t406r1395b463],
18	|	VBD	O	|	rcmod	1	SENT_398	[p26l1188t406r1395b463],
19	|	RB	O	|	advmod	20	SENT_398	[p26l1188t406r1395b463],
20	as	RB	O	as	acomp	18	SENT_398	[p26l1188t406r1395b463],
21	,	,	O	,	_	0	SENT_398	[p26l1188t406r1395b463],
22	B.	NNP	O	B.	nn	23	SENT_398	[p26l1412t408r1452b456],
23	Biomarkers	NNS	O	biomarker	appos	1	SENT_398	[p26l1470t406r1760b456],
24	in	IN	O	in	_	0	SENT_398	[p26l1777t408r1820b455],
25	Alzheimer	NN	O	alzheimer	poss	27	SENT_398	[p26l1836t406r2137b456],
26	's	POS	O	's	_	0	SENT_398	[p26l1836t406r2137b456],
27	disease	NN	O	disease	prep_in	23	SENT_398	[p26l131t484r337b534],
28	:	:	O	:	_	0	SENT_398	[p26l131t484r337b534],
29	not	RB	O	not	neg	30	SENT_398	[p26l354t492r440b534],
30	yet	RB	O	yet	dep	1	SENT_398	[p26l452t492r533b548],
31	surrogate	JJ	O	surrogate	amod	32	SENT_398	[p26l547t492r798b547],
32	endpoints	NNS	O	endpoint	dep	30	SENT_398	[p26l813t484r1093b546],
33	.	.	O	.	_	0	SENT_398	[p26l813t484r1093b546],

1	Ann	NNP	PERSON	Ann	_	0	SENT_399	[p26l1103t486r1219b534],
2	.	.	O	.	_	0	SENT_399	[p26l1103t486r1219b534],

1	N.	NNP	PERSON	N.	nn	3	SENT_400	[p26l1234t486r1282b534],
2	Y.	NNP	PERSON	Y.	nn	3	SENT_400	[p26l1301t486r1333b534],
3	Acad	NNP	PERSON	Acad	_	0	SENT_400	[p26l1343t484r1578b534],
4	.	.	O	.	_	0	SENT_400	[p26l1343t484r1578b534],

1	$	$	MONEY	$	_	0	SENT_401	[p26l1343t484r1578b534],
2	ci	CD	MONEY	ci	num	1	SENT_401	[p26l1343t484r1578b534],
3	.	.	O	.	_	0	SENT_401	[p26l1343t484r1578b534],

1	1180	CD	DATE	1180	_	0	SENT_402	[p26l1595t487r1743b541],
2	,	,	O	,	_	0	SENT_402	[p26l1595t487r1743b541],
3	1	CD	NUMBER	1	number	4	SENT_402	[p26l1762t488r1776b533],
4	19-124	CD	NUMBER	19-124	appos	1	SENT_402	[p26l1795t487r1983b534],
5	(	CD	NUMBER	(	num	7	SENT_402	[p26l133t562r308b617],
6	2009	CD	DATE	2009	num	7	SENT_402	[p26l133t562r308b617],
7	)	NN	O	)	dep	4	SENT_402	[p26l133t562r308b617],
8	.	.	O	.	_	0	SENT_402	[p26l133t562r308b617],

1	Danhof	NNP	PERSON	Danhof	_	0	SENT_403	[p26l132t637r335b696],
2	,	,	O	,	_	0	SENT_403	[p26l132t637r335b696],
3	M.	NNP	O	M.	appos	1	SENT_403	[p26l351t640r424b695],
4	,	,	O	,	_	0	SENT_403	[p26l351t640r424b695],
5	Alvan	NNP	PERSON	Alvan	conj_and	3	SENT_403	[p26l437t638r598b696],
6	,	,	O	,	_	0	SENT_403	[p26l437t638r598b696],
7	G.	NNP	O	G.	conj_and	3	SENT_403	[p26l612t640r676b695],
8	,	,	O	,	_	0	SENT_403	[p26l612t640r676b695],
9	Dahl	NNP	PERSON	Dahl	conj_and	3	SENT_403	[p26l693t638r823b696],
10	,	,	O	,	_	0	SENT_403	[p26l693t638r823b696],
11	S.G.	NNP	LOCATION	S.G.	conj_and	3	SENT_403	[p26l838t640r945b696],
12	,	,	O	,	_	0	SENT_403	[p26l838t640r945b696],
13	Kuhlmann	NNP	PERSON	Kuhlmann	conj_and	3	SENT_403	[p26l962t638r1244b696],
14	,	,	O	,	_	0	SENT_403	[p26l962t638r1244b696],
15	J.	NNP	O	J.	conj_and	3	SENT_403	[p26l1256t640r1290b688],
16	&	CC	O	&	_	0	SENT_403	[p26l1304t640r1341b688],
17	Paintaud	NNP	O	Paintaud	conj_and	3	SENT_403	[p26l1357t638r1599b696],
18	,	,	O	,	_	0	SENT_403	[p26l1357t638r1599b696],
19	G.	NNP	PERSON	G.	nn	20	SENT_403	[p26l1613t640r1664b688],
20	Mechanismbased	NNP	PERSON	Mechanismbased	appos	1	SENT_403	[p26l1680t638r2002b688, p26l133t717r286b767],
21	pharmacokinetic	JJ	O	pharmacokinetic	amod	24	SENT_403	[p26l305t717r1268b781],
22	—	NN	O	—	nn	24	SENT_403	[p26l305t717r1268b781],
23	pharmacodynamic	JJ	O	pharmacodynamic	amod	24	SENT_403	[p26l305t717r1268b781],
24	mode	NN	O	mode	dep	20	SENT_403	[p26l1285t717r1585b780],
25	|	CD	NUMBER	|	num	26	SENT_403	[p26l1285t717r1585b780],
26	ing	NN	O	ing	dep	1	SENT_403	[p26l1285t717r1585b780],
27	—	CD	NUMBER	—	dep	26	SENT_403	[p26l1285t717r1585b780],
28	a	DT	O	a	det	30	SENT_403	[p26l1285t717r1585b780],
29	new	JJ	O	new	amod	30	SENT_403	[p26l1603t732r1713b767],
30	classiﬁcation	NN	O	classiﬁcation	dep	1	SENT_403	[p26l1726t716r2059b767],
31	of	IN	O	of	_	0	SENT_403	[p26l2075t716r2130b767],
32	biomarkers	NNS	O	biomarker	prep_of	30	SENT_403	[p26l133t794r440b843],
33	.	.	O	.	_	0	SENT_403	[p26l133t794r440b843],

1	Pharm	NNP	O	Pharm	_	0	SENT_404	[p26l454t794r633b843],
2	.	.	O	.	_	0	SENT_404	[p26l454t794r633b843],

1	Res	NNP	O	Res	_	0	SENT_405	[p26l648t796r743b843],
2	.	.	O	.	_	0	SENT_405	[p26l648t796r743b843],

1	22	CD	NUMBER	22	_	0	SENT_406	[p26l758t797r838b850],
2	,	,	O	,	_	0	SENT_406	[p26l758t797r838b850],
3	1432-1437	CD	DATE	1432-1437	number	4	SENT_406	[p26l857t797r1142b843],
4	(	CD	NUMBER	(	appos	1	SENT_406	[p26l1159t795r1333b851],
5	2005	CD	DATE	2005	num	6	SENT_406	[p26l1159t795r1333b851],
6	)	NN	O	)	dep	4	SENT_406	[p26l1159t795r1333b851],
7	.	.	O	.	_	0	SENT_406	[p26l1159t795r1333b851],

1	Dickerson	NNP	PERSON	Dickerson	_	0	SENT_407	[p26l132t872r404b929],
2	,	,	O	,	_	0	SENT_407	[p26l132t872r404b929],
3	B.C.	NNP	ORGANIZATION	B.C.	conj_and	1	SENT_407	[p26l421t874r512b922],
4	&	CC	ORGANIZATION	&	_	0	SENT_407	[p26l525t874r562b922],
5	Sperling	NNP	ORGANIZATION	Sperling	conj_and	1	SENT_407	[p26l576t872r805b935],
6	,	,	O	,	_	0	SENT_407	[p26l576t872r805b935],
7	R.A.	NNP	O	R.A.	nn	9	SENT_407	[p26l822t874r915b922],
8	Neuroimaging	NNP	O	Neuroimaging	nn	9	SENT_407	[p26l932t874r1309b935],
9	biomarkers	NNS	O	biomarker	appos	1	SENT_407	[p26l1327t872r1621b922],
10	for	IN	O	for	_	0	SENT_407	[p26l1634t871r1707b922],
11	clinical	JJ	O	clinical	amod	12	SENT_407	[p26l1720t872r1896b922],
12	trials	NNS	O	trial	prep_for	9	SENT_407	[p26l1912t872r2037b922],
13	of	IN	O	of	_	0	SENT_407	[p26l131t949r186b1000],
14	disease	NN	O	disease	prep_of	12	SENT_407	[p26l196t949r681b1014],
15	—	CD	NUMBER	—	num	14	SENT_407	[p26l196t949r681b1014],
16	modifying	VBG	O	modify	partmod	14	SENT_407	[p26l196t949r681b1014],
17	therapies	NNS	O	therapy	dobj	16	SENT_407	[p26l696t950r942b1012],
18	in	IN	O	in	_	0	SENT_407	[p26l958t952r1001b999],
19	Alzheimer	NN	O	alzheimer	poss	21	SENT_407	[p26l1017t950r1319b1000],
20	's	POS	O	's	_	0	SENT_407	[p26l1017t950r1319b1000],
21	disease	NN	O	disease	prep_in	17	SENT_407	[p26l1333t950r1538b1000],
22	.	.	O	.	_	0	SENT_407	[p26l1333t950r1538b1000],

1	NeuroRx	NN	O	neurorx	_	0	SENT_408	[p26l1552t952r1770b1000],
2	2	CD	NUMBER	2	num	1	SENT_408	[p26l1781t953r1825b1007],
3	,	,	O	,	_	0	SENT_408	[p26l1781t953r1825b1007],
4	348-360	CD	NUMBER	348-360	number	5	SENT_408	[p26l1840t953r2064b1000],
5	(	CD	NUMBER	(	appos	1	SENT_408	[p26l133t1028r308b1083],
6	2005	CD	DATE	2005	num	7	SENT_408	[p26l133t1028r308b1083],
7	)	NN	O	)	dep	5	SENT_408	[p26l133t1028r308b1083],
8	.	.	O	.	_	0	SENT_408	[p26l133t1028r308b1083],

1	Guerreiro	NNP	PERSON	Guerreiro	nn	3	SENT_409	[p26l130t1107r389b1162],
2	,	,	O	,	_	0	SENT_409	[p26l130t1107r389b1162],
3	R.	NNP	O	R.	_	0	SENT_409	[p26l406t1107r447b1155],
4	et	FW	O	et	nn	5	SENT_409	[p26l462t1113r511b1155],
5	al.	FW	O	al.	dep	3	SENT_409	[p26l520t1105r590b1162],
6	;	:	O	;	_	0	SENT_409	[p26l520t1105r590b1162],
7	Alzheimer	NNP	ORGANIZATION	Alzheimer	nn	10	SENT_409	[p26l604t1105r872b1155],
8	Genetic	NNP	ORGANIZATION	Genetic	nn	10	SENT_409	[p26l885t1107r1087b1155],
9	Analysis	NNP	ORGANIZATION	Analysis	nn	10	SENT_409	[p26l1101t1105r1312b1169],
10	Group	NNP	ORGANIZATION	Group	dep	3	SENT_409	[p26l1326t1107r1691b1167],
11	.	.	O	.	_	0	SENT_409	[p26l1326t1107r1691b1167],

1	TREM2	NN	O	trem2	nn	2	SENT_410	[p26l1326t1107r1691b1167],
2	variants	NNS	O	variant	_	0	SENT_410	[p26l1705t1107r1912b1155],
3	in	IN	O	in	_	0	SENT_410	[p26l1928t1107r1971b1154],
4	Alzheimer	NN	O	alzheimer	poss	6	SENT_410	[p26l131t1183r433b1233],
5	's	POS	O	's	_	0	SENT_410	[p26l131t1183r433b1233],
6	disease	NN	O	disease	prep_in	2	SENT_410	[p26l447t1183r652b1233],
7	.	.	O	.	_	0	SENT_410	[p26l447t1183r652b1233],

1	N.	NNP	O	N.	nn	2	SENT_411	[p26l666t1185r714b1233],
2	Engl	NNP	O	Engl	_	0	SENT_411	[p26l729t1183r847b1246],
3	.	.	O	.	_	0	SENT_411	[p26l729t1183r847b1246],

1	J.	NNP	O	J.	nn	2	SENT_412	[p26l858t1185r893b1233],
2	Med	NNP	O	Med	_	0	SENT_412	[p26l907t1183r1030b1233],
3	.	.	O	.	_	0	SENT_412	[p26l907t1183r1030b1233],

1	368	CD	NUMBER	368	_	0	SENT_413	[p26l1044t1186r1160b1240],
2	,	,	O	,	_	0	SENT_413	[p26l1044t1186r1160b1240],
3	1	CD	NUMBER	1	number	4	SENT_413	[p26l1179t1187r1193b1232],
4	17-127	CD	NUMBER	17-127	appos	1	SENT_413	[p26l1211t1186r1398b1232],
5	(	CD	NUMBER	(	num	7	SENT_413	[p26l1415t1184r1590b1240],
6	2013	CD	DATE	2013	num	7	SENT_413	[p26l1415t1184r1590b1240],
7	)	NN	O	)	dep	4	SENT_413	[p26l1415t1184r1590b1240],
8	.	.	O	.	_	0	SENT_413	[p26l1415t1184r1590b1240],

1	Guo	NNP	PERSON	Guo	_	0	SENT_414	[p26l130t1263r249b1319],
2	,	,	O	,	_	0	SENT_414	[p26l130t1263r249b1319],
3	L.H.	NNP	PERSON	L.H.	nn	4	SENT_414	[p26l266t1263r358b1311],
4	etal	NNP	O	etal	appos	1	SENT_414	[p26l372t1261r487b1311],
5	.	.	O	.	_	0	SENT_414	[p26l372t1261r487b1311],

1	SORL1	NN	O	sorl1	_	0	SENT_415	[p26l502t1263r661b1311],
2	genetic	JJ	O	genetic	amod	3	SENT_415	[p26l685t1263r882b1324],
3	variants	NNS	O	variant	dep	1	SENT_415	[p26l894t1263r1101b1311],
4	and	CC	O	and	_	0	SENT_415	[p26l1115t1261r1212b1311],
5	cerebrospinal	JJ	O	cerebrospinal	amod	7	SENT_415	[p26l1228t1261r1584b1323],
6	ﬂuid	NN	O	ﬂuid	nn	7	SENT_415	[p26l1599t1260r1714b1311],
7	biomarkers	NNS	O	biomarker	conj_and	3	SENT_415	[p26l1733t1261r2026b1311],
8	of	IN	O	of	_	0	SENT_415	[p26l2041t1260r2095b1311],
9	Alzheimer	NN	O	alzheimer	poss	11	SENT_415	[p26l131t1339r432b1389],
10	's	POS	O	's	_	0	SENT_415	[p26l131t1339r432b1389],
11	disease	NN	O	disease	prep_of	1	SENT_415	[p26l447t1339r652b1389],
12	.	.	O	.	_	0	SENT_415	[p26l447t1339r652b1389],

1	Eur	NNP	O	Eur	_	0	SENT_416	[p26l666t1341r754b1389],
2	.	.	O	.	_	0	SENT_416	[p26l666t1341r754b1389],

1	Arch	NNP	O	Arch	_	0	SENT_417	[p26l766t1339r894b1389],
2	.	.	O	.	_	0	SENT_417	[p26l766t1339r894b1389],

1	Psychiatry	NNP	O	Psychiatry	nn	2	SENT_418	[p26l910t1339r1171b1403],
2	Clin	NNP	O	Clin	_	0	SENT_418	[p26l1181t1339r1286b1389],
3	.	.	O	.	_	0	SENT_418	[p26l1181t1339r1286b1389],

1	Neurosci	NNP	PERSON	Neurosci	_	0	SENT_419	[p26l1301t1341r1532b1389],
2	.	.	O	.	_	0	SENT_419	[p26l1301t1341r1532b1389],

1	262	CD	NUMBER	262	_	0	SENT_420	[p26l1546t1342r1662b1396],
2	,	,	O	,	_	0	SENT_420	[p26l1546t1342r1662b1396],
3	529-534	CD	NUMBER	529-534	number	4	SENT_420	[p26l1677t1342r1902b1389],
4	(	CD	NUMBER	(	appos	1	SENT_420	[p26l1917t1340r2092b1396],
5	2012	CD	DATE	2012	num	6	SENT_420	[p26l1917t1340r2092b1396],
6	)	NN	O	)	dep	4	SENT_420	[p26l1917t1340r2092b1396],
7	.	.	O	.	_	0	SENT_420	[p26l1917t1340r2092b1396],

1	Morgan	NNP	PERSON	Morgan	nn	4	SENT_421	[p26l131t1419r349b1480],
2	,	,	O	,	_	0	SENT_421	[p26l131t1419r349b1480],
3	K.	NNP	O	K.	appos	4	SENT_421	[p26l365t1417r515b1467],
4	The	NNP	O	The	_	0	SENT_421	[p26l365t1417r515b1467],
5	three	CD	NUMBER	three	num	7	SENT_421	[p26l528t1417r666b1467],
6	new	JJ	O	new	amod	7	SENT_421	[p26l683t1432r793b1467],
7	pathways	NNS	O	pathway	dep	4	SENT_421	[p26l808t1417r1056b1481],
8	leading	VBG	O	lead	partmod	4	SENT_421	[p26l1073t1417r1265b1480],
9	to	TO	O	to	_	0	SENT_421	[p26l1280t1424r1333b1467],
10	Alzheimer	NNP	O	Alzheimer	poss	12	SENT_421	[p26l1347t1417r1649b1467],
11	's	POS	O	's	_	0	SENT_421	[p26l1347t1417r1649b1467],
12	disease	NN	O	disease	prep_to	8	SENT_421	[p26l1664t1417r1868b1467],
13	.	.	O	.	_	0	SENT_421	[p26l1664t1417r1868b1467],

1	Neuropathol	NNP	PERSON	Neuropathol	_	0	SENT_422	[p26l131t1495r463b1558],
2	.	.	O	.	_	0	SENT_422	[p26l131t1495r463b1558],

1	Appl	NN	O	appl	_	0	SENT_423	[p26l474t1495r602b1558],
2	.	.	O	.	_	0	SENT_423	[p26l474t1495r602b1558],

1	Neurobiol	NNP	O	Neurobiol	_	0	SENT_424	[p26l617t1495r879b1545],
2	.	.	O	.	_	0	SENT_424	[p26l617t1495r879b1545],

1	37	CD	NUMBER	37	_	0	SENT_425	[p26l893t1498r973b1553],
2	,	,	O	,	_	0	SENT_425	[p26l893t1498r973b1553],
3	353-357	CD	NUMBER	353-357	num	4	SENT_425	[p26l988t1498r1212b1545],
4	(	NN	O	(	appos	1	SENT_425	[p26l1228t1496r1329b1553],
5	201	CD	NUMBER	201	number	6	SENT_425	[p26l1228t1496r1329b1553],
6	1	CD	NUMBER	1	num	7	SENT_425	[p26l1347t1496r1403b1553],
7	)	NN	O	)	dep	4	SENT_425	[p26l1347t1496r1403b1553],
8	.	.	O	.	_	0	SENT_425	[p26l1347t1496r1403b1553],

1	Roses	NNPS	O	Roses	_	0	SENT_426	[p26l132t1575r290b1631],
2	,	,	O	,	_	0	SENT_426	[p26l132t1575r290b1631],
3	A.D.	NNP	O	A.D.	appos	1	SENT_426	[p26l305t1575r407b1623],
4	.	.	O	.	_	0	SENT_426	[p26l305t1575r407b1623],

1	An	DT	O	a	det	5	SENT_427	[p26l421t1576r490b1622],
2	inherited	VBN	O	inherit	amod	5	SENT_427	[p26l508t1573r743b1623],
3	variable	JJ	O	variable	amod	5	SENT_427	[p26l758t1573r967b1623],
4	po	NN	O	po	nn	5	SENT_427	[p26l983t1573r1144b1637],
5	|	NN	O	|	_	0	SENT_427	[p26l983t1573r1144b1637],
6	y	NN	O	y	dep	5	SENT_427	[p26l983t1573r1144b1637],
7	.	.	O	.	_	0	SENT_427	[p26l983t1573r1144b1637],

1	—	NN	O	—	_	0	SENT_428	[p26l983t1573r1144b1637],
2	.	.	O	.	_	0	SENT_428	[p26l983t1573r1144b1637],

1	T	NN	O	t	nn	3	SENT_429	[p26l983t1573r1144b1637],
2	repeat	NN	O	repeat	nn	3	SENT_429	[p26l1158t1581r1325b1636],
3	genotype	NN	O	genotype	_	0	SENT_429	[p26l1339t1581r1593b1637],
4	in	IN	O	in	_	0	SENT_429	[p26l1609t1576r1652b1622],
5	TOMM40	NN	O	tomm40	prep_in	3	SENT_429	[p26l1664t1575r1905b1623],
6	in	IN	O	in	_	0	SENT_429	[p26l1921t1576r1964b1622],
7	Alzheimer	NN	O	alzheimer	nn	8	SENT_429	[p26l131t1650r399b1699],
8	disease	NN	O	disease	prep_in	3	SENT_429	[p26l412t1650r616b1699],
9	.	.	O	.	_	0	SENT_429	[p26l412t1650r616b1699],

1	Arch	NNP	O	Arch	_	0	SENT_430	[p26l627t1650r755b1699],
2	.	.	O	.	_	0	SENT_430	[p26l627t1650r755b1699],

1	Neurol	NNP	O	Neurol	_	0	SENT_431	[p26l771t1650r951b1699],
2	.	.	O	.	_	0	SENT_431	[p26l771t1650r951b1699],

1	67	CD	NUMBER	67	_	0	SENT_432	[p26l964t1654r1045b1707],
2	,	,	O	,	_	0	SENT_432	[p26l964t1654r1045b1707],
3	536-541	CD	NUMBER	536-541	number	4	SENT_432	[p26l1060t1653r1274b1699],
4	(	CD	NUMBER	(	appos	1	SENT_432	[p26l1300t1651r1475b1707],
5	2010	CD	DATE	2010	num	6	SENT_432	[p26l1300t1651r1475b1707],
6	)	NN	O	)	dep	4	SENT_432	[p26l1300t1651r1475b1707],
7	.	.	O	.	_	0	SENT_432	[p26l1300t1651r1475b1707],

1	Tanzi	NNP	PERSON	Tanzi	_	0	SENT_433	[p26l127t1731r275b1786],
2	,	,	O	,	_	0	SENT_433	[p26l127t1731r275b1786],
3	R.E.	NNP	PERSON	R.E.	appos	1	SENT_433	[p26l292t1730r377b1778],
4	.	.	O	.	_	0	SENT_433	[p26l292t1730r377b1778],

1	The	DT	O	the	det	2	SENT_434	[p26l386t1728r484b1778],
2	genetics	NNS	O	genetics	_	0	SENT_434	[p26l499t1731r719b1791],
3	of	IN	O	of	_	0	SENT_434	[p26l734t1728r789b1778],
4	Alzheimer	NN	O	alzheimer	nn	5	SENT_434	[p26l798t1728r1066b1778],
5	disease	NN	O	disease	prep_of	2	SENT_434	[p26l1079t1728r1283b1778],
6	.	.	O	.	_	0	SENT_434	[p26l1079t1728r1283b1778],

1	Cold	NNP	O	Cold	nn	3	SENT_435	[p26l1298t1728r1413b1778],
2	Spring	NNP	DATE	Spring	nn	3	SENT_435	[p26l1422t1730r1585b1791],
3	Harb	NNP	PERSON	Harb	_	0	SENT_435	[p26l1597t1728r1731b1778],
4	.	.	O	.	_	0	SENT_435	[p26l1597t1728r1731b1778],

1	Perspect	NNP	O	Perspect	_	0	SENT_436	[p26l1746t1730r1967b1791],
2	.	.	O	.	_	0	SENT_436	[p26l1746t1730r1967b1791],

1	Med	NNP	O	Med	_	0	SENT_437	[p26l1981t1728r2104b1778],
2	.	.	O	.	_	0	SENT_437	[p26l1981t1728r2104b1778],

1	2	CD	NUMBER	2	_	0	SENT_438	[p26l132t1808r176b1862],
2	,	,	O	,	_	0	SENT_438	[p26l132t1808r176b1862],
3	1-10	CD	NUMBER	1-10	number	4	SENT_438	[p26l195t1808r317b1854],
4	(	CD	NUMBER	(	appos	1	SENT_438	[p26l333t1806r508b1862],
5	2012	CD	DATE	2012	num	6	SENT_438	[p26l333t1806r508b1862],
6	)	NN	O	)	dep	4	SENT_438	[p26l333t1806r508b1862],
7	.	.	O	.	_	0	SENT_438	[p26l333t1806r508b1862],

1	Reiman	NNP	PERSON	Reiman	_	0	SENT_439	[p26l132t1885r340b1941],
2	,	,	O	,	_	0	SENT_439	[p26l132t1885r340b1941],
3	E.M.	NNP	O	E.M.	nn	4	SENT_439	[p26l357t1886r460b1933],
4	etal	NNP	O	etal	appos	1	SENT_439	[p26l474t1883r589b1933],
5	.	.	O	.	_	0	SENT_439	[p26l474t1883r589b1933],

1	Alzheimer	NN	O	alzheimer	poss	4	SENT_440	[p26l603t1883r905b1933],
2	's	POS	O	's	_	0	SENT_440	[p26l603t1883r905b1933],
3	Prevention	NNP	O	Prevention	nn	4	SENT_440	[p26l922t1885r1202b1933],
4	Initiative	NNP	O	Initiative	_	0	SENT_440	[p26l1221t1886r1458b1933],
5	:	:	O	:	_	0	SENT_440	[p26l1221t1886r1458b1933],
6	a	DT	O	a	det	7	SENT_440	[p26l1472t1898r1498b1933],
7	plan	NN	O	plan	dep	4	SENT_440	[p26l1516t1883r1626b1946],
8	to	TO	O	to	aux	9	SENT_440	[p26l1641t1891r1694b1933],
9	accelerate	VB	O	accelerate	infmod	7	SENT_440	[p26l1709t1883r1974b1933],
10	the	DT	O	the	det	11	SENT_440	[p26l1988t1883r2074b1933],
11	evaluation	NN	O	evaluation	dobj	9	SENT_440	[p26l131t1961r405b2011],
12	of	IN	O	of	_	0	SENT_440	[p26l422t1961r477b2011],
13	presym	NN	O	presym	nn	15	SENT_440	[p26l488t1976r678b2025],
14	ptomatic	NN	O	ptomatic	nn	15	SENT_440	[p26l686t1964r921b2024],
15	treatments	NNS	O	treatment	prep_of	11	SENT_440	[p26l934t1969r1235b2011],
16	.	.	O	.	_	0	SENT_440	[p26l934t1969r1235b2011],

1	J.	NNP	O	J.	nn	3	SENT_441	[p26l1245t1964r1280b2011],
2	Alzheimers	NNP	O	Alzheimers	nn	3	SENT_441	[p26l1291t1961r1571b2011],
3	Dis	NNP	O	Dis	_	0	SENT_441	[p26l1583t1963r1673b2011],
4	.	.	O	.	_	0	SENT_441	[p26l1583t1963r1673b2011],

1	26	CD	NUMBER	26	num	2	SENT_442	[p26l1687t1965r1755b2011],
2	(	CD	NUMBER	(	_	0	SENT_442	[p26l1770t1961r1943b2024],
3	suppl	NN	O	suppl	dep	2	SENT_442	[p26l1770t1961r1943b2024],
4	.	.	O	.	_	0	SENT_442	[p26l1770t1961r1943b2024],

1	3	CD	NUMBER	3	num	2	SENT_443	[p26l1958t1962r2018b2019],
2	)	NN	O	)	_	0	SENT_443	[p26l1958t1962r2018b2019],
3	,	,	O	,	_	0	SENT_443	[p26l1958t1962r2018b2019],
4	321-329	CD	NUMBER	321-329	num	5	SENT_443	[p26l132t2041r356b2087],
5	(	NN	O	(	appos	2	SENT_443	[p26l372t2039r473b2095],
6	201	CD	NUMBER	201	number	7	SENT_443	[p26l372t2039r473b2095],
7	1	CD	NUMBER	1	num	8	SENT_443	[p26l491t2039r547b2095],
8	)	NN	O	)	dep	5	SENT_443	[p26l491t2039r547b2095],
9	.	.	O	.	_	0	SENT_443	[p26l491t2039r547b2095],

1	Bateman	NNP	PERSON	Bateman	_	0	SENT_444	[p26l132t2117r376b2172],
2	,	,	O	,	_	0	SENT_444	[p26l132t2117r376b2172],
3	R.J.	NNP	PERSON	R.J.	nn	4	SENT_444	[p26l393t2117r470b2164],
4	etal	NNP	O	etal	appos	1	SENT_444	[p26l484t2115r600b2164],
5	.	.	O	.	_	0	SENT_444	[p26l484t2115r600b2164],

1	Autosoma	NN	O	autosoma	_	0	SENT_445	[p26l614t2115r1182b2164],
2	|	NN	O	|	dep	1	SENT_445	[p26l614t2115r1182b2164],
3	.	.	O	.	_	0	SENT_445	[p26l614t2115r1182b2164],

1	—	NN	O	—	_	0	SENT_446	[p26l614t2115r1182b2164],
2	.	.	O	.	_	0	SENT_446	[p26l614t2115r1182b2164],

1	dominant	JJ	O	dominant	amod	2	SENT_447	[p26l614t2115r1182b2164],
2	Alzheimer	NN	O	alzheimer	poss	4	SENT_447	[p26l1196t2115r1497b2164],
3	's	POS	O	's	_	0	SENT_447	[p26l1196t2115r1497b2164],
4	disease	NN	O	disease	_	0	SENT_447	[p26l1512t2115r1717b2164],
5	:	:	O	:	_	0	SENT_447	[p26l1512t2115r1717b2164],
6	a	DT	O	a	det	7	SENT_447	[p26l1732t2130r1757b2164],
7	review	NN	O	review	dep	4	SENT_447	[p26l1776t2118r1947b2164],
8	and	CC	O	and	_	0	SENT_447	[p26l1961t2115r2057b2164],
9	proposal	NN	O	proposal	dep	4	SENT_447	[p26l133t2193r359b2256],
10	for	IN	O	for	_	0	SENT_447	[p26l374t2193r447b2243],
11	the	DT	O	the	det	12	SENT_447	[p26l459t2193r544b2243],
12	prevention	NN	O	prevention	prep_for	7	SENT_447	[p26l561t2196r845b2256],
13	of	IN	O	of	_	0	SENT_447	[p26l862t2193r917b2243],
14	Alzheimer	NN	O	alzheimer	poss	16	SENT_447	[p26l926t2193r1227b2243],
15	's	POS	O	's	_	0	SENT_447	[p26l926t2193r1227b2243],
16	disease	NN	O	disease	prep_of	12	SENT_447	[p26l1242t2193r1737b2243],
17	.	.	O	.	_	0	SENT_447	[p26l1242t2193r1737b2243],

1	Alzheimers	NNS	O	alzheimer	_	0	SENT_448	[p26l1242t2193r1737b2243],
2	Res	NNP	O	Res	dep	1	SENT_448	[p26l1749t2195r1842b2243],
3	.	.	O	.	_	0	SENT_448	[p26l1749t2195r1842b2243],

1	Ther	NNP	O	Ther	_	0	SENT_449	[p26l1859t2193r1980b2243],
2	.	.	O	.	_	0	SENT_449	[p26l1859t2193r1980b2243],

1	3	CD	NUMBER	3	_	0	SENT_450	[p26l1994t2197r2039b2251],
2	,	,	O	,	_	0	SENT_450	[p26l1994t2197r2039b2251],
3	1	CD	NUMBER	1	num	4	SENT_450	[p26l2058t2197r2072b2242],
4	(	NN	O	(	appos	1	SENT_450	[p26l133t2271r234b2327],
5	201	CD	NUMBER	201	number	6	SENT_450	[p26l133t2271r234b2327],
6	1	CD	NUMBER	1	num	7	SENT_450	[p26l252t2271r307b2327],
7	)	NN	O	)	dep	4	SENT_450	[p26l252t2271r307b2327],
8	.	.	O	.	_	0	SENT_450	[p26l252t2271r307b2327],

1	Hampel	NNP	PERSON	Hampel	nn	3	SENT_451	[p26l132t2348r348b2411],
2	,	,	O	,	_	0	SENT_451	[p26l132t2348r348b2411],
3	H.	NNP	O	H.	_	0	SENT_451	[p26l364t2351r413b2398],
4	et	FW	O	et	nn	5	SENT_451	[p26l427t2356r476b2398],
5	al.	FW	O	al.	dep	3	SENT_451	[p26l485t2348r556b2406],
6	;	:	O	;	_	0	SENT_451	[p26l485t2348r556b2406],
7	Oxford	NNP	ORGANIZATION	Oxford	nn	10	SENT_451	[p26l570t2348r746b2398],
8	Task	NNP	ORGANIZATION	Task	nn	10	SENT_451	[p26l758t2348r872b2398],
9	Force	NNP	ORGANIZATION	Force	nn	10	SENT_451	[p26l887t2351r1025b2398],
10	Group	NNP	ORGANIZATION	Group	dep	3	SENT_451	[p26l1039t2350r1215b2411],
11	.	.	O	.	_	0	SENT_451	[p26l1039t2350r1215b2411],

1	Biomarkers	NNS	O	biomarker	_	0	SENT_452	[p26l1232t2348r1523b2398],
2	for	IN	O	for	_	0	SENT_452	[p26l1536t2348r1609b2398],
3	Alzheimer	NN	O	alzheimer	poss	7	SENT_452	[p26l1622t2348r1923b2398],
4	's	POS	O	's	_	0	SENT_452	[p26l1622t2348r1923b2398],
5	disease	NN	O	disease	nn	7	SENT_452	[p26l1938t2348r2130b2398],
6	therapeutic	JJ	O	therapeutic	amod	7	SENT_452	[p26l130t2426r436b2489],
7	trials	NNS	O	trial	prep_for	1	SENT_452	[p26l448t2426r586b2476],
8	.	.	O	.	_	0	SENT_452	[p26l448t2426r586b2476],

1	Prog	NN	O	prog	_	0	SENT_453	[p26l600t2428r725b2489],
2	.	.	O	.	_	0	SENT_453	[p26l600t2428r725b2489],

1	Neurobiol	NNP	O	Neurobiol	_	0	SENT_454	[p26l740t2426r1002b2476],
2	.	.	O	.	_	0	SENT_454	[p26l740t2426r1002b2476],

1	95	CD	NUMBER	95	_	0	SENT_455	[p26l1015t2429r1096b2484],
2	,	,	O	,	_	0	SENT_455	[p26l1015t2429r1096b2484],
3	579-593	CD	NUMBER	579-593	num	4	SENT_455	[p26l1111t2429r1333b2476],
4	(	NN	O	(	appos	1	SENT_455	[p26l1351t2427r1452b2484],
5	201	CD	NUMBER	201	number	6	SENT_455	[p26l1351t2427r1452b2484],
6	1	CD	NUMBER	1	num	7	SENT_455	[p26l1471t2427r1526b2484],
7	)	NN	O	)	dep	4	SENT_455	[p26l1471t2427r1526b2484],
8	.	.	O	.	_	0	SENT_455	[p26l1471t2427r1526b2484],

1	Wu	NNP	O	Wu	_	0	SENT_456	[p26l128t2506r227b2560],
2	,	,	O	,	_	0	SENT_456	[p26l128t2506r227b2560],
3	L.	NNP	O	L.	nn	5	SENT_456	[p26l243t2506r293b2560],
4	,	,	O	,	_	0	SENT_456	[p26l243t2506r293b2560],
5	Rosa	NNP	PERSON	Rosa	appos	1	SENT_456	[p26l310t2505r590b2560],
6	.	.	O	.	_	0	SENT_456	[p26l310t2505r590b2560],

1	—	NN	O	—	_	0	SENT_457	[p26l310t2505r590b2560],
2	.	.	O	.	_	0	SENT_457	[p26l310t2505r590b2560],

1	Neto	NNP	PERSON	Neto	_	0	SENT_458	[p26l310t2505r590b2560],
2	,	,	O	,	_	0	SENT_458	[p26l310t2505r590b2560],
3	P.	NNP	O	P.	conj_and	1	SENT_458	[p26l608t2505r639b2552],
4	&	CC	O	&	_	0	SENT_458	[p26l653t2505r690b2552],
5	Gauthier	NNP	PERSON	Gauthier	conj_and	1	SENT_458	[p26l703t2503r941b2560],
6	,	,	O	,	_	0	SENT_458	[p26l703t2503r941b2560],
7	5	CD	NUMBER	5	appos	1	SENT_458	[p26l956t2505r996b2552],
8	.	.	O	.	_	0	SENT_458	[p26l956t2505r996b2552],

1	Use	NN	O	use	_	0	SENT_459	[p26l1013t2506r1105b2552],
2	of	IN	O	of	_	0	SENT_459	[p26l1119t2503r1174b2552],
3	biomarkers	NNS	O	biomarker	prep_of	1	SENT_459	[p26l1186t2503r1479b2552],
4	in	IN	O	in	_	0	SENT_459	[p26l1496t2506r1538b2552],
5	clinical	JJ	O	clinical	amod	6	SENT_459	[p26l1555t2503r1731b2552],
6	trials	NNS	O	trial	prep_in	3	SENT_459	[p26l1747t2503r1872b2552],
7	of	IN	O	of	_	0	SENT_459	[p26l1886t2503r1941b2552],
8	Alzheimer	NN	O	alzheimer	nn	9	SENT_459	[p26l131t2581r398b2631],
9	disease	NN	O	disease	prep_of	6	SENT_459	[p26l411t2581r616b2631],
10	:	:	O	:	_	0	SENT_459	[p26l411t2581r616b2631],
11	from	IN	O	from	_	0	SENT_459	[p26l630t2581r752b2631],
12	concept	NN	O	concept	prep_from	13	SENT_459	[p26l769t2589r982b2644],
13	to	TO	O	to	dep	1	SENT_459	[p26l995t2589r1048b2631],
14	application	NN	O	application	pobj	13	SENT_459	[p26l1062t2581r1370b2644],
15	.	.	O	.	_	0	SENT_459	[p26l1062t2581r1370b2644],

1	Mol	NNP	O	Mol	_	0	SENT_460	[p26l1384t2581r1489b2631],
2	.	.	O	.	_	0	SENT_460	[p26l1384t2581r1489b2631],

1	Diagn	NN	O	diagn	_	0	SENT_461	[p26l1504t2583r1668b2644],
2	.	.	O	.	_	0	SENT_461	[p26l1504t2583r1668b2644],

1	Ther	NNP	O	Ther	_	0	SENT_462	[p26l1686t2581r1806b2631],
2	.	.	O	.	_	0	SENT_462	[p26l1686t2581r1806b2631],

1	15	CD	NUMBER	15	_	0	SENT_463	[p26l1824t2585r1900b2639],
2	,	,	O	,	_	0	SENT_463	[p26l1824t2585r1900b2639],
3	313-325	CD	NUMBER	313-325	num	4	SENT_463	[p26l1916t2584r2138b2631],
4	(	NN	O	(	appos	1	SENT_463	[p26l133t2659r234b2715],
5	201	CD	NUMBER	201	number	6	SENT_463	[p26l133t2659r234b2715],
6	1	CD	NUMBER	1	num	7	SENT_463	[p26l252t2659r307b2715],
7	)	NN	O	)	dep	4	SENT_463	[p26l252t2659r307b2715],
8	.	.	O	.	_	0	SENT_463	[p26l252t2659r307b2715],

1	Albert	NNP	PERSON	Albert	_	0	SENT_464	[p26l129t2736r304b2794],
2	,	,	O	,	_	0	SENT_464	[p26l129t2736r304b2794],
3	M.S.	NNP	LOCATION	M.S.	nn	4	SENT_464	[p26l320t2738r424b2786],
4	etal	NNP	O	etal	appos	1	SENT_464	[p26l438t2736r553b2786],
5	.	.	O	.	_	0	SENT_464	[p26l438t2736r553b2786],

1	The	DT	O	the	det	2	SENT_465	[p26l563t2736r660b2786],
2	diagnosis	NN	O	diagnosis	_	0	SENT_465	[p26l674t2736r923b2799],
3	of	IN	O	of	_	0	SENT_465	[p26l938t2736r992b2786],
4	mild	JJ	O	mild	amod	6	SENT_465	[p26l1004t2736r1115b2786],
5	cognitive	JJ	O	cognitive	amod	6	SENT_465	[p26l1132t2739r1375b2799],
6	impairment	NN	O	impairment	prep_of	2	SENT_465	[p26l1391t2739r1699b2799],
7	due	JJ	O	due	_	0	SENT_465	[p26l1713t2736r1813b2786],
8	to	TO	O	to	_	0	SENT_465	[p26l1826t2744r1879b2786],
9	Alzheimer	NNP	O	Alzheimer	poss	11	SENT_465	[p26l130t2814r432b2864],
10	's	POS	O	's	_	0	SENT_465	[p26l130t2814r432b2864],
11	disease	NN	O	disease	prep_due_to	6	SENT_465	[p26l447t2814r652b2864],
12	:	:	O	:	_	0	SENT_465	[p26l447t2814r652b2864],
13	recommendations	NNS	O	recommendation	dep	2	SENT_465	[p26l669t2814r1151b2864],
14	from	IN	O	from	_	0	SENT_465	[p26l1164t2814r1287b2864],
15	the	DT	O	the	det	17	SENT_465	[p26l1302t2814r1388b2864],
16	National	NNP	ORGANIZATION	National	nn	17	SENT_465	[p26l1405t2814r1621b2864],
17	Institute	NNP	ORGANIZATION	Institute	prep_from	13	SENT_465	[p26l1640t2817r1855b2864],
18	on	IN	ORGANIZATION	on	_	0	SENT_465	[p26l1870t2829r1934b2864],
19	AgingAlzheimer	NNP	ORGANIZATION	AgingAlzheimer	poss	22	SENT_465	[p26l1950t2817r2126b2877, p26l130t2892r432b2942],
20	’s	POS	ORGANIZATION	’s	_	0	SENT_465	[p26l1950t2817r2126b2877, p26l130t2892r432b2942],
21	Association	NNP	ORGANIZATION	Association	nn	22	SENT_465	[p26l447t2895r746b2942],
22	workgroups	NNS	O	workgroup	prep_on	17	SENT_465	[p26l761t2892r1078b2955],
23	on	IN	O	on	_	0	SENT_465	[p26l1093t2907r1157b2942],
24	diagnostic	JJ	O	diagnostic	amod	25	SENT_465	[p26l1174t2892r1448b2955],
25	guidelines	NNS	O	guideline	prep_on	13	SENT_465	[p26l1462t2892r1734b2955],
26	for	IN	O	for	_	0	SENT_465	[p26l1747t2892r1820b2942],
27	Alzheimer	NN	O	alzheimer	poss	29	SENT_465	[p26l1832t2892r2134b2942],
28	's	POS	O	's	_	0	SENT_465	[p26l1832t2892r2134b2942],
29	disease	NN	O	disease	prep_for	25	SENT_465	[p26l131t2969r335b3018],
30	.	.	O	.	_	0	SENT_465	[p26l131t2969r335b3018],

1	Alzheimers	NNPS	O	Alzheimers	_	0	SENT_466	[p26l346t2969r626b3018],
2	Dement	NNP	O	Dement	dep	1	SENT_466	[p26l638t2971r853b3018],
3	.	.	O	.	_	0	SENT_466	[p26l638t2971r853b3018],

1	7	CD	NUMBER	7	_	0	SENT_467	[p26l869t2973r912b3026],
2	,	,	O	,	_	0	SENT_467	[p26l869t2973r912b3026],
3	270-279	CD	NUMBER	270-279	num	4	SENT_467	[p26l927t2972r1152b3018],
4	(	NN	O	(	appos	1	SENT_467	[p26l1168t2970r1268b3026],
5	201	CD	NUMBER	201	number	6	SENT_467	[p26l1168t2970r1268b3026],
6	1	CD	NUMBER	1	num	7	SENT_467	[p26l1287t2970r1342b3026],
7	)	NN	O	)	dep	4	SENT_467	[p26l1287t2970r1342b3026],
8	.	.	O	.	_	0	SENT_467	[p26l1287t2970r1342b3026],

1	Dubois	NNP	PERSON	Dubois	_	0	SENT_468	[p26l132t3047r328b3105],
2	,	,	O	,	_	0	SENT_468	[p26l132t3047r328b3105],
3	B.	NNP	O	B.	nn	4	SENT_468	[p26l344t3049r385b3097],
4	etal	NNP	O	etal	appos	1	SENT_468	[p26l399t3047r514b3097],
5	.	.	O	.	_	0	SENT_468	[p26l399t3047r514b3097],

1	Research	NNP	O	Research	nn	2	SENT_469	[p26l531t3047r762b3097],
2	criteria	NNS	O	criterion	poss	9	SENT_469	[p26l778t3050r956b3097],
3	for	IN	O	for	_	0	SENT_469	[p26l971t3047r1044b3097],
4	the	DT	O	the	det	5	SENT_469	[p26l1056t3047r1142b3097],
5	diagnosis	NN	O	diagnosis	prep_for	2	SENT_469	[p26l1156t3047r1405b3111],
6	of	IN	O	of	_	0	SENT_469	[p26l1419t3047r1474b3097],
7	Alzheimer	NN	O	alzheimer	prep_of	5	SENT_469	[p26l1483t3047r1784b3097],
8	's	POS	O	's	_	0	SENT_469	[p26l1483t3047r1784b3097],
9	disease	NN	O	disease	_	0	SENT_469	[p26l1800t3047r2005b3097],
10	:	:	O	:	_	0	SENT_469	[p26l1800t3047r2005b3097],
11	revising	VBG	O	revise	dep	9	SENT_469	[p26l133t3128r334b3189],
12	the	DT	O	the	det	15	SENT_469	[p26l349t3125r435b3175],
13	N	NN	O	n	nn	15	SENT_469	[p26l452t3127r873b3175],
14	|	CD	NUMBER	|	num	15	SENT_469	[p26l452t3127r873b3175],
15	NCDS	NN	O	ncd	dobj	11	SENT_469	[p26l452t3127r873b3175],
16	.	.	O	.	_	0	SENT_469	[p26l452t3127r873b3175],

1	—	NN	O	—	_	0	SENT_470	[p26l452t3127r873b3175],
2	.	.	O	.	_	0	SENT_470	[p26l452t3127r873b3175],

1	ADRDA	NNP	O	ADRDA	_	0	SENT_471	[p26l452t3127r873b3175],
2	criteria	NNS	O	criterion	dep	1	SENT_471	[p26l888t3128r1080b3175],
3	.	.	O	.	_	0	SENT_471	[p26l888t3128r1080b3175],

1	LancetNeuroI	NN	O	lancetneurous	_	0	SENT_472	[p26l1094t3125r1454b3175],
2	.	.	O	.	_	0	SENT_472	[p26l1094t3125r1454b3175],

1	6	CD	NUMBER	6	_	0	SENT_473	[p26l1468t3129r1513b3183],
2	,	,	O	,	_	0	SENT_473	[p26l1468t3129r1513b3183],
3	734-746	CD	NUMBER	734-746	number	4	SENT_473	[p26l1529t3129r1753b3175],
4	(	CD	NUMBER	(	appos	1	SENT_473	[p26l1769t3126r1943b3183],
5	2007	CD	DATE	2007	num	6	SENT_473	[p26l1769t3126r1943b3183],
6	)	NN	O	)	dep	4	SENT_473	[p26l1769t3126r1943b3183],
7	.	.	O	.	_	0	SENT_473	[p26l1769t3126r1943b3183],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_474	[p26l21t3266r140b3287],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	_	0	SENT_474	[p26l149t3266r374b3287],
3	&	CC	O	&	_	0	SENT_474	[p26l381t3266r601b3287],
4	THERAPEUTlCS	NNP	O	THERAPEUTlCS	nn	6	SENT_474	[p26l381t3266r601b3287],
5	|	NNP	O	|	nn	6	SENT_474	[p26l611t3264r613b3294],
6	VOLUME	NNP	O	VOLUME	conj_and	2	SENT_474	[p26l621t3266r729b3287],
7	95	CD	NUMBER	95	num	8	SENT_474	[p26l737t3266r764b3287],
8	NUMBER	NN	O	number	dep	2	SENT_474	[p26l774t3266r882b3287],
9	1	CD	NUMBER	1	number	10	SENT_474	[p26l892t3267r899b3287],
10	]	CD	NUMBER	]	num	11	SENT_474	[p26l912t3264r915b3294],
11	JANUARY	NNP	DATE	JANUARY	dep	8	SENT_474	[p26l924t3266r1042b3287],
12	2014	CD	DATE	2014	num	13	SENT_474	[p26l1049t3266r1108b3287],
13	75	CD	DATE	75	dep	2	SENT_474	[p26l2109t3267r2139b3287],

1	STATE	NN	O	state	_	0	SENT_475	[p26l21t3409r163b3446],

1	ART	NN	O	art	_	0	SENT_476	[p26l306t3409r399b3446],

1	Dubois	NNP	PERSON	Dubois	_	0	SENT_477	[p26l133t3644r329b3701],
2	,	,	O	,	_	0	SENT_477	[p26l133t3644r329b3701],
3	B.	NNP	O	B.	nn	4	SENT_477	[p26l346t3646r386b3693],
4	etal	NNP	O	etal	appos	1	SENT_477	[p26l400t3644r515b3693],
5	.	.	O	.	_	0	SENT_477	[p26l400t3644r515b3693],

1	Revising	VBG	O	revise	_	0	SENT_478	[p26l532t3646r747b3707],
2	the	DT	O	the	det	3	SENT_478	[p26l762t3644r848b3693],
3	deﬁnition	NN	O	deﬁnition	dobj	1	SENT_478	[p26l862t3643r1114b3693],
4	of	IN	O	of	_	0	SENT_478	[p26l1131t3643r1185b3693],
5	Alzheimer	NN	O	alzheimer	poss	7	SENT_478	[p26l1194t3644r1496b3693],
6	's	POS	O	's	_	0	SENT_478	[p26l1194t3644r1496b3693],
7	disease	NN	O	disease	prep_of	3	SENT_478	[p26l1510t3644r1715b3693],
8	:	:	O	:	_	0	SENT_478	[p26l1510t3644r1715b3693],
9	a	DT	O	a	det	11	SENT_478	[p26l1730t3658r1755b3693],
10	new	JJ	O	new	amod	11	SENT_478	[p26l1773t3658r1883b3693],
11	lexicon	NN	O	lexicon	dep	7	SENT_478	[p26l1898t3644r2095b3693],
12	.	.	O	.	_	0	SENT_478	[p26l1898t3644r2095b3693],

1	Lancet	NNP	PERSON	Lancet	nn	2	SENT_479	[p26l132t3723r303b3770],
2	Neurol	NNP	PERSON	Neurol	_	0	SENT_479	[p26l312t3721r491b3770],
3	.	.	O	.	_	0	SENT_479	[p26l312t3721r491b3770],

1	9	CD	NUMBER	9	_	0	SENT_480	[p26l505t3724r551b3777],
2	,	,	O	,	_	0	SENT_480	[p26l505t3724r551b3777],
3	1	CD	NUMBER	1	number	4	SENT_480	[p26l569t3725r584b3769],
4	1	CD	NUMBER	1	appos	1	SENT_480	[p26l602t3725r616b3769],
5	18-1	CD	NUMBER	18-1	dep	4	SENT_480	[p26l635t3724r747b3770],
6	127	CD	NUMBER	127	number	7	SENT_480	[p26l765t3724r854b3769],
7	(	CD	NUMBER	(	dep	1	SENT_480	[p26l871t3722r1045b3777],
8	2010	CD	DATE	2010	num	9	SENT_480	[p26l871t3722r1045b3777],
9	)	NN	O	)	dep	7	SENT_480	[p26l871t3722r1045b3777],
10	.	.	O	.	_	0	SENT_480	[p26l871t3722r1045b3777],

1	33	CD	NUMBER	33	_	0	SENT_481	[p27l10t21r84b67],
2	.	.	O	.	_	0	SENT_481	[p27l10t21r84b67],

1	Bateman	NNP	PERSON	Bateman	nn	4	SENT_482	[p27l133t20r378b75],
2	,	,	O	,	_	0	SENT_482	[p27l133t20r378b75],
3	R.J.	NNP	PERSON	R.J.	appos	4	SENT_482	[p27l394t20r471b67],
4	etal.	NNP	O	etal.	_	0	SENT_482	[p27l485t18r614b75],
5	;	:	O	;	_	0	SENT_482	[p27l485t18r614b75],
6	Dominantly	RB	O	dominantly	advmod	7	SENT_482	[p27l630t18r939b81],
7	Inherited	VBN	O	inherit	dep	4	SENT_482	[p27l954t18r1189b67],
8	Alzheimer	NN	O	alzheimer	prep	7	SENT_482	[p27l1204t18r1472b67],
9	Network	NNP	O	Network	dep	8	SENT_482	[p27l1487t18r1723b67],
10	.	.	O	.	_	0	SENT_482	[p27l1487t18r1723b67],

1	Clinical	JJ	O	clinical	amod	4	SENT_483	[p27l1738t18r1922b67],
2	and	CC	O	and	_	0	SENT_483	[p27l1939t18r2035b67],
3	biomarker	NN	O	biomarker	conj_and	1	SENT_483	[p27l134t96r404b145],
4	changes	NNS	O	change	nsubj	7	SENT_483	[p27l417t96r636b159],
5	in	IN	O	in	prep	4	SENT_483	[p27l652t98r695b145],
6	dominantly	RB	O	dominantly	pcomp	5	SENT_483	[p27l711t96r1015b159],
7	inherited	VBN	O	inherit	_	0	SENT_483	[p27l1030t96r1264b145],
8	Alzheimer	NN	O	alzheimer	poss	10	SENT_483	[p27l1281t96r1582b145],
9	's	POS	O	's	_	0	SENT_483	[p27l1281t96r1582b145],
10	disease	NN	O	disease	dobj	7	SENT_483	[p27l1597t96r1801b145],
11	.	.	O	.	_	0	SENT_483	[p27l1597t96r1801b145],

1	N.	NNP	MISC	N.	nn	2	SENT_484	[p27l1815t98r1863b145],
2	EngI	NNP	MISC	EngI	_	0	SENT_484	[p27l1877t96r2041b159],
3	.	.	O	.	_	0	SENT_484	[p27l1877t96r2041b159],

1	J.	NNP	O	J.	nn	2	SENT_485	[p27l1877t96r2041b159],
2	Med	NNP	O	Med	_	0	SENT_485	[p27l131t173r254b222],
3	.	.	O	.	_	0	SENT_485	[p27l131t173r254b222],

1	367	CD	NUMBER	367	_	0	SENT_486	[p27l269t176r384b229],
2	,	,	O	,	_	0	SENT_486	[p27l269t176r384b229],
3	795-804	CD	NUMBER	795-804	number	4	SENT_486	[p27l399t176r624b222],
4	(	CD	NUMBER	(	appos	1	SENT_486	[p27l639t174r813b229],
5	2012	CD	DATE	2012	num	6	SENT_486	[p27l639t174r813b229],
6	)	NN	O	)	dep	4	SENT_486	[p27l639t174r813b229],
7	.	.	O	.	_	0	SENT_486	[p27l639t174r813b229],

1	34	CD	NUMBER	34	_	0	SENT_487	[p27l10t254r84b300],
2	.	.	O	.	_	0	SENT_487	[p27l10t254r84b300],

1	Vi	NNP	O	Vi	nsubj	2	SENT_488	[p27l129t251r534b314],
2	|	VBD	O	|	_	0	SENT_488	[p27l129t251r534b314],
3	|	CD	NUMBER	|	num	4	SENT_488	[p27l129t251r534b314],
4	emagne	NN	O	emagne	dobj	2	SENT_488	[p27l129t251r534b314],
5	,	,	O	,	_	0	SENT_488	[p27l129t251r534b314],
6	V.L.	NNP	O	V.L.	nn	7	SENT_488	[p27l129t251r534b314],
7	etal.	NNP	O	etal.	appos	4	SENT_488	[p27l548t251r676b308],
8	;	:	O	;	_	0	SENT_488	[p27l548t251r676b308],
9	Australian	JJ	MISC	australian	amod	11	SENT_488	[p27l690t251r951b300],
10	Imaging	NNP	O	Imaging	nn	11	SENT_488	[p27l970t253r1183b314],
11	Biomarkers	NNS	O	biomarker	dep	4	SENT_488	[p27l1202t251r1493b300],
12	and	CC	O	and	_	0	SENT_488	[p27l1507t251r1603b300],
13	Lifestyle	NN	O	lifestyle	nn	16	SENT_488	[p27l1623t250r1834b314],
14	(	CD	NUMBER	(	num	16	SENT_488	[p27l1850t252r1997b308],
15	AIBL	NN	O	aibl	nn	16	SENT_488	[p27l1850t252r1997b308],
16	)	NN	O	)	dep	4	SENT_488	[p27l1850t252r1997b308],

1	Research	NNP	O	Research	nn	2	SENT_489	[p27l135t329r365b378],
2	Group	NNP	O	Group	_	0	SENT_489	[p27l381t331r557b391],
3	.	.	O	.	_	0	SENT_489	[p27l381t331r557b391],

1	Amyloid	NN	O	amyloid	nn	3	SENT_490	[p27l571t329r788b392],
2	B	NN	O	b	nn	3	SENT_490	[p27l807t328r836b391],
3	deposition	NN	O	deposition	_	0	SENT_490	[p27l851t329r1145b391],
4	,	,	O	,	_	0	SENT_490	[p27l851t329r1145b391],
5	neurodegeneration	NN	O	neurodegeneration	appos	3	SENT_490	[p27l1162t329r1687b392],
6	,	,	O	,	_	0	SENT_490	[p27l1162t329r1687b392],
7	and	CC	O	and	_	0	SENT_490	[p27l1701t329r1798b378],
8	cognitive	JJ	O	cognitive	amod	9	SENT_490	[p27l1814t331r2057b392],
9	decline	NN	O	decline	conj_and	3	SENT_490	[p27l132t407r322b456],
10	in	IN	O	in	_	0	SENT_490	[p27l338t409r381b456],
11	sporadic	JJ	O	sporadic	amod	12	SENT_490	[p27l398t407r621b469],
12	Alzheimer	NN	O	alzheimer	poss	14	SENT_490	[p27l635t407r936b456],
13	's	POS	O	's	_	0	SENT_490	[p27l635t407r936b456],
14	disease	NN	O	disease	prep_in	9	SENT_490	[p27l951t407r1156b456],
15	:	:	O	:	_	0	SENT_490	[p27l951t407r1156b456],
16	a	DT	O	a	det	19	SENT_490	[p27l1170t421r1195b456],
17	prospective	JJ	O	prospective	amod	19	SENT_490	[p27l1213t409r1520b469],
18	cohort	NN	O	cohort	nn	19	SENT_490	[p27l1534t407r1708b456],
19	study	NN	O	study	dep	3	SENT_490	[p27l1722t407r1876b470],
20	.	.	O	.	_	0	SENT_490	[p27l1722t407r1876b470],

1	Lancet	NNP	PERSON	Lancet	nn	2	SENT_491	[p27l1890t409r2060b456],
2	Neurol	NNP	PERSON	Neurol	_	0	SENT_491	[p27l132t484r312b533],
3	.	.	O	.	_	0	SENT_491	[p27l132t484r312b533],

1	12	CD	NUMBER	12	_	0	SENT_492	[p27l330t487r406b540],
2	,	,	O	,	_	0	SENT_492	[p27l330t487r406b540],
3	357-367	CD	NUMBER	357-367	number	4	SENT_492	[p27l421t487r645b533],
4	(	CD	NUMBER	(	appos	1	SENT_492	[p27l662t485r836b540],
5	2013	CD	DATE	2013	num	6	SENT_492	[p27l662t485r836b540],
6	)	NN	O	)	dep	4	SENT_492	[p27l662t485r836b540],
7	.	.	O	.	_	0	SENT_492	[p27l662t485r836b540],

1	35	CD	NUMBER	35	_	0	SENT_493	[p27l10t565r84b611],
2	.	.	O	.	_	0	SENT_493	[p27l10t565r84b611],

1	Sabbagh	NNP	PERSON	Sabbagh	_	0	SENT_494	[p27l131t562r377b625],
2	,	,	O	,	_	0	SENT_494	[p27l131t562r377b625],
3	J.J.	NNP	PERSON	J.J.	conj_and	1	SENT_494	[p27l390t564r472b619],
4	,	,	O	,	_	0	SENT_494	[p27l390t564r472b619],
5	Kinney	NNP	PERSON	Kinney	conj_and	1	SENT_494	[p27l489t564r676b625],
6	,	,	O	,	_	0	SENT_494	[p27l489t564r676b625],
7	J.W.	NNP	ORGANIZATION	J.W.	conj_and	1	SENT_494	[p27l688t564r786b611],
8	&	CC	ORGANIZATION	&	_	0	SENT_494	[p27l801t563r837b611],
9	Cummings	NNP	ORGANIZATION	Cummings	conj_and	1	SENT_494	[p27l850t563r1148b625],
10	,	,	O	,	_	0	SENT_494	[p27l850t563r1148b625],
11	J.L.	NNP	O	J.L.	nn	13	SENT_494	[p27l1160t564r1237b611],
12	Animal	NNP	O	Animal	nn	13	SENT_494	[p27l1251t562r1433b611],
13	systems	NNS	O	system	appos	1	SENT_494	[p27l1451t569r1658b625],
14	in	IN	O	in	_	0	SENT_494	[p27l1674t564r1716b611],
15	the	DT	O	the	det	16	SENT_494	[p27l1732t562r1818b611],
16	development	NN	O	development	prep_in	13	SENT_494	[p27l132t640r487b702],
17	of	IN	O	of	_	0	SENT_494	[p27l501t639r556b689],
18	treatments	NNS	O	treatment	prep_of	16	SENT_494	[p27l564t647r852b689],
19	for	IN	O	for	_	0	SENT_494	[p27l865t639r938b689],
20	Alzheimer	NN	O	alzheimer	poss	22	SENT_494	[p27l950t640r1252b689],
21	's	POS	O	's	_	0	SENT_494	[p27l950t640r1252b689],
22	disease	NN	O	disease	prep_for	18	SENT_494	[p27l1266t640r1471b689],
23	:	:	O	:	_	0	SENT_494	[p27l1266t640r1471b689],
24	challenges	NNS	O	challenge	dep	1	SENT_494	[p27l1486t640r1779b703],
25	,	,	O	,	_	0	SENT_494	[p27l1486t640r1779b703],
26	methods	NNS	O	method	conj_and	24	SENT_494	[p27l1795t640r2040b697],
27	,	,	O	,	_	0	SENT_494	[p27l1795t640r2040b697],
28	and	CC	O	and	_	0	SENT_494	[p27l2054t640r2151b689],
29	implications	NNS	O	implication	conj_and	24	SENT_494	[p27l134t718r465b780],
30	.	.	O	.	_	0	SENT_494	[p27l134t718r465b780],

1	Neurobiol	NNP	O	Neurobiol	_	0	SENT_495	[p27l480t718r738b767],
2	.	.	O	.	_	0	SENT_495	[p27l480t718r738b767],

1	Aging	NN	O	aging	_	0	SENT_496	[p27l749t720r900b781],
2	34	CD	NUMBER	34	num	1	SENT_496	[p27l914t721r995b775],
3	,	,	O	,	_	0	SENT_496	[p27l914t721r995b775],
4	169-183	CD	NUMBER	169-183	number	5	SENT_496	[p27l1014t721r1232b767],
5	(	CD	NUMBER	(	appos	1	SENT_496	[p27l1249t719r1424b775],
6	2013	CD	DATE	2013	num	7	SENT_496	[p27l1249t719r1424b775],
7	)	NN	O	)	dep	5	SENT_496	[p27l1249t719r1424b775],
8	.	.	O	.	_	0	SENT_496	[p27l1249t719r1424b775],

1	36	CD	NUMBER	36	_	0	SENT_497	[p27l10t799r84b846],
2	.	.	O	.	_	0	SENT_497	[p27l10t799r84b846],

1	Bales	NNS	O	bale	nsubj	12	SENT_498	[p27l133t796r277b853],
2	,	,	O	,	_	0	SENT_498	[p27l133t796r277b853],
3	K.R.	NNP	O	K.R.	nn	5	SENT_498	[p27l294t796r490b846],
4	The	NNP	O	The	nn	5	SENT_498	[p27l294t796r490b846],
5	value	NN	O	value	conj_and	1	SENT_498	[p27l503t796r644b846],
6	and	CC	O	and	_	0	SENT_498	[p27l658t796r755b846],
7	limitations	NNS	O	limitation	conj_and	1	SENT_498	[p27l773t796r1048b846],
8	of	IN	O	of	_	0	SENT_498	[p27l1063t795r1117b846],
9	transgenic	JJ	O	transgenic	amod	11	SENT_498	[p27l1125t798r1402b859],
10	mouse	NN	O	mouse	nn	11	SENT_498	[p27l1418t811r1593b846],
11	models	NNS	O	model	prep_of	7	SENT_498	[p27l1610t796r1800b846],
12	used	VBN	O	use	_	0	SENT_498	[p27l1817t796r1937b846],
13	in	IN	O	in	_	0	SENT_498	[p27l1956t798r1998b845],
14	drug	NN	O	drug	nn	15	SENT_498	[p27l132t874r254b937],
15	discovery	NN	O	discovery	prep_in	12	SENT_498	[p27l271t874r522b938],
16	for	IN	O	for	_	0	SENT_498	[p27l533t873r605b923],
17	Alzheimer	NN	O	alzheimer	poss	19	SENT_498	[p27l618t874r919b924],
18	's	POS	O	's	_	0	SENT_498	[p27l618t874r919b924],
19	disease	NN	O	disease	prep_for	15	SENT_498	[p27l934t874r1139b923],
20	:	:	O	:	_	0	SENT_498	[p27l934t874r1139b923],
21	an	DT	O	a	nsubj	22	SENT_498	[p27l1153t889r1213b923],
22	update	VBP	O	update	parataxis	12	SENT_498	[p27l1232t874r1429b936],
23	.	.	O	.	_	0	SENT_498	[p27l1232t874r1429b936],

1	Expert	NN	O	expert	_	0	SENT_499	[p27l1443t876r1606b936],
2	Opin	NN	PERSON	opin	dep	1	SENT_499	[p27l1616t876r1747b936],
3	.	.	O	.	_	0	SENT_499	[p27l1616t876r1747b936],

1	Drug	NN	O	drug	_	0	SENT_500	[p27l1762t876r1887b937],
2	Discov	NNP	O	Discov	dep	1	SENT_500	[p27l1899t876r2077b924],
3	.	.	O	.	_	0	SENT_500	[p27l1899t876r2077b924],

1	7	CD	NUMBER	7	_	0	SENT_501	[p27l2092t878r2136b931],
2	,	,	O	,	_	0	SENT_501	[p27l2092t878r2136b931],
3	281-297	CD	NUMBER	281-297	number	4	SENT_501	[p27l133t954r356b1000],
4	(	CD	NUMBER	(	appos	1	SENT_501	[p27l373t952r547b1007],
5	2012	CD	DATE	2012	num	6	SENT_501	[p27l373t952r547b1007],
6	)	NN	O	)	dep	4	SENT_501	[p27l373t952r547b1007],
7	.	.	O	.	_	0	SENT_501	[p27l373t952r547b1007],

1	37	CD	NUMBER	37	_	0	SENT_502	[p27l10t1032r83b1078],
2	.	.	O	.	_	0	SENT_502	[p27l10t1032r83b1078],

1	Prinz	NNP	PERSON	Prinz	_	0	SENT_503	[p27l133t1031r270b1086],
2	,	,	O	,	_	0	SENT_503	[p27l133t1031r270b1086],
3	F.	NNP	O	F.	conj_and	1	SENT_503	[p27l286t1031r330b1086],
4	,	,	O	,	_	0	SENT_503	[p27l286t1031r330b1086],
5	Schlange	NNP	O	Schlange	conj_and	1	SENT_503	[p27l344t1029r594b1092],
6	,	,	O	,	_	0	SENT_503	[p27l344t1029r594b1092],
7	T.	NNP	ORGANIZATION	T.	conj_and	1	SENT_503	[p27l603t1031r642b1078],
8	&	CC	ORGANIZATION	&	_	0	SENT_503	[p27l655t1030r692b1078],
9	Asadullah	NNP	ORGANIZATION	Asadullah	conj_and	1	SENT_503	[p27l704t1029r972b1086],
10	,	,	O	,	_	0	SENT_503	[p27l704t1029r972b1086],
11	K.	NNP	O	K.	nn	12	SENT_503	[p27l989t1031r1031b1078],
12	Believe	NNP	O	Believe	appos	1	SENT_503	[p27l1047t1029r1229b1078],
13	it	PRP	O	it	tmod	12	SENT_503	[p27l1245t1031r1276b1078],
14	or	CC	O	or	cc	15	SENT_503	[p27l1289t1043r1342b1078],
15	not	RB	O	not	advmod	13	SENT_503	[p27l1356t1036r1453b1078],
16	:	:	O	:	_	0	SENT_503	[p27l1356t1036r1453b1078],
17	how	WRB	O	how	advmod	18	SENT_503	[p27l1470t1029r1581b1078],
18	much	RB	O	much	advmod	21	SENT_503	[p27l1596t1029r1740b1078],
19	can	MD	O	can	aux	21	SENT_503	[p27l1755t1043r1843b1078],
20	we	PRP	O	we	nsubj	21	SENT_503	[p27l1859t1043r1934b1078],
21	rely	VB	O	rely	rcmod	1	SENT_503	[p27l1949t1029r2041b1093],
22	on	IN	O	on	_	0	SENT_503	[p27l2054t1043r2118b1078],
23	published	VBN	O	publish	amod	24	SENT_503	[p27l134t1107r390b1169],
24	data	NNS	O	datum	prep_on	21	SENT_503	[p27l406t1107r517b1157],
25	on	IN	O	on	_	0	SENT_503	[p27l533t1121r598b1157],
26	potential	JJ	O	potential	amod	28	SENT_503	[p27l615t1107r845b1169],
27	drug	NN	O	drug	nn	28	SENT_503	[p27l861t1107r982b1170],
28	targets	NNS	O	target	prep_on	24	SENT_503	[p27l996t1108r1203b1170],
29	?	.	O	?	_	0	SENT_503	[p27l996t1108r1203b1170],

1	Nat	NN	PERSON	nat	_	0	SENT_504	[p27l1217t1109r1317b1157],
2	.	.	O	.	_	0	SENT_504	[p27l1217t1109r1317b1157],

1	Rev.	NNP	O	Rev.	nn	3	SENT_505	[p27l1331t1109r1426b1157],
2	Drug	NNP	PERSON	Drug	nn	3	SENT_505	[p27l1440t1109r1565b1170],
3	Discov	NNP	PERSON	Discov	_	0	SENT_505	[p27l1576t1109r1752b1157],
4	.	.	O	.	_	0	SENT_505	[p27l1576t1109r1752b1157],

1	10	CD	NUMBER	10	_	0	SENT_506	[p27l1769t1110r1845b1164],
2	,	,	O	,	_	0	SENT_506	[p27l1769t1110r1845b1164],
3	712	CD	NUMBER	712	num	4	SENT_506	[p27l1860t1110r1952b1156],
4	(	NN	O	(	appos	1	SENT_506	[p27l1968t1108r2068b1164],
5	201	CD	NUMBER	201	number	6	SENT_506	[p27l1968t1108r2068b1164],
6	1	CD	NUMBER	1	num	7	SENT_506	[p27l2086t1108r2141b1164],
7	)	NN	O	)	dep	4	SENT_506	[p27l2086t1108r2141b1164],
8	.	.	O	.	_	0	SENT_506	[p27l2086t1108r2141b1164],

1	38	CD	NUMBER	38	_	0	SENT_507	[p27l10t1187r84b1233],
2	.	.	O	.	_	0	SENT_507	[p27l10t1187r84b1233],

1	Jack	NNP	PERSON	Jack	_	0	SENT_508	[p27l129t1184r253b1240],
2	,	,	O	,	_	0	SENT_508	[p27l129t1184r253b1240],
3	C.R.	NNP	PERSON	C.R.	nn	4	SENT_508	[p27l268t1185r362b1233],
4	Jr	NNP	PERSON	Jr	appos	1	SENT_508	[p27l374t1186r418b1233],
5	et	FW	O	et	nn	6	SENT_508	[p27l431t1191r480b1233],
6	al.	FW	O	al.	dep	4	SENT_508	[p27l489t1184r546b1233],
7	.	.	O	.	_	0	SENT_508	[p27l489t1184r546b1233],

1	Introduction	NN	O	introduction	_	0	SENT_509	[p27l563t1184r888b1233],
2	to	TO	O	to	dep	1	SENT_509	[p27l903t1191r956b1233],
3	the	DT	O	the	det	4	SENT_509	[p27l970t1184r1056b1233],
4	recommendations	NNS	O	recommendation	pobj	2	SENT_509	[p27l1072t1184r1553b1233],
5	from	IN	O	from	dep	1	SENT_509	[p27l1566t1183r1689b1233],
6	the	DT	O	the	det	7	SENT_509	[p27l1704t1184r1790b1233],
7	National	NNP	O	National	pobj	5	SENT_509	[p27l1807t1184r2023b1233],

1	Institute	NNP	O	Institute	_	0	SENT_510	[p27l135t1264r349b1312],
2	on	IN	O	on	_	0	SENT_510	[p27l364t1276r429b1312],
3	Aging-Alzheimer	NNP	O	Aging-Alzheimer	poss	6	SENT_510	[p27l444t1262r924b1325],
4	's	POS	O	's	_	0	SENT_510	[p27l444t1262r924b1325],
5	Association	NNP	O	Association	nn	6	SENT_510	[p27l938t1264r1237b1312],
6	workgroups	NNS	O	workgroup	prep_on	1	SENT_510	[p27l1253t1262r1569b1325],
7	on	IN	O	on	_	0	SENT_510	[p27l1584t1276r1648b1312],
8	diagnostic	JJ	O	diagnostic	amod	9	SENT_510	[p27l1665t1262r1938b1325],
9	guidelines	NNS	O	guideline	prep_on	1	SENT_510	[p27l132t1340r404b1403],
10	for	IN	O	for	_	0	SENT_510	[p27l417t1339r490b1390],
11	Alzheimer	NN	O	alzheimer	poss	13	SENT_510	[p27l502t1340r803b1390],
12	's	POS	O	's	_	0	SENT_510	[p27l502t1340r803b1390],
13	disease	NN	O	disease	prep_for	1	SENT_510	[p27l818t1340r1022b1390],
14	.	.	O	.	_	0	SENT_510	[p27l818t1340r1022b1390],

1	Alzheimers	NNPS	O	Alzheimers	_	0	SENT_511	[p27l1033t1340r1312b1390],
2	Dement	NNP	O	Dement	dep	1	SENT_511	[p27l1324t1342r1540b1390],
3	.	.	O	.	_	0	SENT_511	[p27l1324t1342r1540b1390],

1	7	CD	NUMBER	7	_	0	SENT_512	[p27l1554t1344r1598b1397],
2	,	,	O	,	_	0	SENT_512	[p27l1554t1344r1598b1397],
3	257-262	CD	NUMBER	257-262	num	4	SENT_512	[p27l1613t1343r1836b1390],
4	(	NN	O	(	appos	1	SENT_512	[p27l1853t1341r1954b1397],
5	201	CD	NUMBER	201	number	6	SENT_512	[p27l1853t1341r1954b1397],
6	1	CD	NUMBER	1	num	7	SENT_512	[p27l1972t1341r2028b1397],
7	)	NN	O	)	dep	4	SENT_512	[p27l1972t1341r2028b1397],
8	.	.	O	.	_	0	SENT_512	[p27l1972t1341r2028b1397],

1	39	CD	NUMBER	39	_	0	SENT_513	[p27l10t1421r84b1468],
2	.	.	O	.	_	0	SENT_513	[p27l10t1421r84b1468],

1	McKhann	NNP	PERSON	McKhann	_	0	SENT_514	[p27l132t1418r393b1475],
2	,	,	O	,	_	0	SENT_514	[p27l132t1418r393b1475],
3	G.M.	NNP	O	G.M.	nn	4	SENT_514	[p27l407t1420r522b1468],
4	etal	NN	O	etal	appos	1	SENT_514	[p27l536t1418r651b1468],
5	.	.	O	.	_	0	SENT_514	[p27l536t1418r651b1468],

1	The	DT	O	the	det	2	SENT_515	[p27l661t1418r758b1468],
2	diagnosis	NN	O	diagnosis	_	0	SENT_515	[p27l773t1418r1021b1481],
3	of	IN	O	of	_	0	SENT_515	[p27l1035t1417r1090b1468],
4	dementia	NN	O	dementia	prep_of	2	SENT_515	[p27l1099t1418r1349b1468],
5	due	JJ	O	due	_	0	SENT_515	[p27l1365t1418r1465b1468],
6	to	TO	O	to	_	0	SENT_515	[p27l1478t1425r1530b1468],
7	Alzheimer	NNP	O	Alzheimer	poss	9	SENT_515	[p27l1545t1418r1846b1468],
8	's	POS	O	's	_	0	SENT_515	[p27l1545t1418r1846b1468],
9	disease	NN	O	disease	prep_due_to	4	SENT_515	[p27l1861t1418r2066b1468],
10	:	:	O	:	_	0	SENT_515	[p27l1861t1418r2066b1468],

1	recommendations	NNS	O	recommendation	_	0	SENT_516	[p27l134t1496r615b1546],
2	from	IN	O	from	_	0	SENT_516	[p27l629t1495r751b1546],
3	the	DT	O	the	det	5	SENT_516	[p27l766t1496r852b1546],
4	National	NNP	ORGANIZATION	National	nn	5	SENT_516	[p27l869t1496r1085b1546],
5	Institute	NNP	ORGANIZATION	Institute	prep_from	1	SENT_516	[p27l1104t1498r1319b1546],
6	on	IN	ORGANIZATION	on	_	0	SENT_516	[p27l1334t1511r1398b1546],
7	Aging-Alzheimer	NNP	ORGANIZATION	Aging-Alzheimer	poss	10	SENT_516	[p27l1414t1496r1894b1559],
8	's	POS	ORGANIZATION	's	_	0	SENT_516	[p27l1414t1496r1894b1559],
9	Association	NNP	ORGANIZATION	Association	nn	10	SENT_516	[p27l132t1576r431b1624],
10	workgroups	NNS	O	workgroup	prep_on	1	SENT_516	[p27l446t1574r762b1637],
11	on	IN	O	on	_	0	SENT_516	[p27l777t1589r842b1624],
12	diagnostic	JJ	O	diagnostic	amod	13	SENT_516	[p27l858t1574r1132b1637],
13	guidelines	NNS	O	guideline	prep_on	1	SENT_516	[p27l1146t1574r1417b1637],
14	for	IN	O	for	_	0	SENT_516	[p27l1431t1573r1503b1624],
15	Alzheimer	NN	O	alzheimer	poss	17	SENT_516	[p27l1516t1574r1817b1624],
16	's	POS	O	's	_	0	SENT_516	[p27l1516t1574r1817b1624],
17	disease	NN	O	disease	prep_for	13	SENT_516	[p27l1832t1574r2036b1624],
18	.	.	O	.	_	0	SENT_516	[p27l1832t1574r2036b1624],

1	Alzheimers	NNPS	O	Alzheimers	_	0	SENT_517	[p27l128t1651r408b1700],
2	Dement	NNP	O	Dement	dep	1	SENT_517	[p27l420t1653r635b1700],
3	.	.	O	.	_	0	SENT_517	[p27l420t1653r635b1700],

1	7	CD	NUMBER	7	_	0	SENT_518	[p27l650t1655r694b1707],
2	,	,	O	,	_	0	SENT_518	[p27l650t1655r694b1707],
3	263-269	CD	NUMBER	263-269	num	4	SENT_518	[p27l709t1654r933b1700],
4	(	NN	O	(	appos	1	SENT_518	[p27l949t1652r1049b1707],
5	201	CD	NUMBER	201	number	6	SENT_518	[p27l949t1652r1049b1707],
6	1	CD	NUMBER	1	num	7	SENT_518	[p27l1068t1652r1123b1707],
7	)	NN	O	)	dep	4	SENT_518	[p27l1068t1652r1123b1707],
8	.	.	O	.	_	0	SENT_518	[p27l1068t1652r1123b1707],

1	40	CD	NUMBER	40	_	0	SENT_519	[p27l8t1732r83b1778],
2	.	.	O	.	_	0	SENT_519	[p27l8t1732r83b1778],

1	Sperling	NNP	PERSON	Sperling	_	0	SENT_520	[p27l131t1729r361b1792],
2	,	,	O	,	_	0	SENT_520	[p27l131t1729r361b1792],
3	R.	NNP	O	R.	nn	4	SENT_520	[p27l377t1731r418b1778],
4	etal	NN	O	etal	appos	1	SENT_520	[p27l433t1729r548b1778],
5	.	.	O	.	_	0	SENT_520	[p27l433t1729r548b1778],

1	Amyloid-related	JJ	O	amyloid-related	amod	3	SENT_521	[p27l562t1729r984b1793],
2	imaging	NN	O	imaging	nn	3	SENT_521	[p27l1002t1731r1214b1792],
3	abnormalities	NNS	O	abnormality	nsubj	10	SENT_521	[p27l1231t1729r1592b1778],
4	in	IN	O	in	_	0	SENT_521	[p27l1608t1731r1651b1778],
5	patients	NNS	O	patient	prep_in	3	SENT_521	[p27l1670t1731r1880b1791],
6	with	IN	O	with	_	0	SENT_521	[p27l1893t1729r2006b1778],
7	Alzheimer	NN	O	alzheimer	poss	9	SENT_521	[p27l132t1807r433b1856],
8	's	POS	O	's	_	0	SENT_521	[p27l132t1807r433b1856],
9	disease	NN	O	disease	prep_with	5	SENT_521	[p27l448t1807r639b1856],
10	treated	VBN	O	treat	_	0	SENT_521	[p27l653t1807r840b1856],
11	with	IN	O	with	_	0	SENT_521	[p27l856t1807r969b1856],
12	bapineuzumab	NN	O	bapineuzumab	prep_with	10	SENT_521	[p27l988t1807r1399b1869],
13	:	:	O	:	_	0	SENT_521	[p27l988t1807r1399b1869],
14	a	DT	O	a	det	16	SENT_521	[p27l1413t1821r1438b1856],
15	retrospective	JJ	O	retrospective	amod	16	SENT_521	[p27l1456t1809r1799b1869],
16	analysis	NN	O	analysis	dep	12	SENT_521	[p27l1814t1807r2029b1871],
17	.	.	O	.	_	0	SENT_521	[p27l1814t1807r2029b1871],

1	LancetNeuroI	NN	O	lancetneurous	_	0	SENT_522	[p27l132t1884r491b1933],
2	.	.	O	.	_	0	SENT_522	[p27l132t1884r491b1933],

1	1	CD	NUMBER	1	num	2	SENT_523	[p27l509t1888r528b1932],
2	1	CD	NUMBER	1	_	0	SENT_523	[p27l544t1888r585b1940],
3	,	,	O	,	_	0	SENT_523	[p27l544t1888r585b1940],
4	241-249	CD	NUMBER	241-249	number	5	SENT_523	[p27l600t1887r824b1933],
5	(	CD	NUMBER	(	appos	2	SENT_523	[p27l841t1885r1015b1940],
6	2012	CD	DATE	2012	num	7	SENT_523	[p27l841t1885r1015b1940],
7	)	NN	O	)	dep	5	SENT_523	[p27l841t1885r1015b1940],
8	.	.	O	.	_	0	SENT_523	[p27l841t1885r1015b1940],

1	41	CD	NUMBER	41	_	0	SENT_524	[p27l7t1966r83b2012],
2	.	.	O	.	_	0	SENT_524	[p27l7t1966r83b2012],

1	Pillai	NNP	PERSON	Pillai	_	0	SENT_525	[p27l133t1962r263b2019],
2	,	,	O	,	_	0	SENT_525	[p27l133t1962r263b2019],
3	J.A.	NNP	ORGANIZATION	J.A.	conj_and	1	SENT_525	[p27l275t1964r361b2012],
4	&	CC	ORGANIZATION	&	_	0	SENT_525	[p27l375t1964r412b2012],
5	Cummings	NNP	ORGANIZATION	Cummings	conj_and	1	SENT_525	[p27l425t1964r723b2025],
6	,	,	O	,	_	0	SENT_525	[p27l425t1964r723b2025],
7	J.L.	NNP	O	J.L.	nn	9	SENT_525	[p27l735t1964r812b2012],
8	Clinical	JJ	O	clinical	amod	9	SENT_525	[p27l827t1962r1012b2012],
9	trials	NNS	O	trial	appos	1	SENT_525	[p27l1027t1962r1152b2012],
10	in	IN	O	in	_	0	SENT_525	[p27l1168t1964r1211b2011],
11	predementia	NN	O	predementium	nn	12	SENT_525	[p27l1229t1962r1565b2024],
12	stages	NNS	O	stage	prep_in	9	SENT_525	[p27l1581t1969r1747b2025],
13	ofA	NN	O	ofa	nn	16	SENT_525	[p27l1762t1961r2093b2012],
14	|	NN	O	|	nn	16	SENT_525	[p27l1762t1961r2093b2012],
15	zheimer	NN	O	zheimer	nn	16	SENT_525	[p27l1762t1961r2093b2012],
16	disease	NN	O	disease	dep	9	SENT_525	[p27l132t2039r336b2088],
17	.	.	O	.	_	0	SENT_525	[p27l132t2039r336b2088],

1	Med	NNP	O	Med	_	0	SENT_526	[p27l349t2039r469b2088],
2	.	.	O	.	_	0	SENT_526	[p27l349t2039r469b2088],

1	Clin	NNP	O	Clin	_	0	SENT_527	[p27l485t2039r590b2088],
2	.	.	O	.	_	0	SENT_527	[p27l485t2039r590b2088],

1	North	NNP	O	North	nn	2	SENT_528	[p27l605t2039r750b2088],
2	Am	NNP	O	Am	_	0	SENT_528	[p27l760t2041r862b2088],
3	.	.	O	.	_	0	SENT_528	[p27l760t2041r862b2088],

1	97	CD	NUMBER	97	_	0	SENT_529	[p27l875t2042r956b2095],
2	,	,	O	,	_	0	SENT_529	[p27l875t2042r956b2095],
3	439-457	CD	NUMBER	439-457	number	4	SENT_529	[p27l969t2042r1194b2088],
4	(	CD	NUMBER	(	appos	1	SENT_529	[p27l1211t2040r1385b2095],
5	2013	CD	DATE	2013	num	6	SENT_529	[p27l1211t2040r1385b2095],
6	)	NN	O	)	dep	4	SENT_529	[p27l1211t2040r1385b2095],
7	.	.	O	.	_	0	SENT_529	[p27l1211t2040r1385b2095],

1	42	CD	NUMBER	42	_	0	SENT_530	[p27l7t2119r83b2165],
2	.	.	O	.	_	0	SENT_530	[p27l7t2119r83b2165],

1	Bateman	NNP	PERSON	Bateman	_	0	SENT_531	[p27l133t2118r377b2172],
2	,	,	O	,	_	0	SENT_531	[p27l133t2118r377b2172],
3	R.J.	NNP	LOCATION	R.J.	appos	1	SENT_531	[p27l394t2118r484b2172],
4	,	,	O	,	_	0	SENT_531	[p27l394t2118r484b2172],
5	Munsell	NNP	PERSON	Munsell	conj_and	3	SENT_531	[p27l499t2116r716b2172],
6	,	,	O	,	_	0	SENT_531	[p27l499t2116r716b2172],
7	L.Y.	NNP	LOCATION	L.Y.	conj_and	3	SENT_531	[p27l733t2118r824b2172],
8	,	,	O	,	_	0	SENT_531	[p27l733t2118r824b2172],
9	Morris	NNP	PERSON	Morris	conj_and	3	SENT_531	[p27l840t2118r1016b2172],
10	,	,	O	,	_	0	SENT_531	[p27l840t2118r1016b2172],
11	J.C.	NNP	O	J.C.	conj_and	3	SENT_531	[p27l1028t2117r1125b2172],
12	,	,	O	,	_	0	SENT_531	[p27l1028t2117r1125b2172],
13	Swarm	NNP	O	Swarm	conj_and	3	SENT_531	[p27l1140t2117r1332b2172],
14	,	,	O	,	_	0	SENT_531	[p27l1140t2117r1332b2172],
15	R.	NNP	O	R.	conj_and	3	SENT_531	[p27l1349t2116r1699b2172],
16	,	,	O	,	_	0	SENT_531	[p27l1349t2116r1699b2172],
17	Yarasheski	NNP	LOCATION	Yarasheski	conj_and	3	SENT_531	[p27l1349t2116r1699b2172],
18	,	,	O	,	_	0	SENT_531	[p27l1349t2116r1699b2172],
19	K.E.	NNP	ORGANIZATION	K.E.	conj_and	3	SENT_531	[p27l1716t2118r1802b2165],
20	&	CC	ORGANIZATION	&	_	0	SENT_531	[p27l1816t2117r1853b2165],
21	Holtzman	NNP	ORGANIZATION	Holtzman	appos	1	SENT_531	[p27l1868t2116r2134b2172],
22	,	,	O	,	_	0	SENT_531	[p27l1868t2116r2134b2172],

1	D.M.	NNP	PERSON	D.M.	nn	4	SENT_532	[p27l135t2196r246b2243],
2	Human	NNP	PERSON	Human	nn	4	SENT_532	[p27l263t2196r451b2243],
3	amyloid-beta	NN	O	amyloid-beta	nn	4	SENT_532	[p27l468t2194r816b2257],
4	synthesis	NN	O	synthesis	nsubj	9	SENT_532	[p27l832t2194r1071b2257],
5	and	CC	O	and	_	0	SENT_532	[p27l1086t2194r1183b2243],
6	clearance	NN	O	clearance	nn	7	SENT_532	[p27l1199t2194r1448b2243],
7	rates	NNS	O	rate	conj_and	4	SENT_532	[p27l1464t2201r1587b2243],
8	as	IN	O	as	advmod	9	SENT_532	[p27l1602t2208r1654b2243],
9	measured	VBN	O	measure	_	0	SENT_532	[p27l1671t2194r1927b2243],
10	in	IN	O	in	_	0	SENT_532	[p27l1945t2196r1988b2243],
11	cerebrospinal	JJ	O	cerebrospinal	amod	12	SENT_532	[p27l132t2272r487b2334],
12	ﬂuid	NN	O	ﬂuid	prep_in	9	SENT_532	[p27l502t2271r617b2322],
13	in	FW	O	in	prep	12	SENT_532	[p27l636t2274r678b2321],
14	vivo	FW	O	vivo	pobj	13	SENT_532	[p27l693t2274r813b2322],
15	.	.	O	.	_	0	SENT_532	[p27l693t2274r813b2322],

1	Nat	NN	PERSON	nat	_	0	SENT_533	[p27l827t2274r928b2322],
2	.	.	O	.	_	0	SENT_533	[p27l827t2274r928b2322],

1	Med	NNP	O	Med	_	0	SENT_534	[p27l942t2272r1064b2322],
2	.	.	O	.	_	0	SENT_534	[p27l942t2272r1064b2322],

1	12	CD	NUMBER	12	_	0	SENT_535	[p27l1082t2275r1159b2329],
2	,	,	O	,	_	0	SENT_535	[p27l1082t2275r1159b2329],
3	856-861	CD	NUMBER	856-861	number	4	SENT_535	[p27l1173t2275r1387b2322],
4	(	CD	NUMBER	(	appos	1	SENT_535	[p27l1414t2273r1588b2329],
5	2006	CD	DATE	2006	num	6	SENT_535	[p27l1414t2273r1588b2329],
6	)	NN	O	)	dep	4	SENT_535	[p27l1414t2273r1588b2329],
7	.	.	O	.	_	0	SENT_535	[p27l1414t2273r1588b2329],

1	43	CD	NUMBER	43	_	0	SENT_536	[p27l7t2352r83b2399],
2	.	.	O	.	_	0	SENT_536	[p27l7t2352r83b2399],

1	Wildsmith	NNP	PERSON	Wildsmith	_	0	SENT_537	[p27l130t2349r409b2406],
2	,	,	O	,	_	0	SENT_537	[p27l130t2349r409b2406],
3	K.R.	NNP	O	K.R.	nn	4	SENT_537	[p27l425t2351r515b2399],
4	etal	NNP	O	etal	appos	1	SENT_537	[p27l529t2349r644b2399],
5	.	.	O	.	_	0	SENT_537	[p27l529t2349r644b2399],

1	In	FW	O	in	nn	4	SENT_538	[p27l658t2351r702b2398],
2	vivo	FW	O	vivo	nn	4	SENT_538	[p27l717t2351r818b2399],
3	human	JJ	O	human	amod	4	SENT_538	[p27l834t2349r1017b2399],
4	apolipoprotein	NN	O	apolipoprotein	_	0	SENT_538	[p27l1033t2349r1424b2412],
5	E	NN	O	e	nn	6	SENT_538	[p27l1443t2351r1469b2398],
6	isoform	NN	O	isoform	dep	4	SENT_538	[p27l1485t2348r1679b2399],
7	fractional	JJ	O	fractional	amod	9	SENT_538	[p27l1694t2348r1940b2399],
8	turnover	NN	O	turnover	nn	9	SENT_538	[p27l131t2434r360b2475],
9	rates	NNS	O	rate	dep	6	SENT_538	[p27l375t2434r497b2475],
10	in	IN	O	in	_	0	SENT_538	[p27l514t2428r556b2475],
11	the	DT	O	the	det	12	SENT_538	[p27l571t2426r657b2475],
12	CNS	NN	O	cn	prep_in	4	SENT_538	[p27l672t2428r792b2475],
13	.	.	O	.	_	0	SENT_538	[p27l672t2428r792b2475],

1	PLoS	NN	O	plo	_	0	SENT_539	[p27l806t2428r926b2475],
2	ONE	CD	NUMBER	one	num	3	SENT_539	[p27l937t2428r1050b2475],
3	7	CD	NUMBER	7	dep	1	SENT_539	[p27l1061t2430r1105b2483],
4	,	,	O	,	_	0	SENT_539	[p27l1061t2430r1105b2483],
5	e3801	NN	O	e3801	appos	3	SENT_539	[p27l1120t2429r1268b2475],
6	3	CD	NUMBER	3	number	7	SENT_539	[p27l1283t2429r1309b2475],
7	(	CD	NUMBER	(	dep	1	SENT_539	[p27l1328t2427r1502b2483],
8	2012	CD	DATE	2012	num	9	SENT_539	[p27l1328t2427r1502b2483],
9	)	NN	O	)	dep	7	SENT_539	[p27l1328t2427r1502b2483],
10	.	.	O	.	_	0	SENT_539	[p27l1328t2427r1502b2483],

1	44	CD	NUMBER	44	_	0	SENT_540	[p27l7t2508r83b2554],
2	.	.	O	.	_	0	SENT_540	[p27l7t2508r83b2554],

1	Bateman	NNP	PERSON	Bateman	_	0	SENT_541	[p27l133t2506r377b2561],
2	,	,	O	,	_	0	SENT_541	[p27l133t2506r377b2561],
3	R.J.	NNP	PERSON	R.J.	nn	4	SENT_541	[p27l394t2506r470b2554],
4	etal	NNP	O	etal	appos	1	SENT_541	[p27l485t2504r600b2554],
5	.	.	O	.	_	0	SENT_541	[p27l485t2504r600b2554],

1	A	DT	O	a	det	5	SENT_542	[p27l614t2506r650b2553],
2	gamma	NN	O	gamma	nn	5	SENT_542	[p27l664t2512r1130b2567],
3	—	NN	O	—	nn	5	SENT_542	[p27l664t2512r1130b2567],
4	secretase	NN	O	secretase	nn	5	SENT_542	[p27l664t2512r1130b2567],
5	inhibitor	NN	O	inhibitor	nsubj	6	SENT_542	[p27l1146t2504r1370b2554],
6	decreases	VBZ	O	decrease	_	0	SENT_542	[p27l1383t2504r1641b2554],
7	amy	RB	O	amy	advmod	6	SENT_542	[p27l1655t2504r2003b2568],
8	|	JJ	O	|	amod	12	SENT_542	[p27l1655t2504r2003b2568],
9	oid	NN	O	oid	nn	12	SENT_542	[p27l1655t2504r2003b2568],
10	—	NN	O	—	nn	12	SENT_542	[p27l1655t2504r2003b2568],
11	beta	NN	O	beta	nn	12	SENT_542	[p27l1655t2504r2003b2568],
12	production	NN	O	production	dobj	6	SENT_542	[p27l134t2582r424b2644],
13	in	IN	O	in	_	0	SENT_542	[p27l443t2584r485b2631],
14	the	DT	O	the	det	17	SENT_542	[p27l500t2582r586b2632],
15	central	JJ	O	central	amod	17	SENT_542	[p27l601t2582r777b2632],
16	nervous	JJ	O	nervous	amod	17	SENT_542	[p27l796t2597r1005b2632],
17	system	NN	O	system	prep_in	12	SENT_542	[p27l1020t2584r1341b2646],
18	.	.	O	.	_	0	SENT_542	[p27l1020t2584r1341b2646],

1	Ann	NNP	PERSON	Ann	_	0	SENT_543	[p27l1020t2584r1341b2646],
2	.	.	O	.	_	0	SENT_543	[p27l1020t2584r1341b2646],

1	Neurol	NNP	O	Neurol	_	0	SENT_544	[p27l1356t2582r1536b2632],
2	.	.	O	.	_	0	SENT_544	[p27l1356t2582r1536b2632],

1	66	CD	NUMBER	66	_	0	SENT_545	[p27l1550t2585r1630b2639],
2	,	,	O	,	_	0	SENT_545	[p27l1550t2585r1630b2639],
3	48-54	CD	NUMBER	48-54	number	4	SENT_545	[p27l1643t2585r1805b2632],
4	(	CD	NUMBER	(	appos	1	SENT_545	[p27l1820t2583r1994b2639],
5	2009	CD	DATE	2009	num	6	SENT_545	[p27l1820t2583r1994b2639],
6	)	NN	O	)	dep	4	SENT_545	[p27l1820t2583r1994b2639],
7	.	.	O	.	_	0	SENT_545	[p27l1820t2583r1994b2639],

1	45	CD	NUMBER	45	_	0	SENT_546	[p27l7t2664r83b2710],
2	.	.	O	.	_	0	SENT_546	[p27l7t2664r83b2710],

1	Fleisher	NNP	PERSON	Fleisher	_	0	SENT_547	[p27l133t2660r341b2717],
2	,	,	O	,	_	0	SENT_547	[p27l133t2660r341b2717],
3	A.S.	NNP	O	A.S.	nn	4	SENT_547	[p27l355t2662r448b2710],
4	etal	NN	O	etal	appos	1	SENT_547	[p27l463t2660r578b2710],
5	.	.	O	.	_	0	SENT_547	[p27l463t2660r578b2710],

1	Phase	NN	O	phase	nn	4	SENT_548	[p27l594t2660r745b2710],
2	2	CD	NUMBER	2	num	4	SENT_548	[p27l760t2663r788b2709],
3	safety	NN	O	safety	nn	4	SENT_548	[p27l803t2659r958b2724],
4	trial	NN	O	trial	_	0	SENT_548	[p27l969t2660r1067b2710],
5	targeting	VBG	O	target	partmod	4	SENT_548	[p27l1082t2662r1324b2723],
6	amyloid	NN	O	amyloid	nn	8	SENT_548	[p27l1340t2660r1549b2724],
7	beta	NN	O	beta	nn	8	SENT_548	[p27l1568t2660r1680b2710],
8	production	NN	O	production	dobj	5	SENT_548	[p27l1698t2660r1988b2722],
9	with	IN	O	with	_	0	SENT_548	[p27l131t2738r244b2788],
10	a	DT	O	a	det	14	SENT_548	[p27l261t2753r286b2788],
11	gamma	NN	O	gamma	nn	14	SENT_548	[p27l302t2746r769b2801],
12	—	NN	O	—	nn	14	SENT_548	[p27l302t2746r769b2801],
13	secretase	NN	O	secretase	nn	14	SENT_548	[p27l302t2746r769b2801],
14	inhibitor	NN	O	inhibitor	prep_with	8	SENT_548	[p27l785t2738r1008b2788],
15	in	IN	O	in	_	0	SENT_548	[p27l1023t2740r1066b2787],
16	Alzheimer	NN	O	alzheimer	nn	17	SENT_548	[p27l1082t2738r1349b2788],
17	disease	NN	O	disease	prep_in	14	SENT_548	[p27l1362t2738r1706b2788],
18	.	.	O	.	_	0	SENT_548	[p27l1362t2738r1706b2788],

1	Arch	NNP	O	Arch	_	0	SENT_549	[p27l1362t2738r1706b2788],
2	.	.	O	.	_	0	SENT_549	[p27l1362t2738r1706b2788],

1	Neurol	NNP	O	Neurol	_	0	SENT_550	[p27l1721t2738r1900b2788],
2	.	.	O	.	_	0	SENT_550	[p27l1721t2738r1900b2788],

1	65	CD	NUMBER	65	_	0	SENT_551	[p27l1914t2741r1995b2795],
2	,	,	O	,	_	0	SENT_551	[p27l1914t2741r1995b2795],
3	1031-1038	CD	DATE	1031-1038	number	4	SENT_551	[p27l136t2818r422b2864],
4	(	CD	NUMBER	(	appos	1	SENT_551	[p27l438t2816r612b2871],
5	2008	CD	DATE	2008	num	6	SENT_551	[p27l438t2816r612b2871],
6	)	NN	O	)	dep	4	SENT_551	[p27l438t2816r612b2871],
7	.	.	O	.	_	0	SENT_551	[p27l438t2816r612b2871],

1	46	CD	NUMBER	46	_	0	SENT_552	[p27l7t2896r83b2943],
2	.	.	O	.	_	0	SENT_552	[p27l7t2896r83b2943],

1	Portelius	NNP	PERSON	Portelius	_	0	SENT_553	[p27l133t2893r371b2950],
2	,	,	O	,	_	0	SENT_553	[p27l133t2893r371b2950],
3	E.	NNP	O	E.	nn	4	SENT_553	[p27l388t2895r426b2943],
4	etal	NN	O	etal	appos	1	SENT_553	[p27l440t2893r555b2943],
5	.	.	O	.	_	0	SENT_553	[p27l440t2893r555b2943],

1	Amy	NNP	O	Amy	nn	2	SENT_554	[p27l569t2892r884b2957],
2	|	NNP	O	|	_	0	SENT_554	[p27l569t2892r884b2957],
3	oid	NN	O	oid	dep	2	SENT_554	[p27l569t2892r884b2957],
4	.	.	O	.	_	0	SENT_554	[p27l569t2892r884b2957],

1	—	NN	O	—	_	0	SENT_555	[p27l569t2892r884b2957],
2	.	.	O	.	_	0	SENT_555	[p27l569t2892r884b2957],

1	B	NN	O	b	_	0	SENT_556	[p27l569t2892r884b2957],
2	(	CD	NUMBER	(	num	1	SENT_556	[p27l569t2892r884b2957],
3	1	CD	NUMBER	1	number	4	SENT_556	[p27l569t2892r884b2957],
4	-1	CD	NUMBER	-1	num	6	SENT_556	[p27l897t2897r936b2942],
5	5/1	CD	NUMBER	5/1	number	6	SENT_556	[p27l950t2895r1023b2945],
6	6	CD	NUMBER	6	dep	1	SENT_556	[p27l1037t2894r1082b2950],
7	)	RB	O	)	advmod	8	SENT_556	[p27l1037t2894r1082b2950],
8	as	IN	O	as	dep	1	SENT_556	[p27l1098t2908r1150b2943],
9	a	DT	O	a	det	13	SENT_556	[p27l1165t2908r1190b2943],
10	markerfory	NN	O	markerfory	nn	13	SENT_556	[p27l1208t2892r1777b2957],
11	—	NN	O	—	nn	13	SENT_556	[p27l1208t2892r1777b2957],
12	secretase	NN	O	secretase	nn	13	SENT_556	[p27l1208t2892r1777b2957],
13	inhibition	NN	O	inhibition	pobj	8	SENT_556	[p27l1793t2893r2043b2943],
14	in	IN	O	in	dep	1	SENT_556	[p27l2061t2895r2104b2942],

1	Alzheimer	NN	O	alzheimer	poss	3	SENT_557	[p27l131t2970r433b3019],
2	's	POS	O	's	_	0	SENT_557	[p27l131t2970r433b3019],
3	disease	NN	O	disease	_	0	SENT_557	[p27l447t2970r696b3019],
4	.	.	O	.	_	0	SENT_557	[p27l447t2970r696b3019],

1	J.	NNP	O	J.	nn	3	SENT_558	[p27l447t2970r696b3019],
2	Alzheimers	NNP	O	Alzheimers	nn	3	SENT_558	[p27l708t2970r987b3019],
3	Dis	NNP	O	Dis	_	0	SENT_558	[p27l999t2972r1088b3019],
4	.	.	O	.	_	0	SENT_558	[p27l999t2972r1088b3019],

1	31	CD	NUMBER	31	_	0	SENT_559	[p27l1103t2973r1183b3027],
2	,	,	O	,	_	0	SENT_559	[p27l1103t2973r1183b3027],
3	335-341	CD	NUMBER	335-341	number	4	SENT_559	[p27l1198t2973r1412b3019],
4	(	CD	NUMBER	(	appos	1	SENT_559	[p27l1438t2971r1612b3026],
5	2012	CD	DATE	2012	num	6	SENT_559	[p27l1438t2971r1612b3026],
6	)	NN	O	)	dep	4	SENT_559	[p27l1438t2971r1612b3026],
7	.	.	O	.	_	0	SENT_559	[p27l1438t2971r1612b3026],

1	47	CD	NUMBER	47	_	0	SENT_560	[p27l7t3052r83b3098],
2	.	.	O	.	_	0	SENT_560	[p27l7t3052r83b3098],

1	Sankaranarayanan	NNP	PERSON	Sankaranarayanan	_	0	SENT_561	[p27l131t3048r629b3112],
2	,	,	O	,	_	0	SENT_561	[p27l131t3048r629b3112],
3	S.	NNP	O	S.	nn	4	SENT_561	[p27l644t3050r684b3098],
4	etal	NNP	O	etal	appos	1	SENT_561	[p27l699t3048r814b3098],
5	.	.	O	.	_	0	SENT_561	[p27l699t3048r814b3098],

1	First	NNP	ORDINAL	First	nn	2	SENT_562	[p27l830t3050r936b3098],
2	demonstration	NN	O	demonstration	_	0	SENT_562	[p27l950t3048r1339b3098],
3	of	IN	O	of	_	0	SENT_562	[p27l1356t3047r1410b3098],
4	cerebrospinal	JJ	O	cerebrospinal	amod	5	SENT_562	[p27l1420t3048r1774b3110],
5	ﬂuid	NN	O	ﬂuid	prep_of	2	SENT_562	[p27l1790t3047r1905b3098],
6	and	CC	O	and	_	0	SENT_562	[p27l1921t3048r2017b3098],
7	plasma	NN	O	plasma	nn	9	SENT_562	[p27l134t3126r318b3188],
8	A	NN	O	a	nn	9	SENT_562	[p27l333t3128r369b3175],
9	beta	NN	O	beta	conj_and	5	SENT_562	[p27l386t3126r498b3176],
10	lowering	VBG	O	lower	partmod	2	SENT_562	[p27l516t3126r743b3189],
11	with	IN	O	with	_	0	SENT_562	[p27l759t3126r872b3176],
12	oral	JJ	O	oral	amod	13	SENT_562	[p27l889t3126r984b3176],
13	administration	NN	O	administration	prep_with	10	SENT_562	[p27l1000t3126r1383b3176],
14	of	IN	O	of	_	0	SENT_562	[p27l1399t3125r1454b3176],
15	a	DT	O	a	det	18	SENT_562	[p27l1463t3141r1489b3176],
16	beta	NN	O	beta	nn	18	SENT_562	[p27l1507t3126r1733b3176],
17	—	NN	O	—	nn	18	SENT_562	[p27l1507t3126r1733b3176],
18	site	NN	O	site	prep_of	13	SENT_562	[p27l1507t3126r1733b3176],
19	amyloid	JJ	O	amyloid	amod	21	SENT_562	[p27l1747t3126r1955b3190],
20	precursor	NN	O	precursor	nn	21	SENT_562	[p27l134t3219r384b3266],
21	protein	NN	O	protein	dep	26	SENT_562	[p27l398t3204r827b3267],
22	—	CD	NUMBER	—	num	23	SENT_562	[p27l398t3204r827b3267],
23	c	NN	O	c	dep	21	SENT_562	[p27l398t3204r827b3267],
24	|	NN	O	|	dep	26	SENT_562	[p27l398t3204r827b3267],
25	eaving	JJ	O	eaving	amod	26	SENT_562	[p27l398t3204r827b3267],
26	enzyme	NN	O	enzyme	dep	10	SENT_562	[p27l844t3219r1052b3268],
27	1	CD	NUMBER	1	num	28	SENT_562	[p27l1071t3208r1085b3253],
28	inhibitor	NN	O	inhibitor	dep	26	SENT_562	[p27l1111t3204r1335b3254],
29	in	IN	O	in	_	0	SENT_562	[p27l1350t3206r1392b3253],
30	nonhuman	JJ	O	nonhuman	amod	31	SENT_562	[p27l1411t3204r1699b3254],
31	primates	NNS	O	primate	prep_in	10	SENT_562	[p27l1718t3206r1958b3266],
32	.	.	O	.	_	0	SENT_562	[p27l1718t3206r1958b3266],

1	J.	NNP	PERSON	J.	nn	2	SENT_563	[p27l1968t3206r2003b3254],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_563	[p27l132t3282r417b3332],
3	.	.	O	.	_	0	SENT_563	[p27l132t3282r417b3332],

1	Exp	NN	O	exp	_	0	SENT_564	[p27l432t3284r530b3345],
2	.	.	O	.	_	0	SENT_564	[p27l432t3284r530b3345],

1	Ther	NNP	O	Ther	_	0	SENT_565	[p27l547t3282r667b3332],
2	.	.	O	.	_	0	SENT_565	[p27l547t3282r667b3332],

1	328	CD	NUMBER	328	_	0	SENT_566	[p27l682t3285r797b3339],
2	,	,	O	,	_	0	SENT_566	[p27l682t3285r797b3339],
3	1	CD	NUMBER	1	number	4	SENT_566	[p27l816t3286r830b3331],
4	31-140	CD	NUMBER	31-140	appos	1	SENT_566	[p27l845t3285r1036b3332],
5	(	CD	NUMBER	(	num	7	SENT_566	[p27l1052t3283r1227b3339],
6	2009	CD	DATE	2009	num	7	SENT_566	[p27l1052t3283r1227b3339],
7	)	NN	O	)	dep	4	SENT_566	[p27l1052t3283r1227b3339],
8	.	.	O	.	_	0	SENT_566	[p27l1052t3283r1227b3339],

1	48	CD	NUMBER	48	_	0	SENT_567	[p27l7t3363r83b3410],
2	.	.	O	.	_	0	SENT_567	[p27l7t3363r83b3410],

1	Tai	NNP	PERSON	Tai	nn	3	SENT_568	[p27l128t3362r213b3417],
2	,	,	O	,	_	0	SENT_568	[p27l128t3362r213b3417],
3	L.M.	NNP	O	L.M.	_	0	SENT_568	[p27l230t3362r331b3410],
4	et	FW	O	et	nn	5	SENT_568	[p27l345t3368r394b3410],
5	al.	FW	O	al.	dep	3	SENT_568	[p27l403t3360r460b3410],
6	.	.	O	.	_	0	SENT_568	[p27l403t3360r460b3410],

1	The	DT	O	the	det	2	SENT_569	[p27l469t3360r567b3410],
2	dynamics	NNS	O	dynamics	_	0	SENT_569	[p27l581t3360r831b3424],
3	of	IN	O	of	_	0	SENT_569	[p27l846t3359r900b3410],
4	AB	NNP	O	AB	nn	5	SENT_569	[p27l909t3359r981b3422],
5	distribution	NN	O	distribution	prep_of	2	SENT_569	[p27l996t3360r1300b3410],
6	after	IN	O	after	_	0	SENT_569	[p27l1316t3359r1438b3410],
7	y	NN	O	y	nn	11	SENT_569	[p27l1449t3367r1739b3424],
8	—	CD	NUMBER	—	num	11	SENT_569	[p27l1449t3367r1739b3424],
9	secretase	NN	O	secretase	nn	11	SENT_569	[p27l1449t3367r1739b3424],
10	inhibitor	NN	O	inhibitor	nn	11	SENT_569	[p27l1755t3360r1979b3410],
11	treatment	NN	O	treatment	prep_after	5	SENT_569	[p27l131t3445r407b3495],
12	,	,	O	,	_	0	SENT_569	[p27l131t3445r407b3495],
13	as	IN	O	as	mark	14	SENT_569	[p27l421t3453r473b3488],
14	determined	VBN	O	determine	dep	5	SENT_569	[p27l488t3438r795b3488],
15	by	IN	O	by	_	0	SENT_569	[p27l814t3438r875b3502],
16	experimental	JJ	O	experimental	amod	19	SENT_569	[p27l888t3438r1235b3500],
17	and	CC	O	and	_	0	SENT_569	[p27l1251t3438r1348b3488],
18	modelling	NN	O	modelling	conj_and	16	SENT_569	[p27l1366t3438r1630b3501],
19	approaches	NNS	O	approach	prep_by	14	SENT_569	[p27l1647t3438r1953b3501],
20	in	IN	O	in	_	0	SENT_569	[p27l1969t3440r2012b3487],
21	a	DT	O	a	det	24	SENT_569	[p27l2029t3453r2054b3488],
22	wild	JJ	O	wild	amod	24	SENT_569	[p27l131t3516r239b3566],
23	type	NN	O	type	nn	24	SENT_569	[p27l254t3524r371b3580],
24	rat	NN	O	rat	prep_in	14	SENT_569	[p27l388t3523r467b3566],
25	.	.	O	.	_	0	SENT_569	[p27l388t3523r467b3566],

1	J.	NNP	PERSON	J.	nn	2	SENT_570	[p27l477t3518r512b3566],
2	Pharmacokinet	NNP	PERSON	Pharmacokinet	_	0	SENT_570	[p27l526t3516r925b3566],
3	.	.	O	.	_	0	SENT_570	[p27l526t3516r925b3566],

1	Pharmacodyn	NNP	PERSON	Pharmacodyn	_	0	SENT_571	[p27l940t3516r1309b3580],
2	.	.	O	.	_	0	SENT_571	[p27l940t3516r1309b3580],

1	39	CD	NUMBER	39	_	0	SENT_572	[p27l1324t3519r1404b3573],
2	,	,	O	,	_	0	SENT_572	[p27l1324t3519r1404b3573],
3	227-237	CD	NUMBER	227-237	number	4	SENT_572	[p27l1418t3519r1642b3566],
4	(	CD	NUMBER	(	appos	1	SENT_572	[p27l1659t3517r1833b3573],
5	2012	CD	DATE	2012	num	6	SENT_572	[p27l1659t3517r1833b3573],
6	)	NN	O	)	dep	4	SENT_572	[p27l1659t3517r1833b3573],
7	.	.	O	.	_	0	SENT_572	[p27l1659t3517r1833b3573],

1	49	CD	NUMBER	49	_	0	SENT_573	[p27l7t3597r83b3644],
2	.	.	O	.	_	0	SENT_573	[p27l7t3597r83b3644],

1	Wu	NNP	O	Wu	_	0	SENT_574	[p27l129t3596r227b3651],
2	,	,	O	,	_	0	SENT_574	[p27l129t3596r227b3651],
3	G.	NNP	O	G.	nn	4	SENT_574	[p27l242t3596r292b3644],
4	etal	NN	O	etal	appos	1	SENT_574	[p27l306t3594r421b3644],
5	.	.	O	.	_	0	SENT_574	[p27l306t3594r421b3644],

1	Characterization	NN	O	characterization	_	0	SENT_575	[p27l436t3594r866b3644],
2	of	IN	O	of	_	0	SENT_575	[p27l882t3593r937b3644],
3	plasma	NN	O	plasma	prep_of	1	SENT_575	[p27l949t3594r1133b3656],
4	[	CD	NUMBER	[	number	5	SENT_575	[p27l1151t3593r1447b3656],
5	3	CD	NUMBER	3	num	10	SENT_575	[p27l1151t3593r1447b3656],
6	—	NN	O	—	nn	10	SENT_575	[p27l1151t3593r1447b3656],
7	secretase	NN	O	secretase	nn	10	SENT_575	[p27l1151t3593r1447b3656],
8	(	CD	NUMBER	(	num	10	SENT_575	[p27l1463t3595r1666b3651],
9	BACE1	NN	O	bace1	nn	10	SENT_575	[p27l1463t3595r1666b3651],
10	)	NN	O	)	dep	1	SENT_575	[p27l1463t3595r1666b3651],
11	activity	NN	O	activity	dep	10	SENT_575	[p27l1681t3596r1873b3658],
12	and	CC	O	and	_	0	SENT_575	[p27l1885t3594r1982b3644],
13	soluble	JJ	O	soluble	amod	16	SENT_575	[p27l132t3672r321b3722],
14	amyloid	NN	O	amyloid	nn	16	SENT_575	[p27l336t3672r544b3736],
15	precursor	NN	O	precursor	nn	16	SENT_575	[p27l563t3687r812b3734],
16	proteins	NNS	O	protein	conj_and	10	SENT_575	[p27l827t3674r1041b3734],
17	as	IN	O	as	_	0	SENT_575	[p27l1055t3687r1107b3722],
18	potential	JJ	O	potential	amod	19	SENT_575	[p27l1124t3672r1356b3734],
19	biomarkers	NNS	O	biomarker	prep_as	16	SENT_575	[p27l1375t3672r1668b3722],
20	for	IN	O	for	_	0	SENT_575	[p27l1681t3671r1754b3722],
21	Alzheimer	NN	O	alzheimer	poss	23	SENT_575	[p27l1766t3672r2067b3722],
22	's	POS	O	's	_	0	SENT_575	[p27l1766t3672r2067b3722],
23	disease	NN	O	disease	prep_for	19	SENT_575	[p27l132t3749r381b3798],
24	.	.	O	.	_	0	SENT_575	[p27l132t3749r381b3798],

1	J.	NNP	PERSON	J.	nn	2	SENT_576	[p27l132t3749r381b3798],
2	Neurosci	NNP	PERSON	Neurosci	_	0	SENT_576	[p27l396t3751r624b3798],
3	.	.	O	.	_	0	SENT_576	[p27l396t3751r624b3798],

1	Res	NNP	O	Res	_	0	SENT_577	[p27l639t3751r734b3798],
2	.	.	O	.	_	0	SENT_577	[p27l639t3751r734b3798],

1	90	CD	NUMBER	90	_	0	SENT_578	[p27l749t3752r829b3806],
2	,	,	O	,	_	0	SENT_578	[p27l749t3752r829b3806],
3	2247-2258	CD	DATE	2247-2258	number	4	SENT_578	[p27l844t3752r1133b3798],
4	(	CD	NUMBER	(	appos	1	SENT_578	[p27l1149t3750r1324b3805],
5	2012	CD	DATE	2012	num	6	SENT_578	[p27l1149t3750r1324b3805],
6	)	NN	O	)	dep	4	SENT_578	[p27l1149t3750r1324b3805],
7	.	.	O	.	_	0	SENT_578	[p27l1149t3750r1324b3805],

1	Verheijen	NNP	PERSON	Verheijen	_	0	SENT_579	[p28l129t18r382b81],
2	,	,	O	,	_	0	SENT_579	[p28l129t18r382b81],
3	J.H.	NNP	PERSON	J.H.	nn	4	SENT_579	[p28l393t20r479b68],
4	etal	NNP	O	etal	appos	1	SENT_579	[p28l491t18r601b68],
5	.	.	O	.	_	0	SENT_579	[p28l491t18r601b68],

1	Detection	NN	O	detection	_	0	SENT_580	[p28l616t20r863b68],
2	of	IN	O	of	_	0	SENT_580	[p28l877t17r931b68],
3	a	DT	O	a	det	5	SENT_580	[p28l938t33r964b68],
4	soluble	JJ	O	soluble	amod	5	SENT_580	[p28l978t18r1162b68],
5	form	NN	O	form	prep_of	1	SENT_580	[p28l1173t17r1293b68],
6	of	IN	O	of	_	0	SENT_580	[p28l1308t17r1361b68],
7	BACE	NNP	O	BACE	prep_of	5	SENT_580	[p28l1371t20r1543b68],
8	—	CD	NUMBER	—	number	9	SENT_580	[p28l1371t20r1543b68],
9	1	CD	NUMBER	1	dep	1	SENT_580	[p28l1371t20r1543b68],
10	in	IN	O	in	_	0	SENT_580	[p28l1568t20r1609b67],
11	human	JJ	O	human	amod	13	SENT_580	[p28l1626t18r1804b68],
12	cerebrospinal	JJ	O	cerebrospinal	amod	13	SENT_580	[p28l132t96r475b159],
13	ﬂuid	NN	O	ﬂuid	prep_in	9	SENT_580	[p28l489t96r601b146],
14	by	IN	O	by	_	0	SENT_580	[p28l617t96r678b160],
15	a	DT	O	a	det	18	SENT_580	[p28l688t111r714b146],
16	sensitive	JJ	O	sensitive	amod	18	SENT_580	[p28l729t99r947b146],
17	activity	NN	O	activity	nn	18	SENT_580	[p28l959t99r1143b160],
18	assay	NN	O	assay	prep_by	13	SENT_580	[p28l1154t111r1297b160],
19	.	.	O	.	_	0	SENT_580	[p28l1154t111r1297b160],

1	Clin	NNP	O	Clin	_	0	SENT_581	[p28l1311t96r1411b146],
2	.	.	O	.	_	0	SENT_581	[p28l1311t96r1411b146],

1	Chem	NNP	O	Chem	_	0	SENT_582	[p28l1426t96r1580b146],
2	.	.	O	.	_	0	SENT_582	[p28l1426t96r1580b146],

1	52	CD	NUMBER	52	_	0	SENT_583	[p28l1593t100r1671b154],
2	,	,	O	,	_	0	SENT_583	[p28l1593t100r1671b154],
3	1	CD	NUMBER	1	num	4	SENT_583	[p28l1688t100r1702b145],
4	168-1	CD	NUMBER	168-1	appos	1	SENT_583	[p28l1719t99r1860b146],
5	1	CD	NUMBER	1	number	6	SENT_583	[p28l1877t100r1892b145],
6	74	CD	NUMBER	74	dep	4	SENT_583	[p28l1906t100r1966b145],
7	(	CD	NUMBER	(	num	9	SENT_583	[p28l1980t97r2148b154],
8	2006	CD	DATE	2006	num	9	SENT_583	[p28l1980t97r2148b154],
9	)	NN	O	)	dep	6	SENT_583	[p28l1980t97r2148b154],
10	.	.	O	.	_	0	SENT_583	[p28l1980t97r2148b154],

1	Cummings	NNP	PERSON	Cummings	_	0	SENT_584	[p28l130t176r428b237],
2	,	,	O	,	_	0	SENT_584	[p28l130t176r428b237],
3	J.L.	NNP	PERSON	J.L.	nn	4	SENT_584	[p28l441t177r517b224],
4	Deﬁning	NNP	PERSON	Deﬁning	appos	1	SENT_584	[p28l535t174r755b237],
5	and	CC	O	and	_	0	SENT_584	[p28l772t174r868b224],
6	labeling	VBG	O	label	appos	1	SENT_584	[p28l887t174r1094b237],
7	disease	NN	O	disease	nn	8	SENT_584	[p28l1111t174r1595b238],
8	—	NN	O	—	dobj	6	SENT_584	[p28l1111t174r1595b238],
9	modifying	VBG	O	modify	partmod	8	SENT_584	[p28l1111t174r1595b238],
10	treatments	NNS	O	treatment	dobj	9	SENT_584	[p28l1610t182r1899b224],
11	for	IN	O	for	_	0	SENT_584	[p28l1912t174r1984b224],
12	Alzheimer	NN	O	alzheimer	poss	14	SENT_584	[p28l131t251r433b300],
13	's	POS	O	's	_	0	SENT_584	[p28l131t251r433b300],
14	disease	NN	O	disease	prep_for	10	SENT_584	[p28l447t251r652b300],
15	.	.	O	.	_	0	SENT_584	[p28l447t251r652b300],

1	Alzheimers	NNPS	O	Alzheimers	_	0	SENT_585	[p28l662t251r942b300],
2	Dement	NNP	O	Dement	dep	1	SENT_585	[p28l954t253r1168b300],
3	.	.	O	.	_	0	SENT_585	[p28l954t253r1168b300],

1	5	CD	NUMBER	5	_	0	SENT_586	[p28l1184t255r1227b308],
2	,	,	O	,	_	0	SENT_586	[p28l1184t255r1227b308],
3	406-418	CD	NUMBER	406-418	number	4	SENT_586	[p28l1241t254r1467b300],
4	(	CD	NUMBER	(	appos	1	SENT_586	[p28l1483t252r1657b308],
5	2009	CD	DATE	2009	num	6	SENT_586	[p28l1483t252r1657b308],
6	)	NN	O	)	dep	4	SENT_586	[p28l1483t252r1657b308],
7	.	.	O	.	_	0	SENT_586	[p28l1483t252r1657b308],

1	Beach	NNP	O	Beach	_	0	SENT_587	[p28l133t329r417b387],
2	,	,	O	,	_	0	SENT_587	[p28l133t329r417b387],
3	T.G.	NNP	PERSON	T.G.	conj_and	1	SENT_587	[p28l133t329r417b387],
4	,	,	O	,	_	0	SENT_587	[p28l133t329r417b387],
5	Monsell	NNP	LOCATION	Monsell	conj_and	1	SENT_587	[p28l433t329r650b387],
6	,	,	O	,	_	0	SENT_587	[p28l433t329r650b387],
7	S.E.	NNP	LOCATION	S.E.	conj_and	1	SENT_587	[p28l664t331r762b387],
8	,	,	O	,	_	0	SENT_587	[p28l664t331r762b387],
9	Phillips	NNP	PERSON	Phillips	conj_and	1	SENT_587	[p28l779t329r974b392],
10	,	,	O	,	_	0	SENT_587	[p28l779t329r974b392],
11	L.E.	NNP	ORGANIZATION	L.E.	conj_and	1	SENT_587	[p28l992t332r1072b379],
12	&	CC	ORGANIZATION	&	_	0	SENT_587	[p28l1086t331r1123b379],
13	Kukull	NNP	ORGANIZATION	Kukull	conj_and	1	SENT_587	[p28l1139t329r1309b387],
14	,	,	O	,	_	0	SENT_587	[p28l1139t329r1309b387],
15	W.	NNP	O	W.	nn	16	SENT_587	[p28l1320t332r1381b379],
16	Accuracy	NNP	O	Accuracy	appos	1	SENT_587	[p28l1395t332r1634b393],
17	of	IN	O	of	_	0	SENT_587	[p28l1647t329r1701b379],
18	the	DT	O	the	det	20	SENT_587	[p28l1710t329r1796b379],
19	clinical	JJ	O	clinical	amod	20	SENT_587	[p28l1810t329r1986b379],
20	diagnosis	NN	O	diagnosis	prep_of	16	SENT_587	[p28l132t407r380b470],
21	of	IN	O	of	_	0	SENT_587	[p28l395t407r449b457],
22	Alzheimer	NN	O	alzheimer	nn	23	SENT_587	[p28l459t407r726b457],
23	disease	NN	O	disease	prep_of	20	SENT_587	[p28l739t407r931b457],
24	at	IN	O	at	_	0	SENT_587	[p28l945t415r994b457],
25	National	NNP	ORGANIZATION	National	nn	26	SENT_587	[p28l1010t407r1226b457],
26	Institute	NNP	ORGANIZATION	Institute	prep_at	23	SENT_587	[p28l1245t410r1459b457],
27	on	IN	ORGANIZATION	on	_	0	SENT_587	[p28l1474t422r1539b457],
28	Aging	NNP	ORGANIZATION	Aging	nn	31	SENT_587	[p28l1554t410r1709b470],
29	Alzheimer	NNP	ORGANIZATION	Alzheimer	nn	31	SENT_587	[p28l1724t407r1992b457],
30	Disease	NNP	ORGANIZATION	Disease	nn	31	SENT_587	[p28l134t487r330b535],
31	Centers	NNPS	ORGANIZATION	Centers	prep_on	26	SENT_587	[p28l345t487r555b543],
32	,	,	O	,	_	0	SENT_587	[p28l345t487r555b543],
33	2005-2010	CD	DATE	2005-2010	appos	1	SENT_587	[p28l570t488r905b535],
34	.	.	O	.	_	0	SENT_587	[p28l570t488r905b535],

1	}	NN	O	}	_	0	SENT_588	[p28l570t488r905b535],
2	.	.	O	.	_	0	SENT_588	[p28l570t488r905b535],

1	Neuropathol	NNP	PERSON	Neuropathol	_	0	SENT_589	[p28l920t485r1251b548],
2	.	.	O	.	_	0	SENT_589	[p28l920t485r1251b548],

1	Exp	NN	O	exp	_	0	SENT_590	[p28l1266t488r1363b548],
2	.	.	O	.	_	0	SENT_590	[p28l1266t488r1363b548],

1	Neurol	NNP	O	Neurol	_	0	SENT_591	[p28l1378t485r1558b535],
2	.	.	O	.	_	0	SENT_591	[p28l1378t485r1558b535],

1	71	CD	NUMBER	71	_	0	SENT_592	[p28l1573t489r1652b543],
2	,	,	O	,	_	0	SENT_592	[p28l1573t489r1652b543],
3	266-273	CD	NUMBER	266-273	number	4	SENT_592	[p28l1667t488r1889b535],
4	(	CD	NUMBER	(	appos	1	SENT_592	[p28l1908t486r2082b543],
5	2012	CD	DATE	2012	num	6	SENT_592	[p28l1908t486r2082b543],
6	)	NN	O	)	dep	4	SENT_592	[p28l1908t486r2082b543],
7	.	.	O	.	_	0	SENT_592	[p28l1908t486r2082b543],

1	Cummings	NNP	PERSON	Cummings	nn	8	SENT_593	[p28l130t565r428b626],
2	,	,	O	,	_	0	SENT_593	[p28l130t565r428b626],
3	J.L.	NNP	PERSON	J.L.	nn	4	SENT_593	[p28l441t566r517b613],
4	Alzheimer	NNP	PERSON	Alzheimer	poss	6	SENT_593	[p28l531t563r832b613],
5	's	POS	O	's	_	0	SENT_593	[p28l531t563r832b613],
6	disease	NN	O	disease	appos	1	SENT_593	[p28l847t563r1039b613],
7	clinical	JJ	O	clinical	amod	8	SENT_593	[p28l1053t563r1230b613],
8	trials	NNS	O	trial	_	0	SENT_593	[p28l1245t563r1383b613],
9	:	:	O	:	_	0	SENT_593	[p28l1245t563r1383b613],
10	changing	VBG	O	change	dep	8	SENT_593	[p28l1398t563r1643b626],
11	the	DT	O	the	det	12	SENT_593	[p28l1658t563r1744b613],
12	paradigm	NN	O	paradigm	dobj	10	SENT_593	[p28l1760t563r2025b626],
13	.	.	O	.	_	0	SENT_593	[p28l1760t563r2025b626],

1	Curr	NN	O	curr	_	0	SENT_594	[p28l2040t565r2153b613],
2	.	.	O	.	_	0	SENT_594	[p28l2040t565r2153b613],

1	Psychiatry	NNP	O	Psychiatry	nn	2	SENT_595	[p28l132t641r393b705],
2	Rep.	NNP	O	Rep.	_	0	SENT_595	[p28l402t643r507b704],
3	13	CD	NUMBER	13	num	2	SENT_595	[p28l524t644r601b699],
4	,	,	O	,	_	0	SENT_595	[p28l524t644r601b699],
5	437-442	CD	NUMBER	437-442	num	2	SENT_595	[p28l614t644r839b691],
6	(	NN	O	(	dep	2	SENT_595	[p28l856t642r957b699],
7	201	CD	NUMBER	201	number	8	SENT_595	[p28l856t642r957b699],
8	1	CD	NUMBER	1	num	9	SENT_595	[p28l975t642r1031b699],
9	)	NN	O	)	dep	6	SENT_595	[p28l975t642r1031b699],
10	.	.	O	.	_	0	SENT_595	[p28l975t642r1031b699],

1	Leung	NNP	PERSON	Leung	nn	23	SENT_596	[p28l133t722r306b782],
2	,	,	O	,	_	0	SENT_596	[p28l133t722r306b782],
3	K.K.	NNP	LOCATION	K.K.	conj_and	1	SENT_596	[p28l323t722r427b777],
4	,	,	O	,	_	0	SENT_596	[p28l323t722r427b777],
5	Bartlett	NNP	PERSON	Bartlett	conj_and	1	SENT_596	[p28l444t719r648b777],
6	,	,	O	,	_	0	SENT_596	[p28l444t719r648b777],
7	J.W.	NNP	PERSON	J.W.	conj_and	1	SENT_596	[p28l660t722r771b777],
8	,	,	O	,	_	0	SENT_596	[p28l660t722r771b777],
9	Barnes	NNP	PERSON	Barnes	conj_and	1	SENT_596	[p28l788t721r973b777],
10	,	,	O	,	_	0	SENT_596	[p28l788t721r973b777],
11	J.	NNP	O	J.	conj_and	1	SENT_596	[p28l985t722r1032b777],
12	,	,	O	,	_	0	SENT_596	[p28l985t722r1032b777],
13	Manning	NNP	PERSON	Manning	conj_and	1	SENT_596	[p28l1048t722r1294b782],
14	,	,	O	,	_	0	SENT_596	[p28l1048t722r1294b782],
15	E.N.	NNP	O	E.N.	nn	23	SENT_596	[p28l1311t722r1417b777],
16	,	,	O	,	_	0	SENT_596	[p28l1311t722r1417b777],
17	Ourselin	NNP	LOCATION	Ourselin	nn	23	SENT_596	[p28l1431t719r1663b777],
18	,	,	O	,	_	0	SENT_596	[p28l1431t719r1663b777],
19	S.	NNP	ORGANIZATION	S.	nn	23	SENT_596	[p28l1678t721r1718b769],
20	&	CC	ORGANIZATION	&	_	0	SENT_596	[p28l1732t721r1769b769],
21	Fox	NNP	ORGANIZATION	Fox	nn	23	SENT_596	[p28l1784t722r1884b777],
22	,	,	O	,	_	0	SENT_596	[p28l1784t722r1884b777],
23	N.C.	NNP	LOCATION	N.C.	_	0	SENT_596	[p28l1900t721r2013b777],
24	;	:	O	;	_	0	SENT_596	[p28l1900t721r2013b777],
25	Alzheimer	NNP	O	Alzheimer	poss	29	SENT_596	[p28l131t797r433b847],
26	's	POS	O	's	_	0	SENT_596	[p28l131t797r433b847],
27	Disease	NNP	O	Disease	nn	29	SENT_596	[p28l449t799r646b847],
28	Neuroimaging	NNP	O	Neuroimaging	nn	29	SENT_596	[p28l663t800r1039b860],
29	Initiative	NNP	O	Initiative	dep	23	SENT_596	[p28l1057t800r1293b847],
30	.	.	O	.	_	0	SENT_596	[p28l1057t800r1293b847],

1	Cerebral	JJ	MISC	cerebral	amod	2	SENT_597	[p28l1308t797r1524b847],
2	atrophy	NN	O	atrophy	_	0	SENT_597	[p28l1541t797r1747b861],
3	in	IN	O	in	_	0	SENT_597	[p28l1761t800r1804b846],
4	mild	JJ	O	mild	amod	6	SENT_597	[p28l1822t797r1933b847],
5	cognitive	JJ	O	cognitive	amod	6	SENT_597	[p28l132t878r374b938],
6	impairment	NN	O	impairment	prep_in	2	SENT_597	[p28l391t878r698b938],
7	and	CC	O	and	_	0	SENT_597	[p28l712t875r808b925],
8	Alzheimer	NN	O	alzheimer	nn	9	SENT_597	[p28l824t875r1092b925],
9	disease	NN	O	disease	prep_in	2	SENT_597	[p28l1105t875r1310b925],
10	:	:	O	:	_	0	SENT_597	[p28l1105t875r1310b925],
11	rates	NNS	O	rate	dep	2	SENT_597	[p28l1326t883r1449b925],
12	and	CC	O	and	_	0	SENT_597	[p28l1463t875r1560b925],
13	acceleration	NN	O	acceleration	conj_and	11	SENT_597	[p28l1576t875r1908b925],
14	.	.	O	.	_	0	SENT_597	[p28l1576t875r1908b925],

1	Neurology	NN	O	neurology	_	0	SENT_598	[p28l132t953r397b1017],
2	80	CD	NUMBER	80	num	1	SENT_598	[p28l407t956r488b1011],
3	,	,	O	,	_	0	SENT_598	[p28l407t956r488b1011],
4	648-654	CD	NUMBER	648-654	num	5	SENT_598	[p28l502t956r728b1003],
5	(	NN	O	(	appos	1	SENT_598	[p28l743t954r844b1011],
6	201	CD	NUMBER	201	number	7	SENT_598	[p28l743t954r844b1011],
7	3	CD	NUMBER	3	num	8	SENT_598	[p28l858t954r917b1011],
8	)	NN	O	)	dep	5	SENT_598	[p28l858t954r917b1011],
9	.	.	O	.	_	0	SENT_598	[p28l858t954r917b1011],

1	Fleisher	NNP	PERSON	Fleisher	nn	4	SENT_599	[p28l133t1031r341b1089],
2	,	,	O	,	_	0	SENT_599	[p28l133t1031r341b1089],
3	A.S.	NNP	O	A.S.	appos	4	SENT_599	[p28l355t1033r448b1081],
4	etal.	NNP	O	etal.	_	0	SENT_599	[p28l462t1031r590b1089],
5	;	:	O	;	_	0	SENT_599	[p28l462t1031r590b1089],
6	Alzheimer	NNP	O	Alzheimer	poss	8	SENT_599	[p28l604t1031r905b1081],
7	's	POS	O	's	_	0	SENT_599	[p28l604t1031r905b1081],
8	Disease	NN	O	disease	dep	4	SENT_599	[p28l923t1033r1119b1081],
9	Cooperative	NNP	O	Cooperative	nn	10	SENT_599	[p28l1133t1033r1452b1094],
10	Study	NNP	O	Study	dep	8	SENT_599	[p28l1467t1031r1627b1095],
11	.	.	O	.	_	0	SENT_599	[p28l1467t1031r1627b1095],

1	Chronic	JJ	O	chronic	amod	4	SENT_600	[p28l1642t1031r1844b1081],
2	divalproex	NN	O	divalproex	nn	4	SENT_600	[p28l1859t1031r2135b1094],
3	sodium	NN	O	sodium	nn	4	SENT_600	[p28l132t1109r325b1159],
4	use	NN	O	use	_	0	SENT_600	[p28l344t1124r430b1159],
5	and	CC	O	and	_	0	SENT_600	[p28l445t1109r541b1159],
6	brain	NN	O	brain	nn	7	SENT_600	[p28l560t1109r689b1159],
7	atrophy	NN	O	atrophy	conj_and	4	SENT_600	[p28l706t1109r912b1173],
8	in	IN	O	in	_	0	SENT_600	[p28l926t1112r968b1158],
9	Alzheimer	NN	O	alzheimer	nn	10	SENT_600	[p28l984t1109r1252b1159],
10	disease	NN	O	disease	prep_in	4	SENT_600	[p28l1265t1109r1469b1159],
11	.	.	O	.	_	0	SENT_600	[p28l1265t1109r1469b1159],

1	Neurology	NN	O	neurology	_	0	SENT_601	[p28l1483t1109r1749b1173],
2	77	CD	NUMBER	77	num	1	SENT_601	[p28l1760t1113r1839b1167],
3	,	,	O	,	_	0	SENT_601	[p28l1760t1113r1839b1167],
4	1263-1271	CD	DATE	1263-1271	num	5	SENT_601	[p28l1858t1113r2133b1159],
5	(	NN	O	(	appos	1	SENT_601	[p28l133t1187r234b1243],
6	201	CD	NUMBER	201	number	7	SENT_601	[p28l133t1187r234b1243],
7	1	CD	NUMBER	1	num	8	SENT_601	[p28l252t1187r308b1243],
8	)	NN	O	)	dep	5	SENT_601	[p28l252t1187r308b1243],
9	.	.	O	.	_	0	SENT_601	[p28l252t1187r308b1243],

1	Schott	NNP	PERSON	Schott	_	0	SENT_602	[p28l131t1264r312b1322],
2	,	,	O	,	_	0	SENT_602	[p28l131t1264r312b1322],
3	J.M.	NNP	O	J.M.	conj_and	1	SENT_602	[p28l324t1267r436b1322],
4	,	,	O	,	_	0	SENT_602	[p28l324t1267r436b1322],
5	Bartlett	NNP	PERSON	Bartlett	conj_and	1	SENT_602	[p28l453t1264r657b1322],
6	,	,	O	,	_	0	SENT_602	[p28l453t1264r657b1322],
7	J.W.	NNP	PERSON	J.W.	conj_and	1	SENT_602	[p28l669t1267r780b1322],
8	,	,	O	,	_	0	SENT_602	[p28l669t1267r780b1322],
9	Barnes	NNP	PERSON	Barnes	conj_and	1	SENT_602	[p28l797t1266r982b1322],
10	,	,	O	,	_	0	SENT_602	[p28l797t1266r982b1322],
11	J.	NNP	O	J.	conj_and	1	SENT_602	[p28l994t1267r1041b1322],
12	,	,	O	,	_	0	SENT_602	[p28l994t1267r1041b1322],
13	Leung	NNP	PERSON	Leung	conj_and	1	SENT_602	[p28l1058t1267r1231b1327],
14	,	,	O	,	_	0	SENT_602	[p28l1058t1267r1231b1327],
15	K.K.	NNP	LOCATION	K.K.	conj_and	1	SENT_602	[p28l1248t1267r1352b1322],
16	,	,	O	,	_	0	SENT_602	[p28l1248t1267r1352b1322],
17	Ourselin	NNP	LOCATION	Ourselin	conj_and	1	SENT_602	[p28l1366t1264r1598b1322],
18	,	,	O	,	_	0	SENT_602	[p28l1366t1264r1598b1322],
19	S.	NNP	ORGANIZATION	S.	conj_and	1	SENT_602	[p28l1613t1266r1653b1314],
20	&	CC	ORGANIZATION	&	_	0	SENT_602	[p28l1667t1266r1704b1314],
21	Fox	NNP	ORGANIZATION	Fox	conj_and	1	SENT_602	[p28l1720t1267r1819b1322],
22	,	,	O	,	_	0	SENT_602	[p28l1720t1267r1819b1322],
23	N.C.	NNP	LOCATION	N.C.	appos	1	SENT_602	[p28l1836t1266r1948b1322],
24	;	:	O	;	_	0	SENT_602	[p28l1836t1266r1948b1322],
25	Alzheimer	NNP	O	Alzheimer	poss	29	SENT_602	[p28l131t1342r432b1392],
26	's	POS	O	's	_	0	SENT_602	[p28l131t1342r432b1392],
27	Disease	NNP	O	Disease	nn	29	SENT_602	[p28l449t1344r646b1392],
28	Neuroimaging	NNP	O	Neuroimaging	nn	29	SENT_602	[p28l663t1345r1039b1405],
29	Initiative	NNP	O	Initiative	dep	1	SENT_602	[p28l1057t1345r1281b1392],
30	investigators	NNS	O	investigator	dep	29	SENT_602	[p28l1297t1345r1644b1405],
31	.	.	O	.	_	0	SENT_602	[p28l1297t1345r1644b1405],

1	Reduced	VBN	O	reduce	amod	3	SENT_603	[p28l1661t1342r1886b1392],
2	sample	NN	O	sample	nn	3	SENT_603	[p28l1903t1342r2092b1405],
3	sizes	NNS	O	size	_	0	SENT_603	[p28l132t1423r251b1470],
4	for	IN	O	for	_	0	SENT_603	[p28l265t1420r337b1470],
5	atrophy	NN	O	atrophy	nn	6	SENT_603	[p28l350t1420r556b1484],
6	outcomes	NNS	O	outcome	prep_for	3	SENT_603	[p28l568t1428r829b1470],
7	in	IN	O	in	_	0	SENT_603	[p28l845t1423r888b1469],
8	Alzheimer	NN	O	alzheimer	poss	11	SENT_603	[p28l904t1420r1205b1470],
9	's	POS	O	's	_	0	SENT_603	[p28l904t1420r1205b1470],
10	disease	NN	O	disease	nn	11	SENT_603	[p28l1220t1420r1412b1470],
11	trials	NNS	O	trial	prep_in	3	SENT_603	[p28l1425t1420r1563b1470],
12	:	:	O	:	_	0	SENT_603	[p28l1425t1420r1563b1470],
13	baseline	NN	O	baseline	dep	3	SENT_603	[p28l1579t1420r1795b1470],
14	adjustment	NN	O	adjustment	dep	13	SENT_603	[p28l1809t1420r2123b1483],
15	.	.	O	.	_	0	SENT_603	[p28l1809t1420r2123b1483],

1	Neurobiol	NNP	O	Neurobiol	_	0	SENT_604	[p28l131t1498r389b1548],
2	.	.	O	.	_	0	SENT_604	[p28l131t1498r389b1548],

1	Aging	NN	O	aging	_	0	SENT_605	[p28l401t1501r552b1561],
2	31	CD	NUMBER	31	num	1	SENT_605	[p28l566t1501r646b1556],
3	,	,	O	,	_	0	SENT_605	[p28l566t1501r646b1556],
4	1452-62	CD	NUMBER	1452-62	appos	1	SENT_605	[p28l665t1501r898b1556],
5	,	,	O	,	_	0	SENT_605	[p28l665t1501r898b1556],
6	1462	CD	DATE	1462	appos	4	SENT_605	[p28l917t1501r1107b1548],
7	.	.	O	.	_	0	SENT_605	[p28l917t1501r1107b1548],

1	e1	NN	O	e1	_	0	SENT_606	[p28l917t1501r1107b1548],
2	(	CD	NUMBER	(	num	1	SENT_606	[p28l1134t1499r1308b1556],
3	2010	CD	DATE	2010	num	4	SENT_606	[p28l1134t1499r1308b1556],
4	)	NN	O	)	dep	1	SENT_606	[p28l1134t1499r1308b1556],
5	.	.	O	.	_	0	SENT_606	[p28l1134t1499r1308b1556],

1	Holland	NNP	PERSON	Holland	nn	15	SENT_607	[p28l133t1576r347b1634],
2	,	,	O	,	_	0	SENT_607	[p28l133t1576r347b1634],
3	D.	NNP	O	D.	conj_and	1	SENT_607	[p28l364t1578r424b1634],
4	,	,	O	,	_	0	SENT_607	[p28l364t1578r424b1634],
5	McEvoy	NNP	PERSON	McEvoy	conj_and	1	SENT_607	[p28l440t1579r651b1640],
6	,	,	O	,	_	0	SENT_607	[p28l440t1579r651b1640],
7	L.K.	NNP	LOCATION	L.K.	conj_and	1	SENT_607	[p28l668t1579r767b1634],
8	,	,	O	,	_	0	SENT_607	[p28l668t1579r767b1634],
9	Desikan	NNP	LOCATION	Desikan	conj_and	1	SENT_607	[p28l784t1576r1002b1634],
10	,	,	O	,	_	0	SENT_607	[p28l784t1576r1002b1634],
11	R.S.	NNP	ORGANIZATION	R.S.	conj_and	1	SENT_607	[p28l1019t1578r1105b1626],
12	&	CC	ORGANIZATION	&	_	0	SENT_607	[p28l1119t1578r1156b1626],
13	Dale	NNP	ORGANIZATION	Dale	conj_and	1	SENT_607	[p28l1171t1576r1297b1634],
14	,	,	O	,	_	0	SENT_607	[p28l1171t1576r1297b1634],
15	A.M.	NNP	O	A.M.	_	0	SENT_607	[p28l1311t1579r1438b1634],
16	;	:	O	;	_	0	SENT_607	[p28l1311t1579r1438b1634],
17	Alzheimer	NNP	O	Alzheimer	poss	21	SENT_607	[p28l1452t1576r1753b1626],
18	's	POS	O	's	_	0	SENT_607	[p28l1452t1576r1753b1626],
19	Disease	NNP	O	Disease	nn	21	SENT_607	[p28l1770t1578r1966b1626],
20	Neuroimaging	NNP	O	Neuroimaging	nn	21	SENT_607	[p28l134t1657r510b1718],
21	Initiative	NNP	O	Initiative	dep	15	SENT_607	[p28l529t1657r765b1704],
22	.	.	O	.	_	0	SENT_607	[p28l529t1657r765b1704],

1	Enrichment	NN	O	enrichment	_	0	SENT_608	[p28l782t1654r1084b1704],
2	and	CC	O	and	_	0	SENT_608	[p28l1098t1654r1194b1704],
3	stratiﬁcation	NN	O	stratiﬁcation	conj_and	1	SENT_608	[p28l1211t1654r1536b1704],
4	for	IN	O	for	_	0	SENT_608	[p28l1551t1654r1624b1704],
5	predementia	NN	O	predementium	nn	9	SENT_608	[p28l1639t1654r1975b1717],
6	Alzheimer	NN	O	alzheimer	nn	9	SENT_608	[p28l131t1731r398b1781],
7	disease	NN	O	disease	nn	9	SENT_608	[p28l412t1731r604b1781],
8	clinical	JJ	O	clinical	amod	9	SENT_608	[p28l618t1731r794b1781],
9	trials	NNS	O	trial	prep_for	1	SENT_608	[p28l810t1731r947b1781],
10	.	.	O	.	_	0	SENT_608	[p28l810t1731r947b1781],

1	PLoS	NN	O	plo	_	0	SENT_609	[p28l961t1733r1082b1781],
2	ONE	CD	NUMBER	one	number	3	SENT_609	[p28l1093t1733r1206b1781],
3	7	CD	NUMBER	7	amod	1	SENT_609	[p28l1217t1735r1260b1788],
4	,	,	O	,	_	0	SENT_609	[p28l1217t1735r1260b1788],
5	e47739	NN	O	e47739	appos	1	SENT_609	[p28l1275t1735r1467b1781],
6	(	CD	NUMBER	(	num	5	SENT_609	[p28l1483t1732r1657b1788],
7	2012	CD	DATE	2012	num	8	SENT_609	[p28l1483t1732r1657b1788],
8	)	NN	O	)	dep	5	SENT_609	[p28l1483t1732r1657b1788],
9	.	.	O	.	_	0	SENT_609	[p28l1483t1732r1657b1788],

1	Fox	NNP	PERSON	Fox	nn	4	SENT_610	[p28l132t2017r231b2072],
2	,	,	O	,	_	0	SENT_610	[p28l132t2017r231b2072],
3	N.C.	NNP	LOCATION	N.C.	appos	4	SENT_610	[p28l248t2014r1014b2072],
4	etal.	NNP	O	etal.	_	0	SENT_610	[p28l248t2014r1014b2072],
5	;	:	O	;	_	0	SENT_610	[p28l248t2014r1014b2072],
6	AN1792	NN	O	an1792	nn	8	SENT_610	[p28l248t2014r1014b2072],
7	(	CD	NUMBER	(	num	8	SENT_610	[p28l248t2014r1014b2072],
8	QS	NN	O	q	dep	4	SENT_610	[p28l248t2014r1014b2072],
9	.	.	O	.	_	0	SENT_610	[p28l248t2014r1014b2072],

1	—	NN	O	—	_	0	SENT_611	[p28l248t2014r1014b2072],
2	.	.	O	.	_	0	SENT_611	[p28l248t2014r1014b2072],

1	21	CD	NUMBER	21	_	0	SENT_612	[p28l248t2014r1014b2072],
2	)	NN	O	)	dep	1	SENT_612	[p28l248t2014r1014b2072],
3	.	.	O	.	_	0	SENT_612	[p28l248t2014r1014b2072],

1	—	NN	O	—	_	0	SENT_613	[p28l248t2014r1014b2072],
2	.	.	O	.	_	0	SENT_613	[p28l248t2014r1014b2072],

1	201	CD	NUMBER	201	_	0	SENT_614	[p28l248t2014r1014b2072],
2	Study	NN	O	study	dep	1	SENT_614	[p28l1039t2014r1199b2078],
3	.	.	O	.	_	0	SENT_614	[p28l1039t2014r1199b2078],

1	Effects	NNS	O	effect	_	0	SENT_615	[p28l1215t2014r1384b2064],
2	of	IN	O	of	_	0	SENT_615	[p28l1399t2014r1453b2064],
3	Abeta	NN	O	abeta	nn	4	SENT_615	[p28l1462t2014r1616b2064],
4	immunization	NN	O	immunization	prep_of	1	SENT_615	[p28l1634t2017r1996b2064],
5	(	CD	NUMBER	(	num	7	SENT_615	[p28l133t2092r372b2148],
6	AN1792	NN	O	an1792	nn	7	SENT_615	[p28l133t2092r372b2148],
7	)	NN	O	)	dep	1	SENT_615	[p28l133t2092r372b2148],
8	on	IN	O	on	_	0	SENT_615	[p28l388t2106r453b2141],
9	MRI	NNP	O	MRI	nn	10	SENT_615	[p28l471t2093r564b2140],
10	measures	NNS	O	measure	prep_on	7	SENT_615	[p28l583t2106r830b2141],
11	of	IN	O	of	_	0	SENT_615	[p28l845t2091r899b2141],
12	cerebral	JJ	O	cerebral	amod	13	SENT_615	[p28l909t2091r1117b2141],
13	volume	NN	O	volume	prep_of	10	SENT_615	[p28l1133t2091r1330b2141],
14	in	IN	O	in	_	0	SENT_615	[p28l1346t2094r1389b2140],
15	Alzheimer	NN	O	alzheimer	nn	16	SENT_615	[p28l1405t2091r1672b2141],
16	disease	NN	O	disease	prep_in	13	SENT_615	[p28l1685t2091r1889b2141],
17	.	.	O	.	_	0	SENT_615	[p28l1685t2091r1889b2141],

1	Neurology	NN	O	neurology	_	0	SENT_616	[p28l131t2169r396b2233],
2	64	CD	NUMBER	64	num	1	SENT_616	[p28l406t2173r486b2227],
3	,	,	O	,	_	0	SENT_616	[p28l406t2173r486b2227],
4	1563-1572	CD	DATE	1563-1572	number	5	SENT_616	[p28l505t2173r789b2219],
5	(	CD	NUMBER	(	appos	1	SENT_616	[p28l807t2170r981b2227],
6	2005	CD	DATE	2005	num	7	SENT_616	[p28l807t2170r981b2227],
7	)	NN	O	)	dep	5	SENT_616	[p28l807t2170r981b2227],
8	.	.	O	.	_	0	SENT_616	[p28l807t2170r981b2227],

1	Fagan	NNP	PERSON	Fagan	_	0	SENT_617	[p28l132t2250r299b2311],
2	,	,	O	,	_	0	SENT_617	[p28l132t2250r299b2311],
3	A.M.	NNP	O	A.M.	nn	4	SENT_617	[p28l313t2250r426b2297],
4	etal	NN	O	etal	appos	1	SENT_617	[p28l440t2247r555b2297],
5	.	.	O	.	_	0	SENT_617	[p28l440t2247r555b2297],

1	Inverse	JJ	O	inverse	amod	2	SENT_618	[p28l572t2250r755b2297],
2	relation	NN	O	relation	_	0	SENT_618	[p28l772t2247r968b2297],
3	between	IN	O	between	amod	2	SENT_618	[p28l986t2247r1213b2297],
4	in	FW	O	in	prep	2	SENT_618	[p28l1230t2250r1274b2296],
5	vivo	FW	O	vivo	pobj	4	SENT_618	[p28l1288t2250r1389b2297],
6	amyloid	NN	O	amyloid	nn	8	SENT_618	[p28l1403t2247r1611b2311],
7	imaging	NN	O	imaging	nn	8	SENT_618	[p28l1629t2250r1841b2311],
8	load	NN	O	load	dep	2	SENT_618	[p28l1860t2247r1968b2297],
9	and	CC	O	and	_	0	SENT_618	[p28l1985t2247r2081b2297],
10	cerebrospinal	JJ	O	cerebrospinal	amod	12	SENT_618	[p28l131t2325r485b2388],
11	ﬂuid	NN	O	ﬂuid	nn	12	SENT_618	[p28l501t2325r615b2375],
12	Abeta42	NN	O	abeta42	dep	2	SENT_618	[p28l631t2325r851b2375],
13	in	IN	O	in	_	0	SENT_618	[p28l868t2328r910b2375],
14	humans	NNS	O	human	prep_in	8	SENT_618	[p28l929t2325r1277b2375],
15	.	.	O	.	_	0	SENT_618	[p28l929t2325r1277b2375],

1	Ann	NNP	PERSON	Ann	_	0	SENT_619	[p28l929t2325r1277b2375],
2	.	.	O	.	_	0	SENT_619	[p28l929t2325r1277b2375],

1	Neurol	NNP	O	Neurol	_	0	SENT_620	[p28l1292t2325r1471b2375],
2	.	.	O	.	_	0	SENT_620	[p28l1292t2325r1471b2375],

1	59	CD	NUMBER	59	_	0	SENT_621	[p28l1486t2329r1566b2383],
2	,	,	O	,	_	0	SENT_621	[p28l1486t2329r1566b2383],
3	512-519	CD	NUMBER	512-519	number	4	SENT_621	[p28l1581t2329r1804b2375],
4	(	CD	NUMBER	(	appos	1	SENT_621	[p28l1820t2326r1994b2383],
5	2006	CD	DATE	2006	num	6	SENT_621	[p28l1820t2326r1994b2383],
6	)	NN	O	)	dep	4	SENT_621	[p28l1820t2326r1994b2383],
7	.	.	O	.	_	0	SENT_621	[p28l1820t2326r1994b2383],

1	Jack	NNP	PERSON	Jack	_	0	SENT_622	[p28l128t2403r252b2461],
2	,	,	O	,	_	0	SENT_622	[p28l128t2403r252b2461],
3	C.R.	NNP	PERSON	C.R.	nn	5	SENT_622	[p28l266t2405r360b2453],
4	Jr	NNP	PERSON	Jr	nn	5	SENT_622	[p28l372t2406r416b2453],
5	etal	NN	O	etal	appos	1	SENT_622	[p28l429t2403r544b2453],
6	.	.	O	.	_	0	SENT_622	[p28l429t2403r544b2453],

1	Brain	NN	O	brain	nn	2	SENT_623	[p28l561t2405r688b2453],
2	B	NN	O	b	nsubj	6	SENT_623	[p28l707t2403r968b2467],
3	—	CD	NUMBER	—	num	5	SENT_623	[p28l707t2403r968b2467],
4	amyloid	NN	O	amyloid	nn	5	SENT_623	[p28l707t2403r968b2467],
5	load	NN	O	load	dep	2	SENT_623	[p28l986t2403r1095b2453],
6	approaches	VBZ	O	approach	_	0	SENT_623	[p28l1111t2403r1417b2466],
7	a	DT	O	a	det	8	SENT_623	[p28l1432t2418r1457b2453],
8	plateau	NN	O	plateau	dobj	6	SENT_623	[p28l1475t2403r1682b2466],
9	.	.	O	.	_	0	SENT_623	[p28l1475t2403r1682b2466],

1	Neurology	NN	O	neurology	_	0	SENT_624	[p28l1696t2403r1961b2467],
2	80	CD	NUMBER	80	num	1	SENT_624	[p28l1971t2407r2051b2461],
3	,	,	O	,	_	0	SENT_624	[p28l1971t2407r2051b2461],
4	890-896	CD	NUMBER	890-896	number	5	SENT_624	[p28l131t2484r355b2530],
5	(	CD	NUMBER	(	appos	1	SENT_624	[p28l371t2481r545b2537],
6	2013	CD	DATE	2013	num	7	SENT_624	[p28l371t2481r545b2537],
7	)	NN	O	)	dep	5	SENT_624	[p28l371t2481r545b2537],
8	.	.	O	.	_	0	SENT_624	[p28l371t2481r545b2537],

1	Rinne	NNP	PERSON	Rinne	_	0	SENT_625	[p28l132t2558r734b2616],
2	,	,	O	,	_	0	SENT_625	[p28l132t2558r734b2616],
3	J.O.	NNP	PERSON	J.O.	nn	6	SENT_625	[p28l132t2558r734b2616],
4	etal	JJ	O	etal	amod	6	SENT_625	[p28l132t2558r734b2616],
5	.11	NN	NUMBER	.11	nn	6	SENT_625	[p28l132t2558r734b2616],
6	C	NN	O	c	appos	1	SENT_625	[p28l132t2558r734b2616],
7	.	.	O	.	_	0	SENT_625	[p28l132t2558r734b2616],

1	—	NN	O	—	_	0	SENT_626	[p28l132t2558r734b2616],
2	.	.	O	.	_	0	SENT_626	[p28l132t2558r734b2616],

1	PiB	NNP	O	PiB	nn	3	SENT_627	[p28l132t2558r734b2616],
2	PET	NNP	O	PET	nn	3	SENT_627	[p28l752t2561r846b2608],
3	assessment	NN	O	assessment	_	0	SENT_627	[p28l858t2566r1159b2608],
4	of	IN	O	of	_	0	SENT_627	[p28l1173t2558r1227b2608],
5	change	NN	O	change	dep	13	SENT_627	[p28l1237t2558r1430b2622],
6	in	IN	O	in	_	0	SENT_627	[p28l1447t2561r1489b2607],
7	ﬁbrillar	NN	O	ﬁbrillar	nn	8	SENT_627	[p28l1504t2558r1690b2608],
8	amy	NN	O	amy	prep_in	5	SENT_627	[p28l1703t2558r2050b2622],
9	|	CD	NUMBER	|	num	11	SENT_627	[p28l1703t2558r2050b2622],
10	oid	NN	O	oid	nn	11	SENT_627	[p28l1703t2558r2050b2622],
11	—	NN	O	—	dep	8	SENT_627	[p28l1703t2558r2050b2622],
12	beta	NN	O	beta	nn	13	SENT_627	[p28l1703t2558r2050b2622],
13	load	NN	O	load	prep_of	3	SENT_627	[p28l133t2636r242b2686],
14	in	IN	O	in	_	0	SENT_627	[p28l260t2639r302b2686],
15	patients	NNS	O	patient	prep_in	13	SENT_627	[p28l321t2639r530b2699],
16	with	IN	O	with	_	0	SENT_627	[p28l544t2636r657b2686],
17	Alzheimer	NN	O	alzheimer	poss	19	SENT_627	[p28l673t2636r974b2686],
18	's	POS	O	's	_	0	SENT_627	[p28l673t2636r974b2686],
19	disease	NN	O	disease	prep_with	15	SENT_627	[p28l988t2636r1180b2686],
20	treated	VBN	O	treat	partmod	13	SENT_627	[p28l1193t2636r1380b2686],
21	with	IN	O	with	_	0	SENT_627	[p28l1396t2636r1509b2686],
22	bapineuzumab	NN	O	bapineuzumab	prep_with	20	SENT_627	[p28l1528t2636r1938b2699],
23	:	:	O	:	_	0	SENT_627	[p28l1528t2636r1938b2699],
24	a	DT	O	a	det	25	SENT_627	[p28l1952t2651r1978b2686],
25	phase	NN	O	phase	dep	13	SENT_627	[p28l1996t2636r2149b2699],
26	2	CD	NUMBER	2	dep	25	SENT_627	[p28l131t2718r173b2772],
27	,	,	O	,	_	0	SENT_627	[p28l131t2718r173b2772],
28	double	JJ	O	double	advmod	25	SENT_627	[p28l187t2714r543b2772],
29	—	RB	O	—	advmod	30	SENT_627	[p28l187t2714r543b2772],
30	blind	JJ	O	blind	amod	3	SENT_627	[p28l187t2714r543b2772],
31	,	,	O	,	_	0	SENT_627	[p28l187t2714r543b2772],
32	placebo	NN	O	placebo	nn	33	SENT_627	[p28l560t2714r1073b2777],
33	—	NN	O	—	appos	3	SENT_627	[p28l560t2714r1073b2777],
34	controlled	VBN	O	control	partmod	33	SENT_627	[p28l560t2714r1073b2777],
35	,	,	O	,	_	0	SENT_627	[p28l560t2714r1073b2777],
36	ascending	VBG	O	ascend	xcomp	34	SENT_627	[p28l1087t2714r1505b2778],
37	—	CD	NUMBER	—	num	39	SENT_627	[p28l1087t2714r1505b2778],
38	dose	NN	O	dose	nn	39	SENT_627	[p28l1087t2714r1505b2778],
39	study	NN	O	study	dobj	36	SENT_627	[p28l1520t2714r1673b2778],
40	.	.	O	.	_	0	SENT_627	[p28l1520t2714r1673b2778],

1	LancetNeurol	NN	O	lancetneurol	_	0	SENT_628	[p28l1687t2714r2046b2764],
2	.	.	O	.	_	0	SENT_628	[p28l1687t2714r2046b2764],

1	9	CD	NUMBER	9	_	0	SENT_629	[p28l2060t2718r2105b2772],
2	,	,	O	,	_	0	SENT_629	[p28l2060t2718r2105b2772],
3	363-372	CD	NUMBER	363-372	number	4	SENT_629	[p28l131t2795r354b2841],
4	(	CD	NUMBER	(	appos	1	SENT_629	[p28l371t2792r545b2848],
5	2010	CD	DATE	2010	num	6	SENT_629	[p28l371t2792r545b2848],
6	)	NN	O	)	dep	4	SENT_629	[p28l371t2792r545b2848],
7	.	.	O	.	_	0	SENT_629	[p28l371t2792r545b2848],

1	Blennow	NNP	PERSON	Blennow	_	0	SENT_630	[p28l132t2869r370b2927],
2	,	,	O	,	_	0	SENT_630	[p28l132t2869r370b2927],
3	K.	NNP	O	K.	conj_and	1	SENT_630	[p28l387t2872r442b2927],
4	,	,	O	,	_	0	SENT_630	[p28l387t2872r442b2927],
5	Zetterberg	NNP	PERSON	Zetterberg	conj_and	1	SENT_630	[p28l456t2869r749b2933],
6	,	,	O	,	_	0	SENT_630	[p28l456t2869r749b2933],
7	H.	NNP	ORGANIZATION	H.	conj_and	1	SENT_630	[p28l766t2872r815b2919],
8	&	CC	ORGANIZATION	&	_	0	SENT_630	[p28l829t2871r865b2919],
9	Fagan	NNP	ORGANIZATION	Fagan	conj_and	1	SENT_630	[p28l881t2872r1048b2933],
10	,	,	O	,	_	0	SENT_630	[p28l881t2872r1048b2933],
11	A.M.	NNP	O	A.M.	nn	13	SENT_630	[p28l1062t2872r1175b2919],
12	Fluid	NNP	O	Fluid	nn	13	SENT_630	[p28l1192t2869r1314b2919],
13	biomarkers	NNS	O	biomarker	appos	1	SENT_630	[p28l1333t2869r1625b2919],
14	in	IN	O	in	_	0	SENT_630	[p28l1641t2872r1684b2918],
15	Alzheimer	NN	O	alzheimer	nn	16	SENT_630	[p28l1700t2869r1967b2919],
16	disease	NN	O	disease	prep_in	13	SENT_630	[p28l131t2947r335b2997],
17	.	.	O	.	_	0	SENT_630	[p28l131t2947r335b2997],

1	Cold	NNP	O	Cold	nn	3	SENT_631	[p28l350t2947r465b2997],
2	Spring	NNP	DATE	Spring	nn	3	SENT_631	[p28l473t2949r636b3011],
3	Harb	NNP	PERSON	Harb	_	0	SENT_631	[p28l648t2947r781b2997],
4	.	.	O	.	_	0	SENT_631	[p28l648t2947r781b2997],

1	Perspect	NNP	O	Perspect	_	0	SENT_632	[p28l796t2950r1017b3010],
2	.	.	O	.	_	0	SENT_632	[p28l796t2950r1017b3010],

1	Med	NNP	O	Med	_	0	SENT_633	[p28l1031t2947r1153b2997],
2	.	.	O	.	_	0	SENT_633	[p28l1031t2947r1153b2997],

1	2	CD	NUMBER	2	_	0	SENT_634	[p28l1168t2951r1212b3005],
2	,	,	O	,	_	0	SENT_634	[p28l1168t2951r1212b3005],
3	a006221	CD	NUMBER	a006221	num	4	SENT_634	[p28l1226t2951r1440b2997],
4	(	NN	O	(	appos	1	SENT_634	[p28l1466t2948r1566b3005],
5	201	CD	NUMBER	201	number	6	SENT_634	[p28l1466t2948r1566b3005],
6	2	CD	NUMBER	2	num	7	SENT_634	[p28l1580t2948r1640b3005],
7	)	NN	O	)	dep	4	SENT_634	[p28l1580t2948r1640b3005],
8	.	.	O	.	_	0	SENT_634	[p28l1580t2948r1640b3005],

1	van	NN	PERSON	van	nn	2	SENT_635	[p28l128t3040r220b3075],
2	Rossum	NNP	PERSON	Rossum	_	0	SENT_635	[p28l239t3028r454b3083],
3	,	,	O	,	_	0	SENT_635	[p28l239t3028r454b3083],
4	|	CD	NUMBER	|	appos	2	SENT_635	[p28l471t3028r545b3075],
5	.	.	O	.	_	0	SENT_635	[p28l471t3028r545b3075],

1	A.	NN	O	a.	_	0	SENT_636	[p28l471t3028r545b3075],
2	etal	NN	O	etal	dep	1	SENT_636	[p28l559t3025r674b3075],
3	.	.	O	.	_	0	SENT_636	[p28l559t3025r674b3075],

1	Injury	NNP	O	Injury	nn	2	SENT_637	[p28l690t3028r840b3089],
2	markers	NNS	O	marker	nsubj	3	SENT_637	[p28l854t3025r1061b3075],
3	predict	VBP	O	predict	_	0	SENT_637	[p28l1078t3025r1262b3088],
4	time	NN	O	time	dobj	3	SENT_637	[p28l1274t3028r1393b3075],
5	to	TO	O	to	_	0	SENT_637	[p28l1406t3033r1458b3075],
6	dementia	NN	O	dementia	prep_to	3	SENT_637	[p28l1473t3025r1722b3075],
7	in	IN	O	in	_	0	SENT_637	[p28l1740t3028r1782b3075],
8	subjects	NNS	O	subject	prep_in	6	SENT_637	[p28l1799t3025r2014b3089],
9	with	IN	O	with	_	0	SENT_637	[p28l2028t3025r2141b3075],
10	MCI	NNP	ORGANIZATION	MCI	prep_with	8	SENT_637	[p28l132t3105r228b3153],
11	and	CC	O	and	_	0	SENT_637	[p28l245t3103r341b3153],
12	amyloid	JJ	O	amyloid	amod	13	SENT_637	[p28l357t3103r565b3167],
13	pathology	NN	O	pathology	conj_and	10	SENT_637	[p28l584t3103r862b3167],
14	.	.	O	.	_	0	SENT_637	[p28l584t3103r862b3167],

1	Neurology	NN	O	neurology	_	0	SENT_638	[p28l876t3103r1142b3167],
2	79	CD	NUMBER	79	num	1	SENT_638	[p28l1153t3107r1232b3161],
3	,	,	O	,	_	0	SENT_638	[p28l1153t3107r1232b3161],
4	1809-1816	CD	DATE	1809-1816	number	5	SENT_638	[p28l1251t3107r1536b3153],
5	(	CD	NUMBER	(	appos	1	SENT_638	[p28l1552t3104r1726b3161],
6	2012	CD	DATE	2012	num	7	SENT_638	[p28l1552t3104r1726b3161],
7	)	NN	O	)	dep	5	SENT_638	[p28l1552t3104r1726b3161],
8	.	.	O	.	_	0	SENT_638	[p28l1552t3104r1726b3161],

1	Desikan	NNP	O	Desikan	nn	4	SENT_639	[p28l132t3181r350b3239],
2	,	,	O	,	_	0	SENT_639	[p28l132t3181r350b3239],
3	R.S.	NNP	PERSON	R.S.	appos	4	SENT_639	[p28l367t3183r452b3231],
4	etal.	NNP	PERSON	etal.	_	0	SENT_639	[p28l466t3181r595b3239],
5	;	:	O	;	_	0	SENT_639	[p28l466t3181r595b3239],
6	Alzheimer	NNP	O	Alzheimer	poss	10	SENT_639	[p28l608t3181r909b3231],
7	's	POS	O	's	_	0	SENT_639	[p28l608t3181r909b3231],
8	Disease	NNP	O	Disease	nn	10	SENT_639	[p28l926t3183r1122b3231],
9	Neuroimaging	NNP	O	Neuroimaging	nn	10	SENT_639	[p28l1139t3184r1514b3245],
10	Initiative	NNP	O	Initiative	dep	4	SENT_639	[p28l1533t3184r1769b3231],
11	.	.	O	.	_	0	SENT_639	[p28l1533t3184r1769b3231],

1	Amyloid	NNP	O	Amyloid	nsubj	6	SENT_640	[p28l1783t3181r2021b3245],
2	—	CD	NUMBER	—	num	1	SENT_640	[p28l1783t3181r2021b3245],
3	B-associated	JJ	O	b-associated	amod	5	SENT_640	[p28l133t3259r471b3322],
4	clinical	JJ	O	clinical	amod	5	SENT_640	[p28l487t3259r663b3309],
5	decline	NN	O	decline	dep	1	SENT_640	[p28l680t3259r870b3309],
6	occurs	VBZ	O	occur	_	0	SENT_640	[p28l884t3274r1053b3309],
7	only	RB	O	only	advmod	6	SENT_640	[p28l1067t3259r1180b3323],
8	in	IN	O	in	_	0	SENT_640	[p28l1195t3262r1237b3308],
9	the	DT	O	the	det	10	SENT_640	[p28l1253t3259r1338b3309],
10	presence	NN	O	presence	prep_in	6	SENT_640	[p28l1355t3274r1590b3322],
11	of	IN	O	of	_	0	SENT_640	[p28l1604t3259r1658b3309],
12	elevated	JJ	O	elevated	amod	15	SENT_640	[p28l1668t3259r1890b3309],
13	P	NN	O	p	nn	15	SENT_640	[p28l1909t3262r2054b3309],
14	—	CD	NUMBER	—	num	15	SENT_640	[p28l1909t3262r2054b3309],
15	tau	NN	O	tau	prep_of	10	SENT_640	[p28l1909t3262r2054b3309],
16	.	.	O	.	_	0	SENT_640	[p28l1909t3262r2054b3309],

1	Arch	NNP	O	Arch	_	0	SENT_641	[p28l127t3336r255b3386],
2	.	.	O	.	_	0	SENT_641	[p28l127t3336r255b3386],

1	Neurol	NNP	O	Neurol	_	0	SENT_642	[p28l270t3336r450b3386],
2	.	.	O	.	_	0	SENT_642	[p28l270t3336r450b3386],

1	69	CD	NUMBER	69	_	0	SENT_643	[p28l464t3340r544b3393],
2	,	,	O	,	_	0	SENT_643	[p28l464t3340r544b3393],
3	709-713	CD	NUMBER	709-713	number	4	SENT_643	[p28l560t3340r781b3386],
4	(	CD	NUMBER	(	appos	1	SENT_643	[p28l799t3337r973b3393],
5	2012	CD	DATE	2012	num	6	SENT_643	[p28l799t3337r973b3393],
6	)	NN	O	)	dep	4	SENT_643	[p28l799t3337r973b3393],
7	.	.	O	.	_	0	SENT_643	[p28l799t3337r973b3393],

1	Mattsson	NNP	PERSON	Mattsson	nn	3	SENT_644	[p28l131t3417r383b3472],
2	,	,	O	,	_	0	SENT_644	[p28l131t3417r383b3472],
3	N.	NNP	O	N.	_	0	SENT_644	[p28l400t3417r449b3464],
4	et	FW	O	et	nn	5	SENT_644	[p28l463t3422r512b3464],
5	al.	FW	O	al.	dep	3	SENT_644	[p28l521t3414r591b3472],
6	;	:	O	;	_	0	SENT_644	[p28l521t3414r591b3472],
7	Alzheimer	NN	ORGANIZATION	alzheimer	poss	11	SENT_644	[p28l605t3414r906b3464],
8	's	POS	ORGANIZATION	's	_	0	SENT_644	[p28l605t3414r906b3464],
9	Association	NNP	ORGANIZATION	Association	nn	11	SENT_644	[p28l919t3417r1218b3464],
10	QC	NNP	ORGANIZATION	QC	nn	11	SENT_644	[p28l1234t3416r1312b3470],
11	Program	NNP	ORGANIZATION	Program	dep	3	SENT_644	[p28l1329t3416r1548b3478],
12	Work	NNP	ORGANIZATION	Work	nn	13	SENT_644	[p28l1561t3414r1699b3464],
13	Group	NNP	ORGANIZATION	Group	dep	11	SENT_644	[p28l1710t3416r1886b3477],
14	.	.	O	.	_	0	SENT_644	[p28l1710t3416r1886b3477],

1	CSF	NN	O	csf	nn	3	SENT_645	[p28l1900t3416r1995b3464],
2	biomarker	NN	O	biomarker	nn	3	SENT_645	[p28l133t3492r402b3542],
3	variability	NN	O	variability	_	0	SENT_645	[p28l413t3492r672b3556],
4	in	IN	O	in	_	0	SENT_645	[p28l687t3495r729b3541],
5	the	DT	O	the	det	6	SENT_645	[p28l744t3492r830b3542],
6	Alzheimer	NN	O	alzheimer	poss	11	SENT_645	[p28l844t3492r1145b3542],
7	's	POS	O	's	_	0	SENT_645	[p28l844t3492r1145b3542],
8	Association	NNP	O	Association	nn	11	SENT_645	[p28l1159t3495r1457b3542],
9	quality	NN	O	quality	nn	11	SENT_645	[p28l1474t3492r1654b3556],
10	control	NN	O	control	nn	11	SENT_645	[p28l1667t3492r1850b3542],
11	program	NN	O	program	prep_in	3	SENT_645	[p28l1869t3507r2107b3556],
12	.	.	O	.	_	0	SENT_645	[p28l1869t3507r2107b3556],

1	Alzheimers	NNPS	O	Alzheimers	_	0	SENT_646	[p28l127t3570r406b3619],
2	Dement	NNP	O	Dement	dep	1	SENT_646	[p28l418t3572r633b3619],
3	.	.	O	.	_	0	SENT_646	[p28l418t3572r633b3619],

1	9	CD	NUMBER	9	_	0	SENT_647	[p28l647t3573r692b3626],
2	,	,	O	,	_	0	SENT_647	[p28l647t3573r692b3626],
3	251	CD	NUMBER	251	number	4	SENT_647	[p28l707t3573r790b3619],
4	-261	CD	NUMBER	-261	num	5	SENT_647	[p28l804t3573r920b3619],
5	(	NN	O	(	appos	1	SENT_647	[p28l946t3571r1047b3626],
6	201	CD	NUMBER	201	number	7	SENT_647	[p28l946t3571r1047b3626],
7	3	CD	NUMBER	3	num	8	SENT_647	[p28l1061t3571r1121b3626],
8	)	NN	O	)	dep	5	SENT_647	[p28l1061t3571r1121b3626],
9	.	.	O	.	_	0	SENT_647	[p28l1061t3571r1121b3626],

1	Fodero-Tavoletti	NNP	O	Fodero-Tavoletti	_	0	SENT_648	[p28l132t3648r569b3705],
2	,	,	O	,	_	0	SENT_648	[p28l132t3648r569b3705],
3	M.T.	NNP	O	M.T.	nn	4	SENT_648	[p28l584t3650r684b3697],
4	etal	NNP	O	etal	appos	1	SENT_648	[p28l699t3648r813b3697],
5	.	.	O	.	_	0	SENT_648	[p28l699t3648r813b3697],

1	18F-TH	JJ	O	18f-th	amod	2	SENT_649	[p28l832t3650r1007b3697],
2	K523	NN	O	k523	_	0	SENT_649	[p28l1016t3650r1155b3697],
3	:	:	O	:	_	0	SENT_649	[p28l1016t3650r1155b3697],
4	a	DT	O	a	det	5	SENT_649	[p28l1170t3662r1195b3697],
5	novel	JJ	O	novel	dep	2	SENT_649	[p28l1213t3648r1351b3697],
6	in	FW	O	in	prep	5	SENT_649	[p28l1367t3650r1412b3697],
7	vivo	FW	O	vivo	nn	10	SENT_649	[p28l1427t3650r1527b3697],
8	tau	FW	O	tau	nn	10	SENT_649	[p28l1540t3655r1622b3697],
9	imaging	NN	O	imaging	nn	10	SENT_649	[p28l1640t3650r1853b3711],
10	ligand	NN	O	ligand	pobj	6	SENT_649	[p28l1871t3648r2030b3711],
11	for	IN	O	for	_	0	SENT_649	[p28l2045t3647r2118b3697],
12	Alzheimer	NN	O	alzheimer	poss	14	SENT_649	[p28l130t3725r431b3774],
13	's	POS	O	's	_	0	SENT_649	[p28l130t3725r431b3774],
14	disease	NN	O	disease	prep_for	10	SENT_649	[p28l446t3725r650b3774],
15	.	.	O	.	_	0	SENT_649	[p28l446t3725r650b3774],

1	Brain	NN	O	brain	_	0	SENT_650	[p28l664t3727r793b3774],
2	134	CD	NUMBER	134	num	1	SENT_650	[p28l812t3728r924b3781],
3	,	,	O	,	_	0	SENT_650	[p28l812t3728r924b3781],
4	1089-1	CD	NUMBER	1089-1	num	6	SENT_650	[p28l943t3728r1120b3774],
5	100	CD	NUMBER	100	num	6	SENT_650	[p28l1138t3728r1228b3774],
6	(	NN	O	(	appos	1	SENT_650	[p28l1244t3726r1344b3781],
7	201	CD	NUMBER	201	number	8	SENT_650	[p28l1244t3726r1344b3781],
8	1	CD	NUMBER	1	num	9	SENT_650	[p28l1363t3726r1418b3781],
9	)	NN	O	)	dep	6	SENT_650	[p28l1363t3726r1418b3781],
10	.	.	O	.	_	0	SENT_650	[p28l1363t3726r1418b3781],

1	Zhang	NNP	PERSON	Zhang	_	0	SENT_651	[p29l129t18r310b81],
2	,	,	O	,	_	0	SENT_651	[p29l129t18r310b81],
3	W.	NNP	O	W.	nn	4	SENT_651	[p29l320t20r382b67],
4	etal	NNP	O	etal	appos	1	SENT_651	[p29l396t18r510b67],
5	.	.	O	.	_	0	SENT_651	[p29l396t18r510b67],

1	A	DT	O	a	det	6	SENT_652	[p29l524t20r561b67],
2	highly	RB	O	highly	advmod	3	SENT_652	[p29l577t18r738b81],
3	selective	JJ	O	selective	amod	6	SENT_652	[p29l752t18r978b67],
4	and	CC	O	and	_	0	SENT_652	[p29l992t18r1089b67],
5	speciﬁc	JJ	O	speciﬁc	amod	6	SENT_652	[p29l1106t17r1300b80],
6	PET	NN	O	pet	_	0	SENT_652	[p29l1316t20r1411b67],
7	tracerfor	NN	O	tracerfor	nn	8	SENT_652	[p29l1421t17r1657b67],
8	imaging	NN	O	imaging	dep	6	SENT_652	[p29l1672t20r1884b81],
9	of	IN	O	of	_	0	SENT_652	[p29l1901t17r1955b67],
10	tau	FW	O	tau	nn	11	SENT_652	[p29l1963t25r2045b67],
11	pathologies	NNS	O	pathology	prep_of	8	SENT_652	[p29l133t96r454b159],
12	.	.	O	.	_	0	SENT_652	[p29l133t96r454b159],

1	J.	NNP	O	J.	nn	3	SENT_653	[p29l464t98r499b145],
2	Alzheimers	NNP	O	Alzheimers	nn	3	SENT_653	[p29l510t96r790b145],
3	Dis	NNP	O	Dis	_	0	SENT_653	[p29l802t98r891b145],
4	.	.	O	.	_	0	SENT_653	[p29l802t98r891b145],

1	31	CD	NUMBER	31	_	0	SENT_654	[p29l905t99r985b153],
2	,	,	O	,	_	0	SENT_654	[p29l905t99r985b153],
3	601	CD	NUMBER	601	num	4	SENT_654	[p29l999t99r1083b145],
4	-61	CD	NUMBER	-61	appos	1	SENT_654	[p29l1097t99r1181b145],
5	2	CD	NUMBER	2	num	6	SENT_654	[p29l1195t99r1223b145],
6	(	NN	O	(	dep	4	SENT_654	[p29l1239t97r1340b153],
7	201	CD	NUMBER	201	number	8	SENT_654	[p29l1239t97r1340b153],
8	2	CD	NUMBER	2	num	9	SENT_654	[p29l1354t97r1414b153],
9	)	NN	O	)	dep	6	SENT_654	[p29l1354t97r1414b153],
10	.	.	O	.	_	0	SENT_654	[p29l1354t97r1414b153],

1	Herholz	NNP	O	Herholz	_	0	SENT_655	[p29l132t174r346b231],
2	,	,	O	,	_	0	SENT_655	[p29l132t174r346b231],
3	K.	NNP	PERSON	K.	nn	4	SENT_655	[p29l362t176r404b223],
4	Use	NNP	PERSON	Use	appos	1	SENT_655	[p29l421t176r513b223],
5	of	IN	O	of	_	0	SENT_655	[p29l528t173r582b223],
6	FDG	NNP	O	FDG	nn	7	SENT_655	[p29l594t176r701b223],
7	PET	NNP	O	PET	prep_of	4	SENT_655	[p29l719t176r814b223],
8	as	IN	O	as	_	0	SENT_655	[p29l826t188r877b223],
9	an	DT	O	a	det	11	SENT_655	[p29l892t188r952b223],
10	imaging	NN	O	imaging	nn	11	SENT_655	[p29l970t176r1182b237],
11	biomarker	NN	O	biomarker	prep_as	7	SENT_655	[p29l1201t174r1470b223],
12	in	IN	O	in	_	0	SENT_655	[p29l1485t176r1527b223],
13	clinical	JJ	O	clinical	amod	14	SENT_655	[p29l1544t174r1720b223],
14	trials	NNS	O	trial	prep_in	11	SENT_655	[p29l1735t174r1860b223],
15	of	IN	O	of	_	0	SENT_655	[p29l1875t173r1929b223],
16	Alzheimer	NN	O	alzheimer	poss	18	SENT_655	[p29l130t251r431b300],
17	's	POS	O	's	_	0	SENT_655	[p29l130t251r431b300],
18	disease	NN	O	disease	prep_of	14	SENT_655	[p29l446t251r650b300],
19	.	.	O	.	_	0	SENT_655	[p29l446t251r650b300],

1	Biomark	NNP	O	Biomark	_	0	SENT_656	[p29l664t251r886b300],
2	.	.	O	.	_	0	SENT_656	[p29l664t251r886b300],

1	Med	NNP	O	Med	_	0	SENT_657	[p29l901t251r1023b300],
2	.	.	O	.	_	0	SENT_657	[p29l901t251r1023b300],

1	6	CD	NUMBER	6	_	0	SENT_658	[p29l1037t254r1082b307],
2	,	,	O	,	_	0	SENT_658	[p29l1037t254r1082b307],
3	431-439	CD	NUMBER	431-439	number	4	SENT_658	[p29l1095t254r1321b300],
4	(	CD	NUMBER	(	appos	1	SENT_658	[p29l1336t252r1511b307],
5	2012	CD	DATE	2012	num	6	SENT_658	[p29l1336t252r1511b307],
6	)	NN	O	)	dep	4	SENT_658	[p29l1336t252r1511b307],
7	.	.	O	.	_	0	SENT_658	[p29l1336t252r1511b307],

1	Reiman	NNP	PERSON	Reiman	nn	3	SENT_659	[p29l132t331r339b386],
2	,	,	O	,	_	0	SENT_659	[p29l132t331r339b386],
3	E.M.	NNP	O	E.M.	_	0	SENT_659	[p29l356t331r472b386],
4	;	:	O	;	_	0	SENT_659	[p29l356t331r472b386],
5	Alzheimer	NNP	O	Alzheimer	poss	8	SENT_659	[p29l485t329r786b378],
6	's	POS	O	's	_	0	SENT_659	[p29l485t329r786b378],
7	Disease	NN	ORGANIZATION	disease	nn	8	SENT_659	[p29l803t331r999b378],
8	Biomarkers	NNS	ORGANIZATION	biomarker	nsubj	9	SENT_659	[p29l1015t329r1306b378],
9	Working	VBG	ORGANIZATION	work	dep	3	SENT_659	[p29l1317t329r1537b392],
10	Group	NNP	ORGANIZATION	Group	nn	12	SENT_659	[p29l1554t331r1717b391],
11	forthe	NNP	O	forthe	nn	12	SENT_659	[p29l1730t328r1900b378],
12	Alliance	NNP	ORGANIZATION	Alliance	dobj	9	SENT_659	[p29l1914t329r2120b378],
13	for	IN	ORGANIZATION	for	_	0	SENT_659	[p29l129t406r202b456],
14	Aging	NNP	ORGANIZATION	Aging	nn	15	SENT_659	[p29l214t409r368b470],
15	Research	NNP	ORGANIZATION	Research	prep_for	12	SENT_659	[p29l387t407r632b456],
16	.	.	O	.	_	0	SENT_659	[p29l387t407r632b456],

1	Fluorodeoxyglucose	NN	O	fluorodeoxyglucose	nn	4	SENT_660	[p29l649t407r1180b470],
2	positron	NN	O	positron	nn	4	SENT_660	[p29l1196t409r1411b469],
3	emission	NN	O	emission	nn	4	SENT_660	[p29l1428t409r1657b456],
4	tomography	NN	O	tomography	_	0	SENT_660	[p29l1672t407r2015b470],
5	:	:	O	:	_	0	SENT_660	[p29l1672t407r2015b470],
6	emerging	VBG	O	emerge	amod	7	SENT_660	[p29l131t487r383b548],
7	roles	NNS	O	role	dep	4	SENT_660	[p29l402t485r523b534],
8	in	IN	O	in	_	0	SENT_660	[p29l539t487r581b534],
9	the	DT	O	the	det	10	SENT_660	[p29l597t485r682b534],
10	evaluation	NN	O	evaluation	prep_in	7	SENT_660	[p29l697t485r970b534],
11	of	IN	O	of	_	0	SENT_660	[p29l987t484r1042b534],
12	putative	JJ	O	putative	amod	13	SENT_660	[p29l1053t487r1268b547],
13	Alzheimer	NN	O	alzheimer	poss	16	SENT_660	[p29l1281t485r1582b534],
14	's	POS	O	's	_	0	SENT_660	[p29l1281t485r1582b534],
15	disease-modifying	JJ	O	disease-modifying	amod	16	SENT_660	[p29l1597t484r2081b548],
16	treatments	NNS	O	treatment	prep_of	10	SENT_660	[p29l130t570r430b612],
17	.	.	O	.	_	0	SENT_660	[p29l130t570r430b612],

1	Neurobiol	NNP	O	Neurobiol	_	0	SENT_661	[p29l444t563r702b612],
2	.	.	O	.	_	0	SENT_661	[p29l444t563r702b612],

1	Aging	NN	O	aging	_	0	SENT_662	[p29l713t565r864b626],
2	32	CD	NUMBER	32	num	4	SENT_662	[p29l879t566r945b612],
3	(	NN	O	(	nn	4	SENT_662	[p29l961t563r1134b625],
4	suppl	NN	O	suppl	dep	1	SENT_662	[p29l961t563r1134b625],
5	.	.	O	.	_	0	SENT_662	[p29l961t563r1134b625],

1	1	CD	NUMBER	1	num	2	SENT_663	[p29l1153t564r1208b620],
2	)	CD	NUMBER	)	_	0	SENT_663	[p29l1153t564r1208b620],
3	,	,	O	,	_	0	SENT_663	[p29l1153t564r1208b620],
4	544-547	CD	NUMBER	544-547	num	5	SENT_663	[p29l1223t564r1444b612],
5	(	NN	O	(	appos	2	SENT_663	[p29l1460t564r1560b620],
6	201	CD	NUMBER	201	number	7	SENT_663	[p29l1460t564r1560b620],
7	1	CD	NUMBER	1	num	8	SENT_663	[p29l1579t564r1634b620],
8	)	NN	O	)	dep	5	SENT_663	[p29l1579t564r1634b620],
9	.	.	O	.	_	0	SENT_663	[p29l1579t564r1634b620],

1	Boecke	NNP	PERSON	Boecke	_	0	SENT_664	[p29l132t641r429b698],
2	,	,	O	,	_	0	SENT_664	[p29l132t641r429b698],
3	J.D.	NNP	PERSON	J.D.	nn	4	SENT_664	[p29l132t641r429b698],
4	etal	NNP	O	etal	appos	1	SENT_664	[p29l443t641r558b690],
5	.	.	O	.	_	0	SENT_664	[p29l443t641r558b690],

1	Blood-based	JJ	O	blood-based	amod	3	SENT_665	[p29l575t641r902b690],
2	protein	NN	O	protein	nn	3	SENT_665	[p29l920t643r1106b703],
3	biomarkers	NNS	O	biomarker	_	0	SENT_665	[p29l1125t641r1417b690],
4	for	IN	O	for	_	0	SENT_665	[p29l1430t640r1503b690],
5	diagnosis	NN	O	diagnosis	prep_for	3	SENT_665	[p29l1516t641r1764b704],
6	of	IN	O	of	_	0	SENT_665	[p29l1779t640r1833b690],
7	Alzheimer	NN	O	alzheimer	nn	8	SENT_665	[p29l1842t641r2109b690],
8	disease	NN	O	disease	prep_of	3	SENT_665	[p29l131t718r334b767],
9	.	.	O	.	_	0	SENT_665	[p29l131t718r334b767],

1	Arch	NNP	O	Arch	_	0	SENT_666	[p29l345t718r474b767],
2	.	.	O	.	_	0	SENT_666	[p29l345t718r474b767],

1	Neurol	NNP	O	Neurol	_	0	SENT_667	[p29l488t718r668b767],
2	.	.	O	.	_	0	SENT_667	[p29l488t718r668b767],

1	69	CD	NUMBER	69	_	0	SENT_668	[p29l682t721r762b774],
2	,	,	O	,	_	0	SENT_668	[p29l682t721r762b774],
3	1318-1325	CD	DATE	1318-1325	number	4	SENT_668	[p29l781t721r1064b767],
4	(	CD	NUMBER	(	appos	1	SENT_668	[p29l1082t719r1256b774],
5	2012	CD	DATE	2012	num	6	SENT_668	[p29l1082t719r1256b774],
6	)	NN	O	)	dep	4	SENT_668	[p29l1082t719r1256b774],
7	.	.	O	.	_	0	SENT_668	[p29l1082t719r1256b774],

1	Thambisetty	NNP	O	Thambisetty	_	0	SENT_669	[p29l127t796r467b859],
2	,	,	O	,	_	0	SENT_669	[p29l127t796r467b859],
3	M.	NNP	ORGANIZATION	M.	conj_and	1	SENT_669	[p29l483t798r542b845],
4	&	CC	ORGANIZATION	&	_	0	SENT_669	[p29l556t797r593b845],
5	Lovestone	NNP	ORGANIZATION	Lovestone	conj_and	1	SENT_669	[p29l608t798r888b853],
6	,	,	O	,	_	0	SENT_669	[p29l608t798r888b853],
7	S.	NNP	MISC	S.	nn	9	SENT_669	[p29l903t797r943b845],
8	Blood-based	JJ	MISC	blood-based	amod	9	SENT_669	[p29l960t796r1286b845],
9	biomarkers	NNS	O	biomarker	appos	1	SENT_669	[p29l1305t796r1597b845],
10	of	IN	O	of	_	0	SENT_669	[p29l1612t795r1666b845],
11	Alzheimer	NN	O	alzheimer	poss	13	SENT_669	[p29l1675t796r1976b845],
12	's	POS	O	's	_	0	SENT_669	[p29l1675t796r1976b845],
13	disease	NN	O	disease	prep_of	9	SENT_669	[p29l131t874r335b923],
14	:	:	O	:	_	0	SENT_669	[p29l131t874r335b923],
15	challenging	JJ	O	challenging	amod	13	SENT_669	[p29l350t874r656b937],
16	but	CC	O	but	_	0	SENT_669	[p29l675t874r762b923],
17	feasible	JJ	O	feasible	conj_but	15	SENT_669	[p29l775t873r987b923],
18	.	.	O	.	_	0	SENT_669	[p29l775t873r987b923],

1	Biomark	NNP	O	Biomark	_	0	SENT_670	[p29l1002t874r1225b923],
2	.	.	O	.	_	0	SENT_670	[p29l1002t874r1225b923],

1	Med	NNP	O	Med	_	0	SENT_671	[p29l1238t874r1361b923],
2	.	.	O	.	_	0	SENT_671	[p29l1238t874r1361b923],

1	4	CD	NUMBER	4	_	0	SENT_672	[p29l1374t878r1420b931],
2	,	,	O	,	_	0	SENT_672	[p29l1374t878r1420b931],
3	65-79	CD	NUMBER	65-79	number	4	SENT_672	[p29l1434t877r1593b923],
4	(	CD	NUMBER	(	appos	1	SENT_672	[p29l1609t875r1783b931],
5	2010	CD	DATE	2010	num	6	SENT_672	[p29l1609t875r1783b931],
6	)	NN	O	)	dep	4	SENT_672	[p29l1609t875r1783b931],
7	.	.	O	.	_	0	SENT_672	[p29l1609t875r1783b931],

1	Tiseo	NNP	O	Tiseo	_	0	SENT_673	[p29l127t954r274b1009],
2	,	,	O	,	_	0	SENT_673	[p29l127t954r274b1009],
3	P.J.	NNP	PERSON	P.J.	conj_and	1	SENT_673	[p29l291t954r372b1009],
4	,	,	O	,	_	0	SENT_673	[p29l291t954r372b1009],
5	Rogers	NNP	ORGANIZATION	Rogers	conj_and	1	SENT_673	[p29l388t954r578b1015],
6	,	,	O	,	_	0	SENT_673	[p29l388t954r578b1015],
7	S.L.	NNP	ORGANIZATION	S.L.	conj_and	1	SENT_673	[p29l592t953r676b1001],
8	&	CC	ORGANIZATION	&	_	0	SENT_673	[p29l689t953r726b1001],
9	Friedhoff	NNP	ORGANIZATION	Friedhoff	conj_and	1	SENT_673	[p29l741t951r987b1009],
10	,	,	O	,	_	0	SENT_673	[p29l741t951r987b1009],
11	L.T.	NNP	O	L.T.	appos	1	SENT_673	[p29l1004t954r1081b1001],
12	Pharmacokinetic	JJ	O	pharmacokinetic	amod	15	SENT_673	[p29l1098t952r1537b1001],
13	and	CC	O	and	_	0	SENT_673	[p29l1551t952r1647b1001],
14	pharmacodynamic	JJ	O	pharmacodynamic	amod	15	SENT_673	[p29l133t1030r626b1093],
15	proﬁle	NN	O	proﬁle	nsubj	19	SENT_673	[p29l642t1029r808b1092],
16	of	IN	O	of	_	0	SENT_673	[p29l822t1029r877b1079],
17	donepezil	NN	O	donepezil	nn	18	SENT_673	[p29l886t1030r1144b1092],
18	HCI	NN	ORGANIZATION	hcus	prep_of	15	SENT_673	[p29l1163t1030r1247b1079],
19	following	VBG	DATE	follow	rcmod	11	SENT_673	[p29l1263t1029r1508b1093],
20	evening	NN	DATE	evening	nn	21	SENT_673	[p29l1525t1032r1733b1093],
21	administration	NN	O	administration	tmod	19	SENT_673	[p29l1750t1030r2147b1079],
22	.	.	O	.	_	0	SENT_673	[p29l1750t1030r2147b1079],

1	Br	NN	O	br	_	0	SENT_674	[p29l130t1109r188b1156],
2	.	.	O	.	_	0	SENT_674	[p29l130t1109r188b1156],

1	J.	NNP	PERSON	J.	nn	2	SENT_675	[p29l200t1109r234b1156],
2	Clin	NNP	PERSON	Clin	_	0	SENT_675	[p29l250t1107r355b1156],
3	.	.	O	.	_	0	SENT_675	[p29l250t1107r355b1156],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_676	[p29l369t1107r657b1156],
2	.	.	O	.	_	0	SENT_676	[p29l369t1107r657b1156],

1	46	CD	NUMBER	46	num	2	SENT_677	[p29l671t1110r739b1156],
2	(	CD	NUMBER	(	_	0	SENT_677	[p29l755t1107r927b1168],
3	suppl	NN	O	suppl	dep	2	SENT_677	[p29l755t1107r927b1168],
4	.	.	O	.	_	0	SENT_677	[p29l755t1107r927b1168],

1	1	CD	NUMBER	1	num	2	SENT_678	[p29l946t1108r1001b1163],
2	)	NN	O	)	_	0	SENT_678	[p29l946t1108r1001b1163],
3	,	,	O	,	_	0	SENT_678	[p29l946t1108r1001b1163],
4	13-18	CD	NUMBER	13-18	number	5	SENT_678	[p29l1020t1110r1174b1156],
5	(	CD	NUMBER	(	appos	2	SENT_678	[p29l1191t1108r1365b1163],
6	1998	CD	DATE	1998	num	7	SENT_678	[p29l1191t1108r1365b1163],
7	)	NN	O	)	dep	5	SENT_678	[p29l1191t1108r1365b1163],
8	.	.	O	.	_	0	SENT_678	[p29l1191t1108r1365b1163],

1	Bohnen	NNP	PERSON	Bohnen	_	0	SENT_679	[p29l132t1185r346b1242],
2	,	,	O	,	_	0	SENT_679	[p29l132t1185r346b1242],
3	N.	NNP	O	N.	nn	4	SENT_679	[p29l363t1187r440b1234],
4	|	NNP	O	|	appos	1	SENT_679	[p29l363t1187r440b1234],
5	.	.	O	.	_	0	SENT_679	[p29l363t1187r440b1234],

1	etal	NN	O	etal	_	0	SENT_680	[p29l454t1185r569b1234],
2	.	.	O	.	_	0	SENT_680	[p29l454t1185r569b1234],

1	Degree	NN	O	degree	_	0	SENT_681	[p29l586t1187r773b1248],
2	of	IN	O	of	_	0	SENT_681	[p29l788t1184r842b1234],
3	inhibition	NN	O	inhibition	prep_of	1	SENT_681	[p29l853t1185r1103b1234],
4	of	IN	O	of	_	0	SENT_681	[p29l1120t1184r1174b1234],
5	cortical	JJ	O	cortical	amod	7	SENT_681	[p29l1184t1185r1373b1234],
6	acetylcholinesterase	NN	O	acetylcholinesterase	nn	7	SENT_681	[p29l1389t1185r1924b1248],
7	activity	NN	O	activity	prep_of	3	SENT_681	[p29l1938t1187r2129b1248],
8	and	CC	O	and	_	0	SENT_681	[p29l131t1263r227b1312],
9	cognitive	JJ	O	cognitive	amod	10	SENT_681	[p29l243t1265r485b1326],
10	effects	NNS	O	effect	prep_of	1	SENT_681	[p29l500t1262r672b1312],
11	by	IN	O	by	_	0	SENT_681	[p29l688t1263r750b1326],
12	donepezil	NN	O	donepezil	nn	13	SENT_681	[p29l762t1263r1020b1325],
13	treatment	NN	O	treatment	prep_by	10	SENT_681	[p29l1035t1270r1299b1312],
14	in	IN	O	in	_	0	SENT_681	[p29l1314t1265r1357b1312],
15	Alzheimer	NNP	O	Alzheimer	poss	17	SENT_681	[p29l1373t1263r1674b1312],
16	's	POS	O	's	_	0	SENT_681	[p29l1373t1263r1674b1312],
17	disease	NN	O	disease	prep_in	1	SENT_681	[p29l1688t1263r1892b1312],
18	.	.	O	.	_	0	SENT_681	[p29l1688t1263r1892b1312],

1	J.	NNP	PERSON	J.	nn	2	SENT_682	[p29l1903t1265r1937b1312],
2	Neurol	NNP	PERSON	Neurol	_	0	SENT_682	[p29l1952t1263r2128b1312],
3	.	.	O	.	_	0	SENT_682	[p29l1952t1263r2128b1312],

1	Neurosurg	NNP	LOCATION	Neurosurg	_	0	SENT_683	[p29l130t1343r403b1404],
2	.	.	O	.	_	0	SENT_683	[p29l130t1343r403b1404],

1	Psychiatr	NN	O	psychiatr	_	0	SENT_684	[p29l417t1341r658b1405],
2	.	.	O	.	_	0	SENT_684	[p29l417t1341r658b1405],

1	76	CD	NUMBER	76	_	0	SENT_685	[p29l673t1344r753b1398],
2	,	,	O	,	_	0	SENT_685	[p29l673t1344r753b1398],
3	31	CD	NUMBER	31	num	4	SENT_685	[p29l767t1344r819b1390],
4	5-319	CD	NUMBER	5-319	appos	1	SENT_685	[p29l833t1344r991b1390],
5	(	CD	NUMBER	(	num	7	SENT_685	[p29l1007t1342r1181b1398],
6	2005	CD	DATE	2005	num	7	SENT_685	[p29l1007t1342r1181b1398],
7	)	NN	O	)	dep	4	SENT_685	[p29l1007t1342r1181b1398],
8	.	.	O	.	_	0	SENT_685	[p29l1007t1342r1181b1398],

1	Kaasinen	NNP	PERSON	Kaasinen	nn	3	SENT_686	[p29l132t1421r431b1476],
2	,	,	O	,	_	0	SENT_686	[p29l132t1421r431b1476],
3	V.	NNP	O	V.	_	0	SENT_686	[p29l132t1421r431b1476],
4	et	FW	O	et	nn	5	SENT_686	[p29l445t1426r494b1469],
5	al.	FW	O	al.	dep	3	SENT_686	[p29l503t1419r560b1469],
6	.	.	O	.	_	0	SENT_686	[p29l503t1419r560b1469],

1	Regional	NNP	O	Regional	nn	2	SENT_687	[p29l577t1419r801b1482],
2	effects	NNS	O	effect	_	0	SENT_687	[p29l817t1418r989b1469],
3	of	IN	O	of	_	0	SENT_687	[p29l1004t1418r1058b1469],
4	donepezil	NN	O	donepezil	prep_of	2	SENT_687	[p29l1068t1419r1325b1481],
5	and	CC	O	and	_	0	SENT_687	[p29l1341t1419r1438b1469],
6	rivastigmine	NN	O	rivastigmine	conj_and	4	SENT_687	[p29l1456t1421r1778b1482],
7	on	IN	O	on	_	0	SENT_687	[p29l1793t1434r1857b1469],
8	cortical	JJ	O	cortical	amod	10	SENT_687	[p29l1874t1419r2063b1469],
9	acetylcholinesterase	NN	O	acetylcholinesterase	nn	10	SENT_687	[p29l131t1497r665b1560],
10	activity	NN	O	activity	prep_on	2	SENT_687	[p29l680t1499r870b1560],
11	in	IN	O	in	_	0	SENT_687	[p29l885t1499r927b1546],
12	Alzheimer	NNP	O	Alzheimer	poss	14	SENT_687	[p29l943t1497r1244b1546],
13	's	POS	O	's	_	0	SENT_687	[p29l943t1497r1244b1546],
14	disease	NN	O	disease	prep_in	10	SENT_687	[p29l1259t1497r1507b1546],
15	.	.	O	.	_	0	SENT_687	[p29l1259t1497r1507b1546],

1	J.	NNP	PERSON	J.	nn	2	SENT_688	[p29l1259t1497r1507b1546],
2	Clin	NNP	PERSON	Clin	_	0	SENT_688	[p29l1523t1497r1628b1546],
3	.	.	O	.	_	0	SENT_688	[p29l1523t1497r1628b1546],

1	Psychopharmacol	NN	O	psychopharmacol	_	0	SENT_689	[p29l1643t1497r2109b1561],
2	.	.	O	.	_	0	SENT_689	[p29l1643t1497r2109b1561],

1	22,615-620	CD	NUMBER	22,615-620	num	2	SENT_690	[p29l131t1577r449b1630],
2	(	CD	NUMBER	(	_	0	SENT_690	[p29l465t1575r639b1630],
3	2002	CD	DATE	2002	num	4	SENT_690	[p29l465t1575r639b1630],
4	)	NN	O	)	dep	2	SENT_690	[p29l465t1575r639b1630],
5	.	.	O	.	_	0	SENT_690	[p29l465t1575r639b1630],

1	Farlow	NNP	PERSON	Farlow	nn	3	SENT_691	[p29l131t1652r312b1709],
2	,	,	O	,	_	0	SENT_691	[p29l131t1652r312b1709],
3	M.R.	NNP	O	M.R.	_	0	SENT_691	[p29l328t1654r434b1701],
4	et	FW	O	et	nn	5	SENT_691	[p29l448t1659r497b1701],
5	al.	FW	O	al.	dep	3	SENT_691	[p29l506t1652r563b1701],
6	.	.	O	.	_	0	SENT_691	[p29l506t1652r563b1701],

1	Effectiveness	NN	O	effectiveness	dep	9	SENT_692	[p29l580t1651r918b1701],
2	and	CC	O	and	_	0	SENT_692	[p29l932t1652r1028b1701],
3	tolerability	NN	O	tolerability	conj_and	1	SENT_692	[p29l1043t1652r1328b1716],
4	of	IN	O	of	_	0	SENT_692	[p29l1341t1651r1396b1701],
5	high-dose	JJ	O	high-dose	amod	6	SENT_692	[p29l1407t1652r1671b1715],
6	(	NN	O	(	prep_of	1	SENT_692	[p29l1687t1653r1763b1709],
7	23	CD	NUMBER	23	num	8	SENT_692	[p29l1687t1653r1763b1709],
8	mg/d	NN	O	mg/d	dep	9	SENT_692	[p29l1778t1652r1935b1715],
9	)	CD	NUMBER	)	dep	16	SENT_692	[p29l1778t1652r1935b1715],
10	versus	CC	O	versus	prep	9	SENT_692	[p29l1950t1667r2115b1701],
11	standard-dose	JJ	O	standard-dose	amod	12	SENT_692	[p29l131t1730r510b1780],
12	(	NN	O	(	dep	10	SENT_692	[p29l526t1731r604b1787],
13	10	CD	NUMBER	10	num	16	SENT_692	[p29l526t1731r604b1787],
14	mg/d	JJ	O	mg/d	amod	16	SENT_692	[p29l617t1730r775b1793],
15	)	NN	O	)	nn	16	SENT_692	[p29l617t1730r775b1793],
16	donepezil	NN	O	donepezil	dep	26	SENT_692	[p29l791t1730r1048b1792],
17	in	IN	O	in	_	0	SENT_692	[p29l1066t1732r1109b1779],
18	moderate	JJ	O	moderate	prep_in	16	SENT_692	[p29l1127t1730r1381b1780],
19	to	TO	O	to	_	0	SENT_692	[p29l1394t1737r1447b1780],
20	severe	JJ	O	severe	amod	21	SENT_692	[p29l1462t1744r1629b1780],
21	Alzheimer	NN	O	alzheimer	poss	23	SENT_692	[p29l1642t1730r1944b1780],
22	's	POS	O	's	_	0	SENT_692	[p29l1642t1730r1944b1780],
23	disease	NN	O	disease	prep_to	18	SENT_692	[p29l131t1808r335b1857],
24	:	:	O	:	_	0	SENT_692	[p29l131t1808r335b1857],
25	A	DT	O	a	det	26	SENT_692	[p29l349t1810r385b1857],
26	24-week	JJ	DURATION	24-week	_	0	SENT_692	[p29l400t1808r634b1865],
27	,	,	O	,	_	0	SENT_692	[p29l400t1808r634b1865],
28	randomized	VBN	O	randomize	partmod	26	SENT_692	[p29l650t1808r977b1865],
29	,	,	O	,	_	0	SENT_692	[p29l650t1808r977b1865],
30	double-blind	JJ	O	double-blind	amod	31	SENT_692	[p29l991t1808r1333b1857],
31	study	NN	O	study	dobj	28	SENT_692	[p29l1350t1808r1503b1871],
32	.	.	O	.	_	0	SENT_692	[p29l1350t1808r1503b1871],

1	Clin	NNP	O	Clin	_	0	SENT_693	[p29l1518t1808r1623b1857],
2	.	.	O	.	_	0	SENT_693	[p29l1518t1808r1623b1857],

1	Ther	NNP	O	Ther	_	0	SENT_694	[p29l1640t1808r1760b1857],
2	.	.	O	.	_	0	SENT_694	[p29l1640t1808r1760b1857],

1	32	CD	NUMBER	32	_	0	SENT_695	[p29l1775t1811r1855b1865],
2	,	,	O	,	_	0	SENT_695	[p29l1775t1811r1855b1865],
3	12341251	CD	NUMBER	12341251	number	4	SENT_695	[p29l1874t1811r2028b1857, p29l135t1888r248b1934],
4	(	CD	NUMBER	(	appos	1	SENT_695	[p29l274t1886r448b1941],
5	2010	CD	DATE	2010	num	6	SENT_695	[p29l274t1886r448b1941],
6	)	NN	O	)	dep	4	SENT_695	[p29l274t1886r448b1941],
7	.	.	O	.	_	0	SENT_695	[p29l274t1886r448b1941],

1	Cummings	NNP	PERSON	Cummings	nn	23	SENT_696	[p29l129t1964r426b2026],
2	,	,	O	,	_	0	SENT_696	[p29l129t1964r426b2026],
3	J.L.	NNP	PERSON	J.L.	conj_and	1	SENT_696	[p29l439t1965r529b2020],
4	,	,	O	,	_	0	SENT_696	[p29l439t1965r529b2020],
5	Geldmacher	NNP	O	Geldmacher	conj_and	1	SENT_696	[p29l543t1963r874b2020],
6	,	,	O	,	_	0	SENT_696	[p29l543t1963r874b2020],
7	D.	NNP	O	D.	conj_and	1	SENT_696	[p29l890t1965r951b2020],
8	,	,	O	,	_	0	SENT_696	[p29l890t1965r951b2020],
9	Farlow	NNP	PERSON	Farlow	conj_and	1	SENT_696	[p29l967t1963r1148b2020],
10	,	,	O	,	_	0	SENT_696	[p29l967t1963r1148b2020],
11	M.	NNP	O	M.	conj_and	1	SENT_696	[p29l1164t1965r1236b2020],
12	,	,	O	,	_	0	SENT_696	[p29l1164t1965r1236b2020],
13	Sabbagh	NNP	PERSON	Sabbagh	conj_and	1	SENT_696	[p29l1251t1963r1496b2026],
14	,	,	O	,	_	0	SENT_696	[p29l1251t1963r1496b2026],
15	M.	NNP	O	M.	nn	23	SENT_696	[p29l1512t1965r1584b2020],
16	,	,	O	,	_	0	SENT_696	[p29l1512t1965r1584b2020],
17	Christensen	NNP	PERSON	Christensen	nn	23	SENT_696	[p29l1598t1963r1921b2020],
18	,	,	O	,	_	0	SENT_696	[p29l1598t1963r1921b2020],
19	D.	NNP	ORGANIZATION	D.	nn	23	SENT_696	[p29l1938t1965r1985b2013],
20	&	CC	ORGANIZATION	&	_	0	SENT_696	[p29l1999t1964r2036b2013],
21	Betz	NNP	ORGANIZATION	Betz	nn	23	SENT_696	[p29l133t2043r255b2098],
22	,	,	O	,	_	0	SENT_696	[p29l133t2043r255b2098],
23	P.	NNP	O	P.	_	0	SENT_696	[p29l271t2043r303b2090],
24	High-dose	JJ	O	high-dose	amod	29	SENT_696	[p29l320t2041r590b2104],
25	donepezil	NN	O	donepezil	nn	29	SENT_696	[p29l605t2041r862b2103],
26	(	NN	O	(	nn	29	SENT_696	[p29l880t2042r956b2098],
27	23	CD	NUMBER	23	num	29	SENT_696	[p29l880t2042r956b2098],
28	mg/day	NN	O	mg/day	nn	29	SENT_696	[p29l971t2041r1189b2105],
29	)	NN	O	)	poss	39	SENT_696	[p29l971t2041r1189b2105],
30	for	IN	O	for	_	0	SENT_696	[p29l1203t2040r1276b2091],
31	the	DT	O	the	det	32	SENT_696	[p29l1287t2041r1373b2091],
32	treatment	NN	O	treatment	prep_for	29	SENT_696	[p29l1386t2048r1650b2091],
33	of	IN	O	of	_	0	SENT_696	[p29l1664t2040r1718b2091],
34	moderate	JJ	O	moderate	amod	37	SENT_696	[p29l1730t2041r1983b2091],
35	and	CC	O	and	_	0	SENT_696	[p29l1998t2041r2094b2091],
36	severe	JJ	O	severe	conj_and	34	SENT_696	[p29l131t2134r298b2169],
37	Alzheimer	NN	O	alzheimer	prep_of	32	SENT_696	[p29l311t2119r612b2169],
38	's	POS	O	's	_	0	SENT_696	[p29l311t2119r612b2169],
39	disease	NN	O	disease	dep	23	SENT_696	[p29l627t2119r832b2169],
40	:	:	O	:	_	0	SENT_696	[p29l627t2119r832b2169],
41	drug	NN	O	drug	nn	42	SENT_696	[p29l846t2119r968b2182],
42	proﬁle	NN	O	proﬁle	dep	23	SENT_696	[p29l986t2118r1152b2181],
43	and	CC	O	and	_	0	SENT_696	[p29l1166t2119r1262b2169],
44	clinical	JJ	O	clinical	amod	45	SENT_696	[p29l1279t2119r1455b2169],
45	guidelines	NNS	O	guideline	dep	23	SENT_696	[p29l1472t2119r1755b2182],
46	.	.	O	.	_	0	SENT_696	[p29l1472t2119r1755b2182],

1	CNS	NN	O	cn	_	0	SENT_697	[p29l1771t2121r1873b2169],
2	Neurosci	NN	PERSON	neuroscus	dep	1	SENT_697	[p29l1884t2121r2112b2169],
3	.	.	O	.	_	0	SENT_697	[p29l1884t2121r2112b2169],

1	Ther	NNP	O	Ther	_	0	SENT_698	[p29l132t2196r253b2245],
2	.	.	O	.	_	0	SENT_698	[p29l132t2196r253b2245],

1	19	CD	NUMBER	19	_	0	SENT_699	[p29l270t2199r347b2252],
2	,	,	O	,	_	0	SENT_699	[p29l270t2199r347b2252],
3	294-301	CD	NUMBER	294-301	number	4	SENT_699	[p29l362t2199r576b2245],
4	(	CD	NUMBER	(	appos	1	SENT_699	[p29l602t2197r776b2252],
5	2013	CD	DATE	2013	num	6	SENT_699	[p29l602t2197r776b2252],
6	)	NN	O	)	dep	4	SENT_699	[p29l602t2197r776b2252],
7	.	.	O	.	_	0	SENT_699	[p29l602t2197r776b2252],

1	Sperling	NNP	PERSON	Sperling	_	0	SENT_700	[p29l129t2274r358b2337],
2	,	,	O	,	_	0	SENT_700	[p29l129t2274r358b2337],
3	R.A.	NNP	PERSON	R.A.	nn	4	SENT_700	[p29l375t2276r468b2323],
4	etal	NNP	O	etal	appos	1	SENT_700	[p29l482t2274r597b2323],
5	.	.	O	.	_	0	SENT_700	[p29l482t2274r597b2323],

1	Amyloid-related	JJ	O	amyloid-related	amod	3	SENT_701	[p29l611t2274r1033b2338],
2	imaging	NN	O	imaging	nn	3	SENT_701	[p29l1051t2276r1263b2337],
3	abnormalities	NNS	O	abnormality	_	0	SENT_701	[p29l1280t2274r1640b2323],
4	in	IN	O	in	_	0	SENT_701	[p29l1657t2276r1699b2323],
5	amyloidmodifying	VBG	O	amyloidmodify	prepc_in	3	SENT_701	[p29l1715t2274r1946b2337, p29l132t2351r398b2416],
6	therapeutic	JJ	O	therapeutic	amod	7	SENT_701	[p29l413t2352r718b2414],
7	trials	NNS	O	trial	dobj	5	SENT_701	[p29l730t2352r868b2401],
8	:	:	O	:	_	0	SENT_701	[p29l730t2352r868b2401],
9	recommendations	NNS	O	recommendation	dep	3	SENT_701	[p29l885t2352r1365b2402],
10	from	IN	O	from	_	0	SENT_701	[p29l1378t2351r1501b2401],
11	the	DT	O	the	det	12	SENT_701	[p29l1516t2352r1602b2401],
12	Alzheimer	NN	O	alzheimer	poss	16	SENT_701	[p29l1616t2352r1917b2401],
13	's	POS	O	's	_	0	SENT_701	[p29l1616t2352r1917b2401],
14	Association	NNP	ORGANIZATION	Association	nn	16	SENT_701	[p29l130t2432r428b2480],
15	Research	NNP	ORGANIZATION	Research	nn	16	SENT_701	[p29l447t2430r677b2480],
16	RoundtableWorkgroup	NNP	ORGANIZATION	RoundtableWorkgroup	prep_from	9	SENT_701	[p29l696t2430r1609b2493],
17	.	.	O	.	_	0	SENT_701	[p29l696t2430r1609b2493],

1	AIzheimers	NNP	O	AIzheimers	nn	2	SENT_702	[p29l696t2430r1609b2493],
2	Dement	NNP	PERSON	Dement	_	0	SENT_702	[p29l1621t2432r1836b2480],
3	.	.	O	.	_	0	SENT_702	[p29l1621t2432r1836b2480],

1	7	CD	NUMBER	7	_	0	SENT_703	[p29l1851t2434r1895b2487],
2	,	,	O	,	_	0	SENT_703	[p29l1851t2434r1895b2487],
3	367-385	CD	NUMBER	367-385	num	4	SENT_703	[p29l1910t2433r2131b2480],
4	(	NN	O	(	appos	1	SENT_703	[p29l132t2508r232b2563],
5	201	CD	NUMBER	201	number	6	SENT_703	[p29l132t2508r232b2563],
6	1	CD	NUMBER	1	num	7	SENT_703	[p29l251t2508r306b2563],
7	)	NN	O	)	dep	4	SENT_703	[p29l251t2508r306b2563],
8	.	.	O	.	_	0	SENT_703	[p29l251t2508r306b2563],

1	Sperling	NNP	PERSON	Sperling	_	0	SENT_704	[p29l129t2585r358b2648],
2	,	,	O	,	_	0	SENT_704	[p29l129t2585r358b2648],
3	R.A.	NNP	PERSON	R.A.	nn	4	SENT_704	[p29l375t2587r468b2635],
4	etal	NNP	O	etal	appos	1	SENT_704	[p29l482t2585r597b2635],
5	.	.	O	.	_	0	SENT_704	[p29l482t2585r597b2635],

1	Toward	IN	O	toward	_	0	SENT_705	[p29l607t2585r798b2635],
2	deﬁning	VBG	O	deﬁning	pcomp	1	SENT_705	[p29l815t2584r1031b2648],
3	the	DT	O	the	det	5	SENT_705	[p29l1046t2585r1132b2635],
4	preclinical	JJ	O	preclinical	amod	5	SENT_705	[p29l1149t2585r1411b2647],
5	stages	NNS	O	stage	dobj	2	SENT_705	[p29l1428t2592r1593b2648],
6	of	IN	O	of	_	0	SENT_705	[p29l1608t2584r1662b2635],
7	Alzheimer	NN	O	alzheimer	poss	9	SENT_705	[p29l1671t2585r1972b2635],
8	's	POS	O	's	_	0	SENT_705	[p29l1671t2585r1972b2635],
9	disease	NN	O	disease	prep_of	5	SENT_705	[p29l131t2663r335b2713],
10	:	:	O	:	_	0	SENT_705	[p29l131t2663r335b2713],
11	recommendations	NNS	O	recommendation	dep	5	SENT_705	[p29l352t2663r832b2713],
12	from	IN	O	from	_	0	SENT_705	[p29l845t2662r968b2713],
13	the	DT	O	the	det	15	SENT_705	[p29l983t2663r1069b2713],
14	National	NNP	ORGANIZATION	National	nn	15	SENT_705	[p29l1086t2663r1301b2713],
15	Institute	NNP	ORGANIZATION	Institute	prep_from	11	SENT_705	[p29l1320t2665r1534b2713],
16	on	IN	ORGANIZATION	on	_	0	SENT_705	[p29l1549t2678r1613b2713],
17	Aging-Alzheimer	NNP	ORGANIZATION	Aging-Alzheimer	poss	20	SENT_705	[p29l1629t2663r2108b2726],
18	's	POS	ORGANIZATION	's	_	0	SENT_705	[p29l1629t2663r2108b2726],
19	Association	NNP	ORGANIZATION	Association	nn	20	SENT_705	[p29l130t2743r428b2791],
20	workgroups	NNS	O	workgroup	prep_on	2	SENT_705	[p29l444t2741r759b2804],
21	on	IN	O	on	_	0	SENT_705	[p29l775t2756r839b2791],
22	diagnostic	JJ	O	diagnostic	amod	23	SENT_705	[p29l856t2741r1128b2804],
23	guidelines	NNS	O	guideline	prep_on	2	SENT_705	[p29l1142t2741r1414b2804],
24	for	IN	O	for	_	0	SENT_705	[p29l1427t2740r1499b2791],
25	Alzheimer	NN	O	alzheimer	poss	27	SENT_705	[p29l1512t2741r1813b2791],
26	's	POS	O	's	_	0	SENT_705	[p29l1512t2741r1813b2791],
27	disease	NN	O	disease	prep_for	23	SENT_705	[p29l1827t2741r2031b2791],
28	.	.	O	.	_	0	SENT_705	[p29l1827t2741r2031b2791],

1	Alzheimers	NNPS	O	Alzheimers	_	0	SENT_706	[p29l127t2818r406b2867],
2	Dement	NNP	O	Dement	dep	1	SENT_706	[p29l418t2820r632b2867],
3	.	.	O	.	_	0	SENT_706	[p29l418t2820r632b2867],

1	7	CD	NUMBER	7	_	0	SENT_707	[p29l647t2822r691b2874],
2	,	,	O	,	_	0	SENT_707	[p29l647t2822r691b2874],
3	280-292	CD	NUMBER	280-292	num	4	SENT_707	[p29l706t2821r929b2867],
4	(	NN	O	(	appos	1	SENT_707	[p29l946t2819r1046b2874],
5	201	CD	NUMBER	201	number	6	SENT_707	[p29l946t2819r1046b2874],
6	1	CD	NUMBER	1	num	7	SENT_707	[p29l1065t2819r1120b2874],
7	)	NN	O	)	dep	4	SENT_707	[p29l1065t2819r1120b2874],
8	.	.	O	.	_	0	SENT_707	[p29l1065t2819r1120b2874],

1	Salloway	NNP	PERSON	Salloway	nn	3	SENT_708	[p29l130t2895r369b2959],
2	,	,	O	,	_	0	SENT_708	[p29l130t2895r369b2959],
3	S.	NNP	O	S.	_	0	SENT_708	[p29l384t2897r424b2945],
4	et	FW	O	et	nn	5	SENT_708	[p29l438t2903r487b2945],
5	al.	FW	O	al.	dep	3	SENT_708	[p29l496t2895r566b2952],
6	;	:	O	;	_	0	SENT_708	[p29l496t2895r566b2952],
7	Bapineuzumab	NNP	PERSON	Bapineuzumab	dep	3	SENT_708	[p29l583t2895r978b2957],
8	201	CD	NUMBER	201	num	11	SENT_708	[p29l993t2898r1076b2945],
9	Clinical	JJ	O	clinical	amod	11	SENT_708	[p29l1101t2895r1285b2945],
10	Trial	NNP	O	Trial	nn	11	SENT_708	[p29l1297t2895r1403b2945],
11	Investigators	NNS	O	investigator	dep	7	SENT_708	[p29l1423t2897r1769b2958],
12	.	.	O	.	_	0	SENT_708	[p29l1423t2897r1769b2958],

1	A	DT	O	a	det	2	SENT_709	[p29l1783t2897r1820b2944],
2	phase	NN	O	phase	_	0	SENT_709	[p29l1835t2895r1989b2957],
3	2	CD	NUMBER	2	number	4	SENT_709	[p29l131t2976r158b3022],
4	multiple	JJ	O	multiple	amod	2	SENT_709	[p29l176t2973r392b3035],
5	ascending	VBG	O	ascend	partmod	2	SENT_709	[p29l406t2973r673b3036],
6	dose	NN	O	dose	nn	7	SENT_709	[p29l690t2973r814b3023],
7	trial	NN	O	trial	dobj	5	SENT_709	[p29l827t2973r924b3023],
8	of	IN	O	of	_	0	SENT_709	[p29l941t2972r996b3023],
9	bapineuzumab	NN	O	bapineuzumab	prep_of	7	SENT_709	[p29l1007t2973r1404b3035],
10	in	IN	O	in	_	0	SENT_709	[p29l1421t2975r1463b3022],
11	mild	JJ	O	mild	amod	15	SENT_709	[p29l1482t2973r1593b3023],
12	to	TO	O	to	_	0	SENT_709	[p29l1608t2981r1661b3023],
13	moderate	JJ	O	moderate	amod	14	SENT_709	[p29l1678t2973r1931b3023],
14	Alzheimer	NN	O	alzheimer	prep_to	11	SENT_709	[p29l130t3051r397b3101],
15	disease	NN	O	disease	prep_in	9	SENT_709	[p29l410t3051r614b3101],
16	.	.	O	.	_	0	SENT_709	[p29l410t3051r614b3101],

1	Neurology	NN	O	neurology	_	0	SENT_710	[p29l628t3051r893b3115],
2	73	CD	NUMBER	73	num	1	SENT_710	[p29l905t3054r983b3108],
3	,	,	O	,	_	0	SENT_710	[p29l905t3054r983b3108],
4	2061	CD	DURATION	2061	number	5	SENT_710	[p29l999t3054r1115b3101],
5	-2070	CD	DURATION	-2070	appos	1	SENT_710	[p29l1128t3054r1287b3101],
6	(	CD	NUMBER	(	num	8	SENT_710	[p29l1304t3052r1478b3108],
7	2009	CD	DATE	2009	num	8	SENT_710	[p29l1304t3052r1478b3108],
8	)	NN	O	)	dep	5	SENT_710	[p29l1304t3052r1478b3108],
9	.	.	O	.	_	0	SENT_710	[p29l1304t3052r1478b3108],

1	Zhang	NNP	PERSON	Zhang	nn	19	SENT_711	[p29l129t3129r309b3192],
2	,	,	O	,	_	0	SENT_711	[p29l129t3129r309b3192],
3	D.	NNP	O	D.	conj_and	1	SENT_711	[p29l326t3131r386b3186],
4	,	,	O	,	_	0	SENT_711	[p29l326t3131r386b3186],
5	Wang	NNP	PERSON	Wang	conj_and	1	SENT_711	[p29l397t3131r560b3192],
6	,	,	O	,	_	0	SENT_711	[p29l397t3131r560b3192],
7	Y.	NNP	O	Y.	conj_and	1	SENT_711	[p29l570t3131r622b3186],
8	,	,	O	,	_	0	SENT_711	[p29l570t3131r622b3186],
9	Zhou	NNP	PERSON	Zhou	conj_and	1	SENT_711	[p29l636t3129r786b3186],
10	,	,	O	,	_	0	SENT_711	[p29l636t3129r786b3186],
11	L.	NNP	O	L.	conj_and	1	SENT_711	[p29l803t3131r853b3186],
12	,	,	O	,	_	0	SENT_711	[p29l803t3131r853b3186],
13	Yuan	NNP	O	Yuan	conj_and	1	SENT_711	[p29l863t3131r1006b3186],
14	,	,	O	,	_	0	SENT_711	[p29l863t3131r1006b3186],
15	H.	NNP	ORGANIZATION	H.	nn	19	SENT_711	[p29l1023t3131r1071b3179],
16	&	CC	ORGANIZATION	&	_	0	SENT_711	[p29l1085t3131r1122b3179],
17	Shen	NNP	ORGANIZATION	Shen	nn	19	SENT_711	[p29l1135t3129r1278b3186],
18	,	,	O	,	_	0	SENT_711	[p29l1135t3129r1278b3186],
19	D.	NNP	O	D.	_	0	SENT_711	[p29l1294t3131r1355b3186],
20	;	:	O	;	_	0	SENT_711	[p29l1294t3131r1355b3186],
21	Alzheimer	NNP	O	Alzheimer	poss	25	SENT_711	[p29l1368t3129r1669b3179],
22	's	POS	O	's	_	0	SENT_711	[p29l1368t3129r1669b3179],
23	Disease	NNP	O	Disease	nn	25	SENT_711	[p29l1686t3131r1882b3179],
24	Neuroimaging	NNP	O	Neuroimaging	nn	25	SENT_711	[p29l133t3209r508b3270],
25	Initiative	NNP	O	Initiative	dep	19	SENT_711	[p29l527t3209r763b3257],
26	.	.	O	.	_	0	SENT_711	[p29l527t3209r763b3257],

1	Multimodal	JJ	O	multimodal	amod	2	SENT_712	[p29l779t3207r1078b3257],
2	classiﬁcation	NN	O	classiﬁcation	_	0	SENT_712	[p29l1095t3206r1426b3257],
3	of	IN	O	of	_	0	SENT_712	[p29l1443t3206r1497b3257],
4	Alzheimer	NN	O	alzheimer	poss	6	SENT_712	[p29l1506t3207r1807b3257],
5	's	POS	O	's	_	0	SENT_712	[p29l1506t3207r1807b3257],
6	disease	NN	O	disease	prep_of	2	SENT_712	[p29l1822t3207r2014b3257],
7	and	CC	O	and	_	0	SENT_712	[p29l2028t3207r2124b3257],
8	mild	JJ	O	mild	amod	10	SENT_712	[p29l132t3286r243b3336],
9	cognitive	JJ	O	cognitive	amod	10	SENT_712	[p29l260t3288r502b3349],
10	impairment	NN	O	impairment	conj_and	6	SENT_712	[p29l518t3288r837b3349],
11	.	.	O	.	_	0	SENT_712	[p29l518t3288r837b3349],

1	Neuroimage	NNP	O	Neuroimage	_	0	SENT_713	[p29l852t3288r1167b3349],
2	55	CD	NUMBER	55	num	1	SENT_713	[p29l1182t3289r1261b3342],
3	,	,	O	,	_	0	SENT_713	[p29l1182t3289r1261b3342],
4	856-867	CD	NUMBER	856-867	num	1	SENT_713	[p29l1276t3288r1499b3334],
5	(	NN	O	(	dep	1	SENT_713	[p29l1516t3286r1617b3342],
6	201	CD	NUMBER	201	number	7	SENT_713	[p29l1516t3286r1617b3342],
7	1	CD	NUMBER	1	num	8	SENT_713	[p29l1635t3286r1690b3342],
8	)	NN	O	)	dep	5	SENT_713	[p29l1635t3286r1690b3342],
9	.	.	O	.	_	0	SENT_713	[p29l1635t3286r1690b3342],

1	Kohannim	NNP	PERSON	Kohannim	nn	4	SENT_714	[p29l133t3364r414b3421],
2	,	,	O	,	_	0	SENT_714	[p29l133t3364r414b3421],
3	O.	NNP	O	O.	appos	4	SENT_714	[p29l429t3365r480b3413],
4	etal.	NNP	O	etal.	_	0	SENT_714	[p29l494t3364r622b3421],
5	;	:	O	;	_	0	SENT_714	[p29l494t3364r622b3421],
6	Alzheimer	NNP	O	Alzheimer	poss	10	SENT_714	[p29l635t3364r936b3413],
7	's	POS	O	's	_	0	SENT_714	[p29l635t3364r936b3413],
8	Disease	NNP	O	Disease	nn	10	SENT_714	[p29l954t3366r1149b3413],
9	Neuroimaging	NNP	O	Neuroimaging	nn	10	SENT_714	[p29l1166t3366r1542b3427],
10	Initiative	NNP	O	Initiative	dep	4	SENT_714	[p29l1561t3366r1796b3413],
11	.	.	O	.	_	0	SENT_714	[p29l1561t3366r1796b3413],

1	Boosting	VBG	O	boost	csubj	7	SENT_715	[p29l1813t3366r2041b3427],
2	powerfor	NN	O	powerfor	nn	4	SENT_715	[p29l134t3441r383b3504],
3	clinical	JJ	O	clinical	amod	4	SENT_715	[p29l396t3442r573b3491],
4	trials	NNS	O	trial	dobj	1	SENT_715	[p29l588t3442r712b3491],
5	using	VBG	O	use	xcomp	1	SENT_715	[p29l729t3444r868b3505],
6	classiﬁers	NNS	O	classiﬁers	dobj	5	SENT_715	[p29l884t3441r1130b3491],
7	based	VBN	O	base	_	0	SENT_715	[p29l1147t3442r1299b3491],
8	on	IN	O	on	_	0	SENT_715	[p29l1315t3456r1380b3491],
9	multiple	JJ	O	multiple	amod	10	SENT_715	[p29l1398t3442r1615b3504],
10	biomarkers	NNS	O	biomarker	prep_on	7	SENT_715	[p29l1631t3442r1936b3491],
11	.	.	O	.	_	0	SENT_715	[p29l1631t3442r1936b3491],

1	Neurobiol	NNP	O	Neurobiol	_	0	SENT_716	[p29l132t3520r389b3569],
2	.	.	O	.	_	0	SENT_716	[p29l132t3520r389b3569],

1	Aging	NN	O	aging	_	0	SENT_717	[p29l401t3522r552b3583],
2	31	CD	NUMBER	31	num	1	SENT_717	[p29l566t3523r646b3577],
3	,	,	O	,	_	0	SENT_717	[p29l566t3523r646b3577],
4	1429-1442	CD	DATE	1429-1442	number	5	SENT_717	[p29l665t3523r949b3569],
5	(	CD	NUMBER	(	appos	1	SENT_717	[p29l966t3521r1140b3577],
6	2010	CD	DATE	2010	num	7	SENT_717	[p29l966t3521r1140b3577],
7	)	NN	O	)	dep	5	SENT_717	[p29l966t3521r1140b3577],
8	.	.	O	.	_	0	SENT_717	[p29l966t3521r1140b3577],

1	Goodsaid	NNP	O	Goodsaid	_	0	SENT_718	[p29l131t3598r393b3655],
2	,	,	O	,	_	0	SENT_718	[p29l131t3598r393b3655],
3	F.	NNP	ORGANIZATION	F.	conj_and	1	SENT_718	[p29l410t3600r442b3647],
4	&	CC	ORGANIZATION	&	_	0	SENT_718	[p29l456t3599r492b3647],
5	Frueh	NNP	ORGANIZATION	Frueh	conj_and	1	SENT_718	[p29l508t3598r667b3655],
6	,	,	O	,	_	0	SENT_718	[p29l508t3598r667b3655],
7	F.	NNP	O	F.	nn	8	SENT_718	[p29l684t3600r715b3647],
8	Biomarker	NNP	O	Biomarker	appos	1	SENT_718	[p29l732t3598r999b3647],
9	qualiﬁcation	NN	O	qualiﬁcation	nn	11	SENT_718	[p29l1012t3597r1335b3660],
10	pilot	NN	O	pilot	nn	11	SENT_718	[p29l1354t3598r1471b3660],
11	process	NN	O	process	dep	8	SENT_718	[p29l1486t3612r1682b3660],
12	at	IN	O	at	_	0	SENT_718	[p29l1697t3605r1745b3647],
13	the	DT	O	the	det	15	SENT_718	[p29l1758t3598r1843b3647],
14	US	NNP	ORGANIZATION	US	nn	15	SENT_718	[p29l1860t3599r1926b3647],
15	Food	NNP	ORGANIZATION	Food	prep_at	11	SENT_718	[p29l1943t3598r2070b3647],
16	and	CC	ORGANIZATION	and	_	0	SENT_718	[p29l132t3676r228b3725],
17	Drug	NNP	ORGANIZATION	Drug	nn	18	SENT_718	[p29l247t3678r373b3739],
18	Administration	NNP	ORGANIZATION	Administration	prep_at	11	SENT_718	[p29l389t3676r794b3725],
19	.	.	O	.	_	0	SENT_718	[p29l389t3676r794b3725],

1	AAPSJ	NNP	O	AAPSJ	_	0	SENT_719	[p29l805t3677r983b3725],
2	.	.	O	.	_	0	SENT_719	[p29l805t3677r983b3725],

1	9	CD	NUMBER	9	_	0	SENT_720	[p29l997t3679r1043b3733],
2	,	,	O	,	_	0	SENT_720	[p29l997t3679r1043b3733],
3	E105-E108	CD	NUMBER	e105-e108	number	4	SENT_720	[p29l1059t3678r1344b3725],
4	(	CD	NUMBER	(	appos	1	SENT_720	[p29l1359t3677r1533b3733],
5	2007	CD	DATE	2007	num	6	SENT_720	[p29l1359t3677r1533b3733],
6	)	NN	O	)	dep	4	SENT_720	[p29l1359t3677r1533b3733],
7	.	.	O	.	_	0	SENT_720	[p29l1359t3677r1533b3733],

1	US	NNP	ORGANIZATION	US	nn	2	SENT_721	[p29l133t3755r199b3803],
2	Food	NNP	ORGANIZATION	Food	_	0	SENT_721	[p29l216t3754r343b3803],
3	and	CC	ORGANIZATION	and	_	0	SENT_721	[p29l359t3754r455b3803],
4	Drug	NNP	ORGANIZATION	Drug	nn	5	SENT_721	[p29l475t3756r600b3817],
5	Administration	NNP	ORGANIZATION	Administration	conj_and	2	SENT_721	[p29l616t3754r1021b3803],
6	.	.	O	.	_	0	SENT_721	[p29l616t3754r1021b3803],

1	Guidance	NN	O	guidance	_	0	SENT_722	[p29l1036t3754r1285b3803],
2	for	IN	O	for	_	0	SENT_722	[p29l1298t3753r1371b3803],
3	industry	NN	O	industry	nn	7	SENT_722	[p29l1385t3754r1601b3817],
4	(	CD	NUMBER	(	num	7	SENT_722	[p29l1615t3753r1755b3811],
5	draft	NN	O	draft	nn	7	SENT_722	[p29l1615t3753r1755b3811],
6	guidance	NN	O	guidance	nn	7	SENT_722	[p29l1769t3754r2044b3817],
7	)	NN	O	)	prep_for	1	SENT_722	[p29l1769t3754r2044b3817],
8	.	.	O	.	_	0	SENT_722	[p29l1769t3754r2044b3817],

1	Enrichment	NN	O	enrichment	nn	2	SENT_723	[p30l134t15r436b64],
2	strategies	NNS	O	strategy	_	0	SENT_723	[p30l451t17r703b78],
3	for	IN	O	for	_	0	SENT_723	[p30l716t14r788b64],
4	clinical	JJ	O	clinical	amod	5	SENT_723	[p30l801t15r977b64],
5	trials	NNS	O	trial	prep_for	2	SENT_723	[p30l993t15r1118b64],
6	to	TO	O	to	aux	7	SENT_723	[p30l1131t22r1184b64],
7	support	VB	O	support	infmod	2	SENT_723	[p30l1199t22r1406b77],
8	approval	NN	O	approval	dobj	7	SENT_723	[p30l1420t15r1648b77],
9	of	IN	O	of	_	0	SENT_723	[p30l1664t14r1719b64],
10	human	JJ	O	human	amod	11	SENT_723	[p30l1731t15r1912b64],
11	drugs	NNS	O	drug	prep_of	8	SENT_723	[p30l1929t15r2077b78],
12	and	CC	O	and	_	0	SENT_723	[p30l132t93r228b142],
13	biological	JJ	O	biological	amod	14	SENT_723	[p30l246t93r499b156],
14	products	NNS	O	product	prep_of	8	SENT_723	[p30l517t93r761b155],
15	.	.	O	.	_	0	SENT_723	[p30l517t93r761b155],

1	Rockville	NNP	LOCATION	Rockville	nn	3	SENT_724	[p30l778t93r1020b150],
2	,	,	O	,	_	0	SENT_724	[p30l778t93r1020b150],
3	MD	NNP	O	MD	_	0	SENT_724	[p30l1036t95r1125b142],
4	(	CD	NUMBER	(	num	3	SENT_724	[p30l1141t94r1315b150],
5	2012	CD	DATE	2012	num	6	SENT_724	[p30l1141t94r1315b150],
6	)	NN	O	)	dep	3	SENT_724	[p30l1141t94r1315b150],
7	.	.	O	.	_	0	SENT_724	[p30l1141t94r1315b150],

1	VOLUME	NN	O	volume	nn	3	SENT_725	[p30l544t316r769b358],
2	95	CD	NUMBER	95	num	3	SENT_725	[p30l786t317r843b358],
3	NUMBER	NN	O	number	_	0	SENT_725	[p30l864t316r1088b358],
4	1	CD	NUMBER	1	number	5	SENT_725	[p30l1110t318r1123b358],
5	|	CD	NUMBER	|	dep	3	SENT_725	[p30l1153t312r1157b373],
6	JANUARY	NNP	DATE	JANUARY	dep	5	SENT_725	[p30l1176t316r1422b358],
7	2014	CD	DATE	2014	num	6	SENT_725	[p30l1438t317r1559b358],
8	|	CD	NUMBER	|	num	9	SENT_725	[p30l1578t312r1582b373],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_725	[p30l1601t316r2153b369],

1	84	CD	NUMBER	84	_	0	SENT_726	[p30l7t726r82b772],
2	.	.	O	.	_	0	SENT_726	[p30l7t726r82b772],

1	Hendrix	NNP	PERSON	Hendrix	nsubj	9	SENT_727	[p30l131t723r348b780],
2	,	,	O	,	_	0	SENT_727	[p30l131t723r348b780],
3	S.B.	NNP	O	S.B.	nn	4	SENT_727	[p30l363t724r450b772],
4	Requiring	NNP	O	Requiring	appos	1	SENT_727	[p30l467t725r718b786],
5	an	DT	O	a	det	7	SENT_727	[p30l735t737r795b772],
6	amyloid-B1-42	NN	O	amyloid-b1-42	nn	7	SENT_727	[p30l811t722r1193b786],
7	biomarker	NN	O	biomarker	dep	4	SENT_727	[p30l1211t723r1480b772],
8	may	MD	O	may	aux	9	SENT_727	[p30l1496t737r1605b786],
9	improve	VB	O	improve	_	0	SENT_727	[p30l1620t725r1835b785],
10	the	DT	O	the	det	11	SENT_727	[p30l1848t723r1934b772],
11	efﬁciency	NN	O	efﬁciency	dobj	9	SENT_727	[p30l130t800r383b864],
12	of	IN	O	of	_	0	SENT_727	[p30l396t800r450b850],
13	a	DT	O	a	det	14	SENT_727	[p30l460t815r485b850],
14	study	NN	O	study	prep_of	11	SENT_727	[p30l501t801r655b864],
15	,	,	O	,	_	0	SENT_727	[p30l501t801r655b864],
16	and	CC	O	and	_	0	SENT_727	[p30l669t801r766b850],
17	simulations	NNS	O	simulation	nsubj	19	SENT_727	[p30l783t801r1084b850],
18	may	MD	O	may	aux	19	SENT_727	[p30l1100t815r1210b864],
19	help	VB	O	help	conj_and	9	SENT_727	[p30l1225t801r1337b863],
20	in	IN	O	in	_	0	SENT_727	[p30l1354t803r1396b850],
21	planning	NN	O	planning	nn	22	SENT_727	[p30l1415t801r1645b864],
22	studies	NNS	O	study	prep_in	19	SENT_727	[p30l1662t801r1860b850],
23	.	.	O	.	_	0	SENT_727	[p30l1662t801r1860b850],

1	Alzheimers	NNS	O	alzheimer	_	0	SENT_728	[p30l1870t801r2150b850],
2	Res	NNP	O	Res	dep	1	SENT_728	[p30l130t880r223b927],
3	.	.	O	.	_	0	SENT_728	[p30l130t880r223b927],

1	Ther	NNP	O	Ther	_	0	SENT_729	[p30l240t878r361b927],
2	.	.	O	.	_	0	SENT_729	[p30l240t878r361b927],

1	3	CD	NUMBER	3	_	0	SENT_730	[p30l375t881r419b934],
2	,	,	O	,	_	0	SENT_730	[p30l375t881r419b934],
3	10	CD	NUMBER	10	num	4	SENT_730	[p30l439t881r495b927],
4	(	NN	O	(	appos	1	SENT_730	[p30l512t879r612b934],
5	201	CD	NUMBER	201	number	6	SENT_730	[p30l512t879r612b934],
6	1	CD	NUMBER	1	num	7	SENT_730	[p30l631t879r686b934],
7	)	NN	O	)	dep	4	SENT_730	[p30l631t879r686b934],
8	.	.	O	.	_	0	SENT_730	[p30l631t879r686b934],

1	85	CD	NUMBER	85	_	0	SENT_731	[p30l7t959r82b1005],
2	.	.	O	.	_	0	SENT_731	[p30l7t959r82b1005],

1	Schneider	NNP	PERSON	Schneider	nn	11	SENT_732	[p30l129t956r402b1013],
2	,	,	O	,	_	0	SENT_732	[p30l129t956r402b1013],
3	L.S.	NNP	LOCATION	L.S.	conj_and	1	SENT_732	[p30l418t957r512b1013],
4	,	,	O	,	_	0	SENT_732	[p30l418t957r512b1013],
5	Kennedy	NNP	PERSON	Kennedy	nn	11	SENT_732	[p30l529t956r769b1019],
6	,	,	O	,	_	0	SENT_732	[p30l529t956r769b1019],
7	R.E.	NNP	ORGANIZATION	R.E.	nn	11	SENT_732	[p30l785t958r871b1005],
8	&	CC	ORGANIZATION	&	_	0	SENT_732	[p30l885t957r922b1005],
9	Cutter	NNP	ORGANIZATION	Cutter	nn	11	SENT_732	[p30l934t957r1106b1013],
10	,	,	O	,	_	0	SENT_732	[p30l934t957r1106b1013],
11	G.R.	NNP	LOCATION	G.R.	_	0	SENT_732	[p30l1120t958r1232b1013],
12	;	:	O	;	_	0	SENT_732	[p30l1120t958r1232b1013],
13	Alzheimer	NNP	O	Alzheimer	poss	16	SENT_732	[p30l1244t956r1546b1005],
14	's	POS	O	's	_	0	SENT_732	[p30l1244t956r1546b1005],
15	Disease	NN	O	disease	nn	16	SENT_732	[p30l1563t958r1759b1005],
16	Neuroimaging	NN	O	neuroimaging	dep	11	SENT_732	[p30l1776t958r2152b1019],

1	Initiative	NNP	O	Initiative	_	0	SENT_733	[p30l133t1036r369b1083],
2	.	.	O	.	_	0	SENT_733	[p30l133t1036r369b1083],

1	Requiring	VBG	O	require	_	0	SENT_734	[p30l385t1036r636b1097],
2	an	DT	O	a	det	6	SENT_734	[p30l653t1048r713b1083],
3	amyloid-beta1-42	NN	O	amyloid-beta1-42	nn	6	SENT_734	[p30l730t1034r1196b1097],
4	biomarkerfor	NN	O	biomarkerfor	nn	6	SENT_734	[p30l1214t1033r1567b1083],
5	prodromal	JJ	O	prodromal	amod	6	SENT_734	[p30l1582t1034r1856b1096],
6	Alzheimer	NN	O	alzheimer	poss	8	SENT_734	[p30l130t1112r431b1161],
7	's	POS	O	's	_	0	SENT_734	[p30l130t1112r431b1161],
8	disease	NN	O	disease	dobj	1	SENT_734	[p30l446t1112r638b1161],
9	or	CC	O	or	_	0	SENT_734	[p30l652t1126r705b1161],
10	mild	JJ	O	mild	amod	12	SENT_734	[p30l721t1112r832b1161],
11	cognitive	JJ	O	cognitive	amod	12	SENT_734	[p30l849t1114r1091b1175],
12	impairment	NN	O	impairment	dobj	1	SENT_734	[p30l1107t1114r1415b1174],
13	does	VBZ	O	do	aux	15	SENT_734	[p30l1429t1112r1552b1161],
14	not	RB	O	not	neg	15	SENT_734	[p30l1570t1119r1656b1161],
15	lead	VB	O	lead	dep	1	SENT_734	[p30l1672t1112r1777b1161],
16	to	TO	O	to	_	0	SENT_734	[p30l1792t1119r1845b1161],
17	more	JJR	O	more	dep	18	SENT_734	[p30l1862t1126r1997b1161],
18	efﬁcient	JJ	O	efﬁcient	amod	20	SENT_734	[p30l130t1188r343b1238],
19	clinical	JJ	O	clinical	amod	20	SENT_734	[p30l356t1189r533b1238],
20	tria	NN	O	trium	prep_to	15	SENT_734	[p30l548t1189r976b1238],
21	|	CD	NUMBER	|	num	23	SENT_734	[p30l548t1189r976b1238],
22	s.	NN	O	s.	nn	23	SENT_734	[p30l548t1189r976b1238],
23	AIzheimers	NNS	O	aizheimer	nsubj	1	SENT_734	[p30l548t1189r976b1238],
24	Dement	NNP	O	Dement	dep	23	SENT_734	[p30l988t1191r1203b1238],
25	.	.	O	.	_	0	SENT_734	[p30l988t1191r1203b1238],

1	6	CD	NUMBER	6	_	0	SENT_735	[p30l1217t1192r1262b1245],
2	,	,	O	,	_	0	SENT_735	[p30l1217t1192r1262b1245],
3	367-377	CD	NUMBER	367-377	number	4	SENT_735	[p30l1277t1192r1500b1238],
4	(	CD	NUMBER	(	appos	1	SENT_735	[p30l1517t1190r1691b1245],
5	2010	CD	DATE	2010	num	6	SENT_735	[p30l1517t1190r1691b1245],
6	)	NN	O	)	dep	4	SENT_735	[p30l1517t1190r1691b1245],
7	.	.	O	.	_	0	SENT_735	[p30l1517t1190r1691b1245],

1	86	CD	NUMBER	86	_	0	SENT_736	[p30l7t1270r82b1316],
2	.	.	O	.	_	0	SENT_736	[p30l7t1270r82b1316],

1	Gold	NNP	O	Gold	_	0	SENT_737	[p30l129t1267r265b1324],
2	,	,	O	,	_	0	SENT_737	[p30l129t1267r265b1324],
3	G.	NNP	O	G.	nn	4	SENT_737	[p30l279t1269r330b1316],
4	etal	NN	O	etal	appos	1	SENT_737	[p30l344t1267r459b1316],
5	.	.	O	.	_	0	SENT_737	[p30l344t1267r459b1316],

1	Clinical	JJ	O	clinical	amod	2	SENT_738	[p30l473t1267r658b1316],
2	validity	NN	O	validity	_	0	SENT_738	[p30l674t1267r866b1330],
3	of	IN	O	of	_	0	SENT_738	[p30l879t1266r934b1316],
4	A	DT	O	a	det	7	SENT_738	[p30l943t1269r979b1316],
5	beta-protein	NN	O	beta-protein	nn	7	SENT_738	[p30l995t1267r1321b1329],
6	deposition	NN	O	deposition	nn	7	SENT_738	[p30l1337t1267r1617b1329],
7	staging	NN	O	staging	prep_of	2	SENT_738	[p30l1633t1269r1826b1330],
8	in	IN	O	in	_	0	SENT_738	[p30l1844t1269r1886b1316],
9	brain	NN	O	brain	nn	10	SENT_738	[p30l1905t1267r2034b1316],
10	aging	NN	O	aging	prep_in	2	SENT_738	[p30l130t1347r276b1408],
11	and	CC	O	and	_	0	SENT_738	[p30l293t1345r389b1394],
12	Alzheimer	NN	O	alzheimer	nn	13	SENT_738	[p30l405t1345r673b1394],
13	disease	NN	O	disease	conj_and	10	SENT_738	[p30l686t1345r935b1394],
14	.	.	O	.	_	0	SENT_738	[p30l686t1345r935b1394],

1	J.	NNP	PERSON	J.	nn	2	SENT_739	[p30l686t1345r935b1394],
2	Neuropathol	NNP	PERSON	Neuropathol	_	0	SENT_739	[p30l949t1345r1280b1407],
3	.	.	O	.	_	0	SENT_739	[p30l949t1345r1280b1407],

1	Exp	NN	O	exp	_	0	SENT_740	[p30l1295t1347r1393b1407],
2	.	.	O	.	_	0	SENT_740	[p30l1295t1347r1393b1407],

1	Neurol	NNP	O	Neurol	_	0	SENT_741	[p30l1408t1345r1588b1394],
2	.	.	O	.	_	0	SENT_741	[p30l1408t1345r1588b1394],

1	60	CD	NUMBER	60	_	0	SENT_742	[p30l1602t1348r1682b1402],
2	,	,	O	,	_	0	SENT_742	[p30l1602t1348r1682b1402],
3	946-952	CD	NUMBER	946-952	number	4	SENT_742	[p30l1697t1348r1920b1394],
4	(	CD	NUMBER	(	appos	1	SENT_742	[p30l1937t1346r2111b1402],
5	2001	CD	DATE	2001	num	6	SENT_742	[p30l1937t1346r2111b1402],
6	)	NN	O	)	dep	4	SENT_742	[p30l1937t1346r2111b1402],
7	.	.	O	.	_	0	SENT_742	[p30l1937t1346r2111b1402],

1	87	CD	NUMBER	87	_	0	SENT_743	[p30l7t1426r82b1472],
2	.	.	O	.	_	0	SENT_743	[p30l7t1426r82b1472],

1	Murray	NNP	PERSON	Murray	_	0	SENT_744	[p30l130t1425r324b1486],
2	,	,	O	,	_	0	SENT_744	[p30l130t1425r324b1486],
3	M.E.	NNP	O	M.E.	appos	1	SENT_744	[p30l340t1425r456b1480],
4	,	,	O	,	_	0	SENT_744	[p30l340t1425r456b1480],
5	Graff-Radford	NNP	LOCATION	Graff-Radford	conj_and	3	SENT_744	[p30l471t1422r839b1480],
6	,	,	O	,	_	0	SENT_744	[p30l471t1422r839b1480],
7	N.R.	NNP	PERSON	N.R.	conj_and	3	SENT_744	[p30l856t1425r965b1480],
8	,	,	O	,	_	0	SENT_744	[p30l856t1425r965b1480],
9	Ross	NNP	PERSON	Ross	conj_and	3	SENT_744	[p30l982t1425r1108b1480],
10	,	,	O	,	_	0	SENT_744	[p30l982t1425r1108b1480],
11	O.A.	NNP	O	O.A.	conj_and	3	SENT_744	[p30l1122t1424r1239b1480],
12	,	,	O	,	_	0	SENT_744	[p30l1122t1424r1239b1480],
13	Petersen	NNP	PERSON	Petersen	conj_and	3	SENT_744	[p30l1256t1425r1493b1480],
14	,	,	O	,	_	0	SENT_744	[p30l1256t1425r1493b1480],
15	R.C.	NNP	LOCATION	R.C.	conj_and	3	SENT_744	[p30l1509t1424r1614b1480],
16	,	,	O	,	_	0	SENT_744	[p30l1509t1424r1614b1480],
17	Duara	NNP	PERSON	Duara	conj_and	3	SENT_744	[p30l1630t1425r1797b1480],
18	,	,	O	,	_	0	SENT_744	[p30l1630t1425r1797b1480],
19	R.	NNP	ORGANIZATION	R.	conj_and	3	SENT_744	[p30l1814t1425r1855b1472],
20	&	CC	ORGANIZATION	&	_	0	SENT_744	[p30l1869t1424r1906b1472],
21	Dickson	NNP	ORGANIZATION	Dickson	appos	1	SENT_744	[p30l1921t1423r2140b1480],
22	,	,	O	,	_	0	SENT_744	[p30l1921t1423r2140b1480],

1	D.W.	NNP	PERSON	D.W.	nn	2	SENT_745	[p30l133t1503r243b1550],
2	Neuropathologically	NNP	PERSON	Neuropathologically	nsubj	3	SENT_745	[p30l260t1501r797b1564],
3	deﬁned	VBD	O	deﬁned	_	0	SENT_745	[p30l810t1500r1009b1550],
4	subtypes	NNS	O	subtype	dobj	3	SENT_745	[p30l1026t1501r1263b1564],
5	of	IN	O	of	_	0	SENT_745	[p30l1278t1500r1333b1550],
6	Alzheimer	NN	O	alzheimer	poss	8	SENT_745	[p30l1341t1501r1643b1550],
7	's	POS	O	's	_	0	SENT_745	[p30l1341t1501r1643b1550],
8	disease	NN	O	disease	prep_of	4	SENT_745	[p30l1658t1501r1850b1550],
9	with	IN	O	with	_	0	SENT_745	[p30l1863t1501r1976b1550],
10	distinct	JJ	O	distinct	amod	12	SENT_745	[p30l130t1579r325b1628],
11	clinical	JJ	O	clinical	amod	12	SENT_745	[p30l339t1579r515b1628],
12	characteristics	NNS	O	characteristic	prep_with	3	SENT_745	[p30l532t1579r919b1628],
13	:	:	O	:	_	0	SENT_745	[p30l532t1579r919b1628],
14	a	DT	O	a	det	16	SENT_745	[p30l933t1593r959b1628],
15	retrospective	JJ	O	retrospective	amod	16	SENT_745	[p30l977t1581r1320b1641],
16	study	NN	O	study	dep	12	SENT_745	[p30l1335t1579r1488b1642],
17	.	.	O	.	_	0	SENT_745	[p30l1335t1579r1488b1642],

1	LancetNeuroI	NN	O	lancetneurous	_	0	SENT_746	[p30l1502t1579r1862b1628],
2	.	.	O	.	_	0	SENT_746	[p30l1502t1579r1862b1628],

1	10	CD	NUMBER	10	_	0	SENT_747	[p30l1879t1582r1956b1636],
2	,	,	O	,	_	0	SENT_747	[p30l1879t1582r1956b1636],
3	785-796	CD	NUMBER	785-796	num	4	SENT_747	[p30l131t1659r355b1705],
4	(	NN	O	(	appos	1	SENT_747	[p30l371t1657r472b1712],
5	201	CD	NUMBER	201	number	6	SENT_747	[p30l371t1657r472b1712],
6	1	CD	NUMBER	1	num	7	SENT_747	[p30l490t1657r545b1712],
7	)	NN	O	)	dep	4	SENT_747	[p30l490t1657r545b1712],
8	.	.	O	.	_	0	SENT_747	[p30l490t1657r545b1712],

1	88	CD	NUMBER	88	_	0	SENT_748	[p30l7t1736r82b1783],
2	.	.	O	.	_	0	SENT_748	[p30l7t1736r82b1783],

1	Hoozemans	NNP	MISC	Hoozemans	nn	19	SENT_749	[p30l132t1735r455b1790],
2	,	,	O	,	_	0	SENT_749	[p30l132t1735r455b1790],
3	J.J.	NNP	PERSON	J.J.	appos	19	SENT_749	[p30l468t1735r551b1790],
4	,	,	O	,	_	0	SENT_749	[p30l468t1735r551b1790],
5	Rozemuller	NNP	PERSON	Rozemuller	appos	19	SENT_749	[p30l568t1733r873b1790],
6	,	,	O	,	_	0	SENT_749	[p30l568t1733r873b1790],
7	A.J.	NNP	PERSON	A.J.	appos	19	SENT_749	[p30l887t1735r985b1790],
8	,	,	O	,	_	0	SENT_749	[p30l887t1735r985b1790],
9	van	NNP	PERSON	van	appos	19	SENT_749	[p30l998t1748r1091b1783],
10	Haastert	NNP	PERSON	Haastert	nn	19	SENT_749	[p30l1110t1735r1343b1790],
11	,	,	O	,	_	0	SENT_749	[p30l1110t1735r1343b1790],
12	E.S.	NNP	LOCATION	E.S.	nn	19	SENT_749	[p30l1360t1734r1456b1790],
13	,	,	O	,	_	0	SENT_749	[p30l1360t1734r1456b1790],
14	Eikelenboom	NNP	PERSON	Eikelenboom	nn	19	SENT_749	[p30l1473t1733r1833b1790],
15	,	,	O	,	_	0	SENT_749	[p30l1473t1733r1833b1790],
16	P.	NNP	ORGANIZATION	P.	nn	19	SENT_749	[p30l1850t1735r1882b1783],
17	&	CC	ORGANIZATION	&	_	0	SENT_749	[p30l1896t1734r1933b1783],
18	van	NNP	ORGANIZATION	van	nn	19	SENT_749	[p30l1945t1748r2037b1783],
19	Gool	NNP	ORGANIZATION	Gool	nsubj	27	SENT_749	[p30l131t1812r267b1869],
20	,	,	O	,	_	0	SENT_749	[p30l131t1812r267b1869],
21	W.A.	NNP	PERSON	W.A.	nn	22	SENT_749	[p30l278t1814r392b1862],
22	Neuroinﬂammation	NNP	PERSON	Neuroinﬂammation	appos	19	SENT_749	[p30l409t1811r927b1862],
23	in	IN	O	in	_	0	SENT_749	[p30l945t1814r988b1861],
24	Alzheimer	NNP	O	Alzheimer	poss	26	SENT_749	[p30l1005t1812r1308b1862],
25	's	POS	O	's	_	0	SENT_749	[p30l1005t1812r1308b1862],
26	disease	NN	O	disease	prep_in	22	SENT_749	[p30l1323t1812r1516b1862],
27	wanes	VBZ	O	wane	_	0	SENT_749	[p30l1530t1827r1698b1862],
28	with	IN	O	with	_	0	SENT_749	[p30l1712t1812r1826b1862],
29	age	NN	O	age	prep_with	27	SENT_749	[p30l1843t1827r1950b1875],
30	.	.	O	.	_	0	SENT_749	[p30l1843t1827r1950b1875],

1	J.	NNP	O	J.	nn	2	SENT_750	[p30l1961t1814r1996b1862],
2	Neuroinﬂammation	NNP	O	Neuroinﬂammation	_	0	SENT_750	[p30l131t1888r638b1939],
3	8	CD	NUMBER	8	num	2	SENT_750	[p30l653t1892r699b1946],
4	,	,	O	,	_	0	SENT_750	[p30l653t1892r699b1946],
5	171	CD	NUMBER	171	num	2	SENT_750	[p30l718t1893r798b1938],
6	(	NN	O	(	dep	2	SENT_750	[p30l825t1890r926b1946],
7	201	CD	NUMBER	201	number	8	SENT_750	[p30l825t1890r926b1946],
8	1	CD	NUMBER	1	num	9	SENT_750	[p30l945t1890r1000b1946],
9	)	NN	O	)	dep	6	SENT_750	[p30l945t1890r1000b1946],
10	.	.	O	.	_	0	SENT_750	[p30l945t1890r1000b1946],

1	89	CD	NUMBER	89	_	0	SENT_751	[p30l7t1971r82b2018],
2	.	.	O	.	_	0	SENT_751	[p30l7t1971r82b2018],

1	Bernick	NNP	PERSON	Bernick	_	0	SENT_752	[p30l132t1968r337b2025],
2	,	,	O	,	_	0	SENT_752	[p30l132t1968r337b2025],
3	C.	NNP	O	C.	conj_and	1	SENT_752	[p30l352t1969r412b2025],
4	,	,	O	,	_	0	SENT_752	[p30l352t1969r412b2025],
5	Cummings	NNP	PERSON	Cummings	conj_and	1	SENT_752	[p30l426t1970r726b2031],
6	,	,	O	,	_	0	SENT_752	[p30l426t1970r726b2031],
7	J.	NNP	O	J.	conj_and	1	SENT_752	[p30l739t1970r786b2025],
8	,	,	O	,	_	0	SENT_752	[p30l739t1970r786b2025],
9	Raman	NNP	PERSON	Raman	conj_and	1	SENT_752	[p30l803t1970r997b2025],
10	,	,	O	,	_	0	SENT_752	[p30l803t1970r997b2025],
11	R.	NNP	O	R.	conj_and	1	SENT_752	[p30l1014t1970r1069b2025],
12	,	,	O	,	_	0	SENT_752	[p30l1014t1970r1069b2025],
13	Sun	NNP	O	Sun	conj_and	1	SENT_752	[p30l1084t1970r1195b2025],
14	,	,	O	,	_	0	SENT_752	[p30l1084t1970r1195b2025],
15	X.	NNP	ORGANIZATION	X.	conj_and	1	SENT_752	[p30l1210t1970r1256b2018],
16	&	CC	ORGANIZATION	&	_	0	SENT_752	[p30l1270t1970r1307b2018],
17	Aisen	NNP	ORGANIZATION	Aisen	conj_and	1	SENT_752	[p30l1319t1970r1477b2025],
18	,	,	O	,	_	0	SENT_752	[p30l1319t1970r1477b2025],
19	P.	NNP	O	P.	nn	20	SENT_752	[p30l1494t1970r1526b2018],
20	Age	NNP	O	Age	conj_and	1	SENT_752	[p30l1540t1970r1643b2031],
21	and	CC	O	and	_	0	SENT_752	[p30l1658t1968r1755b2018],
22	rate	NN	O	rate	conj_and	1	SENT_752	[p30l1773t1975r1872b2018],
23	of	IN	O	of	_	0	SENT_752	[p30l1887t1967r1941b2018],
24	cognitive	JJ	O	cognitive	amod	25	SENT_752	[p30l131t2048r375b2109],
25	decline	NN	O	decline	prep_of	22	SENT_752	[p30l390t2046r581b2096],
26	in	IN	O	in	_	0	SENT_752	[p30l597t2048r640b2095],
27	Alzheimer	NN	O	alzheimer	nn	28	SENT_752	[p30l657t2046r926b2096],
28	disease	NN	O	disease	prep_in	25	SENT_752	[p30l939t2046r1146b2096],
29	:	:	O	:	_	0	SENT_752	[p30l939t2046r1146b2096],
30	implications	NNS	O	implication	dep	1	SENT_752	[p30l1162t2046r1483b2108],
31	for	IN	O	for	_	0	SENT_752	[p30l1497t2045r1570b2096],
32	clinical	JJ	O	clinical	amod	33	SENT_752	[p30l1583t2046r1760b2096],
33	trials	NNS	O	trial	prep_for	30	SENT_752	[p30l1776t2046r1914b2096],
34	.	.	O	.	_	0	SENT_752	[p30l1776t2046r1914b2096],

1	Arch	NNP	O	Arch	_	0	SENT_753	[p30l1925t2046r2055b2096],
2	.	.	O	.	_	0	SENT_753	[p30l1925t2046r2055b2096],

1	Neurol	NNP	O	Neurol	_	0	SENT_754	[p30l131t2123r312b2173],
2	.	.	O	.	_	0	SENT_754	[p30l131t2123r312b2173],

1	69	CD	NUMBER	69	_	0	SENT_755	[p30l326t2126r407b2180],
2	,	,	O	,	_	0	SENT_755	[p30l326t2126r407b2180],
3	901	CD	NUMBER	901	num	5	SENT_755	[p30l422t2126r507b2173],
4	-905	CD	NUMBER	-905	num	5	SENT_755	[p30l520t2126r645b2173],
5	(	NN	O	(	appos	1	SENT_755	[p30l664t2124r765b2180],
6	201	CD	NUMBER	201	number	7	SENT_755	[p30l664t2124r765b2180],
7	2	CD	NUMBER	2	num	8	SENT_755	[p30l780t2124r840b2180],
8	)	NN	O	)	dep	5	SENT_755	[p30l780t2124r840b2180],
9	.	.	O	.	_	0	SENT_755	[p30l780t2124r840b2180],

1	90	CD	NUMBER	90	_	0	SENT_756	[p30l7t2205r82b2252],
2	.	.	O	.	_	0	SENT_756	[p30l7t2205r82b2252],

1	Seppala	NNP	PERSON	Seppala	nn	3	SENT_757	[p30l130t2202r443b2264],
2	,	,	O	,	_	0	SENT_757	[p30l130t2202r443b2264],
3	T.T.	NNP	O	T.T.	_	0	SENT_757	[p30l130t2202r443b2264],
4	et	FW	O	et	nn	5	SENT_757	[p30l458t2209r507b2252],
5	al.	FW	O	al.	dep	3	SENT_757	[p30l516t2202r574b2252],
6	.	.	O	.	_	0	SENT_757	[p30l516t2202r574b2252],

1	CSF	NN	O	csf	nn	2	SENT_758	[p30l588t2203r684b2252],
2	biomarkers	NNS	O	biomarker	nsubj	6	SENT_758	[p30l701t2202r997b2252],
3	for	IN	O	for	_	0	SENT_758	[p30l1010t2201r1083b2252],
4	Alzheimer	NN	O	alzheimer	nn	5	SENT_758	[p30l1095t2202r1365b2252],
5	disease	NN	O	disease	prep_for	2	SENT_758	[p30l1378t2202r1572b2252],
6	correlate	VBP	O	correlate	_	0	SENT_758	[p30l1586t2202r1818b2252],
7	with	IN	O	with	_	0	SENT_758	[p30l1832t2202r1946b2252],
8	cortical	JJ	O	cortical	amod	10	SENT_758	[p30l1963t2202r2153b2252],
9	brain	NN	O	brain	nn	10	SENT_758	[p30l133t2280r264b2329],
10	biopsyﬁndings	NNS	O	biopsyﬁndings	prep_with	6	SENT_758	[p30l282t2279r696b2344],
11	.	.	O	.	_	0	SENT_758	[p30l282t2279r696b2344],

1	Neurology	NN	O	neurology	_	0	SENT_759	[p30l710t2280r978b2344],
2	78	CD	NUMBER	78	num	1	SENT_759	[p30l990t2283r1069b2337],
3	,	,	O	,	_	0	SENT_759	[p30l990t2283r1069b2337],
4	1568-1575	CD	DATE	1568-1575	number	5	SENT_759	[p30l1089t2283r1374b2329],
5	(	CD	NUMBER	(	appos	1	SENT_759	[p30l1393t2281r1568b2337],
6	2012	CD	DATE	2012	num	7	SENT_759	[p30l1393t2281r1568b2337],
7	)	NN	O	)	dep	5	SENT_759	[p30l1393t2281r1568b2337],
8	.	.	O	.	_	0	SENT_759	[p30l1393t2281r1568b2337],

1	91	CD	NUMBER	91	_	0	SENT_760	[p30l7t2361r82b2408],
2	.	.	O	.	_	0	SENT_760	[p30l7t2361r82b2408],

1	Zarow	NNP	O	Zarow	_	0	SENT_761	[p30l129t2360r306b2415],
2	,	,	O	,	_	0	SENT_761	[p30l129t2360r306b2415],
3	C.	NNP	O	C.	nn	4	SENT_761	[p30l320t2360r367b2408],
4	etal	NNP	O	etal	appos	1	SENT_761	[p30l381t2358r496b2408],
5	.	.	O	.	_	0	SENT_761	[p30l381t2358r496b2408],

1	Correlates	NNS	O	correlate	_	0	SENT_762	[p30l511t2358r777b2408],
2	of	IN	O	of	_	0	SENT_762	[p30l791t2357r846b2408],
3	hippocampal	JJ	O	hippocampal	amod	5	SENT_762	[p30l858t2358r1205b2420],
4	neuron	NN	O	neuron	nn	5	SENT_762	[p30l1224t2373r1411b2408],
5	number	NN	O	number	prep_of	1	SENT_762	[p30l1429t2358r1640b2408],
6	in	IN	O	in	_	0	SENT_762	[p30l1655t2360r1697b2407],
7	Alzheimer	NNP	O	Alzheimer	poss	9	SENT_762	[p30l1713t2358r2017b2408],
8	's	POS	O	's	_	0	SENT_762	[p30l1713t2358r2017b2408],
9	disease	NN	O	disease	prep_in	1	SENT_762	[p30l131t2435r324b2485],
10	and	CC	O	and	_	0	SENT_762	[p30l339t2435r436b2485],
11	ischemic	JJ	O	ischemic	amod	13	SENT_762	[p30l454t2435r683b2485],
12	vascular	JJ	O	vascular	amod	13	SENT_762	[p30l696t2435r913b2485],
13	dementia	NN	O	dementia	conj_and	9	SENT_762	[p30l927t2435r1192b2485],
14	.	.	O	.	_	0	SENT_762	[p30l927t2435r1192b2485],

1	Ann	NNP	PERSON	Ann	_	0	SENT_763	[p30l1203t2437r1320b2485],
2	.	.	O	.	_	0	SENT_763	[p30l1203t2437r1320b2485],

1	Neurol	NNP	O	Neurol	_	0	SENT_764	[p30l1335t2435r1516b2485],
2	.	.	O	.	_	0	SENT_764	[p30l1335t2435r1516b2485],

1	57	CD	NUMBER	57	_	0	SENT_765	[p30l1531t2439r1612b2492],
2	,	,	O	,	_	0	SENT_765	[p30l1531t2439r1612b2492],
3	896-903	CD	NUMBER	896-903	number	4	SENT_765	[p30l1626t2438r1850b2485],
4	(	CD	NUMBER	(	appos	1	SENT_765	[p30l1869t2436r2044b2492],
5	2005	CD	DATE	2005	num	6	SENT_765	[p30l1869t2436r2044b2492],
6	)	NN	O	)	dep	4	SENT_765	[p30l1869t2436r2044b2492],
7	.	.	O	.	_	0	SENT_765	[p30l1869t2436r2044b2492],

1	92	CD	NUMBER	92	_	0	SENT_766	[p30l7t2517r82b2564],
2	.	.	O	.	_	0	SENT_766	[p30l7t2517r82b2564],

1	Lam	NNP	PERSON	Lam	_	0	SENT_767	[p30l132t2516r254b2571],
2	,	,	O	,	_	0	SENT_767	[p30l132t2516r254b2571],
3	B.	NNP	O	B.	conj_and	1	SENT_767	[p30l271t2516r325b2571],
4	,	,	O	,	_	0	SENT_767	[p30l271t2516r325b2571],
5	Masellis	NNP	PERSON	Masellis	conj_and	1	SENT_767	[p30l341t2514r559b2571],
6	,	,	O	,	_	0	SENT_767	[p30l341t2514r559b2571],
7	M.	NNP	O	M.	conj_and	1	SENT_767	[p30l575t2516r648b2571],
8	,	,	O	,	_	0	SENT_767	[p30l575t2516r648b2571],
9	Freedman	NNP	PERSON	Freedman	conj_and	1	SENT_767	[p30l665t2514r943b2571],
10	,	,	O	,	_	0	SENT_767	[p30l665t2514r943b2571],
11	M.	NNP	O	M.	conj_and	1	SENT_767	[p30l958t2516r1031b2571],
12	,	,	O	,	_	0	SENT_767	[p30l958t2516r1031b2571],
13	Stuss	NNP	LOCATION	Stuss	conj_and	1	SENT_767	[p30l1046t2515r1193b2571],
14	,	,	O	,	_	0	SENT_767	[p30l1046t2515r1193b2571],
15	D.T.	NNP	ORGANIZATION	D.T.	conj_and	1	SENT_767	[p30l1211t2516r1299b2564],
16	&	CC	ORGANIZATION	&	_	0	SENT_767	[p30l1313t2515r1350b2564],
17	Black	NNP	ORGANIZATION	Black	conj_and	1	SENT_767	[p30l1366t2514r1513b2571],
18	,	,	O	,	_	0	SENT_767	[p30l1366t2514r1513b2571],
19	S.E.	NNP	O	S.E.	dep	1	SENT_767	[p30l1528t2515r1613b2564],
20	Clinical	JJ	O	clinical	dep	19	SENT_767	[p30l1628t2514r1829b2571],
21	,	,	O	,	_	0	SENT_767	[p30l1628t2514r1829b2571],
22	imaging	NN	O	imaging	appos	19	SENT_767	[p30l1845t2516r2074b2577],
23	,	,	O	,	_	0	SENT_767	[p30l1845t2516r2074b2577],

1	and	CC	O	and	dep	3	SENT_768	[p30l131t2592r228b2641],
2	pathological	JJ	O	pathological	amod	3	SENT_768	[p30l247t2592r573b2655],
3	heterogeneity	NN	O	heterogeneity	_	0	SENT_768	[p30l592t2592r967b2656],
4	of	IN	O	of	_	0	SENT_768	[p30l980t2591r1035b2641],
5	the	DT	O	the	det	6	SENT_768	[p30l1044t2592r1130b2641],
6	Alzheimer	NN	O	alzheimer	poss	9	SENT_768	[p30l1144t2592r1448b2642],
7	's	POS	O	's	_	0	SENT_768	[p30l1144t2592r1448b2642],
8	disease	NN	O	disease	nn	9	SENT_768	[p30l1463t2592r1656b2642],
9	syndrome	NN	O	syndrome	prep_of	3	SENT_768	[p30l1671t2592r1948b2656],
10	.	.	O	.	_	0	SENT_768	[p30l1671t2592r1948b2656],

1	Alzheimers	NNS	O	alzheimer	_	0	SENT_769	[p30l127t2669r409b2719],
2	Res	NNP	O	Res	dep	1	SENT_769	[p30l421t2671r514b2719],
3	.	.	O	.	_	0	SENT_769	[p30l421t2671r514b2719],

1	Ther	NNP	O	Ther	_	0	SENT_770	[p30l531t2669r653b2719],
2	.	.	O	.	_	0	SENT_770	[p30l531t2669r653b2719],

1	5	CD	NUMBER	5	_	0	SENT_771	[p30l668t2673r713b2726],
2	,	,	O	,	_	0	SENT_771	[p30l668t2673r713b2726],
3	1	CD	NUMBER	1	number	4	SENT_771	[p30l731t2673r746b2718],
4	(	CD	NUMBER	(	appos	1	SENT_771	[p30l772t2670r948b2726],
5	2013	CD	DATE	2013	num	6	SENT_771	[p30l772t2670r948b2726],
6	)	NN	O	)	dep	4	SENT_771	[p30l772t2670r948b2726],
7	.	.	O	.	_	0	SENT_771	[p30l772t2670r948b2726],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_772	[p30l20t2803r139b2824],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_772	[p30l148t2803r373b2824],
3	&	CC	O	&	_	0	SENT_772	[p30l380t2803r600b2824],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_772	[p30l380t2803r600b2824],
5	|	CD	NUMBER	|	num	6	SENT_772	[p30l380t2803r600b2824],
6	CS	NNP	O	CS	conj_and	2	SENT_772	[p30l380t2803r600b2824],
7	|	NNP	O	|	nn	8	SENT_772	[p30l610t2801r612b2831],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_772	[p30l620t2803r728b2824],
9	95	CD	NUMBER	95	num	10	SENT_772	[p30l736t2803r763b2824],
10	NUMBER	NN	O	number	dep	12	SENT_772	[p30l773t2803r881b2824],
11	1	CD	NUMBER	1	num	12	SENT_772	[p30l891t2804r898b2824],
12	|	CD	NUMBER	|	dep	15	SENT_772	[p30l912t2801r914b2831],
13	JANUARY	NNP	DATE	JANUARY	dep	12	SENT_772	[p30l923t2803r1041b2824],
14	2014	CD	DATE	2014	num	15	SENT_772	[p30l1049t2803r1107b2824],
15	77	CD	DATE	77	_	0	SENT_772	[p30l2109t2804r2139b2824],

